Citrus Sinensis ID: 012213
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| O65440 | 992 | Leucine-rich repeat recep | yes | no | 0.993 | 0.468 | 0.741 | 0.0 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.980 | 0.457 | 0.656 | 1e-176 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.963 | 0.450 | 0.639 | 1e-172 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.970 | 0.463 | 0.558 | 1e-146 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.955 | 0.393 | 0.406 | 1e-104 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.974 | 0.399 | 0.396 | 1e-101 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.963 | 0.433 | 0.425 | 1e-100 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.957 | 0.417 | 0.435 | 8e-96 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.938 | 0.440 | 0.413 | 2e-94 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.974 | 0.405 | 0.432 | 8e-93 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 691 bits (1782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/472 (74%), Positives = 403/472 (85%), Gaps = 7/472 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNNFSG P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN N SLP
Sbjct: 521 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 580
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
E+G MKSLTSADFSHNNFSG +P GQ+S+FN+TSF GNP LCG NPCN S S +
Sbjct: 581 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 640
Query: 118 IHNQNGNKS--HVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNS-NSWKLTAFQKLD 174
+ NQN +S + K+KL F LGLL LVF VLA++K R+ RKN+ N WKL FQKL
Sbjct: 641 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 700
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
F S+ ILECVK+N+VIG+GG G+VY+GV PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct: 701 FRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 760
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct: 761 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 820
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDTGASECMSAVAGSYGY 353
L YLHHDCSPLIIHRDVKSNNILL +FEAHVADFGLAK+ +QD GASECMS++AGSYGY
Sbjct: 821 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 880
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
IAPEYAYTL++DEKSDVYSFGVVLLELITGR+PV +FGEEG+DIVQW+K+QTN +++GVV
Sbjct: 881 IAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVV 940
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465
KI+DQRLSN PL+EAM++FFVAMLCVQEH VERPTMREVVQM++QA++PNTF
Sbjct: 941 KIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQPNTF 992
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1591), Expect = e-176, Method: Compositional matrix adjust.
Identities = 304/463 (65%), Positives = 372/463 (80%), Gaps = 4/463 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
S N FSG I EI C LLT++DLS+N LSG IP +IT + ILNYLN+S N L S+P
Sbjct: 510 FSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPG 569
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
+ +M+SLTS DFS+NN SG +P GQ+S+FN TSF GNP LCG YL PC H
Sbjct: 570 SISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGH- 628
Query: 121 QNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--WKLTAFQKLDFGSD 178
Q+ +K + KLL LGLL+CS+ FAV+AIIK R +K S S W+LTAFQ+LDF D
Sbjct: 629 QSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCD 688
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
D+L+ +K++N+IG+GGAG+VY+GV PNG+ VAVK+L +++GSSHD+G +AEI+TLG+IR
Sbjct: 689 DVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIR 748
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HR+IVRL FCSN ETNLLVYEYMPNGSLGEVLHGK+G L W+ R KIA+EAAKGL YL
Sbjct: 749 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYL 808
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAPEY
Sbjct: 809 HHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 868
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLEL+TGR+PVG+FG +G+DIVQW + T+S+K+ V+K+LD
Sbjct: 869 AYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFG-DGVDIVQWVRKMTDSNKDSVLKVLDP 927
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
RLS+ P+ E VF+VAMLCV+E VERPTMREVVQ+L + K
Sbjct: 928 RLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPK 970
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 603 bits (1556), Expect = e-172, Method: Compositional matrix adjust.
Identities = 298/466 (63%), Positives = 367/466 (78%), Gaps = 15/466 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
S N FSG I EI C LLT++DLS+N LSG IP ++T + ILNYLN+S N L S+P
Sbjct: 511 FSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPV 570
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
+ +M+SLTS DFS+NN SG +P GQ+S+FN TSF GN HLCG YL PC
Sbjct: 571 TIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCG--------- 621
Query: 121 QNGNKSHV---PGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--WKLTAFQKLDF 175
+ ++SHV KLL LGLL CS+VFA++AIIK R R S + W+LTAFQ+LDF
Sbjct: 622 KGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDF 681
Query: 176 GSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
DD+L+ +K++N+IG+GGAG+VY+G P G+ VAVK+L ++ GSSHD+G +AEI+TLG
Sbjct: 682 TCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLG 741
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
+IRHR+IVRL FCSN ETNLLVYEYMPNGSLGEVLHGK+G L W R KIA+EAAKGL
Sbjct: 742 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGL 801
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
YLHHDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIA
Sbjct: 802 CYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 861
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415
PEYAYTLKVDEKSDVYSFGVVLLELITG++PVG+FG +G+DIVQW + T+S+K+ V+K+
Sbjct: 862 PEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFG-DGVDIVQWVRSMTDSNKDCVLKV 920
Query: 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
+D RLS+ P+ E VF+VA+LCV+E VERPTMREVVQ+L + K
Sbjct: 921 IDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPK 966
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 261/467 (55%), Positives = 332/467 (71%), Gaps = 13/467 (2%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S NN +G IP I C L +DLS+N ++G IP I + L LN+S NQL S+P
Sbjct: 512 SANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTG 571
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
+GNM SLT+ D S N+ SG +P GQ+ FN TSF GN +LC + C T P
Sbjct: 572 IGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSC---PTRPGQTS 628
Query: 122 NGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
+ N + + +++ + + L+ +AI + K +KN S WKLTAFQKLDF S+D
Sbjct: 629 DHNHTALFSPSRIVITVIAAITGLILISVAIRQMNK-KKNQKSLAWKLTAFQKLDFKSED 687
Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
+LEC+K+ N+IG+GGAG+VYRG PN VA+K+L+G G S D+G +AEI+TLG+IRH
Sbjct: 688 VLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRS-DHGFTAEIQTLGRIRH 746
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
R+IVRL + +NK+TNLL+YEYMPNGSLGE+LHG +G L+WE R ++A+EAAKGL YLH
Sbjct: 747 RHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKGLCYLH 806
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
HDCSPLI+HRDVKSNNILL+SDFEAHVADFGLAK+L D ASECMS++AGSYGYIAPEYA
Sbjct: 807 HDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAPEYA 866
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK-----MQTNSSKEGVVK 414
YTLKVDEKSDVYSFGVVLLELI G++PVG+FG EG+DIV+W + + S VV
Sbjct: 867 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG-EGVDIVRWVRNTEEEITQPSDAAIVVA 925
Query: 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
I+D RL+ PL+ + VF +AM+CV+E RPTMREVV ML K
Sbjct: 926 IVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPK 972
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 206/507 (40%), Positives = 299/507 (58%), Gaps = 60/507 (11%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY-LNVSWNQLNASLP 59
+S+N+F+G IP +GHC L LDLS N++SG IP ++ I L+ LN+SWN L+ +P
Sbjct: 570 LSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIP 629
Query: 60 KE-----------------------MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF 96
+ + +++L S + SHN FSG +P+ +
Sbjct: 630 ERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEM 689
Query: 97 TGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSL----VFAVLAI 152
GN LC C S+++ + Q G SH +L A+GLL+ V VLA+
Sbjct: 690 EGNNGLCSKGFRSCFVSNSSQLTTQRGVHSH-----RLRIAIGLLISVTAVLAVLGVLAV 744
Query: 153 IKTRKFRKNSN---------SWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVT 203
I+ ++ ++ N +W+ T FQKL+F + +L+C+ + NVIG+G +G+VY+
Sbjct: 745 IRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEM 804
Query: 204 PNGEQVAVKKLLGIT--------KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255
PN E +AVKKL +T K S + SAE++TLG IRH+NIVR C NK T
Sbjct: 805 PNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTR 864
Query: 256 LLVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
LL+Y+YM NGSLG +LH + G L WE+R KI + AA+GL+YLHHDC P I+HRD+K+N
Sbjct: 865 LLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKAN 924
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFG 374
NIL+ DFE ++ DFGLAK + D + + +AGSYGYIAPEY Y++K+ EKSDVYS+G
Sbjct: 925 NILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYG 984
Query: 375 VVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEA---MQV 431
VV+LE++TG++P+ +GL IV W K K ++++DQ L P SE MQ
Sbjct: 985 VVVLEVLTGKQPIDPTIPDGLHIVDWVK------KIRDIQVIDQGLQARPESEVEEMMQT 1038
Query: 432 FFVAMLCVQEHGVERPTMREVVQMLAQ 458
VA+LC+ +RPTM++V ML++
Sbjct: 1039 LGVALLCINPIPEDRPTMKDVAAMLSE 1065
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-101, Method: Compositional matrix adjust.
Identities = 200/505 (39%), Positives = 288/505 (57%), Gaps = 49/505 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY-LNVSWNQLNASLP 59
+S+N FSG IP +G C L LDL N LSG IP ++ I L LN+S N+L +P
Sbjct: 569 LSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIP 628
Query: 60 KE-----------------------MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF 96
+ + N+++L S + S+N+FSG +P+ + +
Sbjct: 629 SKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDL 688
Query: 97 TGNPHLCGSYLNPC--NYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIK 154
GN LC S + C Y + + + L + L + ++ +A+I+
Sbjct: 689 EGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIR 748
Query: 155 TRKFRKNSNS--------WKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNG 206
R+ N W+ T FQKL+F D I+ C+ + NVIG+G +GVVYR NG
Sbjct: 749 ARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNG 808
Query: 207 EQVAVKKLLGITKGSSHD-------NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
E +AVKKL HD + SAE++TLG IRH+NIVR C N+ T LL+Y
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
+YMPNGSLG +LH +RGS L W++R +I + AA+GL+YLHHDC P I+HRD+K+NNIL+
Sbjct: 869 DYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIG 928
Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 379
DFE ++ADFGLAK + + C + VAGSYGYIAPEY Y++K+ EKSDVYS+GVV+LE
Sbjct: 929 LDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLE 988
Query: 380 LITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEA---MQVFFVAM 436
++TG++P+ EG+ +V W + G +++LD L + +EA MQV A+
Sbjct: 989 VLTGKQPIDPTVPEGIHLVDWVRQN-----RGSLEVLDSTLRSRTEAEADEMMQVLGTAL 1043
Query: 437 LCVQEHGVERPTMREVVQMLAQAQK 461
LCV ERPTM++V ML + ++
Sbjct: 1044 LCVNSSPDERPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-100, Method: Compositional matrix adjust.
Identities = 207/486 (42%), Positives = 304/486 (62%), Gaps = 35/486 (7%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N+ +G IP +IGHC L L+LSQNHL+G IP +I+ + + +++S N L ++P + G
Sbjct: 522 NSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFG 581
Query: 64 NMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYL-NPCNY------SSTT 116
+ K++T+ + S+N G IP G ++ N + F+ N LCG + PCN ++
Sbjct: 582 SSKTITTFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADI 640
Query: 117 PIHNQNGNKSHVPGK--YKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--------WK 166
H++ G + L A+G+ LV A K+ R + WK
Sbjct: 641 DGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWK 700
Query: 167 LTAFQKLDFGSDDILECV-KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS--- 222
LTAFQ+L+F +DD++EC+ K +N++G G G VY+ PNGE +AVKKL G K +
Sbjct: 701 LTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIR 760
Query: 223 -HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL-- 279
+G+ AE+ LG +RHRNIVRL C+N++ +L+YEYMPNGSL ++LHG +
Sbjct: 761 RRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAA 820
Query: 280 -KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
+W +IAI A+G+ YLHHDC P+I+HRD+K +NILL++DFEA VADFG+AK +Q
Sbjct: 821 AEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQ-- 878
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV-GDFGEEGLDI 397
E MS VAGSYGYIAPEYAYTL+VD+KSD+YS+GV+LLE+ITG+R V +FG EG I
Sbjct: 879 -TDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFG-EGNSI 936
Query: 398 VQWTKMQTNSSKEGVVKILDQRL--SNTPLSEAM-QVFFVAMLCVQEHGVERPTMREVVQ 454
V W + + +KE V ++LD+ + S + + E M Q+ +A+LC +RP MR+V+
Sbjct: 937 VDWVRSKL-KTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLL 995
Query: 455 MLAQAQ 460
+L +A+
Sbjct: 996 ILQEAK 1001
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 8e-96, Method: Compositional matrix adjust.
Identities = 212/487 (43%), Positives = 288/487 (59%), Gaps = 39/487 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTY-LDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
+S N+ SG IP E+G LT LDLS N +G IP + + L L++S N L+ +
Sbjct: 579 LSYNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDI- 637
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIH 119
K +G++ SL S + S NNFSG IP + ++TS+ N +LC S L+ SS T
Sbjct: 638 KVLGSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCHS-LDGITCSSHT--G 694
Query: 120 NQNGNKSHVPGKYKLLFALGLLLCSLVFAVLA----IIKTRKFRKN-------------- 161
NG KS K++ ++L S+ A+LA I++ K
Sbjct: 695 QNNGVKSP-----KIVALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDF 749
Query: 162 SNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT--- 218
S W FQKL ++I+ + D NVIG+G +G+VY+ PNG+ VAVKKL
Sbjct: 750 SYPWTFIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNN 809
Query: 219 -KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS 277
+G S + +AEI+ LG IRHRNIV+L +CSNK LL+Y Y PNG+L ++L G R
Sbjct: 810 EEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNRN- 868
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
L WE R KIAI AA+GL+YLHHDC P I+HRDVK NNILL+S +EA +ADFGLAK + +
Sbjct: 869 -LDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMN 927
Query: 338 T-GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD 396
+ MS VAGSYGYIAPEY YT+ + EKSDVYS+GVVLLE+++GR V +GL
Sbjct: 928 SPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLH 987
Query: 397 IVQWTKMQTNSSKEGVVKILDQRLSNTP---LSEAMQVFFVAMLCVQEHGVERPTMREVV 453
IV+W K + + E + +LD +L P + E +Q +AM CV VERPTM+EVV
Sbjct: 988 IVEWVKKKMGTF-EPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEVV 1046
Query: 454 QMLAQAQ 460
+L + +
Sbjct: 1047 TLLMEVK 1053
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 197/476 (41%), Positives = 284/476 (59%), Gaps = 37/476 (7%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N FSG + I L L+L+ N +G IP +I + +LNYL++S N + +P +
Sbjct: 502 NQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQ 561
Query: 64 NMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNG 123
++K L + S+N SG++P + + SF GNP LCG C
Sbjct: 562 SLK-LNQLNLSYNRLSGDLPPSLAKDMYKN-SFIGNPGLCGDIKGLCGSE---------- 609
Query: 124 NKSHVPGKYKLLFALGLLLCSLVFAVLA--IIKTRKFRK----NSNSWKLTAFQKLDFGS 177
N++ G LL ++ +L ++ A +A K R F+K + W L +F KL F
Sbjct: 610 NEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSE 669
Query: 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT-------------KGSSHD 224
+ILE + ++NVIG G +G VY+ V NGE VAVK+L + K D
Sbjct: 670 HEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQD 729
Query: 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
AE+ TLGKIRH+NIV+L CS ++ LLVYEYMPNGSLG++LH +G L W+ R
Sbjct: 730 EAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTR 789
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-ASEC 343
KI ++AA+GLSYLHHD P I+HRD+KSNNIL++ D+ A VADFG+AK + TG A +
Sbjct: 790 FKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKS 849
Query: 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVG-DFGEEGLDIVQWTK 402
MS +AGS GYIAPEYAYTL+V+EKSD+YSFGVV+LE++T +RPV + GE+ D+V+W
Sbjct: 850 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK--DLVKW-- 905
Query: 403 MQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
+ + ++G+ ++D +L + E ++ V +LC + RP+MR VV+ML +
Sbjct: 906 VCSTLDQKGIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQE 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 8e-93, Method: Compositional matrix adjust.
Identities = 210/486 (43%), Positives = 290/486 (59%), Gaps = 30/486 (6%)
Query: 1 MSRNNFSGIIPVEIGH-CLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
M N FSG IP ++G L ++LS N SG IP +I +H+L YL+++ N L+ +P
Sbjct: 620 MGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIP 679
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS-STTPI 118
N+ SL +FS+NN +G++P + TSF GN LCG +L C+ S S+ P
Sbjct: 680 TTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPH 739
Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSW---KLTAFQKLD- 174
+ S G+ ++ + + SL+ + + R + + + K FQ+ D
Sbjct: 740 ISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDI 799
Query: 175 -------FGSDDILECVK---DNNVIGRGGAGVVYRGVTPNGEQVAVKKL-----LGITK 219
F DILE K D+ ++GRG G VY+ V P+G+ +AVKKL
Sbjct: 800 YFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNN 859
Query: 220 GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYEYMPNGSLGEVLHGKRGS 277
++ DN AEI TLGKIRHRNIVRL +FC ++ +NLL+YEYM GSLGE+LHG +
Sbjct: 860 SNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSH 919
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
+ W R IA+ AA+GL+YLHHDC P IIHRD+KSNNIL++ +FEAHV DFGLAK + D
Sbjct: 920 SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI-D 978
Query: 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI 397
S+ +SAVAGSYGYIAPEYAYT+KV EK D+YSFGVVLLEL+TG+ PV E+G D+
Sbjct: 979 MPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL-EQGGDL 1037
Query: 398 VQWTKMQTNSSKEGVVKILDQRLS----NTPLSEAMQVFFVAMLCVQEHGVERPTMREVV 453
WT+ +ILD L+ + L+ + V +A+LC + +RPTMREVV
Sbjct: 1038 ATWTRNHIRDHSL-TSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVV 1096
Query: 454 QMLAQA 459
ML ++
Sbjct: 1097 LMLIES 1102
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| 224053641 | 913 | predicted protein [Populus trichocarpa] | 1.0 | 0.512 | 0.857 | 0.0 | |
| 224075393 | 988 | predicted protein [Populus trichocarpa] | 1.0 | 0.473 | 0.853 | 0.0 | |
| 225424960 | 988 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.473 | 0.834 | 0.0 | |
| 255583922 | 991 | Receptor protein kinase CLAVATA1 precurs | 1.0 | 0.472 | 0.838 | 0.0 | |
| 356524179 | 994 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.470 | 0.802 | 0.0 | |
| 356499319 | 988 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.473 | 0.789 | 0.0 | |
| 356553634 | 986 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.474 | 0.787 | 0.0 | |
| 357494021 | 967 | Receptor-like protein kinase [Medicago t | 0.997 | 0.482 | 0.746 | 0.0 | |
| 224589616 | 963 | leucine-rich repeat receptor-like protei | 0.993 | 0.482 | 0.743 | 0.0 | |
| 15235366 | 992 | leucine-rich receptor-like protein kinas | 0.993 | 0.468 | 0.741 | 0.0 |
| >gi|224053641|ref|XP_002297907.1| predicted protein [Populus trichocarpa] gi|222845165|gb|EEE82712.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/470 (85%), Positives = 435/470 (92%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNN SG IP EIG C LTYLDLSQN LSGPIPVQITQIHILNYLN+SWN LN SLPK
Sbjct: 444 MSRNNLSGNIPPEIGDCRTLTYLDLSQNQLSGPIPVQITQIHILNYLNISWNHLNQSLPK 503
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI-- 118
E+G+MKSLTSADFSHNNFSG IPEFGQYSFFNSTSF+GNP LCGSYLNPCNYSST+P+
Sbjct: 504 EIGSMKSLTSADFSHNNFSGSIPEFGQYSFFNSTSFSGNPQLCGSYLNPCNYSSTSPLQF 563
Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
H+QN + S VPGK+KLLFALGLL CSLVFAVLAIIKTRK R+NSNSWKLTAFQKL+FG +
Sbjct: 564 HDQNSSTSQVPGKFKLLFALGLLGCSLVFAVLAIIKTRKIRRNSNSWKLTAFQKLEFGCE 623
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
+ILECVK+NN+IGRGGAG+VYRG+ PNGE VAVKKLLGI++GSSHDNGLSAE++TLG+IR
Sbjct: 624 NILECVKENNIIGRGGAGIVYRGLMPNGEPVAVKKLLGISRGSSHDNGLSAEVQTLGQIR 683
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HRNIVRL AFCSNKETNLLVYEYMPNGSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 684 HRNIVRLLAFCSNKETNLLVYEYMPNGSLGEVLHGKRGGFLKWDTRLKIAIEAAKGLCYL 743
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLIIHRDVKSNNILL+SDFEAHVADFGLAK+LQDTGASECMSA+AGSYGYIAPEY
Sbjct: 744 HHDCSPLIIHRDVKSNNILLSSDFEAHVADFGLAKFLQDTGASECMSAIAGSYGYIAPEY 803
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK QT SSKE VVKILDQ
Sbjct: 804 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKTQTKSSKERVVKILDQ 863
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
L++ PL EAMQVFFVAMLCVQE VERPTMREVVQMLA+A++PNT+ Q
Sbjct: 864 GLTDIPLIEAMQVFFVAMLCVQEQSVERPTMREVVQMLAEAKQPNTYHKQ 913
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075393|ref|XP_002304615.1| predicted protein [Populus trichocarpa] gi|222842047|gb|EEE79594.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2166), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/470 (85%), Positives = 431/470 (91%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNN SG IP EIG C LTYLDLSQN LSGPIPV ITQIHILNYLN+SWN LN SLPK
Sbjct: 519 MSRNNLSGNIPSEIGDCPTLTYLDLSQNQLSGPIPVHITQIHILNYLNISWNHLNQSLPK 578
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI-- 118
E+G+MKSLTSADFSHNNFSG IPEFGQYSFFNSTSF GNP LCGSYLNPCNYSS +P+
Sbjct: 579 EIGSMKSLTSADFSHNNFSGSIPEFGQYSFFNSTSFIGNPQLCGSYLNPCNYSSMSPLQL 638
Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
H+QN ++S V GK+KLLFALGLL+CSLVFA LAIIKTRK R+NSNSWKLTAFQKL FGS+
Sbjct: 639 HDQNSSRSQVHGKFKLLFALGLLVCSLVFAALAIIKTRKIRRNSNSWKLTAFQKLGFGSE 698
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DILEC+K+NN+IGRGGAG VYRG+ GE VAVKKLLGI+KGSSHDNGLSAE++TLG+IR
Sbjct: 699 DILECIKENNIIGRGGAGTVYRGLMATGEPVAVKKLLGISKGSSHDNGLSAEVQTLGQIR 758
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HRNIVRL AFCSNKE+NLLVYEYMPNGSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 759 HRNIVRLLAFCSNKESNLLVYEYMPNGSLGEVLHGKRGGFLKWDTRLKIAIEAAKGLCYL 818
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK+L+DTG SECMSA+AGSYGYIAPEY
Sbjct: 819 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKFLRDTGNSECMSAIAGSYGYIAPEY 878
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK QT SSKEGVVKILDQ
Sbjct: 879 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKTQTKSSKEGVVKILDQ 938
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
RL++ PL EAMQVFFVAMLCVQE VERPTMREVVQMLAQA++PNTF M+
Sbjct: 939 RLTDIPLIEAMQVFFVAMLCVQEQSVERPTMREVVQMLAQAKQPNTFHME 988
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225424960|ref|XP_002264952.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/470 (83%), Positives = 426/470 (90%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
M RNNFSGIIP EIGHCL LTYLDLSQN +SGPIPVQI QIHILNYLN+SWN +N +LPK
Sbjct: 519 MRRNNFSGIIPPEIGHCLSLTYLDLSQNQISGPIPVQIAQIHILNYLNLSWNHMNQNLPK 578
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIH- 119
E+G MKSLTS DFSHNNFSG IP+ GQYSFFNS+SF GNP LCGSYLN CNYSS +P+
Sbjct: 579 EIGFMKSLTSVDFSHNNFSGWIPQIGQYSFFNSSSFVGNPQLCGSYLNQCNYSSASPLES 638
Query: 120 -NQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
NQ+ SHVPGK+KL+ AL LL+CSL+FAVLAI+KTRK RK SNSWKLTAFQKL+FGS+
Sbjct: 639 KNQHDTSSHVPGKFKLVLALSLLICSLIFAVLAIVKTRKVRKTSNSWKLTAFQKLEFGSE 698
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DILEC+KDNNVIGRGGAG+VYRG PNGEQVAVKKL GI+KGSSHDNGLSAEI+TLG+IR
Sbjct: 699 DILECLKDNNVIGRGGAGIVYRGTMPNGEQVAVKKLQGISKGSSHDNGLSAEIQTLGRIR 758
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HRNIVRL AFCSNKETNLLVYEYMPNGSLGEVLHGKRG LKW+ RLKIAIEAAKGL YL
Sbjct: 759 HRNIVRLLAFCSNKETNLLVYEYMPNGSLGEVLHGKRGGHLKWDTRLKIAIEAAKGLCYL 818
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLI+HRDVKSNNILLNSD+EAHVADFGLAK+LQD G SECMSA+AGSYGYIAPEY
Sbjct: 819 HHDCSPLILHRDVKSNNILLNSDYEAHVADFGLAKFLQDNGTSECMSAIAGSYGYIAPEY 878
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLELITGRRPVG FGEEGLDIVQW+K+QTN SKEGVVKILD+
Sbjct: 879 AYTLKVDEKSDVYSFGVVLLELITGRRPVGGFGEEGLDIVQWSKIQTNWSKEGVVKILDE 938
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
RL N P EA+Q FFVAMLCVQEH VERPTMREV+QMLAQA++PNTF MQ
Sbjct: 939 RLRNVPEDEAIQTFFVAMLCVQEHSVERPTMREVIQMLAQAKQPNTFHMQ 988
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583922|ref|XP_002532709.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223527555|gb|EEF29676.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/470 (83%), Positives = 428/470 (91%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNNFS IP EIG+C +LT+LDLSQN LSGPIPVQI+QIHILNY N+SWN LN SLPK
Sbjct: 522 MSRNNFSSNIPSEIGNCPMLTFLDLSQNQLSGPIPVQISQIHILNYFNISWNHLNQSLPK 581
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI-- 118
E+G+MKSLTSADFSHNNFSG IPEFGQY+FFNS+SF GNP LCG LN CN SS + +
Sbjct: 582 EIGSMKSLTSADFSHNNFSGSIPEFGQYTFFNSSSFAGNPLLCGYDLNQCNNSSFSSLQF 641
Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
H++N +KS VPGK+KLL ALGLLLCSLVFAVLAIIKTRK RKNS SWKLTAFQKL+FG
Sbjct: 642 HDENNSKSQVPGKFKLLVALGLLLCSLVFAVLAIIKTRKRRKNSRSWKLTAFQKLEFGCG 701
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DILECVK+NN+IGRGGAG+VY+G+ PNGEQVAVKKLLGI+KGSSHDNGLSAEI+TLG+IR
Sbjct: 702 DILECVKENNIIGRGGAGIVYKGIMPNGEQVAVKKLLGISKGSSHDNGLSAEIQTLGRIR 761
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HRNIVRL FCSNKE NLLVYEYMP+GSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 762 HRNIVRLLGFCSNKEMNLLVYEYMPHGSLGEVLHGKRGGFLKWDTRLKIAIEAAKGLCYL 821
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLIIHRDVKSNNILLNS+FEAHVADFGLAK+LQDTG SECMSA+AGSYGYIAPEY
Sbjct: 822 HHDCSPLIIHRDVKSNNILLNSEFEAHVADFGLAKFLQDTGTSECMSAIAGSYGYIAPEY 881
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLELITGRRPVG F EEGLDIVQWTK+QTNSSKE V+KILDQ
Sbjct: 882 AYTLKVDEKSDVYSFGVVLLELITGRRPVGAFEEEGLDIVQWTKIQTNSSKEKVIKILDQ 941
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
RLS+ PL+EA QVFFVAMLCVQEH VERPTMREVVQMLAQA+ PNTF MQ
Sbjct: 942 RLSDIPLNEATQVFFVAMLCVQEHSVERPTMREVVQMLAQAKLPNTFHMQ 991
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524179|ref|XP_003530709.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/470 (80%), Positives = 417/470 (88%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S NNFSG IP EIG+C+LLTYLDLSQN LSGPIPVQ +QIHILNYLNVSWN LN SLPK
Sbjct: 525 ISANNFSGTIPPEIGNCVLLTYLDLSQNQLSGPIPVQFSQIHILNYLNVSWNHLNQSLPK 584
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
E+ MK LTSADFSHNNFSG IPE GQ+S FNSTSF GNP LCG PCN SST + +
Sbjct: 585 ELRAMKGLTSADFSHNNFSGSIPEGGQFSIFNSTSFVGNPQLCGYDSKPCNLSSTAVLES 644
Query: 121 QNGN--KSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
Q + K VPGK+K LFAL LL CSLVFA LAIIK+RK R++SNSWKLTAFQKL++GS+
Sbjct: 645 QTKSSAKPGVPGKFKFLFALALLGCSLVFATLAIIKSRKTRRHSNSWKLTAFQKLEYGSE 704
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DI C+K++NVIGRGG+GVVYRG P GE+VAVKKLLG KGSSHDNGLSAEI+TLG+IR
Sbjct: 705 DIKGCIKESNVIGRGGSGVVYRGTMPKGEEVAVKKLLGNNKGSSHDNGLSAEIKTLGRIR 764
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HR IV+L AFCSN+ETNLLVY+YMPNGSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 765 HRYIVKLLAFCSNRETNLLVYDYMPNGSLGEVLHGKRGEFLKWDTRLKIAIEAAKGLCYL 824
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK++QD GASECMS++AGSYGYIAPEY
Sbjct: 825 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKFMQDNGASECMSSIAGSYGYIAPEY 884
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK+QTN +KE V+KILD+
Sbjct: 885 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKLQTNWNKEMVMKILDE 944
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
RL + PL+EAMQVFFVAMLCV EH VERPTMREVV+MLAQA++PNTFQMQ
Sbjct: 945 RLDHIPLAEAMQVFFVAMLCVHEHSVERPTMREVVEMLAQAKQPNTFQMQ 994
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499319|ref|XP_003518489.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/470 (78%), Positives = 413/470 (87%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MS NNFSG IP EIG+CLLLTYLDLSQN L+GPIPVQ++QIHI+NYLNVSWN L+ SLP+
Sbjct: 519 MSVNNFSGSIPPEIGNCLLLTYLDLSQNQLAGPIPVQLSQIHIMNYLNVSWNHLSQSLPE 578
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
E+G MK LTSADFSHN+FSG IPE GQ+S FNSTSF GNP LCG LNPC +SS + +
Sbjct: 579 ELGAMKGLTSADFSHNDFSGSIPEEGQFSVFNSTSFVGNPQLCGYELNPCKHSSNAVLES 638
Query: 121 QNGNKSH--VPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
Q+ + VPGKYKLLFA+ LL CSL FA LA IK+RK R++SNSWKLT FQ L+FGS+
Sbjct: 639 QDSGSARPGVPGKYKLLFAVALLACSLAFATLAFIKSRKQRRHSNSWKLTTFQNLEFGSE 698
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DI+ C+K++NVIGRGGAGVVY G PNGEQVAVKKLLGI KG SHDNGLSAEIRTLG+IR
Sbjct: 699 DIIGCIKESNVIGRGGAGVVYHGTMPNGEQVAVKKLLGINKGCSHDNGLSAEIRTLGRIR 758
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HR IVRL AFCSN+ETNLLVYEYMPNGSLGE+LHGKRG FLKW+ RLKIA EAAKGL YL
Sbjct: 759 HRYIVRLLAFCSNRETNLLVYEYMPNGSLGEILHGKRGEFLKWDTRLKIATEAAKGLCYL 818
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLIIHRDVKSNNILLNS+FEAHVADFGLAK+LQDTG SECMS++AGSYGYIAPEY
Sbjct: 819 HHDCSPLIIHRDVKSNNILLNSEFEAHVADFGLAKFLQDTGTSECMSSIAGSYGYIAPEY 878
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLEL+TGRRPVG+FGEEGLDIVQWTK+QTN S + VVKILD+
Sbjct: 879 AYTLKVDEKSDVYSFGVVLLELLTGRRPVGNFGEEGLDIVQWTKLQTNWSNDKVVKILDE 938
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
RL + PL EA QV+FVAMLCVQE VERPTMREVV+MLAQA+KPNTFQ Q
Sbjct: 939 RLCHIPLDEAKQVYFVAMLCVQEQSVERPTMREVVEMLAQAKKPNTFQKQ 988
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553634|ref|XP_003545159.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/470 (78%), Positives = 412/470 (87%), Gaps = 2/470 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MS NNFSG IP EIG+CLLLTYLDLSQN LSGPIPVQ++QIHI+NYLNVSWN L+ SLPK
Sbjct: 517 MSVNNFSGSIPPEIGNCLLLTYLDLSQNQLSGPIPVQLSQIHIMNYLNVSWNHLSQSLPK 576
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
E+G MK LTSADFSHN+FSG IPE GQ+S NSTSF GNP LCG LNPC +SS + +
Sbjct: 577 ELGAMKGLTSADFSHNDFSGSIPEEGQFSVLNSTSFVGNPQLCGYDLNPCKHSSNAVLES 636
Query: 121 QNGNKSH--VPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
Q+ + VPGKYKLLFA+ LL CSL FA LA IK+RK R++SNSWKLT FQ L+FGS+
Sbjct: 637 QDSGSARPGVPGKYKLLFAVALLACSLAFATLAFIKSRKQRRHSNSWKLTTFQNLEFGSE 696
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DI+ C+K++N IGRGGAGVVY G PNGEQVAVKKLLGI KG SHDNGLSAEIRTLG+IR
Sbjct: 697 DIIGCIKESNAIGRGGAGVVYHGTMPNGEQVAVKKLLGINKGCSHDNGLSAEIRTLGRIR 756
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
HR IVRL AFCSN+ETNLLVYEYMPNGSLGEVLHGKRG FLKW+ RLKIA EAAKGL YL
Sbjct: 757 HRYIVRLLAFCSNRETNLLVYEYMPNGSLGEVLHGKRGEFLKWDTRLKIATEAAKGLCYL 816
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
HHDCSPLIIHRDVKSNNILLNS+FEAHVADFGLAK+LQDTG SECMS++AGSYGYIAPEY
Sbjct: 817 HHDCSPLIIHRDVKSNNILLNSEFEAHVADFGLAKFLQDTGTSECMSSIAGSYGYIAPEY 876
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
AYTLKVDEKSDVYSFGVVLLEL+TGRRPVG+FGEEGLDIVQWTK+QTN SK+ VVKILD+
Sbjct: 877 AYTLKVDEKSDVYSFGVVLLELLTGRRPVGNFGEEGLDIVQWTKLQTNWSKDKVVKILDE 936
Query: 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQMQ 468
RL + P+ EA Q++FVAMLCVQE VERPTMREVV+MLAQA++PNTFQ Q
Sbjct: 937 RLCHIPVDEAKQIYFVAMLCVQEQSVERPTMREVVEMLAQAKQPNTFQKQ 986
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494021|ref|XP_003617299.1| Receptor-like protein kinase [Medicago truncatula] gi|355518634|gb|AET00258.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/473 (74%), Positives = 410/473 (86%), Gaps = 6/473 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MS NNFSG IP+EIG C LT+LDLSQN LSGPIP+Q++QIHILNYLNVSWN LN +LPK
Sbjct: 495 MSFNNFSGTIPIEIGKCSSLTFLDLSQNKLSGPIPIQVSQIHILNYLNVSWNYLNQTLPK 554
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
E+G++K LTSADFSHN+FSG +PE GQ+S FNSTSF GNP LCG LNPCN SS+ + +
Sbjct: 555 ELGSIKGLTSADFSHNDFSGSVPEIGQFSVFNSTSFVGNPKLCGYDLNPCNKSSSETLES 614
Query: 121 QN--GNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRK-FRKNSNSWKLTAFQKLDFGS 177
Q G K +P KYKLLFAL LL+CSLVFA AI+K RK +++SN WKLTAFQK+++GS
Sbjct: 615 QKNGGEKPGIPAKYKLLFALALLVCSLVFATFAIMKGRKGIKRDSNPWKLTAFQKIEYGS 674
Query: 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
+DIL CVK++N+IGRGGAGVVY G PNGE+VAVKKLLGI KG S+DNGLSAEI+TLG+I
Sbjct: 675 EDILGCVKESNIIGRGGAGVVYGGTMPNGEKVAVKKLLGINKGCSYDNGLSAEIKTLGRI 734
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
RHR IV+L AFCSN++TNLLVYEYM NGSLGEVLHGKRG FL+W++R+KIA EAAKGL Y
Sbjct: 735 RHRYIVKLLAFCSNRDTNLLVYEYMTNGSLGEVLHGKRGGFLEWDVRVKIATEAAKGLCY 794
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDTGA-SECMSAVAGSYGYIA 355
LHHDC PLI+HRDVKSNNILLNS+FEAHVADFGLAK+ LQDTG SECMS++ GSYGYIA
Sbjct: 795 LHHDCCPLIVHRDVKSNNILLNSEFEAHVADFGLAKFLLQDTGGTSECMSSIVGSYGYIA 854
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415
PEYAYTLKVDEKSDVYSFGVVLLEL+TGRRPVGDFGEEG+DIVQWTK++T+ +KE VVKI
Sbjct: 855 PEYAYTLKVDEKSDVYSFGVVLLELLTGRRPVGDFGEEGMDIVQWTKLKTDWNKESVVKI 914
Query: 416 LDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQM 467
LD RL +N PL EAMQ+FFVAM CV+E VERPTMREVV+ML Q ++PN FQ+
Sbjct: 915 LDGRLHNNIPLDEAMQLFFVAMCCVEEQSVERPTMREVVEMLGQVKQPNIFQV 967
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224589616|gb|ACN59341.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/472 (74%), Positives = 404/472 (85%), Gaps = 7/472 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNNFSG P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN N SLP
Sbjct: 492 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 551
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
E+G MKSLTSADFSHNNFSG +P GQ+S+FN+TSF GNP LCG NPCN S S +
Sbjct: 552 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 611
Query: 118 IHNQNGNKS--HVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNS-NSWKLTAFQKLD 174
+ NQN +S + K+KL F LGLL LVF VLA++K R+ RKN+ N WKL FQKL
Sbjct: 612 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 671
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
F S+ ILECVK+N+VIG+GGAG+VY+GV PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct: 672 FRSEHILECVKENHVIGKGGAGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 731
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct: 732 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 791
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDTGASECMSAVAGSYGY 353
L YLHHDCSPLIIHRDVKSNNILL +FEAHVADFGLAK+ +QD GASECMS++AGSYGY
Sbjct: 792 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 851
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
IAPEYAYTL++DEKSDVYSFGVVLLELITGR+PV +FGEEG+DIVQW+K+QTN +++GVV
Sbjct: 852 IAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVV 911
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465
KI+DQRLSN PL+EAM++FFVAMLCVQEH VERPTMREVVQM++QA++PNTF
Sbjct: 912 KIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQPNTF 963
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15235366|ref|NP_193760.1| leucine-rich receptor-like protein kinase BAM3 [Arabidopsis thaliana] gi|325511402|sp|O65440.3|BAME3_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3; AltName: Full=Protein BARELY ANY MERISTEM 3; Flags: Precursor gi|2982444|emb|CAA18252.1| CLV1 receptor kinase like protein [Arabidopsis thaliana] gi|7268822|emb|CAB79027.1| CLV1 receptor kinase like protein [Arabidopsis thaliana] gi|332658897|gb|AEE84297.1| leucine-rich receptor-like protein kinase BAM3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/472 (74%), Positives = 403/472 (85%), Gaps = 7/472 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNNFSG P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN N SLP
Sbjct: 521 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 580
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
E+G MKSLTSADFSHNNFSG +P GQ+S+FN+TSF GNP LCG NPCN S S +
Sbjct: 581 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 640
Query: 118 IHNQNGNKS--HVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNS-NSWKLTAFQKLD 174
+ NQN +S + K+KL F LGLL LVF VLA++K R+ RKN+ N WKL FQKL
Sbjct: 641 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 700
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
F S+ ILECVK+N+VIG+GG G+VY+GV PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct: 701 FRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 760
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct: 761 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 820
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDTGASECMSAVAGSYGY 353
L YLHHDCSPLIIHRDVKSNNILL +FEAHVADFGLAK+ +QD GASECMS++AGSYGY
Sbjct: 821 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 880
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
IAPEYAYTL++DEKSDVYSFGVVLLELITGR+PV +FGEEG+DIVQW+K+QTN +++GVV
Sbjct: 881 IAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVV 940
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465
KI+DQRLSN PL+EAM++FFVAMLCVQEH VERPTMREVVQM++QA++PNTF
Sbjct: 941 KIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQPNTF 992
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.993 | 0.468 | 0.694 | 8.6e-175 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.978 | 0.456 | 0.610 | 5.5e-148 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.967 | 0.452 | 0.597 | 4.2e-143 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.970 | 0.463 | 0.533 | 3.5e-123 | |
| UNIPROTKB|Q5Z9N5 | 994 | P0481E08.42 "Os06g0717200 prot | 0.976 | 0.459 | 0.514 | 1.1e-117 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.623 | 0.280 | 0.490 | 1.4e-95 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.602 | 0.250 | 0.498 | 6.6e-85 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.630 | 0.258 | 0.467 | 7.4e-85 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.626 | 0.258 | 0.456 | 5.1e-84 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.647 | 0.303 | 0.475 | 1.5e-82 |
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1698 (602.8 bits), Expect = 8.6e-175, P = 8.6e-175
Identities = 328/472 (69%), Positives = 378/472 (80%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MSRNNFSG P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN N SLP
Sbjct: 521 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 580
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
E+G MKSLTSADFSHNNFSG +P GQ+S+FN+TSF GNP LCG NPCN S S +
Sbjct: 581 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 640
Query: 118 IHNQNGNKSH--VPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNS-NSWKLTAFQKLD 174
+ NQN +S + K+K ++K R+ RKN+ N WKL FQKL
Sbjct: 641 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 700
Query: 175 FGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
F S+ ILECVK+N+ PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct: 701 FRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 760
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct: 761 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 820
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL-QDTGASECMSAVAGSYGY 353
L YLHHDCSPLIIHRDVKSNNILL +FEAHVADFGLAK++ QD GASECMS++AGSYGY
Sbjct: 821 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 880
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
IAPEYAYTL++DEKSDVYSFGVVLLELITGR+PV +FGEEG+DIVQW+K+QTN +++GVV
Sbjct: 881 IAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVV 940
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465
KI+DQRLSN PL+EAM++FFVAMLCVQEH VERPTMREVVQM++QA++PNTF
Sbjct: 941 KIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQPNTF 992
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1445 (513.7 bits), Expect = 5.5e-148, P = 5.5e-148
Identities = 282/462 (61%), Positives = 343/462 (74%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S N FSG I EI C LLT++DLS+N LSG IP +IT + ILNYLN+S N L S+P
Sbjct: 511 SHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGS 570
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
+ +M+SLTS DFS+NN SG +P GQ+S+FN TSF GNP LCG YL PC H Q
Sbjct: 571 ISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGH-Q 629
Query: 122 NGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
+ +K + K IIK R +K S S W+LTAFQ+LDF DD
Sbjct: 630 SHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDD 689
Query: 180 ILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
+L+ +K++N PNG+ VAVK+L +++GSSHD+G +AEI+TLG+IRH
Sbjct: 690 VLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRH 749
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
R+IVRL FCSN ETNLLVYEYMPNGSLGEVLHGK+G L W+ R KIA+EAAKGL YLH
Sbjct: 750 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLH 809
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
HDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAPEYA
Sbjct: 810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 869
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419
YTLKVDEKSDVYSFGVVLLEL+TGR+PVG+FG+ G+DIVQW + T+S+K+ V+K+LD R
Sbjct: 870 YTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGD-GVDIVQWVRKMTDSNKDSVLKVLDPR 928
Query: 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
LS+ P+ E VF+VAMLCV+E VERPTMREVVQ+L + K
Sbjct: 929 LSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPK 970
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1399 (497.5 bits), Expect = 4.2e-143, P = 4.2e-143
Identities = 276/462 (59%), Positives = 339/462 (73%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S N FSG I EI C LLT++DLS+N LSG IP ++T + ILNYLN+S N L S+P
Sbjct: 512 SHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVT 571
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
+ +M+SLTS DFS+NN SG +P GQ+S+FN TSF GN HLCG YL PC + +Q
Sbjct: 572 IASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGT-----HQ 626
Query: 122 NGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
+ K + K IIK R R S + W+LTAFQ+LDF DD
Sbjct: 627 SHVKP-LSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDD 685
Query: 180 ILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
+L+ +K++N P G+ VAVK+L ++ GSSHD+G +AEI+TLG+IRH
Sbjct: 686 VLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRH 745
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
R+IVRL FCSN ETNLLVYEYMPNGSLGEVLHGK+G L W R KIA+EAAKGL YLH
Sbjct: 746 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLH 805
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
HDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAPEYA
Sbjct: 806 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 865
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419
YTLKVDEKSDVYSFGVVLLELITG++PVG+FG+ G+DIVQW + T+S+K+ V+K++D R
Sbjct: 866 YTLKVDEKSDVYSFGVVLLELITGKKPVGEFGD-GVDIVQWVRSMTDSNKDCVLKVIDLR 924
Query: 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
LS+ P+ E VF+VA+LCV+E VERPTMREVVQ+L + K
Sbjct: 925 LSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPK 966
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
Identities = 249/467 (53%), Positives = 312/467 (66%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S NN +G IP I C L +DLS+N ++G IP I + L LN+S NQL S+P
Sbjct: 512 SANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTG 571
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
+GNM SLT+ D S N+ SG +P GQ+ FN TSF GN +LC + C T P
Sbjct: 572 IGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSC---PTRPGQTS 628
Query: 122 NGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
+ N + + + I + K +KN S WKLTAFQKLDF S+D
Sbjct: 629 DHNHTALFSPSRIVITVIAAITGLILISVAIRQMNK-KKNQKSLAWKLTAFQKLDFKSED 687
Query: 180 ILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
+LEC+K+ N PN VA+K+L+G G S D+G +AEI+TLG+IRH
Sbjct: 688 VLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRS-DHGFTAEIQTLGRIRH 746
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
R+IVRL + +NK+TNLL+YEYMPNGSLGE+LHG +G L+WE R ++A+EAAKGL YLH
Sbjct: 747 RHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKGLCYLH 806
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
HDCSPLI+HRDVKSNNILL+SDFEAHVADFGLAK+L D ASECMS++AGSYGYIAPEYA
Sbjct: 807 HDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAPEYA 866
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQW---TKMQTNSSKEG--VVK 414
YTLKVDEKSDVYSFGVVLLELI G++PVG+FGE G+DIV+W T+ + + VV
Sbjct: 867 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGE-GVDIVRWVRNTEEEITQPSDAAIVVA 925
Query: 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
I+D RL+ PL+ + VF +AM+CV+E RPTMREVV ML K
Sbjct: 926 IVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPK 972
|
|
| UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 247/480 (51%), Positives = 311/480 (64%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N +G IP E+ C L +DLS+N SG IP IT + IL LNVS N+L LP
Sbjct: 515 VSGNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKILCTLNVSRNRLTGELPP 574
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYL-NPCNYSSTTPIH 119
EM NM SLT+ D S+N+ SG +P GQ+ FN +SF GNP LCG + + C S
Sbjct: 575 EMSNMTSLTTLDVSYNSLSGPVPMQGQFLVFNESSFVGNPGLCGGPVADACPPSMAG--- 631
Query: 120 NQNGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRK--------FRKNSNSWKLTAFQ 171
G S + ++ + RK R+ S +WK+TAFQ
Sbjct: 632 GGGGAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGCSAWRSAARRRSGAWKMTAFQ 691
Query: 172 KLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEI 231
KL+F ++D++ECVK++N T G ++A+K+L+G G HD G SAE+
Sbjct: 692 KLEFSAEDVVECVKEDNIIGKGGAGIVYHGVT-RGAELAIKRLVG-RGGGEHDRGFSAEV 749
Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
TLG+IRHRNIVRL F SN+ETNLL+YEYMPNGSLGE+LHG +G L WE R ++A EA
Sbjct: 750 TTLGRIRHRNIVRLLGFVSNRETNLLLYEYMPNGSLGEMLHGGKGGHLGWEARARVAAEA 809
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
A GL YLHHDC+P IIHRDVKSNNILL+S FEAHVADFGLAK+L SECMSA+AGSY
Sbjct: 810 ACGLCYLHHDCAPRIIHRDVKSNNILLDSAFEAHVADFGLAKFLGGA-TSECMSAIAGSY 868
Query: 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT-----N 406
GYIAPEYAYTL+VDEKSDVYSFGVVLLELITGRRPVG FG+ G+DIV W + T N
Sbjct: 869 GYIAPEYAYTLRVDEKSDVYSFGVVLLELITGRRPVGGFGD-GVDIVHWVRKVTAELPDN 927
Query: 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ--AQKPNT 464
S V+ + D+RL+ P++ + ++ VAM CV+E RPTMREVV ML+ + +PN+
Sbjct: 928 SDTAAVLAVADRRLTPEPVALMVNLYKVAMACVEEASTARPTMREVVHMLSNPNSAQPNS 987
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 1.4e-95, Sum P(2) = 1.4e-95
Identities = 152/310 (49%), Positives = 210/310 (67%)
Query: 165 WKLTAFQKLDFGSDDILECV-KDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSS- 222
WKLTAFQ+L+F +DD++EC+ K +N PNGE +AVKKL G K +
Sbjct: 699 WKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGK 758
Query: 223 ---HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL 279
+G+ AE+ LG +RHRNIVRL C+N++ +L+YEYMPNGSL ++LHG +
Sbjct: 759 IRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMT 818
Query: 280 ---KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
+W +IAI A+G+ YLHHDC P+I+HRD+K +NILL++DFEA VADFG+AK +Q
Sbjct: 819 AAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQ 878
Query: 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVG-DFGEEGL 395
E MS VAGSYGYIAPEYAYTL+VD+KSD+YS+GV+LLE+ITG+R V +FGE G
Sbjct: 879 ---TDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGE-GN 934
Query: 396 DIVQWTKMQTNSSKEGVVKILDQRL--SNTPLSEAM-QVFFVAMLCVQEHGVERPTMREV 452
IV W + + + KE V ++LD+ + S + + E M Q+ +A+LC +RP MR+V
Sbjct: 935 SIVDWVRSKLKT-KEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDV 993
Query: 453 VQMLAQAQKP 462
+ +L +A KP
Sbjct: 994 LLILQEA-KP 1002
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 674 (242.3 bits), Expect = 6.6e-85, Sum P(2) = 6.6e-85
Identities = 149/299 (49%), Positives = 192/299 (64%)
Query: 175 FGSDDILECVK---DNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSH-----DNG 226
F DILE K D+ P+G+ +AVKKL +G+++ DN
Sbjct: 807 FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNS 866
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
AEI TLGKIRHRNIVRL +FC ++ +NLL+YEYM GSLGE+LHG + + W R
Sbjct: 867 FRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTR 926
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
IA+ AA+GL+YLHHDC P IIHRD+KSNNIL++ +FEAHV DFGLAK + D S+ +
Sbjct: 927 FAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI-DMPLSKSV 985
Query: 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404
SAVAGSYGYIAPEYAYT+KV EK D+YSFGVVLLEL+TG+ PV E+G D+ WT+
Sbjct: 986 SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL-EQGGDLATWTRNH 1044
Query: 405 TNSSKEGVVKILDQRLSNTP----LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459
+ILD L+ L+ + V +A+LC + +RPTMREVV ML ++
Sbjct: 1045 IRDHSL-TSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIES 1102
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 7.4e-85, Sum P(2) = 7.4e-85
Identities = 142/304 (46%), Positives = 193/304 (63%)
Query: 165 WKLTAFQKLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHD 224
W+ T FQKL+F D I+ C+ + N NGE +AVKKL HD
Sbjct: 767 WQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHD 826
Query: 225 -------NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS 277
+ SAE++TLG IRH+NIVR C N+ T LL+Y+YMPNGSLG +LH +RGS
Sbjct: 827 EKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGS 886
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
L W++R +I + AA+GL+YLHHDC P I+HRD+K+NNIL+ DFE ++ADFGLAK + +
Sbjct: 887 SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDE 946
Query: 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI 397
C + VAGSYGYIAPEY Y++K+ EKSDVYS+GVV+LE++TG++P+ EG+ +
Sbjct: 947 GDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHL 1006
Query: 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457
V W + Q S E + L R + E MQV A+LCV ERPTM++V ML
Sbjct: 1007 VDWVR-QNRGSLEVLDSTLRSR-TEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
Query: 458 QAQK 461
+ ++
Sbjct: 1065 EIKQ 1068
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 5.1e-84, Sum P(2) = 5.1e-84
Identities = 142/311 (45%), Positives = 197/311 (63%)
Query: 160 KNSNSWKLTAFQKLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGIT- 218
+N +W+ T FQKL+F + +L+C+ + N PN E +AVKKL +T
Sbjct: 761 ENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTV 820
Query: 219 -------KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271
K S + SAE++TLG IRH+NIVR C NK T LL+Y+YM NGSLG +L
Sbjct: 821 PNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLL 880
Query: 272 HGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330
H + G L WE+R KI + AA+GL+YLHHDC P I+HRD+K+NNIL+ DFE ++ DFG
Sbjct: 881 HERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFG 940
Query: 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390
LAK + D + + +AGSYGYIAPEY Y++K+ EKSDVYS+GVV+LE++TG++P+
Sbjct: 941 LAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPT 1000
Query: 391 GEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEA---MQVFFVAMLCVQEHGVERP 447
+GL IV W K K ++++DQ L P SE MQ VA+LC+ +RP
Sbjct: 1001 IPDGLHIVDWVK------KIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRP 1054
Query: 448 TMREVVQMLAQ 458
TM++V ML++
Sbjct: 1055 TMKDVAAMLSE 1065
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 1.5e-82, Sum P(2) = 1.5e-82
Identities = 154/324 (47%), Positives = 204/324 (62%)
Query: 152 IIKTRKFR--KNSN--SWKLTAFQKLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGE 207
I K RK R K+S + K +F KL F +I +C+ + N GE
Sbjct: 647 IAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGE 706
Query: 208 QVAVKKLLGITKGS----SHDN----GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
VAVKKL KG S D+ +AE+ TLG IRH++IVRL CS+ + LLVY
Sbjct: 707 VVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVY 766
Query: 260 EYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
EYMPNGSL +VLHG R G L W RL+IA++AA+GLSYLHHDC P I+HRDVKS+NIL
Sbjct: 767 EYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNIL 826
Query: 318 LNSDFEAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 375
L+SD+ A VADFG+AK Q +G+ E MS +AGS GYIAPEY YTL+V+EKSD+YSFGV
Sbjct: 827 LDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGV 886
Query: 376 VLLELITGRRPV-GDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFV 434
VLLEL+TG++P + G++ D+ +W + T K G+ ++D +L E +V +
Sbjct: 887 VLLELVTGKQPTDSELGDK--DMAKW--VCTALDKCGLEPVIDPKLDLKFKEEISKVIHI 942
Query: 435 AMLCVQEHGVERPTMREVVQMLAQ 458
+LC + RP+MR+VV ML +
Sbjct: 943 GLLCTSPLPLNRPSMRKVVIMLQE 966
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O65440 | BAME3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7415 | 0.9935 | 0.4687 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 468 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 1e-60
Identities = 155/490 (31%), Positives = 239/490 (48%), Gaps = 65/490 (13%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N SG IP E+ C L LDLS N LSG IP +++ +L+ L++S NQL+ +PK
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCG----SYLNPCNYSSTT 116
+GN++SL + SHN+ G +P G + N+++ GN LCG S L PC T
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT 625
Query: 117 PIHNQNGNKSHVPGKYKLLFALG-LLLCSLVFAVLAIIKTR------KFRKNSNSWKLTA 169
P + + LG L+ +LV I+ R + +W+L
Sbjct: 626 PSW-----------WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF 674
Query: 170 FQK---LDFGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDN 225
F +DIL +K+ NVI RG G Y+G + NG Q VK++ + ++
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------NDVNS 728
Query: 226 GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL 285
S+EI +GK++H NIV+L C +++ L++EY+ +L EVL L WE R
Sbjct: 729 IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRR 783
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
KIAI AK L +LH CSP ++ ++ I+++ E H+ L L C
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-------CTD 835
Query: 346 AVAG-SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV-GDFGEEGLDIVQWTK- 402
S Y+APE T + EKSD+Y FG++L+EL+TG+ P +FG G IV+W +
Sbjct: 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARY 894
Query: 403 --------MQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
M + S G V + +Q E ++V +A+ C RP +V++
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSV-NQN-------EIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 455 MLAQAQKPNT 464
L A + ++
Sbjct: 947 TLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 9e-47
Identities = 76/269 (28%), Positives = 115/269 (42%), Gaps = 23/269 (8%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G G G VY G+ VA+K + K + EI+ L K++H NIVRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+++ LV EY G L ++L KRG + E R + L YLH I
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEAR-FYLRQILSALEYLHSKG---I 118
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HRD+K NILL+ D +ADFGLA+ L ++ G+ Y+APE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGK 175
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426
D++S GV+L EL+TG+ P F + + + K+ +S
Sbjct: 176 AVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGK--------PKPPFPPPEWDIS 224
Query: 427 EAMQVFFVAMLCVQEHGVERPTMREVVQM 455
+ +L +R T E +Q
Sbjct: 225 PEAKDLIRKLLVKDPE--KRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 79/283 (27%), Positives = 120/283 (42%), Gaps = 35/283 (12%)
Query: 184 VKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
+ +G G G VY+G +VAVK L + E R + K+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLD 59
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
H NIV+L C+ +E ++V EYMP G L + L R L L A++ A+G+ YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG---ASECMSAVAGSYGYIA 355
IHRD+ + N L+ + ++DFGL++ L D + ++A
Sbjct: 120 ESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMA 172
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414
PE K KSDV+SFGV+L E+ T G P G+ + V++
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAE------------VLE 215
Query: 415 ILDQRLSNTPLSEAMQVFFVAML-CVQEHGVERPTMREVVQML 456
L + + ML C E +RPT E+V++L
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-46
Identities = 90/273 (32%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G G VY+ G+ VAVK L ++ S D EIR L ++ H NIVRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+K+ LV EY G L + L + G + E + KIA++ +GL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAK-KIALQILRGLEYLHSNG---II 120
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-YAYTLKVDE 366
HRD+K NILL+ + +ADFGLAK L +S ++ G+ Y+APE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN---- 422
K DV+S GV+L EL+TG+ P F E + + +IL L
Sbjct: 179 KVDVWSLGVILYELLTGKPP---FSGENILDQLQL----------IRRILGPPLEFDEPK 225
Query: 423 -TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ SE + L +RPT E++Q
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPS--KRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-46
Identities = 72/194 (37%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
+G GG G VY G++VA+K + S + L EI L K+ H NIV+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
++ LV EY GSL ++L + L + L+I ++ +GL YLH S IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 309 RDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-YAYTLKVDE 366
RD+K NILL+SD + +ADFGL+K L + + G+ Y+APE E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 367 KSDVYSFGVVLLEL 380
KSD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 189 VIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHRN 241
+G G G VY+G +VAVK L +G+S + E + K+ H N
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKLSHPN 62
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
IVRL C+ E +V EYMP G L + L L + L++A++ AKG+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK 121
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG----ASECMSAVAGSYGYIAP 356
+ +HRD+ + N L+ + ++DFGL++ + + + ++AP
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAP 173
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415
E K KSDV+SFGV+L E+ T G +P G ++++ ++G
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEEVLELL-------EDG---- 220
Query: 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
RL P + +++ + + C +RPT E+V+ L
Sbjct: 221 --YRLP-RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 9e-45
Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 184 VKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
+ +G G G VY+G +VAVK L E R + K+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
H N+V+L C+ +E +V EYM G L L K L L A++ A+G+ YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYL 118
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG---ASECMSAVAGSYGYIA 355
IHRD+ + N L+ + ++DFGL++ L D + ++A
Sbjct: 119 ESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMA 171
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414
PE K KSDV+SFGV+L E+ T G +P G+ + V++
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE------------VLE 214
Query: 415 ILDQRLSNTPLSEAMQVFFVAML-CVQEHGVERPTMREVVQML 456
L + ML C E +RPT E+V++L
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 10/209 (4%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
++GRG G VY + GE +AVK + L EIR L ++H NIVR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 247 AFCSNKETN-LLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCS 303
++E N L ++ EY+ GSL +L K G + +R K + +GL+YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIR-KYTRQILEGLAYLHSNG-- 121
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
I+HRD+K NIL++SD +ADFG AK L D E +V G+ ++APE +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDFGE 392
+D++S G ++E+ TG+ P + G
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 5e-41
Identities = 83/288 (28%), Positives = 122/288 (42%), Gaps = 44/288 (15%)
Query: 188 NVIGRGGAGVVYRGV----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+G G G VY+G +VAVK L + E R + K+ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-------LKWEMRLKIAIEAAKGLS 296
RL C+ +E LV EYM G L + L R F L + L AI+ AKG+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG----ASECMSAVAGSYG 352
YL S +HRD+ + N L+ D ++DFGL++ + D + +
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172
Query: 353 YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411
++APE KSDV+SFGV+L E+ T G P S E
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----------------SNEE 215
Query: 412 VVKIL--DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457
V++ L RL P +++ + + C Q +RPT E+V+ L
Sbjct: 216 VLEYLRKGYRLPK-PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 75/214 (35%), Positives = 115/214 (53%), Gaps = 25/214 (11%)
Query: 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
LE VK V+G+G +GVVY+ P G+ A+KK+ + L E++TL
Sbjct: 3 LERVK---VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCES 58
Query: 240 RNIVRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+V+ AF E ++ V EYM GSL ++L K+ + + IA + KGL YL
Sbjct: 59 PYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE- 357
H IIHRD+K +N+L+NS E +ADFG++K L++T +C + V G+ Y++PE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV-GTVTYMSPER 171
Query: 358 -----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y+Y +D++S G+ LLE G+ P
Sbjct: 172 IQGESYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 73/206 (35%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG+GG G VY+ G++VA+K + +K EI+ L K +H NIV K
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII--NEIQILKKCKHPNIV--KY 62
Query: 248 FCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ S K+ L +V E+ GSL ++L + + E KGL YLH S
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL-TESQIAYVCKELLKGLEYLH---SNG 118
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
IIHRD+K+ NILL SD E + DFGL+ L DT A M G+ ++APE D
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGKPYD 175
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFG 391
K+D++S G+ +EL G+ P +
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
++IGRG GVVY+G+ G+ VA+K++ + EI L ++H NIV+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPL 305
++ ++ EY NGSL +++ K G F E + + + + +GL+YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK-KFGPFP--ESLVAVYVYQVLQGLAYLHEQG--- 119
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
+IHRD+K+ NIL D +ADFG+A L D + ++V G+ ++APE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGAS 177
Query: 366 EKSDVYSFGVVLLELITGRRPVGD 389
SD++S G ++EL+TG P D
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 4e-31
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA--EIRTLGKIRHRNIVR 244
IG+G G VY +G+ +K++ S A E++ L K+ H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLH--GKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
K +V EY G L + + K G E L ++ L YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE----Y 358
S I+HRD+K NI L S+ + DFG++K L T + V G+ Y++PE
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDLAKTVVGTPYYLSPELCQNK 178
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y + KSD++S G VL EL T + P
Sbjct: 179 PY----NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 2e-30
Identities = 74/213 (34%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLL-GITKGSSHDNGLSAEIRTLGKIRH-RNIVRLK 246
+G G G VY + + VA+K L + S EI+ L + H NIV+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F ++ + LV EY+ GSL ++L R L L I + L YLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 306 IIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGAS----ECMSAVAGSYGYIAPEYAY 360
IIHRD+K NILL+ D + DFGLAK L D G++ S G+ GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 361 TL---KVDEKSDVYSFGVVLLELITGRRPVGDF 390
L SD++S G+ L EL+TG P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 69/198 (34%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G G V+ G +VAVK L G+ E + + K+RH +V+L A C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
S +E +V EYM GSL + L G L+ + +A + A+G++YL S IHR
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+ + NIL+ + +ADFGLA+ ++D + A + APE A + KSD
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA-KFPIKWTAPEAANYGRFTIKSD 186
Query: 370 VYSFGVVLLELIT-GRRP 386
V+SFG++L E++T GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G G V+ G+ N VAVK L G+ AE + + K+RH +++L A C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ +E +V E M GSL E L G G LK + +A + A G++YL + IHR
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---YGYIAPEYAYTLKVDE 366
D+ + N+L+ + VADFGLA+ +++ + A G+ + APE A +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKE----DIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 367 KSDVYSFGVVLLELIT-GRRP 386
KSDV+SFG++L E++T GR P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 83/284 (29%), Positives = 129/284 (45%), Gaps = 36/284 (12%)
Query: 183 CVKDNNVIGRGGAGVVYRG-VTPNGEQ---VAVKKLLGITKGSSHDN---GLSAEIRTLG 235
V VIG G G V RG + G++ VA+K L K S D E +G
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL----KAGSSDKQRLDFLTEASIMG 60
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
+ H NI+RL+ + +++ EYM NGSL + L G F + + A G+
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGM 119
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
YL +HRD+ + NIL+NS+ V+DFGL++ L+D+ A+ + A
Sbjct: 120 KYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414
PE K SDV+SFG+V+ E+++ G RP D + V+K
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD----------MSNQD-------VIK 219
Query: 415 ILDQ--RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
++ RL P+ ++ + + C Q+ ERPT ++V L
Sbjct: 220 AVEDGYRLP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 8e-29
Identities = 85/278 (30%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
+G G +GVV + + P G+ +AVK + + + + E+ L K IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCSP 304
AF +N + ++ + EYM GSL ++L +G E L KIA+ KGL+YLH
Sbjct: 66 GAFYNNGDISICM-EYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLHEKHK- 121
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
IIHRDVK +NIL+NS + + DFG++ L ++ A G+ Y+APE
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDY 176
Query: 365 DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ------ 418
KSD++S G+ L+EL TGR P N +G+ ++L
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYP---------------PENDPPDGIFELLQYIVNEPP 221
Query: 419 -RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
RL + S Q F LC+ + ERP+ +E+++
Sbjct: 222 PRLPSGKFSPDFQDF--VNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 8/201 (3%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVR-L 245
N IG+G GVV++ V ++V K + ++K + + E R L K+ I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
++F + N+++ EY NG L ++L +RG L + + I+ GL++LH S
Sbjct: 66 ESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I+HRD+KS N+ L++ + D G+AK L D + + + G+ Y++PE +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYN 179
Query: 366 EKSDVYSFGVVLLELITGRRP 386
EKSDV++ GVVL E TG+ P
Sbjct: 180 EKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 72/271 (26%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G GVV+ G VA+K I +G+ ++ E + + K+ H N+V+L C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKM---IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ + +V EYM NG L L ++G E L + + + + YL + IHR
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKL-GTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYAYTLKVDEK 367
D+ + N L+ D V+DFGLA+Y+ D + S+ + + PE + K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD---DQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 368 SDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426
SDV+SFGV++ E+ + G+ P F +NS E V + P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERF--------------SNS--EVVESVSAGYRLYRPKL 225
Query: 427 EAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457
+V+ + C E +RP ++++ L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
VIG G VVY + PN E+VA+K++ + K + + L E++ + + H N+V K
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVV--K 63
Query: 247 AFCSNKETNLL--VYEYMPNGSLGEVL-HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ S + L V Y+ GSL +++ L + + E KGL YLH S
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS--AVAGSYGYIAPEYAYT 361
IHRD+K+ NILL D +ADFG++ L D G G+ ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 362 LK-VDEKSDVYSFGVVLLELITGRRP 386
+ D K+D++SFG+ +EL TG P
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
DILE +G G G VY+ + G+ VA+K + + + + EI L +
Sbjct: 6 DILEK------LGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQE--IIKEISILKQC 55
Query: 238 RHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
IV+ K T+L +V EY GS+ +++ + + E+ I + KGL
Sbjct: 56 DSPYIVKYYG-SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-ILYQTLKGLE 113
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
YLH S IHRD+K+ NILLN + +A +ADFG++ L DT A + V G+ ++AP
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAP 168
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390
E + + K+D++S G+ +E+ G+ P D
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G G V+ G+ N +VA+K L D E++ L ++RH++++ L A C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVC 71
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
S E ++ E M GSL L G L + +A + A+G++YL IHR
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+ + NIL+ D VADFGLA+ +++ + Y + APE A KSD
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSD 186
Query: 370 VYSFGVVLLELIT 382
V+SFG++L E+ T
Sbjct: 187 VWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
K+ IG G +G VY+ G++VA+KK + + + EI + +H NIV
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKK---MRLRKQNKELIINEILIMKDCKHPNIV 78
Query: 244 R-LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
++ E +V EYM GSL +++ + + E +GL YLH
Sbjct: 79 DYYDSYLVGDEL-WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--- 133
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S +IHRD+KS+NILL+ D +ADFG A L T ++V G+ ++APE
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 363 KVDEKSDVYSFGVVLLELITGRRP 386
K D++S G++ +E+ G P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 81/281 (28%), Positives = 133/281 (47%), Gaps = 29/281 (10%)
Query: 183 CVKDNNVIGRGGAGVVYRGV--TPNGEQVAVK-KLLGITKGSSHDNGLSAEIRTLGKIRH 239
+ VIG G G V+RG+ P ++VAV K L +E +G+ H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
NI+RL+ + + +++ EYM NG+L + L G F +++ + + A G+ YL
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLS 124
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD-TGASECMSAVAGSYGYIAPEY 358
D + +HRD+ + NIL+NS+ E V+DFGL++ L+D + S + APE
Sbjct: 125 -DMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
K SDV+SFG+V+ E+++ G RP D S V+K ++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-----------------SNHEVMKAIN 224
Query: 418 Q--RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
RL P+ V+ + + C Q+ RP ++V +L
Sbjct: 225 DGFRLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 71/207 (34%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 188 NVIGRGGAGVVYRG-VTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G G V P GEQVAVK L + H + EI L + H NI
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 243 VRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
V+ K C L+ EY+P+GSL + L R + L + + KG+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-LLFSSQICKGMDYLG- 126
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAPEYA 359
S IHRD+ + NIL+ S+ ++DFGLAK L +D + APE
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRP 386
T K SDV+SFGV L EL T P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 74/217 (34%), Positives = 117/217 (53%), Gaps = 26/217 (11%)
Query: 189 VIGRGGAGVVYRGVT-PNGEQVAVKKL-LGITKGSSHDN-------GLSAEIRTLGKIRH 239
+IG+G G VY + GE +AVK++ L T HD+ L +EI TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 240 RNIVRLKAFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
NIV+ F E L ++ EY+P GS+G L G F + ++ + +GL+YL
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLR-TYGRF-EEQLVRFFTEQVLEGLAYL 124
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE- 357
H S I+HRD+K++N+L+++D ++DFG++K D ++ ++ GS ++APE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 358 -----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
Y+ KV D++S G V+LE+ GRRP D
Sbjct: 182 IHSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 72/212 (33%), Positives = 111/212 (52%), Gaps = 10/212 (4%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G+G G V+ G +VA+K L G+ E + + K+RH +V+L A
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
S +E +V EYM GSL + L G+ G +L+ + +A + A G++Y+ +HR
Sbjct: 71 S-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+++ NIL+ + VADFGLA+ ++D + A + APE A + KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 185
Query: 370 VYSFGVVLLELIT-GRRPV-GDFGEEGLDIVQ 399
V+SFG++L EL T GR P G E LD V+
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 76/272 (27%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G GVV+ G +VA+K I +G+ + E + + K+ H +V+L C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ ++ +V E+M NG L L ++G K +M L + + +G+ YL + IHR
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYAYTLKVDEK 367
D+ + N L++S V+DFG+ +Y+ D E S+ + + PE K K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD---DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 368 SDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ--RLSNTP 424
SDV+SFGV++ E+ T G+ P S VV+++ + RL
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPF-----------------EKKSNYEVVEMISRGFRLYRPK 224
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
L+ +M V+ V C E RPT E+++ +
Sbjct: 225 LA-SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG+G G V G G++VAVK L S+ AE + +RH N+V+L
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+V EYM GSL + L + + + +L A++ +G+ YL +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYAYTLKVDEK 367
D+ + N+L++ D A V+DFGLAK +G + APE K K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 368 SDVYSFGVVLLELIT-GRRP 386
SDV+SFG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 33/284 (11%)
Query: 183 CVKDNNVIGRGGAGVVYRG-VTPNGEQ---VAVKKL-LGITKGSSHDNGLSAEIRTLGKI 237
CVK VIG G G V RG + G++ VA+K L G T+ D +E +G+
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEASIMGQF 62
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
H NI+ L+ + +++ E+M NG+L L G F ++ + + A G+ Y
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGIAAGMKY 121
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---YGYI 354
L + + +HRD+ + NIL+NS+ V+DFGL+++L+D + ++ G +
Sbjct: 122 LS-EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
APE K SDV+S+G+V+ E+++ G RP D S + V+
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----------------SNQDVI 221
Query: 414 KILDQRLSNTPLSEAMQVFFVAML-CVQEHGVERPTMREVVQML 456
++Q P + ML C Q+ RP ++V L
Sbjct: 222 NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
IG G G VY+ GE VA+KK+ + + G EI+ L K+RH NIVR
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 245 LKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSF----LKWEMRLKIAIEAAKGLSYL 298
LK ++K +V+EYM + L +L F +K M+ + +GL YL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYL 116
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
H + I+HRD+K +NIL+N+D +ADFGLA+ +++ + V + Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW-YRPPEL 172
Query: 359 -----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y +V D++S G +L EL G+
Sbjct: 173 LLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 54/283 (19%)
Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS---HDNGLSAEIRTLGKIRHRNIVRL 245
+G G G VY G+ +G+ AVK++ G + L EI L K++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 246 KAFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
+E NL ++ E +P GSL ++L K GSF + +RL + GL YLH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTR-QILLGLEYLH---DR 121
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY-----A 359
+HRD+K NIL++++ +ADFG+AK + + + GS ++APE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGG 178
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419
Y L D++S G +LE+ TG+ P EGV + +
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPPWSQL-------------------EGVAAVF--K 213
Query: 420 LSNTP--------LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ + LS+ + F + C+Q RPT E+++
Sbjct: 214 IGRSKELPPIPDHLSDEAKDFI--LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G G GVVY+ GE VA+KK+ + + + G+ + EI L +++H NIV+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLSYLHHDC 302
L + LV+EY L + L + G L I + +GL+Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCH--- 115
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE----- 357
S I+HRD+K NIL+N D +ADFGLA+ + + Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGR 384
Y+ V D++S G + E+ITG+
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG G G+V++ GE VA+KK+ N EI+ L +H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+ +LV EYMP L EVL + + +++ KG++Y+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH---ANGIMH 122
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY-TLKVDEK 367
RD+K N+L+++D +ADFGLA+ L S + Y APE Y K D
Sbjct: 123 RDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 368 SDVYSFGVVLLELITGR 384
D+++ G + EL+ G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 71/206 (34%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 190 IGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDNGL----SAEIRTLGKIRHRNIV 243
+G+G G V R G+ A+K L K E L +I H IV
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKVL---KKKKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 244 RLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
+L AF + E L LV EY P G L L K G F + R A E L YLH
Sbjct: 57 KLHYAFQT--EEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAA-EIVLALEYLHSL 112
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
II+RD+K NILL++D + DFGLAK L G+ + G+ Y+APE
Sbjct: 113 G----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLL 166
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRP 386
+ D +S GV+L E++TG+ P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 80/275 (29%), Positives = 115/275 (41%), Gaps = 26/275 (9%)
Query: 190 IGRGGAGVVYRG--VTPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G G GVV RG T G+ VAVK L D+ L E + + H N++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK-EAAIMHSLDHENLIRL 61
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
++V E P GSL + L A++ A G+ YL S
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA-VAGSYGYIAPEYAYTLKV 364
IHRD+ + NILL SD + + DFGL + L M + + + APE T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 365 DEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423
SDV+ FGV L E+ T G P G G I++ KEG +RL
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPW--AGLSGSQILK------KIDKEG------ERLER- 222
Query: 424 PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
P + ++ V + C + +RPT + + L +
Sbjct: 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
V+G G G VY+GV P GE+ VA+K L T + + E + + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG-----SFLKWEMRLKIAIEAAKGLSYL 298
RL C + L+ + MP G L + + + L W ++ AKG+SYL
Sbjct: 73 RLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 299 --HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYI 354
++HRD+ + N+L+ + + DFGLAK L D E A G ++
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDEKE-YHAEGGKVPIKWM 178
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
A E KSDV+S+GV + EL+T G +P
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLL----GITKGSSHDNGLSAEIRTLGKIRHRNIV 243
V+G+G G VY G+T G+ +AVK++ + L E+ L ++H NIV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ C + T + E++P GS+ +L+ + G + K + G++YLH++C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLHNNC- 122
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA----SECMSAVAGSYGYIAPEYA 359
++HRD+K NN++L + + DFG A+ L G S + ++ G+ ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419
KSD++S G + E+ TG+ P+ + + M + G++ L
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLA-------SMDRLAAMFYIGAHRGLMPRLPDS 233
Query: 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
S + FV C+ ERP+ ++++
Sbjct: 234 FSAAAID------FVTS-CLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-23
Identities = 78/265 (29%), Positives = 128/265 (48%), Gaps = 35/265 (13%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G G V+ G +VA+K L +GS AE + +++H +VRL A
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ +E ++ EYM NGSL + L G L + +A + A+G++++ IHR
Sbjct: 71 T-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---YGYIAPEYAYTLKVDE 366
D+++ NIL++ +ADFGLA+ ++D +A G+ + APE
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 367 KSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425
KSDV+SFG++L E++T GR P + M TN V++ L+ R P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP-------------YPGM-TNPE---VIQNLE-RGYRMPR 224
Query: 426 SEA--MQVFFVAMLCVQEHGVERPT 448
+ +++ + LC +E ERPT
Sbjct: 225 PDNCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG G G+V+ G +VA+K I +G+ + E + + K+ H +V+L C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ + LV+E+M +G L + L +RG F + E L + ++ +G++YL +IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQ-ETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYAYTLKVDEK 367
D+ + N L+ + V+DFG+ +++ D + S+ + + +PE K K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD---DQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 368 SDVYSFGVVLLELIT-GRRP 386
SDV+SFGV++ E+ + G+ P
Sbjct: 182 SDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 67/223 (30%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 189 VIGRGGAGVVYRGVTPNGEQ------VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G G V+ G + E VAVK L + + E L +H NI
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENI 70
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKW----------EMRLKIAIE 290
V+ C+ + ++V+EYM +G L + L HG +FLK L+IA++
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGASECMSAVA 348
A G+ YL S +HRD+ + N L+ D + DFG+++ Y D V
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD------YYRVG 181
Query: 349 GS----YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
G ++ PE K +SDV+SFGVVL E+ T G++P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVR-- 244
VIG G G VY+ G+ VA+K ++ I + + + E L K H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIE--DEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 245 ---LKAFCSNKETNL-LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYL 298
+K + L LV E GS+ +++ G K+G LK E I E +GL+YL
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE- 357
H +IHRD+K NILL + E + DFG++ L T + G+ ++APE
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEV 184
Query: 358 ----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
D +SDV+S G+ +EL G+ P+ D
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 31/296 (10%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E + + + +G G G V + N + K + + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 242 IVRL-KAFCSNKETNL-LVYEYMPNGSL----GEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
IV+ AF +++ + EY GSL +V KRG + ++ KIA KGL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGL 118
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
SYLH S IIHRD+K +NILL + + DFG++ L ++ A + S+ Y+A
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSF-YMA 171
Query: 356 PEY----AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411
PE Y++ SDV+S G+ LLE+ R P GE L ++ N
Sbjct: 172 PERIQGKPYSI----TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--- 224
Query: 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ---MLAQAQKPNT 464
++ D+ + SE + F C+++ RPT ++++ + AQ +K
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQ--CLEKDPTRRPTPWDMLEHPWIKAQMKKKVN 278
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
V+G G GVV + GE VA+KK S D+ E++ L ++RH NI
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE-----SEDDEDVKKTALREVKVLRQLRHENI 62
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
V LK K LV+EY+ +L E+L G +R I + + ++Y H H+
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHSHN 120
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
IIHRD+K NIL++ + DFG A+ L+ AS VA + Y APE
Sbjct: 121 ----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPE---- 171
Query: 362 LKVDEKS-----DVYSFGVVLLELITGR 384
L V + + DV++ G ++ EL+ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 8e-23
Identities = 69/198 (34%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G G V+ G +VAVK L G+ E + + K+RH +V+L A
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
S +E +V EYM GSL + L G LK + +A + A G++Y+ IHR
Sbjct: 71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D++S NIL+ +ADFGLA+ ++D + A + APE A + KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 185
Query: 370 VYSFGVVLLELIT-GRRP 386
V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 188 NVIGRGGAGVVYRGVT-PNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
N IG G G VY V GE +AVK++ + + ++ E++ L ++H N+V+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKY 64
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
++E + EY G+L E+L R L + ++ +GL+YLH S
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHG 119
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAPEYAYTLK 363
I+HRD+K NI L+ + + DFG A L++ + E + ++AG+ Y+APE K
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 364 VDEK---SDVYSFGVVLLELITGRRP 386
+D++S G V+LE+ TG+RP
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 70/180 (38%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
GE VAVKKL T D EI L ++H NIV+ K C S NL LV EY+P
Sbjct: 33 GEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
GSL + L R ++ L A + KG+ YL S +HRD+ + NIL+ S+
Sbjct: 91 YGSLRDYLQKHRERLDHRKL-LLYASQICKGMEYLG---SKRYVHRDLATRNILVESENR 146
Query: 324 AHVADFGLAKYL-QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
+ DFGL K L QD + + APE K SDV+SFGVVL EL T
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-22
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 29/267 (10%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G GVV G VA+K I +GS ++ E + + K+ H +V+L C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ + +V EYM NG L L F ++ L++ + +G++YL S IHR
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHR 124
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYAYTLKVDEK 367
D+ + N L++ V+DFGL++Y+ D E S+V + + PE K K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 368 SDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426
SDV++FGV++ E+ + G+ P F NS E V K+ P
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERF--------------NNS--ETVEKVSQGLRLYRPHL 225
Query: 427 EAMQVFFVAMLCVQEHGVERPTMREVV 453
+ +V+ + C E ERPT ++++
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 64/180 (35%), Positives = 95/180 (52%), Gaps = 8/180 (4%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYMP 263
GEQVAVK L + G+ H L EI L + H NIV+ K C+ N L+ E++P
Sbjct: 33 GEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
+GSL E L + + + + +LK A++ KG+ YL S +HRD+ + N+L+ S+ +
Sbjct: 92 SGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147
Query: 324 AHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
+ DFGL K ++ D + + APE K SDV+SFGV L EL+T
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 49/285 (17%)
Query: 190 IGRGGAGVVYRGV--TPNGEQ--VAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNI 242
+G G G V +GV +G++ VAVK L K G E + ++ H I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL----KQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG---SFLKWEMRLKIAIEAAKGLSYLH 299
VRL C E +LV E P G L + L +R S LK E+ ++A+ G++YL
Sbjct: 59 VRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAM----GMAYLE 112
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPE 357
S +HRD+ + N+LL + +A ++DFG+++ L G+ + AG + + APE
Sbjct: 113 ---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG-AGSDYYRATTAGRWPLKWYAPE 168
Query: 358 YAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDF-GEEGLDIVQWTKMQTNSSKEGVVKI 415
K KSDV+S+GV L E + G +P G+ G E V+ +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE------------------VIAM 210
Query: 416 LDQ--RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
L+ RL +++ + + C + +RPT E+ +
Sbjct: 211 LESGERLPRPEECPQ-EIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 41/287 (14%)
Query: 183 CVKDNNVIGRGGAGVVYRG--VTPNGEQ--VAVKKL-LGITKGSSHDNGLSAEIRTLGKI 237
C+K VIG G G V G P + VA+K L G T+ D +E +G+
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD--FLSEASIMGQF 62
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
H NI+ L+ + + ++V EYM NGSL L G F ++ + + A G+ Y
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKY 121
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI--- 354
L D +HRD+ + NIL+NS+ V+DFGL++ L+D + +A G I
Sbjct: 122 LS-DMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEAAYTTRGGKIPIR 174
Query: 355 --APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411
APE K SDV+S+G+V+ E+++ G RP W S +
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------W-----EMSNQD 217
Query: 412 VVKILDQ--RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
V+K +++ RL P+ + + + C Q+ ERP ++V +L
Sbjct: 218 VIKAIEEGYRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 72/246 (29%), Positives = 123/246 (50%), Gaps = 15/246 (6%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-K 246
+G G GVV + + P+G +A +KL+ + + N + E++ L + IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
AF S+ E ++ + E+M GSL +VL K+ + + KI+I +GL+YL I
Sbjct: 67 AFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREKHK--I 121
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HRDVK +NIL+NS E + DFG++ L D+ A+ S V G+ Y++PE
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYTV 177
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426
+SD++S G+ L+E+ GR P+ + L+ + + +KE + +
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR-- 235
Query: 427 EAMQVF 432
M +F
Sbjct: 236 -PMAIF 240
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
IG+G G VY+GV +VAVK T S+ L E L + H NIV+L
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK-----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
C K+ +V E +P GSL L K+ L + L+++++AA G+ YL
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNC-- 114
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----APEYAY 360
IHRD+ + N L+ + ++DFG+++ + + V+ I APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSREEEGG-----IYTVSDGLKQIPIKWTAPEALN 168
Query: 361 TLKVDEKSDVYSFGVVLLELITG 383
+ +SDV+S+G++L E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA--EIRTLGKIRHRNIVR-L 245
V+GRG G+V+ +++ + K + + + D L+A E + L + H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ F +K ++V EY P G+L E + + S L + L ++ L LHH + L
Sbjct: 66 ENFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKL 121
Query: 306 IIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
I+HRD+K+ NILL+ + DFG++K L + V G+ YI+PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPY 178
Query: 365 DEKSDVYSFGVVLLELITGRR 385
++KSD+++ G VL EL + +R
Sbjct: 179 NQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+ V+G+G G+VY ++A+K++ + S + L EI ++HRNIV
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDC 302
+ S + E +P GSL +L K G E + + +GL YLH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 303 SPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
I+HRD+K +N+L+N+ ++DFG +K L G + C G+ Y+APE
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV--- 180
Query: 362 LKVDE-------KSDVYSFGVVLLELITGRRPVGDFGE 392
+D+ +D++S G ++E+ TG+ P + GE
Sbjct: 181 --IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G+G G V+ G +VA+K L G+ E + + K+RH +V L A
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
S +E +V E+M GSL + L G +LK + +A + A G++Y+ IHR
Sbjct: 71 S-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHR 126
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+++ NIL+ + +ADFGLA+ ++D + A + APE A + KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 185
Query: 370 VYSFGVVLLELIT-GRRP 386
V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
N IG G G+VYR T +GE VA+KK+ + + +G+ EI L +RH NI
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV----RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 243 VRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
V LK K + LV EY L +L F + +++ + ++ +GL YLH
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-LMLQLLRGLQYLHE 126
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
+ IIHRD+K +N+LL +ADFGLA+ M+ + Y APE
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLL 181
Query: 361 TLKVDEKS-DVYSFGVVLLELITGR 384
+ D+++ G +L EL+ +
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKG--SSHDNGL--SA--EIRTLGKIRHRNI 242
+G G VVY+ G VA+KK I G +G+ +A EI+ L +++H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK---IKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 243 VRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+ L F NL V+E+M L +V+ K +++ + +GL YLH
Sbjct: 65 IGLLDVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLH-- 119
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY--- 358
S I+HRD+K NN+L+ SD +ADFGLA+ + M+ + Y APE
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS--PNRKMTHQVVTRWYRAPELLFG 176
Query: 359 --AYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y + V D++S G + EL+ R P
Sbjct: 177 ARHYGVGV----DMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 10/206 (4%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKL---LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G+G G VY + G ++AVK++ + N L EI+ L ++H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ ET + EYMP GS+ + L K L + K + +G+ YLH S +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLH---SNM 124
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAPEYAYTLKV 364
I+HRD+K NIL +S + DFG +K LQ +S M +V G+ +++PE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 365 DEKSDVYSFGVVLLELITGRRPVGDF 390
K+DV+S G ++E++T + P +F
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
IG+G G VY+ + + VA+K I + D + EI+ L + R I +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKV---IDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHD 301
K + L ++ EY GS ++L K G E IA E GL YLH +
Sbjct: 65 YG-SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLD--ET--YIAFILREVLLGLEYLHEE 117
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
IHRD+K+ NILL+ + + +ADFG++ L T + + G+ ++APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQ 172
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGD 389
DEK+D++S G+ +EL G P+ D
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 79/289 (27%), Positives = 139/289 (48%), Gaps = 29/289 (10%)
Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRH 239
+K V+G G G VY+G+ P GE V + K+L T G + E + + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
++VRL C + T LV + MP+G L + +H + + + ++ L ++ AKG+ YL
Sbjct: 69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLE 126
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPE 357
++HRD+ + N+L+ S + DFGLA+ L+ G + +A G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWMALE 181
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
+ K +SDV+S+GV + EL+T FG + D + T+ + ++G
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT-------FGGKPYDGIP-TREIPDLLEKG------ 227
Query: 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ-AQKPNTF 465
+RL P+ + V+ V + C RP +E+ ++ A+ P +
Sbjct: 228 ERLPQPPIC-TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E +K +G G G V+ G N +VAVK L G+ E + ++H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDK 62
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+VRL A + +E ++ EYM GSL + L G + + + + A+G++Y+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---YGYIAPEY 358
IHRD+++ N+L++ +ADFGLA+ ++D +A G+ + APE
Sbjct: 123 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEA 175
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
KSDV+SFG++L E++T G+ P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 61/296 (20%)
Query: 190 IGRGGAGVVYRG-----VTPNGE-QVAVKKLLGITKGSSHDNGLSAEIR-------TLGK 236
+G+G G+VY G V E +VA+K + ++N E + +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--------NENASMRERIEFLNEASVMKE 65
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIA 288
++VRL S + L+V E M G L L +R + +++A
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK------YLQDTGASE 342
E A G++YL + +HRD+ + N ++ D + DFG+ + Y + G
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG- 181
Query: 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402
+ V ++APE KSDV+SFGVVL E+ T + + +GL
Sbjct: 182 -LLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT----LAEQPYQGL------- 225
Query: 403 MQTNSSKEGVVK-ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457
S E V+K ++D + P + ++ + +C Q + RPT E+V L
Sbjct: 226 -----SNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 18/229 (7%)
Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRH 239
++ ++G G G V++G+ P G+ + + K + G ++ + +G + H
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
IVRL C L V + P GSL + + R S L + L ++ AKG+ YL
Sbjct: 69 AYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLE 126
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
++HR++ + NILL SD +ADFG+A L S ++A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 360 YTLKVDEKSDVYSFGVVLLELIT-------GRRP--VGDFGEEGLDIVQ 399
+ +SDV+S+GV + E+++ G RP V D E+G + Q
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 72/218 (33%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD----NGLSAEIRTLGKIRHRNI 242
N IG G G VY+ + P G A+K + G +H+ + EI L + H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYG-----NHEDTVRRQICREIEILRDVNHPNV 134
Query: 243 VRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
V+ F N E +L+ E+M GSL E H FL +A + G++YLH
Sbjct: 135 VKCHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQFLA-----DVARQILSGIAYLH-- 185
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
I+HRD+K +N+L+NS +ADFG+++ L T C S+V G+ Y++PE T
Sbjct: 186 -RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSV-GTIAYMSPERINT 242
Query: 362 LKVDEK-----SDVYSFGVVLLELITGRRPVGDFGEEG 394
D++S GV +LE GR P G G +G
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG-VGRQG 279
|
Length = 353 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 67/214 (31%), Positives = 118/214 (55%), Gaps = 19/214 (8%)
Query: 189 VIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHD-------NGLSAEIRTLGKIRHR 240
+IG G G VY G+ +GE +AVK++ + +S + L+ EI L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 241 NIVRLKAFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
NIV+ S +L ++ EY+P GS+ +L+ G+F + +R + + KGL+YLH
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVR-QILKGLNYLH 123
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ----DTGASECMSAVAGSYGYIA 355
+ IIHRD+K NIL+++ ++DFG++K L+ T + ++ GS ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
PE K+D++S G +++E++TG+ P D
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 187 NNVIGRGGAGVVYRGVT--PNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
VIG+G G V V + A+K K + KGS + E R L ++ H
Sbjct: 5 LRVIGKGAFGKV-CIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNHPF 61
Query: 242 IVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
+V L +F E N+ LV + + G L L ++ F + +++ I E L YLH
Sbjct: 62 LVNLWYSFQD--EENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALEYLH 117
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
S IIHRD+K +NILL+ H+ DF +A + ++ +G+ GY+APE
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGYMAPEVL 171
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRP 386
D +S GV E + G+RP
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG+G G V G G +VAVK + K + AE + ++RH N+V+L
Sbjct: 13 TIGKGEFGDVMLG-DYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
++ L +V EYM GSL + L + S L + LK +++ + + YL + +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAK---YLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
HRD+ + N+L++ D A V+DFGL K QDTG + APE K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEALREKKF 176
Query: 365 DEKSDVYSFGVVLLELIT-GRRP 386
KSDV+SFG++L E+ + GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 86/294 (29%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 184 VKDNNVIGRGGAGVV--YRGVTPN---GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
+K V+G G G V Y N GE VAVK L G + +G EI L +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNTSGWKKEINILKTLY 64
Query: 239 HRNIVRLKAFCSNK--ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
H NIV+ K CS + + L+ EY+P GSL + L + L L A + +G++
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMA 121
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL---------QDTGASECMSAV 347
YLH S IHRD+ + N+LL++D + DFGLAK + ++ G S
Sbjct: 122 YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF--- 175
Query: 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407
+ A E K SDV+SFGV L EL+T ++ +++ + Q
Sbjct: 176 -----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT- 229
Query: 408 SKEGVVKILD-----QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
VV++++ RL P + +V+ + C + RPT R ++ +L
Sbjct: 230 ----VVRLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
IG+G G V + +G+ + K++ L +E+ L +++H NIVR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 246 -KAFCSNKETNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHH-- 300
+ + +T +V EY G L +++ + +++ E +I + L H+
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
D ++HRD+K NI L+++ + DFGLAK L +S + V Y Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTPY-YMSPEQLN 183
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRP 386
+ DEKSD++S G ++ EL P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH---RNIVR 244
+IGRG G VYRG P G VA+K ++ + + + E+ L ++R NI +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
K L ++ EY GS+ ++ + + + I E L Y+H
Sbjct: 67 YYG-SYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHKVG- 121
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
+IHRD+K+ NIL+ + + DFG+A L S S G+ ++APE K
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEVITEGK 177
Query: 364 V-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422
D K+D++S G+ + E+ TG P D + + + K RL +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSD--VDAFRAMML-----------IPKSKPPRLED 224
Query: 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
S+ ++ F A C+ E ER + E+++
Sbjct: 225 NGYSKLLREFVAA--CLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 60/164 (36%), Positives = 91/164 (55%), Gaps = 10/164 (6%)
Query: 227 LSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL 285
L EIR + ++ H +I+R L A C + NL V E+M GS+ +L K G+F K + +
Sbjct: 50 LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS-KYGAF-KEAVII 106
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-AHVADFGLAKYL--QDTGASE 342
+ +GLSYLH + IIHRDVK N+L++S + +ADFG A L + TGA E
Sbjct: 107 NYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ G+ ++APE + DV+S G V++E+ T + P
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 50/226 (22%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
+ IG G GVV V G +VA+KK+ + D+ + A EI+ L +R
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-----DDLIDAKRILREIKLLRHLR 57
Query: 239 HRNIVRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
H NI+ L + +V E M L +V+ + + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK----------SPQPLTDDHIQ 106
Query: 294 --------GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM- 344
GL YLH S +IHRD+K +NIL+NS+ + + DFGLA+ + +
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 345 -SAVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
V + Y APE YT + D++S G + EL+T +
Sbjct: 164 TEYVVTRW-YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+ +G G G VY GV VAVK L + + E + +I+H N+V+L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
C+ + ++ E+M G+L + L + + L +A + + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---YGYIAPEYAYTLK 363
IHRD+ + N L+ + VADFGL++ + + +A AG+ + APE K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 364 VDEKSDVYSFGVVLLELIT 382
KSDV++FGV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 87/299 (29%), Positives = 131/299 (43%), Gaps = 38/299 (12%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIR 232
F DD + D IG G G VY E VA+KK+ K S+ + E+R
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 233 TLGKIRHRNIVRLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
L ++RH N + K C +E T LV EY GS ++L + + E+ I A
Sbjct: 68 FLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-AICHGA 124
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
+GL+YLH IHRD+K+ NILL +ADFG A S S V Y
Sbjct: 125 LQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPY 176
Query: 352 GYIAPEYAYTLKVDE-----KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406
++APE L +DE K DV+S G+ +EL + P+ + M
Sbjct: 177 -WMAPE--VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------------MNAM 220
Query: 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM-LAQAQKPNT 464
S+ + + LS+ S+ + F C+Q+ +RP+ E+++ ++P T
Sbjct: 221 SALYHIAQNDSPTLSSNDWSDYFRNF--VDSCLQKIPQDRPSSEELLKHRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 33/272 (12%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
+IG G G V +G G++VAVK K E + K+ H+N+VRL
Sbjct: 13 IIGEGEFGAVLQG-EYTGQKVAVK----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+ + V E M G+L L + + + L+ +++ A+G+ YL S ++H
Sbjct: 68 ILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+ + NIL++ D A V+DFGLA+ + G V + APE K KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKHKKFSSKS 178
Query: 369 DVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427
DV+S+GV+L E+ + GR P + KM KE V ++ P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP-------------YPKMSLKEVKECV----EKGYRMEPPEG 221
Query: 428 AMQVFFVAML-CVQEHGVERPTMREVVQMLAQ 458
+V M C + +RP+ ++ + L +
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 70/208 (33%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G VY+ GE VA+K ++ + G + + EI L + RH NIV
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEI-IQQEISMLKECRHPNIVAY- 65
Query: 247 AFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
F S + L V EY GSL ++ RG L + E KGL+YLH
Sbjct: 66 -FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHETG-- 121
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
IHRD+K NILL D + +ADFG++ L T A S + Y ++APE A +
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-KSFIGTPY-WMAPEVAAVERK 178
Query: 365 ---DEKSDVYSFGVVLLELITGRRPVGD 389
D K D+++ G+ +EL + P+ D
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 36/273 (13%)
Query: 190 IGRGGAGVVYRGVTPNGEQV-AVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK- 246
+G+G G VY+ + Q A+K++ LG ++ ++ EIR L + H NI+ K
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPNIISYKE 66
Query: 247 AFC-SNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
AF NK +V EY P G L + + K+ + + +I I+ +GL LH
Sbjct: 67 AFLDGNKL--CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---E 121
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
I+HRD+KS NILL ++ + D G++K L+ A G+ Y+APE
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRP 177
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423
KSD++S G +L E+ T P + S ++ K+ +
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPP----------------FEARSMQDLRYKVQRGKYPPI 221
Query: 424 P--LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
P S+ +Q F +ML V+ RP +++
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPK--LRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 71/221 (32%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKLLGITKGSSHDNGLSAEI----RTLGKIRHRNIVR 244
+G GG G V V A+K + K + G I L + H IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC---VKKRHIVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 245 L-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA--IEAAKGLSYLHHD 301
L + F K +L+ EY G L +L RG F ++ R IA + A YLH+
Sbjct: 58 LYRTFKDKKYIYMLM-EYCLGGELWTILR-DRGLFDEYTARFYIACVVLA---FEYLHNR 112
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA--SECMSAVAGSYGYIAPEY- 358
II+RD+K N+LL+S+ + DFG AK L+ + C G+ Y+APE
Sbjct: 113 G---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAPEII 164
Query: 359 ---AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD 396
Y V D +S G++L EL+TGR P FGE+ D
Sbjct: 165 LNKGYDFSV----DYWSLGILLYELLTGRPP---FGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAF 248
+G G GVV + + +KL+ + + N + E++ L + IV AF
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
S+ E ++ + E+M GSL +VL K + E+ K++I +GL+YL I+H
Sbjct: 73 YSDGEISICM-EHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMH 127
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RDVK +NIL+NS E + DFG++ L D+ A ++ G+ Y++PE +S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQS 183
Query: 369 DVYSFGVVLLELITGRRPV 387
D++S G+ L+EL GR P+
Sbjct: 184 DIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
DD E + + +G G GVV++ + +KL+ + + N + E++ L +
Sbjct: 4 DDDFEKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 238 RHRNIVRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
IV AF S+ E ++ + E+M GSL +VL K+ + ++ K++I KGL+
Sbjct: 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 117
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
YL I+HRDVK +NIL+NS E + DFG++ L D+ A ++ G+ Y++P
Sbjct: 118 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSP 171
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387
E +SD++S G+ L+E+ GR P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 189 VIGRGGAGVVYRG--VTPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKI-RHRNI 242
+IG G V N ++ A+K K I + + E L ++ H I
Sbjct: 8 IIGEGSFSTVVLAKEKETN-KEYAIKILDKRQLIKEKKVKY--VKIEKEVLTRLNGHPGI 64
Query: 243 VRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
++L + E NL V EY PNG L + + K GS + R A E L YLH
Sbjct: 65 IKL-YYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAA-EILLALEYLH-- 119
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA------------- 348
S IIHRD+K NILL+ D + DFG AK L + E A
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 349 -----GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ Y++PE + SD+++ G ++ +++TG+ P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 180 ILECVKDNNVIGRGGAGVVYRG--VTPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRT 233
L V+ +G G G VY+G PN VA+K L + E
Sbjct: 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAEL 61
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--------------HGKRGSFL 279
+ ++H NIV L C+ ++ +++EY+ +G L E L S L
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 280 KWEMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
L IAI+ A G+ YL HH +HRD+ + N L+ ++DFGL++ +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 380
S ++ PE K +SD++SFGVVL E+
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 190 IGRGGAGVVY----RGVTPNGEQ--VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+G G G V+ + P ++ VAVK L ++ + D AE+ T+ ++H++IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV--LQHQHIV 70
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLK-----------WEMRLKIAIE 290
R C+ L+V+EYM +G L L HG L L IA +
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
A G+ YL S +HRD+ + N L+ + DFG+++ + T
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 351 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSK 409
++ PE K +SD++SFGVVL E+ T G++P W ++ S+
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-------------WYQL---SNT 231
Query: 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREV 452
E + I R P + +V+ + C Q +R ++++
Sbjct: 232 EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 32/274 (11%)
Query: 189 VIGRG--GAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVR- 244
V+G+G G +YR T + V K++ +T+ S + + EI L ++H NI+
Sbjct: 7 VLGKGAFGEATLYRR-TEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
F + T L+ EY G+L + + ++G + EM L + +SY+H
Sbjct: 65 YNHFMDDN-TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KA 120
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD--TGASECMSAVAGSYGYIAPEYAYTL 362
I+HRD+K+ NI L + DFG++K L + A + G+ Y++PE +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV----GTPYYMSPELCQGV 176
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422
K + KSD+++ G VL EL+T +R F + +Q N +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLVVKIVQGNYTPV-----------V 222
Query: 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ S + + +Q+ +RPT EV+
Sbjct: 223 SVYSSELISLVHS--LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 85/311 (27%), Positives = 142/311 (45%), Gaps = 46/311 (14%)
Query: 174 DFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
D ++D LE + D +G G G V + V KK++ I SS + E++
Sbjct: 1 DLRNED-LETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQI 56
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
+ + R IV N+ + E+M GSL + K+G + E+ KIA+ +
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVE 114
Query: 294 GLSYL---HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA-- 348
GL+YL H I+HRD+K +NIL+NS + + DFG+ + E ++++A
Sbjct: 115 GLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADT 161
Query: 349 --GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406
G+ Y++PE K KSDV+S G+ ++EL G+ P D Q M
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF--SNIDDDGQDDPM--- 216
Query: 407 SSKEGVVKILDQ-------RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LA 457
G++ +L Q RL ++ E ++ F C+ + ERPT +++ M
Sbjct: 217 ----GILDLLQQIVQEPPPRLPSSDFPEDLRDF--VDACLLKDPTERPTPQQLCAMPPFI 270
Query: 458 QAQKPNTFQMQ 468
QA + + +Q
Sbjct: 271 QALRASNVDLQ 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 21/260 (8%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
V+G G G N +Q K + + K SS E L K++H NIV K
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+V EY G L + + +RG + L+ ++ G+ ++H ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLH 123
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+KS NI L + + + DFG A+ L GA C G+ Y+ PE + + KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC--TYVGTPYYVPPEIWENMPYNNKS 181
Query: 369 DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEA 428
D++S G +L EL T + P Q NS K ++K+ P +
Sbjct: 182 DIWSLGCILYELCTLKHP----------------FQANSWKNLILKVCQGSYKPLPSHYS 225
Query: 429 MQVFFVAMLCVQEHGVERPT 448
++ + + + RP+
Sbjct: 226 YELRSLIKQMFKRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG+G G V++G+ +QV K++ + + + EI L + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
++ EY+ GS ++L + G F ++++ + E KGL YLH S IHR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLK-EILKGLDYLH---SEKKIHR 125
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+K+ N+LL+ + +ADFG+A L DT + G+ ++APE D K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 370 VYSFGVVLLELITGRRPVGD 389
++S G+ +EL G P D
Sbjct: 184 IWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLKA 247
IG G G +Y + + V K + +TK + S E+ L K++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF-- 64
Query: 248 FCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F S +E L V EY G L + ++ +RG + L ++ + GL ++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121
Query: 306 IIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
I+HRD+KS NI L+ + A + DFG+A+ L D+ E G+ Y++PE
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQNRPY 179
Query: 365 DEKSDVYSFGVVLLELITGRRP 386
+ K+D++S G VL EL T + P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 5e-18
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 8/201 (3%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG+G G VY+G+ ++V K++ + + + EI L + I R
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
++ EY+ GS ++L K G L+ I E KGL YLH S IHR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLH---SERKIHR 125
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+K+ N+LL+ + +ADFG+A L DT + G+ ++APE D K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 370 VYSFGVVLLELITGRRPVGDF 390
++S G+ +EL G P D
Sbjct: 184 IWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
++GRG G VY + G ++AVK++ + S N L EI+ L +RH IV+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 245 LKAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ E L EYMP GS+ + L K L + + + +G+SYLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLH--- 123
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS-----AVAGSYGYIAPE 357
S +I+HRD+K NIL +S + DFG +K +Q CMS +V G+ +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI----CMSGTGIKSVTGTPYWMSPE 179
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390
K+DV+S ++E++T + P ++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG G GVVY+ GE VA+KK+ + EI+ L ++ H NI++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+K LV+E+M + L +++ ++ + ++ + +GL++ H S I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIK-SYLYQLLQGLAFCH---SHGILH 121
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV-DEK 367
RD+K N+L+N++ +ADFGLA+ + V + Y APE K
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRW-YRAPELLLGDKGYSTP 179
Query: 368 SDVYSFGVVLLELITGR 384
D++S G + EL++ R
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 21/269 (7%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
++G+G G V++G + VAVK LS E R L + H NIV+L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
C+ ++ +V E +P G L K+ LK + +K A++AA G++YL S IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLE---SKNCIH 116
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+ + N L+ + ++DFG+++ +D G + APE + +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 369 DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEA 428
DV+S+G++L E + L + + M ++E V K R+S P
Sbjct: 176 DVWSYGILLWETFS------------LGVCPYPGMTNQQAREQVEK--GYRMS-CPQKCP 220
Query: 429 MQVFFVAMLCVQEHGVERPTMREVVQMLA 457
V+ V C RP E+ + LA
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 85/286 (29%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 188 NVIGRGGAGVVYRG--VTPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
VIG+G G VY G + +G+ AVK L IT + L I + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVL 59
Query: 244 RLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------LKIAIEAAKGL 295
L C E + L+V YM HG +F++ E + ++ AKG+
Sbjct: 60 SLLGICLPSEGSPLVVLPYM--------KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGM 111
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGASECMSAVAGSYGY 353
YL S +HRD+ + N +L+ F VADFGLA+ Y ++ + + +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412
+A E T K KSDV+SFGV+L EL+T G P D + DI T +G
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDI-------TVYLLQG- 218
Query: 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
++L PL E M C RPT E+V + Q
Sbjct: 219 RRLLQPEYCPDPLYEVMLS------CWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 31/190 (16%)
Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
+G + ++ KIA+ K L YLH S +IHRDVK +N+L+N + + + DFG++
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISG 152
Query: 334 YLQDTGASECMSAVAGSYGYIAPE--------YAYTLKVDEKSDVYSFGVVLLELITGRR 385
YL D+ A + AG Y+APE Y D KSDV+S G+ ++EL TGR
Sbjct: 153 YLVDSVAK---TIDAGCKPYMAPERINPELNQKGY----DVKSDVWSLGITMIELATGRF 205
Query: 386 PVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVE 445
P + + Q VV+ +L S Q FV C++++ E
Sbjct: 206 PYDSWKTPFQQLKQ------------VVEEPSPQLPAEKFSPEFQ-DFVNK-CLKKNYKE 251
Query: 446 RPTMREVVQM 455
RP E++Q
Sbjct: 252 RPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 69/226 (30%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 190 IGRGGAGVVY---RGVTPNGEQVAVKKLLGITK----GSSHDNGLSAEIRTLGKIRHRNI 242
I +G G V+ + T G+ A+K I K + + + E L + + +
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKV---IKKADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 243 VRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
V+L +F K NL LV EY+P G L +L GS + R+ IA E L YLH
Sbjct: 56 VKLYYSFQGKK--NLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIA-EIVLALEYLH- 110
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-------LQDTGASECMSAVAGSYGY 353
S IIHRD+K +NIL++S+ + DFGL+K + E + G+ Y
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDY 167
Query: 354 IAPE------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393
IAPE ++ T D +S G +L E + G P F E
Sbjct: 168 IAPEVILGQGHSKT------VDWWSLGCILYEFLVGIPP---FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-R 238
I E V+ V+G G G VY+G Q+A K++ +T+ + + EI L K
Sbjct: 17 IFELVE---VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEE--IKLEINMLKKYSH 71
Query: 239 HRNIVRL------KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
HRNI K+ + + LV E+ GS+ +++ +G+ LK + I E
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
+GL++LH + +IHRD+K N+LL + E + DFG++ L T + G+
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 186
Query: 353 YIAPEYAYTLKVDE--------KSDVYSFGVVLLELITGRRPVGD 389
++APE + DE +SD++S G+ +E+ G P+ D
Sbjct: 187 WMAPE---VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
++G+G G VY + G ++AVK++ + S N L EI+ L + H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 245 LKAFCSN-KETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ E L ++ E+MP GS+ + L K L + K + +G+SYLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLH--- 123
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAPEYAYT 361
S +I+HRD+K NIL +S + DFG +K LQ S M +V G+ +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDF 390
K+D++S G ++E++T + P +F
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRL-K 246
++G G G VY+G Q+A K++ +T + + EI L K HRNI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 247 AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
AF + LV E+ GS+ +++ +G+ LK E I E +GLS+LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
+IHRD+K N+LL + E + DFG++ L T + G+ ++APE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPE---V 182
Query: 362 LKVDE--------KSDVYSFGVVLLELITGRRPVGDF 390
+ DE KSD++S G+ +E+ G P+ D
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E +K +G G G V+ +VAVK + GS AE + ++H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 62
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+L A + KE ++ E+M GSL + L GS + + + A+G++++
Sbjct: 63 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYA 359
IHRD+++ NIL+++ +ADFGLA+ ++D +E + + + APE
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAI 175
Query: 360 YTLKVDEKSDVYSFGVVLLELIT-GRRP 386
KSDV+SFG++L+E++T GR P
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 71/230 (30%), Positives = 106/230 (46%), Gaps = 38/230 (16%)
Query: 189 VIGRGGAGVV---YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR- 244
IG G G+V Y VT G+ VA+KKL + +H E+ + + H+NI+
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 245 LKAFCSNKETN-----LLVYEYMPNGSLGEVLH----GKRGSFLKWEMRLKIAIEAAKGL 295
L F K LV E M + +L +V+ +R S+L ++M G+
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLYQMLC--------GI 131
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
+LH S IIHRD+K +NI++ SD + DFGLA+ G S M+ + Y A
Sbjct: 132 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 185
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRR--PVGDFGEEGLDIVQWTKM 403
PE + E D++S G ++ E+I G P D I QW K+
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH------IDQWNKI 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 58/180 (32%), Positives = 92/180 (51%), Gaps = 13/180 (7%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
+VAVK +L T SS L +E++ + + H NIV L C+ L++ EY G
Sbjct: 67 KVAVK-MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
L L KR SFL E L + + AKG+++L S IHRD+ + N+LL +
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182
Query: 327 ADFGLAKYLQDTGASECMSAVAGS----YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
DFGLA+ + ++ V G+ ++APE + +SDV+S+G++L E+ +
Sbjct: 183 CDFGLARDIM----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
++G+G G VY G ++A K++ + S + L EI+ L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 245 LKAFCSNK-ETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
++ E L ++ EYMP GS+ + L K L + K + +G+SYLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH--- 123
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS-----AVAGSYGYIAPE 357
S +I+HRD+K NIL +S + DFG +K LQ CMS +V G+ +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI----CMSGTGIRSVTGTPYWMSPE 179
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390
K+DV+S G ++E++T + P ++
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 190 IGRGGAGVVYRGVTPNGEQ--VAVKKL------LGITKGSSHDN--GLSAEIRTLGK-IR 238
+G G G VY+ N Q +A+K++ G K + + +E+ + + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 239 HRNIVRL-KAFCSNKETNLLVYEYMPNGSLGE---VLHGKRGSFLKWEMRL-KIAIEAAK 293
H NIVR K F N +V + + LGE L K+ F E R+ I ++
Sbjct: 68 HPNIVRYYKTFLENDRL-YIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNIFVQMVL 124
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
L YLH + I+HRD+ NNI+L D + + DFGLAK +++V G+ Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILY 179
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
PE EK+DV++FG +L ++ T
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
F ++D+ KD IGRG G V + + P+G +AVK++ L ++
Sbjct: 1 FTAEDL----KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMDLDV 55
Query: 234 LGKIRH-RNIVRLKAFCSNKETNLLVYEYMPNG--SLGEVLHGKRGSFLKWEMRLKIAIE 290
+ + IV+ + + E M + ++ S + E+ KIA+
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
K L+YL + IIHRDVK +NILL+ + + DFG++ L D+ A + AG
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGC 170
Query: 351 YGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRP 386
Y+APE D +SDV+S G+ L E+ TG+ P
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG+G G V++G+ ++V K++ + + + EI L + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 70
Query: 250 SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
K+T L ++ EY+ GS ++L + G + ++ I E KGL YLH S IH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIA-TILREILKGLDYLH---SEKKIH 124
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+K+ N+LL+ E +ADFG+A L DT + G+ ++APE D K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 369 DVYSFGVVLLELITGRRP 386
D++S G+ +EL G P
Sbjct: 183 DIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
DI E + + +G G G VY+ A K++ + EI L + +
Sbjct: 5 DIWEIIGE---LGDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMVEIDILSECK 60
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
H NIV L + ++ E+ G+L ++ + ++R + + + L++L
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFL 119
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
H S +IHRD+K+ NILL D + +ADFG++ + T + G+ ++APE
Sbjct: 120 H---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEV 174
Query: 359 AY--TLK---VDEKSDVYSFGVVLLELITGRRP 386
T K D K+D++S G+ L+EL P
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 87/297 (29%), Positives = 136/297 (45%), Gaps = 34/297 (11%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHD-NGLSAEI 231
F +D + D IG G G VY R V N E VA+KK+ K S+ + E+
Sbjct: 18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
+ L +I+H N + K + T LV EY GS ++L + + E+ I A
Sbjct: 77 KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGA 134
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
+GL+YLH S +IHRD+K+ NILL + +ADFG A AS S V Y
Sbjct: 135 LQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPY 186
Query: 352 GYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408
++APE + + D K DV+S G+ +EL + P+ + M S+
Sbjct: 187 -WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------------MNAMSA 232
Query: 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ-MLAQAQKPNT 464
+ + L + S+ + F + C+Q+ +RPT E+++ M ++P T
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDS--CLQKIPQDRPTSEELLKHMFVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-L 245
IG+G VVY+ + +G VA+KK + + + + L EI L ++ H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCS 303
+F N E N+ V E G L ++ H K+ L E + K ++ L ++H S
Sbjct: 69 ASFIENNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---S 124
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA--VAGSYGYIAPEYAYT 361
I+HRD+K N+ + + + D GL ++ +S+ +A + G+ Y++PE +
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHE 180
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP 386
+ KSD++S G +L E+ + P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 190 IGRG--GAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLS-AEIRTLGKIRHRNIVRLK 246
IG G G ++ + +G+Q +K++ I+K S + S E+ L ++H NIV+ +
Sbjct: 8 IGEGSFGKAILVKSKE-DGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+V +Y G L + ++ +RG + L ++ L ++H I
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKI 122
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HRD+KS NI L D + DFG+A+ L T E G+ Y++PE +
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VELARTCIGTPYYLSPEICENRPYNN 180
Query: 367 KSDVYSFGVVLLELIT 382
KSD+++ G VL E+ T
Sbjct: 181 KSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 43/223 (19%)
Query: 190 IGRGGAGVVYRG-----VTPNGEQ-VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RH 239
+G G G V + PN VAVK L K + + LS +E+ + I +H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRL 285
+NI+ L C+ + +V EY +G+L + L +R L + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK------YLQDTG 339
A + A+G+ +L S IHRD+ + N+L+ D +ADFGLA+ Y + T
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
++APE + +SDV+SFGV+L E+ T
Sbjct: 193 NGRL------PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 42/288 (14%)
Query: 190 IGRGGAGVVYRG----VTPNGEQ--VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+G G G V+ ++P ++ VAVK L T + D AE+ T ++H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT--NLQHEHIV 70
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFL--------KWEM----RLKIAI 289
+ C + + ++V+EYM +G L + L HG L K E+ L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
+ A G+ YL S +HRD+ + N L+ ++ + DFG+++ + T
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 350 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408
++ PE K +SDV+SFGV+L E+ T G++P W ++ S+
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQL---SN 231
Query: 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
E + I R+ P +V+ + + C Q +R ++E+ ++L
Sbjct: 232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 177 SDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG--LSA--EI 231
S D E + N I G GVVYR GE VA+KKL K G +++ EI
Sbjct: 3 SVDEYEKL---NRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREI 55
Query: 232 RTLGKIRHRNIVRLK--AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
L K++H NIV +K SN + +V EY+ + L ++ + FL+ E++ + +
Sbjct: 56 NILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LML 113
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
+ G+++LH + I+HRD+K++N+LLN+ + DFGLA+ + +
Sbjct: 114 QLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVV 168
Query: 350 SYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 384
+ Y APE Y+ + D++S G + EL+T +
Sbjct: 169 TLWYRAPELLLGAKEYSTAI----DMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 31/290 (10%)
Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
+K V+G G G VY+G+ P+GE VA+K L T ++ L E + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVG 67
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ RL C T LV + MP G L + + + ++ L ++ AKG+SYL
Sbjct: 68 SPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSYL 125
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAP 356
++HRD+ + N+L+ S + DFGLA+ L D +E A G ++A
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETE-YHADGGKVPIKWMAL 180
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416
E + +SDV+S+GV + EL+T FG + D + ++ K
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT-------FGAKPYDGIPAREIPDLLEK------- 226
Query: 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ-AQKPNTF 465
+RL P+ + V+ + + C RP RE+V ++ A+ P+ F
Sbjct: 227 GERLPQPPIC-TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 69/227 (30%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 188 NVIGRGGAGVVYRGVTPN------GEQ-VAVKKLLGITKGS--SHDNGLSAEIRTLGKIR 238
N +G G G VY G + G VAVK L KG+ E +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAK 293
H NIV+L C E ++ E M G L L R L + L I ++ AK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 294 GLSYLH--HDCSPLIIHRDVKSNNILL-----NSDFEAHVADFGLAK------YLQDTGA 340
G YL H IHRD+ + N L+ ++D + DFGLA+ Y + G
Sbjct: 118 GCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG- 171
Query: 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
E + V ++APE K +SDV+SFGV++ E++T G++P
Sbjct: 172 -EGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRN 241
+ IG G G+V P G +VA+KK+ S ++ EI+ L + +H N
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI------SPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 242 IV------RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS------FLKWEMRLKIAI 289
I+ R +F S + +V E M L +++ + S FL +R
Sbjct: 65 IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK-YLQDTGASECMSAVA 348
GL Y+H S ++HRD+K +N+LLN++ + + DFGLA+ + + ++
Sbjct: 118 ----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 349 GSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELITGR 384
+ Y APE K K+ D++S G +L E+++ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
IG G GVV + T +G++VA+KK+ + D A E++ L +H NI
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 243 VRLKAFCSNKETNL----LVYEYMPNGSLGEVLHGKR-------GSFLKWEMRLKIAIEA 291
+ ++ + +V + M + L ++H + FL +R
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC--MSAVAG 349
GL Y+H S +IHRD+K +N+L+N D E + DFG+A+ L + M+
Sbjct: 119 --GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 350 SYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPV 387
+ Y APE +L + D++S G + E++ GRR +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 65/226 (28%), Positives = 93/226 (41%), Gaps = 31/226 (13%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+ + +G G G VY G+ QVAVK L + L E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-EALIMS 64
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-----HGKRGSFLKWEMRLKIAIE 290
K H+NIVRL + ++ E M G L L +R S L + L A +
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAK------YLQDTGAS 341
AKG YL IHRD+ + N LL A +ADFG+A+ Y + G +
Sbjct: 125 VAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
M + ++ PE K+DV+SFGV+L E+ + G P
Sbjct: 182 --MLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 58/296 (19%)
Query: 189 VIGRGGAGVVYRGVTP-----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+GRG G V+ GE + + K L TK + + E+ K+ H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE-------MRLKIAIEAAKGLS 296
RL C E + ++ EY G L + L + K + ++ + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY- 353
+L +HRD+ + N L++S E V+ L+K D SE Y
Sbjct: 132 HLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNSE-------YYKLR 176
Query: 354 --------IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQ 404
+APE KSDV+SFGV++ E+ T G P +E +
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--------- 227
Query: 405 TNSSKEGVVKILDQRLSNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
N + G +++ P L + M C + +RP+ E+V L +
Sbjct: 228 LNRLQAGKLEL--PVPEGCPSRLYKLMTR------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 36/252 (14%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGIT-----KGSSHDNGLSAEIRTLGKIRHRNIVR 244
+G G G V+ E K++ I K H + E R L ++ H I+R
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH---VHNEKRVLKEVSHPFIIR 65
Query: 245 LKAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
L F + + L + EY+P G L L G F L A E L YLH
Sbjct: 66 L--FWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSN-STGLFYASEIVCALEYLH--- 118
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S I++RD+K NILL+ + + DFG AK L+D + C G+ Y+APE +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-----GTPEYLAPEVIQSK 173
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI--------VQWTKMQTNSSKEGVVK 414
++ D ++ G+++ E++ G P F + I +++ + +K+ + K
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPF--FDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK 231
Query: 415 IL----DQRLSN 422
+L +RL N
Sbjct: 232 LLVVDRTRRLGN 243
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 69/214 (32%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKA 247
IG+G G VY+ +G AVK L I S D + AE L + H N+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 248 FCSNKETNL-----LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHH 300
+ + LV E GS+ E++ G G L M I A GL +LH+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY-- 358
+ IIHRDVK NNILL ++ + DFG++ L T S G+ ++APE
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIA 201
Query: 359 ---AYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
Y D + DV+S G+ +EL G P+ D
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
+ +G G G V T G +VA+KKL + + H E+R L + H N++ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 246 KAFC--SNKETNLLVYEYMP--NGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLS 296
F S+ E VY L ++ ++ S FL +++ +GL
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI--------LRGLK 132
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
Y+H S IIHRD+K +NI +N D E + DFGLA++ + M+ + Y AP
Sbjct: 133 YIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAP 184
Query: 357 E-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
E Y V D++S G ++ EL+TG+
Sbjct: 185 EIMLNWMHYNQTV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHD-NGLSAEI 231
F DD + D IG G G VY R V + E VA+KK+ K S+ + E+
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
R L K+RH N ++ + + T LV EY GS ++L + + E+ + A
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGA 124
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
+GL+YLH S +IHRDVK+ NILL+ + DFG A + + G+
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTP 175
Query: 352 GYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRPV 387
++APE + + D K DV+S G+ +EL + P+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHD-NGLSAEIR 232
F DD E + IG G G VY + E VAVKK+ K ++ + E++
Sbjct: 14 FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
L +++H N + K + T LV EY GS ++L + + E+ I A
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGAL 131
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
+GL+YLH +IHRD+K+ NILL + +ADFG A + +S S V Y
Sbjct: 132 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPY- 182
Query: 353 YIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRPV 387
++APE + + D K DV+S G+ +EL + P+
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 39/215 (18%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR-HRNI 242
+G+G G+V++ + E VA+KK+ + N A EI L ++ H NI
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFD-----AFRNATDAQRTFREIMFLQELGDHPNI 69
Query: 243 VRL----KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
V+L KA N + LV+EYM L V+ R + L+ + I + K L Y+
Sbjct: 70 VKLLNVIKA--ENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRYIMYQLLKALKYI 123
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA----VAGSYGYI 354
H S +IHRD+K +NILLNSD +ADFGLA+ L + + VA + Y
Sbjct: 124 H---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW-YR 179
Query: 355 APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
APE YT V D++S G +L E++ G+
Sbjct: 180 APEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 46/205 (22%)
Query: 208 QVAVKKLLGITKGSSHDNGLSA---EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
VAVK L + + DN E++ L ++ NI RL C+ ++ EYM N
Sbjct: 48 LVAVKVL----RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 265 GSLGEVL-----------HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
G L + L + L + L +A + A G+ YL S +HRD+ +
Sbjct: 104 GDLNQFLQKHVAETSGLACNSK--SLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT 158
Query: 314 NNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----------APEYAYTL 362
N L+ ++ +ADFG+ + + Y + A E
Sbjct: 159 RNCLVGKNYTIKIADFGM-----------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLG 207
Query: 363 KVDEKSDVYSFGVVLLELIT-GRRP 386
K KSDV++FGV L E++T R
Sbjct: 208 KFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 36/81 (44%), Positives = 50/81 (61%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
NN SG IP EIG L +LDL N+L+GPIP + + L YL + N+L+ +P +
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 64 NMKSLTSADFSHNNFSGEIPE 84
+++ L S D S N+ SGEIPE
Sbjct: 282 SLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 76/302 (25%), Positives = 131/302 (43%), Gaps = 47/302 (15%)
Query: 184 VKDNNVI-----GRGGAGVVYRG----VTPNGEQ--VAVKKLLGITKGSSHDNGLSAEIR 232
+K +N++ G G G V+ + P ++ VAVK L + + D AE+
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSF---------LKW 281
T ++H +IV+ C + ++V+EYM +G L + L HG L
Sbjct: 62 T--NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341
L IA + A G+ YL S +HRD+ + N L+ + + DFG+++ + T
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQW 400
++ PE K +SDV+S GVVL E+ T G++P W
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------W 223
Query: 401 TKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREV---VQMLA 457
++ N E + + R+ P + +V+ + + C Q R ++E+ +Q LA
Sbjct: 224 YQLSNNEVIECITQ---GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280
Query: 458 QA 459
+A
Sbjct: 281 KA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G VY+ + GE VA+KK+ + EI+ L ++ HRNIV LK
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 247 AFCSNKETNL----------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
++K+ L LV+EYM + +G +L F + ++ + +GL+
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIK-SFMKQLLEGLN 130
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
Y H +HRD+K +NILLN+ + +ADFGLA+ L ++ S + + Y P
Sbjct: 131 YCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKVITLWYRPP 186
Query: 357 EYAYTLKVDEKS----DVYSFGVVLLELITGRRPV 387
E L +E+ DV+S G +L EL T ++P+
Sbjct: 187 EL---LLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 179 DILECVKDNNVIGRGGAGVV---YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+I D +G G G+V +T G+ VA+KK++ E++ L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLT--GQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 236 KIRHRNIVRLK-AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
+RH NI+ L F S E V E + L +L + L+ + + +G
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP---LEKQFIQYFLYQILRG 120
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
L Y+H S ++HRD+K +NIL+N + + + DFGLA+ +QD M+ + Y
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQ----MTGYVSTRYYR 172
Query: 355 APEYAYTL-KVDEKSDVYSFGVVLLELITGR 384
APE T K D + D++S G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
K V+G G G VY+G+ P GE+ VA+K+L T ++ L E + + +
Sbjct: 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDN 68
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKR-GS--FLKWEMRLKIAIEAAKG 294
++ RL C T L+ + MP G L + + H GS L W ++ AKG
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---Y 351
++YL ++HRD+ + N+L+ + + DFGLAK L GA E G
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKEYHAEGGKVPI 175
Query: 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411
++A E +SDV+S+GV + EL+T FG + D + +++ + K
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT-------FGSKPYDGIPASEISSILEK-- 226
Query: 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ-AQKPNTF 465
+RL P+ + V+ + + C RP RE++ ++ A+ P +
Sbjct: 227 -----GERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 187 NNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
IG G G VY+GV +P E VAVK T S + L E + + H +I
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHI 69
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
V+L + +V E P G L L + S L + + + + L+YL
Sbjct: 70 VKLIGVITENPV-WIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLE--- 124
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY--GYIAPEYAY 360
S +HRD+ + N+L++S + DFGL++YL+D A G ++APE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED---ESYYKASKGKLPIKWMAPESIN 181
Query: 361 TLKVDEKSDVYSFGVVLLE-LITGRRP 386
+ SDV+ FGV + E L+ G +P
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 68/229 (29%), Positives = 98/229 (42%), Gaps = 59/229 (25%)
Query: 188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIR---H 239
IG G G VY+ N G VA+KK+ + G+ EI L ++ H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS----EEGIPLSTLREIALLKQLESFEH 60
Query: 240 RNIVRLKAFCSNKETN-----LLVYEYM-----------PNGSLGEVLHGKRGSFLKWEM 283
NIVRL C T+ LV+E++ P L +K M
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET-------IKDLM 113
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
R + +G+ +LH S I+HRD+K NIL+ SD + +ADFGLA+ A
Sbjct: 114 R-----QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--- 162
Query: 344 MSAVAGSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+++V + Y APE YA + D++S G + EL RRP
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPV------DMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 190 IGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
IG G GVV+ R G+ VA+KK + S D+ + EIR L +++H N+
Sbjct: 9 IGEGSYGVVFKCRNRE-TGQIVAIKKFV-----ESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
V L K LV+EY + L E+ RG + + KI + + +++ H H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY--- 358
C IHRDVK NIL+ + + DFG A+ L G + VA + Y APE
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRW-YRAPELLVG 174
Query: 359 --AYTLKVDEKSDVYSFGVVLLELITG 383
Y V DV++ G V EL+TG
Sbjct: 175 DTQYGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 73/228 (32%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
IG G G+V T G VAVKKL + +H E+ L + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 248 FCSNKETN-----LLVYEYMPNGSLGEVLH----GKRGSFLKWEMRLKIAIEAAKGLSYL 298
F K LV E M + +L +V+H +R S+L ++M G+ +L
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC--------GIKHL 139
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA--VAGSYGYIAP 356
H S IIHRD+K +NI++ SD + DFGLA+ T + M V Y Y AP
Sbjct: 140 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYVVTRY-YRAP 191
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD-IVQWTKM 403
E + E D++S G ++ EL+ G +G D I QW K+
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIF-----QGTDHIDQWNKV 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG G G+V + G+QVAVKK+ + L E+ + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+ +V E++ G+L +++ R + E + + + LSYLH+ +IH
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+KS++ILL SD ++DFG Q + ++ G+ ++APE L +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 369 DVYSFGVVLLELITGRRP 386
D++S G++++E+I G P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
++G G G+V + G+ VA+KK L S D+ + EIR L ++RH N+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL-----ESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
V L K+ LV+E++ + L ++ G L K + +G+ + H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH--- 117
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S IIHRD+K NIL++ + DFG A+ L G VA + Y APE L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRW-YRAPEL---L 172
Query: 363 KVDEKS----DVYSFGVVLLELITG 383
D K D+++ G ++ E++TG
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 6/191 (3%)
Query: 190 IGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IGRG G V+ G + + VAVK L E R L + H NIVRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIGV 61
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
C+ K+ +V E + G L + G LK + +++ AA G+ YL IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHC---IH 117
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+ + N L+ ++DFG+++ +D + + APE + +S
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 369 DVYSFGVVLLE 379
DV+SFG++L E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 1/93 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N SG IP +IG L LDL N L G IP +T + L +L ++ NQL +P+
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 61 EMGNMKSLTSADFSHNNFSGEIP-EFGQYSFFN 92
E+G MKSL +NN SGEIP E G + N
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
|
Length = 968 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 190 IGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
IG G G+V G QVAVKK+ + K + L E+ + +H NIV + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHPNIVEMYSS 84
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ E +V E++ G+L +++ R + E + + K LS+LH + +I
Sbjct: 85 YLVGDEL-WVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLH---AQGVI 137
Query: 308 HRDVKSNNILLNSDFEAHVADFGL-AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
HRD+KS++ILL SD ++DFG A+ ++ + S V Y ++APE L
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPY-WMAPEVISRLPYGT 194
Query: 367 KSDVYSFGVVLLELITGRRP 386
+ D++S G++++E++ G P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
VIG+G GVV + T GE+VA+KK+ + + S + EI+ L +RH +IV +K
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 248 FC---SNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
S +E +V+E M L +V+ K L E + + L Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-ESDLHQVI--KANDDLTPEHHQFFLYQLLRALKYIH--- 120
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAK-YLQDTGASECMSAVAGSYGYIAPEY--A 359
+ + HRD+K NIL N+D + + DFGLA+ DT + + + Y APE +
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 360 YTLKVDEKSDVYSFGVVLLELITGR 384
+ K D++S G + E++TG+
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 40/264 (15%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
VAVK L K + D LS +E+ + I +H+NI+ L C+ ++ EY
Sbjct: 47 VAVKML----KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102
Query: 265 GSLGEVLHGKRG-----SF---------LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
G+L E L +R SF L ++ + A + A+G+ YL S IHRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDV 370
+ + N+L+ D +ADFGLA+ + + + + ++APE + +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 371 YSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQ 430
+SFGV+L E+ T +G G+ + + K+ KEG R+ + P + +
Sbjct: 220 WSFGVLLWEIFT----LGGSPYPGIPVEELFKLL----KEG------HRM-DKPANCTHE 264
Query: 431 VFFVAMLCVQEHGVERPTMREVVQ 454
++ + C +RPT +++V+
Sbjct: 265 LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 34/179 (18%)
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
K+ + K L YL +IHRDVK +NILL++ + DFG++ L D+ A +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172
Query: 346 AVAGSYGYIAPEY----AYTLKVDEKSDVYSFGVVLLELITGRRPV----GDFGEEGLDI 397
AG Y+APE K D ++DV+S G+ L+EL TG+ P +F
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------- 225
Query: 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAML--CVQEHGVERPTMREVVQ 454
E + KIL + + P +E F + + C+ + +RP RE++Q
Sbjct: 226 ------------EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI- 237
E +K +VIG G G V R + A+K L + H + + E+ L K+
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLG 60
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEM 283
H NI+ L C N+ + EY P G+L + L R S L +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK----YLQDT- 338
L+ A + A G+ YL IHRD+ + N+L+ + + +ADFGL++ Y++ T
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
G S Y YT KSDV+SFGV+L E+++
Sbjct: 178 GRLPVRWMAIESLNY----SVYT----TKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 190 IGRGGAGVVYRGVTPNG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G V G G +V VK+L L E++ ++ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQCL 61
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL---KWEMRLKIAIEAAKGLSYLHHDCS 303
C LLV E+ P G L L RG + ++ ++A E A GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLA--KYLQDTGASECMSAVAGSYGYIAPEYA-- 359
IH D+ N L +D + D+GLA +Y +D ++ AV ++APE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPELVEI 176
Query: 360 -----YTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
+KS+++S GV + EL T +P D +E +++ + +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVREQDIK----- 229
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
L + + S+ + + V C + RPT EV ++L
Sbjct: 230 --LPKPQLDLKYSD--RWYEVMQFCWLDPE-TRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 56/225 (24%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNIV 243
IGRG G+V + E+VA+KK+ ++ DN + A EI+ L + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-----ANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 244 RLK---------AFCSNKETNLLVYEYMPNGSLGEVLHGKRG-------SFLKWEMRLKI 287
+K AF +VYE M + L +++ + FL +R
Sbjct: 68 AIKDIMPPPHREAF----NDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR--- 119
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
GL Y+H S ++HRD+K +N+LLN++ + + DFGLA+ + G + M+
Sbjct: 120 ------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEY 168
Query: 348 AGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGRRPV 387
+ Y APE YT + DV+S G + EL+ GR+P+
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRL-- 245
IG+G G V++ + NG + AVK L I D + AE L + H N+V+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 246 ---KAFCSNKETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHH 300
K N + LV E GS+ +++ G KRG ++ + I EA GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY-- 358
+ + IHRDVK NNILL ++ + DFG++ L T S G+ ++APE
Sbjct: 143 NKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIA 197
Query: 359 ---AYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390
D + DV+S G+ +EL G P+ D
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 78/283 (27%), Positives = 125/283 (44%), Gaps = 40/283 (14%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVK--KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
V+G G G V+ +GE AVK + G+++ N AE+ L +IV+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK--NRAQAEVCCLLNCDFFSIVKC 96
Query: 246 -KAFCSNKETN-------LLVYEYMPNGSLGEVLHGKRGS---FLKWEMRLKIAIEAAKG 294
+ F N LV +Y G L + + + + F + E L + I+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQV--- 152
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
L +HH S +IHRD+KS NILL S+ + DFG +K T + + G+ Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414
APE +K+D++S GV+L EL+T +RP +G ++ +E + K
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENM-----------EEVMHK 256
Query: 415 ILDQRLSNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
L R P +S MQ A+L RP+ +++ M
Sbjct: 257 TLAGRYDPLPPSISPEMQEIVTALLSSDPK--RRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 76/308 (24%), Positives = 134/308 (43%), Gaps = 60/308 (19%)
Query: 181 LECVKDNNVIGRGGAGVVYR----GVTPNGEQ--VAVKKLLGITKGSSHD--NGLSAEIR 232
+E V+D IG+G G V++ G+ P VAVK L + +S D E
Sbjct: 7 IEYVRD---IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAA 60
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH-------------------- 272
+ + H NIV+L C+ + L++EYM G L E L
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
G L +L IA + A G++YL +HRD+ + N L+ + +ADFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 333 K--YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGD 389
+ Y D + A+ ++ PE + + +SDV+++GVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY-- 233
Query: 390 FGEEGLDIVQWTKMQTNSSKEGVVK-ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT 448
+G + E V+ + D + + P + ++++ + LC + +RP+
Sbjct: 234 YG---------------MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPS 278
Query: 449 MREVVQML 456
+ ++L
Sbjct: 279 FASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
+G+GG G V V G+ A KKL L KG + E + L K+ R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVS 57
Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
L A+ + +L LV M G L + G+ G F + A + GL +LH
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAA-QIICGLEHLHQR 114
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
I++RD+K N+LL+ ++D GLA L+ + + AG+ GY+APE
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQG 168
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393
D D ++ G L E+I GR P E+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
IG+G +G VY + G++VA+K++ + + EI + + +H NIV L +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA------KGLSYLHHD 301
+ E +V EY+ GSL +V+ E + AA + L +LH
Sbjct: 85 YLVGDEL-WVVMEYLAGGSLTDVVT---------ETCMDEGQIAAVCRECLQALEFLH-- 132
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
S +IHRD+KS+NILL D + DFG Q T S + G+ ++APE
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP 386
K D++S G++ +E++ G P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 70/223 (31%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLGITKGSSHDN----GLSAEIR---TLGKIRHR 240
V+GRG G V+ GE A+K L KG L E R T RH
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKAL---KKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLH 299
+V L A ++ V EY G L ++H F E R A GL YLH
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFS--EPRAVFYAACVVLGLQYLH 118
Query: 300 -HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
+ I++RD+K +N+LL+++ +ADFGL K + G + S G+ ++APE
Sbjct: 119 ENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEV 172
Query: 359 ----AYTLKVDEKSDVYSFGVVLLELITGRRPV-GDFGEEGLD 396
+YT V D + GV++ E++ G P GD EE D
Sbjct: 173 LTETSYTRAV----DWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 190 IGRGGAGVVYR----GVTPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRN 241
+G G G V R G+ + V + + K ++ D L+ +E+ + I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG-----SF---------LKWEMRLKI 287
I+ L C+ + ++ EY G+L E L +R +F L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
A + A+G+ YL S IHRD+ + N+L+ D +ADFGLA+ + D + S
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
++APE + +SDV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG G GVVY+ GE VA+KK+ T+ + EI L ++ H NIV+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+ LV+E++ + L + + S + + + +GL++ H S ++H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA-----YTLK 363
RD+K N+L+N++ +ADFGLA+ + V + Y APE Y+
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYYSTA 181
Query: 364 VDEKSDVYSFGVVLLELITGR 384
V D++S G + E++T R
Sbjct: 182 V----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 65/270 (24%), Positives = 120/270 (44%), Gaps = 29/270 (10%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
++G G G VY+ ++ K++ + + +E+ L K I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 248 --FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F N+ + + E+M GSL ++ K + + +IA+ KGL+YL S
Sbjct: 67 AFFVENRIS--ICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYL---WSLK 115
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I+HRDVK +N+L+N+ + + DFG++ L ++ A G+ Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYG 171
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425
SDV+S G+ +EL GR P + ++ +Q I+D+ P+
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC---------IVDEDPPVLPV 222
Query: 426 SEAMQVF--FVAMLCVQEHGVERPTMREVV 453
+ + F F+ C+++ ERP ++
Sbjct: 223 GQFSEKFVHFITQ-CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 53/154 (34%), Positives = 79/154 (51%), Gaps = 17/154 (11%)
Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDCSP 304
FC+ KE V EY+ NG G+++ + S E R + A E GL +LH
Sbjct: 62 FCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KK 115
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK---YLQDTGASECMSAVAGSYGYIAPEYAYT 361
II+RD+K +N+LL+ D +ADFG+ K + ++ C G+ YIAPE
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-----GTPDYIAPEILKG 170
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
K +E D +SFGV+L E++ G+ P E+ L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 184 VKDNNVIGRGGAGVVYRG-VTPNGEQV--AVKKLLGITKGSSHDNGLSAEIRTLGKI-RH 239
+K +VIG G G V + + +G ++ A+K++ H + + E+ L K+ H
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHH 67
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRL 285
NI+ L C ++ L EY P+G+L + L R S L + L
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
A + A+G+ YL IHRD+ + NIL+ ++ A +ADFGL++ Q+ + M
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMG 183
Query: 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
+ ++A E SDV+S+GV+L E+++
Sbjct: 184 RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 189 VIGRGGAGVVYRGV--TPNGEQ--VAVK--KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
++G G G V G +G Q VAVK KL T S +E + H N+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNV 63
Query: 243 VRLKAFCSNKETN------LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAA 292
++L C + +++ +M +G L L R L + LK ++ A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGASECMSAVAGS 350
G+ YL + IHRD+ + N +L D VADFGL+K Y D ++ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--P 178
Query: 351 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
+IA E KSDV++FGV + E+ T G+ P
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 13/216 (6%)
Query: 184 VKDNNVIGRGGAGVVYRGVT--PNGEQVAVK-KLLGITKGSSHDNGLSAEIRTLGKIRHR 240
+K ++G G G + RG P+ ++ V L G AE TLG+ H
Sbjct: 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS 66
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
NIVRL+ + T ++V EYM NG+L L G + ++ + + A G+ YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-MGMLPGLASGMKYL-- 123
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG--YIAPEY 358
+H+ + ++ +L+NSD ++ F LQ+ + + ++G + APE
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEE 393
SDV+SFG+V+ E+++ G RP D +
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 24/205 (11%)
Query: 190 IGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDN-----GLSAEIRTLGKIRHR-N 241
I +G G VY + + G+ A+K L K S + AE +
Sbjct: 4 ISKGAFGSVYLAKKRS-TGDYFAIKVL----KKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+ +L +K+ LV EY+ G ++ G W + E G+ LH
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR 116
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
IIHRD+K N+L++ + DFGL++ G+ Y+APE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILG 167
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP 386
+ D+ SD +S G V+ E + G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 69/267 (25%), Positives = 124/267 (46%), Gaps = 40/267 (14%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
+VAVK L K + + LS +E+ + I +H+NI+ L C+ ++ EY
Sbjct: 52 KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107
Query: 264 NGSLGEVLHGKRGSFLKW----------EMRLK----IAIEAAKGLSYLHHDCSPLIIHR 309
G+L E L +R +++ ++ K A + A+G+ YL S IHR
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHR 164
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+ + N+L+ D +ADFGLA+ + + + ++APE + +SD
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 370 VYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAM 429
V+SFGV+L E+ T +G G+ + + K+ KEG R+ + P +
Sbjct: 225 VWSFGVLLWEIFT----LGGSPYPGVPVEELFKLL----KEG------HRM-DKPSNCTN 269
Query: 430 QVFFVAMLCVQEHGVERPTMREVVQML 456
+++ + C +RPT +++V+ L
Sbjct: 270 ELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
IG+G +G VY + G++VA+K++ + + EI + + ++ NIV L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ E +V EY+ GSL +V+ + + + E + L +LH S +I
Sbjct: 85 YLVGDEL-WVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLH---SNQVI 137
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+KS+NILL D + DFG Q T S + G+ ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 368 SDVYSFGVVLLELITGRRP 386
D++S G++ +E++ G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRT---LGKIRHRNIVRL 245
+G G VY+G GE VA+K++ + + S IR + +++H NIVRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ +LV+EYM + L + + HG RG+ L + KG+++ H +
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN-- 119
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ---DTGASECMSAVAGSYGYIAPEYAY 360
++HRD+K N+L+N E +ADFGLA+ +T ++E + + Y AP+
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TLWYRAPDVLL 173
Query: 361 TLKVDEKS-DVYSFGVVLLELITGR 384
+ S D++S G ++ E+ITGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 27/261 (10%)
Query: 209 VAVKKLLG-ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
VAVK L +TK + +D EI+ + ++++ NI+RL C + + ++ EYM NG L
Sbjct: 47 VAVKMLRADVTKTARND--FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 268 GEVLHGK--RGSFLK--------WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
+ L + +F L +A++ A G+ YL S +HRD+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 377
+ + + +ADFG+++ L ++A E K SDV++FGV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 378 LELIT--GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVA 435
E+ T +P +E +++ T + + LS TPL + VF +
Sbjct: 222 WEMFTLCKEQPYSLLSDE--QVIENTGEFFRNQGRQIY------LSQTPLCPS-PVFKLM 272
Query: 436 MLCVQEHGVERPTMREVVQML 456
M C +RPT ++ L
Sbjct: 273 MRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 190 IGRGGAGVV-YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG G G+V V +G+ VAVKK+ + L E+ + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
+ +V E++ G+L +++ R + E + + K LS LH + +IH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIH 139
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
RD+KS++ILL D ++DFG Q + ++ G+ ++APE L +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 369 DVYSFGVVLLELITGRRP 386
D++S G++++E++ G P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 72/295 (24%), Positives = 121/295 (41%), Gaps = 53/295 (17%)
Query: 189 VIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G G V + VAVK +L SS L +E L ++ H ++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLH-------------GKRGSF---------LK 280
++L CS LL+ EY GSL L G R S L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDT 338
+ A + ++G+ YL ++HRD+ + N+L+ + ++DFGL++ Y +D+
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDI 397
+ ++A E + +SDV+SFGV+L E++T G P E L
Sbjct: 183 YVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL-- 238
Query: 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREV 452
+ ++T E R N SE M + + + C ++ +RPT ++
Sbjct: 239 --FNLLKTGYRME--------RPENC--SEEM--YNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNIVR 244
IG G G V++ E VA+K++ + D G+ SA EI L +++H+NIVR
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 245 LKAFCSNKETNLLVYEYMP-------NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
L + + LV+EY + G++ SF+ + KGL++
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM---------FQLLKGLAF 114
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAP 356
H S ++HRD+K N+L+N + E +ADFGLA+ G C SA + Y P
Sbjct: 115 CH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPP 168
Query: 357 EYAYTLKVDEKS-DVYSFGVVLLELITGRRPV 387
+ + K+ S D++S G + EL RP+
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+D +G G G V + G +VA+KKL + E+R L ++H N++
Sbjct: 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVI 77
Query: 244 RL-KAFCSNKETNLL--VYEYMP--NGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSY 297
L F + + Y MP LG+++ ++ S E R++ + + KGL Y
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----EDRIQFLVYQMLKGLKY 133
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
+H + IIHRD+K N+ +N D E + DFGLA+ SE M+ + Y APE
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SE-MTGYVVTRWYRAPE 185
Query: 358 YAYT-LKVDEKSDVYSFGVVLLELITGR 384
+ + D++S G ++ E++TG+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 188 NVIGRGGAGVVYRG-VTPNGEQV--AVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIV 243
+VIG G G V + + +G ++ A+K++ H + + E+ L K+ H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAI 289
L C ++ L EY P+G+L + L R S L + L A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK----YLQDT-GASECM 344
+ A+G+ YL IHRD+ + NIL+ ++ A +ADFGL++ Y++ T G
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
S Y YT SDV+S+GV+L E+++
Sbjct: 177 WMAIESLNY----SVYT----TNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 3e-13
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
IG+G +G VY + G++VA++++ + + EI + + ++ NIV L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ E +V EY+ GSL +V+ + + + E + L +LH S +I
Sbjct: 86 YLVGDEL-WVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+KS+NILL D + DFG Q T S + G+ ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 368 SDVYSFGVVLLELITGRRP 386
D++S G++ +E+I G P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKA 247
+G G G V T G +VAVKKL + H E+R L ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 248 FC---SNKETN-LLVYEYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYL 298
F S +E N + + ++ L ++ ++ + FL +++ +GL Y+
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYI 136
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
H S IIHRD+K +N+ +N D E + DFGLA++ D M+ + Y APE
Sbjct: 137 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 188
Query: 359 AYT-LKVDEKSDVYSFGVVLLELITGR 384
+ ++ D++S G ++ EL+TGR
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 67/266 (25%), Positives = 123/266 (46%), Gaps = 40/266 (15%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
VAVK L K + + LS +E+ + I +H+NI+ L C+ ++ EY
Sbjct: 50 VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
G+L E L +R +++ +M K + + A+G+ YL S IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDV 370
+ + N+L+ + +ADFGLA+ + + + + ++APE + +SDV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 371 YSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQ 430
+SFGV++ E+ T +G G+ + + K+ KEG R+ + P + +
Sbjct: 223 WSFGVLMWEIFT----LGGSPYPGIPVEELFKLL----KEG------HRM-DKPANCTNE 267
Query: 431 VFFVAMLCVQEHGVERPTMREVVQML 456
++ + C RPT +++V+ L
Sbjct: 268 LYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 46/297 (15%)
Query: 190 IGRGGAGVVYRGVTPN---GE---QVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHRN 241
+G+G G+VY G + GE +VAVK + + +S + E + +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKT---VNESASLRERIEFLNEASVMKGFTCHH 70
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIEA 291
+VRL S + L+V E M +G L L G+ L+ EM +++A E
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAEI 128
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
A G++YL+ + +HRD+ + N ++ DF + DFG+ + + +T
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
++APE SD++SFGVVL E+ + +P +GL S E
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-----QGL------------SNE 228
Query: 411 GVVK-ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466
V+K ++D + P + +V + +C Q + RPT E+V +L P +F
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP-SFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 8e-13
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 229 AEIRTLGKIRHRNIVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
E R L IRH +V L +F + NL LV EY+P G L K G F + R
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDS--NLYLVMEYVPGGELFS-HLRKSGRFPEPVARFY 106
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
A + L YLH I++RD+K N+LL+SD + DFG AK ++ + C
Sbjct: 107 AA-QVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--- 159
Query: 347 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ Y+APE + + D ++ G+++ E++ G P
Sbjct: 160 --GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
IG G G+V +G QVAVK ++ + K + L E+ + +H+N+V + K+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKS 86
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ +E +L+ E++ G+L +++ R L E + + L YLH S +I
Sbjct: 87 YLVGEELWVLM-EFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVI 139
Query: 308 HRDVKSNNILLNSDFEAHVADFGL-AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
HRD+KS++ILL D ++DFG A+ +D + ++ G+ ++APE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGT 196
Query: 367 KSDVYSFGVVLLELITGRRP 386
+ D++S G++++E++ G P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 65/240 (27%), Positives = 94/240 (39%), Gaps = 60/240 (25%)
Query: 189 VIGRGGAGVVYRGVTPNGEQV-AVKKLLGITKGSSHDNGLSAEIRT----LGKIRHRNIV 243
VIGRG G V+ + QV A+K L K A +R L IV
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLR---KSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 244 RLKAFCSNKETNLL--VYEYMPNGSL------GEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
+L + S ++ L V EYMP G L +V + F E+ L A+++ L
Sbjct: 65 KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL--ALDSVHKL 120
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMS-------- 345
+ IHRD+K +NIL+++D H+ ADFGL K + E
Sbjct: 121 GF---------IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 346 -------------------AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ G+ YIAPE + D +S GV+L E++ G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 190 IGRGGAGVVYRGVTPNGE---QVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G G G V G + +VAVK + + I S ++ LS E + + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDHPNVMRL 65
Query: 246 KAFCSNKETN------LLVYEYMPNGSLGE-VLHGKRGS---FLKWEMRLKIAIEAAKGL 295
C + +++ +M +G L +L+ + G +L +M +K + A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
YL S IHRD+ + N +LN + VADFGL+K + + +IA
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
E KSDV+SFGV + E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
IG+G +G V+ + G++VA+K++ + K + ++ EI + ++++ NIV L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIIN-EILVMKELKNPNIVNFLDS 84
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
F E +V EY+ GSL +V+ + + + E + L +LH + +I
Sbjct: 85 FLVGDEL-FVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+KS+N+LL D + DFG Q T S + G+ ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 368 SDVYSFGVVLLELITGRRP 386
D++S G++ +E++ G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 181 LECVKDNNVIGRGGAGVVYRG--VTPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTLG 235
L V+ +G G +Y+G P + VA+K L I E +
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMA 62
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-----HGKRG----------SFLK 280
++ H NIV L + ++ +++EY+ G L E L H G S L
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
L IAI+ A G+ YL S +H+D+ + NIL+ ++D GL++ +
Sbjct: 123 HGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
Query: 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFG-EEGLDIV 398
++ PE K SD++SFGVVL E+ + G +P F +E +++V
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 399 Q 399
+
Sbjct: 240 R 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+C+ KE V EY+ G L + H + A E GL +LH S
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKG 116
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I++RD+K +NILL++D +ADFG+ K A C G+ YIAPE K +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--TFCGTPDYIAPEILLGQKYN 174
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
D +SFGV+L E++ G+ P EE L
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSA--EIRTLGKIRHRNIVRLK 246
+G G VY+G++ NG+ VA+K I+ + +A E L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKV---ISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
KET V+EYM + L + + G + +RL + +GL+Y+H I
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HI 124
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-------EYA 359
+HRD+K N+L++ E +ADFGLA+ + S+ S+ + Y P +Y+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 360 YTLKVDEKSDVYSFGVVLLELITGR 384
L D++ G + +E++ G+
Sbjct: 183 SAL------DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 182 ECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDNGLS-------AEIR 232
ECV + IG G G V+ R + G VA+K++ + + + G+ A +R
Sbjct: 4 ECVAE---IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLR 56
Query: 233 TLGKIRHRNIVRLKAFCS----NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
L H N+VRL C+ ++ET L LV+E++ + L L + E +
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 115
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
+ +GL +LH S ++HRD+K NIL+ S + +ADFGLA+ A +++V
Sbjct: 116 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSV 169
Query: 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387
+ Y APE D++S G + E+ R+P+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 174 DFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
D +++ E + + +G G G VY+ +A K++ TK EI
Sbjct: 7 DLDPNEVWEIIGE---LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEI 62
Query: 234 LGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSLGEV-LHGKRGSFLKWEMRLKIAIEA 291
L H IV+L AF + + +++ E+ P G++ + L RG L I +
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRG--LTEPQIQVICRQM 119
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
+ L YLH S IIHRD+K+ N+LL D + +ADFG++ ++ + + G+
Sbjct: 120 LEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTP 174
Query: 352 GYIAPEYAY--TLK---VDEKSDVYSFGVVLLEL 380
++APE T+K D K+D++S G+ L+E+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLS-------AEIRTLGKIRHRN 241
IG G G VY+ P+ G VA+K + + ++++GL A ++ L H N
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 242 IVRLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
IVRL C+ T+ LV+E++ + L L L E + + +GL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
+LH +C I+HRD+K NIL+ S + +ADFGLA+ A ++ V + Y AP
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP 176
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387
E D++S G + E+ R+P+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
VAVK L ++ ++ L EI+ + +++ NI+RL A C + ++ EYM NG L
Sbjct: 49 VAVKMLREDANKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 269 EVL--HGKRGSFLKWEMR-------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
+ L H + + K ++ + +A + A G+ YL S +HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 379
++ +ADFG+++ L +++ E K SDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 380 LIT 382
++T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 24/175 (13%)
Query: 227 LSAEIRTLGKIRHRNIVRL----KAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLK 280
E ++ H NIV L +A LL V+EY+P +L EVL L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-----PPGLLFAVFEYVPGRTLREVLAAD--GALP 77
Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAH--VADFGLAKYLQD 337
++ ++ L+ H+ I+HRD+K NI+++ + H V DFG+ L
Sbjct: 78 AGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134
Query: 338 TGASECMSA-----VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387
++ + V G+ Y APE V SD+Y++G++ LE +TG+R V
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
+G G G V + GE+VA+KKL + E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 248 FCSNKETN-----LLVYEYMP---NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
F S + LV YM +G L + +L ++M GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
S IIHRD+K N+ +N D E + DFGLA++ A M+ + Y APE
Sbjct: 135 ---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVI 186
Query: 360 YT-LKVDEKSDVYSFGVVLLELITGR 384
+ ++ D++S G ++ E++TG+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 190 IGRGGAGVVYRGVTPN---GEQVAVKKLLGITKGSSHDN-GLSA----EIRTLGKIRHRN 241
IGRG G VY+ N G++ A+KK KG G+S EI L +++H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHEN 63
Query: 242 IVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLH---GKRGSFLKWEMRLKIAIEAAKGLS 296
+V L + F + + ++ L+++Y + L +++ + + M + + G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQD---TGASECMSAVAG 349
YLH S ++HRD+K NIL+ + + D GLA+ A V
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL--DPVVV 177
Query: 350 SYGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELIT 382
+ Y APE YT + D+++ G + EL+T
Sbjct: 178 TIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKI-RHRNIVRLK 246
+G G G VY GE VA+KK+ K S + ++ E+++L K+ H NIV+LK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM--KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 247 -AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK-IAIEAAKGLSYLHHDCSP 304
F N E V+EYM G+L +++ ++G E ++ I + +GL+++H
Sbjct: 65 EVFRENDELYF-VFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHG-- 119
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
HRD+K N+L++ +ADFGLA+
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 10/201 (4%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
VIG+G G V + K+L I K + ++ L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ V +Y+ G L L +R SF + R A E A L YLH S
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
II+RD+K NILL+S + DFGL K + S+ S G+ Y+APE D
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + G VL E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
+G+G G VY+ + P G +A+K++ + S N + E+ L K IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCSPLII 307
+ + EYM GSL ++ G + E L +I KGL +L + + II
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY--------- 358
HRDVK N+L+N + + + DFG++ L + A + G Y+APE
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQN 181
Query: 359 -AYTLKVDEKSDVYSFGVVLLELITGRRP 386
YT+ +SDV+S G+ +LE+ GR P
Sbjct: 182 PTYTV----QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 34/227 (14%)
Query: 190 IGRGGAGVV---YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
IG G G+V Y V VA+KKL + +H E+ + + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 246 KAFCSNK-----ETNLLVYEYMPNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLS 296
F K + LV E M + +L +V L +R S+L ++M G+
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIK 133
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
+LH S IIHRD+K +NI++ SD + DFGLA+ G S M+ + Y AP
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM 403
E + E D++S G ++ E++ R + G + +D QW K+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYID--QWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 41/290 (14%)
Query: 189 VIGRG---GAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
++GR A V RG P + VA +L + +++ +E+ L H IV+
Sbjct: 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYAR---SELHCLAACDHFGIVKH 130
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGK---RGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ + LL+ EY G L + + + F ++E+ L + + L +H
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK 189
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
++HRD+KS NI L + DFG +K D+ + + S+ G+ Y+APE
Sbjct: 190 ---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422
+ +K+D++S GV+L EL+T RP + S +E I+ Q L
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRP----------------FKGPSQRE----IMQQVLYG 286
Query: 423 T------PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466
P+S M+ +L ++ RPT ++++ N FQ
Sbjct: 287 KYDPFPCPVSSGMKALLDPLL--SKNPALRPTTQQLLHTEFLKYVANLFQ 334
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 190 IGRGGAGVVYRGVTPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKA 247
IG G G+V E+ VA+KKL + +H E+ + + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 248 FCSNKETN-----LLVYEYMPNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
F K +V E M + +L +V L +R S+L ++M G+ +L
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHL 142
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
H S IIHRD+K +NI++ SD + DFGLA+ G S M+ + Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 196
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRR--PVGDFGEEGLDIVQWTKM 403
+ E D++S G ++ E+I G P D I QW K+
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG--ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
V+G+GG G V V G+ A KKL I K L+ E + L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRFVVSL 65
Query: 246 KAFCSNKETNLLVYEYMPNGSLG-EVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDCS 303
K+ LV M G L + H F E R A E GL LH +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE--EGRAVFYAAEICCGLEDLHQE-- 121
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
I++RD+K NILL+ ++D GLA ++ + + + G+ GY+APE +
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNER 177
Query: 364 VDEKSDVYSFGVVLLELITGRRP 386
D ++ G +L E+I G+ P
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 64/201 (31%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
VIG+G G V+ +G AVK L I K ++ ++ L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
E V +Y+ G L L +R FL+ R A E A + YLH S
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARF-YAAEVASAIGYLH---SLN 116
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
II+RD+K NILL+S + DFGL K + E S G+ Y+APE D
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + G VL E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G G VY+ G VA+KK+L K L EI+ L K++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 248 FC-----SNKETNLLVYEYMP--NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
+K VY P + L +L + +++ ++ +G++YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC-YMLQLLEGINYLH- 132
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLA----------KYLQDTGASECMSAVAGS 350
I+HRD+K+ NIL+++ +ADFGLA K G + + V
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 351 YGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGRRPV 387
+ Y PE YT V D++ G V E+ T RRP+
Sbjct: 191 W-YRPPELLLGERRYTTAV----DIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 62/273 (22%), Positives = 121/273 (44%), Gaps = 33/273 (12%)
Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
V+G+G G V +R +G+Q +KKL E + L +++H NIV
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ ++ L +V + G L L ++G L ++ ++ A L YLH
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-- 121
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
I+HRD+K+ N+ L V D G+A+ L++ + S + G+ Y++PE
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIGTPYYMSPELFSNKP 178
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423
+ KSDV++ G + E+ T + F + ++ + V +I++ +L
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHA---FNAKDMNSL-------------VYRIIEGKLPPM 222
Query: 424 PLSEAMQV--FFVAMLCVQEHGVERPTMREVVQ 454
P + ++ ML + +RP+++ +++
Sbjct: 223 PKDYSPELGELIATMLSKRPE--KRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG--ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
V+G+GG G V V G+ A K+L I K L+ E + L K+ + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQFVVNL 65
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
K+ LV M G L ++ + E L A E GL LH +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--- 122
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
++RD+K NILL+ ++D GLA + + E + G+ GY+APE +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + G ++ E+I G+ P
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 36/213 (16%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNIV 243
IG G GVV+ P +G++VA+KK+ + N +S E++ L +H N+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV-----FQNLVSCKRVFRELKMLCFFKHDNV- 61
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL-----KIAI-EAAKGLSY 297
L A + ++ +E + + E++ + L K+ + + +GL Y
Sbjct: 62 -LSALDILQPPHIDPFEEIY--VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA-VAGSYGYIAP 356
LH S I+HRD+K N+L+NS+ + DFGLA+ +++ S+ M+ V Y Y AP
Sbjct: 119 LH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQY-YRAP 173
Query: 357 EYA-----YTLKVDEKSDVYSFGVVLLELITGR 384
E YT V D++S G + EL+ R
Sbjct: 174 EILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 56/237 (23%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNIV 243
IG+GG G VY P +VA+KK I + S +N L E + + H IV
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKK---IREDLS-ENPLLKKRFLREAKIAADLIHPGIV 65
Query: 244 RLKAFCSNKETNLLVYEYMP----------------NGSLGEVLHGKR--GSFLKWEMRL 285
+ + CS+ + VY MP SL + L K G+FL
Sbjct: 66 PVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS----- 117
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ--------- 336
I + + Y+H S ++HRD+K +NILL E + D+G A + +
Sbjct: 118 -IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 337 DTGASECMSA-------VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
D + + G+ Y+APE + E +D+Y+ GV+L +++T P
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 34/228 (14%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
+G+GG G V+ + GE VA+K LL H + E L + +V+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH---VLTERDILTTTKSEWLVK 65
Query: 245 LKAFCSNKETNLLVYEYMPNG-------SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
L + E L EY+P G +LG VL F EM A++A L Y
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFE--AVDALHELGY 122
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
IHRD+K N L+++ + DFGL+K G ++V GS Y+APE
Sbjct: 123 ---------IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPV-GDFGEEGL-DIVQWTKM 403
D D +S G +L E + G P G E ++ W +
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAF 248
+G G G VY+ +A K++ TK EI L H NIV+L AF
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
E NL ++ E+ G++ V+ + ++R+ + + + L+YLH + II
Sbjct: 72 --YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY--TLK-- 363
HRD+K+ NIL D + +ADFG++ ++T + + G+ ++APE T K
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 364 -VDEKSDVYSFGVVLLEL 380
D K+DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
+G G G VY+ + ++A K++ + G + + EI + + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
++E + EY GSL ++ H G + ++ + E +GL+YLH S +HR
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAY-VCRETLQGLAYLH---SKGKMHR 130
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK---VDE 366
D+K NILL + + +ADFG+A + T A + G+ ++APE A K ++
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 367 KSDVYSFGVVLLELITGRRPVGDF 390
D+++ G+ +EL + P+ D
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 7/158 (4%)
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
+H + +L + K+ V EY+ G L + H +R A E GL +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
LH II+RD+K +N+LL+S+ +ADFG+ K + S G+ YIAPE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPE 166
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
D ++ GV+L E++ G+ P E+ L
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 190 IGRGGAGVVYRGVTPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G G G V +GV ++ VA+K L + S D + E + ++ + IVR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDE-MMREAEIMHQLDNPYIVRMI 61
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
C E +LV E G L + L GK+ + +++ + + G+ YL
Sbjct: 62 GVCE-AEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
+HRD+ + N+LL + A ++DFGL+K L D + SA + APE K
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 366 EKSDVYSFGVVLLELIT-GRRP 386
+SDV+S+G+ + E + G++P
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
VAVK +L + N E++ L +++ NI+RL C +++ ++ EYM NG L
Sbjct: 49 VAVK-ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 269 EVLHGKR-----------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV 311
+ L + + L +A++ A G+ YL S +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 312 KSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVY 371
+ N L+ + +ADFG+++ L ++A E K SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 372 SFGVVLLELIT--GRRPVGDFGEE 393
+FGV L E++ +P G+ +E
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
+G+GG G V + G+ A KKL L KG G E R L K+ R IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYE---GAMVEKRILAKVHSRFIVS 57
Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
L A+ +T+L LV M G L ++ + + GL +LH
Sbjct: 58 L-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
II+RD+K N+LL++D ++D GLA L+D AG+ G++APE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGFMAPELLQG 171
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393
+ D D ++ GV L E+I R P GE+
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 10/144 (6%)
Query: 252 KETNLLVYEYMPNGSLGEVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
KE V E++ G L + H +G F + A E GL +LH S II+RD
Sbjct: 68 KEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATF-YAAEIVCGLQFLH---SKGIIYRD 121
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDV 370
+K +N++L+ D +ADFG+ K ++ S G+ YIAPE LK D
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 371 YSFGVVLLELITGRRPV-GDFGEE 393
+SFGV+L E++ G+ P GD +E
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLG---ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
VIGRG G V + ++V KLL + K S D+ E R + + V +
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWV-V 106
Query: 246 KAFCSNKETNLL--VYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLSYL 298
+ FC+ ++ L V EYMP G L ++ K F E+ L + + GL
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL--- 163
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
IHRDVK +N+LL+ +ADFG + +TG C +AV G+ YI+PE
Sbjct: 164 --------IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEV 214
Query: 359 AYTLKVD----EKSDVYSFGVVLLELITGRRP 386
+ D + D +S GV L E++ G P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 49/166 (29%), Positives = 69/166 (41%), Gaps = 7/166 (4%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
E R L RH + LK K+ V EY+ G L H R +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
E L YLH S I++RD+K N++L+ D + DFGL K + + M G
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCG 157
Query: 350 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
+ Y+APE D + GVV+ E++ GR P + E L
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 38/194 (19%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETN--LLVYEY 261
G+ A+K + K N L EI+ L ++ H NI+RL +++T LV+E
Sbjct: 23 TGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLK-IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
M + +L E++ G++ E R+K + K L ++H + I HRD+K NIL+
Sbjct: 82 M-DMNLYELIKGRKRPLP--EKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD 135
Query: 321 DFEAHVADFGLAKYLQDTG------------ASECMSAVAGSYGYIAPEYAYTLKVDEKS 368
D +ADFG + + A EC+ G YG K
Sbjct: 136 D-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL-LTDGYYGP-------------KM 180
Query: 369 DVYSFGVVLLELIT 382
D+++ G V E+++
Sbjct: 181 DIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 226 GLSAEIRTLGKIRHRNIVRLKA-FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
G + E L I H +I++LK F NK T L++ Y + L L KR
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKR--------N 178
Query: 285 LKI----AIEAA--KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
+ I AIE + + + YLH + IIHRD+K+ NI +N + + DFG A + D
Sbjct: 179 IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD 396
A++ AG+ APE D++S G+VL E+ T + F ++GLD
Sbjct: 236 NANK-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL--FEKDGLD 290
|
Length = 391 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 50/203 (24%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-L 245
IGRG VYR + + VA+KK + + + + + EI L ++ H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHPNVIKYL 68
Query: 246 KAFCSNKETNLLVYEYMPNGSLGE-VLHGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCS 303
+F + E N+ V E G L + + + K+ L E + K ++ + ++H S
Sbjct: 69 DSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
++HRD+K N+ + + + D GL ++ + + ++ G+ Y++PE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 364 VDEKSDVYSFGVVLLELITGRRP 386
+ KSD++S G +L E+ + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
VIG+G G V E+ K+L I K + +S L ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ V +Y+ G L L +R FL+ R A E A L YLH S
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARF-YAAEIASALGYLH---SLN 116
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I++RD+K NILL+S + DFGL K ++ + S G+ Y+APE + D
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + G VL E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 13/215 (6%)
Query: 190 IGRGGAGVVYRGV--TPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G G G V +G+ E+ VAVK L + + L E + ++ + IVR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
C E+ +LV E G L + L + + + ++ + + G+ YL
Sbjct: 63 GICE-AESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETN---F 116
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
+HRD+ + N+LL + A ++DFGL+K L D + + + APE K
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 366 EKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399
KSDV+SFGV++ E + G++P G +G ++ Q
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPY--KGMKGNEVTQ 209
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 44/230 (19%)
Query: 187 NNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-------------EIR 232
+G G G V + T G+ VA+KK+ I + S+ E++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 233 TLGKIRHRNIVRLKA-FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
+ +I+H NI+ L + NL V + M L +V+ K L I ++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINL-VMDIM-ASDLKKVVDRK--IRLTESQVKCILLQI 128
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA-KYLQDTGASEC------- 343
GL+ LH +HRD+ NI +NS +ADFGLA +Y +
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 344 ----MSAVAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 384
M++ + Y APE Y V D++S G + EL+TG+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAV----DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 37/108 (34%), Positives = 58/108 (53%), Gaps = 5/108 (4%)
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
A E A GL +LH S II+RD+K +N++L+++ +ADFG+ K G +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TF 161
Query: 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
G+ YIAPE + D ++FGV+L E++ G+ P E+ L
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 8/139 (5%)
Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
C + L LV EY+ G L + H +R L E A E L++LH II
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---II 118
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
+RD+K +N+LL++D + D+G+ K + G + S G+ YIAPE +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 368 SDVYSFGVVLLELITGRRP 386
D ++ GV++ E++ GR P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG G G VY+ N ++A K++ + G + EI + +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
++ + E+ GSL ++ H G + ++ ++ E +GL YLH +HR
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAY-VSRETLQGLYYLHSKGK---MHR 130
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK---VDE 366
D+K NILL + +ADFG++ + T A + G+ ++APE A + ++
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 367 KSDVYSFGVVLLELITGRRPVGDF 390
D+++ G+ +EL + P+ D
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 8 GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKS 67
G IP +I L ++LS N + G IP + I L L++S+N N S+P+ +G + S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 68 LTSADFSHNNFSGEIPEF--GQYSFFNSTSFTGNPHLCG-SYLNPCNYSSTTPIHNQNGN 124
L + + N+ SG +P G+ S +FT N LCG L C
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG------------- 538
Query: 125 KSHVPGKYKLLFALGLLLCSLVFAVLAII 153
H+ K+ A G+ + L + A+
Sbjct: 539 -PHLSVGAKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 24/156 (15%)
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLV--------YEYMPNGSLGEVLHGKRGSFLKWEMRL 285
L + H +++R+K + +V Y Y+ R L + L
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK----------RSRPLPIDQAL 160
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
I + +GL YLH + IIHRDVK+ NI +N + + D G A++ +
Sbjct: 161 IIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFL 214
Query: 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 381
+AG+ APE K + K+D++S G+VL E++
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 10/201 (4%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG--ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
V+G+GG G V V G+ A KKL I K L+ E R L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSRFVVSL 65
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
K+ LV M G L ++ + + A E GL L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---R 122
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I++RD+K NILL+ ++D GLA + + E + G+ GY+APE K
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEVINNEKYT 179
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + G ++ E+I G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
V EY+ G L + H ++ K + A E + GL +LH II+RD+K +N+
Sbjct: 78 FVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNV 132
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 376
+L+S+ +ADFG+ K G G+ YIAPE + D +++GV+
Sbjct: 133 MLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 377 LLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408
L E++ G+ P F E D + + M+ N S
Sbjct: 191 LYEMLAGQPP---FDGEDEDELFQSIMEHNVS 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 69/214 (32%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLG---ITKGSSHDNGLSAEIRTLGKIRHRN---I 242
VIGRG G V + +QV KLL + K S D+ E R + + H N I
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS--DSAFFWEERDI--MAHANSEWI 105
Query: 243 VRLK-AFCSNKETNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLS 296
V+L AF +K +V EYMP G L ++ K F E+ L A++A +
Sbjct: 106 VQLHYAFQDDKYL-YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL--ALDAIHSMG 162
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
+ IHRDVK +N+LL+ +ADFG + G C +AV G+ YI+P
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISP 212
Query: 357 EYAYTLKVD----EKSDVYSFGVVLLELITGRRP 386
E + D + D +S GV L E++ G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL--- 245
+G G G V T ++VAVKKL + H E+R L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 246 ---KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSY 297
N LV M L ++ ++ S FL +++ +GL Y
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQL--------LRGLKY 133
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
+H S IIHRD+K +N+ +N D E + DFGLA+ D M+ + Y APE
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPE 185
Query: 358 YAYT-LKVDEKSDVYSFGVVLLELITGR 384
+ ++ D++S G ++ EL+ G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 190 IGRGGAG-VVYRGVTPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G+GG G V V G+ A KKL + K S L E L K+ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMAL-LEKEILEKVNSPFIVNL- 58
Query: 247 AFCSNKETNL-LVYEYMPNGSLG-EVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
A+ +T+L LV M G L + + G+RG L+ E + + + G+ +LH S
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLH---S 113
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
I++RD+K N+LL+ ++D GLA L+D + ++ AG+ GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEP 170
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDFGEE 393
D ++ G + E++ GR P D E+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 189 VIGRGGAGVVY--RGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
V+G+G G V+ R +T G+ A+K L T E L ++ H IV+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 245 LK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
L AF E L L+ +++ G L L K F + +++ +A E A L +LH
Sbjct: 63 LHYAF--QTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDHLH--- 115
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S II+RD+K NILL+ + + DFGL+K D + S G+ Y+APE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS-FCGTVEYMAPEVVNRR 173
Query: 363 KVDEKSDVYSFGVVLLELITGRRP 386
+ +D +SFGV++ E++TG P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLL--GITKGSSHDNGLSA--EIRTLGKIRHRNIVR 244
IG+G G V++ + VA+KK+L +G ++A EI+ L ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP----ITALREIKILQLLKHENVVN 75
Query: 245 LKAFCSNKETN--------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
L C K T LV+E+ + L +L K F E++ K+ GL
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIK-KVMKMLLNGLY 133
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGASECMSAVAGSYGYI 354
Y+H I+HRD+K+ NIL+ D +ADFGLA+ L + + Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 355 APEYAYTLKVDEKS-----DVYSFGVVLLELITGRRPV 387
PE L + E+ D++ G ++ E+ T R P+
Sbjct: 191 PPE----LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
FG D E ++ +G G VY+G + NG+ VA+K ++ + + E
Sbjct: 1 FGKADSYEKLEK---LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFTAIREASL 56
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
L ++H NIV L KET LV+EY+ + L + + G ++L + + +
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLR 114
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
GLSY+H I+HRD+K N+L++ E +ADFGLA+ + S S + Y
Sbjct: 115 GLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWY 169
Query: 354 IAP-------EYAYTLKVDEKSDVYSFGVVLLELITG 383
P EY+ L D++ G + +E+I G
Sbjct: 170 RPPDVLLGSTEYSTCL------DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 63/267 (23%), Positives = 122/267 (45%), Gaps = 30/267 (11%)
Query: 198 VYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLKAFCSNKETNL 256
+Y+G+ N ++V ++ KG ++ EI+ L +I NI+++ F + +L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 257 ----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDV 311
L+ EY G L EVL ++ L ++ +L +AI+ KGL L+ + P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNL 149
Query: 312 KSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVY 371
S + L+ +++ + GL K L V SY + ++ + K D+Y
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKDDIY 206
Query: 372 SFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQV 431
S GVVL E+ TG+ P E L + + N + +K+ PL +++
Sbjct: 207 SLGVVLWEIFTGKIPF-----ENLTTKEIYDLIINKNNS--LKL--------PLDCPLEI 251
Query: 432 FFVAMLCVQEHGVERPTMREVVQMLAQ 458
+ C ++RP ++E++ L+
Sbjct: 252 KCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 48/157 (30%), Positives = 65/157 (41%), Gaps = 7/157 (4%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
E R L RH + LK + V EY G L H R E
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 102
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
E L YLH S +++RD+K N++L+ D + DFGL K GA+ M G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157
Query: 350 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ Y+APE D + GVV+ E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 8/200 (4%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLK 246
V+G+GG G V V G+ A KKL ++ E + L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
K+ LV M G L ++ E + A E GL LH I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
++RD+K NILL+ ++D GLA + + E + G+ GY+APE +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 367 KSDVYSFGVVLLELITGRRP 386
D + G ++ E+I G+ P
Sbjct: 181 SPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 37/161 (22%)
Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
IG G GVVY+ GE VA+KK+ + + D G+ + EI L ++ H NIVR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 245 LKAFCSNKETNL-LVYEYM-----------PNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
L + E L LV+E++ P L L +L +++
Sbjct: 63 LLDVV-HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS---YL-YQL--------L 109
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
+G++Y H S ++HRD+K N+L++ + +ADFGLA+
Sbjct: 110 QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 185 KDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
K N+IG G GVVY + E+VA+KK+L + + N E+ + + H NI+
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQYKN---RELLIMKNLNHINII 122
Query: 244 RLKAF----CSNK-ETNL---LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKG 294
LK + C K E N+ +V E++P + H R + +K+ + + +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEA-HVADFGLAKYLQDTGASECMSAVAGSYGY 353
L+Y+H S I HRD+K N+L++ + + DFG AK L +S + + Y
Sbjct: 183 LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRF-Y 236
Query: 354 IAPEYA-----YTLKVDEKSDVYSFGVVLLELITG 383
APE YT + D++S G ++ E+I G
Sbjct: 237 RAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IGRG VYR +G VA+KK + + + + + EI L ++ H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKYY 68
Query: 247 A-FCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCS 303
A F + E N+ V E G L ++ H K+ L E + K ++ L ++H S
Sbjct: 69 ASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---S 124
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
++HRD+K N+ + + + D GL ++ + + ++ G+ Y++PE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 364 VDEKSDVYSFGVVLLELITGRRP 386
+ KSD++S G +L E+ + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 8/139 (5%)
Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
C E+ L V E++ G L + H +R L E + E + L++LH II
Sbjct: 64 CFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGII 118
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
+RD+K +N+LL+++ + D+G+ K + + S G+ YIAPE
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 368 SDVYSFGVVLLELITGRRP 386
D ++ GV++ E++ GR P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 48/158 (30%), Positives = 66/158 (41%), Gaps = 9/158 (5%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIA 288
E R L RH + LK + V EY G L H R F + R A
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
E L YLH S +++RD+K N++L+ D + DFGL K + M
Sbjct: 103 -EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156
Query: 349 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N G IP + + L +L L+ N L G IP ++ Q+ L ++ + +N L+ +P E+G
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233
Query: 64 NMKSLTSADFSHNNFSGEIP-EFG-----QYSFFNSTSFTG 98
+ SL D +NN +G IP G QY F +G
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSG 274
|
Length = 968 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 24/166 (14%)
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ N ++L + + ++L+ +Y+ +G L ++L K G + E++ KI + + L+ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVK-KIIRQLVEALNDL 125
Query: 299 HHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
H IIH D+K N+L + + ++ D+GL K G C G+ Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYD---GTLDYFSPE 176
Query: 358 ------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI 397
Y + D ++ GV+ EL+TG+ P + +E LD+
Sbjct: 177 KIKGHNYDVSF------DWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 46/157 (29%), Positives = 66/157 (42%), Gaps = 6/157 (3%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
E R L RH + LK + V EY G L H R +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
E L YLH + + +++RD+K N++L+ D + DFGL K GA+ M G
Sbjct: 103 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 158
Query: 350 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ Y+APE D + GVV+ E++ GR P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
IG G GVVY+G G+ VA+KK+ + S + G+ + EI L +++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
L+ + L++E++ + L + L +G ++ E+ + +G+ + H S
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY----- 358
++HRD+K N+L+++ +ADFGLA+ V + Y APE
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPV--GD 389
Y+ V D++S G + E+ T ++P+ GD
Sbjct: 178 RYSTPV----DIWSIGTIFAEMAT-KKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 48/139 (34%), Positives = 71/139 (51%), Gaps = 8/139 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
L+ +Y+ G L L+ +R F + E+R+ IA E L +LH II+RD+K NI
Sbjct: 82 LILDYVNGGELFTHLY-QREHFTESEVRVYIA-EIVLALDHLHQLG---IIYRDIKLENI 136
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV--DEKSDVYSFG 374
LL+S+ + DFGL+K E + G+ Y+APE D+ D +S G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFL-AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 375 VVLLELITGRRPVGDFGEE 393
V+ EL+TG P GE+
Sbjct: 196 VLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 53/180 (29%), Positives = 76/180 (42%), Gaps = 14/180 (7%)
Query: 217 ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG 276
I K + EI L I HR I+ L K T +V MP + R
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRS 179
Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
L E + I + L+YLH IIHRDVK+ NI L+ A + DFG A L
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 337 DTGASECMSAVAGSYGYIAPEYAYTLKVD---EKSDVYSFGVVLLELITGRRPVGDFGEE 393
+ +G+ +PE L +D K+D++S G+VL E+ + FG++
Sbjct: 237 AHPDTPQCYGWSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTL--FGKQ 291
|
Length = 392 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 64/287 (22%), Positives = 124/287 (43%), Gaps = 41/287 (14%)
Query: 190 IGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHRN 241
+G+G G+VY G+ +VA+K + + +S + E + + +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG--------SFLKWEMRLKIAIEAAK 293
+VRL S + L++ E M G L L R + + +++A E A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
G++YL+ + +HRD+ + N ++ DF + DFG+ + + +T +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412
++PE SDV+SFGVVL E+ T +P +G+ S E V
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGM------------SNEQV 230
Query: 413 VK-ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
++ +++ L + P + +F + +C Q + RP+ E++ + +
Sbjct: 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 8/139 (5%)
Query: 249 CSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
C E+ L V EY+ G L + H +R L E + E + L+YLH II
Sbjct: 64 CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 118
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
+RD+K +N+LL+S+ + D+G+ K + + S G+ YIAPE
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 368 SDVYSFGVVLLELITGRRP 386
D ++ GV++ E++ GR P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 64/201 (31%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG-ITKGSSHDNGLSAEIRTLGK-IRHRNIVRL 245
VIG+G G V+ +G+ AVK L I + AE L K ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
E V +++ G L L +R SF + R A E A L YLH S
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAA-EIASALGYLH---SIN 116
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I++RD+K NILL+S + DFGL K + S+ + G+ Y+APE D
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + G VL E++ G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 67/248 (27%), Positives = 103/248 (41%), Gaps = 67/248 (27%)
Query: 189 VIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRT----LGKIRHRNI 242
VIGRG G V R V G A+KKL K + A +R L + + +
Sbjct: 8 VIGRGAFGEV-RLVQKKDTGHIYAMKKLR---KSEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 243 VRLKAFCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-----AIEAAKGL 295
V+L + S E L L+ EY+P G + +L K+ +F + E R I AI++ L
Sbjct: 64 VKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE------------- 342
Y IHRD+K +N+LL++ ++DFGL L+ + +E
Sbjct: 121 GY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 343 ------------------------CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 378
S V G+ YIAPE +++ D +S GV++
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 379 ELITGRRP 386
E++ G P
Sbjct: 231 EMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 51/152 (33%), Positives = 78/152 (51%), Gaps = 20/152 (13%)
Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH- 299
IV LK F +++L LV +YM G L L K G F + + IA E L +LH
Sbjct: 58 IVGLK-FSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLHK 114
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
+D I++RD+K NILL++ + DFGL+K + ++ + G+ Y+APE
Sbjct: 115 YD----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE-- 166
Query: 360 YTLKVDEKS-----DVYSFGVVLLELITGRRP 386
+ +DEK D +S GV++ E+ G P
Sbjct: 167 --VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 29/173 (16%)
Query: 166 KLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHD 224
KL ++KLD +G G VY+G + G+ VA+K++ H+
Sbjct: 3 KLETYKKLD--------------KLGEGSYATVYKGRSKLTGQLVALKEI-----RLEHE 43
Query: 225 NGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLK 280
G E L ++H NIV L K+T LV+EY+ + L + + G L
Sbjct: 44 EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMD-DCGGGLS 101
Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
+ +GL+Y H ++HRD+K N+L++ E +ADFGLA+
Sbjct: 102 MHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 34/203 (16%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV----- 258
P E++ K++ ++ + L EI LG++ H NI++++ ++ ++
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ---LENEILALGRLNHENILKIEEILRSEANTYMITQKYD 246
Query: 259 ---YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
Y +M + + + L + R I + + Y+H +IHRD+K N
Sbjct: 247 FDLYSFMYDEAFDW-----KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLEN 297
Query: 316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI------APEYAYTLKVDEKSD 369
I LN D + + DFG A + A YG++ +PE E +D
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEK-------EREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 370 VYSFGVVLLELITGRR-PVGDFG 391
++S G++LL++++ P+GD G
Sbjct: 351 IWSCGLILLDMLSHDFCPIGDGG 373
|
Length = 501 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 189 VIGRGGAGVVY--RGVTPN--GEQVAVKKLLGIT-----KGSSHDNGLSAEIRTLGKIRH 239
V+G G G V+ R V+ + G+ A+K L T K + H E + L IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIRQ 63
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ + +T L L+ +Y+ G L L +R F + E+++ E L +L
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSG-EIVLALEHL 121
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
H II+RD+K NILL+S+ + DFGL+K E + G+ Y+AP+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDI 177
Query: 359 AYTLKV--DEKSDVYSFGVVLLELITGRRPVGDFGEE 393
D+ D +S GV++ EL+TG P GE+
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 41/214 (19%)
Query: 190 IGRGGAGVVYRG---VTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
IG G GVVY+ VT E +A+KK+ + D G+ + EI L +++H NI
Sbjct: 10 IGEGTYGVVYKARDRVT--NETIALKKI----RLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAI-EAAKGLS 296
VRL+ +++ LV+EY+ L K+ F K +K + + +G++
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEA-HVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
Y H S ++HRD+K N+L++ A +ADFGLA+ + V + Y A
Sbjct: 117 YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171
Query: 356 PE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
PE Y+ V D++S G + E++ +
Sbjct: 172 PEILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 52/226 (23%)
Query: 190 IGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR-H 239
+G+G G+V + E VA+KK+ + + A E++ L R H
Sbjct: 8 LGQGAYGIVCSARNAETSE-EETVAIKKITNV-----FSKKILAKRALRELKLLRHFRGH 61
Query: 240 RNIVRL---KAFCSNKETNLLVYEYMPNGSLGEVLHGKR-------GSFLKWEMRLKIAI 289
+NI L L +YE + L +++ + SF+ +
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC----- 116
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
GL Y+H S ++HRD+K N+L+N+D E + DFGLA+ G SE AG
Sbjct: 117 ----GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSENPGENAG 164
Query: 350 -------SYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELITGRRPV 387
+ Y APE + + K+ DV+S G +L EL+ GR+PV
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH--GKRGSFLKWEMRLK 286
AE L ++ IV LK + E LV ++ NG GE+ H + G F R
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI-NG--GELFHHLQREGRFDLSRARFY 98
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA--DFGLAKYLQDTGASECM 344
A E L LH +I+RD+K NILL D++ H+A DFGL K + +
Sbjct: 99 TA-ELLCALENLH---KFNVIYRDLKPENILL--DYQGHIALCDFGLCKL--NMKDDDKT 150
Query: 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
+ G+ Y+APE + D ++ GV+L E++TG P D
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 21/139 (15%)
Query: 257 LVYEYMPNGSLGEVLH-----GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV 311
+V EYMP G L ++ K F E+ L A++A + + IHRDV
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL--ALDAIHSMGF---------IHRDV 168
Query: 312 KSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD----EK 367
K +N+LL+ +ADFG + G C +AV G+ YI+PE + D +
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 368 SDVYSFGVVLLELITGRRP 386
D +S GV L E++ G P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 190 IGRGGAGVVYRGVTPNG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G V G +G QV VK+L ++ E + ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRL--KIAIEAAKGLSYLHHDCS 303
C+ LLV E+ P G L L R + + ++A E A GL +LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLA--KYLQDTGASECMSAVAGSYGYIAPE---- 357
IH D+ N LL +D + D+GL+ KY +D + V +IAPE
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDE 176
Query: 358 -YAYTLKVDE--KSDVYSFGVVLLELIT-GRRP 386
+ L VD+ +S+V+S GV + EL G +P
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 36/238 (15%)
Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVV----YRGVTPNGEQVAVK-- 212
+ +++SWKL+ F+ +G G G V ++G GE A+K
Sbjct: 9 KPDTSSWKLSDFEM--------------GETLGTGSFGRVRIAKHKG---TGEYYAIKCL 51
Query: 213 KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMPNGSLGEVL 271
K I K + ++ E L ++ H IV + +F L+ E++ G L L
Sbjct: 52 KKREILKMKQVQH-VAQEKSILMELSHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHL 109
Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
K G F + A E YLH S II+RD+K N+LL++ V DFG
Sbjct: 110 R-KAGRFPNDVAKFYHA-ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF 164
Query: 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
AK + D + C G+ Y+APE + + D ++ GV+L E I G P D
Sbjct: 165 AKKVPDRTFTLC-----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
+G G G+V+ V + ++VAVKK++ +T S + L EI+ + ++ H NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV-LTDPQSVKHALR-EIKIIRRLDHDNIVKVYEV 70
Query: 249 CSNKETNL--------------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
++L +V EYM L VL ++G + RL + +G
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARL-FMYQLLRG 126
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYL-QDTGASECMSAVAGSYG 352
L Y+H S ++HRD+K N+ +N+ D + DFGLA+ + +S +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 353 YIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGR 384
Y +P YT + D+++ G + E++TG+
Sbjct: 184 YRSPRLLLSPNNYT----KAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 32/81 (39%), Positives = 47/81 (58%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
NN +G IP +G+ L YL L QN LSGPIP I + L L++S N L+ +P+ +
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 64 NMKSLTSADFSHNNFSGEIPE 84
+++L NNF+G+IP
Sbjct: 306 QLQNLEILHLFSNNFTGKIPV 326
|
Length = 968 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 188 NVIGRGGAG---VVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IV 243
+++GRG G VV T G+ A+K + + E R + I + I
Sbjct: 7 SLVGRGHFGEVQVVREKAT--GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-----LKIAIEAAKGLSYL 298
+L+ +K+ LV EY P G L +L+ F + + L +AI + + Y
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY- 123
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
+HRD+K N+L++ +ADFG A L V G+ YIAPE
Sbjct: 124 --------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEV 174
Query: 359 AYTLKVDEKS------DVYSFGVVLLELITGRRP 386
T+ D K D +S GV+ E+I GR P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 7/197 (3%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
V+G G GVV + E VA+KK + E++ L ++ NIV LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ LV+EY+ L E+L ++R I + K + + H + I+
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DIV 122
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+K N+L++ + + DFG A+ L + + VA + Y +PE +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPYGKA 181
Query: 368 SDVYSFGVVLLELITGR 384
D++S G +L EL G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 7/109 (6%)
Query: 288 AIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
A E L +LH H +I+RD+K +NILL+++ +ADFG+ K G + +
Sbjct: 102 AAEVTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTT 155
Query: 347 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
G+ YIAPE L+ D ++ GV++ E++ G+ P E+ L
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 32/84 (38%), Positives = 46/84 (54%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N+ SG IP + L L L N+ +G IPV +T + L L + N+ + +PK
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+G +LT D S NN +GEIPE
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGL---SAEIRTLGKIRHRNIVRL 245
+G+G G VY + +K L I G + N + E + L K+ H IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 246 KA-------------FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEA 291
A +C ++ + + E G +L E +W ++L +
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE------NQVCEWFIQLLL---- 117
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
G+ Y+H I+HRD+K+ NI L ++ + DFG+++ L G+ + + G+
Sbjct: 118 --GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTP 169
Query: 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLEL 380
Y++PE D KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
V EY+ G L + ++ K + A E A GL +LH S II+RD+K +N+
Sbjct: 78 FVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNV 132
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 376
+L+S+ +ADFG+ K G + G+ YIAPE + D ++FGV+
Sbjct: 133 MLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190
Query: 377 LLELITGRRP 386
L E++ G+ P
Sbjct: 191 LYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 39/101 (38%), Positives = 53/101 (52%), Gaps = 4/101 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
+S N SG I I + ++LS N LSGPIP I T L YLN+S N S+P
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 60 KEMGNMKSLTSADFSHNNFSGEIP-EFGQYSFFNSTSFTGN 99
+ G++ +L + D S+N SGEIP + G +S GN
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
|
Length = 968 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
+G G V++G + E + K + + H+ G E+ L ++H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRL----EHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ LV+EY+ + L + L G+ + + +GLSY H
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQ---DTGASECMS-------AVAGSYGYIA 355
I+HRD+K N+L+N E +ADFGLA+ T ++E ++ + GS Y
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGR 384
P D++ G +L E+ TGR
Sbjct: 184 P-----------IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 54/151 (35%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 190 IGRGGAGVVYRGVTPNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
I RG G VY G N ++ VKK I K H + AE L + IV L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ--VQAERDALALSKSPFIVHL 69
Query: 246 KAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDC 302
+ S + N LV EY+ G + +LH G F + EM +K E A L YLH H
Sbjct: 70 --YYSLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDE-EMAVKYISEVALALDYLHRHG- 124
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
IIHRD+K +N+L++++ + DFGL+K
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 181 LECVKDNNVIGRGGAGVVYRGV---TPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTL 234
L V+ +G G VY+G T GEQ VA+K L +G + E
Sbjct: 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKHEAMMR 62
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-----HGKRGSF---------LK 280
+++H NIV L + ++ +++ Y + L E L H GS L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 281 WEMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
+ I + A G+ +L HH ++H+D+ + N+L+ ++D GL + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
+ M +++PE K SD++S+GVVL E+ + G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 24/82 (29%), Positives = 41/82 (50%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N+ G IP +G C L + L N SG +P + T++ ++ +L++S N L +
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449
Query: 64 NMKSLTSADFSHNNFSGEIPEF 85
+M SL + N F G +P+
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDS 471
|
Length = 968 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN------LLV 258
+ ++VAVK L SS E + + H N+++L +++
Sbjct: 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 259 YEYMPNGSLGEVLH----GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
+M +G L L G+ L + ++ I+ A G+ YL S IHRD+ +
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAAR 142
Query: 315 NILLNSDFEAHVADFGLAK--YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYS 372
N +LN + VADFGL+K Y D C S + ++A E SDV++
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWA 200
Query: 373 FGVVLLELIT-GRRP 386
FGV + E++T G+ P
Sbjct: 201 FGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 37/114 (32%), Positives = 61/114 (53%), Gaps = 9/114 (7%)
Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
+ G F + EMR A E GL ++H+ +++RD+K NILL+ ++D GLA
Sbjct: 90 QHGVFSEAEMRF-YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA- 144
Query: 334 YLQDTGASECMSAVAGSYGYIAPE-YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
D + ++V G++GY+APE + D +D +S G +L +L+ G P
Sbjct: 145 --CDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 39/118 (33%), Positives = 62/118 (52%), Gaps = 17/118 (14%)
Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
+ G F + EMR A E GL ++H+ +++RD+K NILL+ ++D GLA
Sbjct: 90 QHGVFSEKEMRF-YATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA- 144
Query: 334 YLQDTGASECMSAVAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGRRP 386
D + ++V G++GY+APE AY D +D +S G +L +L+ G P
Sbjct: 145 --CDFSKKKPHASV-GTHGYMAPEVLQKGTAY----DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 18/148 (12%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSL----GEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
N+V L + ++++ LV ++ G L + L+ +W + +A++A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
LH + I+ RD+ NNILL+ + F ++D+ E + + Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGR 384
E + E D +S G +L EL+TG+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 189 VIGRGGAGVVY--RGVT--PNGEQVAVKKLLGIT-----KGSSHDNGLSAEIRTLGKIRH 239
V+G+GG G V+ R VT G+ A+K L T K ++H AE L ++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK---AERNILEAVKH 59
Query: 240 RNIVRLK-AFCSNKETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSY 297
IV L AF + + L+ EY+ G L +H +R G F++ ++ E + L +
Sbjct: 60 PFIVDLIYAFQTGGKL-YLILEYLSGGEL--FMHLEREGIFMEDTACFYLS-EISLALEH 115
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
LH II+RD+K NILL++ + DFGL K + G+ Y+APE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPE 170
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ D +S G ++ +++TG P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
+G G VY+G + + + K + + H+ G E+ L ++H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+++ LV+EY+ + L + L S ++L + + +GL+Y H
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRR---K 124
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY-TLKV 364
++HRD+K N+L+N E +ADFGLA+ + ++ S + Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 365 DEKSDVYSFGVVLLELITGR 384
+ D++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
A E L +LH II+RD+K +N+LL+ + +ADFG+ K G + S
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTF 156
Query: 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ YIAPE + D ++ GV+L E++ G P
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
L+ +Y+ G + L+ +R +F + E+R E L +LH I++RD+K NI
Sbjct: 82 LILDYVSGGEMFTHLY-QRDNFSEDEVRFYSG-EIILALEHLH---KLGIVYRDIKLENI 136
Query: 317 LLNSDFEAHVADFGLAK-YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKS-DVYSFG 374
LL+S+ + DFGL+K +L + E + G+ Y+APE K+ D +S G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLSE--EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 375 VVLLELITGRRPVGDFGE 392
+++ EL+TG P GE
Sbjct: 195 ILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 48/181 (26%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
L E L + + AKG+S+L S IHRD+ + NILL + DFGLA+ +++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI- 397
++APE + +SDV+S+G++L E+ + +G G+ +
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSSPYPGMPVD 323
Query: 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457
++ KM KEG ++L + + + + M+ C ++RPT +++VQ++
Sbjct: 324 SKFYKM----IKEG-YRMLSPECAPSEMYDIMKS------CWDADPLKRPTFKQIVQLIE 372
Query: 458 Q 458
Q
Sbjct: 373 Q 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 66/265 (24%), Positives = 107/265 (40%), Gaps = 55/265 (20%)
Query: 189 VIGRG--GAGVVYRG-VTPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVR 244
+IG+ +V+ P VAVKK+ + S D L EI T +++H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 245 -LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHH 300
+ +F + E +V M GS ++L + F + L IA + L Y+H
Sbjct: 64 YVTSFIVDSEL-YVVSPLMAYGSCEDLL---KTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS------YGY- 353
IHR VK+++ILL+ D + + +G +S + + +
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVL-----------SGLRYSVSMIKHGKRQRVVHDFP 165
Query: 354 ---------IAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402
++PE +EKSD+YS G+ EL G P D + T+
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD--------MPATQ 217
Query: 403 MQTNSSKEGVVKILDQRLSNTPLSE 427
M + V +LD+ S PL E
Sbjct: 218 MLLEKVRGTVPCLLDK--STYPLYE 240
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 66/286 (23%), Positives = 119/286 (41%), Gaps = 49/286 (17%)
Query: 190 IGRGGAGVVYRGV-------TPNGEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHR 240
+G+G +Y+GV G V +L + GS H + L+ + ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVL-GSDHRDSLAFFETASLMSQLSHK 61
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLH 299
++V+L C E N++V EY+ G L LH ++ + L W +L +A + A L YL
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 300 HDCSPLIIHRDVKSNNILL--NSDFEAHVADFGLAKYLQDTGASECMSAVAGSY-----G 352
++H +V NIL+ E +V K L D G ++ ++
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPF---IK-LSDPGIP--ITVLSREERVERIP 169
Query: 353 YIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
+IAPE + +D +SFG LLE+ + GEE L + ++ + +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN-------GEEPLSTLSSSEKERFYQDQ 222
Query: 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ + D L+ + C +RP+ R +++ L
Sbjct: 223 HRLPMPDC----AELANLI------NQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/223 (24%), Positives = 84/223 (37%), Gaps = 53/223 (23%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+L +K+ V +Y+P G + +L + G F + R IA E + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIA-ELTCAIESVHKM 120
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGL---------AKYLQDTG------------A 340
IHRD+K +NIL++ D + DFGL +KY Q
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 341 SECMSA--------------------VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 380
SE + G+ YIAPE + D +S GV+L E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 381 ITGRRPVGDF--GEEGLDIVQWTKM-----QTNSSKEGVVKIL 416
+ G+ P E L ++ W Q S+E IL
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLIL 280
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM-RLKIAIEAAKGLSYLHHDCSP 304
FCS K +V EY+ G +L K L +M R+ A E L YLH +
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFA-ETVLALEYLH---NY 120
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK-------------YLQDTGASECM-SAVAGS 350
I+HRD+K +N+L+ S + DFGL+K ++ + E + V G+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI-EKDTREFLDKQVCGT 179
Query: 351 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV-GDFGEE 393
YIAPE + D ++ G++L E + G P GD EE
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N+FSG +P E L+ +LD+S N+L G I + + L L+++ N+ LP
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE-FGQYS 89
G+ K L + D S N FSG +P G S
Sbjct: 471 SFGS-KRLENLDLSRNQFSGAVPRKLGSLS 499
|
Length = 968 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 33/177 (18%)
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK-------YLQDTGA 340
+ + A+G+ +L S IHRD+ + NILL+ + + DFGLA+ Y++ A
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399
+ ++APE + +SDV+SFGV+L E+ + G P
Sbjct: 237 RLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP------------- 276
Query: 400 WTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ +Q N +E ++ D P + +++ + + C Q ERPT +V++L
Sbjct: 277 YPGVQIN--EEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
+G G V++G + E + K + + H+ G E+ L ++H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
++ LV+EY+ + L + + G+ + + +GL+Y H
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY-TLKV 364
++HRD+K N+L+N E +ADFGLA+ + ++ S + Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 365 DEKSDVYSFGVVLLELITGR 384
+ D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 30/187 (16%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMR 284
L E+ + +++H+NIVR NK L + E+ G L + F K E
Sbjct: 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 285 --LKIAIEAAKGLSYLHH----DCSPLIIHRDVKSNNILLNSDFE--------------- 323
+ I + L+Y H+ ++HRD+K NI L++
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 324 --AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLE 379
A + DFGL+K + G + G+ Y +PE T D+KSD+++ G ++ E
Sbjct: 179 PIAKIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 380 LITGRRP 386
L +G+ P
Sbjct: 236 LCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 17/113 (15%)
Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--- 333
L E + + + A+G+ +L S IHRD+ + NILL+ + + DFGLA+
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 334 ----YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
Y++ A + ++APE + +SDV+SFGV+L E+ +
Sbjct: 225 KDPDYVRKGDARLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 51/234 (21%), Positives = 92/234 (39%), Gaps = 59/234 (25%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
L+ E++P G + +L K+ + + E + IA E + +H IHRD+K +N+
Sbjct: 78 LIMEFLPGGDMMTLLM-KKDTLTEEETQFYIA-ETVLAIDSIHQLG---FIHRDIKPDNL 132
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMS------------------------------- 345
LL+S ++DFGL L+ +E
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 346 --AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM 403
+ G+ YIAPE ++ D +S GV++ E++ G P F E
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP---FCSE---------- 239
Query: 404 QTNSSKEGVVKILDQRLSNT-----PLSEAMQVFFVAMLCVQEHGVERPTMREV 452
+ +E K+++ + + P+SE + + C EH + P + E+
Sbjct: 240 ---TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEI 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL---- 362
+HRD+K +N+LL+ + +ADFG + G + AV G+ YI+PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMEDGM 182
Query: 363 -KVDEKSDVYSFGVVLLELITGRRP 386
K + D +S GV + E++ G P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 15/105 (14%)
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
IAI++ L Y +HRD+K +NIL++ + +ADFG L + G + A
Sbjct: 113 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 347 VAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRRP 386
V G+ YI+PE + K + D +S GV + E++ G P
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 12/107 (11%)
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
L+ + + A+G+ +L S IHRDV + N+LL A + DFGLA+ + + +
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN----DSN 267
Query: 345 SAVAGS----YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
V G+ ++APE + +SDV+S+G++L E+ + G+ P
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 31/247 (12%)
Query: 190 IGRGGAGVVYRGVTPNGE--QVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G G G V N + VA+K+ I K D+ S E + L I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHDC 302
++ LV E+ V+ G+ +FL+ R + AA+ + +
Sbjct: 97 YGSFKDESYLYLVLEF--------VIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S I++RD+K N+LL+ D + DFG AK + + C G+ YIAPE +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYIAPEILLNV 203
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQ--------WTKMQTNSSKEGVVK 414
+ +D ++ G+ + E++ G P + E L I Q + K N+ K + K
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPF--YANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261
Query: 415 ILDQRLS 421
+L L+
Sbjct: 262 LLSHDLT 268
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 190 IGRGGAGVVYRGV---------TPNGEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIR 238
+GRG +Y G+ + +K +L + S D L+ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
H++IV L C N++V E++ G L +H ++ L + K+A + A LSYL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA-------SECMSAVAGSY 351
++H +V + NILL E + G L D G EC+ +
Sbjct: 122 E---DKDLVHGNVCTKNILLAR--EGIDGECGPFIKLSDPGIPITVLSRQECVERIP--- 173
Query: 352 GYIAPEYAYTLKV-DEKSDVYSFGVVLLEL-ITGRRPVGD 389
+IAPE K +D +SFG L E+ G P+ D
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 58/240 (24%)
Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
++G+G G V+ +G G+ A+K K I + + E L + H
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLDHPF 62
Query: 242 IVRLKA-FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
+ L A F + ET L LV +Y P G L +L + G L E+ A E L YLH
Sbjct: 63 LPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYG----- 352
I++RD+K NILL+ H+ +DF L+K + GS
Sbjct: 121 LLG---IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 353 ----------------------YIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
YIAPE + V D ++ G++L E++ G P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 190 IGRGGAGVVYRGVTPNGE---QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
+GRG G VY+ +G+ + A+K++ +G+ EI L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF-------LKWEMRLKIAIEAAKGLSY 297
K F S+ + + L+++Y + L ++ R S L M + + G+ Y
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 298 LHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKYLQDTGASEC-MSAVAGSYG 352
LH + ++HRD+K NIL+ + +AD G A+ + V ++
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 353 YIAPEYAYTLKVDEKS-DVYSFGVVLLELIT 382
Y APE + K+ D+++ G + EL+T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 60/210 (28%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLK-----W 281
+ AE L + + +VRL +K+ V +Y+P G + +L + G F + +
Sbjct: 48 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPEDLARFY 106
Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL---------A 332
L A+E+ + + IHRD+K +NIL++ D + DFGL +
Sbjct: 107 IAELTCAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 333 KYLQ-----------------DTGASEC-------------------MSAVAGSYGYIAP 356
KY Q D C ++ G+ YIAP
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E + D +S GV+L E++ G+ P
Sbjct: 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 60/210 (28%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-- 284
+ AE L + + +V+L +K+ V +Y+P G + +L + F + R
Sbjct: 48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMEVFPEVLARFY 106
Query: 285 ---LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL---------A 332
L +AIE+ + + IHRD+K +NIL++ D + DFGL +
Sbjct: 107 IAELTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 333 KYLQ-----------------DTGASEC-------------------MSAVAGSYGYIAP 356
KY Q D C ++ G+ YIAP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E + D +S GV+L E++ G+ P
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 46/220 (20%)
Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRN-IV 243
IG G G VY+ N G+ VA+KK T+ + G+ EI L + IV
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 244 RLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLS 296
RL +E N LV+EY+ + + RG + + KG++
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEA-HVADFGLAKYLQDTGASECMSAVAGSYG--- 352
+ H ++HRD+K N+L++ +AD GL S SY
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL---------GRAFSIPVKSYTHEI 172
Query: 353 ----YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITG 383
Y APE Y+ V D++S G + E+
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 17/112 (15%)
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK---- 333
L E + + + AKG+ +L S IHRD+ + NILL+ + + DFGLA+
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 334 ---YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
Y++ A + ++APE + +SDV+SFGV+L E+ +
Sbjct: 232 DPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY----AYT 361
IIHRD+K+ N+L+N + + DFG A + + + ++ +AG+ APE YT
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 362 LKVDEKSDVYSFGVVLLE 379
V D++S G+V+ E
Sbjct: 341 PSV----DIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 190 IGRGGAGVVYRGVTPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
+GRG G VY+ +G+ A+K++ +G+ EI L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF-------LKWEMRLKIAIEAAKGLSY 297
K F S+ + + L+++Y + L ++ R S L M + + G+ Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 298 LHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKYLQDTGASEC-MSAVAGSYG 352
LH + ++HRD+K NIL+ + +AD G A+ + V ++
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 353 YIAPEYAYTLKVDEKS-DVYSFGVVLLELIT 382
Y APE + K+ D+++ G + EL+T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 188 NVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHR 240
+++ G G ++ G+ E+V VK + +S L E L + H+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 241 NIVRLKAFCS-NKETNLLVYEYMPNGSLGEVLHGKR------GSFLKWEMRLKIAIEAAK 293
NI+ + C + E ++Y YM G+L L R L + + +AI+ A
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG- 352
G+SYLH +IH+D+ + N +++ + + + D L++ L Y
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL-----------FPMDYHC 174
Query: 353 ----------YIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
++A E + SDV+SFGV+L EL+T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 27/148 (18%)
Query: 253 ETNL-LVYEYMPNGSL-------GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
E NL LV +Y G L + L F EM L AI++ L Y
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL--AIDSVHQLGY------- 123
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA-GSYGYIAPEYAYTL- 362
+HRD+K +N+LL+ + +ADFG L G S VA G+ YI+PE +
Sbjct: 124 --VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAME 179
Query: 363 ----KVDEKSDVYSFGVVLLELITGRRP 386
+ + D +S GV + E++ G P
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 190 IGRGGAGVVYRG---VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G V +V VK+L S N + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKA-NASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLSYLH-HDCS 303
C LLV+EY G L L ++ ++ L ++A E A G++++H H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGL--AKYLQDTGASECMSAVAGSYGYIAPEYA-- 359
+H D+ N L SD V D+G+ ++Y +D +E V ++APE
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LRWLAPELVGE 175
Query: 360 -----YTLKVDEKSDVYSFGVVLLEL 380
T + + S+V++ GV L EL
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 40/177 (22%)
Query: 245 LKAFCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+K F S +K L+ E++P G + +L K+ + + + IA E + +H
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIA-ETVLAIDAIHQLG 121
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-------------------- 342
IHRD+K +N+LL++ ++DFGL L+ +E
Sbjct: 122 ---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 343 -------------CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ G+ YIAPE ++ D +S GV++ E++ G P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 27/80 (33%), Positives = 40/80 (50%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
NNF+G IPV + L L L N SG IP + + + L L++S N L +P+ +
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 64 NMKSLTSADFSHNNFSGEIP 83
+ +L N+ GEIP
Sbjct: 378 SSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 33/103 (32%), Positives = 42/103 (40%), Gaps = 24/103 (23%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N FSG IP +G LT LDLS N+L+G IP + L L + N L +PK +G
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
Query: 64 NMKSLTSA------------------------DFSHNNFSGEI 82
+SL D S+NN G I
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 18/198 (9%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
TP G V V+ H L E+ RH NI+ + ++ +M
Sbjct: 22 TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
GS +L + + I A +GL+YLH + IHR++K+++IL++ D
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDG 138
Query: 323 EAHVAD----FGLAKYLQDTGASECMSAVAGSY-GYIAPE------YAYTLKVDEKSDVY 371
++ + L + Q + S +++PE Y Y + KSD+Y
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV----KSDIY 194
Query: 372 SFGVVLLELITGRRPVGD 389
S G+ EL TGR P D
Sbjct: 195 SVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 29/124 (23%), Positives = 54/124 (43%), Gaps = 3/124 (2%)
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
Y+ + + +L L L + A+G+ +L S +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 378
+ DFGLA+ + + ++APE + SDV+S+G++L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 379 ELIT 382
E+ +
Sbjct: 331 EIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N S +P EI L LDLS N + + ++ + L+ L +S N+L LP+
Sbjct: 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNP 100
+GN+ +L + D S+N S I G + +GN
Sbjct: 250 SIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNS 288
|
Length = 394 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 189 VIGRGGAGVV------YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
VIGRG ++ Y+ P GE V V+++ + L E+ H NI
Sbjct: 5 VIGRGFEDLMTVNLARYK---PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 243 VRLKA-FCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIA---IEAAKGLS 296
V +A F ++ E +V +M GS +++ H F+ L IA K L
Sbjct: 62 VPYRATFIADNEL-WVVTSFMAYGSAKDLICTH-----FMDGMSELAIAYILQGVLKALD 115
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV-------AG 349
Y+HH +HR VK+++IL++ D + +++ GL L + + V
Sbjct: 116 YIHHMG---YVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVK 170
Query: 350 SYGYIAPE-YAYTLK-VDEKSDVYSFGVVLLELITGRRPVGD 389
+++PE L+ D KSD+YS G+ EL G P D
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 29/144 (20%), Positives = 54/144 (37%), Gaps = 16/144 (11%)
Query: 193 GGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV--RLKAFCS 250
G VY + E +K I E+ L + + + ++ A
Sbjct: 9 GLTNRVYL-LGTKDEDYVLK----INPSREKGADREREVAILQLLARKGLPVPKVLASGE 63
Query: 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
+ + L+ E++ +L EV E + IA + A+ L+ LH ++ H D
Sbjct: 64 SDGWSYLLMEWIEGETLDEVSE---------EEKEDIAEQLAELLAKLHQLPLLVLCHGD 114
Query: 311 VKSNNILLNSDFEAHVADFGLAKY 334
+ NIL++ + D+ A Y
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 32/122 (26%), Positives = 45/122 (36%), Gaps = 19/122 (15%)
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
SL ++L RG L E + ++ L LH R KS NILL ++
Sbjct: 1 VSLADILE-VRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLT--WDG 48
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384
+ G T S + APE EK+D+YS G+ L E +
Sbjct: 49 LLKLDGSV--AFKTPE---QSRPDPYFM--APEVIQGQSYTEKADIYSLGITLYEALDYE 101
Query: 385 RP 386
P
Sbjct: 102 LP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 3/98 (3%)
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
+ + + A G+ +L S +HRD+ + N+L+ + DFGLA+ +
Sbjct: 242 VGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK 298
Query: 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
+ ++APE + SDV+SFG++L E+ T
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 4/80 (5%)
Query: 5 NFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGN 64
+ GI + +DLS ++SG I I ++ + +N+S NQL+ +P ++
Sbjct: 59 LWQGITCNNSSR---VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFT 115
Query: 65 M-KSLTSADFSHNNFSGEIP 83
SL + S+NNF+G IP
Sbjct: 116 TSSSLRYLNLSNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
+ ++ H+++V C + +++V EY+ GSL L K + + +L++A + A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAW 111
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA---VAGS 350
L +L + H +V + N+LL + + + K L D G S + +
Sbjct: 112 ALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLER 167
Query: 351 YGYIAPE---YAYTLKVDEKSDVYSFGVVLLELITG 383
++ PE L + +D +SFG L E+ +G
Sbjct: 168 IPWVPPECIENPQNLSL--AADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.002
Identities = 20/59 (33%), Positives = 27/59 (45%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF 78
L LDLS N L+ + L L++S N L + P+ + SL S D S NN
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 11/100 (11%)
Query: 189 VIGRGGAGVVYR------GVTPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKI-RHR 240
+GRG G V + + + VAVK L G T +S L E++ L I H
Sbjct: 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHL 71
Query: 241 NIVRLKAFCSNKETNLLV-YEYMPNGSLGEVLHGKRGSFL 279
N+V L C+ L+V EY G+L L KR F
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFS 111
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 178 DDILECVKDNNVIGRG-GAGVVYRGV--TPNG---EQVAVK---KLLGITKGSSHDNGLS 228
D E +DN V+GR G+G R V T +G Q +K K+L T SS L
Sbjct: 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM 88
Query: 229 AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLK 280
+E++ + + H NIV L C+ ++ EY G L + LH + +FL+
Sbjct: 89 SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQ 141
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.38 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.7 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.56 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.53 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.47 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.45 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.39 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.37 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.34 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.32 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.32 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.3 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.28 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.25 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.23 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.21 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=527.50 Aligned_cols=429 Identities=33% Similarity=0.584 Sum_probs=314.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+++|.+|..+++|++|++|+|++|+++|.+|..+.++++|+.|||++|+++|.+|..+..+++|+.|++++|+++|
T Consensus 506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 56777777788788888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCCcccccccCcccccCCCCCCCCCC----CCCCCCCCCcCCCCCCCCccCCCchh-hhhhhhHHHHHHHH-hhheeee
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHLCGSYL----NPCNYSSTTPIHNQNGNKSHVPGKYK-LLFALGLLLCSLVF-AVLAIIK 154 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~lcg~~~----~~c~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~ 154 (468)
.+|..+.+..+....+.+|+.+||... .+|.. ....+.... ++++++++++++++ +++.+++
T Consensus 586 ~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (968)
T PLN00113 586 SLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR------------VRKTPSWWFYITCTLGAFLVLALVAFGFVFIR 653 (968)
T ss_pred eCCCcchhcccChhhhcCCccccCCccccCCCCCcc------------ccccceeeeehhHHHHHHHHHHHHHHHHHHHH
Confidence 888777777777778888888887531 12211 001111111 22222222222222 2222222
Q ss_pred ecccc---cCC---CCcccccccc---cccccchhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCch
Q 012213 155 TRKFR---KNS---NSWKLTAFQK---LDFGSDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHD 224 (468)
Q Consensus 155 ~~~~~---~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~ 224 (468)
+++.. +.. ..+....+.. .....+++.+.++..+.||+|+||.||+|.+ .++..||||++.....
T Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----- 728 (968)
T PLN00113 654 GRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----- 728 (968)
T ss_pred hhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----
Confidence 22111 100 1111111110 0122344456778889999999999999997 5789999998853321
Q ss_pred hHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 012213 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304 (468)
Q Consensus 225 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 304 (468)
....|++.+++++|||||+++|+|.+.+..++||||+++|+|.++++. ++|..+.+++.|||+|++|||..+++
T Consensus 729 -~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~ 802 (968)
T PLN00113 729 -IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSP 802 (968)
T ss_pred -ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCC
Confidence 123568899999999999999999999999999999999999999952 89999999999999999999977666
Q ss_pred CeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 012213 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384 (468)
Q Consensus 305 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~ 384 (468)
+|+||||||+||+++.++.+++. ||.+..... .....+++.|+|||++.+..++.++|||||||++|||+||+
T Consensus 803 ~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~ 875 (968)
T PLN00113 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875 (968)
T ss_pred CeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCC
Confidence 79999999999999999988875 665543321 12235789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC---CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 385 RPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 385 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.||+........+.+|++...... .....+|+.+. ..+.++..++.+++.+||+.+|++||||+||+++|+++..
T Consensus 876 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 876 SPADAEFGVHGSIVEWARYCYSDC--HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCcccCCCCcHHHHHHHhcCcc--chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 999764444566888887654433 34555665552 2345677889999999999999999999999999998855
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-58 Score=446.28 Aligned_cols=289 Identities=45% Similarity=0.756 Sum_probs=249.6
Q ss_pred CcccccccccccccchhhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCcc
Q 012213 164 SWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 243 (468)
....+++.++..+ +++|...+.||+|+||.||+|...+|+.||||++....... ..+|.+|++++.+++|||+|
T Consensus 61 ~~~~fs~~el~~A----T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 61 PLRSFSYDELRKA----TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred CcceeeHHHHHHH----HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcc
Confidence 3445566666666 88999999999999999999999999999999886544332 35699999999999999999
Q ss_pred ceeEEEecCC-eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 244 RLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 244 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
+|+|||.+.+ +.+||||||++|||.++|+......++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++
T Consensus 135 ~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~ 214 (361)
T KOG1187|consen 135 KLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF 214 (361)
T ss_pred cEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence 9999999998 599999999999999999976543789999999999999999999999988999999999999999999
Q ss_pred ceEEeeccccccccccCCCcccccc-ccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-CCCcCHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAV-AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFG-EEGLDIVQW 400 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~-~~~~~~~~~ 400 (468)
++||+|||+|+..... ....... .||.+|+|||+...+..++|+|||||||+++|++||+.|.+... .....+.+|
T Consensus 215 ~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999999999765421 1111222 89999999999999999999999999999999999999988633 344569999
Q ss_pred HHHhhcccccchhhhccccCC--CCCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 401 TKMQTNSSKEGVVKILDQRLS--NTPL-SEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 401 ~~~~~~~~~~~~~~~~d~~~~--~~~~-~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
+....... .+.+++|+++. ..+. .++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 293 ~~~~~~~~--~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 293 AKPLLEEG--KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHCc--chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 98877777 89999999984 4443 6888899999999999999999999999999776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=396.36 Aligned_cols=259 Identities=34% Similarity=0.531 Sum_probs=215.9
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-eeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 260 (468)
+.+...+.||+|+||+||+|.++....||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 344555679999999999999975555999999876554444678999999999999999999999999888 7999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccccccccC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDTG 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 339 (468)
|+++|+|.++++..+...+++..+++++.|||+|+.|||+.+. ||||||||+|||++.++ ++||+|||+++......
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999987556679999999999999999999996543 99999999999999997 99999999998765321
Q ss_pred CCccccccccCccccCccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc-
Q 012213 340 ASECMSAVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL- 416 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 416 (468)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... ... ...++
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~--------------~~~v~~ 260 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQV--------------ASAVVV 260 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHH--------------HHHHHh
Confidence 3344578999999999999 56899999999999999999999999987542 111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.......+......+..++..||+.||++||++.|++.+|+.+.
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 22223334447778888999999999999999999999998664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=364.88 Aligned_cols=254 Identities=29% Similarity=0.419 Sum_probs=213.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-eeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv 258 (468)
...++..+.||+|..|+|||+.++ +++.+|+|++.. ...+...+++.+|++++++++||+||.++|.|..+. ...++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 345566789999999999999985 678899999843 333444578999999999999999999999999988 49999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||||++|||++++... ..+++....+|+.++++||.|||+. ++||||||||+|+|+++.|++||||||.+..+.+.
T Consensus 157 mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999999643 4589999999999999999999962 33999999999999999999999999999987643
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
...+..||..|||||.+.+..|+.++||||||++++|+.+|+.||........+..+ .+..+++.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-----------Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-----------LLCAIVDE 297 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-----------HHHHHhcC
Confidence 346788999999999999999999999999999999999999999764221122221 34455554
Q ss_pred cCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLS-EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~-~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....+.. ...++..++..|++.||.+||++.|+++
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 45555554 7888999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=384.30 Aligned_cols=260 Identities=30% Similarity=0.435 Sum_probs=221.5
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.++..+.||+|.||.||.|.++....||+|.++... ...+.|.+|+.+|++++|++||+++|+|..++..+|||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4455678999999999999999888899999987542 2336699999999999999999999999998899999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
|+.|+|.++|....+..+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+... .+..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEY 358 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC-CCce
Confidence 99999999998767778999999999999999999999777 9999999999999999999999999999544 3333
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......-...|.|||.+....++.|||||||||+||||+| |+.||..+...+ .+..+-.+..
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~le~GyR 422 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELLERGYR 422 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHHhccCc
Confidence 33333445679999999999999999999999999999999 999997754221 2222223333
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCC
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNT 464 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 464 (468)
-..|..++..+.+++..||+.+|++|||++.+...|+++...+.
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 56677899999999999999999999999999999998865543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=372.36 Aligned_cols=249 Identities=28% Similarity=0.385 Sum_probs=212.5
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
..|..+++||+|||+.||.+++ ..|+.||+|++..... .....+.+.+||++.+.++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 8899999999865322 3344577899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|+|++++|..+++ +...+.+.++..++.||+.||.|||+.+ |+|||||-.|++++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-- 170 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC--
Confidence 9999999999996 5567999999999999999999999877 99999999999999999999999999998863
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
......+.+|||.|+|||++.....+..+||||+||++|-||+|++||+... +.+ ...++...
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vke-----------ty~~Ik~~- 233 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKE-----------TYNKIKLN- 233 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHH-----------HHHHHHhc-
Confidence 3345678999999999999999999999999999999999999999997522 111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
-...|.....+..+++..+++.+|.+|||+++|+.
T Consensus 234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11233355667788999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=355.62 Aligned_cols=201 Identities=32% Similarity=0.493 Sum_probs=179.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
...|...+.||+|+||+||+|+++ ++..||||.+....-..+..+-+..|+++|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 455677778999999999999984 6899999998655434445567889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC------CceEEeeccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD------FEAHVADFGLAK 333 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgla~ 333 (468)
|||.||+|.+|++... .+++.....++.|||.||++||+++ ||||||||+|||++.. ..+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999997554 5899999999999999999999887 9999999999999875 568999999999
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
.+.+ .....+.+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||+.
T Consensus 164 ~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9863 2334678999999999999999999999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=343.35 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=212.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeE-EEecCCe-eEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA-FCSNKET-NLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~l 257 (468)
...|.+.++||+|+||+|||+.. .+|..||.|.+.-........+....|+.+|++++|||||++++ .+.++.+ ..|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 55688889999999999999986 68999999998754445555577889999999999999999998 3444444 789
Q ss_pred EEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCS-PLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
||||+..|+|...++. +....+++..+++++.|+++||.++|..-. ..|+||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999998853 345579999999999999999999997321 2389999999999999999999999999999
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+.. ........+|||.||+||.+...+|+.++||||+||++|||+.-++||.+. ++.+. ..+
T Consensus 178 l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L-----------~~K 239 (375)
T KOG0591|consen 178 LSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSL-----------CKK 239 (375)
T ss_pred hcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHH-----------HHH
Confidence 863 333456788999999999999999999999999999999999999999763 23222 223
Q ss_pred hccccCCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 415 ILDQRLSNTP-LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 415 ~~d~~~~~~~-~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
+-.......+ .-++..+.+++..|+..||+.||+...+++.+.
T Consensus 240 I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 240 IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 3333444444 567888999999999999999999655555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.69 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=206.3
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCC-----chhHHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS-----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
.+.+.|...+.+|+|+||.|-+|.. ++|+.||||.++....... ......+|+++|++++|||||++.+++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3466777889999999999999987 5799999999976544221 112357999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEeec
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADF 329 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df 329 (468)
+..|+||||++||+|.+.+-.+. .+.+.....+++|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999885433 4777788899999999999999888 9999999999999776 77999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
|+|+... ....+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.+.-.+..
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------- 389 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------- 389 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----------
Confidence 9999754 456678899999999999998664 33488999999999999999999986321110
Q ss_pred ccccchhhhccccCCCC---CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNT---PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~---~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.+...+.... -.....+..+++.+++..||++|||+.|+++
T Consensus 390 ----l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 ----LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1222223333222 2345677889999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.36 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=221.7
Q ss_pred ccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+....+.||+|+||.||+|+.. +...||||.++..... ....+|++|++++..++|||||+|+|+|.+++..+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 3445678999999999999853 3467999999765432 23467999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCC--------C----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCce
Q 012213 257 LVYEYMPNGSLGEVLHGKR--------G----SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~--------~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 324 (468)
+|+|||..|+|.++|.... + .+++..+.+.||.|||.|++||.+.. +|||||.++|+|+.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996422 1 23888999999999999999999666 9999999999999999999
Q ss_pred EEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHH
Q 012213 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKM 403 (468)
Q Consensus 325 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 403 (468)
||+|||+++..-..+.........-..+|||||.+..++++++||||||||+|||++| |+.||.+...+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---------- 712 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---------- 712 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----------
Confidence 9999999997765555544434445789999999999999999999999999999999 99999875432
Q ss_pred hhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 404 QTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
+.+.-+-+..+.+.++.++.++..++..||+..|++||+++||-..|+.+....
T Consensus 713 ------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 ------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 144445556667788899999999999999999999999999999999875443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=359.26 Aligned_cols=262 Identities=29% Similarity=0.390 Sum_probs=214.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.+.....||+|+||+||+|.|. ..||||++......+...+.|+.|+..+++-||.||+-+.|||..+.. .+|+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 455667899999999999999995 359999998777777777899999999999999999999999998877 99999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
+|+|-+|+.++|-.+ ..++..+.+.||.|||+|+.|||.++ |||||||+.||++.++++|||+|||++..-..-..
T Consensus 468 wCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999554 56899999999999999999999877 99999999999999999999999999975432222
Q ss_pred CccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 341 SECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
........|...|||||++.. .+|+..+||||||+++|||+||..||.....+.. . |.. . ....-
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--i-fmV---G------rG~l~ 611 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--I-FMV---G------RGYLM 611 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--E-EEe---c------ccccC
Confidence 233344567889999999864 4689999999999999999999999984332211 0 100 0 01111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+++.....++..++.+|+..||..++++||.+.+|+.+|+++.+
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 22223334567788889999999999999999999998888765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=341.05 Aligned_cols=244 Identities=27% Similarity=0.290 Sum_probs=203.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..++||+|+||.||.++.+ .++.+|+|++++...-. .......+|..+|.+++||.||+++-.|++.+..+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 577889999999999999999975 47889999987644322 2346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
+||+.||.|..+|.. ...+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~-- 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL-- 176 (357)
T ss_pred EeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc--
Confidence 999999999999964 345899999999999999999999888 9999999999999999999999999998543
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+. .. ..+++...
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~-----------~~~~I~~~ 240 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KK-----------MYDKILKG 240 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HH-----------HHHHHhcC
Confidence 233345668999999999999999999999999999999999999999976331 11 12222223
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP 447 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP 447 (468)
.+...+.-...+..+++...+..||++|-
T Consensus 241 k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 KLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 32222322455667788899999999996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=354.60 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=204.5
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++.... .......+..|+.++..+ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 45688889999999999999974 235689999986432 222335688999999999 8999999999887654
Q ss_pred -eeEEEEeccCCCChhhhcccCC---------------------------------------------------------
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKR--------------------------------------------------------- 275 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 275 (468)
..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5789999999999999886422
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCcc
Q 012213 276 ---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352 (468)
Q Consensus 276 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 352 (468)
...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 124788899999999999999999877 99999999999999999999999999986542222222233456788
Q ss_pred ccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHH
Q 012213 353 YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQV 431 (468)
Q Consensus 353 y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 431 (468)
|+|||++.+..++.++||||||+++|||++ |..||....... .+... +.+......+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~-----------~~~~~~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQR-----------LKDGTRMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHH-----------HhcCCCCCCCCCCCHHH
Confidence 999999998899999999999999999997 999997632111 11111 11111111222345568
Q ss_pred HHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 432 FFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 432 ~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.+++..||+.||++|||+.|++++|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=340.73 Aligned_cols=254 Identities=30% Similarity=0.454 Sum_probs=203.5
Q ss_pred ccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC--eeEEEE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--TNLLVY 259 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 259 (468)
++...+.||+|+||+||++...+ |+..|||...... ....+.+.+|+.+|++++|||||+++|.....+ .+.+.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 46677899999999999999864 8999999876442 111466899999999999999999999855555 588999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccc-
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQD- 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~- 337 (468)
||+++|||.+++....+ .++++.+.+++.||++||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999986665 7999999999999999999999777 999999999999999 79999999999987653
Q ss_pred cCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
...........||+.|||||++..+ ....++|||||||++.||+||++||.+. .....+.- ....
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~----------~ig~ 237 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALL----------LIGR 237 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHH----------HHhc
Confidence 1122234467899999999999963 3335999999999999999999999763 11111111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
.......+........+++..|+..+|++|||++++++--
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1122344455667788899999999999999999999844
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.28 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=220.8
Q ss_pred hccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
...++.++||.|.||.||+|.++- ...||||.++.... ++....|..|..+|.++.||||++|.|+.......++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 446678999999999999999842 35699999975443 3344679999999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|+|||++|+|+.+|+.+.+ .+.+.+..-++.+||.|+.||.+.+ +|||||.++|||++.+..+|++|||+++.+.+
T Consensus 708 iTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999986654 4899999999999999999999887 99999999999999999999999999998864
Q ss_pred cCCCcccccccc--CccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 338 TGASECMSAVAG--SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 338 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.. ....+...| ..+|.|||.+...+++.++|||||||++||.++ |.+||.++.+. +.+..
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIka 846 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIKA 846 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------HHHHH
Confidence 33 222233333 469999999999999999999999999999999 99999875432 13444
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+-+.-....|++++..+.+|++.||+.|=.+||++.||+..|.++..
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 44444567789999999999999999999999999999999998743
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=319.07 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=206.0
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+....+|+|+||.|||.+++ .|+.||||++......+...+-..+||++|++++|+|+|.++.+|..+...+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 34666778999999999999986 58999999998766655555678899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|++..-|.++=+ ....++.....+++.|++.|+.|+|..+ +|||||||+|||++.++.+||||||+|+.+.. .
T Consensus 82 ~~dhTvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p 154 (396)
T KOG0593|consen 82 YCDHTVLHELER--YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--P 154 (396)
T ss_pred ecchHHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence 998755544433 2234888999999999999999999777 99999999999999999999999999998864 3
Q ss_pred CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
....+..+.|..|.|||++.+ ..|...+||||+||++.||++|.+-|.+.+ +.++++...+....-. ..-.+++...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktLG~L~-prhq~iF~~N 232 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTLGNLI-PRHQSIFSSN 232 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHHcccC-HHHHHHhccC
Confidence 334566778999999999887 789999999999999999999999887643 2223333222111111 1111111111
Q ss_pred -------C---------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 -------L---------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 -------~---------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ .........-+++++..|++.||.+|++-+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 0111223345789999999999999999998874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.20 Aligned_cols=271 Identities=27% Similarity=0.381 Sum_probs=215.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||.|..++||+|.. +.++.||||++.-.....+ .+.+.+|+..++.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 46788889999999999999986 5679999999976555444 577999999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
.||.+||+.+++...-...+++..+..|.+++++||.|||+.| .||||||+.|||++++|.+||+|||.+-.+...+
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999998776677999999999999999999999888 9999999999999999999999999987776544
Q ss_pred CCccc--cccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh-h
Q 012213 340 ASECM--SAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV-K 414 (468)
Q Consensus 340 ~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 414 (468)
..... ....||+.|||||++.. ..|+.|+||||||++..|+.+|..||..+..... ............. .
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQNDPPTLLTS 255 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhcCCCCCcccc
Confidence 22211 45689999999999654 3699999999999999999999999987553211 0111111110000 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCC
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPN 463 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~ 463 (468)
..+. +........+.+++..|+..||.+|||++++++ +++..+..+
T Consensus 256 ~~~~---d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 256 GLDK---DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred cCCh---HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 0010 111223346788999999999999999999987 566555443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=371.95 Aligned_cols=262 Identities=28% Similarity=0.426 Sum_probs=215.7
Q ss_pred hccCCcceEcccCCcceEEEEcC--CCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP--NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
+..+..+.||+|.||.||.|... +|. .||||.+...... .+..+|.+|..+|++++|||||+++|.|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~-~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE-QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34555789999999999999864 343 4899988755432 3346799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 256 LLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
++++|||++|+|..+|++.+ ...+.....+.++.|||+|+.||++.+ +|||||.++|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998653 346888999999999999999999776 9999999999999999999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
+|+.+.+...........-...|||||.+..+.+++|+|||||||++||++| |..||...++..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------- 912 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence 9996554444333333234579999999999999999999999999999999 999998754321
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
.+..+........+..+...+.+++..||+.+|++||++..+++.+..+....
T Consensus 913 -v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 913 -VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred -HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 12222222334456778899999999999999999999999999988775443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=329.94 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=201.2
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHH--hCCCCCCccceeEEEecCC----ee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL--GKIRHRNIVRLKAFCSNKE----TN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~~----~~ 255 (468)
......++||+|+||.||||++. ++.||||++....+ +.|.+|-++. -.++|+||++++++-.... ++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k-----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK-----QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH-----HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34555689999999999999995 59999999864433 4466665554 4558999999999876555 78
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------SPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
+||++|.+.|||.+||.... ++|....+|+..+++||+|||+.. +++|+|||||++|||+.+|+++.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999997554 899999999999999999999864 567999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCC-CC-----cchhhHHHHHHHHHHHhCCCCCCC--CCCCCcCHHHHH
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK-VD-----EKSDVYSFGVVLLELITGRRPVGD--FGEEGLDIVQWT 401 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~G~~l~elltg~~p~~~--~~~~~~~~~~~~ 401 (468)
|+|..+............+||.+|||||++.+.- +. .+.||||+|.+||||++...-+.. .++-...+..-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999987555555556689999999999987642 22 478999999999999997655431 110000000000
Q ss_pred HHhhcccccchhhhc-----cccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 402 KMQTNSSKEGVVKIL-----DQRLS--NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~-----d~~~~--~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
. ....-+.+.+.+ .+.+. ......+..+.+.+..||+.||+.|.|+.=|.+++.++....
T Consensus 441 G--~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 G--NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred c--CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0 000001111111 11110 111245667889999999999999999999999988775443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.62 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=212.5
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+....|.....||+|+.|.||.|.. .+++.||||++........ +-+.+|+.+|+..+|+|||.+++.|...++.|+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3355677788999999999999986 5688899999975544443 558899999999999999999999988899999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|||||++|+|.|.+.... +++.+...|+.+++.||+|||..+ |+|||||.+|||++.+|.+||+|||++..+..
T Consensus 348 VMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999999986543 899999999999999999999888 99999999999999999999999999988764
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
... ...+.+||++|||||+.....|++|+||||||++++||+-|.+||-.... +. .+.-+.+
T Consensus 422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lr------------AlyLIa~ 483 (550)
T KOG0578|consen 422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LR------------ALYLIAT 483 (550)
T ss_pred ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HH------------HHHHHhh
Confidence 332 44677899999999999999999999999999999999999999964221 00 0111111
Q ss_pred ccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 418 QRL--SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 418 ~~~--~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
... ...+......+.++..+|+..||++||++.|+++ +|+.+.
T Consensus 484 ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 484 NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 111 2234456677889999999999999999999997 554443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=333.82 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=204.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 257 (468)
.+.|+..+.||+|.||.||||++ .+|+.||+|++.-....+.......+||.+|++++||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45567778999999999999997 5789999999976554455456678999999999999999999988776 68999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|+|||++ +|.-++. ..+-.++..++..+++|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999975 7777776 33446899999999999999999999877 99999999999999999999999999998874
Q ss_pred cCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc--hhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG--VVK 414 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 414 (468)
. .....+..+-|..|.|||++.+. .|+.++|+||.||||.||++|++.|.+..+ -.++....+.......+- ..+
T Consensus 271 ~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 S-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred C-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhcccccc
Confidence 3 33346677789999999988764 699999999999999999999999987432 111111111110000000 011
Q ss_pred hcc-----------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILD-----------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d-----------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+-. ..+.+.........++++..++..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 110 1111111122345678888899999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.90 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=199.2
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCc-hhHHHHHHHHHhCCCCCCccceeEEEec----CCeeEEEEecc
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH-DNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLVYEYM 262 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 262 (468)
..||+|++|.||+|.+ +|+.||||++......... .+.+.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 6899999998754333222 3567899999999999999999999876 34678999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
++|+|.+++... ..+++....+++.+++.|+.|||+. + ++||||||+||++++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999999753 3588999999999999999999974 5 7899999999999999999999999998654221
Q ss_pred ccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .++........ .+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~---------~~ 240 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKN---------NS 240 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC---------CC
Confidence 23457899999999876 6799999999999999999999999975321 11111111110 00
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
...+......+.+++.+||+.||++|||++|+++.|+..+
T Consensus 241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1122234567889999999999999999999999998865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.40 Aligned_cols=251 Identities=34% Similarity=0.527 Sum_probs=197.6
Q ss_pred CcceEcccCCcceEEEEcC-----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 186 DNNVIGRGGAGVVYRGVTP-----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
..+.||.|.||.||+|.+. .+..|+||.+... ......+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3578999999999999986 3577999998542 222235789999999999999999999999998888999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.......+++.++.+|+.|||.||+|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998775667999999999999999999999877 99999999999999999999999999987632222
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
............|+|||.+....++.++||||||+++|||+| |+.||.+... .++ ..++.+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~-----------~~~~~~~~ 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEI-----------IEKLKQGQ 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHH-----------HHHHHTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccc-----------cccccccc
Confidence 233344557789999999998889999999999999999999 7899865321 111 11222222
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
....+......+.+++..||+.+|++||+|+++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2223334566788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=344.48 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=204.0
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+ .++..||||+++.... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 44688889999999999999974 2456899999864322 22335688999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCC----------------------------------------------------------
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR---------------------------------------------------------- 275 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 275 (468)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886422
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 276 ---------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 276 ---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
...+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124788999999999999999999877 99999999999999999999999999986643222
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||.+.+..++.++||||||+++|||++ |..||.....+. ....+.. .. .
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~---~~-----------~ 334 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIK---EG-----------Y 334 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHH---hC-----------c
Confidence 222223345678999999999999999999999999999998 899987533211 1111111 00 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+.....++.+++..|++.||++||++.||+++|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011112245678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=339.65 Aligned_cols=244 Identities=32% Similarity=0.518 Sum_probs=206.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
++.+...+-||.|+.|.||.|+++ ++.||||+++.. -+.+|+-|++++|+||+.+.|+|....-++||||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred HHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 555666788999999999999995 688999987522 3468999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
||+.|-|...|+. +..+.......|.++||.|+.|||... |||||||+-|||+..+..+||+|||-++...+.
T Consensus 193 fCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred ccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 9999999999964 445778888999999999999999665 999999999999999999999999999876532
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc-cc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD-QR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~ 419 (468)
..+..++||..|||||++....+++|+|||||||+|||||||..||.+.+..-+ -| .+. ..
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---Iw--------------GVGsNs 327 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IW--------------GVGSNS 327 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---EE--------------eccCCc
Confidence 445678999999999999999999999999999999999999999987442211 01 011 11
Q ss_pred C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
+ ...+..++.-+..++..||+..|..||++++|+.-|+-+
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 1 234556777888899999999999999999999988644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=305.00 Aligned_cols=265 Identities=24% Similarity=0.343 Sum_probs=206.1
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|...+.+|+|.||.||+|++ ..|+.||||+++.............+||+.|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 456678999999999999997 5799999999986655444446688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
|+ .+|+..++.+ ...+...+...++.++.+|++|||... |+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 83 m~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 96 6999998743 456888999999999999999999877 999999999999999999999999999998754433
Q ss_pred ccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHH------------HHHHHhhccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIV------------QWTKMQTNSS 408 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~------------~~~~~~~~~~ 408 (468)
. ...+-|..|.|||++.+. .|+..+||||.||++.||+-|.+-|.+.. +..++. +|..+..-..
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCcccccccc
Confidence 3 333678899999988764 69999999999999999999887776532 111111 1221111000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
--.+...-.+.+......+....++++..++..+|.+|.+++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00001010111122233455667899999999999999999999873
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.83 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=202.6
Q ss_pred hccCCcceEcccCCcceEEEEcCC-----------------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccc
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-----------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 244 (468)
.+|...+.||+|+||.||++.+.+ +..||+|.+.... .......+.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 467778899999999999997532 3369999886432 1222356889999999999999999
Q ss_pred eeEEEecCCeeEEEEeccCCCChhhhcccCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 012213 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307 (468)
Q Consensus 245 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 307 (468)
+++++.+.+..++||||+++|+|.+++.... ...++|....+++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 124788999999999999999999877 99
Q ss_pred ecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh--CCC
Q 012213 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRR 385 (468)
Q Consensus 308 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~ 385 (468)
||||||+|||++.++.+||+|||+++.+.............++..|+|||+.....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986643322222334456789999999988889999999999999999987 566
Q ss_pred CCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 386 PVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 386 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
||..... .....+......... ... ....+......+.+++.+||+.+|++|||+.||.+.|++
T Consensus 241 p~~~~~~--~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD--EQVIENAGEFFRDQG---RQV----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH--HHHHHHHHHHhhhcc---ccc----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7765321 112222211111110 000 011122345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=344.94 Aligned_cols=259 Identities=26% Similarity=0.359 Sum_probs=207.4
Q ss_pred hccCCcceEcccCCcceEEEEcCC--C---cEEEEEEecccC-CCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN--G---EQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
++....+.||+|+||.||+|.++. + ..||||..+... .......+|..|.+++++++|||||+++|++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999999743 2 238999887522 3344457899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++|||+|+||+|.++|..... .++..++.+++.++|+||+|||..+ ++||||.++|+|++.+..+||+|||+++.-
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999985443 6899999999999999999999777 999999999999999999999999998753
Q ss_pred cccCCCcccc-ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 336 QDTGASECMS-AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 336 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
. ...... ...-...|+|||.+....+++++|||||||++||+++ |..||.+.... ++..|+.
T Consensus 313 ~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~----------- 376 (474)
T KOG0194|consen 313 S---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV----------- 376 (474)
T ss_pred c---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH-----------
Confidence 2 111111 2235679999999999999999999999999999999 89999764321 1111110
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.+......+...+..+..+...||..+|++||+|.++.+.|+.+...
T Consensus 377 --~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 377 --KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred --hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11111223334566677788899999999999999999999987654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.84 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=203.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+. ++..||||++..... ......+.+|+.+++.+ +|+||++++++|....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 456888899999999999998742 345799999864332 22335688999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCC----------------------------------------------------------
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR---------------------------------------------------------- 275 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 275 (468)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885321
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccc
Q 012213 276 ----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345 (468)
Q Consensus 276 ----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 345 (468)
...+++.++++++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 124788999999999999999999877 9999999999999999999999999998654322222222
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC-CCC
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL-SNT 423 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~ 423 (468)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+... +.... ...
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~------------~~~~~~~~~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKM------------VKRGYQMSR 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHH------------HHcccCccC
Confidence 3345678999999998899999999999999999998 999997633211 01110 00000 001
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
+......+.+++..||+.||++||++.||+++|+++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112245678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.48 Aligned_cols=249 Identities=27% Similarity=0.336 Sum_probs=205.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC--C-CchhHHHHHHHHHhCCC-CCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG--S-SHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 255 (468)
...|..++.||+|+||+|+.|.+ .+++.||+|.+...... . ...+.+.+|+.+++.++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 56788899999999999999977 46899999965443111 1 23356778999999999 99999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeecccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKY 334 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~ 334 (468)
++||||+.+|+|.+++.. ...+.+..+.+++.|++.|++|+|..+ |+||||||+|+|++.+ +++||+|||++..
T Consensus 96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999975 445888999999999999999999877 9999999999999999 9999999999997
Q ss_pred ccccCCCccccccccCccccCccccCCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLK-VD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++... .. ..
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~-----------l~ 232 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PN-----------LY 232 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HH-----------HH
Confidence 63 2334456789999999999999877 76 789999999999999999999986221 11 11
Q ss_pred hhhccccCCCCCHHH-HHHHHHHHHhhcccCCCCCCCHHHHH
Q 012213 413 VKILDQRLSNTPLSE-AMQVFFVAMLCVQEHGVERPTMREVV 453 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~-~~~~~~l~~~c~~~~P~~RPt~~ev~ 453 (468)
.+ +.......+... ...+..++.+|+..+|.+|+++.||+
T Consensus 233 ~k-i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RK-IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HH-HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 111111222222 67788999999999999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=334.87 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=205.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
..+|..++.||.|+|++|++|+.+ .++.||||++.+.-. .....+-...|-+.|.+| .||.|++|+-.|++....|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 566888899999999999999974 588999998754221 112224567888889999 89999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|+||+++|+|.++|+.. ..+++.....++.+|+.||+|||..| ||||||||+|||||.|++++|+|||-|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999744 45899999999999999999999777 99999999999999999999999999998864
Q ss_pred cCCC---------cc--ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 338 TGAS---------EC--MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 338 ~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
.... .. ....+||..|.+||++.....+..+|+|+|||+||+|+.|.+||.+.++ |.
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yl----- 294 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------YL----- 294 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------HH-----
Confidence 3222 11 1457899999999999999999999999999999999999999976431 11
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...++++-.. ..+......+.+|+.+.+..||.+|+|.+||.+
T Consensus 295 ----iFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 295 ----IFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ----HHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1222222111 122223356667888999999999999988866
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=325.20 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=203.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|+..+.||+|+||.||+|.++ .+..||+|.++.... ......+.+|+..+.+++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 356788899999999999999763 356899998865322 222356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999998743 246899999999999999999999877 9999999999999999999999999876542
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.. .........++..|+|||...+..++.++||||||+++||+++ |+.||...... +.... +
T Consensus 159 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~-----------~ 221 (266)
T cd05064 159 SE-AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKA-----------V 221 (266)
T ss_pred cc-chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH-----------H
Confidence 11 1111122345678999999998899999999999999999876 99999753211 11111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.+......+......+.+++..||+.+|++||+++||.+.|.++
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111122334556788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=332.59 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=211.0
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCC-eeE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE-TNL 256 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 256 (468)
+.++|...+.||.|+||+||+|+. .+|+.||||+++..... .++-.-.+|++.|+++. ||||+++.+++.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 367788889999999999999986 56889999999754433 33334568999999998 999999999998888 899
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||| ..+|+++++.+ +..+++..+..|+.||.+||+|+|++| +.|||+||+|||+.....+||+|||+|+.+.
T Consensus 87 fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999999 47999999865 778999999999999999999999888 9999999999999999999999999999876
Q ss_pred ccCCCccccccccCccccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc------
Q 012213 337 DTGASECMSAVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK------ 409 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 409 (468)
.. ...+..+.|..|.|||++ ...-|+.+.|+||+||+++|+.+-++-|.+.++ .+++...........+
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhH
Confidence 33 334677889999999976 466799999999999999999999999977442 2222221111111111
Q ss_pred cchhhhccccCC--------CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 410 EGVVKILDQRLS--------NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 410 ~~~~~~~d~~~~--------~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..+...+.-++. ..-.....+..+++..|++.||.+|||+.|.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 112222222221 1122366788999999999999999999999873
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=326.85 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=207.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.+.|+..+.||+|+||.||+|.... ...||+|.+..... ......+.+|+..+.+++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 4567788999999999999998643 25799998763322 2223568899999999999999999999999899
Q ss_pred eEEEEeccCCCChhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRG--------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 320 (468)
.+++|||+++|+|.+++..... ..+++...+.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence 9999999999999999864321 45889999999999999999999877 999999999999999
Q ss_pred CCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHH
Q 012213 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399 (468)
Q Consensus 321 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 399 (468)
++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... ++..
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE 237 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence 99999999999986543322222334456789999999988889999999999999999998 99999753321 1111
Q ss_pred HHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 400 WTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 400 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
+ +........+...+..+.+++.+||+.+|.+||+++||++.|+++
T Consensus 238 ~--------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 M--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H--------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 111112223345567888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=322.95 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=207.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++|+|++++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 46678889999999999999998888899999875322 224678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.......+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 157 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE- 157 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc-
Confidence 999999999997666667899999999999999999999877 9999999999999999999999999998764321
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||+.....++.++||||||+++|||+| |+.||...... ....+.. .. .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~----~~-------~--- 221 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQ----RG-------Y--- 221 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHH----cC-------C---
Confidence 111223345678999999988889999999999999999999 99999653211 1111110 00 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
...........+.+++.+|++.+|++||+++++.+.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0111122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=328.16 Aligned_cols=252 Identities=24% Similarity=0.277 Sum_probs=200.5
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|+..+.||+|+||+||+|.+ .+|+.||||.+...... ......+.+|+.++.+++|+|++++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 55678899999999999987 57899999988643221 22234578899999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence 99999998886544456899999999999999999999877 999999999999999999999999999865321
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......||..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+.....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~------------~~~~~~~~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVD------------RRVKEDQE 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHH------------HHhhcccc
Confidence 122345689999999999999999999999999999999999999976432110 00000 00000011
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
..+......+.+++.+|++.||++||+ ++|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 122234556788999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=303.27 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=211.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|++++.||+|.||.||.|+. +++..||+|++...+-. .....++.+|+++-+.++||||+++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 67889999999999999999987 46788999998754432 22336789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
+||.++|++...|.......+++.....++.|+|.|+.|+|..+ |+||||||+|+|++.++..||+|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998778788999999999999999999999766 9999999999999999999999999997532
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....+.+||..|.+||...+...+..+|+|++|++.||++.|.+||.....+ +...++..-
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~k~ 237 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIRKV 237 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHHHc
Confidence 33456789999999999999999999999999999999999999999763311 011222111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ ...+......+.+++..|+..+|.+|.+..||+.
T Consensus 238 ~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 D-LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred c-ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 1223445566778999999999999999999986
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=320.44 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=202.0
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.|+..+.||+|+||.||++.++++..+|+|.+.... .....+..|+.++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4566778999999999999999888899999875322 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.++++... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||.++...... .
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-Y 155 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc-e
Confidence 99999999987543 35899999999999999999999877 9999999999999999999999999998654221 1
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||...+..++.++||||||+++|||++ |+.||..... .....+. . ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i---~-----------~~~~ 219 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI---S-----------RGFR 219 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---H-----------CCCC
Confidence 11222335668999999988889999999999999999999 9999965321 1111111 1 1111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
...+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112223456789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=319.58 Aligned_cols=256 Identities=30% Similarity=0.426 Sum_probs=207.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|++|.||+|.+.+++.||+|.+.... ...+.+.+|+.++++++|||++++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45678889999999999999998888899999886432 223668899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++....+..+++..+..++.+++.|+.|||+.+ ++||||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 157 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI- 157 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc-
Confidence 999999999997655567899999999999999999999877 9999999999999999999999999998765221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.........+..|+|||+..+..++.++||||||+++|||+| |+.||...... ..+.... .. .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~--~~----------~ 221 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVD--QG----------Y 221 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHH--cC----------C
Confidence 111112223458999999998899999999999999999999 99999653211 0011100 00 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0112223456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=326.96 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=208.9
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.|+..+.||+|+||.||||.+ ..++.||+|++.-.. ..+..+.+.+|+.++.+++++||.+++|.+..+...+++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456668999999999999998 457889999886443 344456789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
|.+|++.+.+. .+..+++....-++.++..|+.|||.++ .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-- 165 (467)
T ss_pred hcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh--
Confidence 99999999995 3344577888888999999999999777 9999999999999999999999999998776432
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC-
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL- 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~- 420 (468)
....+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+.+.... .+..++-...
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvlflIpk~~P 228 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVLFLIPKSAP 228 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEEEeccCCCC
Confidence 2236788999999999999989999999999999999999999999875431 1222222222
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHh
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQ 458 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~ 458 (468)
..........+.+++..|++.+|+.||++.++++ +++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 2233355667889999999999999999999986 4554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.86 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=206.2
Q ss_pred hhccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||.||+|.++. ...||||.+.... .......+.+|+..+++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 3567888999999999999998743 4579999875432 2223356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
++|||+++++|.+++.... ..+++..+.+++.+++.|++|||+.+ |+||||||+||++++++.++|+|||+++.+.
T Consensus 82 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 82 IITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999997543 36899999999999999999999877 9999999999999999999999999998775
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
............++..|+|||...+..++.++||||||+++|||++ |..||...... ..... +
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~--------------~ 221 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKA--------------V 221 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHH--------------H
Confidence 2222222223345678999999998899999999999999999998 99998653211 11111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.+......+......+.+++..|++.+|++||+++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111112233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.49 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=205.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 253 (468)
.+.|...+.||+|+||.||+|.+. .+..||||++..... ....+.+.+|++++.++. ||||++++++|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 456778899999999999999863 234699999864322 223356889999999996 999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCC----------------------------------------------------------
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR---------------------------------------------------------- 275 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 275 (468)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999875421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 012213 276 ------------------------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319 (468)
Q Consensus 276 ------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 319 (468)
...+++..+.+++.|++.||+|||+.+ |+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999877 99999999999999
Q ss_pred CCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHH
Q 012213 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIV 398 (468)
Q Consensus 320 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 398 (468)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||.....+. ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TF- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HH-
Confidence 999999999999986643222222233456788999999988889999999999999999997 999986532111 00
Q ss_pred HHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 399 QWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+.. +........+......+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 350 -~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 -YNK------------IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHH------------HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000 00000111222345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.90 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=215.8
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+.+++.||+|-||.|-......+..||||+++..... ....+|..|+++|.+++||||++++|+|..++..++|+|||+
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 4557899999999999999988899999999765432 234779999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
+|+|.+++........+-....+|+.|||.|++||.+.. +|||||.++|+|+|.++++||+|||+++-+-..+....
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999997665444566777889999999999999766 99999999999999999999999999997664555555
Q ss_pred ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC-
Q 012213 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL- 420 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~- 420 (468)
....+-..+|||+|.+.-+++++++|||+||+++||+++ ...||.+...+. .++ ....+++..-
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vve-----------n~~~~~~~~~~ 762 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVE-----------NAGEFFRDQGR 762 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHH-----------hhhhhcCCCCc
Confidence 555667889999999999999999999999999999876 788987643221 111 2222332221
Q ss_pred ---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 421 ---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 421 ---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
...|.-+...+.++++.||..|-++||+++++...|.+.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 344667788899999999999999999999999988764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.60 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=211.1
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
++|-..+.||+|+||.||||+-+ +.+.||+|.+.+..+..++.+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 34566788999999999999875 57889999998877777777789999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+.| +|..+|.. +..++++.+..++.++..||.|||+.+ |.|||+||.|||++..+++|+||||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9976 99999963 445999999999999999999999776 99999999999999999999999999998752 3
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
....+...||+.|||||+..++.|+..+|.||+||++||+++|++||... .+.+.++... ...
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~------------~d~ 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSIL------------KDP 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHh------------cCC
Confidence 34456788999999999999999999999999999999999999999642 2233332222 222
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+......+..++...+..||.+|.|-.+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2334466677888999999999999999888765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.38 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=205.2
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
..|...+.||+|+||.||+|.+. .++.||+|.+... ......+.+|++.++.++|+|++++++++......+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 34667789999999999999975 5788999987532 2223568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~- 158 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 158 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce-
Confidence 999999999997655567899999999999999999999877 9999999999999999999999999998764221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||...+..++.++||||||+++|||++ |..||..... .++....... .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~--------~--- 222 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKG--------Y--- 222 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC--------C---
Confidence 111122234568999999998899999999999999999998 9999865321 1111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0112223456788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=328.32 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=202.8
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
..|+..+.||+|+||.||+|.+. +++ .||+|.+.... ......++..|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 45778899999999999999864 333 38999886322 223345788999999999999999999999764 568
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+++||+++|+|.+++.... ..+++...++++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997533 35889999999999999999999877 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
............++..|+|||++.+..++.++||||||+++|||++ |+.||.+.. ..++.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~~~~~~~~-------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKG-------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhCC--------
Confidence 3322222223334678999999999999999999999999999998 999986532 11111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.....+......+.+++..||+.+|.+||++.+++..|..+...
T Consensus 228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00111223445678899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=330.63 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=203.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 252 (468)
.++|+..+.||+|+||.||+|... .++.||+|++.... .....+.+..|+.++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 357888999999999999999742 24789999886432 222335677899999999 899999999988654
Q ss_pred CeeEEEEeccCCCChhhhcccCCC--------------------------------------------------------
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRG-------------------------------------------------------- 276 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 276 (468)
...++++||+++|+|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 457899999999999998854221
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccc
Q 012213 277 ---SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353 (468)
Q Consensus 277 ---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 353 (468)
..++|..+.+++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++..+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25899999999999999999999777 999999999999999999999999999876433222223344567789
Q ss_pred cCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHH
Q 012213 354 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVF 432 (468)
Q Consensus 354 ~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 432 (468)
+|||++.+..++.++|||||||++|||++ |..||.+..... .+... ... ......+......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~~-~~~----------~~~~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRR-LKE----------GTRMRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHHH-Hhc----------cCCCCCCccCCHHHH
Confidence 99999999999999999999999999998 999996532111 01110 000 001111223346688
Q ss_pred HHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 433 FVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 433 ~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+++.+|++.+|++||++.|+++.|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.15 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=206.0
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.+.|...+.||+|+||.||+|...+ +..||||.+..... ....+.+.+|+++++.++|+|++++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 3457778899999999999998643 47899998864332 2233678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
.++||||+++++|.+++.... ...+++.++..++.+++.|+.|||+.+ ++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 999999999999999986432 235789999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 401 (468)
.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.....+ ...+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~- 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC- 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH-
Confidence 999999999976542222222233445788999999999999999999999999999999 99998653321 11111
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.........+......+.+++..||+.+|++||++.||++.|++
T Consensus 237 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 -------------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111122223445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.50 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=209.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
...|+..+.||.|+||.||+|.+.+++.+|+|.+..... .....+..|+.+++.++|+|++++++++...+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 456778899999999999999998899999999864322 223568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++....+..+++..+..++.+++.|++|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999998766667899999999999999999999877 99999999999999999999999999986642211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
......++..|+|||......++.++||||||+++|+|++ |+.||..... .....+. ....
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~--------------~~~~ 221 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQI--------------TAGY 221 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHH--------------HhCC
Confidence 1223345778999999988889999999999999999999 8999965321 1111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1122234456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=330.21 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=222.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe-eEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-NLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 258 (468)
.++|...+.+|+|+||.++..+++ ++..|++|++.-.............|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 456777889999999999999874 57789999997666555555578899999999999999999999999888 8999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|+|++||++.+.+...++..++++....|+.|++.|+.|||+.. |+|||||+.||+++.+..++|+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998888888999999999999999999999776 999999999999999999999999999988643
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+... .+.++...
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------Li~ki~~~ 221 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------LILKINRG 221 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----------------HHHHHhhc
Confidence 3 23467889999999999999999999999999999999999999998644221 33444444
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.....+..+..++..++..|+..+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4566777888999999999999999999999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=318.34 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=202.7
Q ss_pred cCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe-----
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET----- 254 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 254 (468)
|...+.||+|+||.||+|.... +..||+|+++...........+..|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3567889999999999998742 3679999987543333334578899999999999999999998866554
Q ss_pred -eEEEEeccCCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 255 -NLLVYEYMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 255 -~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
.++++||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 68999999999999988543 2236899999999999999999999877 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
|+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+.... .+.++
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~-------- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDY-------- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------
Confidence 99987653322222222345678999999988889999999999999999999 89998653211 11111
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
..+......+......+.+++.+|++.||++||++.|+++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 ------LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111222334566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=331.08 Aligned_cols=243 Identities=23% Similarity=0.289 Sum_probs=195.6
Q ss_pred ceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
+.||+|+||.||++.+ .+|+.||+|++..... .......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 4688999999864322 1222346778999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 345 (468)
+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 999998643 35899999999999999999999877 999999999999999999999999998754211 22234
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCH
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 425 (468)
...||+.|+|||++.+..++.++|||||||++|||+||+.||...+.+ .+... +.. .....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~--------------~~~-~~~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL--------------ILM-EEIRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHH--------------HHc-CCCCCCC
Confidence 567999999999999999999999999999999999999999653211 01100 000 0111222
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 426 SEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 426 ~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.....+.+++.+|++.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3455678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=323.19 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=207.3
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+|...+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+..+++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45667789999999999999752 34568888875322 12235688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 012213 256 LLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 321 (468)
++||||+++++|.+++.... ...+++..++.++.+|+.|++|||+.+ ++||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999986432 234899999999999999999999887 9999999999999999
Q ss_pred CceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHH
Q 012213 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQW 400 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 400 (468)
+.++|+|||++................++..|+|||+..+..++.++||||||+++|||+| |+.||...... ...+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~- 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIE- 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH-
Confidence 9999999999976543222222234456788999999998899999999999999999999 99998653211 0111
Q ss_pred HHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCC
Q 012213 401 TKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNT 464 (468)
Q Consensus 401 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 464 (468)
.+........+...+..+.+++.+|++.+|++||++++|+++|+++.++..
T Consensus 237 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 237 -------------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred -------------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 111111111222345678899999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=320.35 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=202.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||.||+|.+. .+..||||++..... .....++.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 567888899999999999998753 356799998753321 1223568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
.++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986432 124678899999999999999999877 999999999999999999999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+.... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~~~~-- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QVLRF-- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH--
Confidence 99999976543222211222345778999999998889999999999999999999 78898653211 11111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
..+......+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 234 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 ---------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---------HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111222344578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=315.88 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=202.0
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.|+..+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4566778999999999999998777789999875322 2235689999999999999999999999988889999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++..... .+++..++.++.+|+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++...... .
T Consensus 81 ~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~ 155 (256)
T cd05113 81 MSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-Y 155 (256)
T ss_pred CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-e
Confidence 999999999874333 6899999999999999999999877 9999999999999999999999999998654221 1
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||...... .... .+.....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~--------------~~~~~~~ 219 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVE--------------KVSQGLR 219 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH--------------HHhcCCC
Confidence 11122335678999999988889999999999999999999 99998653311 0111 1111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
...+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112234567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=322.76 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=205.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.+++|||++++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 346778899999999999999752 34568899875432 2223568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR-----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 323 (468)
.++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999986432 235899999999999999999999877 999999999999999999
Q ss_pred eEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHH
Q 012213 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 324 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 402 (468)
++|+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |..||...... ...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~---- 232 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI---- 232 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----
Confidence 99999999986543222222233445778999999998889999999999999999999 99998653211 011
Q ss_pred HhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 403 MQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
..+........+......+.+++.+|++.+|.+|||+.||.+.|+++...
T Consensus 233 ----------~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ----------ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----------HHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111111122345688999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=320.14 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=203.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+.|+..+.||+|+||.||+|.+ .++..||+|.+..... ......+.+|+.++++++|||++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 34567778999999999999984 3567899999864322 22235688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 012213 256 LLVYEYMPNGSLGEVLHGKR---------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 320 (468)
++||||+++++|.+++.... ...+++.+.+.++.+++.||+|||+.+ ++||||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcC
Confidence 99999999999999985321 224789999999999999999999877 999999999999999
Q ss_pred CCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHH
Q 012213 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399 (468)
Q Consensus 321 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 399 (468)
++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||...... .+.+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence 99999999999987643322222334446778999999988889999999999999999999 99998653211 1111
Q ss_pred HHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 400 WTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 400 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
... .......+......+.+++..|++.+|++||++.+|.+.|+.
T Consensus 238 ~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVR--------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH--------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 110 000111222345667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.71 Aligned_cols=245 Identities=24% Similarity=0.286 Sum_probs=198.3
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4677889999999999999985 688999999854322 11233568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 82 YVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999999643 35889999999999999999999877 999999999999999999999999999865421
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +.....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~-----------i~~~~~ 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEK-----------ILAGKL 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-----------HHhCCc
Confidence 1235689999999999988899999999999999999999999975321 111111 111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
..+......+.+++.+|++.||.+||+ ++|+++
T Consensus 216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 112223456788999999999999995 787765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=332.47 Aligned_cols=249 Identities=29% Similarity=0.370 Sum_probs=208.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..-|+.++-||+|+.|.|..|++ ..|+.+|||.+...... ......+++||.+|+.+.|||+++++++++++.+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 34567788899999999999998 67999999999776432 33346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
.||+++|.|.+++-. .+++++.++.+++.||..|+.|+|..+ |+|||+||+|+|||.++++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 999999999999953 345889999999999999999999877 9999999999999999999999999997532
Q ss_pred CCCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
......+.+|++.|.|||++.+.+|. .++||||.||+||.||||+.||++.+ +-. .+.++..
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~-----------LLlKV~~ 226 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRV-----------LLLKVQR 226 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHH-----------HHHHHHc
Confidence 33445678999999999999999886 78999999999999999999998522 111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..-+.|.+...++.+++.+|+..||++|-|++||++
T Consensus 227 -G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 227 -GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 112234556678889999999999999999999987
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=319.72 Aligned_cols=263 Identities=19% Similarity=0.233 Sum_probs=200.2
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|+||+||++.++ +++.||||++..........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4677889999999999999985 578899999875544334446688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
++++.+..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 155 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SN 155 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc-cc
Confidence 99887765543 2345889999999999999999999877 999999999999999999999999999876422 22
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHH-----------HHHHhhccccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQ-----------WTKMQTNSSKE 410 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~-----------~~~~~~~~~~~ 410 (468)
.......|++.|+|||++.+..++.++|||||||++|||++|++||....... .+.. +........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNP-- 232 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccc--
Confidence 22234568999999999998889999999999999999999999997633111 0000 000000000
Q ss_pred chhhhccccCC-------CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVVKILDQRLS-------NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~~~~d~~~~-------~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......+... .........+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 000113456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=317.11 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=197.5
Q ss_pred CCcceEcccCCcceEEEEcCCCc---EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC------Cee
Q 012213 185 KDNNVIGRGGAGVVYRGVTPNGE---QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ETN 255 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 255 (468)
..++.||+|+||.||+|.+.++. .||+|.++.........+.+..|+..++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999975433 589998765433333346788999999999999999999987432 245
Q ss_pred EEEEeccCCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 256 LLVYEYMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
++++||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 2335899999999999999999999877 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++.+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||...... .+.. .. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~--~~--~~--- 229 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYD--YL--RQ--- 229 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH--HH--Hc---
Confidence 987653222111223345678999999998899999999999999999999 89998653211 1111 10 01
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
......+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 -------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111223345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=314.20 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=204.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.+++.++|||++++++++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 356788899999999999999987777899998864222 23568999999999999999999998754 56789999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.......+++..+..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||.++.+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999997655556899999999999999999999877 99999999999999999999999999986643221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||....... .+.. .....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~~------------~~~~~ 220 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ------------VERGY 220 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HHHH------------HhcCC
Confidence 11223446678999999988889999999999999999999 888986532110 0100 00000
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
...........+.+++.+|++.+|++||++.+++++|++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1112234556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=314.21 Aligned_cols=254 Identities=30% Similarity=0.441 Sum_probs=204.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 456788899999999999999988888999999864332 2356899999999999999999999875 456789999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.++++......+++.++..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999997655556899999999999999999999877 99999999999999999999999999986642221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......++..|+|||+..+..++.++||||||+++|||++ |..||.+... ....++ +....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~--------------~~~~~ 220 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ--------------VERGY 220 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH--------------HHcCC
Confidence 11122335678999999988889999999999999999999 8999965321 111111 10110
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
....+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223445678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.50 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=201.0
Q ss_pred hccCCcceEcccCCcceEEEEcC-C-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-N-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
..|...+.||+|+||.||+|... + ++.||+|.+... .......+..|+.+++.++||||+++++++...+..++||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34777899999999999999864 3 577888865322 1222345788999999999999999999999999999999
Q ss_pred eccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999988542 2346889999999999999999999777 99999999999999999999999999987653
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. .....
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~-----------~~~~~ 285 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIM-----------QQVLY 285 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH-----------HHHHh
Confidence 3222233456799999999999999999999999999999999999999965321 1111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+......+.+++..|++.+|++||++.+++.
T Consensus 286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111222234456888999999999999999999874
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=320.92 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=203.7
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
..|...+.||+|+||.||+|.+. ++..||+|++..... ......+..|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 45667788999999999999863 257899999864332 12235688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 012213 256 LLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 321 (468)
++++||+++++|.+++.... ...+++..+.+++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 99999999999999985221 234788999999999999999999877 9999999999999999
Q ss_pred CceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHH
Q 012213 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQW 400 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 400 (468)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+... .++
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~ 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDV 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence 9999999999886643322222334456789999999988889999999999999999998 8888865321 111
Q ss_pred HHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 401 TKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 401 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.. .+.+......+......+.+++..|++.+|++||+++||++.|+.
T Consensus 236 ~~-----------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IE-----------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-----------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 111111222233455668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=312.97 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=196.7
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 266 (468)
+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999984 68899999875322 22233568999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccc
Q 012213 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346 (468)
Q Consensus 267 L~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 346 (468)
|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99998643 345899999999999999999999777 99999999999999999999999999876542111111111
Q ss_pred cccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc-CCCCC
Q 012213 347 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR-LSNTP 424 (468)
Q Consensus 347 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~~ 424 (468)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+... ....+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~------------~~~~~~~~~~~~~~ 218 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----Q------------TREAIEQGVRLPCP 218 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----H------------HHHHHHcCCCCCCc
Confidence 223467999999998889999999999999999998 99998653211 0 00001000 11122
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
......+.+++.+|++.+|++|||+.|+.++|+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 3345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.44 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=204.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------ 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 253 (468)
.++|...+.||+|+||+||+|.+ .+|+.||||++............+.+|+..+..++|+|++++.+.+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 46788899999999999999986 46899999998654433334456889999999999999999887765432
Q ss_pred --eeEEEEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 254 --TNLLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 254 --~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 257999999999999998643 2346899999999999999999999777 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~------ 256 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHK------ 256 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH------
Confidence 99987653322333345679999999999999999999999999999999999999996522 1111111
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.........+......+.+++..|++.+|++||++.++++.
T Consensus 257 -----~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 -----TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111122233445678889999999999999999999863
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=317.39 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=199.6
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+.|+..+.||+|+||+||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 45677789999999999999874 344 47777764221 12223567788889999999999999998864 4567
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 85 ~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 8999999999999997433 45899999999999999999999877 9999999999999999999999999998764
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
............++..|+|||...+..++.++||||||+++||+++ |+.||.+.... ...++.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~----~~------- 227 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLE----KG------- 227 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH----CC-------
Confidence 3322222334557789999999998899999999999999999998 99999753211 1111110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.....+..+...+.+++..||..+|++|||+.|+++.|+.+..
T Consensus 228 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 ---ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0011111234566788999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=313.76 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=205.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 456778899999999999999999999999999864332 2357899999999999999999999874 456899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++....+..+++.++..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 999999999987666667899999999999999999999777 9999999999999999999999999997654211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||+..+..++.++||||||+++||+++ |+.||...... ..... . .+..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~---~-----------~~~~ 220 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQN---L-----------ERGY 220 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHH---H-----------HcCC
Confidence 111223345678999999988889999999999999999999 99999753211 11111 0 0000
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
....+......+.+++.+|++.+|++||+++++...|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111222334578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=313.02 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=206.0
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|++|.||+|.+. +++.|++|.+............+..|+++++.++|||++++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 556688999999999999874 6889999988644333344567889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.++++......+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+.... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~ 156 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--N 156 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--c
Confidence 9999999998665667999999999999999999999877 9999999999999999999999999998765322 1
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
......|++.|+|||+..+..++.++|+||||+++|||++|+.||..... ... ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-----------~~~~~~~~~~~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GAL-----------ILKIIRGVFPP 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHH-----------HHHHHcCCCCC
Confidence 22345688999999999988899999999999999999999999965321 010 11111112222
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.+......+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=313.47 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=201.0
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.+|+..+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+++++.++|||++++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3567788999999999999998877889999875322 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++...+...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 81 MANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999997433 36899999999999999999999877 99999999999999999999999999976542211
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||...+..++.++||||||+++|||++ |+.||...... .. +... .....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~--~~~~---------~~~~~--- 219 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EV--VESV---------SAGYR--- 219 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HH--HHHH---------HcCCc---
Confidence 11112223467999999998899999999999999999999 89998653211 11 1110 00001
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
...+......+.+++.+|++.+|++|||+.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111223466788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=329.12 Aligned_cols=247 Identities=25% Similarity=0.283 Sum_probs=199.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 456788899999999999999985 588999999864322 122335688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999998643 35788999999999999999999877 999999999999999999999999999865421
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+ ..+...
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~------------~~i~~~ 230 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIY------------EKILAG 230 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHH------------HHHhcC
Confidence 1235689999999999998999999999999999999999999965321 0111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
.. ..+......+.+++..|++.||.+||+ ++|++.
T Consensus 231 ~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 231 RL-KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred Cc-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 111223445778999999999999997 677663
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=319.20 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=194.9
Q ss_pred ccCCcceEcccCCcceEEEEcC--CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC---CCCCccceeEEEec-----C
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSN-----K 252 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 252 (468)
.|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 4677889999999999999873 467899998865443333334566777776665 69999999998852 3
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
...++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 45789999996 69999987655566899999999999999999999877 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc-ccccc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN-SSKEG 411 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 411 (468)
+..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||.+.... +.......... ...+.
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEED 232 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhh
Confidence 865422 2234556899999999998888999999999999999999999999763321 11111100000 00000
Q ss_pred h-------hhhccccCCC----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 V-------VKILDQRLSN----TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~-------~~~~d~~~~~----~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...+...... ........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 00122345678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=311.48 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=202.8
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.|.....||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4577788999999999999998887889999875332 22356889999999999999999999875 4567899999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.++++......+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence 99999999997655556899999999999999999999877 9999999999999999999999999997664221 1
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||...+..++.++||||||+++|||+| |+.||.+.... ....+. .....
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~--------------~~~~~ 221 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQV--------------ERGYR 221 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH--------------HcCCC
Confidence 11122345678999999988889999999999999999999 99999753211 111110 00000
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
...+......+.+++.+|++.+|++||++++|.++|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11222345678889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=329.02 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=218.3
Q ss_pred cCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
+...+.||-|.||.||.|.|+. .-.||||.++.. ....++|..|..+|+.++|||+|+|+|+|..+...|||+|||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 4456889999999999999964 667999998643 334578999999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
.+|+|.+||..-....++....+.++.||+.|++||..+. +|||||.++|+|+.++..+||+|||+++++..+ ...
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCC-cee
Confidence 9999999998777777888889999999999999999877 999999999999999999999999999988632 222
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC-
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL- 420 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~- 420 (468)
......-.+.|.|||-+....++.|+|||+|||+||||.| |..||.+.+ +. .+..+++...
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lS------------qVY~LLEkgyR 484 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS------------QVYGLLEKGYR 484 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HH------------HHHHHHhcccc
Confidence 2223334678999999999999999999999999999999 999997633 11 3334444333
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCC
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNT 464 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 464 (468)
-+.+..+...+.++++.||+.+|.+||++.|+-+.+|.+...+.
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 45567889999999999999999999999999999998865553
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=329.53 Aligned_cols=244 Identities=26% Similarity=0.327 Sum_probs=204.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|...++||+|+||+|+++..+ +++.+|||.+++... ..+..+..+.|-.++... +||.++.++..|+++++.++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 567788899999999999999985 578899999987554 334456778888887766 59999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+.||++..+.+ ...+++..+.-++..|+.||+|||+++ |||||||-+|||||.+|++||+|||+++.-.
T Consensus 447 vmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC-
Confidence 999999999655554 345899999999999999999999888 9999999999999999999999999998643
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.....+++.+||+.|||||++.+..|+.++|.|||||+|||||.|..||.+.+++. ....++.
T Consensus 520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----------------~FdsI~~ 582 (694)
T KOG0694|consen 520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDSIVN 582 (694)
T ss_pred -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhc
Confidence 33446788999999999999999999999999999999999999999998744321 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
. -..+|.....+...++.+.+..+|++|..+
T Consensus 583 d-~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 D-EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C-CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 133566677888899999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.93 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=200.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+...+||+|+||.||+++.+ .|..+|+|++++..- ...+.+...+|-.+|....+|+||+++-.|++.+..|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 577888999999999999999975 588999999976433 223346688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+|||++..+|. +...+++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+|||++.-+...
T Consensus 220 MEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999995 3446899999999999999999999888 999999999999999999999999999543210
Q ss_pred ----------------------CCC-----cc------------------ccccccCccccCccccCCCCCCcchhhHHH
Q 012213 339 ----------------------GAS-----EC------------------MSAVAGSYGYIAPEYAYTLKVDEKSDVYSF 373 (468)
Q Consensus 339 ----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 373 (468)
... .. ....+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 00 012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCC--cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC---
Q 012213 374 GVVLLELITGRRPVGDFGEEG--LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT--- 448 (468)
Q Consensus 374 G~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt--- 448 (468)
||++||||.|.+||....... ..+..|....... .......+..++|.+|+. ||+.|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999997633211 1233333221111 111223667788888888 9999965
Q ss_pred HHHHH
Q 012213 449 MREVV 453 (468)
Q Consensus 449 ~~ev~ 453 (468)
++||.
T Consensus 439 ~~EIK 443 (550)
T KOG0605|consen 439 AEEIK 443 (550)
T ss_pred HHHHh
Confidence 55554
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=328.21 Aligned_cols=269 Identities=24% Similarity=0.329 Sum_probs=197.0
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----eeEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNLL 257 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 257 (468)
|+..+.||+|+||.||+|.+. +++.||||++............+.+|+++++.++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 566789999999999999974 6899999998654333333356889999999999999999999885432 4799
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 82 VFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 999995 7899888533 35899999999999999999999877 99999999999999999999999999986532
Q ss_pred cCC-CccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc-c----
Q 012213 338 TGA-SECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS-K---- 409 (468)
Q Consensus 338 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~---- 409 (468)
... ........||..|+|||++.+ ..++.++|||||||++|||+||++||...... ....+........ .
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence 221 122234578999999998865 67899999999999999999999999653210 0000000000000 0
Q ss_pred ----cchhhhcc---ccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 410 ----EGVVKILD---QRLS----NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 410 ----~~~~~~~d---~~~~----~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
......++ .... .........+.+++.+|++.+|++|||++|+++ .++.+.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 00000000 0000 000112345678999999999999999999986 344443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.03 Aligned_cols=239 Identities=23% Similarity=0.241 Sum_probs=191.3
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||+|+||.||+|.+. +++.||+|++..... .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999985 578899999864322 222335678899999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++..... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 9999643 35899999999999999999999877 999999999999999999999999999754322 1223456
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 427 (468)
.||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........ .... ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~-----------~~~~-~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKI-----------LQEP-LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHH-----------HcCC-CCCCCcC
Confidence 78999999999999999999999999999999999999997532 11111111 1111 1122234
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHH
Q 012213 428 AMQVFFVAMLCVQEHGVERPTMREV 452 (468)
Q Consensus 428 ~~~~~~l~~~c~~~~P~~RPt~~ev 452 (468)
...+.+++..|++.||++||++.++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 4567789999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.06 Aligned_cols=268 Identities=28% Similarity=0.390 Sum_probs=202.3
Q ss_pred cCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNL 256 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 256 (468)
++..+.||+|+||+||++.. .++..||+|.+..... ......+.+|++++++++|||++++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 36778999999999988642 4678899998864322 22345688999999999999999999988653 3578
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
++|||+++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 85 lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999998643 4899999999999999999999877 9999999999999999999999999998765
Q ss_pred ccCCCc-cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASE-CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
...... ......++..|+|||......++.++||||||+++|||+||+.|+............+... ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG--QMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc--ccchhhhhhh
Confidence 322111 1122345667999999988889999999999999999999999986532211111111000 0000011111
Q ss_pred ccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 416 LDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 416 ~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+... ...+......+.+++..|++.+|++|||+++|+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22111 1223344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=325.47 Aligned_cols=243 Identities=24% Similarity=0.298 Sum_probs=194.4
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
+.||+|+||.||++... +|..||+|.+..... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 689999999865322 1222345778999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 345 (468)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 999888643 35899999999999999999999877 999999999999999999999999998753211 12223
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCH
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 425 (468)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... . + ..+.... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~--~------------~~~~~~~-~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L--F------------ELILMEE-IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--H--H------------HHHhcCC-CCCCC
Confidence 4568999999999998899999999999999999999999996532110 0 0 0011000 11122
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 426 SEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 426 ~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.....+.+++..|++.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3345677899999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.41 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=206.0
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|...+.||+|+||.||+|.+ ..+..||||++..... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 45678889999999999999974 2345799998764322 23335688999999999 7999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..+++|||+++|+|.++++......+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997655556899999999999999999999877 9999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~-------------- 254 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFY-------------- 254 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHH--------------
Confidence 6643222112223345778999999988889999999999999999998 999986533110 011
Q ss_pred hhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 413 VKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 413 ~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
+.++... ...+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 255 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 -KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111 111122345788899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=300.47 Aligned_cols=239 Identities=25% Similarity=0.289 Sum_probs=196.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||.|+||.|-+++.+ +|..+|+|++..... .-.+.+...+|..+|+.+.||.++++++.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 567788899999999999999975 578899999865332 123335578899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||++||.|.++++.. ..++++.+..+|.+|+.||+|||..+ |++||+||+|||+|.+|.+||+|||.|+.+..
T Consensus 123 meyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred EeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999999743 35999999999999999999999777 99999999999999999999999999997652
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.+-+.+||+.|+|||.+.+..+..++|.|||||++|||+.|.+||.+... +. ...+++..
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~------------iY~KI~~~ 256 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQ------------IYEKILEG 256 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HH------------HHHHHHhC
Confidence 24578999999999999999999999999999999999999999976432 11 12223322
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVER 446 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~R 446 (468)
.+ ..|.--...+.+++...++.|-.+|
T Consensus 257 ~v-~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KV-KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc-cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22 1233334455567777777777777
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=325.53 Aligned_cols=243 Identities=23% Similarity=0.271 Sum_probs=195.2
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
+.||+|+||.||++.+. +++.||+|++..... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 688999999865322 2223356788999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 345 (468)
+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 999888643 35899999999999999999999877 999999999999999999999999998753211 12234
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCH
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 425 (468)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......... .....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~------------~~~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILM------------EDIKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhcc------------CCccCCC
Confidence 46789999999999988999999999999999999999999965321 111111000 0011122
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 426 SEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 426 ~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.....+.+++.+|++.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 3345677899999999999997 8898875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=328.07 Aligned_cols=247 Identities=21% Similarity=0.256 Sum_probs=199.0
Q ss_pred hhccCCcceEcccCCcceEEEEcCC--CcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.|+..+.||+|+||.||+|.+++ +..||+|++..... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 5678888999999999999998643 36899998854322 22233568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999643 35889999999999999999999877 99999999999999999999999999986542
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.. +..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~------------i~~ 242 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQK------------ILE 242 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHH------------Hhc
Confidence 1 2345789999999999988899999999999999999999999975321 111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
... ..+......+.+++.+|++.+|++|+ +++|+++
T Consensus 243 ~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 243 GII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 111 11222334567899999999999995 8888765
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=311.45 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=197.2
Q ss_pred eEcccCCcceEEEEc---CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.||+|+||.||+|.+ .++..+|+|++..........+.+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 35788999988644433334467899999999999999999999885 45678999999999
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC-ccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-ECM 344 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~ 344 (468)
+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+...... ...
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999643 35899999999999999999999877 999999999999999999999999999876432221 111
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
....++..|+|||......++.++||||||+++|||++ |+.||..... ..+....... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~i~~~-----------~~~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQMIESG-----------ERMEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHCC-----------CCCCC
Confidence 22334578999999988889999999999999999998 9999975321 1111111110 01112
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
+......+.+++.+||+.+|++||++++|++.|++.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.69 Aligned_cols=260 Identities=18% Similarity=0.279 Sum_probs=208.1
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
++|+..+.||+|+||.||+|... +++.||||.+..... .......+.+|+++++.++|||++++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 45778899999999999999974 689999998764332 2232356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||+++|+|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 2345788999999999999999999877 99999999999999999999999999987642
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.. .......+++.|+|||...+..++.++|+||||+++|||++|+.||..... ....+......
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~----------- 222 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIEQ----------- 222 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHhc-----------
Confidence 21 122345688899999999888899999999999999999999999865221 12222221110
Q ss_pred ccCCC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 418 QRLSN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 418 ~~~~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..... ........+.+++.+||+.+|++||++.||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01111 12234567889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.26 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=205.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||++.+.+ ...+|+|.+..... ......+.+|+.++.++ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4567778899999999999998642 35789998764322 22335688899999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGK--------------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 319 (468)
..+++|||+++|+|.++++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 2346899999999999999999999777 99999999999999
Q ss_pred CCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHH
Q 012213 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIV 398 (468)
Q Consensus 320 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 398 (468)
+++.+||+|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||....... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence 999999999999987653322222223345678999999988889999999999999999998 999986532110 01
Q ss_pred HHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 399 QWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
. .+........+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 245 ~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K--------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H--------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 00011111223344567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.85 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=200.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|+..+.||+|+||+||++.+. +++.||||++...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 566789999999999999874 6889999998643221 12224577899999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99999999886544456899999999999999999999877 9999999999999999999999999998654211
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ... .+...+.....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~------------~~~~~~~~~~~ 222 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KRE------------EVERRVKEDQE 222 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHH------------HHHHHhhhccc
Confidence 1234468999999999998889999999999999999999999997633211 000 01111111112
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
..+......+.+++..|++.||++|| ++.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 22333556678899999999999999 8888855
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.76 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=206.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 254 (468)
.++|...+.||+|+||.||+|.+.+ +..|++|++.... .......+.+|+.++++++|+|++++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4567788999999999999999865 6889999876332 22334668899999999999999999998866 567
Q ss_pred eEEEEeccCCCChhhhcccCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRG------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 328 (468)
.++++||+++|+|.+++..... ..+++.++..++.+++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999864322 45899999999999999999999877 99999999999999999999999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
||+++.+.............++..|+|||+..+..++.++||||||+++||+++ |+.||..... .++.......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~ 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAYLKDG 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHcC
Confidence 999986643222222233456778999999988889999999999999999999 9999965321 1222111111
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
. ...........+.+++.+||..+|++|||+.|+++.|+++..
T Consensus 236 ~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 Y-----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C-----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 001112234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.14 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=207.0
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|...+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+..+++++|+|++++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45678889999999999999998888899999886432 223678999999999999999999999998889999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++....+..+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999998666567899999999999999999999887 9999999999999999999999999998664211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||...+..++.++||||||+++||++| |+.||...... ...+. +....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~--------------~~~~~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQ--------------VERGY 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------------HHcCC
Confidence 111122234568999999998889999999999999999999 99999653211 11111 11000
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
....+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011122235678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=308.49 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=209.6
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
++|+..+.||+|+||.||+|... +|+.||+|.++..... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45777889999999999999986 7899999988643322 222467889999999999999999999999999999999
Q ss_pred eccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||+++|+|.+++.. .....+++.++..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 23346899999999999999999999877 99999999999999999999999999876542
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
... ......++..|+|||...+..++.++||||||+++|+|++|+.||.... .+..++.... ..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-----------~~ 222 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI-----------EK 222 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh-----------hc
Confidence 211 1233457889999999988889999999999999999999999986422 2222221111 01
Q ss_pred ccCCCCCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 418 QRLSNTPL-SEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 418 ~~~~~~~~-~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
......+. .....+.+++.+|++.+|++||++.+|+++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111222 44567889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=316.32 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=202.9
Q ss_pred cCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
|...+.||+|+||.||+|... ....+++|.+..... ......+..|+.+++.++||||+++++.+...+..++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 556789999999999999863 235688887753322 2223568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 012213 258 VYEYMPNGSLGEVLHGKR----------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 315 (468)
++||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 135889999999999999999999877 9999999999
Q ss_pred EEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 012213 316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEG 394 (468)
Q Consensus 316 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~ 394 (468)
|++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||+| |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222233445678999999988889999999999999999999 99999653211
Q ss_pred cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.+..+.. .. .. ...+......+.+++..|++.+|++||++.|+++.|+++-..
T Consensus 237 -~~~~~~~---~~--------~~---~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 -RLFNLLK---TG--------YR---MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HHHHHHh---CC--------CC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111110 00 00 111223446788999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.26 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=201.2
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.|+..+.||+|+||.||+|.+. +++.||||++...... ......+..|+.++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4677889999999999999985 5889999998643221 2233567889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999643 35889999999999999999999887 99999999999999999999999999976542
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc-c
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ-R 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~ 419 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+...... ...+.. .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~------~~~~~~~~ 221 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE----TWENLKYW------KETLQRPV 221 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH----HHHHHHhc------cccccCCC
Confidence 2234568999999999998899999999999999999999999997532110 01110000 000000 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
...........+.+++..|+..+|.+||++.|+++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 010011335667889999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.88 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=194.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||+||+|.+. +++.||||.+.... .......+.+|+++++.++|+||+++++++...+..++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 455667789999999999999874 68999999985432 1222356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+.. ..++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999986543 2467788899999999999999877 9999999999999999999999999998764221
Q ss_pred CCccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... +|......
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~-------- 287 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCA-------- 287 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHH--------
Confidence 12234578999999998743 23456899999999999999999999732211 12211110
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.........+......+.+++..||+.||++||++.|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111223345678899999999999999999999873
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.82 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=204.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 253 (468)
.+++...+.||+|+||.||+|.+. .+..||||++..... ......+..|++++.++. ||||++++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 456777899999999999999853 346799999965332 222346889999999997 999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCC---------------------------------------------------------
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRG--------------------------------------------------------- 276 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 276 (468)
..++|+||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999864321
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 277 ---------------------------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 277 ---------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
..+++...+.++.|++.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 23677888999999999999999776 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999986542222112223456788999999988889999999999999999998 899986532111
Q ss_pred HHHHHHHhhcccccchhhhcccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQR-LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
. ..+.+... ....+......+.+++..||+.+|.+||+++||++.|+++.
T Consensus 350 ---~-----------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---Q-----------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---H-----------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 00101110 01122234567888999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.61 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=205.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|...+.||+|+||.||+|.+++ +..||+|.+..... ......+.+|+.++..++|||++++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4567788999999999999998743 36799998753321 1223468899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999986432 224789999999999999999999777 999999999999999999999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++.+.............++..|+|||...+..++.++||||||+++||++| |..||...... ....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~---- 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFV---- 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHH----
Confidence 99999986653332222234456789999999988889999999999999999998 99998653211 111111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.+......+......+.+++..|++.+|++|||+.|+++.|++
T Consensus 235 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 ----------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111112233346778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.51 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=206.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.+.|...+.||+|+||.||+|.+. ++..+|+|.+.... .......+..|++++..+ +|||++++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 456788899999999999999752 23579999886432 222335688899999999 79999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
.+..++||||+++|+|.+++.... ...+++.++++++.|++.||+|||+.+ ++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 999999999999999999997532 135899999999999999999999877 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.++|+|||.++...............++..|+|||...+..++.++||||||+++|||++ |..||....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----- 247 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 247 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence 99999999999999976542221111222234568999999988889999999999999999998 889986422
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
..+....... ......+......+.+++..|++.+|++||+|.||++.|+++...+
T Consensus 248 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 248 VEELFKLLKE-----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHHHc-----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111110 0011222334567788999999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.79 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=201.4
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++...+.||+|+||.||++... ++..+|+|.+.... ......+.+|++.++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45667789999999999999642 35678899875432 22235789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 256 LLVYEYMPNGSLGEVLHGKRG-------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
++++||+++|+|.+++..... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 999999999999999864321 35889999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 401 (468)
.++|+|||++..+.............+++.|+|||+..+..++.++|||||||++|||++ |++||...... +.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~- 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----EA- 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----HH-
Confidence 999999999976542222112223345678999999998899999999999999999998 99998653211 00
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
............+......+.+++.+||+.||.+||++.||.+.|+.
T Consensus 234 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ----------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----------HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111111222344667899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.54 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=207.1
Q ss_pred hhccCCcceEcccCCcceEEEEc--------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT--------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.+.|...+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+..++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 56677889999999999999974 134579999875332 222335688999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
....++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999987532 235788999999999999999999877 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
+++++.+||+|||+++.+.............++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 99999999999999987653332222333446678999999988889999999999999999999 888885432
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
..++....... .....+......+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 245 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLLKEG-----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHcC-----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 12222111111 11112234456788899999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=315.16 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=204.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||.||+|..+ .+..||+|.+..... ......+.+|+..++.++|||++++++++.+...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 567888899999999999999753 245799998753322 2223457889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
.++||||+++|+|.+++.... .....+..+..++.|++.||.|||+.+ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 134567888999999999999999777 999999999999999999999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||..... .++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~--- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLK--- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---
Confidence 99999986543222222222345678999999988889999999999999999999 7889865321 11111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.+.+......+......+.+++.+|++.+|++|||+.|+++.|++...+
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 233 --------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred --------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1111111122223356788999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=320.67 Aligned_cols=264 Identities=24% Similarity=0.298 Sum_probs=201.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||.||++.+. ++..||+|.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 356788899999999999999985 57889999876432 2223356899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999999643 34889999999999999999999742 3999999999999999999999999999765321
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc-c---------
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS-K--------- 409 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~--------- 409 (468)
......|+..|+|||++.+..++.++|||||||++|||+||+.||...+... +........... .
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcc
Confidence 1234568999999999998899999999999999999999999996532110 100000000000 0
Q ss_pred ----------------------cchhhhccccCCCC-CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 410 ----------------------EGVVKILDQRLSNT-PLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 410 ----------------------~~~~~~~d~~~~~~-~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
+....+........ ......++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000001110 11244578899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=315.37 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=196.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 356788899999999999999985 6889999998643322 22245778999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 156 (303)
T cd07869 83 EYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP- 156 (303)
T ss_pred ECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence 9995 6888877643 345788999999999999999999877 999999999999999999999999998754321
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch---hhh
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV---VKI 415 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 415 (468)
........+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.......+..-.........+.. ...
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 157 -SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 122234568899999998765 458899999999999999999999997633211111000000000000000 000
Q ss_pred --ccc-cC---CCCC-H------HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 --LDQ-RL---SNTP-L------SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 --~d~-~~---~~~~-~------~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.++ .. .... . .....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 00 0000 0 11245678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=307.01 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=197.7
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
++||+|+||.||+|...++..||+|.+..... ......+.+|++.++.++|||++++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999988899999998764322 22234688999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++...... ........
T Consensus 80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLK 154 (250)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCC
Confidence 99986433 35789999999999999999999877 999999999999999999999999998754321 11111223
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 426 (468)
.++..|+|||+..+..++.++||||||+++||+++ |..||...... . ....... ......+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~-~~~~~~~----------~~~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----Q-AREQVEK----------GYRMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----H-HHHHHHc----------CCCCCCCCC
Confidence 34678999999998889999999999999999999 99999653211 0 0000000 001112223
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 427 EAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 427 ~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=316.08 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=200.2
Q ss_pred hccCCcceEcccCCcceEEEEcCC-Cc--EEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-GE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
++|+..+.||+|+||.||+|.+.+ +. .+++|.++... .....+.+..|+.++.++ +|||++++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 457778899999999999998754 33 46888775322 122235688999999999 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 012213 258 VYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 323 (468)
++||+++|+|.++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999986432 135889999999999999999999877 999999999999999999
Q ss_pred eEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHH
Q 012213 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 324 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 402 (468)
+||+|||++..... .........+..|+|||+..+..++.++|||||||++|||++ |..||...... ++..
T Consensus 158 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYE 229 (297)
T ss_pred EEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 99999999864321 111112223567999999988889999999999999999998 99999653211 1111
Q ss_pred HhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 403 MQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
. .........+......+.+++.+|++.+|.+||++.++++.|+++...
T Consensus 230 ~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 230 K-----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred H-----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 111001112223446678899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.09 Aligned_cols=246 Identities=25% Similarity=0.317 Sum_probs=192.6
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHH---hCCCCCCccceeEEEecCCeeEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTL---GKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
|+..+.||+|+||.||+|.+. +++.||||++..... .....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 445688999999999999874 688999999864322 122234566666554 567899999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|..+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988853 35899999999999999999999877 999999999999999999999999998754321
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +... .+...
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~-----------~i~~~ 216 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFD-----------SIVND 216 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHH-----------HHHhC
Confidence 22234567899999999999989999999999999999999999999753211 1111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
. ...+......+.+++.+|++.||.+|| ++.++++
T Consensus 217 ~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 E-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1 111223345677899999999999999 4566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=314.47 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=197.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|...+.||+|+||+||+|... +++.||+|.+..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 356778899999999999999875 688999998864332 222346789999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++ |+|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~- 156 (288)
T cd07871 83 EYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP- 156 (288)
T ss_pred eCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC-
Confidence 9997 5999888633 345789999999999999999999877 999999999999999999999999999764322
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHHHHHHhhcc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNS 407 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~ 407 (468)
........+++.|+|||++.+ ..++.++||||+||++|||+||++||........ ....|......
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN- 234 (288)
T ss_pred -CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc-
Confidence 112234567899999998765 5689999999999999999999999975321100 00011100000
Q ss_pred cccchhhhccccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRLSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.......+.....+ ........+++.+|++.||.+|||++|+++
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 --EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred --hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111100000000 112345678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=322.05 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=215.0
Q ss_pred ccCCcceEcccCCcceEEEEcC---CCc--EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP---NGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.....++||.|.||.||+|... .|+ .||||.-+.... ++..+.|..|..+|++++||||++++|.|.+ ...++
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 3445689999999999999863 344 478887765333 3335789999999999999999999999976 46799
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|||.++.|.|..||..+ ...++......++.||..||+|||+.. +|||||.++|||+.+...+||+|||+++.+.+
T Consensus 468 vmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999843 446888899999999999999999655 99999999999999999999999999999875
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
..... .+...-...|||||.+.-..++.++|||.|||.+||++. |..||.+.... +.+..+-
T Consensus 544 ~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iE 606 (974)
T KOG4257|consen 544 DAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIE 606 (974)
T ss_pred cchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEec
Confidence 44433 334456789999999999999999999999999999998 99999873321 2445555
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.++....|..++..+..++.+||+.+|.+||++.|+...|+++..
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 566677788899999999999999999999999999999987654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=312.74 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=195.5
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||+|+||.||++..+ +|+.||+|++...... ......+..|++++++++||||+++.+++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999874 5899999998642221 11223456799999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++.......+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 99887555556899999999999999999999877 999999999999999999999999999865422 122345
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 427 (468)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....... ..............
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKR-----------RTLEDEVKFEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHH-----------HhhccccccccccC
Confidence 68999999999988889999999999999999999999997533211 1111111 11111111111123
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 428 AMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 428 ~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
...+.+++..|++.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 45678899999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=310.12 Aligned_cols=260 Identities=20% Similarity=0.293 Sum_probs=207.9
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
++|+..+.||+|+||.||+|.. .+++.+|||.+...... ......+.+|+.+++.++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3567778999999999999996 57899999987643322 222356889999999999999999999999999999999
Q ss_pred eccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||+++++|.+++.. .....+++..+..++.+|+.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 22346899999999999999999999877 99999999999999999999999999886642
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.. .......++..|+|||+..+..++.++||||||+++|||++|..||.....+ ...+.... . .
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~--------~---~ 222 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI--------E---Q 222 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh--------h---c
Confidence 22 1223456889999999998888999999999999999999999998653211 11111110 0 1
Q ss_pred ccCCC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 418 QRLSN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 418 ~~~~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..... ........+.+++.+|++.+|++||||.+|+++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111 11234567888999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=322.02 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=201.4
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 252 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++..... ......+..|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 46788899999999999999974 3578899999864322 22235688899999999 689999999988654
Q ss_pred CeeEEEEeccCCCChhhhcccCCC--------------------------------------------------------
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRG-------------------------------------------------------- 276 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 276 (468)
...+++|||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999999864321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 277 ---------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 277 ---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
..+++..+.+++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 23688889999999999999999877 999999999999999999999999999865422222222233
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 426 (468)
.++..|+|||...+..++.++||||||+++|||++ |..||....... ..... .. .......+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~-~~----------~~~~~~~~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRR-LK----------EGTRMRAPDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHH-Hh----------ccCCCCCCCC
Confidence 45678999999988889999999999999999997 999986532110 00110 00 0000111112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 427 EAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 427 ~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
....+.+++..||+.+|++||++.||++.|+.+-.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.12 Aligned_cols=259 Identities=25% Similarity=0.310 Sum_probs=210.9
Q ss_pred hccCCcceEcccCCcceEEEEcCCC-cEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEE-Eec------C
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNG-EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAF-CSN------K 252 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~ 252 (468)
.++++.+.|.+|||+.||.|.+..+ ..||+|++... .........+||.+|++|+ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3466789999999999999999766 99999998654 3344467899999999996 9999999993 221 2
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
-+++|.||||.+|+|-|++..+....+.+.++++|+.++++|+++||.. +++|||||||-+||||+.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3568999999999999999866666699999999999999999999976 678999999999999999999999999999
Q ss_pred ccccccC-CCcc------ccccccCccccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHH
Q 012213 333 KYLQDTG-ASEC------MSAVAGSYGYIAPEYA---YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 333 ~~~~~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 402 (468)
.-..... .... .-....|+.|.|||++ .+..+++|+|||||||+||-|+....||++.+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 6432111 1100 0123468999999976 46789999999999999999999999997632
Q ss_pred HhhcccccchhhhccccCC-CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 403 MQTNSSKEGVVKILDQRLS-NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
-..+++.... .....+...+..||..|++++|.+||++-||+..+.++....
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 2334444442 223578899999999999999999999999999998876543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=311.62 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=201.7
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+.|+..+.||+|+||+||+|.+. +|+ .||+|.+..... ......+..|+.++..++|||++++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45777899999999999999863 444 489998864322 2223568899999999999999999999875 4578
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997433 35899999999999999999999777 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
............++..|+|||...+..++.++||||||+++|||++ |..||...... .+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~------------ 226 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEK------------ 226 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC------------
Confidence 3222211222345678999999988889999999999999999998 99998653211 11111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
......+......+.+++..||+.||++||++.|+++.|+++..
T Consensus 227 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 --GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00011122345567889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.59 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=193.7
Q ss_pred ceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 188 NVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.||+|+||.||++.. .+++.||||.+..... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578899999864321 122234577899999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 9999999998643 35788889999999999999999877 9999999999999999999999999987543221
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...+.....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~-----------~~~~~~~~~- 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKT-----------IDKILKGKL- 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHH-----------HHHHHcCCC-
Confidence 122345789999999999988899999999999999999999999975321 111 111111111
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
..+......+.+++.+|++.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11222345678899999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=308.26 Aligned_cols=250 Identities=30% Similarity=0.443 Sum_probs=204.4
Q ss_pred ceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 188 NVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+.||+|+||.||+|.+.. +..|++|.+....... ....+.+|++.+..++|+|++++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999864 7889999986544332 34678999999999999999999999999999999999999
Q ss_pred CCChhhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 264 NGSLGEVLHGKR-------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 264 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+++|.+++.... ...+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999997542 356899999999999999999999877 9999999999999999999999999998775
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
............++..|+|||......++.++||||+|+++|||++ |..||..... .+... .+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~-----------~~ 220 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLE-----------YL 220 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-----------HH
Confidence 4332233344567889999999988889999999999999999999 6999976421 11111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
.+......+......+.+++..|++.+|++|||+.|+++.|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111112223344677889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=319.55 Aligned_cols=242 Identities=26% Similarity=0.299 Sum_probs=189.4
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhC-CCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGK-IRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+. +++.||+|.++.... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 578899999865322 12222445566666654 4899999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 9999988643 35889999999999999999999877 9999999999999999999999999997543221 223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +.... + .......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~-----------i-~~~~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDS-----------I-LNDRPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHH-----------H-HcCCCCCC
Confidence 4567899999999999889999999999999999999999999753311 11110 0 01111122
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMR-EVV 453 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~-ev~ 453 (468)
......+.+++..|++.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23345667899999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=324.26 Aligned_cols=243 Identities=23% Similarity=0.280 Sum_probs=194.1
Q ss_pred ceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
+.||+|+||.||++.+ .+|+.||+|.+..... .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 4688999999865322 1222356778999999999999999999999999999999999999
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 999988643 358999999999999999999996 56 999999999999999999999999998754321 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.....+ ..... +.......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~------------i~~~~~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFEL------------ILMEEIRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHH------------HhcCCCCCC
Confidence 3456899999999999989999999999999999999999999653211 11111 000011112
Q ss_pred HHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
......+.+++.+|++.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 22345677899999999999996 8998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=314.71 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=200.8
Q ss_pred hccCCcceEcccCCcceEEEEcCC---------------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCcccee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN---------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 246 (468)
..|+..+.||+|+||.||++.... ...||+|.+.... .......+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 467788999999999999987642 2248999876432 222335688999999999999999999
Q ss_pred EEEecCCeeEEEEeccCCCChhhhcccCC----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 012213 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKR----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316 (468)
Q Consensus 247 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 316 (468)
+++......++||||+++++|.+++.... ...+++..+++++.+++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985432 124789999999999999999999877 99999999999
Q ss_pred EEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 012213 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRRPVGDFGEEG 394 (468)
Q Consensus 317 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~~~ 394 (468)
++++++.+||+|||++................++..|+|||......++.++||||||+++|||++ +..||.....+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999976543222222233445778999999988889999999999999999998 66777653211
Q ss_pred cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
............. . .......+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~---~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENTGEFFRNQ---G----RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHhhhhc---c----ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111000000 0 000011122234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=320.79 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=191.2
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+. +++.||+|.+...... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5788999998754322 22234577888888776 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 9999888543 35899999999999999999999877 999999999999999999999999999754321 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---CcCHHHHHHHhhcccccchhhhccccCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE---GLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......|...... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-----------~~~~ 222 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-----------EKQI 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-----------cCCC
Confidence 4467899999999999999999999999999999999999999642211 1111122111111 1111
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
..+......+.+++.+|++.||++||+.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2233345667789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=313.94 Aligned_cols=258 Identities=25% Similarity=0.414 Sum_probs=203.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|+.++++++|||++++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 456778899999999999999863 467899998763321 2223568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 314 (468)
.++|+||+++|+|.+++.... ...+++..++.++.+++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999986321 124788999999999999999999877 999999999
Q ss_pred cEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 012213 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEE 393 (468)
Q Consensus 315 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~ 393 (468)
||++++++.++|+|||++..+..............+..|+|||...+..++.++|||||||++|||++ |..||.+...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999876542222222223334678999999988889999999999999999998 8888864321
Q ss_pred CcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 394 GLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.++.. .+.+......+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ----~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVIY-----------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHH-----------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 111111111222345678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=311.45 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=201.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.+.|...+.||+|+||.||+|.+.+ +..||+|.+..... ......+..|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4668888999999999999998853 56788887753322 2223468889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---ceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRG-----SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 326 (468)
.++||||+++++|.++++.... ..+++..+.+++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 25899999999999999999999877 99999999999998765 5999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVMEFVT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH
Confidence 99999987632221111122233568999999998899999999999999999997 99999753211 1111111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.. .....+......+.+++.+|++.+|++||++.+|++.|.+
T Consensus 236 ~~-----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GG-----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cC-----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11 0111222345678889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=306.21 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=204.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+|++++++++......++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 356778899999999999999875 78999999865432 34678999999999999999999999998899999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999997655557899999999999999999999877 9999999999999999999999999998653211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.....+..|+|||+..+..++.++||||||+++||+++ |+.||...... .+.... ... .
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~----~~~----------~ 216 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHV----EKG----------Y 216 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH----hcC----------C
Confidence 12334668999999988889999999999999999998 99998653211 011000 000 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+...+..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0111223456788899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.56 Aligned_cols=238 Identities=24% Similarity=0.282 Sum_probs=189.7
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||+||+|.++ +++.||||++..... .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 578999999864321 223335567788888776 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 9999988643 35889999999999999999999877 999999999999999999999999998754211 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... +.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~-----------i~~~~-~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEA-----------ILNDE-VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHH-----------HhcCC-CCCC
Confidence 4457899999999999889999999999999999999999999753211 11111 11111 1112
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
......+.+++..|++.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=301.77 Aligned_cols=267 Identities=28% Similarity=0.333 Sum_probs=201.7
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC----eeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 257 (468)
......+.||+|.||+||+|.++ |+.||||+|......+.. -+.||..-..++|+||+.+++.-..++ ..+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWf---rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWF---RETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccchhhhh---hHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 44556789999999999999995 899999999654432221 134454455669999999999875544 4689
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-----DCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
|++|.+.|||.|||.. ..++.+..++++..+|.||+|||. +|.+.|.|||||+.|||+..++.+.|+|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999974 348899999999999999999996 46888999999999999999999999999999
Q ss_pred ccccccCCC--ccccccccCccccCccccCCCC----C--CcchhhHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 012213 333 KYLQDTGAS--ECMSAVAGSYGYIAPEYAYTLK----V--DEKSDVYSFGVVLLELITG----------RRPVGDFGEEG 394 (468)
Q Consensus 333 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~s~G~~l~elltg----------~~p~~~~~~~~ 394 (468)
......... ......+||.+|||||++...- + -..+||||||.++||+.-. +.||.+.-..+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 876533211 1234568999999999886432 1 1479999999999999764 35666533222
Q ss_pred cCHHHHHHHhhcccccchhhhccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRL--SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
-++.+..+.+ ..+-+.+.. .....+.+..+.+++..||..+|..|-|+-.|-+.|.++.+.
T Consensus 444 Ps~eeMrkVV-------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 444 PSFEEMRKVV-------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCHHHHhcce-------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2222221111 011111111 334567888899999999999999999999999999988743
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=316.84 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=203.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.++|...+.||+|+||.||+|... ....+|+|.+..... ......+..|+.++.++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 456778899999999999999742 245689998764322 22335688899999999 69999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
....+++|||+++|+|.+++.... ...+++.+..+++.|++.||.|||+.+ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999986432 235889999999999999999999877 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999986643222211222234567999999988889999999999999999999 89998653211 1
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+.... ........+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 245 ~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 LFKLL--------------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHH--------------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11110 011111122334557778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=313.50 Aligned_cols=267 Identities=30% Similarity=0.409 Sum_probs=200.4
Q ss_pred hccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KET 254 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 254 (468)
++|+..+.||+|+||+||++.. .++..||+|++.... ....+.+.+|++++++++|||++++.+++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4577789999999999999974 357899999976432 2223578899999999999999999998754 346
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 789999999999999996432 35899999999999999999999877 99999999999999999999999999987
Q ss_pred ccccCCCcc-ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc----
Q 012213 335 LQDTGASEC-MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---- 409 (468)
Q Consensus 335 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 409 (468)
+........ .....++..|+|||+..+..++.++||||||+++|||++|..|+...... |.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 231 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQMI 231 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhcccccccccc
Confidence 643222111 11222345699999998888999999999999999999988775432110 1000000000
Q ss_pred -cchhhhcccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 410 -EGVVKILDQR-LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 410 -~~~~~~~d~~-~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..+.+.+... ....+......+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0001111111 11122234567889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=308.75 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=203.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
..+|+..+.||+|+||.||+|.+. .+..+|+|.+.... .......+..|+.++.+++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356778899999999999999864 23368999875422 2223457899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++..+.
T Consensus 82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999997443 45899999999999999999999877 9999999999999999999999999998765
Q ss_pred ccCCCc-cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGASE-CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
...... ......++..|+|||+..+..++.++||||||+++||+++ |+.||...... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~------------- 222 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAI------------- 222 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHH-------------
Confidence 322111 1112233568999999998889999999999999999887 99999653311 111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.+......+...+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 -EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11101111223455678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=322.23 Aligned_cols=252 Identities=22% Similarity=0.240 Sum_probs=195.8
Q ss_pred cCCcceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
|+..+.||+|+||.||++.. .+++.||+|++..... .....+.+..|+.++..+ +|+||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56778999999999999876 3578999999864322 122235678899999999 5899999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999998643 35889999999999999999999877 9999999999999999999999999998654
Q ss_pred ccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ..........
T Consensus 157 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~--------- 225 (332)
T cd05614 157 SEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK--------- 225 (332)
T ss_pred ccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc---------
Confidence 222 2223345789999999998765 478899999999999999999999975322111 1111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.+. ..+......+.+++.+|++.||++|| +++|+++
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011 11222345677899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=308.37 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=202.4
Q ss_pred hccCCcceEcccCCcceEEEEcCC-C---cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-G---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+|+..+.||+|+||.||+|.+.. + ..+|+|++.... .......+..|++++++++|||++++.+++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456778999999999999998753 3 368999875332 12233568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++++|.+++.... ..+++.++..++.+++.|++|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997433 45899999999999999999999877 99999999999999999999999999986643
Q ss_pred cCCCcc-ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGASEC-MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
...... ......+..|+|||+.....++.++||||||+++|||++ |+.||..... .++.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~---------- 224 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAIN---------- 224 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHh----------
Confidence 221111 111223457999999988889999999999999999998 9999965321 11111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
..............+.+++.+|++.+|++||++.+|++.|+++
T Consensus 225 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111112223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=310.18 Aligned_cols=254 Identities=26% Similarity=0.292 Sum_probs=202.5
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC--------C----CchhHHHHHHHHHhCCCCCCccceeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG--------S----SHDNGLSAEIRTLGKIRHRNIVRLKA 247 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~----~~~~~~~~e~~~l~~l~h~niv~l~~ 247 (468)
...|+....||+|.||.|-+|.+ .+++.||||++...... . ...++..+||.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 67788999999999999999997 46899999998643221 0 11246889999999999999999999
Q ss_pred EEecC--CeeEEEEeccCCCChhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCce
Q 012213 248 FCSNK--ETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324 (468)
Q Consensus 248 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 324 (468)
+..++ +..|||+|||..|.+...= .... ++..++++++.++..||+|||.++ ||||||||+|+|++++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 98764 4689999999988876543 2333 899999999999999999999888 9999999999999999999
Q ss_pred EEeecccccccccc---CCCccccccccCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCH
Q 012213 325 HVADFGLAKYLQDT---GASECMSAVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI 397 (468)
Q Consensus 325 kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 397 (468)
||+|||.+...... +........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----- 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----- 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----
Confidence 99999999866321 1222334578999999999887633 45789999999999999999999975221
Q ss_pred HHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
.+...+++...+ .....+....+.+++.+++..||++|-+..+|..-.
T Consensus 325 -----------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 -----------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 114455555555 222335667788999999999999999999986543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=312.15 Aligned_cols=247 Identities=26% Similarity=0.284 Sum_probs=194.5
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||+|+||+||++.+. +++.||+|++....... ...+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999874 68899999986432211 1224577899999999999999999999999999999999999999
Q ss_pred hhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccc
Q 012213 268 GEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345 (468)
Q Consensus 268 ~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 345 (468)
.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887432 2346899999999999999999999877 9999999999999999999999999997664221 1223
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCH
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 425 (468)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ...... ....+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~-----------~~~~~~-~~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK-----------QRILND-SVTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHH-----------Hhhccc-CCCCcc
Confidence 45789999999999999999999999999999999999999975332110 00000 011111 111223
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 426 SEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 426 ~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.....+.+++..|++.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3456778899999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.63 Aligned_cols=271 Identities=21% Similarity=0.282 Sum_probs=201.3
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
..|+..+.||+|+||.||++.+. .++.||+|... ...+.+|+.++++++||||+++++++......++|+|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 46888899999999999999984 67889999642 1347789999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
++. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 164 ~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 995 7888888643 34889999999999999999999877 999999999999999999999999999754321 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CC--c---CHHHHHHHhhc-------c
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE-EG--L---DIVQWTKMQTN-------S 407 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~--~---~~~~~~~~~~~-------~ 407 (468)
........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+ . .+......... .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1223345799999999999988999999999999999999999988754211 10 0 00000000000 0
Q ss_pred cccchhhhc----c---ccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCCCccC
Q 012213 408 SKEGVVKIL----D---QRLSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPNTFQM 467 (468)
Q Consensus 408 ~~~~~~~~~----d---~~~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~~~~~ 467 (468)
......... . ......+ ......+.+++.+|++.||++|||++|+++ .+.++..+-..||
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~ 390 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNPM 390 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCCC
Confidence 000000000 0 0000000 123456788999999999999999999985 5555554444444
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=306.68 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=194.8
Q ss_pred EcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 012213 190 IGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 266 (468)
||+|+||.||+|.+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 899999999999763 35569999876432 2223356889999999999999999999885 456799999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc-ccc
Q 012213 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-CMS 345 (468)
Q Consensus 267 L~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 345 (468)
|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998643 346899999999999999999999877 9999999999999999999999999998654322211 112
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
...++..|+|||...+..++.++||||||+++||+++ |..||...... ++..... .......+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~-----------~~~~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVMSFIE-----------QGKRLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHH-----------CCCCCCCC
Confidence 2234578999999988889999999999999999997 99999753211 1111111 11111222
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.....++.+++..||..+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34456788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=306.94 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=204.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.++..+|+|.+... ......+.+|+++++.++|+|++++.+++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4567888999999999999999888888999987532 2223568899999999999999999999887 77899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.......+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN-E 156 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC-C
Confidence 999999999997655667899999999999999999999877 999999999999999999999999999765422 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||++....++.++|+||||+++|+++| |+.||...... ....+.. . ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~----~----------~~ 220 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALE----R----------GY 220 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHh----C----------CC
Confidence 112223345678999999988889999999999999999999 99999653211 1111110 0 00
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
...........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122345668889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=313.19 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=204.2
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-----------------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCcc
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-----------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 243 (468)
...|+..+.||+|+||.||+|.+.+ +..||+|.+..... ....+.+.+|++++++++|||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 3567888999999999999988643 24589998764322 22345788999999999999999
Q ss_pred ceeEEEecCCeeEEEEeccCCCChhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 012213 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR---------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314 (468)
Q Consensus 244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 314 (468)
++++++...+..++++||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999999999999999999999986433 125899999999999999999999877 999999999
Q ss_pred cEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCC
Q 012213 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRRPVGDFGE 392 (468)
Q Consensus 315 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~ 392 (468)
||+++.++.++|+|||+++...............++..|+|||+..+..++.++||||||+++|||++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999986543332223334456789999999988889999999999999999998 6778754321
Q ss_pred CCcCHHHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 393 EGLDIVQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.............. +... ...+.....++.+++.+|++.+|++|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDD--------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccc--------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111100000 0000 11122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=327.71 Aligned_cols=253 Identities=26% Similarity=0.280 Sum_probs=201.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|...+.||+|+||+||+|.+. +++.||||++...... ......+..|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4677889999999999999985 6899999998653322 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC-
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG- 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 339 (468)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999754 45899999999999999999999877 9999999999999999999999999998765322
Q ss_pred --------------------------CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 012213 340 --------------------------ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393 (468)
Q Consensus 340 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 393 (468)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~- 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL- 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence 00122345689999999999999999999999999999999999999976331
Q ss_pred CcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 012213 394 GLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-MREVVQ 454 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-~~ev~~ 454 (468)
...+........ . ..+.. .......+.+++..|+. +|.+||+ +.|+++
T Consensus 236 ---~~~~~~i~~~~~--~------~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 ---QETYNKIINWKE--S------LRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ---HHHHHHHhccCC--c------ccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 111111110000 0 00111 11135667788899997 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=323.69 Aligned_cols=240 Identities=25% Similarity=0.293 Sum_probs=192.6
Q ss_pred ceEcccCCcceEEEEc----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 188 NVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+.||+|+||.||++.. .+|+.||+|++............+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999987543333333557789999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 99999998643 35899999999999999999999877 999999999999999999999999999765322 122
Q ss_pred ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +... .+.... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~-----------~i~~~~-~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMT-----------MILKAK-LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHH-----------HHHcCC-CCC
Confidence 33467899999999999888999999999999999999999999753211 1111 111111 111
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTMRE 451 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~~e 451 (468)
+......+.+++..|++.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2223456778999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=305.77 Aligned_cols=274 Identities=25% Similarity=0.353 Sum_probs=211.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-----CCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-----KET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 254 (468)
...|...+.||+|+||.|+.|.+ .+|+.||+|++..........++..+|+++|+.++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 44555578999999999999997 578999999998666666667888999999999999999999998754 446
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++|+|+| +.+|.+.++.+ ..+.......++.||++||.|+|+.+ |+||||||+|++++.+...||+|||+|+.
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 79999999 67999999643 34889999999999999999999777 99999999999999999999999999998
Q ss_pred ccccCCCccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CCcCHH----------HHHH
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGE-EGLDIV----------QWTK 402 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~~~~~----------~~~~ 402 (468)
.........++..+.|..|.|||++. ...|+.+.||||.||++.||++|++-|.+.+. +...+. .+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 86443344557788899999999764 56799999999999999999999999977431 111000 0000
Q ss_pred HhhcccccchhhhccccC--CC-----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCCC
Q 012213 403 MQTNSSKEGVVKILDQRL--SN-----TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPNT 464 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~--~~-----~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~~ 464 (468)
.. .+.+...+.... .. .........+++..+++..||.+|+|++|+++ .|+....++.
T Consensus 255 i~----s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 255 IR----SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred hc----cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 00 001111111111 11 11233456788999999999999999999997 5666655543
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.96 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=197.2
Q ss_pred ceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 188 NVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+..|+.+++.+.|+|++++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999997632 268999988644332 33467889999999999999999999876 456799999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc-
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE- 342 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 342 (468)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.......
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999997443 5899999999999999999999877 9999999999999999999999999998764322211
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......++..|+|||...+..++.++||||||+++|||++ |..||..... ..+..+.. ... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~---~~~-----------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE---SGE-----------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH---cCC-----------cC
Confidence 1112223568999999998899999999999999999998 9999975331 11222211 000 01
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..+......+.+++.+|++.+|++||++.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 122234467889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=297.46 Aligned_cols=266 Identities=25% Similarity=0.285 Sum_probs=201.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe--cCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 257 (468)
.+.|+..+.|++|+||.||+|+++ +++.||+|+++.........-.-.+||.+|.+++|||||.+-.+.. +-+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 567888899999999999999984 6889999999765543332234679999999999999999988764 4457899
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|||||+. +|..+++... .++...++.-+..|+++|++|||... |+|||||++|+|+...|.+||+|||+|+.+..
T Consensus 155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 9999975 8988887544 56888999999999999999999888 99999999999999999999999999998864
Q ss_pred cCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh---hcccccchh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ---TNSSKEGVV 413 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 413 (468)
. ....+..+-|..|.|||++-+. .|++.+|+||+||++.||+++++-|.+..+. .++....+.. ....+..+.
T Consensus 230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCCcc
Confidence 3 2335566779999999987654 6999999999999999999999999774421 1111111110 001111111
Q ss_pred hhc---cccCCCCC--------HH--HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KIL---DQRLSNTP--------LS--EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~---d~~~~~~~--------~~--~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
++- ...+.+.+ .. ....-+++....+..||.+|-|++|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 100 00011111 11 2355678888899999999999999876
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=318.82 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=195.2
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||++.+. +++.||||.++..... ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999874 5789999998753322 22235578899999888 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 9999888533 45899999999999999999999877 999999999999999999999999998753211 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---CcCHHHHHHHhhcccccchhhhccccCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE---GLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....++....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 222 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----------KQI 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------CCC
Confidence 4567899999999999999999999999999999999999999642211 11112222111111 111
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCC------HHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPT------MREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt------~~ev~~ 454 (468)
..+......+.+++.+|++.||.+||+ ++|+++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122234556788999999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=306.18 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=202.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||++.+. +++.+|+|.+..... ....+.+..|+.+++.++|+|++++.+++..++..+++|||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 566789999999999999875 688999998854322 223466888999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++|+|.+++.......+++.....++.+++.||.|||+.+ ++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 9999999987655666899999999999999999999877 99999999999999999999999999976643221
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
......++..|+|||+..+..++.++|+||||+++|+|++|+.||...+. ..... .+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~-----------~~~~~~~~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLIL-----------KVCQGSYKP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHH-----------HHhcCCCCC
Confidence 22345688999999999988899999999999999999999999965221 11111 111111111
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.+......+.+++.+||+.+|++||++.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222344567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.98 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=214.9
Q ss_pred cCCcceEcccCCcceEEEEc-CCCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
++..++||+|+||+||||.+ ++|+ +||+|++..... .+...++.+|+..|.+++|||+++++|+|..+. ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34568999999999999998 4454 588898865433 333467999999999999999999999998776 8899
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
++|||.|+|.++++..++ .+.....+.|..|||+|+.|||++. ++||||.++|||+.+-..+||.|||+++.+...
T Consensus 776 tq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999986554 5778889999999999999999777 999999999999999999999999999998866
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
+.........-.+.|||-|.+....++.++|||||||++||++| |..||++...+ .+.+++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHh
Confidence 66655555566789999999999999999999999999999999 99999875422 2233322
Q ss_pred -ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 418 -QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 418 -~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+.....+..+...+..++.+||..|+..||+++++...+.++.
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2235567788889999999999999999999999999988763
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=308.34 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=201.9
Q ss_pred hccCCcceEcccCCcceEEEEcCC-C---cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-G---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
..++..+.||+|+||.||+|.+.. + ..||||.+.... .......|..|+..++.++|||++++.+++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 346778999999999999998753 3 359999875432 22234578999999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++.... ..+++.+++.++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++..+..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999987543 45899999999999999999999877 99999999999999999999999999986643
Q ss_pred cCCCcccc-ccc--cCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 338 TGASECMS-AVA--GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 338 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
........ ... .+..|+|||+..+..++.++||||||+++||+++ |..||...... ....+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~---~------ 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQ---D------ 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc---C------
Confidence 22211111 111 2457999999998899999999999999999987 99999653311 11222110 0
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.. ...+.+.+..+.+++..|++.+|.+||++.+|+..|+++
T Consensus 228 ----~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----YR-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----Cc-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 111223455678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=319.48 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=192.3
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+. +++.||+|.+..... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 478999999865322 222234567788888765 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 9999988643 35889999999999999999999877 9999999999999999999999999987543221 223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~-----------~i~~~~~-~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFE-----------SILHDDV-LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHH-----------HHHcCCC-CCC
Confidence 4456899999999999889999999999999999999999999753311 1111 1111111 111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCC-------CHHHHHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERP-------TMREVVQ 454 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RP-------t~~ev~~ 454 (468)
......+.+++..|++.||++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12345677899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=316.71 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=190.1
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhC-CCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGK-IRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+. +++.||||.+..... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999985 478899999865322 12223456667777775 4899999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence 9999998643 35889999999999999999999877 999999999999999999999999998753211 1122
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+..... ......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~---------------~~~~~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIR---------------MDNPCYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---------------hCCCCCC
Confidence 3456899999999999989999999999999999999999999753211 1111110 0001111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMR-EVV 453 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~-ev~ 453 (468)
......+.+++.+|++.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 22345677899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=314.70 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=200.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCc--EEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
..+|+..+.||+|+||.||+|.+. ++. .+|+|.+.... .......+.+|++++.++ +|+||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 456778899999999999999874 344 35777765322 222335688899999999 8999999999999999999
Q ss_pred EEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 257 LVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
+|+||+++|+|.++++... ...+++.+++.++.|++.|++|||+.+ ++||||||+||++++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCC
Confidence 9999999999999986432 235789999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 401 (468)
.+||+|||++..... ........++..|+|||+..+..++.++||||||+++|||+| |..||...... +..
T Consensus 162 ~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY 233 (303)
T ss_pred cEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHH
Confidence 999999999864321 111112234668999999988889999999999999999998 99999653211 111
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.... .......+......+.+++.+|++.+|++||++.++++.|+++...
T Consensus 234 ~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 EKLP-----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHh-----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 0000111122345678899999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=310.96 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=201.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-----------------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCcc
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-----------------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 243 (468)
.++|+..+.||+|+||.||++.+. ++..||+|++.... .......+..|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 346788899999999999998543 23468999876432 222235688999999999999999
Q ss_pred ceeEEEecCCeeEEEEeccCCCChhhhcccCCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 012213 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG---------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314 (468)
Q Consensus 244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 314 (468)
++++++...+..++||||+++|+|.+++..... ..+++.+...++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 999999999999999999999999999864321 24778899999999999999999877 999999999
Q ss_pred cEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCC
Q 012213 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRRPVGDFGE 392 (468)
Q Consensus 315 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~ 392 (468)
||++++++.++|+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999986543222222223344678999998888889999999999999999998 7788865321
Q ss_pred CCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 393 EGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
. ............. .. ......+..+...+.+++.+||+.||.+||++.||++.|++
T Consensus 240 ~--~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 E--QVIENTGEFFRDQ---GR----QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHHHhhc---cc----cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111110000000 00 00011122344678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=317.90 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=191.4
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCC-CccceeEEEecCCeeEEEEe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHR-NIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e 260 (468)
|+..+.||+|+||.||+|.+. +++.||||++..... .......+..|++++..++|+ +|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 566789999999999999875 467899999865322 222335677899999999765 68889999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 82 YVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 99999999998643 34889999999999999999999877 999999999999999999999999998753211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...... ... ..+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~--------------~~i~~~~- 217 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELF--------------QSIMEHN- 217 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH--------------HHHHcCC-
Confidence 12234457899999999999989999999999999999999999999753211 011 1111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
...+......+.+++.+|+..+|.+|++.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122334567789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.62 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=199.0
Q ss_pred ceEcccCCcceEEEEcCC--C--cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 188 NVIGRGGAGVVYRGVTPN--G--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+..|+..+++++|||++++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998743 3 26899988654332 344678999999999999999999999988 88899999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC-c
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-E 342 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 342 (468)
+++|.+++.......+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+...... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999997544356899999999999999999999877 999999999999999999999999999877532221 1
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+........ ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~----------~~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKKIDKE----------GERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhc----------CCcC
Confidence 1223457789999999998899999999999999999999 9999864321 1111111000 0011
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
..+...+..+.+++..|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=304.06 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=201.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 261 (468)
|+..+.||+|++|.||++.++ +++.||+|++..........+.+..|++++++++|+|++++.+.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567789999999999999975 57889999986543333344568899999999999999999998764 4457899999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++.......+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++..+....
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-- 156 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-- 156 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence 99999999997655566899999999999999999999887 9999999999999999999999999998764322
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......+++.|+|||+..+..++.++||||||++++||++|+.||...+ ...+... .....+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~-----------~~~~~~~ 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYR-----------IIEGKLP 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH-----------HHhcCCC
Confidence 22334567899999999999899999999999999999999999986422 1111111 1111112
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+......+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 223345567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=325.45 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=192.7
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.|+..+.||+|+||+||+|.+ .+++.||+|++..... .......+..|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 356778999999999999987 4678999999864322 22233568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998643 35888999999999999999999877 99999999999999999999999999864321000
Q ss_pred C---------------------------------------------ccccccccCccccCccccCCCCCCcchhhHHHHH
Q 012213 341 S---------------------------------------------ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 375 (468)
Q Consensus 341 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 375 (468)
. .......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0012346999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHh--hcccCCCCCCCHHHHH
Q 012213 376 VLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAML--CVQEHGVERPTMREVV 453 (468)
Q Consensus 376 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~--c~~~~P~~RPt~~ev~ 453 (468)
++|||+||+.||....... .......... . .... .......++.+++.+ |+..+|..||++.|++
T Consensus 237 il~elltG~~Pf~~~~~~~----~~~~i~~~~~-----~---~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTE----TQLKVINWEN-----T---LHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHH----HHHHHHcccc-----c---cCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997532111 0000000000 0 0000 011123344455554 6677878899999998
Q ss_pred H
Q 012213 454 Q 454 (468)
Q Consensus 454 ~ 454 (468)
.
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=308.35 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=202.6
Q ss_pred hccCCcceEcccCCcceEEEEcCC-Cc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-GE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
..|+..+.||+|+||.||+|.+++ |+ .+|+|.+..... ......+.+|+..+.+++|||++++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 456777899999999999998743 33 588887754322 2233568899999999999999999999987 7889
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+|+||+++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997543 34899999999999999999999876 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
............++..|+|||......++.++|+||||+++||+++ |+.||..... .++......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~--------- 226 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLEK--------- 226 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHhC---------
Confidence 3222221222234568999999988889999999999999999999 9999965321 122211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
......+......+.+++..||..+|.+||++.++++.|+++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 227 --GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111122234456788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=303.68 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=200.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe-cCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-NKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 259 (468)
.+.|...+.||+|+||.||++... |..||+|.+... ...+.+.+|+.++++++|+|++++++++. .....++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 346777899999999999999775 788999987532 22356889999999999999999999764 456689999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++.......+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999997655556899999999999999999999877 9999999999999999999999999987543211
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ..+.........
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~---------- 216 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGY---------- 216 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCC----------
Confidence 22334678999999998889999999999999999998 999986422 111111111100
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 -KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0111223456778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=317.01 Aligned_cols=243 Identities=25% Similarity=0.291 Sum_probs=193.2
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||+||+|.+. +++.||||.+..... .......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999885 578999999865322 222335567888888877 799999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT 153 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence 9999988643 35899999999999999999999877 999999999999999999999999998753211 1122
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ...... +.... ...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~-----------i~~~~-~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQS-----------ILEDE-VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHH-----------HHcCC-CCCC
Confidence 345689999999999999999999999999999999999999965321 111111 11111 1112
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTM-----REVVQ 454 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~-----~ev~~ 454 (468)
......+.+++.+|++.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2334567889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.47 Aligned_cols=200 Identities=29% Similarity=0.405 Sum_probs=172.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 456888899999999999999985 57788888775432 2223356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++... ..+++.....++.+++.||.|||+.+ +++||||||+||++++++.+||+|||++..+...
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999999643 34889999999999999999999632 2999999999999999999999999999765321
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12334689999999999988899999999999999999999999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=322.59 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=172.5
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||+||++... +++.||+|++..... .......+..|+.++.+++|+||+++++++.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5677899999999999999875 588999999864322 12223567889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 82 FLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999643 45899999999999999999999877 99999999999999999999999999976532110
Q ss_pred C---------------------------------ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 012213 341 S---------------------------------ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387 (468)
Q Consensus 341 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 387 (468)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012357999999999999989999999999999999999999999
Q ss_pred CC
Q 012213 388 GD 389 (468)
Q Consensus 388 ~~ 389 (468)
..
T Consensus 237 ~~ 238 (363)
T cd05628 237 CS 238 (363)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=323.56 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=198.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||++.+. +++.||+|.+..... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 567888899999999999999875 588999999864322 112234577899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999998643 3788888999999999999999877 999999999999999999999999999866422
Q ss_pred CCCccccccccCccccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+. +
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~------------~ 258 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYS------------K 258 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHH------------H
Confidence 21 122345799999999987653 4789999999999999999999999753211 1111 1
Q ss_pred hcccc--C-CCCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 012213 415 ILDQR--L-SNTPLSEAMQVFFVAMLCVQEHGVE--RPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~--~-~~~~~~~~~~~~~l~~~c~~~~P~~--RPt~~ev~~ 454 (468)
+.+.. + ..........+.+++..|++.+|++ ||++.|+++
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11110 0 0111123567778999999999988 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.93 Aligned_cols=252 Identities=24% Similarity=0.438 Sum_probs=200.3
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
..|+..+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......++|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 3466678999999999999998878899999875322 2235689999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++.... ..+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-Y 155 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-c
Confidence 99999999987433 35789999999999999999999877 9999999999999999999999999997654221 1
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++.+|+|||+..+..++.++||||||+++|||++ |+.||...... ......... ...
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~-----~~~----- 220 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINAG-----FRL----- 220 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHhCC-----CCC-----
Confidence 11122334678999999988889999999999999999998 99998653211 111110000 000
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
..+......+.+++.+|++.+|++||++.|++++|.
T Consensus 221 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 -YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011123467888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=304.26 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=201.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC---CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+.|+..+.||+|++|.||++... +++.||+|.+....... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 45788899999999999999874 68999999886433221 123468889999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|+||+++++|.+++... ..+++.....++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998643 34888999999999999999999887 99999999999999999999999999976542
Q ss_pred cCCCc-cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 338 TGASE-CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 338 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
..... ......++..|+|||+..+..++.++||||||+++|||++|+.||...... .........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~---------- 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQ---------- 222 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHhcc----------
Confidence 21111 112345788999999999988999999999999999999999998653211 100000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
......+......+.+++..|+..+|.+|||+.|+++.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112223445667889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.55 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=193.7
Q ss_pred ceEcccCCcceEEEEcCC-Cc--EEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccC
Q 012213 188 NVIGRGGAGVVYRGVTPN-GE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+.||+|+||.||+|.+.+ +. .+++|.+.... .......+..|++++.++ +|||++++++++......+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999854 33 46888775322 122235688999999999 79999999999999999999999999
Q ss_pred CCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 264 NGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 264 ~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
+|+|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999986432 124789999999999999999999877 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
|++..... .........+..|+|||+.....++.++||||||+++|||++ |..||..... .+.......
T Consensus 157 gl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~-- 226 (270)
T cd05047 157 GLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQ-- 226 (270)
T ss_pred CCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHHhC--
Confidence 99863221 111112234567999999988889999999999999999997 9999965321 111111100
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
......+......+.+++.+|++.+|.+|||+.|++..|+++-
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0001112223456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=315.71 Aligned_cols=242 Identities=26% Similarity=0.306 Sum_probs=189.9
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.++ +|+.||+|.+..... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999985 578999999865322 122234566777777654 899999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.... .....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence 9999988643 35889999999999999999999877 99999999999999999999999999874321 11223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+ +... .......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~--~~~~-------------~~~~~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--EL--FESI-------------RVDTPHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH--HHHH-------------HhCCCCCC
Confidence 4567899999999999999999999999999999999999999753211 00 1000 00011112
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMR-EVV 453 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~-ev~ 453 (468)
.....++.+++..|++.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345677899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.31 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=205.2
Q ss_pred hccCCcceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK 252 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 252 (468)
..|+..+.||+|+||.||+|.+. .+..||+|.+.... .......+..|+.++.++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45778899999999999999752 12368999875322 222335788999999999 799999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 318 (468)
+..++++||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999986432 235889999999999999999999877 9999999999999
Q ss_pred cCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCH
Q 012213 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDI 397 (468)
Q Consensus 319 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~ 397 (468)
+.++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----V 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----H
Confidence 9999999999999986643222222222334568999999998899999999999999999999 889986532 1
Q ss_pred HHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
.++...... ......+......+.+++..|++.+|++||++.|+++.|+++....
T Consensus 243 ~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLKE-----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHc-----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222221111 1111122234567889999999999999999999999999886433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=301.83 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=198.7
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
+.||+|+||.||++.+.+++.||+|++...... .....+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999877999999987643322 2345789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++.... ..+++..+..++.+++.|++|||+.+ ++||||+|+||+++.++.++|+|||++...............
T Consensus 80 ~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99986432 35789999999999999999999877 999999999999999999999999999765421111111222
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc-CCCCCH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR-LSNTPL 425 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~~~ 425 (468)
..+..|+|||...+..++.++|+||||+++|||+| |..||...... .+... +... ....+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----~~~~~------------~~~~~~~~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----QTRER------------IESGYRMPAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----HHHHH------------HhcCCCCCCCc
Confidence 34567999999988889999999999999999999 88998653311 11111 0000 011122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 426 SEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 426 ~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
.....+.+++.+|++.+|.+|||+.|+++.|..
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=302.65 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=205.2
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||.+.. .+++.+++|++............+.+|+.++++++|+|++++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56778999999999999886 46889999988654433444567889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++.......+++.++..++.+++.|++|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 9999999997655567899999999999999999999877 99999999999999999999999999986643221
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
......+++.|+|||+..+..++.++||||||+++|||++|..||.... ..+... .+.......
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~-----------~~~~~~~~~ 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVV-----------KIVQGNYTP 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHH-----------HHHcCCCCC
Confidence 2234568999999999988888999999999999999999999986422 111111 111111222
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.+......+.+++..|++.+|.+||++.|+++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 223345668889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.33 Aligned_cols=253 Identities=29% Similarity=0.391 Sum_probs=192.7
Q ss_pred ceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCeeEEEEecc
Q 012213 188 NVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVYEYM 262 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 262 (468)
+.||+|+||.||+|.+. +...||+|++.... .......+..|+.+++.++|||++++++++.. +...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999863 23579999875322 12223568889999999999999999998754 55678999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC-
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS- 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 341 (468)
++|+|.+++.... ...++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+......
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999997433 34678888999999999999999877 999999999999999999999999999765422111
Q ss_pred -ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 342 -ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 342 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......++..|+|||+..+..++.++||||||+++|||++| .+||.... ..+...... ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~-----------~~~ 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLL-----------QGR 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHh-----------cCC
Confidence 111233457789999999888899999999999999999994 56665322 111111111 111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
....+...+..+.+++..||+.+|++||++.||++.|+++..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111112234568889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.35 Aligned_cols=253 Identities=22% Similarity=0.234 Sum_probs=198.2
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||+||++.+. +++.||+|++..... .......+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4677889999999999999874 688999999875432 22234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999743 235899999999999999999999877 99999999999999999999999999987643222
Q ss_pred CccccccccCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 341 SECMSAVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+... .... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i-~~~~-----~ 226 (330)
T cd05601 158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNI-MNFQ-----R 226 (330)
T ss_pred -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHHH-HcCC-----C
Confidence 1223456899999999886 456789999999999999999999999653211 111111 0000 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ..........+.+++..|+. +|++||+++++++
T Consensus 227 ~~~---~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLK---FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccC---CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 01111234557778888997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.17 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=199.0
Q ss_pred cCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------ 253 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 253 (468)
|...+.||+|+||.||+|.+. ++..||||.+..........+++.+|+.++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345678999999999999853 3688999998654433444467889999999999999999999886532
Q ss_pred eeEEEEeccCCCChhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
..++++||+++|+|.+++.... ...+++....+++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998874322 225788999999999999999999877 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
|+++...............++..|++||...+..++.++||||||+++|||++ |++||..... ..+..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~------ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI------ 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH------
Confidence 99986642222112223345678999999988889999999999999999999 8999865321 11111111
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.......+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 230 --------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 --------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001111123446788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.81 Aligned_cols=242 Identities=25% Similarity=0.306 Sum_probs=191.4
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 260 (468)
|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+..|..++..+ +|++++++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 566789999999999999875 567899999865332 122224466777777777 58999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-- 154 (323)
T cd05616 82 YVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154 (323)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence 99999999988643 34889999999999999999999877 999999999999999999999999999754311
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .+.. .+.+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~--------------~i~~~~- 217 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ--------------SIMEHN- 217 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHH--------------HHHhCC-
Confidence 12234567899999999999999999999999999999999999999753311 1111 111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
...+......+.+++.+|++.+|++|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11222345567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=318.83 Aligned_cols=239 Identities=27% Similarity=0.310 Sum_probs=188.2
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHH-HHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||+||+|.+. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999985 689999999864322 1122234455554 46788999999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 9999988643 35889999999999999999999877 99999999999999999999999999875321 12223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+... .+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~-----------~i~~~~~-~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYD-----------NILNKPL-RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHH-----------HHHcCCC-CCC
Confidence 456789999999999998999999999999999999999999975321 11111 1111111 111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMR 450 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ 450 (468)
......+.+++.+|++.||++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12355678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.96 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=204.0
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||++... +|+.||+|++...........++.+|+.++++++|||++++.+++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 567789999999999999874 6889999998654333333457899999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++.......+++.++.+++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 156 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--E 156 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--h
Confidence 9999999997655556899999999999999999999877 9999999999999999999999999998654221 1
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
......|++.|+|||+..+..++.++|+||||+++++|++|+.||.... ..+.. .+........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~-----------~~~~~~~~~~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLV-----------LKIIRGSYPP 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHH-----------HHHhcCCCCC
Confidence 1223457889999999988889999999999999999999999986422 11111 1111122222
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+......+.+++.+|++.+|.+||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 23344567888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.35 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=198.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|+..+.||+|+||+||++.+. +++.||||.+....... .....+..|+.++++++|++++++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 456688999999999999875 68899999886432221 2224567899999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986555556899999999999999999999777 9999999999999999999999999987653211
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....+ ....+....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~------------~~~~~~~~~ 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV------------ERLVKEVQE 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH------------Hhhhhhhhh
Confidence 1233468999999999998899999999999999999999999997632111 00000 000000001
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
..+......+.+++..|++.||++||| ++|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111223455778999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=323.33 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=195.3
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||+||+|.+. +++.||||++..... .......+..|+.++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5677899999999999999985 588999999864321 12223557889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 82 YLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999998643 35899999999999999999999877 99999999999999999999999999876532110
Q ss_pred Cc------------------------------------cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 012213 341 SE------------------------------------CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384 (468)
Q Consensus 341 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~ 384 (468)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246899999999999989999999999999999999999
Q ss_pred CCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 012213 385 RPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT---MREVVQ 454 (468)
Q Consensus 385 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt---~~ev~~ 454 (468)
.||...... +...... ..... . . ..........+.+++..|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~-----~~~~~i~-~~~~~---~---~-~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQ-----ETYRKII-NWKET---L---Q-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHH-----HHHHHHH-cCCCc---c---C-CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999753211 1000000 00000 0 0 00011123456677888886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=287.33 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=208.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----Ce
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 254 (468)
.++|.+.+.+|+|||+.||.++. .+++.||+|++..... +..+...+|++..++++|||++++++++..+ .+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 46788999999999999999985 5788899999875442 3346788999999999999999999887443 34
Q ss_pred eEEEEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
.|++++|...|||.+.+... .+..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999998643 3457999999999999999999999875 46999999999999999999999999999
Q ss_pred ccccccCCC-------ccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHH
Q 012213 333 KYLQDTGAS-------ECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 333 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 402 (468)
....-.-.. +.+.....|..|.|||++. +...++++|||||||+||+|+.|..||+..-+.+.+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS------ 250 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS------ 250 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe------
Confidence 765321111 1223456899999999875 446889999999999999999999999752212211
Q ss_pred HhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 403 MQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..-.+....+ ..........+.+++.+|++.||.+||++.+++..+..+.
T Consensus 251 --------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 --------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1222222222 1112237788999999999999999999999999987754
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=305.38 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=189.6
Q ss_pred eEcccCCcceEEEEcCC---CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGAGVVYRGVTPN---GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.||+|+||.||+|.+.+ +..+|+|++..... ......+.+|+..+++++|||++++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998643 45789998754332 222346888999999999999999999999999999999999999
Q ss_pred ChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 266 SLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 266 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+|.++++... ....++..+..++.|++.|++|||+.+ ++||||||+||+++.+++++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999996432 224677888899999999999999877 9999999999999999999999999997543222222
Q ss_pred cccccccCccccCccccCCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 343 CMSAVAGSYGYIAPEYAYTL-------KVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
......++..|+|||+.... .++.++||||||+++|||++ |+.||....... ...+. . .. ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~--~-~~---~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT--V-RE---QQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH--h-hc---ccCC
Confidence 22334577889999987542 35789999999999999997 999996533211 11110 0 00 0111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
..++... ......+.+++..|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 112334667888898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.89 Aligned_cols=268 Identities=26% Similarity=0.334 Sum_probs=203.7
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe-----e
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-----N 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~ 255 (468)
-.|...+++|+|+||.||+|... +++.||||+.-...+. -.+|+.+|++++|||||+++-+|....+ .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 34667789999999999999974 4689999998544332 2479999999999999999988854332 3
Q ss_pred EEEEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeecccc
Q 012213 256 LLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLA 332 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla 332 (468)
.+|||||| -+|.++++.. ....++...+.-+..||.+||+|||..+ |+||||||+|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 59999997 4898888631 2345777777889999999999999877 9999999999999986 89999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
+.+...... .....|..|.|||++.+. .|+.+.||||.||++.||+.|++-|.+.+ ...++....+...-..++.
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHH
Confidence 988643222 445678899999988765 69999999999999999999999998733 3345555555444443333
Q ss_pred hhhhccc-------cC-----CC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCC
Q 012213 412 VVKILDQ-------RL-----SN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPN 463 (468)
Q Consensus 412 ~~~~~d~-------~~-----~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~ 463 (468)
+..+--. .+ .. .......+..+++.+++..+|.+|.++.|++. .+.+++.++
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 3222111 11 01 22344567889999999999999999999986 555555544
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=308.70 Aligned_cols=271 Identities=29% Similarity=0.403 Sum_probs=205.2
Q ss_pred hccCCcceEcccCCcceEEEEcC-----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KET 254 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 254 (468)
+.|+..+.||+|+||.||+|.+. ++..||||.+...... .....+..|++.++.++|+|++++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45666789999999999999853 3678999998654332 234679999999999999999999999877 557
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.+++|||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 899999999999999997443 35899999999999999999999877 99999999999999999999999999987
Q ss_pred ccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh-hcccccch
Q 012213 335 LQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ-TNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 412 (468)
....... .......++..|+|||...+..++.++||||||+++|||+||+.|+......... +.... .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRL 235 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHH
Confidence 6522111 1112234556799999998888999999999999999999999998652211110 00000 00000011
Q ss_pred hhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 413 VKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 413 ~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+.+.... ...+......+.+++.+|++.+|++||||.||+++|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111111 1112234467889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=304.52 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=202.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCC----cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNG----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|...+.||+|+||.||+|.+.+. ..||+|....... ....+.+.+|+.+++.++|||++++++++.+ ...+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34567788999999999999987432 4688898753321 2233578999999999999999999999875 4578
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999996433 35899999999999999999999877 9999999999999999999999999998764
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.... .......++..|+|||......++.++||||||+++||+++ |..||...... ....+.. .
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~----~-------- 223 (270)
T cd05056 159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIE----N-------- 223 (270)
T ss_pred cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH----c--------
Confidence 3211 11122334568999999988889999999999999999997 99999753321 1111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
......+......+.+++.+|+..+|.+|||+.++++.|+++...+
T Consensus 224 --~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 224 --GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0001112234567888999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=319.25 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=195.7
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----eeEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNLL 257 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 257 (468)
|+..+.||+|+||.||++.+ .+++.||||++............+.+|+++++.++|+||+++++++.... ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 56778999999999999997 47899999998643333333456889999999999999999999998776 7899
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999996 678887753 335899999999999999999999877 99999999999999999999999999986542
Q ss_pred cCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC-c----------CHHHHHHHhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEG-L----------DIVQWTKMQT 405 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~-~----------~~~~~~~~~~ 405 (468)
. .........++..|+|||++.+. .++.++|||||||++|||++|+.||...+... . ...++....
T Consensus 156 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~- 233 (372)
T cd07853 156 D-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC- 233 (372)
T ss_pred C-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh-
Confidence 2 22223345678999999988764 47899999999999999999999997633110 0 000000000
Q ss_pred cccccchhhhccccC---------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 406 NSSKEGVVKILDQRL---------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~---------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+...+.+.... ..........+.+++.+|++.||++|||+.|+++
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 234 ----EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred ----HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000000 0011122456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=307.92 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=197.6
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|+..+.||+|+||+||+|.+ .+++.||+|.+...... ......+..|+++++.++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567899999999999987 46889999988543221 12224577899999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 99999999887554456999999999999999999999877 999999999999999999999999999765321
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......|+..|+|||++.+..++.++|+||||+++|||++|+.||........ ...+... .... ..
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-----------~~~~-~~ 222 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-----------VLET-EE 222 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-----------hhcc-cc
Confidence 112345689999999999888899999999999999999999999975331110 1111110 0000 01
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
.........+.+++..|++.+|++||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111223455678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=308.21 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=201.5
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
....|+..+.||+|+||.||+|.+ .+++.||+|.+...... ....+..|+.+++.++|+|++++++++......++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 356788889999999999999986 46889999988643322 236688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999998642 4789999999999999999999877 999999999999999999999999998765422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .......+++.|+|||...+..++.++|||||||++|||++|+.||...... ..+.... .... .
T Consensus 170 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~~-~~~~--------~ 234 (296)
T cd06654 170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIA-TNGT--------P 234 (296)
T ss_pred c--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHHh-cCCC--------C
Confidence 1 1123346889999999998888999999999999999999999999653211 1111110 0000 0
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....+......+.+++.+|+..+|++||++.|+++
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 01112234456778999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=315.68 Aligned_cols=260 Identities=27% Similarity=0.332 Sum_probs=197.1
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----- 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 253 (468)
+.+.|+..+.||+|+||.||++.+. +|..||||++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4678888999999999999999874 5889999998654333333466889999999999999999999886543
Q ss_pred -eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
..++||||++ ++|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 4689999996 466666642 3788899999999999999999877 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK--- 409 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 409 (468)
+.... ........||..|+|||.+.+..++.++|||||||++|||+||+.||...+. ...|.........
T Consensus 171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH----IDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCcH
Confidence 75432 1222345689999999999999999999999999999999999999976331 1112111100000
Q ss_pred -------cchhhhcccc-------------------CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 -------EGVVKILDQR-------------------LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 -------~~~~~~~d~~-------------------~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......... ...........+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 00011112356789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.55 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=200.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+.|+..+.||+|+||.||+|.+. +|+ .||+|.+..... ......+.+|+.+++.++||||++++++|... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 345677789999999999999874 344 468887753322 22234688999999999999999999998754 46
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 7999999999999998643 335889999999999999999999877 999999999999999999999999999876
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.............++..|+|||+..+..++.++||||||+++|||++ |+.||.+... ....++.. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~----~~------ 227 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE----KG------ 227 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----CC------
Confidence 53222222223445678999999998889999999999999999998 9999865321 11111111 00
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.....+......+.+++..||..+|++||++.++++.|+++...
T Consensus 228 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ----ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111122345678899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.14 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=197.0
Q ss_pred ceEcccCCcceEEEEcCC-------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 188 NVIGRGGAGVVYRGVTPN-------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.||+|+||.||+|.+.+ +..+|+|.+..... ......+.+|+..++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998743 25789998753221 2234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-----ceEEeecc
Q 012213 261 YMPNGSLGEVLHGK-----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-----EAHVADFG 330 (468)
Q Consensus 261 ~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg 330 (468)
|+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.+. .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999998643 2234789999999999999999999777 99999999999999887 89999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
++..+.............++..|+|||++.+..++.++||||||+++|||+| |+.||...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~-------- 226 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV-------- 226 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH--------
Confidence 9976543222222223345788999999999899999999999999999998 99998653211 111110
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
........+......+.+++.+|++.+|.+||++.+|++.|++
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 ------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0001111222345677899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.93 Aligned_cols=252 Identities=24% Similarity=0.277 Sum_probs=195.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||++.+. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 567888899999999999999985 578899998854222 122234578899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+...
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999998643 3788999999999999999999877 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+ .+
T Consensus 196 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~~~------------~~ 258 (370)
T cd05621 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----GTY------------SK 258 (370)
T ss_pred C-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----HHH------------HH
Confidence 2 1122456799999999988654 3788999999999999999999999753211 111 11
Q ss_pred hcccc--C-CCCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 012213 415 ILDQR--L-SNTPLSEAMQVFFVAMLCVQEHGVE--RPTMREVVQM 455 (468)
Q Consensus 415 ~~d~~--~-~~~~~~~~~~~~~l~~~c~~~~P~~--RPt~~ev~~~ 455 (468)
+.+.. + ..........+.+++..|+..+|.+ ||++.|+++.
T Consensus 259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111 1 0111123445667777888755443 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=337.47 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=201.7
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+|+..+.||+|+||.||+|.+. +|+.||+|++...... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 45778899999999999999975 5889999998643222 222356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 260 EYMPNGSLGEVLHGKR---------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
||+++|+|.+++.... ....++..+++++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886321 224667888999999999999999877 9999999999999999999999999
Q ss_pred ccccccccCC----------------CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 012213 331 LAKYLQDTGA----------------SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG 394 (468)
Q Consensus 331 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 394 (468)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123468999999999999999999999999999999999999996522111
Q ss_pred cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHhc
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-TMREVVQMLAQA 459 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-t~~ev~~~L~~~ 459 (468)
. . +.. ...++.........+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 239 i--~-~~~-----------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I--S-YRD-----------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h--h-hhh-----------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0 000 0000000000112345577899999999999995 677787877765
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.69 Aligned_cols=264 Identities=21% Similarity=0.234 Sum_probs=194.7
Q ss_pred cceEccc--CCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 187 NNVIGRG--GAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 187 ~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
.++||+| +|++||++.. .+|+.||+|++............+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 7889999987 568999999986543333334567889999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc-
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE- 342 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 342 (468)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+......+...
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999996544456899999999999999999999877 9999999999999999999999998765432111111
Q ss_pred ----cccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc-------c
Q 012213 343 ----CMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS-------K 409 (468)
Q Consensus 343 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 409 (468)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ............ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccchhh
Confidence 1122346778999999875 4688999999999999999999999975332110 000000000000 0
Q ss_pred c-----chhhhccccC------------------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 E-----GVVKILDQRL------------------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~-----~~~~~~d~~~------------------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ ......+... ..........+.+++..|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000000000 0111223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=323.74 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=193.5
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|...+.||+|+||+||++.. .+++.||||++..... .......+.+|++++.+++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 467778999999999999987 4688999998854322 12233567889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 82 FLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999998643 35889999999999999999999877 99999999999999999999999999964321100
Q ss_pred C------------c---------------------------------cccccccCccccCccccCCCCCCcchhhHHHHH
Q 012213 341 S------------E---------------------------------CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 375 (468)
Q Consensus 341 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 375 (468)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001246899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCC---CCHHHH
Q 012213 376 VLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVER---PTMREV 452 (468)
Q Consensus 376 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~R---Pt~~ev 452 (468)
++|||+||+.||...... ..+........ . + .+. ........+.+++.+|+. +|.+| |++.|+
T Consensus 237 il~elltG~~Pf~~~~~~----~~~~~i~~~~~--~---~---~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSH----ETYRKIINWRE--T---L---YFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHH----HHHHHHHccCC--c---c---CCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999653211 01111100000 0 0 000 111223456778888887 66665 599988
Q ss_pred HHH
Q 012213 453 VQM 455 (468)
Q Consensus 453 ~~~ 455 (468)
+..
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=302.31 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=207.5
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCC-chhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS-HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++......+ ..-.+.+||++|+.++||||+.++.+|+.++...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45677788999999999999987 6799999998876544332 224578999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||..+|.|+||+.. ...+++.+...++.||..|+.|+|+.+ ++|||||-+|||+|+++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 999999999999964 345999999999999999999999877 99999999999999999999999999988763
Q ss_pred CCCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.....+++|++-|.+||...+..|. +.+|.||+||+||.++.|..||++.+- -..+ .++-.
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lv-----------rQIs~ 267 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLV-----------RQISR 267 (668)
T ss_pred --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHH-----------HHhhc
Confidence 2345678999999999999998875 899999999999999999999987541 1111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
.... ..+.+....-++++++..+|++|.|+.+|..-.
T Consensus 268 GaYr--EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 GAYR--EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccc--CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 112334456689999999999999999998754
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=303.83 Aligned_cols=255 Identities=24% Similarity=0.282 Sum_probs=199.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.++.+++|||++++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45688889999999999999997 5678899998854322 22356788999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.++++.. ..+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++..+....
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 86 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999998643 35889999999999999999999877 9999999999999999999999999998664221
Q ss_pred CCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 340 ASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||........ ...+ . .....
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~-------~---~~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM-------S---KSNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee-------e---cCCCC
Confidence 1123346788999999874 34578899999999999999999999864321100 0000 0 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
... ..........+.+++..|++.+|++||+++++++.|
T Consensus 228 ~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPK-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCC-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 111123346788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.73 Aligned_cols=245 Identities=24% Similarity=0.273 Sum_probs=189.1
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHH-HHHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEI-RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||+||+|.+. +++.||+|.+...... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999985 5678999998643211 11123344444 356788999999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~ 153 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT 153 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence 9999998643 34778888899999999999999877 999999999999999999999999999754321 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~-----------i~~~~~-~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN-----------ILNKPL-QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHH-----------HHhCCc-CCC
Confidence 456799999999999999999999999999999999999999975321 111111 111111 111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
......+.+++.+|++.+|.+||++.+.+..+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 22345677899999999999999987654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=304.43 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=196.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK------ 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 252 (468)
...|+..+.||+|+||.||+|.+. +++.||+|.+.... .....+..|+.++.++ +|+|++++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456777889999999999999874 57889999885432 2235688999999998 699999999998653
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
...+++|||+++++|.+++.......+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45789999999999999998655567899999999999999999999877 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
...... ........|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..+.... ..
T Consensus 159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~~-~~ 231 (272)
T cd06637 159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIP-RN 231 (272)
T ss_pred eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHHh-cC
Confidence 865422 12234456899999999875 345788999999999999999999999653211 1111100 00
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. .. ..........+.+++.+|+..+|.+|||+.|+++
T Consensus 232 ---~-----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 ---P-----AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---C-----CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00 0111123456788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.12 Aligned_cols=244 Identities=23% Similarity=0.262 Sum_probs=191.3
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|... +++.||+|++...... ....+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 5788999998653322 22235578899998888 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 9999888533 35899999999999999999999877 999999999999999999999999998753211 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE-EGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++....... .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~ 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-----------KPIRI 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-----------CCCCC
Confidence 456789999999999999999999999999999999999999965321 111111221111111 11112
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
+......+.+++.+|++.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22334567789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=304.56 Aligned_cols=264 Identities=21% Similarity=0.305 Sum_probs=196.5
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|++|.||+|.+. +++.||+|++............+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 566788999999999999975 6889999998654433333456889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 263 PNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 155 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--V 155 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--c
Confidence 7 68888886433 256899999999999999999999877 999999999999999999999999999765322 1
Q ss_pred ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHH------------HHHHHhhccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIV------------QWTKMQTNSS 408 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~------------~~~~~~~~~~ 408 (468)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||....... ... .|........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhHH
Confidence 12233456889999998765 457899999999999999999999997532110 000 0100000000
Q ss_pred -ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 -KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 -~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....................++.+++.+|++.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000011123456678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.94 Aligned_cols=245 Identities=25% Similarity=0.290 Sum_probs=190.1
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHH-HHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||+||+|.+. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999874 688999999864322 1122234555554 46778999999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT 153 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence 999988853 345899999999999999999999877 99999999999999999999999999875321 11223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.. ..+....+. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~-----------~~~~~~~~~-~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMY-----------DNILHKPLV-LR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHH-----------HHHHcCCcc-CC
Confidence 456789999999999999999999999999999999999999975321 1111 111111110 11
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
......+.+++..|++.+|.+||++.+.++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 12345677899999999999999886544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=305.07 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=192.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC---CCCCccceeEEEec-----CCe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSN-----KET 254 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~ 254 (468)
|+..+.||+|+||+||+|.+. +++.||+|.+............+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 566789999999999999885 588999998865433322223456677776655 79999999998864 234
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.+++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 789999997 58988887655556899999999999999999999877 99999999999999999999999999986
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh-
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV- 413 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 413 (468)
.... .......++..|+|||++.+..++.++|||||||++|||++|++||....... .+................
T Consensus 158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 158 YSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcc
Confidence 6422 12234567899999999998899999999999999999999999996532211 111111000000000000
Q ss_pred ------hhccccC----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 ------KILDQRL----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ------~~~d~~~----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.... ..........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0001123455779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=299.32 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=202.0
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||++.. .+++.+|+|.+............+..|+++++.++|||++++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 56678999999999999987 46788999998654433444567899999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeeccccccccccCCC
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~~~ 341 (468)
++++|.+++.......+++..+.+++.+++.|+.|||+.+ ++|+||+|+||+++++ +.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 9999999998665667899999999999999999999877 9999999999999865 458999999998764321
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......++..|+|||...+..++.++||||||+++|+|++|+.||...+. ....... ......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~-----------~~~~~~ 219 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKI-----------MSGTFA 219 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHH-----------HhcCCC
Confidence 12235678899999999988899999999999999999999999865321 1111111 111111
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+......+.+++..|++.+|++|||+.|+++
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 122234566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=306.45 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=202.3
Q ss_pred hccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--Ce
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ET 254 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 254 (468)
..|+..+.||+|+||.||++.. .++..||+|.+..... ......+.+|+.+++.++|||++++.+++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3467788999999999999973 3578899999864322 23345789999999999999999999998775 56
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||+++++|.+++... ...+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 78999999999999998643 235899999999999999999999877 99999999999999999999999999987
Q ss_pred ccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC----------CCcCHHHHHHH
Q 012213 335 LQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE----------EGLDIVQWTKM 403 (468)
Q Consensus 335 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~----------~~~~~~~~~~~ 403 (468)
+...... .......++..|+|||+..+..++.++||||||+++|||+|++.|...... .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence 6532221 122334567789999999888899999999999999999998776532100 0000011110
Q ss_pred hhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 404 QTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
...+......+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 238 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 ----------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ----------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011111112223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.90 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=199.3
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCC-------chhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS-------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
|.....||+|++|.||+|.+. +++.||+|.+........ ..+.+..|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456789999999999999874 578999998865433211 124578899999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++++||+++++|.+++... ..+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.++.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999643 35889999999999999999999877 999999999999999999999999999876
Q ss_pred cccCCC----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 336 QDTGAS----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 336 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
...... .......|+..|+|||...+..++.++||||||+++|||++|+.||...... . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~------------~ 220 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----Q------------A 220 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----H------------H
Confidence 521111 1112345788999999998888999999999999999999999999753211 0 0
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.+.........+......+.+++.+|++.+|.+||++.||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 IFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111112223344567788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.18 Aligned_cols=239 Identities=28% Similarity=0.310 Sum_probs=187.2
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHH-HHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+. +++.||+|.+..... .......+..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 578999999864322 1122234555554 57889999999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 999988853 335788889999999999999999877 999999999999999999999999998753211 1223
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+. ..... .+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~-----------~i~~~~-~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYD-----------NILHKP-LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHH-----------HHhcCC-CCCC
Confidence 445789999999999988899999999999999999999999965321 11111 111111 1122
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMR 450 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ 450 (468)
......+.+++.+|++.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23455678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=312.50 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=191.0
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 260 (468)
|+..+.||+|+||+||+|.+. +|+.||+|++..... .......+..|..++..+. |++++++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 556789999999999999874 688999999864322 2222345777888888875 5778889999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 82 YVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999998643 35899999999999999999999877 9999999999999999999999999987543211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ... ..+....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~--------------~~i~~~~- 217 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELF--------------QSIMEHN- 217 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHH--------------HHHHhCC-
Confidence 1233456899999999999888999999999999999999999999763311 111 1111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
...+......+.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11122334567789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=316.11 Aligned_cols=261 Identities=25% Similarity=0.315 Sum_probs=197.3
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC------
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ 252 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 252 (468)
+.++|+..+.||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4678888999999999999999874 588999999865443334446678899999999999999999988543
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
...++||||++ +++.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 34689999996 467666642 3788999999999999999999877 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc-----
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS----- 407 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 407 (468)
+.... ........||..|+|||++.+..++.++|||||||++|||++|+.||.+.+. ...|.......
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCP 239 (355)
T ss_pred ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 86532 2222345689999999999998999999999999999999999999975321 11111100000
Q ss_pred -----cccchhhhccc---------------cC----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 408 -----SKEGVVKILDQ---------------RL----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 408 -----~~~~~~~~~d~---------------~~----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
........++. .. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 00 00111224567899999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=297.25 Aligned_cols=255 Identities=22% Similarity=0.241 Sum_probs=211.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
...|+..+.||+|.-|+||++.+++ +..+|+|++.+..-. .....+...|-++|+.++||.++.|++.++.+...+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 5667788899999999999999865 478999998654433 23335678899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc-
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD- 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~- 337 (468)
||||+||+|..+++.+.+..+++..+..++.++..||+|||..| ||+|||||+||||.++|++.|+||.++..+..
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999888899999999999999999999999888 99999999999999999999999999864310
Q ss_pred ------c-------------------------CCC----------------------ccccccccCccccCccccCCCCC
Q 012213 338 ------T-------------------------GAS----------------------ECMSAVAGSYGYIAPEYAYTLKV 364 (468)
Q Consensus 338 ------~-------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 364 (468)
. ... ......+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 000 01123579999999999999999
Q ss_pred CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC-CCCHHHHHHHHHHHHhhcccCC
Q 012213 365 DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS-NTPLSEAMQVFFVAMLCVQEHG 443 (468)
Q Consensus 365 ~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~~c~~~~P 443 (468)
+.++|.|+|||++|||+.|+.||.+.+.+ +.+..++-..+. ......+..+.++|...+..||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999999875432 244555554441 2223667788899999999999
Q ss_pred CCCCC----HHHHHH
Q 012213 444 VERPT----MREVVQ 454 (468)
Q Consensus 444 ~~RPt----~~ev~~ 454 (468)
++|-. +.||-+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99988 777654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.89 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=200.0
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
|+..+.||+|+||+||+|...+++.+|||.+....... .....+.+|++.+++++|+|++++.+++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56778999999999999998889999999876432211 11245888999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 82 EFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999643 34789999999999999999999877 9999999999999999999999999997653211
Q ss_pred C----CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 340 A----SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 340 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
. ........++..|+|||+..+..++.++||||||+++|||++|+.||...+... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~--------- 223 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMFYIGAH--------- 223 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHHHhhhc---------
Confidence 1 112234568899999999998889999999999999999999999996532111 00000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......+......+.+++.+|++.+|++||++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 -RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011122234566788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.21 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=195.8
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|+||.||+|.+ .+++.||+|.+.... .......+.+|++++.+++|||++++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 456778999999999999987 468889999885432 222335688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 3678889999999999999999877 999999999999999999999999999765421
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--CHHHHHHHhhcccccchhhhcccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--DIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
......++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+... ..+..
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------~~~~~ 216 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-----------IVDED 216 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-----------HhccC
Confidence 22345689999999999988899999999999999999999999975321111 11111111 01111
Q ss_pred CCC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 420 LSN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 420 ~~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
... ........+.+++.+|++.+|++||+++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 100 011234567889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.22 Aligned_cols=253 Identities=21% Similarity=0.239 Sum_probs=191.8
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.|+..+.||+|+||.||+|.+. +++.||||.+..... .......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 4677889999999999999874 588999999854321 12223567899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999643 35788999999999999999999877 99999999999999999999999999853310000
Q ss_pred -----------------------------------------CccccccccCccccCccccCCCCCCcchhhHHHHHHHHH
Q 012213 341 -----------------------------------------SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 379 (468)
Q Consensus 341 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~e 379 (468)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCC---CHHHHHH
Q 012213 380 LITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP---TMREVVQ 454 (468)
Q Consensus 380 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP---t~~ev~~ 454 (468)
|++|+.||...... ++........ ... . . .........+.+++.+|+ .+|++|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~-----~~~~~i~~~~----~~~-~--~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPA-----ETQLKVINWE----TTL-H--I-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHH-----HHHHHHhccC----ccc-c--C-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999763311 1111000000 000 0 0 001112334455666655 4999999 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=321.22 Aligned_cols=203 Identities=24% Similarity=0.311 Sum_probs=170.6
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.|+..+.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 3667789999999999999874 578899999864321 12223568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998643 35788999999999999999999877 99999999999999999999999999753321000
Q ss_pred ---------------------------------------------CccccccccCccccCccccCCCCCCcchhhHHHHH
Q 012213 341 ---------------------------------------------SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 375 (468)
Q Consensus 341 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 375 (468)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 012213 376 VLLELITGRRPVGDF 390 (468)
Q Consensus 376 ~l~elltg~~p~~~~ 390 (468)
++|||++|++||...
T Consensus 237 il~elltG~~Pf~~~ 251 (382)
T cd05625 237 ILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=294.73 Aligned_cols=272 Identities=22% Similarity=0.277 Sum_probs=205.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC-ccceeEEEecCC-----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKE----- 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 253 (468)
.+.|...+.||+|+||+||+|+. .+|+.||+|++.-....+.......+|+.++++++|+| |+++.+++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34456667899999999999997 46889999999765543223345789999999999999 999999998877
Q ss_pred -eeEEEEeccCCCChhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKRG--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
..++|+||++ -+|.+++..... ..++...+..++.||.+||+|||+.+ |+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7789999994 699999875443 35777889999999999999999777 9999999999999999999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHH---Hhhc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK---MQTN 406 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~---~~~~ 406 (468)
+|+...- .....+...+|..|.|||++.+. .|++..||||+||++.||+++++-|.+..+ ..++..-.. ....
T Consensus 166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCc
Confidence 9996642 22334567789999999998876 799999999999999999999998876432 111111111 1111
Q ss_pred ccccchhhhccccC--C-CC-CH-------HHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHhc
Q 012213 407 SSKEGVVKILDQRL--S-NT-PL-------SEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQA 459 (468)
Q Consensus 407 ~~~~~~~~~~d~~~--~-~~-~~-------~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~--L~~~ 459 (468)
..+..+..+.+... . .. +. .......+++.+|++.+|.+|.|+..+++. +.+.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11222222222221 0 00 10 111367889999999999999999999985 5544
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=301.99 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=187.2
Q ss_pred eEcccCCcceEEEEcCC---CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGAGVVYRGVTPN---GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.||+|+||.||+|...+ ...+++|.+.... .......+.+|+..++.++|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997643 3467888764322 2222356788999999999999999999999999999999999999
Q ss_pred ChhhhcccCCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 266 SLGEVLHGKRG---SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 266 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+|.+++..... ...++.....++.||+.|++|||+.+ |+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975432 23568888999999999999999877 9999999999999999999999999987543222111
Q ss_pred cccccccCccccCccccC-------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 343 CMSAVAGSYGYIAPEYAY-------TLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
......++..|+|||+.. ...++.++||||||+++|||++ |..||....... . .... .... ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~--~~~~-~~~~---~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--V--LKQV-VREQ---DIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--H--HHHH-hhcc---Ccc
Confidence 123334567899999864 3456789999999999999999 888886532110 0 0000 0000 001
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
+.+ ...+......+.+++..|+ .||++|||++||++.|.
T Consensus 230 ~~~---~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPK---PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC---CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 1112234455667788888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.46 Aligned_cols=239 Identities=22% Similarity=0.343 Sum_probs=185.6
Q ss_pred ceEcccCCcceEEEEcCC-------------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 188 NVIGRGGAGVVYRGVTPN-------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
+.||+|+||.||+|.... ...|++|.+.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998532 2258888765432 2223568889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-------eEEe
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-------AHVA 327 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~ 327 (468)
.++||||+++|+|..++... ...+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++. ++++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999999888643 345899999999999999999999777 999999999999987664 8999
Q ss_pred eccccccccccCCCccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCCcCHHHHHHHhh
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELI-TGRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+...... +...
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~--- 220 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----EKER--- 220 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----HHHH---
Confidence 99998754311 2345788899999886 567899999999999999998 588888652211 1000
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
....... ........+.+++.+||+.||.+||++.+|++.+
T Consensus 221 ---------~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 ---------FYEGQCM-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------HHhcCcc-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000000 0111234677899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=318.55 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=211.8
Q ss_pred hccCCcceEcccCCcceEEEEcC--CCc--EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP--NGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+.+...++||+|.||.|++|.|. +|. .||||.+....... ....|.+|+..|.+++|+|+++|||+..+ ....+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 34555688999999999999985 343 58999997665543 44779999999999999999999999887 67889
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|+|.++.|||.+.|+......+.......++.|||.|+.||..++ +|||||.++|+|+-....+||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999998755567788888999999999999999766 99999999999999999999999999998875
Q ss_pred cCCCccc-cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGASECM-SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
......+ ....-.+.|+|||.+...+++.++|||+|||+||||+| |..||-+.... .+.+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------qIL~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------QILKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------HHHHh
Confidence 4443333 23345678999999999999999999999999999999 99999764311 22222
Q ss_pred c-cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 416 L-DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 416 ~-d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
+ +.++...+..+..++.+++..||..+|++|||+..|.+.+-
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 3 34446677889999999999999999999999999985443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.50 Aligned_cols=254 Identities=30% Similarity=0.444 Sum_probs=198.1
Q ss_pred cCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||+||++.... ++.||+|.+...............|+..+++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3456899999999999999864 568999998754433222223455999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++. ....+++..+..++.|+++||++||+.+ ++|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred cccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccc
Confidence 9999999997 3345899999999999999999999887 9999999999999999999999999997642 2223
Q ss_pred cccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 343 CMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......++..|+|||... +..++.++||||+|+++|+|++|..||..... .+......... ....... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~-------~~~~~~~-~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL-------KRPLPSS-S 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH-------HTHHHHH-T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc-------ccccccc-c
Confidence 345567899999999998 88899999999999999999999999976410 00000000000 0000000 0
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.........+.+++..|++.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111277889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.43 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=199.2
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||++.. .++.||+|.+... .....+.+|+.++++++|||++++++++... ..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 35678889999999999999975 6788999987532 2235688999999999999999999998654 5799999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.......+++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999997655556899999999999999999999877 999999999999999999999999998754321
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+....... .
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~-----------~ 214 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVEKG-----------Y 214 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHhCC-----------C
Confidence 112234568999999988889999999999999999998 9999865321 1111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
....+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011122345677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.70 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=201.5
Q ss_pred hccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||+|+||.||+|.+.+ ++.|++|.+..... .+.+.+|++.+++++|+|++++++++......++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 457788899999999999999865 78999998854322 4679999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ...+++..+..++.+++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 79 YCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred cCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999998632 346899999999999999999999877 99999999999999999999999999987653221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
......++..|+|||+..+..++.++||||||+++|||++|+.||........ ... ..... ...
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~---------~~~~~-~~~ 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM---------IPNKP-PPT 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh---------hccCC-CCC
Confidence 22334578899999999988999999999999999999999999975321110 000 00000 000
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+......+.+++..|++.+|++|||+.||++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112234456888999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=316.46 Aligned_cols=255 Identities=22% Similarity=0.236 Sum_probs=195.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||++.+. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 577888999999999999999985 578899998854222 122234577899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 122 ~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 122 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999998643 3788889999999999999999877 999999999999999999999999999876432
Q ss_pred CCCccccccccCccccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
. ........||+.|+|||++... .++.++|||||||++|||++|+.||...+.. ..+... .... .
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i-~~~~--~--- 264 (371)
T cd05622 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSKI-MNHK--N--- 264 (371)
T ss_pred C-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----HHHHHH-HcCC--C---
Confidence 2 1122356799999999998654 3789999999999999999999999753211 111111 0000 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVE--RPTMREVVQM 455 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~--RPt~~ev~~~ 455 (468)
... ..........+.+++..|+..++.+ ||++.|+++.
T Consensus 265 --~~~-~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 --SLT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --ccc-CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 000 0111234456677888899744333 7789988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.26 Aligned_cols=251 Identities=29% Similarity=0.473 Sum_probs=200.3
Q ss_pred CCcceEcccCCcceEEEEcCC-----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 185 KDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
+..+.||+|+||.||++.+.+ +..||+|.+..... ....+.+..|+..+..++|+|++++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999854 47899999854322 113467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997544433899999999999999999999877 9999999999999999999999999998765332
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
... .....+++.|+|||...+..++.++||||+|++++||++ |+.||..... ..+.... ...
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~--------------~~~ 220 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYL--------------KKG 220 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH--------------hcC
Confidence 211 112336789999999988889999999999999999999 8888865221 1111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
.....+......+.+++.+|++.+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112223556788899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=285.18 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=204.5
Q ss_pred cchhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC--Cch----hHHHHHHHHHhCC-CCCCccceeEE
Q 012213 177 SDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS--SHD----NGLSAEIRTLGKI-RHRNIVRLKAF 248 (468)
Q Consensus 177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~----~~~~~e~~~l~~l-~h~niv~l~~~ 248 (468)
.+++...|...+.+|+|..++|.+... +.|..+|+|++....... ... +.-..|+.+|+++ .||+|+.+.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 345677888999999999999998876 468889999886543322 111 3456799999998 69999999999
Q ss_pred EecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 012213 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328 (468)
Q Consensus 249 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 328 (468)
++.+.-.++|+|.|+.|.|.|+|.+.. .+++....+|+.|+..|++|||... ||||||||+|||+|++.++||+|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999997554 4899999999999999999999877 99999999999999999999999
Q ss_pred ccccccccccCCCccccccccCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHH
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 402 (468)
||+++.+.. .......+||++|+|||.+. ...|+..+|+||.||++|.++.|.+||.. +
T Consensus 167 FGFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------------R 231 (411)
T KOG0599|consen 167 FGFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------------R 231 (411)
T ss_pred cceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------------H
Confidence 999998763 34456789999999999764 34688999999999999999999999843 1
Q ss_pred HhhcccccchhhhccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 403 MQTNSSKEGVVKILDQRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.-- +.-++.+.. +..=.+......+++.+|++.||.+|-|++|+++
T Consensus 232 kQmlM----LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 232 KQMLM----LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHH----HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11100 111111111 1111234566788999999999999999999886
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.23 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=191.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 252 (468)
.+.|+..+.||+|+||.||+|.+. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 356888899999999999999974 57899999874321 2345799999999999999999876432
Q ss_pred -CeeEEEEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEee
Q 012213 253 -ETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVAD 328 (468)
Q Consensus 253 -~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~D 328 (468)
...++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 13568999997 577776642 23446899999999999999999999877 99999999999999765 799999
Q ss_pred ccccccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||++||.+.... ..+..........
T Consensus 215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p 290 (440)
T PTZ00036 215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTP 290 (440)
T ss_pred cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 99998764221 1234567999999998765 46899999999999999999999999763311 1111111100000
Q ss_pred cccchhh----hccccCC---------CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 408 SKEGVVK----ILDQRLS---------NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 408 ~~~~~~~----~~d~~~~---------~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
..+.... ..+..+. ..+.....++.+++.+|+..||.+|||+.|+++ .+.++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0000000 0000000 011123456889999999999999999999985 44443
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.56 Aligned_cols=248 Identities=27% Similarity=0.355 Sum_probs=199.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+..|++++++++|||++++++++......++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 44666788999999999999874 577899998753322 2233568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.. ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 9999999999863 34889999999999999999999877 9999999999999999999999999998664221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||+..+..++.++||||||+++|||+||+.|+....... ...+ ..+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~--------------~~~~~~ 218 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFL--------------IPKNSP 218 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhh--------------hhcCCC
Confidence 12233457889999999998889999999999999999999999986532111 0000 000111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..........+.+++.+|++.+|++||+|.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1122234566788999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=299.03 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=195.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
++++.....||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 445556678999999999999964 57789999875332 223357889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGS-FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~ 337 (468)
||+++++|.+++...... ..++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999753221 2278888999999999999999877 999999999999986 67999999999976542
Q ss_pred cCCCccccccccCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.. .......++..|+|||+..+. .++.++||||||+++|+|++|+.||....... ...|...
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~------------ 225 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVG------------ 225 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhh------------
Confidence 21 122334578999999988654 37899999999999999999999996532111 0111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........+......+.+++.+|++.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000111122334556788999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=303.61 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=204.4
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+....|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+..|+.+++.++|+|++++++++...+..++
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 3457788899999999999999997 5789999998864332 223568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++++|.+++.. ..+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999999853 24789999999999999999999877 99999999999999999999999999976542
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
... ......+++.|+|||...+..++.++||||||+++|++++|+.||...+....... ....
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~~~~ 230 (297)
T cd06656 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------IATN 230 (297)
T ss_pred Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------eccC
Confidence 221 12334678899999999988899999999999999999999999965332110000 0000
Q ss_pred cc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 418 QR-LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 418 ~~-~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.. ....+......+.+++.+|++.+|++||++.++++ .++..
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 00 01122234455778999999999999999999998 44433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.44 Aligned_cols=196 Identities=23% Similarity=0.380 Sum_probs=159.3
Q ss_pred cceEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCeeEEEEec
Q 012213 187 NNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLVYEY 261 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 261 (468)
+..||+|+||+||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 46789999885332 12457889999999999999999998854 4567899999
Q ss_pred cCCCChhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCceEEeecc
Q 012213 262 MPNGSLGEVLHGK-------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFG 330 (468)
Q Consensus 262 ~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg 330 (468)
++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 5888776422 1235889999999999999999999877 9999999999999 456789999999
Q ss_pred ccccccccCC-CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 331 LAKYLQDTGA-SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 331 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+++.+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9987643221 122234678999999998876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.93 Aligned_cols=238 Identities=23% Similarity=0.389 Sum_probs=188.5
Q ss_pred ceEcccCCcceEEEEcCCCc-----------EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 188 NVIGRGGAGVVYRGVTPNGE-----------QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.+++.++|||++++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999986543 4777766433221 4678999999999999999999999988 7789
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-------ceEEeec
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-------EAHVADF 329 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Df 329 (468)
+|+||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999975432 6899999999999999999999777 99999999999999887 7999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
|++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... .+.....
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~~~~~- 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKERFYQ- 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHHHHHh-
Confidence 99986542 1234467789999998876 78999999999999999999 57777653211 1111110
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
+... .+......+.+++..|+..+|.+|||+.||++.|+
T Consensus 221 ----------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ----------DQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----------cCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 01111267889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=299.39 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=199.3
Q ss_pred cCCcceEcccCCcceEEEEcCC--CcEEEEEEecccCCC--------CCchhHHHHHHHHHhC-CCCCCccceeEEEecC
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKLLGITKG--------SSHDNGLSAEIRTLGK-IRHRNIVRLKAFCSNK 252 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~ 252 (468)
|+..+.||+|+||.||+|.+.. ++.+|+|.+...... .....++..|+.++.+ ++|||++++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5667889999999999999865 688999987543211 1122456778887765 7999999999999999
Q ss_pred CeeEEEEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 253 ETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
+..+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998753 233468999999999999999999995 45 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
|.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||.... .......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~------ 224 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATK------ 224 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHH------
Confidence 9998754322 3345568899999999998889999999999999999999999986422 1111111
Q ss_pred cchhhhccccCCCC-CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 410 EGVVKILDQRLSNT-PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 410 ~~~~~~~d~~~~~~-~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
..+...... .......+.+++.+|++.||++||++.|+..++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 225 -----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111111 11234567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.69 Aligned_cols=260 Identities=26% Similarity=0.333 Sum_probs=196.8
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC------
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ 252 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 252 (468)
+.++|...+.||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678888999999999999999874 578899999865433333445678899999999999999999987543
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35699999996 577777642 3788999999999999999999877 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc------
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN------ 406 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 406 (468)
+.... ........+|..|+|||++.+..++.++|||||||++|||++|+.||...+. ...|......
T Consensus 174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCP 246 (364)
T ss_pred cccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCH
Confidence 86532 1222345689999999999999999999999999999999999999975331 1111111000
Q ss_pred ---------------cccc----chhhhccccC----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 ---------------SSKE----GVVKILDQRL----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ---------------~~~~----~~~~~~d~~~----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ...+...... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0000000000 0001112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=316.68 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=193.9
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
..|...+.||+|+||.||+|.+. .++.||||... ...+.+|+.++++++|+||+++++++...+..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35778899999999999999985 47889999532 1336789999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
++. ++|.+++... ...++|.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 241 ~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 994 7898888643 236899999999999999999999877 99999999999999999999999999987643222
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---C---cCHHHHHHHhh---ccccc-
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE---G---LDIVQWTKMQT---NSSKE- 410 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~---~---~~~~~~~~~~~---~~~~~- 410 (468)
........||..|+|||++.+..++.++|||||||++|||++|..|+...... . ..+........ .....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223457999999999999999999999999999999999988765331110 0 11111111100 00000
Q ss_pred ----chhhhcc----ccCCCCC-------HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 ----GVVKILD----QRLSNTP-------LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ----~~~~~~d----~~~~~~~-------~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....... ....... ......+.+++.+|++.||.+|||+.|+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 0000000 011235778999999999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=298.47 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=186.6
Q ss_pred eEcccCCcceEEEEcCCCc---EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGAGVVYRGVTPNGE---QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.||+|+||.||+|...++. .+++|.+..... ....+.+.+|+..++.++|||++++++++......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999764433 455666543221 223467899999999999999999999999999999999999999
Q ss_pred ChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 266 SLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 266 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
+|.++++... ....++.....++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997532 234677778899999999999999877 99999999999999999999999999864321111112
Q ss_pred ccccccCccccCccccCC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 344 MSAVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.....++..|+|||+... ..++.++||||||+++|||++ |..||..... .+........ .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~---~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKD---QQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhh---ccccc
Confidence 234567889999998743 245789999999999999997 5778864321 1111111111 11122
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
.++.... .....+.+++..|| .+|++||+++||++.|.
T Consensus 230 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222221 23455667888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=308.10 Aligned_cols=253 Identities=27% Similarity=0.339 Sum_probs=211.4
Q ss_pred chhhhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCC-CchhHHHHHHHHHhCCC-CCCccceeEEEecCCe
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET 254 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 254 (468)
+.+.+.|+..+.||+|.||.||+++.+. |+.+|+|.+....... .....+.+|+.+|+++. |||||.+.+++++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3446678888999999999999999865 9999999997654432 23457899999999998 9999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CceEEeecc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFG 330 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg 330 (468)
.++|||++.||.|.+.+... .+++..+..++.||+.++.|||..+ |+||||||+|+|+... +.+|++|||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999998755 2899999999999999999999877 9999999999999653 479999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+..+...
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------------- 246 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------------- 246 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---------------
Confidence 9998763 4456788999999999999999999999999999999999999999987442211
Q ss_pred chhhhccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 411 GVVKILDQRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 411 ~~~~~~d~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..++..... ...-......+.+++..++..||.+|+|+.++++-
T Consensus 247 -~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 247 -FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111111 11223446677889999999999999999999983
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.40 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=196.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|...+.||+|+||+||+|.++ +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 356778899999999999999875 578899999864432 222245778999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9997 4888887533 345789999999999999999999877 9999999999999999999999999997643221
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHHHHHHhhcc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNS 407 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~ 407 (468)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||........ ....|.......
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12234467899999998764 4688999999999999999999999976331100 000111110000
Q ss_pred cccchhhhccccCC-----CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRLS-----NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~~-----~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ....-.+... .........+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 E---FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred h---hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 0000000000 000122345678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=300.10 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=199.9
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||.|++|.||+|.+. +++.||+|.+.... .......+.+|+.+++.++|+|++++.+++.+....++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4666788999999999999975 68899999885432 223345688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999998743 6899999999999999999999877 9999999999999999999999999998775321
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......++..|+|||+..+..++.++||||||+++|||+||+.||...+.. ...... ... ...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~--------~~~---~~~ 216 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLI--------PKN---NPP 216 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHh--------hhc---CCC
Confidence 1223456788999999999888999999999999999999999999653311 010000 000 001
Q ss_pred CCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLS-EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~-~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..... ....+.+++..|+..+|++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 4456788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=303.53 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=200.9
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||.|++|.||+|.+ .+++.|++|.+..... ...+.+.+|++.++.++|||++++++++...+..++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 45678889999999999999986 5789999998864322 22366889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... .+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999988632 4899999999999999999999877 9999999999999999999999999987654221
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
. ......++..|+|||...+..++.++|||||||++|+|++|+.||...+.. .......... ..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~~---------~~ 233 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNG---------TP 233 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcC---------Cc
Confidence 1 123346888999999999888999999999999999999999999653311 1100000000 00
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....+......+.+++.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01112233456778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.53 Aligned_cols=260 Identities=21% Similarity=0.297 Sum_probs=199.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 257 (468)
...|.+.+.||+|+||+||+|.+. .+..||+|.+............+..|+.++.+++|||||++++++.. ....++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 567888999999999999999985 46778899876543333344678899999999999999999998854 356889
Q ss_pred EEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCcEEEcCC----------
Q 012213 258 VYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCS----PLIIHRDVKSNNILLNSD---------- 321 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~dlk~~Nill~~~---------- 321 (468)
||||+++|+|.++|... ....+++..++.|+.||+.||+|||..+. .+|+||||||+|||++.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998642 22468999999999999999999997432 349999999999999642
Q ss_pred -------CceEEeeccccccccccCCCccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 012213 322 -------FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGE 392 (468)
Q Consensus 322 -------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 392 (468)
..+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~- 247 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN- 247 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence 34899999999865422 12234568999999998854 458899999999999999999999996422
Q ss_pred CCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 393 EGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
....+.... ... .+ + ........+.+++..||+.+|.+||++.|++. .+..+
T Consensus 248 ---~~~qli~~l-k~~-------p~--l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 ---NFSQLISEL-KRG-------PD--L--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred ---cHHHHHHHH-hcC-------CC--C--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 111111111 000 00 0 01123456788999999999999999999984 55544
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.88 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=202.1
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||+|+||+||++.+. +++.||+|.+..... ......+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46777889999999999999875 588899998754322 2234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|+++++|.+++... ..+++.....++.+++.||.|||+ .+ ++||||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999988643 358999999999999999999996 35 999999999999999999999999998754321
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC------cCHHHHHHHhhcccccchh
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG------LDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 413 (468)
......|+..|+|||++.+..++.++|||||||++||++||+.||....... ..+..+..
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 223 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----------- 223 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH-----------
Confidence 1224568999999999988889999999999999999999999997633211 01111111
Q ss_pred hhccccCCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 414 KILDQRLSNTP-LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 414 ~~~d~~~~~~~-~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
..........+ ......+.+++.+|++.||++|||+.|++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111111 12445688899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.80 Aligned_cols=239 Identities=20% Similarity=0.314 Sum_probs=184.1
Q ss_pred eEcccCCcceEEEEcCC-------------------------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCcc
Q 012213 189 VIGRGGAGVVYRGVTPN-------------------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 243 (468)
.||+|+||.||+|.... ...|++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999997421 1358888875322 12235678899999999999999
Q ss_pred ceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-
Q 012213 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF- 322 (468)
Q Consensus 244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~- 322 (468)
+++++|.+....++||||+++|+|..++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999998643 345889999999999999999999777 99999999999997643
Q ss_pred ------ceEEeeccccccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCC
Q 012213 323 ------EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELI-TGRRPVGDFGEEG 394 (468)
Q Consensus 323 ------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~ell-tg~~p~~~~~~~~ 394 (468)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999988643211 22346788999998865 56899999999999999995 6999987532211
Q ss_pred cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
...+. .... ..+......+.+++..||+.+|++||++.+|++.|.
T Consensus 230 --~~~~~---------------~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERFY---------------EKKH-RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHH---------------Hhcc-CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11110 0000 011112245788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.55 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=201.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|...+.||+|+||.||+|..+ +|..||+|.+..........+.+.+|+.+++.++|+|++++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 566789999999999999985 5788999988654333333467889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-eEEeeccccccccccCCC
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-AHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~~ 341 (468)
++++|.+++.......+++..+..++.+++.||+|||+.+ ++|+||||+||++++++. ++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-- 156 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc--
Confidence 9999999997655556899999999999999999999877 999999999999998864 6999999998764322
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..++...... ....
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-----------~~~~ 220 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ-----------GYFA 220 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc-----------ccCC
Confidence 11223458899999999988889999999999999999999999986422 2222222111 1111
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.........+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 122233456888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=303.49 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=198.6
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|+||.||++.+. ++..+|+|.+..... .....++.+|++++.+++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4677889999999999999875 577888888753321 22235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999643 458899999999999999999997 35 999999999999999999999999998765322
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc-----------
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK----------- 409 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 409 (468)
......++..|+|||...+..++.++||||||+++|||++|+.||...+.. ....+.........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCC
Confidence 123456889999999988888999999999999999999999998642211 11111100000000
Q ss_pred -----------cchhhhccccCCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 410 -----------EGVVKILDQRLSNTP-LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 410 -----------~~~~~~~d~~~~~~~-~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
+.............+ ......+.+++.+|++.+|++||++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000111 1134568899999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=299.68 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=201.7
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
++|+....||+|+||.||+|..+ +...|++|.+.... .....+.+..|++++++++|+|++++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 56778889999999999999864 24578898774322 222346789999999999999999999999998999
Q ss_pred EEEEeccCCCChhhhcccCCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 012213 256 LLVYEYMPNGSLGEVLHGKRG-------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 328 (468)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999975442 25899999999999999999999877 99999999999999999999999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
||++...... .........++..|+|||...+..++.++||||||+++|||++ |..||...... ....... ..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~---~~ 234 (275)
T cd05046 161 LSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQ---AG 234 (275)
T ss_pred cccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHH---cC
Confidence 9998754322 1122233456778999999988888999999999999999999 88898653211 1111111 00
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
. .. ...+......+.+++.+|++.+|++||++.|+++.|.+
T Consensus 235 ~---~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 K---LE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C---cC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 00 01112344578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=297.07 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=201.8
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCeeEEEEe
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLVYE 260 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 260 (468)
|+..+.||.|+||.||++.+ .+++.||+|.+..........+.+..|+.+++.++|+|++++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 55678899999999999987 467889999886543333344678899999999999999999998754 445789999
Q ss_pred ccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 261 YMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 261 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
|+++++|.+++... ....+++..++.++.+++.||.|||..+ +.+++|+||+|+||++++++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998643 2346899999999999999999999333 3349999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
.... ......++..|+|||...+..++.++||||||+++|+|++|+.||...+. ..+.. .+.
T Consensus 162 ~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~-----------~~~ 223 (265)
T cd08217 162 HDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLAS-----------KIK 223 (265)
T ss_pred CCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHHH-----------HHh
Confidence 3221 12345689999999999988899999999999999999999999975331 11111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.......+......+.+++..|++.+|++||++.||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111223334556778899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=295.25 Aligned_cols=253 Identities=27% Similarity=0.310 Sum_probs=201.7
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||+|+||.||+|.+. +++.+++|.+...... ..+.+..|+.++++++|||++++++++.+....+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 45777889999999999999874 5788999988643322 34678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999988643 245889999999999999999999877 9999999999999999999999999998664321
Q ss_pred CccccccccCccccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.......++..|+|||...+. .++.++||||||+++|||+||+.||........ .... .. ..+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~----~~-------~~~~ 222 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLI----SK-------SNFP 222 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH----Hh-------ccCC
Confidence 122345678899999998776 788999999999999999999999975331100 0000 00 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.............+.+++.+|+..+|.+|||+.+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111122345567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=296.14 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=202.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||.|+||+||+|... ++..+|+|++....... ....+.+|++.++.++|+|++++++.+...+..++++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 5677899999999999999964 67889999886433222 446789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 262 MPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
+++++|.+++..... ..+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999975433 46899999999999999999999877 99999999999999999999999999987653322
Q ss_pred Cc--cccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 341 SE--CMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 341 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.. ......|+..|+|||++... .++.++|+||||+++|||++|+.||....... ....... .. .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~----~~--------~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQ----ND--------P 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhc----CC--------C
Confidence 21 22334688999999998776 78899999999999999999999997533211 0111100 00 0
Q ss_pred ccCCCC--CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNT--PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~--~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... .......+.+++..|++.+|++||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011110 1234566789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.77 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=194.8
Q ss_pred cCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||+|.+.. +..+++|.+.... ....+.+..|+++++.++|||++++++++......++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 5667889999999999999864 6778888874322 223356888999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 85 ~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 85 AGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 999999887642 346899999999999999999999877 999999999999999999999999998765321 11
Q ss_pred cccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 343 CMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
......++..|+|||++. +..++.++|||||||++|||++|++||....... ..... .... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~----~~~~--------~ 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKI----AKSE--------P 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHH----hhcC--------C
Confidence 223456889999999874 3457789999999999999999999986532110 00000 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ...+......+.+++..||+.+|.+||++.++++
T Consensus 226 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 PT-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0112233456788999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=298.84 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=197.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|...+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.++|||++++++++...+..++|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 456778899999999999999874 688999998864322 22345788999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ..+++.+...++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 86 EFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 999999999998643 35899999999999999999999887 999999999999999999999999998765421
Q ss_pred CCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 340 ASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
........|+..|+|||++. ...++.++|||||||++|||++|..||........ . +... ... .
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~--~~~~--~~~-------~ 226 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-L--FLMT--KSN-------F 226 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-H--Hhhh--ccC-------C
Confidence 11223456899999999874 45688999999999999999999999865321110 0 0000 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..............+.+++.+|++.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000001112345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=316.48 Aligned_cols=203 Identities=26% Similarity=0.341 Sum_probs=172.6
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.|+..+.||+|+||.||++... +++.||+|++..... .......+..|+.++..++||+++++++++.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4667789999999999999875 588999999864322 22233567889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999998643 35889999999999999999999877 99999999999999999999999999875532110
Q ss_pred C---------------------------------ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 012213 341 S---------------------------------ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387 (468)
Q Consensus 341 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 387 (468)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0012346999999999999999999999999999999999999999
Q ss_pred CCC
Q 012213 388 GDF 390 (468)
Q Consensus 388 ~~~ 390 (468)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=300.83 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=194.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++|||++++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566788999999999999984 6889999998654333333356788999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+ ++|.+++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.++|+|||+++...... .
T Consensus 82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~ 154 (284)
T cd07839 82 D-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R 154 (284)
T ss_pred C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence 6 5888877643 345899999999999999999999877 9999999999999999999999999998654211 1
Q ss_pred cccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc------------CHHHHHHHhhcccc
Q 012213 343 CMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL------------DIVQWTKMQTNSSK 409 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~------------~~~~~~~~~~~~~~ 409 (468)
......++..|+|||++.+. .++.++|||||||++|||+||..|+........ ....|.........
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22344578899999987664 478999999999999999999988643221100 01111111100000
Q ss_pred cchhhhccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 EGVVKILDQRL--SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~~~~~~~d~~~--~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ....... ..........+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 0000000 0001123456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=313.12 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=194.9
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK----- 252 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 252 (468)
++.+.|...+.||+|+||+||+|.+ .+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4467888899999999999999987 4678999999864332222335677899999999999999999887533
Q ss_pred -CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 253 -ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 253 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
...+++++++ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 7899888753 34899999999999999999999877 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...+.. ..+..+.........+
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9865421 234568999999998876 56889999999999999999999999653210 0011111100000000
Q ss_pred --------chhhhccccCCCCCH--------HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 --------GVVKILDQRLSNTPL--------SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 --------~~~~~~d~~~~~~~~--------~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....... .+...+. .....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0100010 11234678999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=298.81 Aligned_cols=264 Identities=24% Similarity=0.306 Sum_probs=199.0
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|+||.||+|.++ +|+.||+|++..........+.+.+|+.+++.++|+|++++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4677789999999999999986 588999998865433333335678999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 82 CDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred cCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999888877532 35899999999999999999999877 99999999999999999999999999987653221
Q ss_pred ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc---------ccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS---------KEG 411 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~ 411 (468)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+.... ..+..+........ ...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcccccc
Confidence 2233457889999998765 45789999999999999999999999763321 11111111000000 000
Q ss_pred hhhhccccCC-CCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVKILDQRLS-NTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~~-~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+... ..+ ......+.+++.+|++.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 000 112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=301.11 Aligned_cols=240 Identities=19% Similarity=0.364 Sum_probs=186.8
Q ss_pred ceEcccCCcceEEEEcCC--------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999998642 2347888764322 222356888999999999999999999999989999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--------eEEeeccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--------AHVADFGL 331 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfgl 331 (468)
||+++|+|.++++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||+
T Consensus 79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999997443 35899999999999999999999877 999999999999988765 59999998
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGR-RPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
+..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...... ......
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~~~~~~----- 218 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----KKLQFY----- 218 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----HHHHHH-----
Confidence 865432 123457889999999876 45789999999999999999984 565432211 111100
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
... ...+......+.+++..|++.+|++|||++++++.|+
T Consensus 219 -------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 -------EDR-HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------Hcc-ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 1112223456789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=313.99 Aligned_cols=262 Identities=23% Similarity=0.229 Sum_probs=196.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
...|...+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 345788899999999999999753 3578999987432 235689999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
+||++. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..+..
T Consensus 164 v~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 164 VMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999995 78888883 3346899999999999999999999877 99999999999999999999999999987653
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--CHHHHHHHhhcc-------c
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--DIVQWTKMQTNS-------S 408 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-------~ 408 (468)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... .+..-....... .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3333333456799999999999998999999999999999999999999976432210 011000000000 0
Q ss_pred ccchhhh---ccccC-CCCC-------HHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 409 KEGVVKI---LDQRL-SNTP-------LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 409 ~~~~~~~---~d~~~-~~~~-------~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
...+.+. +.... .... ......+.+++.+|+..||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00000 0000 0123456788999999999999999999873
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=294.82 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=199.2
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC---CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG---SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
|+..+.||+|++|.||+|... +++.|++|.+...... ....+.+..|+.+++.++|+|++++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 556788999999999999986 7899999988643321 223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ..+++..+..++.+++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999998643 35889999999999999999999877 9999999999999999999999999988654322
Q ss_pred CCccccccccCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
......++..|+|||...... ++.++|+||||+++|+|++|+.||..... ......... ..
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~----------~~ 218 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGR----------SK 218 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHh----------cc
Confidence 234456889999999887766 89999999999999999999999975331 111100000 01
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....+......+.+++.+|++.+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122234566778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=301.11 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=199.9
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|+||.||++.+. ++..||+|.+.... .......+.+|+.++++++|+|++++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4667789999999999999985 78999999885321 222235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 262 MPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 262 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
+++++|.+++.... ...+++..+..++.+++.||.|||+. + ++||||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999886432 23689999999999999999999963 5 999999999999999999999999999765321
Q ss_pred CCccccccccCccccCccccCCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
......++..|+|||...+.. ++.++|+|||||++|||++|+.||...... .+.. ...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~--------~~~ 220 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFA--------QLS 220 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHH--------HHH
Confidence 123345788999999885543 578999999999999999999999652211 0000 112
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.+......+......+.+++.+|++.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 221 AIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 22222223334446677888999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=300.53 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC---CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG---SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
|+..+.||+|+||.||+|.+. +++.||||++...... ......+..|++++++++|+|++++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 556678999999999999975 6899999998754433 222345778999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+ +|+|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 999999997543 36899999999999999999999887 9999999999999999999999999998765322
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc------cch
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK------EGV 412 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 412 (468)
.......++..|+|||.+.+ ..++.++|||||||++|||++|.+||....... .+............ ...
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence 12233456788999998754 457899999999999999999988876532110 00000000000000 000
Q ss_pred hhhccccC-C-----CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 413 VKILDQRL-S-----NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 413 ~~~~d~~~-~-----~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
........ . .........+.+++.+|++.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 0 0112234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=296.11 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=192.0
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC---CchhHHHHHHHHHhCCCCCCccceeEEEec--CCeeE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNL 256 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 256 (468)
+|+..+.||+|+||.||+|.+. ++..||+|++....... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 4677899999999999999874 58899999876433221 223468889999999999999999998865 35678
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+++||+++++|.+++... ..+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++..+.
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999999998643 34789999999999999999999777 9999999999999999999999999997654
Q ss_pred ccCC-CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGA-SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||...... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~-~~~~~--------- 223 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAI-FKIAT--------- 223 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHH-HHHhc---------
Confidence 2111 11122345788999999999888999999999999999999999999753211 100 00000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......+......+..++ .||..+|++||+++||++
T Consensus 224 -~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 -QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000111222233344454 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.22 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=197.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+. ++..|++|.+... .......+..|+..++.++|+|++++++++..+...++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 356778889999999999999985 4788999987532 2223456888999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|..++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 9999999988875433 45899999999999999999999777 999999999999999999999999998754321
Q ss_pred CCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 340 ASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
........++..|+|||++. ...++.++|||||||++|||++|+.||...... ..........
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~------ 231 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSE------ 231 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHhcCC------
Confidence 11223445788999999874 345678999999999999999999998653211 0000000000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ...+......+.+++.+|++.+|++||++.|+++
T Consensus 232 --~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 --PPT-LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --Ccc-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 1112234456788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=299.04 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=197.5
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||.|++|.||+|.+. +|+.||||++............+..|++++++++|||++++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 667789999999999999874 6889999988654433333456889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+ ++|.+++.......+++..+..++.+++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 155 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R 155 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--c
Confidence 5 68999887665667899999999999999999999877 9999999999999999999999999987654221 1
Q ss_pred cccccccCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc------------
Q 012213 343 CMSAVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK------------ 409 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 409 (468)
......++..|+|||+..+.. ++.++||||||+++|||+||+.||...... ...............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 123345688999999876544 688999999999999999999999653211 111111110000000
Q ss_pred -cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 -EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 -~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....................+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000000112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.03 Aligned_cols=242 Identities=28% Similarity=0.466 Sum_probs=202.1
Q ss_pred ceEcccCCcceEEEEcCCC-cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 012213 188 NVIGRGGAGVVYRGVTPNG-EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 266 (468)
-++|+|.||+||.|++.+. ..+|||.+.. +.+...+-+..||.+-+.++|.|||+++|.+.+++..-+.||-+||||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 4799999999999999664 4689998753 333344668999999999999999999999999998889999999999
Q ss_pred hhhhcccCCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccccCCCccc
Q 012213 267 LGEVLHGKRGS-FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 267 L~~~l~~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|.++|..+=+. .-.+.+.-.+.+||++||.|||+.. |||||||-.|||++. .|.+||+|||-++.+. +-...+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 99999755443 2267788889999999999999887 999999999999965 8999999999999875 344456
Q ss_pred cccccCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc---
Q 012213 345 SAVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR--- 419 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--- 419 (468)
.+.-||..|||||++..+ .|..++|||||||++.||.||++||-+.++... .++.-.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------------------AMFkVGmyK 795 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------------------AMFKVGMYK 795 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------------------hhhhhccee
Confidence 778899999999999765 599999999999999999999999987543211 111111
Q ss_pred -CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 -LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 -~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
-...|.+...+...++++|..+||.+||++.++++
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 14566778888999999999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=293.93 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=209.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+-|.+.+.||+|+||.||||.++ +|+.+|+|++.- ....+++..|+.++.+++.|++|+++|.|......++||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 345677889999999999999984 689999998742 233467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|||-.||+.+.++. +..++.+.+...++.+.++||+|||... -+|||||+.|||++.+|.+||+|||.|..+.+..
T Consensus 108 EYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999999974 4467999999999999999999999776 7999999999999999999999999998775332
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
....++.||+.|||||++..-.|+.++||||+|++..||..|++||.+...- ....++-..
T Consensus 184 --AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------------RAIFMIPT~ 244 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------------RAIFMIPTK 244 (502)
T ss_pred --HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------------ceeEeccCC
Confidence 2235678999999999999999999999999999999999999999874321 111122222
Q ss_pred C---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 L---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. -..++....++.+++..|+-.+|++|-|+.++++
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2 2345677788999999999999999999998876
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=296.96 Aligned_cols=252 Identities=29% Similarity=0.401 Sum_probs=202.3
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.|+..+.||+|++|.||++.++ +++.||+|++..... .....++.+|++.+++++|||++++++++......++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4566788999999999999985 688999998865332 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
+++++|.+++.... ..+++....+++.+++.|++|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999997543 568899999999999999999997 66 99999999999999999999999999876542211
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
....++..|+|||+..+..++.++||||||+++|+|++|+.||...........+.... ......
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~ 221 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----------IVNEPP 221 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----------HhcCCC
Confidence 12667889999999998899999999999999999999999997643221222222211 111111
Q ss_pred CCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 SNTPLS-EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 ~~~~~~-~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+.. ....+.+++..|+..+|++|||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 112222 4566889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.26 Aligned_cols=202 Identities=25% Similarity=0.295 Sum_probs=170.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||+||++... +++.||+|.+..... .......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5677899999999999999974 588999999864221 12223558889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (331)
T cd05597 82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156 (331)
T ss_pred cCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence 99999999999642 345889999999999999999999877 9999999999999999999999999987654222
Q ss_pred CccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 341 SECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 112233468999999998863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=296.46 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=196.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCC--------chhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS--------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
|...+.||+|+||.||+|... +|+.||+|.+........ ..+.+..|+..++.++|||++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 456789999999999999864 688999998753221111 12357889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||+++++|.+++... ..+++..+..++.+|+.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 99999999999999998644 45889999999999999999999877 99999999999999999999999999986
Q ss_pred ccccCCCccccccccCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
..............++..|+|||...... ++.++||||||+++||+++|..||..... ...+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~----~ 229 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLGNKR----S 229 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhhccc----c
Confidence 54322222233456889999999887654 78999999999999999999999864221 11111100000 0
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+.. .........+.+++..|++.+|.+||++.||++
T Consensus 230 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000010 111223567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.68 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=201.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||.|+||.||+|.+. +++.||+|.+..... ......+..|+.+++.++|||++++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 44667788999999999999975 578999998753321 2233568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.. ..+++.+...++.+++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 9999999999863 34788999999999999999999777 9999999999999999999999999997664322
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||++.+..++.++||||||+++|||+||+.||....... .. ........
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~-----------~~~~~~~~ 218 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VL-----------FLIPKNNP 218 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hh-----------hhhhcCCC
Confidence 12233457889999999988889999999999999999999999997532111 00 00000111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..........+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22334566778899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.03 Aligned_cols=195 Identities=23% Similarity=0.393 Sum_probs=158.2
Q ss_pred cceEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCeeEEEEec
Q 012213 187 NNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLVYEY 261 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 261 (468)
+..||+|+||+||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 367999999999999864 35789999875332 12457889999999999999999998853 4567899999
Q ss_pred cCCCChhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCceEEeecc
Q 012213 262 MPNGSLGEVLHGK-------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFG 330 (468)
Q Consensus 262 ~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg 330 (468)
++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 5777776421 1235889999999999999999999877 9999999999999 556789999999
Q ss_pred ccccccccCCC-ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 331 LAKYLQDTGAS-ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 331 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
+++........ .......+|+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99876432211 12234568999999998876 4588999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.73 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=206.8
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 260 (468)
..|++.+.||+||.+.||++...+.+.||+|++............|..|++.|.+++ |.+|++|++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 346778899999999999999988899999988766666666678999999999995 9999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|= ..+|.++|.........| .+..+..|++.|+.++|++| |||.||||.|+|+-. |.+||+|||+|..+.....
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 86 579999998766665667 67788999999999999998 999999999999864 6899999999998886666
Q ss_pred CccccccccCccccCccccCCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTL-----------KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.-.....+||+.||+||.+... +++.++||||+||+||+|+.|++||.... -.|.+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~aK------- 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIAK------- 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHHH-------
Confidence 6666778999999999987532 36789999999999999999999997521 12333
Q ss_pred cchhhhccccC----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 EGVVKILDQRL----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~~~~~~~d~~~----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+..+.|+.- ...+. ..++++++..|++.||++||+..|+++
T Consensus 582 --l~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 --LHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 344444422 22221 223889999999999999999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=307.75 Aligned_cols=189 Identities=26% Similarity=0.352 Sum_probs=161.1
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.|+..+.||+|+||.||+|.+. +++.||+|.... .....|+.++++++||||+++++++......++|+||
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 5778899999999999999985 467889886321 2245689999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 139 ~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~ 210 (357)
T PHA03209 139 YS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---A 210 (357)
T ss_pred cC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc---C
Confidence 94 688888864 3346899999999999999999999877 99999999999999999999999999975321 1
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 387 (468)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999989999999999999999999955544
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=300.72 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=196.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|...+.||+|+||.||+|.++ +++.||+|.+..... ......+.+|+..++.++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 456788899999999999999875 578899998864332 222345778999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++ ++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 84 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 84 EYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred eccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 9997 6898888643 345889999999999999999999777 9999999999999999999999999997643211
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHHHHHHhhcc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNS 407 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~ 407 (468)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||++||...+.... ....|.......
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 12233457889999998765 4578899999999999999999999975321100 000111100000
Q ss_pred ccc--chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKE--GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~--~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... .........+..........+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00000000000001122345778999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=312.42 Aligned_cols=242 Identities=23% Similarity=0.206 Sum_probs=184.0
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC---CCCCccceeEEEecCCeeEEEEeccCC
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
||+|+||+||+|.+. +++.||||++..... .......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 588999999854221 112223345566666555 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~ 153 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT 153 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence 999998864 345899999999999999999999877 999999999999999999999999998754321 1223
Q ss_pred cccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
....||+.|+|||++.+. .++.++|||||||++|||+||+.||..... .+........ +..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~---------~~~~~-- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFG---------KVRFP-- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcC---------CCCCC--
Confidence 456789999999988654 488999999999999999999999965321 1111110000 00111
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCC----HHHHHH
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPT----MREVVQ 454 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt----~~ev~~ 454 (468)
.......+.+++.+|++.+|++||+ +.|+++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123455678999999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=300.48 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=198.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+..|++++++++|||++++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456788889999999999999974 68899999875322 223356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999998643 345899999999999999999999887 9999999999999999999999999987653221
Q ss_pred CCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 340 ASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||...+... .. .+
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~-----------~~ 219 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VL-----------LK 219 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HH-----------HH
Confidence 1223456889999999874 3457789999999999999999999997532110 00 00
Q ss_pred hccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 415 ILDQRL--SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 415 ~~d~~~--~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
+..... ...+......+.+++..|++.+|.+||++.++++-
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 220 ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111000 11122334567789999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=302.73 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=201.6
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|++|+||+|... +++.||+|.+....... .....+..|++.+..++|+||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4667789999999999999986 48999999986543221 233568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999997655567899999999999999999999877 99999999999999999999999999876532111
Q ss_pred C---------------------------ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 012213 341 S---------------------------ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393 (468)
Q Consensus 341 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 393 (468)
. .......|+..|+|||+..+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 0111235788999999999888999999999999999999999999753311
Q ss_pred CcCHHHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCC----HHHHHH
Q 012213 394 GLDIVQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPT----MREVVQ 454 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt----~~ev~~ 454 (468)
..+ .++.+... ..........+.+++.+|++.+|++||+ +.|++.
T Consensus 239 ----~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ----ETF------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ----HHH------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111 11111111 1111125677889999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.00 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=199.8
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||+|.+. +++.|++|.+............+..|+.+++.++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 566789999999999999874 6889999998654433334567899999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++... ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 82 SGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999999643 34789999999999999999999877 9999999999999999999999999998765322211
Q ss_pred c--ccccccCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 343 C--MSAVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 343 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. .....++..|+|||++.+.. .+.++||||||+++||+++|+.||...+... ......... ..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~~--------~~ 224 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGAG--------HK 224 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhcC--------CC
Confidence 1 12356788999999988766 8899999999999999999999997532110 000000000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+. ........+.+++..|++.+|.+||++.|++.
T Consensus 225 ~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011 11122556678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.36 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=200.1
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||+|+||.||+|.+ .+++.||+|.+..... ......+.+|+..+.+++|||++++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4566778999999999999987 4678999998753222 2233568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.. ..+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 9999999999863 24889999999999999999999877 9999999999999999999999999987654221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......++..|+|||...+..++.++|+||||+++|+|++|..||..... ..+..... ....
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~-----------~~~~ 218 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLIP-----------KNNP 218 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHHh-----------cCCC
Confidence 112334678899999999888899999999999999999999999865321 11111110 0111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..........+.+++.+|++.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11222345667789999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=301.24 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=198.5
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.|+..+.||+|+||.||+|.++ +++.||+|++..........+.+.+|+++++.++|||++++++++...+..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4667789999999999999985 588999998765433333345688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.++.... ..+++.++..++.||+.||+|||+.+ ++||||+|+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 82 VDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred CCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 9999998877533 34899999999999999999999877 9999999999999999999999999998764322
Q ss_pred ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc--ccccchhhhcc-
Q 012213 342 ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN--SSKEGVVKILD- 417 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~d- 417 (468)
.......++..|+|||+..+ ..++.++||||||+++|||++|++||..... ...+...... .-........+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHHhcc
Confidence 22234557889999998865 4577899999999999999999999864221 1111111100 00000000000
Q ss_pred -----ccC-CC---------CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 -----QRL-SN---------TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 -----~~~-~~---------~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... .. ........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00 01123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=308.93 Aligned_cols=255 Identities=20% Similarity=0.202 Sum_probs=192.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||+||++.+. +++.||+|.+..... .......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5677889999999999999975 578899998864221 12223457889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 y~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999743 235889999999999999999999877 99999999999999999999999999986643221
Q ss_pred CccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 341 SECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.. ..+........ .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~i~~~~~--~---- 226 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIMNHEE--R---- 226 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----HHHHHHHcCCC--c----
Confidence 12234568999999998865 46788999999999999999999999653210 11111110000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVE--RPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~--RPt~~ev~~ 454 (468)
..+..........+.+++.+|+..++.+ |++++++++
T Consensus 227 --~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 --FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred --ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0011111123456667788877765443 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.71 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=199.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++|||++++++++......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 566788999999999999974 6899999998755433333467899999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+++|.+++.... ..+++.++..++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 999999986433 56899999999999999999999877 99999999999999999999999999987653221 2
Q ss_pred cccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc----------ccc
Q 012213 343 CMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS----------KEG 411 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~ 411 (468)
......++..|+|||.+.+. .++.++||||+|+++|||+||.+||..... .....+........ ...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 23345688999999988654 468999999999999999999888864321 11111111000000 000
Q ss_pred hhhhccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVKILDQRL-----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~-----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+..... .....+....+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 0001123477889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=292.24 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=195.0
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC---CchhHHHHHHHHHhCCCCCCccceeEEEecC--Cee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 255 (468)
++|+..+.||+|+||.||+|.+. ++..||+|.+....... .....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 35677899999999999999874 58899999875332211 1234678899999999999999999988764 457
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
+++|||+++++|.+++... ..+++....+++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 7999999999999998643 34788899999999999999999877 999999999999999999999999999865
Q ss_pred cccCC-CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGA-SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
..... ........++..|+|||...+..++.++||||||+++|||++|+.||...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~----------- 221 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKI----------- 221 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHH-----------
Confidence 42111 11123345888999999998888999999999999999999999999653211 000000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.........+......+..++.+|+. +|++||+++||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00111122333455667788888885 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=296.74 Aligned_cols=253 Identities=29% Similarity=0.391 Sum_probs=195.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEe-----cCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCS-----NKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~~ 253 (468)
.++|+..+.||+|+||.||++.+. +++.+|+|.+.... .....+.+|+.+++.+ +|||++++++++. ..+
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 678889999999999999999874 57889999875322 2235688899999999 6999999999874 345
Q ss_pred eeEEEEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
..++||||+++++|.++++. .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCc
Confidence 67999999999999998753 23346889999999999999999999777 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
+..+.... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+....
T Consensus 171 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~~~~~-- 242 (286)
T cd06638 171 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RALFKIP-- 242 (286)
T ss_pred eeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHHhhcc--
Confidence 98664221 12234568999999998753 45788999999999999999999999753211 0110000
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
. ...... ..+......+.+++.+|++.+|++|||+.|+++.
T Consensus 243 ~-------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 R-------NPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-------cCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000 0111223467889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=304.89 Aligned_cols=256 Identities=22% Similarity=0.221 Sum_probs=192.2
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||+||++.++ .++.||+|.+..... .......+..|+.++..++|++|+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5677889999999999999975 467899998854221 12223457889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 82 y~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 99999999999742 235889999999999999999999877 9999999999999999999999999997654222
Q ss_pred CccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 341 SECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...+ ..+......... .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~-~----- 225 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHK-E----- 225 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCC-c-----
Confidence 22223457999999999875 3468899999999999999999999996532 111111111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhccc--CCCCCCCHHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQE--HGVERPTMREVVQM 455 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~--~P~~RPt~~ev~~~ 455 (468)
..............+.+++.+|+.. ++..||+++|+++.
T Consensus 226 -~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 -RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0001111122344566677776644 44447899988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.68 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=197.5
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||.|++|.||+|.+. +|..||+|++............+.+|++.++.++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 355678999999999999874 7899999998654433333356888999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 5 79999987655456899999999999999999999877 9999999999999999999999999997653221 1
Q ss_pred cccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc----------ccc
Q 012213 343 CMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS----------KEG 411 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~ 411 (468)
......++..|+|||++.+. .++.++||||||+++|||++|+.||...+.. ..+........... .+.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 12233568899999987654 5789999999999999999999999753211 01111111000000 000
Q ss_pred ---hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 ---VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ---~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...................+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000001111123356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.20 Aligned_cols=252 Identities=29% Similarity=0.405 Sum_probs=204.7
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|++|.||+|.+. +++.|+||++...... .....+..|+..+.+++|+|++++++++......++|+||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 4667789999999999999986 4899999988644322 3346799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
+++++|.+++... ..+++..++.++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999643 458999999999999999999997 66 99999999999999999999999999987643222
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
. .....++..|+|||...+..++.++|+||||+++|||+||+.||...... ...+- ...+.....
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~-----------~~~~~~~~~ 220 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFEL-----------MQAICDGPP 220 (264)
T ss_pred c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHH-----------HHHHhcCCC
Confidence 1 12445788999999999888999999999999999999999999764320 11111 111111111
Q ss_pred CCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 421 SNTPLS-EAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 421 ~~~~~~-~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
...+.. ....+.+++..|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222223 56788899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=283.97 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=200.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|.|+.||+..+ +.|+.+|+|.+..........+++.+|+.+-+.++||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 56778889999999999999876 57889999877544444445577999999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEeecccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAKYLQ 336 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~ 336 (468)
|+|.|++|..-+-.+ ...++..+-..+.||+.||.|+|..+ |||||+||+|+++.+. ..+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999996544222 34677788889999999999999877 9999999999999653 459999999999876
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
....+...+|||+|||||+....+|+..+|||+.||+||-++.|++||.+.+.+ .+++ .+.
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye--------------~I~ 225 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYE--------------QIK 225 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHH--------------HHh
Confidence 445567789999999999999999999999999999999999999999763311 1221 111
Q ss_pred cccC--CC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRL--SN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~--~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... .. .=........+++.+|+..||++|.|+.|.+.
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111 00 11122345667999999999999999998764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=297.74 Aligned_cols=264 Identities=24% Similarity=0.297 Sum_probs=199.9
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+|+..+.||+|+||.||+|.++ +++.||||++..........+.+.+|+++++.++|+|++++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 4677889999999999999985 578999998865433333446789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
++++.+..+... ...+++..+..++.+|+.|++|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 998777666543 234899999999999999999999877 99999999999999999999999999987653322
Q ss_pred ccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc----------
Q 012213 342 ECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE---------- 410 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 410 (468)
.......++..|+|||+..+. .++.++||||||+++|||++|+.||...... +..............
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCc
Confidence 122345678899999999887 8899999999999999999999999753211 000000000000000
Q ss_pred ch--hhhccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GV--VKILDQRL-----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~--~~~~d~~~-----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ....+... ...+......+.+++..|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 0011123577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=308.95 Aligned_cols=250 Identities=30% Similarity=0.376 Sum_probs=202.0
Q ss_pred chhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCC-chhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS-HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
+|..+.|...+.||+|+||.||-|.+ .+.+.||||++....+.+. .-..+..|+..|.+++|||++.+.|+|-...+.
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 34456677778899999999999998 5678899999976554332 225688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
||||||| -||-.|++.- ...++.+..+..|..+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|.+.
T Consensus 102 WLVMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc
Confidence 9999999 5788887752 2346888999999999999999999766 999999999999999999999999999876
Q ss_pred cccCCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
.+. ..++|||+|||||++. .+.|+-++||||+|++..|+.-.++|+..++.-. .+
T Consensus 177 ~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----------------AL 234 (948)
T KOG0577|consen 177 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------AL 234 (948)
T ss_pred Cch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----------------HH
Confidence 532 4578999999999864 5679999999999999999999999986543110 01
Q ss_pred hhhccccCCC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VKILDQRLSN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~~~d~~~~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.-+....-.. ...+....+..++..|++.-|.+|||.+++++
T Consensus 235 YHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 235 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111111111 12356677889999999999999999999876
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=300.27 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=200.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.+.....||+|+||.||++... ++..||||++.... ....+.+.+|+..++.++|+|++++++.+...+..++||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 344555677999999999999874 68899999875322 223356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... .+++.+...++.+|+.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 99 EFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred eCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999999999988532 4789999999999999999999877 9999999999999999999999999987654221
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......++..|+|||+..+..++.++||||||+++|||++|+.||...... ... . .+...+...
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~---~--------~~~~~~~~~ 237 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAM---R--------RIRDNLPPR 237 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---H--------HHHhcCCCc
Confidence 1223456889999999998888999999999999999999999999652210 000 0 001111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHhccCC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQAQKP 462 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~--L~~~~~~ 462 (468)
.. ........+..++..|+..+|++|||++|+++. ++....+
T Consensus 238 ~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 238 VK-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred cc-cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 11 111234467788999999999999999999974 4444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.51 Aligned_cols=261 Identities=17% Similarity=0.230 Sum_probs=189.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC------CCccceeEEEecC-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH------RNIVRLKAFCSNK- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~- 252 (468)
..+|+..+.||+|+||+||+|.+. .++.||||++..... ....+..|+.++..++| .+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 467888899999999999999874 578899999854321 12345567777666654 4588888888764
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCC---------
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDF--------- 322 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~--------- 322 (468)
...++|||++ +++|.+++... ..+++..+..++.||+.||+|||. .+ |+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 4678999988 78898888643 358999999999999999999997 36 99999999999998765
Q ss_pred -------ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC-
Q 012213 323 -------EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG- 394 (468)
Q Consensus 323 -------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~- 394 (468)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 49999999876432 12245678999999999999999999999999999999999999997633210
Q ss_pred cC---------HHHHHHHhhcccccchhhhcccc------C------------CCCCHHHHHHHHHHHHhhcccCCCCCC
Q 012213 395 LD---------IVQWTKMQTNSSKEGVVKILDQR------L------------SNTPLSEAMQVFFVAMLCVQEHGVERP 447 (468)
Q Consensus 395 ~~---------~~~~~~~~~~~~~~~~~~~~d~~------~------------~~~~~~~~~~~~~l~~~c~~~~P~~RP 447 (468)
.. ...|....... ...++++.. . ..........+.+++..|++.||++||
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTE---EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccch---hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 00 01111110000 000011000 0 000011234577999999999999999
Q ss_pred CHHHHHH--HHHh
Q 012213 448 TMREVVQ--MLAQ 458 (468)
Q Consensus 448 t~~ev~~--~L~~ 458 (468)
|++|+++ .+.+
T Consensus 431 ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 431 NARQMTTHPYVLK 443 (467)
T ss_pred CHHHHhcCccccc
Confidence 9999987 4444
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.46 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=191.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHH-HhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRT-LGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||.||+|.+. +|+.||+|++...... ....++..|+.. ++..+|||++++++++......+++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4667789999999999999985 6899999988643222 222445556665 566789999999999999999999999
Q ss_pred ccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 261 YMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 261 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|++ |+|.+++... ....+++..++.++.||+.||+|||+. + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 7888877542 234689999999999999999999975 5 99999999999999999999999999986542
Q ss_pred cCCCccccccccCccccCccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYT----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
. .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ... +.
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~------------~~ 218 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQ------------LK 218 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHH------------HH
Confidence 1 11223457889999998764 45688999999999999999999999653211 111 11
Q ss_pred hhccccCCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTP-LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~-~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..........+ ......+.+++..|+..+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111 123456788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=295.57 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=195.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|++|.||+|..+ +++.||+|.+...... .....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 456778899999999999999985 6889999998643322 22244678999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++ ++|.+++.... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9997 59999886433 36889999999999999999999877 9999999999999999999999999987543211
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHH------------HHHHHhhc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIV------------QWTKMQTN 406 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~------------~~~~~~~~ 406 (468)
.......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.........+. .|......
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11122346789999998865 4588999999999999999999999965321000000 01000000
Q ss_pred ccccch-hhhc-cccCCCC--CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 SSKEGV-VKIL-DQRLSNT--PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~-~~~~-d~~~~~~--~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... .... ...+... .......+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000 0000000 0111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.09 Aligned_cols=252 Identities=28% Similarity=0.351 Sum_probs=197.9
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+..+.|+..+.||+|+||+||+|... +++.||+|++...... ......+.+|+++++.++|||++++.+++...+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 344567888899999999999999874 6889999988543322 22235688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++|+||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999996 67777765332 35899999999999999999999877 999999999999999999999999998765
Q ss_pred cccCCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
... ....++..|+|||++. ...++.++||||||+++|||+||+.||...+.. .........
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~----- 229 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQN----- 229 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcC-----
Confidence 321 2345788999999874 456889999999999999999999998653211 100000000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.............+.+++..||+.+|++||++.+|+..
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 -----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011122345678899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=292.63 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=196.2
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC---CCCccceeEEEecCCeeEEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 259 (468)
|+..+.||+|+||.||+|.+ .+++.||+|.+.... .....+.+.+|+.++++++ |||++++++++......++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 55668899999999999997 568899999875432 2233456888999998886 999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... .+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998643 5899999999999999999999887 9999999999999999999999999998765322
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.......|+..|+|||...+ ..++.++||||||+++|+|++|+.||...... .+... .......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~--------~~~~~~~ 220 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML--------IPKSKPP 220 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc--------cccCCCC
Confidence 22234568899999998765 45789999999999999999999999753211 11100 0000001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.. ......+.+++..|++.+|++||++.|+++
T Consensus 221 ~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 114456788999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=290.56 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=198.8
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEEEE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVY 259 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 259 (468)
.|+..+.||.|++|.||++.+. +++.+|+|.+..... .....++.+|+++++.++||||+++++++.+. ...++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4666789999999999999984 578899998864322 23346789999999999999999999988653 3679999
Q ss_pred eccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||+++++|.+++.. .....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 23345889999999999999999999877 99999999999999999999999999875432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.. .....++..|+|||...+..++.++||||||+++|||++|+.||...........+.......... ..+ .
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN---PEL-K 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---hhh-c
Confidence 11 123457889999999998899999999999999999999999997642211111222211111110 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..........+.+++.+|++.+|++|||+.|+++
T Consensus 230 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 0101123567889999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.41 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=196.5
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.|+....||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+..+..++|||++++++++...+..++++||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3444567999999999999874 688999999854322 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..+....
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-- 171 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-- 171 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--
Confidence 999999998753 34889999999999999999999877 9999999999999999999999999987654221
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...... ....... .. . .. ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~--~-----~~-~~ 237 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLR----DS--P-----PP-KL 237 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh----cc--C-----CC-Cc
Confidence 1223456889999999999888999999999999999999999999653211 1111000 00 0 00 00
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.........+.+++..|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011123345778999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=294.53 Aligned_cols=252 Identities=28% Similarity=0.362 Sum_probs=195.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC-----C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK-----E 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~ 253 (468)
.++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 67788889999999999999988 468899999875321 2235678899999988 799999999998654 3
Q ss_pred eeEEEEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
..++|+||+++++|.++++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 579999999999999988632 3346899999999999999999999877 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
+........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..+..+. .
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~----~ 247 (291)
T cd06639 175 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP----R 247 (291)
T ss_pred chhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh----c
Confidence 986542211 12334678999999987543 3688999999999999999999999753211 0011110 0
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ... ...+......+.+++.+|++.+|++||++.|+++
T Consensus 248 ~~---~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NP---PPT------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CC---CCC------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 000 0112233456889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.71 Aligned_cols=244 Identities=25% Similarity=0.294 Sum_probs=197.6
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||.||++.+. +++.||+|.+..... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 4667789999999999999875 589999998864322 12234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999998644 45899999999999999999999877 999999999999999999999999999876422
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.....+++.|+|||...+...+.++||||||+++|+|++|+.||..... ...+ .......
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~------------~~~~~~~- 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIY------------EKILEGK- 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHH------------HHHhcCC-
Confidence 2345688999999999888889999999999999999999999965331 0001 1111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVV 453 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~ 453 (468)
...+......+.+++.+|+..+|.+|| +++|++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 111222356778899999999999998 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=290.35 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=200.1
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
|+..+.||+|++|.||+|.. .+++.||+|.+....... ...+.+..|++.+++++|+|++++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 56778999999999999986 568999999886433211 1235788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQD 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~ 337 (468)
+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+..+..
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 82 VEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999998643 35889999999999999999999887 99999999999998876 599999999987653
Q ss_pred cCC--CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGA--SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... ........++..|+|||...+..++.++||||+|+++|+|++|..||...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------- 225 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIAS--------- 225 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhc---------
Confidence 211 11122346788999999998888999999999999999999999999643211 11111100000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......+......+.+++..|+..+|++||++.|+++
T Consensus 226 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 -ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00112233445677888999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.04 Aligned_cols=250 Identities=30% Similarity=0.412 Sum_probs=197.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC-----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE----- 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 253 (468)
.++|+..+.||+|++|.||+|.++ +++.+++|.+..... ..+.+..|+.+++++ .|+|++++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 567888999999999999999985 578899998754322 236789999999999 6999999999997644
Q ss_pred -eeEEEEeccCCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999986433 456899999999999999999999777 9999999999999999999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhh
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
++....... .......++..|+|||++.. ..++.++||||||+++|||++|+.||...... ....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---- 228 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RALF---- 228 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HHHH----
Confidence 987654221 22234568899999998753 34678999999999999999999999653211 0000
Q ss_pred cccccchhhhccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 406 NSSKEGVVKILDQRL--SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~--~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
++..... ...+......+.+++.+|+..||++|||+.|+++
T Consensus 229 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 --------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --------HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0111001 1112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=287.79 Aligned_cols=251 Identities=30% Similarity=0.427 Sum_probs=204.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEEEEe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYE 260 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 260 (468)
|...+.||+|++|.||+|... +++.|++|++..........+.+.+|+..+++++|+|++++++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 556789999999999999986 688999999865543334457789999999999999999999999888 88999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.... .+++..+..++.+++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 82 YVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred ecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999987543 6899999999999999999999877 99999999999999999999999999987653322
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc-cc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD-QR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~ 419 (468)
........++..|+|||...+...+.++||||||+++++|++|..||...... ..-. ..... ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-----------~~~~~~~~ 221 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----MAAL-----------YKIGSSGE 221 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHH-----------HhccccCC
Confidence 11234456889999999998888999999999999999999999999764310 0000 00010 11
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....+......+.+++.+|++.+|.+||++.|+++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 12223344677889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=294.03 Aligned_cols=253 Identities=27% Similarity=0.367 Sum_probs=203.2
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+..+.|+..+.||+|++|.||+|.+. ++..|++|++..... ....+.+|++.++.++|+|++++++++......++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34667888899999999999999986 688999999864332 34678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
++||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999997543 36899999999999999999999877 99999999999999999999999999876542
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
... ......++..|+|||...+..++.++||||||+++|+|++|+.||...... .......... ..
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~~~~~---~~---- 234 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLITTKG---IP---- 234 (286)
T ss_pred chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcC---CC----
Confidence 211 123345788999999998888999999999999999999999998653211 0000000000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...........+.+++..|++.+|.+||++.++++
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 --PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01111123456788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=293.91 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=195.9
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec------C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN------K 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~ 252 (468)
...|+..+.||+|+||.||+|.+ .+++.+|+|.+.... .....+..|+.++.++ +|+|++++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 56778889999999999999998 457889999874321 2235678899999888 69999999999853 4
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
...+++|||+++|+|.+++.......+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 56799999999999999997655566889999999999999999999877 999999999999999999999999998
Q ss_pred ccccccCCCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
....... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||........
T Consensus 169 ~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------------ 234 (282)
T cd06636 169 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------------ 234 (282)
T ss_pred hhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------------
Confidence 7653211 1223456889999999875 34678899999999999999999999965321100
Q ss_pred cccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......... ..........+.+++..||+.+|.+||++.|+++
T Consensus 235 ----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 ----LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000000 1111234567889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=297.77 Aligned_cols=257 Identities=21% Similarity=0.216 Sum_probs=199.0
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+|+..+.||+|+||.||++.+. .++.|++|.+...... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4667789999999999999975 5788999988644321 1223567889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC-
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG- 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 339 (468)
|+++++|.+++... ..+++..+..++.+++.|+.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999643 35899999999999999999999877 9999999999999999999999999986421000
Q ss_pred ------------CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 340 ------------ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 340 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........++..|+|||++....++.++|+||||+++|||++|..||.+... .++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc
Confidence 00011224578899999999888899999999999999999999999965321 1111111100
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
. . ............+.+++.+|++.+|++||++.++.+.|+.
T Consensus 232 ~------~---~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 D------I---EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c------c---CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 0 0011111344567899999999999999998777777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.57 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=200.9
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|+..+.||+|+||.||+|.+. +++.||+|.+....... ...+.+.+|++.+++++|||++++++++......++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 567789999999999999985 58999999886433222 3346789999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++++|.+++... ..+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 9999999999644 46889999999999999999999877 9999999999999999999999999998664321
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......|+..|+|||...+..++.++|+||||+++|+|++|+.||...... ...+... .......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~-----------~~~~~~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRA-----------KQETADV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHH-----------Hhccccc
Confidence 223456788999999998888999999999999999999999999764322 1111111 1110111
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCH--HHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTM--REVV 453 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~--~ev~ 453 (468)
..+......+.+++.+|++.+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2223345778899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=288.16 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=204.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||++.+. ++..|++|++............+..|++.++.++|+|++++.+.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 566788999999999999985 5889999998755444344567889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 263 PNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 263 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
++++|.+++.... ...+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999997543 457899999999999999999999877 9999999999999999999999999998765322
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...+ ..+.... ......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~-----------~~~~~~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALK-----------ILKGQY 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHH-----------HhcCCC
Confidence 12234568889999999988889999999999999999999999986532 1111111 111112
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+......+.+++..|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2222244567788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=301.77 Aligned_cols=274 Identities=24% Similarity=0.330 Sum_probs=200.9
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC--Ce
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK--ET 254 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~ 254 (468)
.+.++|+..+.||+|+||.||+|.+. +++.+|||++............+..|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34677888999999999999999985 578999998865333333335577899999999 999999999998653 35
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||++ ++|.+++... .++|..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 799999997 6999888643 5889999999999999999999877 99999999999999999999999999987
Q ss_pred ccccCCC---ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHH
Q 012213 335 LQDTGAS---ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQ 399 (468)
Q Consensus 335 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~ 399 (468)
+...... .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6533221 22334568899999998754 4578899999999999999999999965321100 0000
Q ss_pred HHHHhhcccccchhhhccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHhc
Q 012213 400 WTKMQTNSSKEGVVKILDQRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQA 459 (468)
Q Consensus 400 ~~~~~~~~~~~~~~~~~d~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~--L~~~ 459 (468)
|.........+......+... ..........+.+++.+|++.+|++|||+.++++. +.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000000000000000000 00111135668899999999999999999999974 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=294.89 Aligned_cols=262 Identities=21% Similarity=0.228 Sum_probs=193.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCe-----e
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET-----N 255 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~ 255 (468)
+|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++ |||++++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4677889999999999999975 6889999987654433333356888999999995 6999999999877665 7
Q ss_pred EEEEeccCCCChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGL 331 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl 331 (468)
++||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 8988876432 246899999999999999999999877 999999999999999 88999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc---c
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN---S 407 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~ 407 (468)
++.+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||..... .......... .
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~ 231 (295)
T cd07837 158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLGTP 231 (295)
T ss_pred ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 986532211 1123356788999998764 4578999999999999999999999965321 1111110000 0
Q ss_pred cccchhhh---cc---------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKI---LD---------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~---~d---------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........ .+ ..+..........+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 00 0000001123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=293.84 Aligned_cols=267 Identities=23% Similarity=0.281 Sum_probs=198.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 257 (468)
.+.|+..+.||+|+||.||+|.++ +++.+|+|.++...........+.+|+.++.+++|||++++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 456788899999999999999985 588999999875444333334577899999999999999999998877 78999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||++ ++|.+++.... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999997 59998886433 36899999999999999999999887 99999999999999999999999999987653
Q ss_pred cCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHHHHHHhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQT 405 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~ 405 (468)
.. .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||........ ....|.....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 21 112334578899999988654 468999999999999999999999975331100 0001111100
Q ss_pred cccc--cchhhhccccCC-CCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 406 NSSK--EGVVKILDQRLS-NTPLS-EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 406 ~~~~--~~~~~~~d~~~~-~~~~~-~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ..........+. ..+.. ....+.+++..|++.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000000110 11111 2556778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=292.91 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=199.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
...|+..+.||+|+||.||++... ++..||+|.+..... ...+.+..|+.+++.++|||++++++++...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 467788899999999999999864 678899998753222 22356889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... .+++..+..++.+++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999998643 3789999999999999999999877 9999999999999999999999999987654222
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
. ......+++.|+|||......++.++||||||+++||+++|+.||........ +..+ . ....
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~----~----------~~~~ 232 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI----A----------TNGT 232 (293)
T ss_pred c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh----h----------cCCC
Confidence 1 22334688899999999888899999999999999999999999975321110 0000 0 0000
Q ss_pred C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 420 L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 420 ~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
. ..........+.+++..||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11122234567789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=293.94 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=195.3
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
++|+..+.||+|++|+||+|.+. +|+.||+|++............+.+|++++++++|||++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 45777889999999999999975 68899999886543333333568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccccC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~ 339 (468)
|++ ++|.+++.......+++.....++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 58888876544445688889999999999999999877 999999999999985 567999999999765321
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc--c----cccc-
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN--S----SKEG- 411 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--~----~~~~- 411 (468)
........+++.|+|||++.+ ..++.++||||||+++|+|+||+.||......+ ........ . .+..
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID----ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChhhcccc
Confidence 111233457889999998765 457899999999999999999999997532110 11100000 0 0000
Q ss_pred --hhhh-------ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 --VVKI-------LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 --~~~~-------~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ...............+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000011123455788999999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=291.50 Aligned_cols=246 Identities=25% Similarity=0.262 Sum_probs=194.0
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||+|+||+||++.+. +|+.||+|.+..... .......+..|+++++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 688999998864322 122234567899999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++.......+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99997655456899999999999999999999877 99999999999999999999999999976542 1122344
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 427 (468)
.++..|+|||...+..++.++||||||+++|+|++|+.||........ .. .+.+.........+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~------------~~~~~~~~~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KE------------ELKRRTLEMAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HH------------HHHhccccccccCCccC
Confidence 578899999999888899999999999999999999999975332110 00 01111111111222234
Q ss_pred HHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 428 AMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 428 ~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
...+.+++..|++.+|++|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56778899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=292.02 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=201.1
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
..+...+.||+|++|.||++.. .+++.+++|++..... ...+.+.+|+.+++.++|||++++++++...+..++++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3455567999999999999986 4688999998753222 223568899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.. ..+++..+..++.+++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~- 169 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV- 169 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-
Confidence 9999999999865 34889999999999999999999877 9999999999999999999999999887554221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......|+..|+|||...+..++.++||||||+++|||++|+.||..... ..+........ .. .
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~--------~~-~ 234 (285)
T cd06648 170 -PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNL--------PP-K 234 (285)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcC--------CC-C
Confidence 112335588999999999888899999999999999999999999864221 11111100000 00 0
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccC
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQK 461 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~ 461 (468)
..........+.+++.+|++.+|++||++.++++ .+++...
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 1111124467889999999999999999999996 4444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.10 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=194.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+..++.++|+||+++.+++...+..++|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356778899999999999999874 688999999864332 222245778999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+. +++.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 77777765332 34778889999999999999999877 9999999999999999999999999997543221
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHH-HHHHhhc---------cc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQ-WTKMQTN---------SS 408 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~---------~~ 408 (468)
.......++..|+|||...+ ..++.++||||||+++|||++|+.||.........+.. |...... ..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11233456889999998865 45788999999999999999999999753321110000 1000000 00
Q ss_pred ccchhhhccccCCC------CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSN------TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~------~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.............. ........+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 00112356778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=294.65 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=194.4
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---- 254 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 254 (468)
..+.|+..+.||+|+||.||+|... +++.||||++............+.+|+.++++++|||++++++++.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3567888999999999999999974 68899999886443333333456789999999999999999999876543
Q ss_pred ----eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 255 ----NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 255 ----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
.++||||+. ++|.+++... ...+++.+...++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 499999996 5888877643 335899999999999999999999877 9999999999999999999999999
Q ss_pred ccccccccCCC--ccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 331 LAKYLQDTGAS--ECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 331 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
++..+...... .......++..|+|||...+. .++.++||||||+++|||+||+.||...... ............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 99866432211 112334578899999987654 4788999999999999999999998653211 000000000000
Q ss_pred -ccc------------------chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 -SKE------------------GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 -~~~------------------~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+ .........+. .......+.+++.+|+..+|++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcc--cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00000000000 0011345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.48 Aligned_cols=252 Identities=27% Similarity=0.344 Sum_probs=197.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. ++..||+|++...... ......+..|++.+++++|||++++++++.++...++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 345777889999999999999974 6889999988643222 22235688899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||++ |++.+.+... ...+++.++..++.+++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 104 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred EeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99996 5787777532 345899999999999999999999877 99999999999999999999999999875432
Q ss_pred CCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.....++..|+|||++. ...++.++||||||+++|||++|+.||...... ..+ ..+
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~------------~~~ 236 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SAL------------YHI 236 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHH------------HHH
Confidence 12345788999999873 456889999999999999999999998653211 001 111
Q ss_pred ccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 416 LDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 416 ~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
..... ..........+.+++.+|++.+|.+||++.||++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 11111 111223445678899999999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=287.39 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=202.4
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|+||.||++... +++.+++|++............+..|+++++.++|+||+++.+++......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 566789999999999999864 6789999998654433333456788999999999999999999999999999999999
Q ss_pred CCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 263 PNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 263 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
++++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999998642 2346899999999999999999999777 999999999999999999999999999876532
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
......++..|+|||...+..++.++|+||||+++|||++|+.||...+.. .... .......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~-----------~~~~~~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRY-----------KVQRGKY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH-----------HHhcCCC
Confidence 222345788999999999888999999999999999999999999753311 1000 1111112
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+......+.+++..|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2233455677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=295.30 Aligned_cols=253 Identities=27% Similarity=0.365 Sum_probs=193.6
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 259 (468)
+++...+.||+|+||.||++.+. +++.||+|++...... .....+..|+..+.++. |+||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 34556688999999999999874 5789999988643322 33456889999999996 999999999999999999999
Q ss_pred eccCCCChhhh---cccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 260 EYMPNGSLGEV---LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 260 e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
||++ +++.++ +.......+++.....++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++..+
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9986 455443 3323335689999999999999999999974 5 999999999999999999999999999765
Q ss_pred cccCCCccccccccCccccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
..... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...-.......
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~----- 226 (288)
T cd06616 159 VDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKG----- 226 (288)
T ss_pred ccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCC-----
Confidence 42211 1234578899999998765 688999999999999999999999965321 11100000000
Q ss_pred hhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.+ ..........+.+++.+|++.+|++|||+.||++
T Consensus 227 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 ---DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ---CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 1111235567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=304.35 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=194.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEE--ecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe--eEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET--NLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~--~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv 258 (468)
.+...+||+|+|-+||||.+. +|-.||--. +......+...++|..|+.+|+.|+||||++++.+|.+... .-+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345678999999999999984 466676322 33333444445789999999999999999999999977655 6799
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeeccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQD 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~ 337 (468)
+|.+..|+|..|+...+ .++......|+.||++||.|||.+ .+||+|||||..||+++.+ |.|||+|.|+|..+..
T Consensus 122 TEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999996544 478889999999999999999987 5789999999999999875 8999999999998753
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc-ccchhhhc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS-KEGVVKIL 416 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 416 (468)
.. ...+.|||.|||||+.. ..|++.+||||||++++||+|+.+||.+. ....+.-+.+.... +..+.++-
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----TNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh----CCHHHHHHHHHcCCCHHHhhccC
Confidence 22 23478999999999877 68999999999999999999999999752 22222222211111 11112211
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..++.+++.+|+.. .++|||+.|++.
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 34567799999999 899999999986
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.51 Aligned_cols=248 Identities=31% Similarity=0.437 Sum_probs=200.2
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|++|.||++.+. ++..+++|++..... .....+.+|++.++.++|+|++++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 556688999999999999985 688999999865433 23467899999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++.... ..+++..+..++.+++.|+.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999987542 45899999999999999999999877 99999999999999999999999999987653221
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
.....++..|+|||...+..++.++||||||+++|+|++|+.||...+.. ......... .... ..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~---~~~~------~~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIATN---GPPG------LR 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhc---CCCC------cC
Confidence 33456889999999998888999999999999999999999998753211 111000000 0000 01
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........+.+++..|++.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112466888999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=300.02 Aligned_cols=273 Identities=22% Similarity=0.311 Sum_probs=198.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----e
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----T 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 254 (468)
.++|+..+.||+|+||.||+|.+ .+|+.||+|++..... ......+..|+.++++++|+|++++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46788899999999999999987 4689999999864322 223356788999999999999999999875443 4
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++++||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 789999996 588877753 34899999999999999999999877 99999999999999999999999999986
Q ss_pred ccccCCC-ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 335 LQDTGAS-ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+... ....+.........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHH
Confidence 5422211 11233568899999998654 568899999999999999999999996532100 00000000000000011
Q ss_pred hhhcccc-------C---CCC-----CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHhccCC
Q 012213 413 VKILDQR-------L---SNT-----PLSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQAQKP 462 (468)
Q Consensus 413 ~~~~d~~-------~---~~~-----~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~--L~~~~~~ 462 (468)
..+.+.. . ... .......+.+++.+|++.+|++|||+.|+++. ++.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 1111100 0 000 01224568899999999999999999999985 6555433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=292.30 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=210.4
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.-|...+-||+|.|+.|-+|++ -.|++||||++.+..-.......+..|++.|+.++|||||++|.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4466678899999999999886 479999999997665555445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccccC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~ 339 (468)
.=.+|+|.+|+-.. ...+.+....+++.||..|+.|+|+.. +|||||||+||.+-+ -|-+||.|||++..+.+
T Consensus 98 LGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 99999999998633 334889999999999999999999888 999999999998866 57899999999987652
Q ss_pred CCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....+.+|+..|.|||.+.+..|+ +++||||+||+||.+++|++||..-+. .+.+..++|.
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmImDC 234 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMIMDC 234 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhhhcc
Confidence 3345678999999999999998887 789999999999999999999986321 1244455554
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..|.-...++.+++..|+..||++|.+.+||+.
T Consensus 235 KY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 33 235566778899999999999999999999975
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.72 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=196.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC------C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------E 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 253 (468)
.+.|+..+.||+|+||.||+|.+. +++.||+|.+............+.+|+.+++.++|||++++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 567888899999999999999974 689999998864333333345677899999999999999999988643 3
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+. ++|.+.+... +++.....++.|++.||+|||..+ ++||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 4689999995 5888877532 788999999999999999999877 9999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc------
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS------ 407 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 407 (468)
..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+. ...|......-
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----IDQWNKIIEQLGTPSDE 239 (353)
T ss_pred eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcCCCCHH
Confidence 65422 122344578899999999998999999999999999999999999965321 11111110000
Q ss_pred ---------------c----ccchhhhccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 ---------------S----KEGVVKILDQRL-----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ---------------~----~~~~~~~~d~~~-----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. .....+...... ..........+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000011111110 0001133556789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.32 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=194.5
Q ss_pred cCCcceEcccCCcceEEEEcC---CCcEEEEEEecccC-CCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL 257 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 257 (468)
|+..+.||+|+||.||+|.+. +++.||+|.+.... ........+.+|+.++.+++|||++++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 566788999999999999985 47899999987533 1122235678899999999999999999999888 78999
Q ss_pred EEeccCCCChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCceEEeecc
Q 012213 258 VYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEAHVADFG 330 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 330 (468)
||||+++ ++.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999974 6766664222 236889999999999999999999877 999999999999999 9999999999
Q ss_pred ccccccccCC-CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcC--------HHH-
Q 012213 331 LAKYLQDTGA-SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD--------IVQ- 399 (468)
Q Consensus 331 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~--------~~~- 399 (468)
++..+..... ........++..|+|||...+ ..++.++||||||+++|||++|++||......... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643222 112234567889999998765 45789999999999999999999999764322200 000
Q ss_pred -----------HHHHhhcccccchhhhcccc-CCCCC--------HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 400 -----------WTKMQTNSSKEGVVKILDQR-LSNTP--------LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 400 -----------~~~~~~~~~~~~~~~~~d~~-~~~~~--------~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
|.............+..... ..... ......+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000000000000000 00000 023456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.48 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=201.4
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|++|.||++.+. +++.|++|.+............+.+|++++++++|+|++++++++.+....++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 566789999999999999875 5789999998765443344467899999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++... ..+++..+..++.+++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 82 ENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 999999998644 46899999999999999999999777 999999999999999999999999999876532221
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ........ ......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~------------~~~~~~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV------------QDDHPP 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh------------ccCCCC
Confidence 2345678899999998888889999999999999999999999865321 11111110 001111
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+......+.+++.+|+..+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 22233566778999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.66 Aligned_cols=263 Identities=25% Similarity=0.274 Sum_probs=194.7
Q ss_pred cCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCC---CCCCccceeEEEecCCe-----
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSNKET----- 254 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 254 (468)
|+..+.||+|+||.||+|.++. ++.||+|++............+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4566889999999999999864 89999999864433322234466777766555 69999999999988776
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.+++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58998887544456899999999999999999999877 99999999999999999999999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc-h-
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG-V- 412 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~- 412 (468)
+..... .....++..|+|||...+..++.++||||||+++|||++|++||...... ..+..+........... .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence 643211 12334788999999999888999999999999999999999998753211 11111111000000000 0
Q ss_pred -----hhhcccc----CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 -----VKILDQR----LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 -----~~~~d~~----~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....... ...........+.+++..|++.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 01111233466788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=289.18 Aligned_cols=261 Identities=18% Similarity=0.239 Sum_probs=183.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCCC----cEEEEEEecccCCCCCch----------hHHHHHHHHHhCCCCCCcccee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNG----EQVAVKKLLGITKGSSHD----------NGLSAEIRTLGKIRHRNIVRLK 246 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~----------~~~~~e~~~l~~l~h~niv~l~ 246 (468)
.+.|...+.||+|+||+||+|.+.++ ..+|+|... ........ .....+...+..+.|+++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~-~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIEN-LENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEecc-ccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 35788899999999999999997654 445555432 21111100 1122334456677899999999
Q ss_pred EEEecCC----eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 247 AFCSNKE----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 247 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
+++.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 9765543 3467778763 4666665432 23578888999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCH
Q 012213 323 EAHVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI 397 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 397 (468)
.++|+|||+++.+...+.. .......||+.|+|||+..+..++.++|||||||++|||++|+.||........ .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-L 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-H
Confidence 9999999999876422211 112234699999999999999999999999999999999999999976432211 1
Q ss_pred HHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
..-... +.+..+..... ........+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKC------DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHH------HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 110000 00111111111 01123466888999999999999999999998763
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.69 Aligned_cols=197 Identities=29% Similarity=0.362 Sum_probs=171.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-C-----CCccceeEEEecCCe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-H-----RNIVRLKAFCSNKET 254 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~ 254 (468)
-+|.+.++||+|+||.|.|+.+. .++.||||+++.... ...+-..|+.+|..++ | -|+|++++++...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 36788999999999999999985 589999999875432 2345678999999986 4 389999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CceEEeecccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD--FEAHVADFGLA 332 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla 332 (468)
.|||+|.+ .-+|+++++.+.-..++......++.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 579999999888888999999999999999999999887 9999999999999764 46999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+..... ......+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.
T Consensus 339 c~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 339 CFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 875421 12455678999999999999999999999999999999998888664
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=286.66 Aligned_cols=259 Identities=22% Similarity=0.249 Sum_probs=192.2
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecC--CeeEEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNK--ETNLLVY 259 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 259 (468)
|+..+.||+|+||.||+|... +++.||+|+++........ .....|+..+.++. |+|++++++++.+. +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 345678999999999999874 6889999988654332222 23457888888885 99999999999887 8899999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++.+....
T Consensus 80 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9996 68888876433 46899999999999999999999877 999999999999999 999999999998764222
Q ss_pred CCccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .....++..|+|||+.. +..++.++|||||||++|||++|+.||...+. .+...+.........+.+.+....
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcc
Confidence 1 12345788999999764 45578899999999999999999999965321 112222211111111100000000
Q ss_pred ------cC--------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 ------RL--------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ------~~--------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..........+.+++.+|++.+|++||+++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 0001134577899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.24 Aligned_cols=267 Identities=25% Similarity=0.294 Sum_probs=196.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------ 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 253 (468)
.+.|+..+.||+|+||.||+|.++ +|+.||+|++............+.+|+.+++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 567888899999999999999985 5889999998654433333356788999999999999999999987655
Q ss_pred ----eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 254 ----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 254 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
..++|+||+++ ++.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999975 777776543 346899999999999999999999877 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
|++..+..... .......++..|+|||...+ ..++.++|||||||++|||++|++||..... ...+...........
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPC 238 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Confidence 99987653221 11223346788999998764 4578999999999999999999999965221 111111111000000
Q ss_pred ccchhhhc--------cc------cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKIL--------DQ------RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~--------d~------~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+. +. ............+.+++..|++.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 00 000001112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=317.45 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=210.1
Q ss_pred hccCCcceEcccCCcceEEEEcC----C----CcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP----N----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK 252 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 252 (468)
++++..+.+|+|.||.|++|... . ...||||.++..... .+.+.+..|+++|+.+ +|+|++.++|+|..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 44456679999999999999742 1 457999998866554 5567899999999999 599999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCC--------C------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKR--------G------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~--------~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 318 (468)
+..++|+||+..|+|.+++...+ + ..+.....+.++.|||.|++||++.. ++||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999998655 0 13888999999999999999999665 9999999999999
Q ss_pred cCCCceEEeeccccccccccCCCcccccc-ccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 319 NSDFEAHVADFGLAKYLQDTGASECMSAV-AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 319 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
+.+..+||+|||+|+.............. .-...|||||.+....|+.++|||||||+||||+| |..||.+.... .+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HH
Confidence 99999999999999976543333212111 13457999999999999999999999999999999 99999762200 01
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
....+-++.....|..+..++.+++..||+.+|++||++.|+.+.++..
T Consensus 531 --------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 --------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1122223333455666788888999999999999999999999999884
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=299.29 Aligned_cols=274 Identities=23% Similarity=0.319 Sum_probs=201.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----Ce
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 254 (468)
...|...+.||+|+||+||+|.+. +++.||||++............+..|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 456778889999999999999874 688999999865433333345677899999999999999999987644 34
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7898888643 35899999999999999999999877 99999999999999999999999999986
Q ss_pred ccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc---
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE--- 410 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 410 (468)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|++||...+... .+............+
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhh
Confidence 64321 22234457889999998764 468899999999999999999999996532100 000000000000000
Q ss_pred -----chhhhcc-------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHhccCCC
Q 012213 411 -----GVVKILD-------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQAQKPN 463 (468)
Q Consensus 411 -----~~~~~~d-------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~--L~~~~~~~ 463 (468)
...+.+. .............+.+++.+|++.+|++|||++|+++- ++.++.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0000000 00001112345667899999999999999999999975 66655444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=287.70 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=186.3
Q ss_pred eEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCc-hhHHHHHHHH---HhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 189 VIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSH-DNGLSAEIRT---LGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+||+|+||.||++.+. +++.+|+|.+......... ...+..|..+ +...+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999984 5889999988644322221 1223444433 334479999999999999999999999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999988643 35899999999999999999999877 9999999999999999999999999987553211
Q ss_pred ccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 344 MSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
.....|+..|+|||... +..++.++|||||||++|||++|+.||........ ........ ... ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~---------~~~---~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL---------TVN---VE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhh---------cCC---cC
Confidence 12346899999999886 45688999999999999999999999975332111 11110000 000 11
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQM 455 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~~ 455 (468)
.+......+.+++..|++.||++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233456778899999999999999 59988873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=291.74 Aligned_cols=265 Identities=26% Similarity=0.311 Sum_probs=195.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 257 (468)
.++|+..+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 567888899999999999999984 589999999864433332233467899999999999999999998754 46799
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58888876432 46899999999999999999999887 99999999999999999999999999987643
Q ss_pred cCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc----h
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG----V 412 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 412 (468)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.. ....-........... .
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchhh
Confidence 221 1223345788999998865 45789999999999999999999999753211 0000000000000000 0
Q ss_pred h------hh-cc-ccCC---CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 V------KI-LD-QRLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~------~~-~d-~~~~---~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. .. .. .... .........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00 00 0000 000112455678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=287.79 Aligned_cols=263 Identities=27% Similarity=0.324 Sum_probs=196.3
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEEEEe
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYE 260 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 260 (468)
|+..+.||+|+||.||+|.+. +++.+|+|++............+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 345678999999999999985 488999999976543333345688999999999999999999999888 78999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|++ ++|.+++.... ..+++..+..++.+|+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 58988886432 46899999999999999999999877 99999999999999999999999999987653321
Q ss_pred CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhh----cccccchhhh
Q 012213 341 SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT----NSSKEGVVKI 415 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 415 (468)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ......... ........++
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhccccccc
Confidence 12233456788999997654 457899999999999999999999997533210 000000000 0000000000
Q ss_pred -----ccc------cCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 -----LDQ------RLSNTPLS-EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 -----~d~------~~~~~~~~-~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... .+...... +...+.+++..|++.+|.+||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000001 2567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.25 Aligned_cols=268 Identities=19% Similarity=0.207 Sum_probs=194.8
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
+.+|.|+++.||++.. +++.||||++............+..|++.++.++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344555555555544 689999999875433334456799999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC-----c
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-----E 342 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-----~ 342 (468)
.+++.......+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+..+...+.. .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998655556889999999999999999999877 999999999999999999999999998765422211 1
Q ss_pred cccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc---------ccccc
Q 012213 343 CMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN---------SSKEG 411 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~ 411 (468)
......++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+.+-...... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcCC
Confidence 1123456778999998865 358899999999999999999999997532111 01000000000 00000
Q ss_pred hhh----hccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 412 VVK----ILDQRL-----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 412 ~~~----~~d~~~-----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
... ..+... ..........+.+++..||+.+|++|||++|+++ .++.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 000000 1112233457888999999999999999999997 455544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.54 Aligned_cols=263 Identities=24% Similarity=0.294 Sum_probs=193.2
Q ss_pred ceEccc--CCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRG--GAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
..||+| +||+||++.+. +|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999974 789999998865433333446788999999999999999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc-
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC- 343 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~- 343 (468)
++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987654456899999999999999999999877 99999999999999999999999986643321111110
Q ss_pred ----ccccccCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHH--------------
Q 012213 344 ----MSAVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM-------------- 403 (468)
Q Consensus 344 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~-------------- 403 (468)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCccccccchh
Confidence 0112345679999998763 47899999999999999999999997532110 00000000
Q ss_pred --hhcccccch--------------hhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 404 --QTNSSKEGV--------------VKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 404 --~~~~~~~~~--------------~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......... ....+..+ ..........+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000000 00011111 1112345667899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=287.20 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=195.4
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|++|.||+|.+. +|+.||||++...... .....+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 567789999999999999985 5889999988654322 22356778999999999999999999999999999999999
Q ss_pred CCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 263 PNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 7 58888876433 246899999999999999999999877 9999999999999999999999999997654221
Q ss_pred ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--CH---------HHHHHHhhccc-
Q 012213 342 ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--DI---------VQWTKMQTNSS- 408 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~---------~~~~~~~~~~~- 408 (468)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+.+.... .+ ..|........
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 12233457889999998765 4578999999999999999999999976332110 00 00100000000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........+.............+.+++..|++.+|.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000000001123456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=284.35 Aligned_cols=243 Identities=25% Similarity=0.307 Sum_probs=195.8
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||.|++|.||++.+. +++.||+|.+...... ....+.+..|+.+++.++|||++++++++.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999985 4889999998643322 23346789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 9999643 34889999999999999999999877 9999999999999999999999999998765321 22334
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc-ccCCCCCHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD-QRLSNTPLS 426 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~ 426 (468)
.++..|+|||......++.++|+||||+++|||++|..||.....+ ..... .+..+ ......+..
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~ 218 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIY-----------NDILKGNGKLEFPNY 218 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHH-----------HHHhccCCCCCCCcc
Confidence 6788999999998888999999999999999999999999764321 11111 11111 111222223
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 427 EAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 427 ~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
....+.+++..|++.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3567889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.76 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=198.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec----CCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 255 (468)
..+|+..+.||+|+||.||+|... +|+.||+|++............+..|+.++++++||||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 356778889999999999999874 68999999987543333344667889999999999999999988753 3467
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++|+||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6899988643 34899999999999999999999877 999999999999999999999999999766
Q ss_pred cccCCC--ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc-----
Q 012213 336 QDTGAS--ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS----- 407 (468)
Q Consensus 336 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 407 (468)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.. ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEV 235 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHh
Confidence 432211 11234568899999998765 46889999999999999999999999653211 000000000000
Q ss_pred ----cccchhhhccccC--CCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 ----SKEGVVKILDQRL--SNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ----~~~~~~~~~d~~~--~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.+.+..+... ...+ ......+.+++..|++.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0001111111000 0111 123567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=272.18 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=196.8
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 259 (468)
+.++....||.|+.|.||++..+ .|..+|||.+.... +.+..+++...+.++.+.. .|+||+.+|||..+...++.|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34556678999999999999985 47889999986443 3344467778888776664 899999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|.|. ...+.++. .-..++++...-++...+..||.||-++. +|+|||+||+|||+|+.|++|+||||++.++-+.
T Consensus 171 elMs-~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 171 ELMS-TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHH-HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 9984 44555554 33345888888999999999999998754 4999999999999999999999999999877533
Q ss_pred CCccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
...+..+|.+.|||||.+.- .+|+-++||||||++++|+.||+.||...+.+.. .+.+++
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---------------~ltkvl 308 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---------------VLTKVL 308 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH---------------HHHHHH
Confidence 33456679999999998864 4688999999999999999999999987554322 223333
Q ss_pred cccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRLSN--TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~~~--~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.+... ........+.++...|+..|+.+||...++++
T Consensus 309 n~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 309 NEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred hcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 322211 11225677889999999999999999999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.19 Aligned_cols=250 Identities=24% Similarity=0.254 Sum_probs=199.9
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
+.|..-++||+||||.||-.+.+ +|..+|.|++..... .........+|-.+|.++..+.||.+--+|++++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45666789999999999998874 588899998743221 1111234678899999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
..|.||+|.-+|.......+++..+..++.+|+.||++||+.. ||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g- 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG- 340 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC-
Confidence 9999999999998777678999999999999999999999877 999999999999999999999999999987632
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
......+||.+|||||++.+..|+...|.||+||+||||+.|+.||....+.. .++.+...+-..
T Consensus 341 --~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-------------k~eEvdrr~~~~ 405 (591)
T KOG0986|consen 341 --KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-------------KREEVDRRTLED 405 (591)
T ss_pred --CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-------------hHHHHHHHHhcc
Confidence 23345589999999999999999999999999999999999999997633210 011222222222
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMR 450 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ 450 (468)
..+++..-..+...+....+..||++|..-+
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2233444455666777788999999996443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=286.22 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=198.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+..+.||+|++|.||+|... +++.+++|++............+..|+.++++++|+|++++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345678999999999999884 6889999998654443334467889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++ +|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 74 8888886433 46899999999999999999999877 9999999999999999999999999998765332 1
Q ss_pred cccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc-cccchhhhc----
Q 012213 343 CMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS-SKEGVVKIL---- 416 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---- 416 (468)
......++..|+|||...+. .++.++|+||||+++|+|+||+.||...+... ...-....... ..+...+..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhhh
Confidence 22334578899999988766 78899999999999999999999996533110 00000000000 000000000
Q ss_pred -------cc---cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 -------DQ---RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 -------d~---~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+. ............+.+++..|++.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 001111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.31 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=195.3
Q ss_pred EcccCCcceEEEEcCC-CcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||+|+||.||++.+.+ |+.+++|.+...... ......+.+|++++++++|||++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 899999988643321 12335688999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC------C
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA------S 341 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------~ 341 (468)
.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997433 5899999999999999999999877 99999999999999999999999999876432211 1
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......++..|+|||.......+.++||||||+++||+++|+.||.....+ ..... ......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~-----------~~~~~~- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQN-----------ILNGKI- 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-----------HhcCCc-
Confidence 1223455788999999998888999999999999999999999999653211 11111 111111
Q ss_pred CCCHH--HHHHHHHHHHhhcccCCCCCCCHHHHHHHHHh
Q 012213 422 NTPLS--EAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458 (468)
Q Consensus 422 ~~~~~--~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~ 458 (468)
..+.. ....+.+++..|++.+|++|||+.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 01111 25677899999999999999999666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=280.85 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=187.7
Q ss_pred hccCCcceE--cccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVI--GRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
+.++..+.+ |+|+||.||++..+ ++..+|+|.+....... . |+.....+ +|||++++++++...+..++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----h--hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 444554554 99999999999874 67889999875322111 1 22222222 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeecccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQ 336 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~ 336 (468)
||||+++++|.+++.... .+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999996543 6899999999999999999999877 99999999999999998 99999999987654
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.||.....+......|....
T Consensus 162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 223 (267)
T PHA03390 162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------------ 223 (267)
T ss_pred CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------------
Confidence 21 234578999999999988899999999999999999999999975433332333332221
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-MREVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-~~ev~~ 454 (468)
.. ...........+.+++..|++.+|.+||+ ++|+++
T Consensus 224 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QK-KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cc-cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 11112245567888999999999999996 688874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.05 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=190.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 252 (468)
...|+...+||+||||.|||++.+ ||+.||||++.... .......+.+|+..+++++|||||+++..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456777889999999999999985 89999999997654 344456788999999999999999987542100
Q ss_pred --------------------------------------------------------------------------------
Q 012213 253 -------------------------------------------------------------------------------- 252 (468)
Q Consensus 253 -------------------------------------------------------------------------------- 252 (468)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 012213 253 --------------------------------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300 (468)
Q Consensus 253 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~ 300 (468)
...||-||||+...++++++.+.-. -.....++++.+|+.||+|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHh
Confidence 1126777888877777777543211 1467789999999999999998
Q ss_pred cCCCCeeecCCCCCcEEEcCCCceEEeecccccccc---------------ccCC-CccccccccCccccCccccCCC--
Q 012213 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ---------------DTGA-SECMSAVAGSYGYIAPEYAYTL-- 362 (468)
Q Consensus 301 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~---------------~~~~-~~~~~~~~gt~~y~aPE~~~~~-- 362 (468)
.| ||||||||.||++|++..|||+|||+|.... ..+. ....+...||.-|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 88 9999999999999999999999999998721 0011 1133567899999999998755
Q ss_pred -CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC---CHHHHHHHHHHHHhh
Q 012213 363 -KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT---PLSEAMQVFFVAMLC 438 (468)
Q Consensus 363 -~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~---~~~~~~~~~~l~~~c 438 (468)
.|+.|+|+||+||+++||+. ||...- +.. ..+..+-++.+... ..+....-..++.++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ERa--------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSM-ERA--------------SILTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchH-HHH--------------HHHHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 49999999999999999986 665411 000 02222333333222 445566667899999
Q ss_pred cccCCCCCCCHHHHHH
Q 012213 439 VQEHGVERPTMREVVQ 454 (468)
Q Consensus 439 ~~~~P~~RPt~~ev~~ 454 (468)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=287.58 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=198.5
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
++....||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++|+|++++++++...+..+++|||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33346799999999999987 468899999874322 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++... .+++.....++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~ 171 (292)
T cd06657 100 EGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 171 (292)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--c
Confidence 999999987532 4789999999999999999999877 9999999999999999999999999987654221 1
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
......++..|+|||...+..++.++|+||||+++|||++|..||..... ........ ......+.
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~--------~~~~~~~~- 237 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIR--------DNLPPKLK- 237 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH--------hhCCcccC-
Confidence 22345678999999999888899999999999999999999999865221 11111100 00111110
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccC
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQK 461 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~ 461 (468)
........+.+++.+|++.+|.+||++.|+++ .+.+...
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 11123445678899999999999999999998 4554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=287.14 Aligned_cols=257 Identities=24% Similarity=0.256 Sum_probs=198.5
Q ss_pred cCCcceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
|+..+.||+|++|.||++.. .+++.||||.+..... .....+.+..|+.++.++ +|||++++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 55678999999999999975 3578899998864322 122235678999999999 5999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ..+++.....++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999998643 35889999999999999999999777 9999999999999999999999999988654
Q ss_pred ccCCCccccccccCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
... ........|+..|+|||...+.. .+.++||||||+++|||++|..||...... .....+...
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~----------- 223 (288)
T cd05583 157 AEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRR----------- 223 (288)
T ss_pred ccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHH-----------
Confidence 322 11223345789999999987654 788999999999999999999999642211 111111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.... ....+......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 224 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 ILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111 1112222345677899999999999999999888777644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=285.34 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=195.1
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|...+.||+|++|+||+|... +++.|++|++...... .......+|+..+.+++ |+|++++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 345678999999999999985 4788999988643322 22234567899999999 99999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+ +|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 9 889999987655557899999999999999999999877 99999999999999999999999999986542211
Q ss_pred ccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHHHHHHhhccc-
Q 012213 342 ECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNSS- 408 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~~- 408 (468)
.....++..|+|||... ...++.++|+||||++++||++|++||........ .-..|........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 23345788999999774 45578999999999999999999999865321100 0000111100000
Q ss_pred c-cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 K-EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~-~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ..........+..........+.+++.+|++.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0 000000000000001112466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=287.24 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=192.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+.+ ++.||||.+..... ......+..|+..+.+.. |+||+++++++.+....+++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4667888999999999999999865 88999999864322 222345667777666664 99999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|||++ +++.+++... ...+++..+..++.+++.|++|||+ .+ |+||||+|+||++++++.++|+|||++..+..
T Consensus 93 ~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99985 5777766532 2368999999999999999999996 35 99999999999999999999999999976542
Q ss_pred cCCCccccccccCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+. ..
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~-----------~~ 229 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEV-----------LT 229 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHH-----------HH
Confidence 221 12335788999999987554 788999999999999999999999642211 011 11
Q ss_pred hhccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 414 KILDQRLS--NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 414 ~~~d~~~~--~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..++.... ........++.+++.+|++.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111110 0111234568889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=285.48 Aligned_cols=252 Identities=24% Similarity=0.259 Sum_probs=194.6
Q ss_pred cCCcceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
|+..+.||+|+||.||++.. .+|+.||+|++..... .....+.+..|+.++.++ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56678999999999999986 3689999999864322 122335678899999999 5899999999999988999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 82 LILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999998643 35788999999999999999999877 9999999999999999999999999998654
Q ss_pred ccCCCccccccccCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
... ........|+..|+|||..... .++.++||||||+++|+|++|+.||..... ......+......
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~-------- 226 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILK-------- 226 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhc--------
Confidence 221 1222345688999999988753 467899999999999999999999964221 1111222111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.....+......+.+++.+|++.+|++|| +..+++.
T Consensus 227 ----~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 ----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11112223445677899999999999997 6676655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.95 Aligned_cols=243 Identities=23% Similarity=0.264 Sum_probs=185.9
Q ss_pred eEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCc-hhHHHHHH---HHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 189 VIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSH-DNGLSAEI---RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
.||+|+||.||+|.+. +++.||+|.+......... ...+..|. ..++...||+++++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 5889999988643222111 12233343 34455679999999999999999999999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
+|+|.+++.. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 9999998853 345899999999999999999999877 9999999999999999999999999987653221
Q ss_pred ccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 344 MSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
.....|+..|+|||...+. .++.++||||+|+++|||++|+.||........ ...... ..... ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~---------~~~~~---~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM---------TLTMA---VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHH---------hhccC---CC
Confidence 1234689999999998754 688999999999999999999999976321111 000000 00001 11
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.+......+.+++.+|+..+|.+|| ++.|+++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222356788899999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.13 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=195.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC---CCCchhHHHHHHHHHhCCCCCCccceeEEEecC--Cee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 255 (468)
.+|...+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|++++++++|+|++++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 35777899999999999999874 588999998743211 122335788999999999999999999998764 457
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++++||+++++|.+++... ..+++....+++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998643 34788999999999999999999877 999999999999999999999999999865
Q ss_pred cccCC-CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGA-SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
..... ........++..|+|||+..+..++.++|+||||+++||+++|+.||...... . .+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~---------~~~~ 220 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------A---------AIFK 220 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------H---------HHHH
Confidence 42111 11123356889999999998888999999999999999999999999653211 0 0011
Q ss_pred hcc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILD-QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d-~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... +.....+......+.+++..|+. +|.+||+..+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 110 01112233455678889999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.63 Aligned_cols=272 Identities=19% Similarity=0.274 Sum_probs=186.4
Q ss_pred chhhhccCCcceEcccCCcceEEEEcCC--CcEEEEEEe--------------c-ccCCCCCchhHHHHHHHHHhCCCCC
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKL--------------L-GITKGSSHDNGLSAEIRTLGKIRHR 240 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~--------------~-~~~~~~~~~~~~~~e~~~l~~l~h~ 240 (468)
+.+.+.|+..+.||+|+||+||++..+. +...+.|.+ . ...........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999987532 222222211 0 0111112234678999999999999
Q ss_pred CccceeEEEecCCeeEEEEeccCCCChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 241 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
||+++++++...+..++|++++. ++|.+++.... ...........++.||+.||.|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999984 67777764322 112335667789999999999999877 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCC-Cc
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRR-PVGDFGEE-GL 395 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~-p~~~~~~~-~~ 395 (468)
++.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|.. |+...... ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999998765321 222234578999999999999999999999999999999999875 44332111 11
Q ss_pred CHHHHHHHhh---ccccc---chhhhcccc-CC---CCCH------HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 396 DIVQWTKMQT---NSSKE---GVVKILDQR-LS---NTPL------SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 396 ~~~~~~~~~~---~~~~~---~~~~~~d~~-~~---~~~~------~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+........ ....+ .+.+.++.. .. .... .....+.+++.+|++.||++|||+.|++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111110000 00000 000111000 00 0000 01234567788999999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=290.74 Aligned_cols=271 Identities=24% Similarity=0.300 Sum_probs=203.7
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----eeEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNLL 257 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 257 (468)
|+..+.||+|++|.||+|... +++.||+|++..........+.+.+|+..++.++|+||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 567789999999999999985 4889999998764433444467899999999999999999999987775 7899
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
+|||++ ++|.+++.... .+++..+..++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred Eecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 999997 58988886433 6899999999999999999999877 99999999999999999999999999987653
Q ss_pred cCC-CccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc---------
Q 012213 338 TGA-SECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN--------- 406 (468)
Q Consensus 338 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 406 (468)
... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHhhh
Confidence 221 0122344578899999999887 78999999999999999999999997643110 0000000000
Q ss_pred ccccchhhhccccC-------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCC
Q 012213 407 SSKEGVVKILDQRL-------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKP 462 (468)
Q Consensus 407 ~~~~~~~~~~d~~~-------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~ 462 (468)
.......+.+.... ..........+.+++..||+.+|.+||++++++. .+++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00000111111000 0011123456789999999999999999999998 36655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=285.32 Aligned_cols=248 Identities=27% Similarity=0.343 Sum_probs=192.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|...+.||+|+||+||+|.+. +++.|++|++....... .....+..|++.++.++|||++++++++.+....++|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 344566678999999999999874 68899999886433322 2234678899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+. |++.+++... ...+++.++..++.||+.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-- 172 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-- 172 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC--
Confidence 99995 6787777533 345899999999999999999999877 9999999999999999999999999886432
Q ss_pred CCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
......|+..|+|||++. ...++.++||||||+++|||++|..||..... ........... .
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~---~--- 237 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND---S--- 237 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC---C---
Confidence 122456788999999874 45688899999999999999999999865321 11111100000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ..........+.+++.+|++.+|.+||++.+++.
T Consensus 238 --~--~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 --P--TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --C--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0011122345778999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=281.57 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=194.9
Q ss_pred cCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCC---CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
|...+.||+|+||.||++.+.. +..+++|.++.... .......+..|+.+++.++|||++++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5667899999999999998753 44566666554322 1222245677899999999999999999999999999999
Q ss_pred eccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||+++++|.+++.. .....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++ +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 23456899999999999999999999877 999999999999975 5699999999976642
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.. .......++..|+|||...+..++.++|+||||+++|+|++|..||.... ..... .....
T Consensus 158 ~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~-----------~~~~~ 219 (260)
T cd08222 158 SC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVV-----------LRIVE 219 (260)
T ss_pred Cc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHH-----------HHHHc
Confidence 21 22234557889999999888888999999999999999999999986421 11111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+......+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2222233455667889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=289.66 Aligned_cols=268 Identities=21% Similarity=0.254 Sum_probs=192.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------ 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 253 (468)
.++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|++.++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 567888899999999999999974 6889999988654333322345778999999999999999999875433
Q ss_pred --eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 254 --TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 254 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
..++|+||+. +++.+.+... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 3589999996 4677766532 346899999999999999999999877 99999999999999999999999999
Q ss_pred cccccccCCC---------ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHH
Q 012213 332 AKYLQDTGAS---------ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 332 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 401 (468)
++........ .......+++.|+|||...+ ..++.++||||||+++|||++|++||.+..... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 9865422211 11123456788999998765 458899999999999999999999997532110 000000
Q ss_pred HHhhccc------ccchhhhc----cccCCC----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 402 KMQTNSS------KEGVVKIL----DQRLSN----TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 402 ~~~~~~~------~~~~~~~~----d~~~~~----~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....... ...+.... ...... ........+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00000000 000000 00112256789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=287.06 Aligned_cols=249 Identities=28% Similarity=0.338 Sum_probs=194.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +++.+|+|.+...... .....++.+|+++++.++|+|++++.+++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 445667788999999999999974 5788999988643222 22234678899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
+||+. |++.+++... ...+++.++..++.+++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 99996 6888777533 345889999999999999999999877 999999999999999999999999998765421
Q ss_pred CCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ..... .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~-----------~ 226 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYH-----------I 226 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHH-----------H
Confidence 2345788999999874 346788999999999999999999998653211 01100 0
Q ss_pred ccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 416 LDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 416 ~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
..... ..........+.+++.+||+.+|++||++.++++.-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00011 111223456678899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=293.39 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=195.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------ 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 253 (468)
...|...+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 456778899999999999999974 6899999998653322333356789999999999999999999886543
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++|+||+. .+|.++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4589999996 47766542 24889999999999999999999877 9999999999999999999999999987
Q ss_pred cccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc---ccc
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN---SSK 409 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 409 (468)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.. ..+...... ...
T Consensus 166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~ 236 (342)
T cd07879 166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----DQLTQILKVTGVPGP 236 (342)
T ss_pred CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCH
Confidence 5431 1223457889999998866 46889999999999999999999999753211 011100000 000
Q ss_pred c--------chhhhcc-------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCC
Q 012213 410 E--------GVVKILD-------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPN 463 (468)
Q Consensus 410 ~--------~~~~~~d-------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~ 463 (468)
+ .....+. ..+..........+.+++..|++.||++||++.|++. .+++.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 0 0000000 0000000123355789999999999999999999995 477665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=298.37 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEE-EEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVA-VKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~va-vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|++...||.|+||.||||..++...+| .|.+. . ......+.+.-||++|..+.||+||+|++.|...+..+++.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-t-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-T-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-c-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 345667788999999999999987655554 45442 2 22334467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|||.||-++.++- .-+..+.+.++..++++++.||.|||+.. |||||||+.|||++-+|.++|+|||.+-... .
T Consensus 109 EFC~GGAVDaiml-EL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~ 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIML-ELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--S 182 (1187)
T ss_pred eecCCchHhHHHH-HhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--h
Confidence 9999999988775 34456899999999999999999999776 9999999999999999999999999985432 1
Q ss_pred CCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 340 ASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.-.....+.||++|||||+.+ ..+|+.++||||||++|.||..+.+|-.+.+.-. .+.+
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR----------------VllK 246 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----------------VLLK 246 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH----------------HHHH
Confidence 223345678999999999754 5679999999999999999999999976533110 1111
Q ss_pred hccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRL--SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~--~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+..... .-.|......+-++...|+..+|..||++.++++
T Consensus 247 iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 247 IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111 2235566777889999999999999999999876
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.95 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=207.2
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.-++..+..||.|.||.||.|.. .+|+-.|||-++.........+...+|+.++..++|||+|+++|+-...+..+|-|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34566678999999999999997 46888999987654444444567889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|||++|+|.+.+.. +...++.....+..|++.|++|||+.| ||||||||.||+|+.+|.+|++|||.|..+.+..
T Consensus 1314 EyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999999953 334677777778899999999999888 9999999999999999999999999999876431
Q ss_pred --CCccccccccCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 340 --ASECMSAVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 340 --~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.........||+.|||||.+.+.+ -.-+.||||+||++.||+||+.||...+.+ |.-+..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~--------- 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYH--------- 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhH---------
Confidence 111223567999999999987543 557899999999999999999999886643 433221
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
+--......|.....+-.+++..|+..||++|-++.|+++-
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11223345566667777899999999999999999888764
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.36 Aligned_cols=265 Identities=23% Similarity=0.255 Sum_probs=194.0
Q ss_pred hccC-CcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCC------------chhHHHHHHHHHhCCCCCCccceeE
Q 012213 182 ECVK-DNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS------------HDNGLSAEIRTLGKIRHRNIVRLKA 247 (468)
Q Consensus 182 ~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~ 247 (468)
++|. ..+.||+|+||+||+|.+. +++.||||++........ ....+.+|+++++.++|+|++++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4444 4578999999999999974 689999998864322210 0124678999999999999999999
Q ss_pred EEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 012213 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 248 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
++...+..++||||++ |+|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6999988533 34889999999999999999999877 9999999999999999999999
Q ss_pred eccccccccccCC------------CccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 012213 328 DFGLAKYLQDTGA------------SECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEG 394 (468)
Q Consensus 328 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 394 (468)
|||++........ ........++..|+|||.+.+. .++.++||||||+++|||+||+.||...+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999976541110 1111233467889999988764 4689999999999999999999999754321
Q ss_pred cCHHHHHHHhhccc-ccchhh------------hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 395 LDIVQWTKMQTNSS-KEGVVK------------ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 395 ~~~~~~~~~~~~~~-~~~~~~------------~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
............. ...... ................+.+++..|++.+|++||+++|++.
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 -DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111110000000 000000 0000000111123456789999999999999999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=280.24 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=187.4
Q ss_pred ceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHH-HhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRT-LGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+. +++.||||.+....... .....+..|... ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999874 58899999885432211 111234445444 4455899999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999998643 35889999999999999999999877 99999999999999999999999999875432 2
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
....++..|+|||...+..++.++||||||+++|||++|..||...... ..+..... .. .+. .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~-------~~~-~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDNILS-RR-------INW-PEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHh-cc-------cCC-CCccc
Confidence 2345788999999998888899999999999999999999999653211 11111100 00 000 00111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
......+.+++.+|++.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 234567889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=284.36 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=199.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 259 (468)
+|...+.||+|+||.||+|... +++.||+|.+..... .......+..|++++++++ ||||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 4667789999999999999985 689999998864322 1222356788999999998 999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999999643 35999999999999999999999877 9999999999999999999999999998664322
Q ss_pred CC------------------ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHH
Q 012213 340 AS------------------ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 340 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 401 (468)
.. .......++..|+|||......++.++||||||++++++++|+.||..... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~ 229 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------YL 229 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------HH
Confidence 11 122334578899999999888899999999999999999999999975331 00
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH----HHHHH
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM----REVVQ 454 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~----~ev~~ 454 (468)
......+. ....+......+.+++..|++.+|.+||++ +|+++
T Consensus 230 ---------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ---------TFQKILKL-EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---------HHHHHHhc-CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00111111 111222335668899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=281.74 Aligned_cols=263 Identities=25% Similarity=0.312 Sum_probs=196.9
Q ss_pred CCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 185 KDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
+..+.||+|++|.||+|... +++.||+|.+..........+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 44578999999999999985 48999999987554333334567889999999999999999999999999999999997
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
++|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 -~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 82 -MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred -cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 69999997542 35899999999999999999999887 99999999999999999999999999986643221 2
Q ss_pred ccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----------CHHHHHHHhhccc-cc
Q 012213 344 MSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNSS-KE 410 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~~-~~ 410 (468)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ....|........ ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234457789999998766 789999999999999999999999965321100 0001111100000 00
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....................+.+++..|+..+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000001112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=284.36 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=195.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+. +++.||||++..........+.+..|+++++.++|||++++.+++.. ....+++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 567888999999999999999865 78999999886433333334668899999999999999999998865 5578899
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
+||+ +++|.+++... .+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 89 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 89 TELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred eehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 9998 57898888532 4788888999999999999999877 99999999999999999999999999875431
Q ss_pred CCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC----------cCHHHHHHHhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG----------LDIVQWTKMQTNS 407 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~----------~~~~~~~~~~~~~ 407 (468)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ....+|.......
T Consensus 161 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 161 ----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred ----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 1123456889999998765 568999999999999999999999996532100 0001111110000
Q ss_pred cccchhhhccccC-CCCCH-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 408 SKEGVVKILDQRL-SNTPL-----SEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 408 ~~~~~~~~~d~~~-~~~~~-----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
. ...-...... ...+. .....+.+++.+|++.+|++||++.+++..
T Consensus 237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 N--TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred h--hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000000 01111 124678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=288.10 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=190.4
Q ss_pred cCCcceEcccCCcceEEEEcC-C--CcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC----Cee
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-N--GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK----ETN 255 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~ 255 (468)
|+..+.||+|+||.||++.+. . +..||+|++............+.+|+.++.++ .||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 556788999999999999975 3 67899998864333333345678899999999 599999999875432 456
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||+++.+
T Consensus 82 ~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 78889885 689988853 345899999999999999999999887 999999999999999999999999999866
Q ss_pred cccCCC--ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC----------cCHHHHHH
Q 012213 336 QDTGAS--ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG----------LDIVQWTK 402 (468)
Q Consensus 336 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~----------~~~~~~~~ 402 (468)
...... .......|+..|+|||+..+ ..++.++||||||+++|+|++|++||...+... ....++..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 11233568899999998765 468899999999999999999999997533110 00000000
Q ss_pred Hhhcccccchhhhcc----ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 403 MQTNSSKEGVVKILD----QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d----~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
............... ..+..........+.+++.+|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 0000001112456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=291.05 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=205.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
...|.+...||+|.|+.|..|.+. .+..||+|.+.+..-.......+.+|+++|..++|||||+++.+...+...++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456778899999999999999974 6899999998776666555566889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+.+|.+++++.... .+.+..+..++.|+.+|++|||.++ |+|||||++|+||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec---
Confidence 9999999999996433 3556888899999999999999887 9999999999999999999999999999876
Q ss_pred CCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
........+|++.|.|||++.+..|. +.+|+||+|+++|-|+.|..||++..-... -...+-.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L----------------r~rvl~g 270 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL----------------RPRVLRG 270 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc----------------cchheee
Confidence 33445678999999999999988765 899999999999999999999986321110 0001111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+ ..+.-...++.+++.+.+-.+|.+|+++++|.+
T Consensus 271 k~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 271 KY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ee-cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11 112223345667888999999999999999976
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=286.11 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=196.8
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC----
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE---- 253 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 253 (468)
++.++|+..+.||+|+||.||+|.+ .++..||||++............+..|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3466788889999999999999986 46899999988543222222356789999999999999999999886544
Q ss_pred --eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 254 --TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 254 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 7899888753 34899999999999999999999877 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHH-----------H
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIV-----------Q 399 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-----------~ 399 (468)
+...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||....... .+. .
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 9765321 123457889999998875 458899999999999999999999997532110 000 0
Q ss_pred HHHHhhcccccchhhhccc-------cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 400 WTKMQTNSSKEGVVKILDQ-------RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 400 ~~~~~~~~~~~~~~~~~d~-------~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
|....... ........ .+..........+.+++.+|++.||++|||+.+++. .++..
T Consensus 239 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 239 FVQKLQSE---DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHhhcch---hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000 00000000 000001122345778999999999999999999984 45544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=295.15 Aligned_cols=267 Identities=27% Similarity=0.352 Sum_probs=200.0
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------eeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------TNL 256 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 256 (468)
+...+.||+|+||.||+|++ ..|+.||||.+..... ....+....|+++|++++|+|||++++.-.+.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 44567899999999999995 6799999999876542 333466789999999999999999998765443 458
Q ss_pred EEEeccCCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CC--ceEEeeccc
Q 012213 257 LVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--DF--EAHVADFGL 331 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~--~~kl~Dfgl 331 (468)
+|||||++|||+..|.... ...+++.+.+.+..+++.||.|||+.+ |+||||||.||++-. +| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999997543 347999999999999999999999888 999999999999843 33 379999999
Q ss_pred cccccccCCCccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-CcCHHHHHHHhhcccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE-GLDIVQWTKMQTNSSK 409 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 409 (468)
|+.+++. ......+||..|.+||+.. .+.|+..+|.|||||++|++.||..||...... ...-..|.-......
T Consensus 171 Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~- 246 (732)
T KOG4250|consen 171 ARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS- 246 (732)
T ss_pred cccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC-
Confidence 9987632 2567889999999999998 588999999999999999999999999763322 111223332211111
Q ss_pred cchhhhccccC-------------CCCCHHHHHHHHHHHHhhcccCCCCCC--CHHHHHHHHHhc
Q 012213 410 EGVVKILDQRL-------------SNTPLSEAMQVFFVAMLCVQEHGVERP--TMREVVQMLAQA 459 (468)
Q Consensus 410 ~~~~~~~d~~~-------------~~~~~~~~~~~~~l~~~c~~~~P~~RP--t~~ev~~~L~~~ 459 (468)
.+.-..+... ..........+.......+..+|++|- .+.+....+.++
T Consensus 247 -~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 247 -GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred -ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1111111111 111233445566677778888888887 555555554443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=289.92 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=192.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC------C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------E 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 253 (468)
.++|...+.||+|+||.||+|.+ .+++.||+|++............+.+|+.++++++||||+++.+++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 56788889999999999999986 5688999999865332222335678899999999999999999987543 3
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccc
Confidence 357888876 78998887532 4899999999999999999999877 9999999999999999999999999987
Q ss_pred cccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc-
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG- 411 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 411 (468)
.... ......++..|+|||...+ ..++.++||||||+++|||++|+.||...+... .+............+.
T Consensus 169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 169 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELL 242 (345)
T ss_pred cccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 5431 1234467889999998765 568899999999999999999999996532110 0000000000000000
Q ss_pred ----------hhhhccc----cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 ----------VVKILDQ----RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ----------~~~~~d~----~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....+.. ............+.+++..|++.+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000 000000112445789999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=292.40 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---- 254 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 254 (468)
+.++|+....||+|++|.||+|.+. +++.||||++............+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888899999999999999985 57899999876433223333567789999999999999999988766554
Q ss_pred --eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 255 --NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 255 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 6799998864 34899999999999999999999877 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc----
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS---- 407 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 407 (468)
...... .....++..|+|||...+ ..++.++||||||+++||+++|+.||...... ............
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHH
Confidence 865421 233467889999998765 36789999999999999999999999653211 000000000000
Q ss_pred -----cccchhhhccccC-------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 -----SKEGVVKILDQRL-------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 -----~~~~~~~~~d~~~-------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.....+.... ..........+.+++..|++.+|++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000111111000 0001122567889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=266.34 Aligned_cols=205 Identities=27% Similarity=0.413 Sum_probs=173.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 254 (468)
...|+....||+|.||.||||.-++ ...+|+|+++.............+|+.++++++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999996432 2369999998776655555678899999999999999999998876 778
Q ss_pred eEEEEeccCCCChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CceEEe
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVA 327 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 327 (468)
.++++||.+. +|.+.++..+ ...++...+..|+.||+.|+.|||+.- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999975 8888876433 347889999999999999999999888 9999999999999887 899999
Q ss_pred eccccccccccCCCc-cccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 328 DFGLAKYLQDTGASE-CMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 328 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
|+|+++.+.+.-... ....++-|+.|.|||++.+. .|+++.||||.||++.||+|-.+-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999987543222 33456679999999988765 599999999999999999999988865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=272.38 Aligned_cols=238 Identities=29% Similarity=0.313 Sum_probs=192.0
Q ss_pred EcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
||+|+||.||++.+. +++.+|+|.+...... ......+..|+.++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999985 5889999988654322 12345788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccccc
Q 012213 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 268 ~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
.+++.... .+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99996443 4899999999999999999999877 9999999999999999999999999998764321 223445
Q ss_pred ccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHH
Q 012213 348 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 427 (468)
.++..|+|||...+...+.++|+||||+++||+++|+.||...+. ..... ...... ...+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~-----------~~~~~~-~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYE-----------KILKDP-LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH-----------HHhcCC-CCCCCCC
Confidence 678899999999888889999999999999999999999965331 11111 111111 1122223
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHH
Q 012213 428 AMQVFFVAMLCVQEHGVERPTMRE 451 (468)
Q Consensus 428 ~~~~~~l~~~c~~~~P~~RPt~~e 451 (468)
...+.+++..|+..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 566788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.21 Aligned_cols=270 Identities=21% Similarity=0.285 Sum_probs=192.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 252 (468)
..+|...+.||+|+||.||+|.+. +|..||+|++..... ...+.+.+|++++++++|||++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 456788899999999999999874 588999998854332 3335688999999999999999999776543
Q ss_pred -------CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCce
Q 012213 253 -------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEA 324 (468)
Q Consensus 253 -------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~ 324 (468)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ ++||||||+||+++. ++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35689999997 589888753 24889999999999999999999887 999999999999975 5678
Q ss_pred EEeeccccccccccCCC-ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHH
Q 012213 325 HVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 325 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 402 (468)
+++|||++..+...... .......++..|+|||.... ..++.++|||||||++|||++|+.||........ ......
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 99999999765422111 11123357889999997654 5688899999999999999999999965321100 000000
Q ss_pred Hhhcccc---c----chhh-hc-cccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 403 MQTNSSK---E----GVVK-IL-DQRLSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 403 ~~~~~~~---~----~~~~-~~-d~~~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
....... . .... .. +......+ .....++.+++..|++.||++|||+.|++. .++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 0000000 0 0000 00 00000111 122356778999999999999999999984 455443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=265.10 Aligned_cols=250 Identities=25% Similarity=0.285 Sum_probs=197.7
Q ss_pred hhhhccCC-cceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec----
Q 012213 179 DILECVKD-NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN---- 251 (468)
Q Consensus 179 ~~~~~~~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 251 (468)
.++++|.+ .++||-|-.|.|-....+ .++++|+|++... ....+|++.--.. .|||||+++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 34566655 478999999999988774 6889999988643 3467788875444 69999999998743
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEee
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVAD 328 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 328 (468)
....++|||.|+||.|.+.+..+....+.+.++..|+.||+.|+.|||... |.||||||+|+|.+. +..+||+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecc
Confidence 445679999999999999999888888999999999999999999999776 999999999999965 55699999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
||+|+.-. ......+.+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||........ .
T Consensus 208 fGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--s---------- 272 (400)
T KOG0604|consen 208 FGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--S---------- 272 (400)
T ss_pred cccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--C----------
Confidence 99998643 23445677889999999999999999999999999999999999999975332111 0
Q ss_pred ccchhhhccccCCCCCHHH----HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPLSE----AMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~----~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+.-+......++.++ +....++++..+..+|++|-|++|++.
T Consensus 273 -pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 273 -PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 011111222222333333 455678999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=270.30 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=196.1
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 259 (468)
++++....||.|+||+|+|-.+ +.|+..|||++..... ..+.+++..|.+...+- +.||||+++|.+..++..++.|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3445567899999999999887 5789999999976544 34446788888875554 6899999999999999999999
Q ss_pred eccCCCChhhh---cccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 260 EYMPNGSLGEV---LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 260 e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
|.| .-||+.+ .+......+++.-.-.|......||.||-+.. .|||||+||+|||+|..|.+||||||++..+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 4576554 33334456888888899999999999998743 49999999999999999999999999997765
Q ss_pred ccCCCccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+ +...+..+|...|||||.+.. ..|+-++||||+|++|||+.||+.||..+++ ..+ .+..
T Consensus 220 ~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfe-----------ql~~ 281 (361)
T KOG1006|consen 220 D---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFE-----------QLCQ 281 (361)
T ss_pred H---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHH-----------HHHH
Confidence 2 233456678999999998864 3589999999999999999999999987543 111 1222
Q ss_pred hccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRL-----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~-----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
++-+.. ..........+..++-.|+..|-..||...++.+
T Consensus 282 Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 282 VVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 221111 1122346677888999999999999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=271.88 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=212.5
Q ss_pred ccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCee
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETN 255 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 255 (468)
+++...++-+|.||.||.|.|.+ .+.|.||.++.... .-+...+..|--.+..+.|||+.++.+++.+ .+..
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 45556678899999999997643 45577887754322 2334567888888999999999999998865 4466
Q ss_pred EEEEeccCCCChhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 256 LLVYEYMPNGSLGEVLHG------KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
+++|.++.-|+|..+|.. +....+...+...++.|++.|++|||+.+ +||.||.++|.++|+...+||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence 889999999999999962 22335777888999999999999999877 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.+++.+.+.+.............||+||.+....|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------------- 506 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------------- 506 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------------
Confidence 99999887776666666778899999999999999999999999999999999 999998744221
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
-..-+.|+.....|.+++.+++.++..||...|++||+++|++.-|.++.
T Consensus 507 --m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 --MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred --HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11223344445567889999999999999999999999999999998864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=267.24 Aligned_cols=250 Identities=24% Similarity=0.270 Sum_probs=200.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..++||+|.||.|.+.+-+ .++.+|+|++++...-. +....-..|-++|...+||.+..+--.++..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 456777899999999999999864 68889999987654422 3234456788999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||..||.|.-+|. +...+++.....+...|..||.|||+.+ ||.||+|-+|.|+|.+|++||+|||+++.- .
T Consensus 247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--c
Confidence 99999999988885 3445888888889999999999999766 999999999999999999999999999753 2
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....+++.+||+.|+|||++....|..++|.|.+||++|||++|+.||...+.+ .+-+++-.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----------------kLFeLIl~ 382 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----------------KLFELILM 382 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----------------HHHHHHHh
Confidence 3445678899999999999999999999999999999999999999999763321 12222211
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.-..+|.....+...+....+..||.+|. .+.||.+
T Consensus 383 ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11223334444555677788999999994 3455543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.45 Aligned_cols=148 Identities=32% Similarity=0.401 Sum_probs=129.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|...+.||+|+||+||+|.+. +++.||||++...... ......+..|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 456778899999999999999985 6889999998643321 22235688899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
|||+++++|.+++... ..+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998643 35788999999999999999999877 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=266.32 Aligned_cols=220 Identities=23% Similarity=0.181 Sum_probs=175.2
Q ss_pred cCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhc
Q 012213 193 GGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271 (468)
Q Consensus 193 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 271 (468)
|.+|.||++.+. +++.||+|++.... .+..|...+....|||++++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999984 67899999985432 2334555555667999999999999999999999999999999998
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCc
Q 012213 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351 (468)
Q Consensus 272 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~ 351 (468)
... ..+++.....++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 77 ~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 77 SKF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred HHh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 643 34899999999999999999999877 999999999999999999999999988655421 12334567
Q ss_pred cccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHH
Q 012213 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQV 431 (468)
Q Consensus 352 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 431 (468)
.|+|||...+..++.++||||+|+++|||++|+.|+....... ...... ..+......+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~~~~---~~~~~~~~~~ 205 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTHTTL---NIPEWVSEEA 205 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------cccccc---CCcccCCHHH
Confidence 8999999988889999999999999999999998875421100 000000 1112234567
Q ss_pred HHHHHhhcccCCCCCCCHH
Q 012213 432 FFVAMLCVQEHGVERPTMR 450 (468)
Q Consensus 432 ~~l~~~c~~~~P~~RPt~~ 450 (468)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 7899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=264.22 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=193.5
Q ss_pred cceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEeccCC
Q 012213 187 NNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
.+.||+|+|+.|-.... .+|.+||||++.+... ....+..+|++++..++ |+||+.+++||+++...|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 46899999999998875 6899999999865432 33467889999999995 99999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---ceEEeeccccccccccC--
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKYLQDTG-- 339 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~-- 339 (468)
|+|.+.++... .+++.++.++.++||.||.|||++| |.|||+||+|||..+.. -+|||||.+..-+....
T Consensus 161 GplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 161 GPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred chHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999997443 4899999999999999999999888 99999999999997644 48999999876443111
Q ss_pred ---CCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc-c-
Q 012213 340 ---ASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS-K- 409 (468)
Q Consensus 340 ---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~- 409 (468)
......+.+|+..|||||+.. ...|+.++|.||+||++|-|++|.+||.+.-. .-+.|.+...-.. .
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg---~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG---ADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC---CcCCccCCCccHHHHH
Confidence 112234567889999999753 34688999999999999999999999987321 1122322111000 0
Q ss_pred cchhhhccccCCCCCHHH----HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 EGVVKILDQRLSNTPLSE----AMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~----~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....+.+.. .++|..+ ..+..+++...+..||..|.++.+++.
T Consensus 313 ~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0111122221 2333333 344567777788899999999998876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=278.53 Aligned_cols=196 Identities=27% Similarity=0.463 Sum_probs=176.0
Q ss_pred cceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 187 NNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.+.||.|.||+||-|.+ ++|+.||||++.+.........++.+|+.+|.+++||.||.+..-|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 58899999999999998 57999999999887777777788999999999999999999999999999999999999 56
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEeeccccccccccCCCc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+..+.+-..+...+++.....++.||+.||.|||.++ |+|+||||+|||+.+. ..+||||||+|+++.. ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence 7666665566667888888899999999999999888 9999999999999765 4699999999999763 33
Q ss_pred cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 343 CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
....++||+.|+|||++..+.|...-|+||.||++|--++|..||.+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 44678899999999999999999999999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=282.56 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=205.2
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec-----CC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN-----KE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~ 253 (468)
.+.|++.+.||+|.+|.||++.. ++++..|||++.... +..++.+.|.++++.. .|||++.++|++.. ++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 56688889999999999999987 568889999875433 3336688899998888 69999999998853 56
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..+||||||.+||..|+++...+..+.|.....|+..+++|+.+||+.. ++|||||-.|||++.++.+|++|||++.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 7899999999999999998877888999999999999999999999766 9999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.+... -....+..||+.|||||++.- ..|+.++|+||+|++..||--|.+|+.++..
T Consensus 172 QldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------------- 233 (953)
T KOG0587|consen 172 QLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------------- 233 (953)
T ss_pred eeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------------
Confidence 77532 223345679999999998753 3577899999999999999999999987542
Q ss_pred ccchhhhcccc----C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQR----L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~----~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...++-.. . ...+.....++.+++..|+..|-++||++.++++
T Consensus 234 ---mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 ---MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 12222111 1 2335667788999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=258.32 Aligned_cols=237 Identities=30% Similarity=0.406 Sum_probs=191.4
Q ss_pred CCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhcc
Q 012213 194 GAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272 (468)
Q Consensus 194 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 272 (468)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999986 489999999865433221 4679999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCcc
Q 012213 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352 (468)
Q Consensus 273 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 352 (468)
.... +++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 80 KRGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred hccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 5433 889999999999999999999877 9999999999999999999999999998765321 2344567889
Q ss_pred ccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHH--HHHH
Q 012213 353 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS--EAMQ 430 (468)
Q Consensus 353 y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~--~~~~ 430 (468)
|+|||......++.++||||||++++++++|..||...... ....++.. .......... ....
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~--------------~~~~~~~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIG--------------KPKPPFPPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHh--------------ccCCCCccccccCCHH
Confidence 99999998888999999999999999999999998652111 11111110 1111110111 4567
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHH
Q 012213 431 VFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 431 ~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.46 Aligned_cols=259 Identities=18% Similarity=0.218 Sum_probs=169.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEE------E
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF------C 249 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~ 249 (468)
.++|+..+.||+|+||.||+|.+.+ +..||||++..... . +....+ .+....+.++..++.. +
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V--EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678889999999999999999854 68999998753221 1 111111 1222222233222211 2
Q ss_pred ecCCeeEEEEeccCCCChhhhcccCCCC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 012213 250 SNKETNLLVYEYMPNGSLGEVLHGKRGS------------------FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV 311 (468)
Q Consensus 250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 311 (468)
......++|+||+++++|.+++...... ......+..++.||+.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 4566789999999999999988643210 1123345679999999999999877 999999
Q ss_pred CCCcEEEcC-CCceEEeeccccccccccCCCccccccccCccccCccccCCC----------------------CCCcch
Q 012213 312 KSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL----------------------KVDEKS 368 (468)
Q Consensus 312 k~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 368 (468)
||+|||+++ ++.+||+|||+++.+.. +.........+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~-~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRV-GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccc-ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 57999999999986542 222233456789999999954321 244567
Q ss_pred hhHHHHHHHHHHHhCCCCCCCC--------CCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcc
Q 012213 369 DVYSFGVVLLELITGRRPVGDF--------GEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQ 440 (468)
Q Consensus 369 Dv~s~G~~l~elltg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~ 440 (468)
|||||||++|||+++..|++.. ...+.+...|...............+ ...........+++.+|++
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGF-----EVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhh-----hhccccchHHHHHHHHHcc
Confidence 9999999999999977665431 01112233333221111000000000 0000112234579999999
Q ss_pred cCCCCCCCHHHHHH
Q 012213 441 EHGVERPTMREVVQ 454 (468)
Q Consensus 441 ~~P~~RPt~~ev~~ 454 (468)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=277.25 Aligned_cols=240 Identities=23% Similarity=0.277 Sum_probs=191.8
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
+.+.|+....+|.|+|+.|-...+ .+++..+||++.... ..-.+|+.++... .|||++++.+.+.+..+.++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 356677778899999999988876 467889999986542 2234567665555 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCceEEeecccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL-NSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgla~~~~ 336 (468)
|||.+.++-+.+.+...+. .. ..+..|+.+|+.|+.|||.+| +|||||||+|||+ ++.++++|+|||.++...
T Consensus 394 v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999999988877754332 22 677789999999999999887 9999999999999 589999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
.. ....+-|..|.|||+.....|++++|+||||++||+||+|+.||...+.+ .++.. .+
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~---------------~i 526 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT---------------RI 526 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH---------------hh
Confidence 32 33446688999999999999999999999999999999999999764422 11111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ........+....+++.+|++.||.+||+|.|+..
T Consensus 527 ~--~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 Q--MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred c--CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 0 01222455667788999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.32 Aligned_cols=251 Identities=23% Similarity=0.239 Sum_probs=197.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|.+.++||+|+||.|..++.+ .++.||.|++.....- .....-|..|-.+|..-+.+-|+.+.-+|.+..+.|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 567889999999999999999985 4678999998763221 12225689999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||||+||+|-.++.... .+++..+..++..|.-||.-||+.| +|||||||.|||+|..|++||+|||.+-.+...
T Consensus 154 MdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999996433 6999999999999999999999877 999999999999999999999999999888744
Q ss_pred CCCccccccccCccccCccccC----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 339 GASECMSAVAGSYGYIAPEYAY----T-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
+ .-.....+|||.|++||++. + +.|++.+|.||+||++|||+.|..||.... ++. ...
T Consensus 229 G-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lve-----------TY~ 291 (1317)
T KOG0612|consen 229 G-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVE-----------TYG 291 (1317)
T ss_pred C-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHH-----------HHH
Confidence 3 33456678999999999875 2 568999999999999999999999996411 111 233
Q ss_pred hhccccC-CCCC--HHHHHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 012213 414 KILDQRL-SNTP--LSEAMQVFFVAMLCVQEHGVERPT---MREVVQ 454 (468)
Q Consensus 414 ~~~d~~~-~~~~--~~~~~~~~~l~~~c~~~~P~~RPt---~~ev~~ 454 (468)
++++..- ..+| .+.+....+++..-+. +|+.|-. ++++-.
T Consensus 292 KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 292 KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 3333211 1112 2344555666665444 5667776 777643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=233.34 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=197.5
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|+.-+.||+|.||+||||+.. .++.||+|++.-....+.......+||-+++.++|.|||++++....+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 344568999999999999975 5788999998766555544567889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
. -+|..+...-. ..++.+....++.|+.+||.++|... +.|||+||+|.|++.+|+.|++|||+++.+.- .-.
T Consensus 84 d-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--pvr 156 (292)
T KOG0662|consen 84 D-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVR 156 (292)
T ss_pred h-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--ceE
Confidence 4 68888876444 34888999999999999999999766 99999999999999999999999999997652 223
Q ss_pred cccccccCccccCccccCCCC-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHH---Hhhcccccchhhhcc
Q 012213 343 CMSAVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTK---MQTNSSKEGVVKILD 417 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~d 417 (468)
..+..+-|..|.+|.++.+.+ |++..|+||-||++.|+.. |++-|.+.+.+ .++....+ ...++.+..+.++-|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCCC
Confidence 445566789999999988765 8999999999999999998 66666553321 11211111 112222333344444
Q ss_pred ccCC-CCC-----HHHH----HHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLS-NTP-----LSEA----MQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~-~~~-----~~~~----~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... .++ .+.. ..-.++....+.-+|..|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 3331 111 0111 12245666677779999999998775
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=239.64 Aligned_cols=203 Identities=29% Similarity=0.430 Sum_probs=168.2
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.....||+|++|.|-+-++ .+|...|||++..... ....++...|+.+..+. .+|.+|.++|.+......++.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34456799999999998887 5799999999875433 44446778888886555 699999999999999999999999
Q ss_pred cCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 262 MPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 262 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
| ..||+.+-.. ..+..+++...-+|+..+..||.|||++-+ ++|||+||+|||++.+|.+|+||||++..+.++
T Consensus 127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS- 202 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS- 202 (282)
T ss_pred h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh-
Confidence 9 4688766432 345678999999999999999999998654 999999999999999999999999999887532
Q ss_pred CCccccccccCccccCccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 393 (468)
-..+...|...|||||.+.. ..|+-++||||+|+++.||.+++.||+.+...
T Consensus 203 --iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 203 --IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred --hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 22344678899999998753 46899999999999999999999999875543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=261.70 Aligned_cols=242 Identities=25% Similarity=0.284 Sum_probs=189.9
Q ss_pred hccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCC-CCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 258 (468)
..|....+||+|+||.|-+|.-+. .+.+|||+++....- .+..+--..|-++|... +-|.++++..+++.-+..++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 346677899999999999997653 467999998765442 22223334566666555 568999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+.||+|--.+..- ..+.++.+..+|.+||-||-+||+++ |++||||-.||++|.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 501 (683)
T ss_pred EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--
Confidence 9999999998887633 34788899999999999999999877 9999999999999999999999999997432
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
-....+.+.+||+.|+|||.+...+|+.++|.|||||+||||+.|++||++.+++. ....+.+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI~eh 565 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAIMEH 565 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHHc
Confidence 23345678899999999999999999999999999999999999999998755332 12222222
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP 447 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP 447 (468)
. ..++...+.+...+...-+...|.+|.
T Consensus 566 n-vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 N-VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c-CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2 223444555666677777788888884
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=285.57 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=186.5
Q ss_pred cCCcceEcccCCcc-eEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGV-VYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
|...+++|.|+-|+ ||+|.. +|+.||||++.... .+...+||..|+.- +|||||++++.-.++...|++.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 34457889999876 799988 57999999985322 24567899999888 599999999999999999999999
Q ss_pred cCCCChhhhcccC-CC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---C--CceEEeecccccc
Q 012213 262 MPNGSLGEVLHGK-RG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---D--FEAHVADFGLAKY 334 (468)
Q Consensus 262 ~~~gsL~~~l~~~-~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgla~~ 334 (468)
| ..+|.+++... .. ....-...+.+..|++.||++||..+ ||||||||+|||++. + .+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 57999999864 11 11111345678899999999999766 999999999999976 3 5699999999998
Q ss_pred ccccCC-CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 335 LQDTGA-SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
+..... ........||-+|+|||++....-+.++||||+||++|+.++ |++||.+.-....++.. ... .+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~~--~L 732 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GNY--TL 732 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Ccc--ce
Confidence 864322 223456789999999999999888889999999999999999 59999862211111110 000 00
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. +...+ ++ +..+++..+++++|..||++.+|+.
T Consensus 733 ~~-----L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VH-----LEPLP-DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee-----eccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 11111 11 6778999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=273.69 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=179.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-----------------CCCcEEEEEEecccCCCC------------CchhHHHHHH
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-----------------PNGEQVAVKKLLGITKGS------------SHDNGLSAEI 231 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~ 231 (468)
.++|+..++||+|+||+||+|.+ .+++.||||++....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56788999999999999999964 245689999986432211 0112244577
Q ss_pred HHHhCCCCCCc-----cceeEEEec--------CCeeEEEEeccCCCChhhhcccCCC----------------------
Q 012213 232 RTLGKIRHRNI-----VRLKAFCSN--------KETNLLVYEYMPNGSLGEVLHGKRG---------------------- 276 (468)
Q Consensus 232 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------- 276 (468)
..+.+++|.++ ++++++|.. .+..++||||+++|+|.++++...+
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677787753 3567999999999999999874321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCc
Q 012213 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356 (468)
Q Consensus 277 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 356 (468)
..++|..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+... .........+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeCh
Confidence 13567889999999999999999877 999999999999999999999999999765421 11111223347899999
Q ss_pred cccCCCC----------------------CCcchhhHHHHHHHHHHHhCCC-CCCCCCC-------CCcCHHHHHHHhhc
Q 012213 357 EYAYTLK----------------------VDEKSDVYSFGVVLLELITGRR-PVGDFGE-------EGLDIVQWTKMQTN 406 (468)
Q Consensus 357 E~~~~~~----------------------~~~~~Dv~s~G~~l~elltg~~-p~~~~~~-------~~~~~~~~~~~~~~ 406 (468)
|.+.... ...+.||||+||+++||++|.. |+..... ...++..|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1235799999999999999875 7654211 01122223221110
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCC---CCCCCHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHG---VERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P---~~RPt~~ev~~ 454 (468)
. .+.. ..........+++.+++..+| .+|+|++|+++
T Consensus 460 ~--------~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 K--------YDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C--------CCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 1111 111234556778888888765 68999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=260.37 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=193.1
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCc------hhHHHHHHHHHhCCCCCCccceeEEEe-cCC
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSH------DNGLSAEIRTLGKIRHRNIVRLKAFCS-NKE 253 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~ 253 (468)
++|-..++||+|||+.||||.+ ...+.||||+-.. .+.... .+...+|..+-+.+.||.||++++|+. +.+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHql-NK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQL-NKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehh-ccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4455567899999999999987 4567788886532 222211 134567999999999999999999985 455
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEeecc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFG 330 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 330 (468)
..|-|+|||+|.+|+-||+..+ .+++.++..|+.||..||.||.+. +++|||-||||.|||+.+ .|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6789999999999999996543 589999999999999999999976 688999999999999954 5789999999
Q ss_pred ccccccccCCC-----ccccccccCccccCccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHH
Q 012213 331 LAKYLQDTGAS-----ECMSAVAGSYGYIAPEYAYT----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 331 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 401 (468)
+++++...... ..++..+||+.|++||.+.- .+++.|+||||.||++|.++.|+.||..... ..++.+..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdILqeN 697 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDILQEN 697 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHHHhhh
Confidence 99998754332 23456789999999998753 3578899999999999999999999976322 11222221
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVV 453 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~ 453 (468)
. +.+.-.-.+... .-...+...++++|++..-++|....++.
T Consensus 698 T---------IlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 T---------ILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred c---------hhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 111111111111 12344566789999999888887777664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-34 Score=246.46 Aligned_cols=267 Identities=21% Similarity=0.330 Sum_probs=191.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-------- 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 251 (468)
...|+....||+|.||.||+|+.+ .|+.||+|+..-.......-....+|+++|..++|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345666788999999999999975 46778988764322222222456789999999999999999887743
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
....++|+++|+. +|.-+|.. ....++..++.++++++..||.|+|... |+|||+||.|+|++.++.+||+|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 3346899999974 77777753 3345889999999999999999999665 99999999999999999999999999
Q ss_pred cccccccCC--CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC--------------
Q 012213 332 AKYLQDTGA--SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG-------------- 394 (468)
Q Consensus 332 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~-------------- 394 (468)
++.+..... ....+..+-|..|.+||.+.+ ..|+++.|||+-||++.||+|+.+-+.+..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987653222 222345566899999998765 569999999999999999999998886633210
Q ss_pred ------cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 395 ------LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 395 ------~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.-|.......-.+.-...+..++. +.-.....++++...+..||.+|+++.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k--p~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK--PYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcc--cccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 011111111111000011111111111 0011235678888999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=252.59 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=202.8
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-C-C----CccceeEEEe
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-H-R----NIVRLKAFCS 250 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~ 250 (468)
+.+..+|.+...+|+|.||.|-...+. .+..||||+++...+.. +...-|++++.++. + | -+|.+.+|+.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr---eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR---EAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh---hHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 344788999999999999999999874 36889999987654432 45677999999993 2 2 3677888999
Q ss_pred cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----------
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---------- 320 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---------- 320 (468)
..++.++|+|.+ |-|+.+++..+.-.+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 999999999998 679999999877788999999999999999999999777 999999999999942
Q ss_pred ----------CCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 321 ----------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 321 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+..++|+|||.|+.-... ....+.|..|.|||++.+..++..+||||+||+|+|+.||..-|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 345899999999864422 25567899999999999999999999999999999999999999764
Q ss_pred CC-CCcCHHHHH-----HHhhccc----------cc--------chhhhccccC-----CCCCHHHHHHHHHHHHhhccc
Q 012213 391 GE-EGLDIVQWT-----KMQTNSS----------KE--------GVVKILDQRL-----SNTPLSEAMQVFFVAMLCVQE 441 (468)
Q Consensus 391 ~~-~~~~~~~~~-----~~~~~~~----------~~--------~~~~~~d~~~-----~~~~~~~~~~~~~l~~~c~~~ 441 (468)
++ +.....+-+ ....... -+ ......+... ......+..++++++..++..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 41 111000000 0000000 00 0011111111 122346677899999999999
Q ss_pred CCCCCCCHHHHHH
Q 012213 442 HGVERPTMREVVQ 454 (468)
Q Consensus 442 ~P~~RPt~~ev~~ 454 (468)
||.+|+|+.|++.
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=242.47 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=196.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCc-hhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSH-DNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
...|....+||+|+|+.|-.+.++ ..+.+|+|++++.....++ .+=.+.|-.+..+. +||.+|.+..++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 456777899999999999999885 4678999988765544332 23345555555555 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|.||++||+|--++. +...++++.+..+...|.-||.|||+.| |+.||||-.|+|+|.+|++||+|||+++.--
T Consensus 329 vieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l- 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL- 402 (593)
T ss_pred EEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-
Confidence 999999999977664 3445899999999999999999999888 9999999999999999999999999998532
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC--CCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD--FGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.....+++.+||+.|.|||.+.+..|...+|.|++||+++||+.|+.||+- ++....+..++.- ++
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf-----------qv 470 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF-----------QV 470 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH-----------HH
Confidence 334556789999999999999999999999999999999999999999975 2222222222211 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP 447 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP 447 (468)
+-.+....+.....+...+...-++.||.+|.
T Consensus 471 ilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 11122233445566667778888999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=261.56 Aligned_cols=244 Identities=22% Similarity=0.270 Sum_probs=194.5
Q ss_pred hccCCcceEcccCCcceEEEEcCCCc-EEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGE-QVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+++...-||-|+||.|-++..++.. .+|+|.+++... ...+.+....|-.+|..++.|.||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44555677999999999998875433 378887765322 2233355778999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|-|-||.|...|..+ ..++..+...++..+.+|++|||..+ ||+|||||+|.++|.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 999999999999643 35888888899999999999999777 99999999999999999999999999998753
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
...+-+.+||+.|.|||.+.....+.++|.||+|+++||++||.+||.+.+. ...+.. +.+.+|.
T Consensus 573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktYn~---------ILkGid~- 637 (732)
T KOG0614|consen 573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTYNL---------ILKGIDK- 637 (732)
T ss_pred -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHHHH---------HHhhhhh-
Confidence 3344578999999999999999999999999999999999999999987442 111111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPT 448 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt 448 (468)
...|........+++.+.+..+|.+|..
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1233344556677888888899999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=256.78 Aligned_cols=203 Identities=25% Similarity=0.317 Sum_probs=169.1
Q ss_pred ccCCcceEcccCCcceEEEEcCCC-cEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPNG-EQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.|...+-||-|+||+|.++...|. ..||.|.+.+... ........++|..+|....++-||+|+-.|.+++..|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 355567899999999999987554 4588998754322 12223457889999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC-
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG- 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 339 (468)
|++||++-.+|-.. ..+++..+..++.++++|+++.|+.| +|||||||.|||+|.+|++||+|||++.-+....
T Consensus 710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999988633 45888999999999999999999887 9999999999999999999999999996542110
Q ss_pred -------CCc--------------------------------cccccccCccccCccccCCCCCCcchhhHHHHHHHHHH
Q 012213 340 -------ASE--------------------------------CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 380 (468)
Q Consensus 340 -------~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el 380 (468)
... .....+||+.|+|||++....++..+|.||.||+||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000 00124699999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 012213 381 ITGRRPVGDF 390 (468)
Q Consensus 381 ltg~~p~~~~ 390 (468)
+.|++||-..
T Consensus 865 ~~g~~pf~~~ 874 (1034)
T KOG0608|consen 865 LVGQPPFLAD 874 (1034)
T ss_pred hhCCCCccCC
Confidence 9999999763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=242.14 Aligned_cols=200 Identities=26% Similarity=0.386 Sum_probs=166.8
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----eeE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNL 256 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 256 (468)
+.+..+.||-|+||.||.+.+ ++|+.||.|++......-...+++-+|+++|...+|.|++..++...-.. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345668899999999999998 58999999999766554444578899999999999999999888664332 457
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+++|.|. .+|.+.+- ....++.+.+.-+..||.+||.|||..+ |.||||||.|.|++++...||||||+++.-.
T Consensus 134 V~TELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 8888884 58888774 3445788888889999999999999777 9999999999999999999999999999765
Q ss_pred ccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
. +....++..+-|.+|.|||.+++. .|+.++||||.||++.|++..+.-|..
T Consensus 208 ~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 208 Q-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred h-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 3 333445556678999999999875 599999999999999999999888865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=228.65 Aligned_cols=211 Identities=35% Similarity=0.541 Sum_probs=181.2
Q ss_pred EcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCChh
Q 012213 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 268 (468)
||+|++|.||++...+ ++.+++|++....... ....+.+|+..++.++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999864 8999999986443321 2356899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccccCCCcccccc
Q 012213 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAV 347 (468)
Q Consensus 269 ~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 347 (468)
+++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 9987432 35889999999999999999999877 999999999999999 89999999999986643221 12335
Q ss_pred ccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHH
Q 012213 348 AGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426 (468)
Q Consensus 348 ~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 426 (468)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999998877 788999999999999999
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 427 EAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 427 ~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346678899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=222.43 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=192.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCC--eeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE--TNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~ 256 (468)
.++|++.+.+|+|.++.||.|.. .+.++++||.++.... +.+.+|+++|..++ ||||+++++...++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46788889999999999999986 5678999999976543 66899999999997 999999999987654 567
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeeccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYL 335 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~ 335 (468)
||+||+.+.+...+-. .+........+.+++.||.|+|+.| |+|||+||.|+++|.. -..+|+|+|+|.++
T Consensus 112 LiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877665542 2566777889999999999999777 9999999999999975 56999999999988
Q ss_pred cccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhh---------
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT--------- 405 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 405 (468)
..... ....+.+..|.-||++.. ..|+-.-|+|||||++.+|+..+.||-.......+++..++...
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 64322 233455677899998765 45888999999999999999999998653333333333322211
Q ss_pred ---cccccchhhhccccC---------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 406 ---NSSKEGVVKILDQRL---------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 406 ---~~~~~~~~~~~d~~~---------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..-.....+++...- .+...-...+.++++...+..|..+|||+.|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111111100 0000111356778888999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=225.82 Aligned_cols=200 Identities=35% Similarity=0.474 Sum_probs=170.4
Q ss_pred cCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
|...+.||+|++|.||++...+ ++.+++|.+...... ...+.+.+|++.+.+++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 3456789999999999999865 889999998643322 13467889999999999999999999999989999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
++++|.+++...... +++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA 154 (225)
T ss_pred CCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence 999999998754322 789999999999999999999877 9999999999999999999999999998765332 11
Q ss_pred cccccccCccccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 343 CMSAVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=222.43 Aligned_cols=255 Identities=16% Similarity=0.267 Sum_probs=193.3
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeE-EEecCCeeE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKA-FCSNKETNL 256 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~ 256 (468)
+.+.|.+.+.+|+|.||.+-++.++ +.+.+++|-+.... ....+|.+|...--.+ .|.||+.-++ .++..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3677889999999999999999986 45678888764332 2336788888775556 5899998776 567778889
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-C-CCceEEeecccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-S-DFEAHVADFGLAKY 334 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~-~~~~kl~Dfgla~~ 334 (468)
+++||+|.|+|.+-+.. ..+-+....+++.|++.|+.|||++. +||||||.+|||+- . ...+||||||+.+.
T Consensus 99 F~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999999988754 34778888999999999999999776 99999999999993 3 35799999999875
Q ss_pred ccccCCCccccccccCccccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.+ .......-+..|.+||..... ...+.+|+|.||++++.++||+.||......+..+..|.++..+...
T Consensus 173 ~g-----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 173 VG-----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred cC-----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence 43 112233346679999976532 36688999999999999999999998644455667777766544432
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
++.........++.++..+-+.++|++|=...++.++-+
T Consensus 248 ---------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ---------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ---------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 222222234556777888889999999966666666544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=225.86 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=196.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------ 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 253 (468)
..+|.....+|.|.- .|..|.+ -.+++||+|++..........++..+|...+..+.|+|+++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 445666778888887 6666655 35889999998765555555677889999999999999999999885433
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
+.++|||+| .++|...++. .++-.+...+..|+.+|+.|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 568999999 5799888872 2677888999999999999999777 9999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc----
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---- 409 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 409 (468)
.-. ..-.++....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+. ..+-+|.+....-+.
T Consensus 167 ~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHH
Confidence 533 223456677889999999999888999999999999999999999988742 233444433221110
Q ss_pred ----------------cch-----hh-hccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 ----------------EGV-----VK-ILDQRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ----------------~~~-----~~-~~d~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.. .+ +-|..+ .+.+.-....+-+++.+++-.+|++|-+++++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 00 111111 1112223445678899999999999999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=249.00 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=199.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+....+|.|.||.|||+++ ..++..|||.++-... +.......|+-+++.++||||+.++|.+...+..+++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 45677788999999999999998 4688899998875443 23355788999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|||.+|+|++.-+. ..++++.+...+.+...+|++|||..+ -+|||||-.||++++.+.+|++|||.+-.+..
T Consensus 92 EycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred EecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999998763 345889999999999999999999777 89999999999999999999999999876542
Q ss_pred CCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 340 ASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
.-.......||++|||||+.. .+.|...+|||+.|++..|+---++|..+..... +... -.+..+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~L------mTkS~~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALFL------MTKSGF 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHHH------hhccCC
Confidence 122335677999999999764 5679999999999999999988888854422100 0000 011122
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVV 453 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~ 453 (468)
++...+........+-+++..|+..+|++||+++..+
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 2222333344556677899999999999999988654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=242.25 Aligned_cols=197 Identities=23% Similarity=0.319 Sum_probs=165.7
Q ss_pred ccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCC------CCchhHHHHHHHHHhCCC---CCCccceeEEEecC
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG------SSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNK 252 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 252 (468)
.|...+.+|.|+||.|+.+.++. ...|+||.+.+...- .......-.||.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 36667899999999999999864 566888877654321 111134567999999997 99999999999999
Q ss_pred CeeEEEEecc-CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 253 ETNLLVYEYM-PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 253 ~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
+.++|+||-. ++-+|.+++..+. .+++.++..|++|++.|+++||+.+ |||||||-+||.++.+|.+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999999976 4568999996544 4899999999999999999999888 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVG 388 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~ 388 (468)
|.... +......+||..|.|||++.+.+|- ..-|||++|++||.++...-||.
T Consensus 717 aa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 87543 2345678899999999999988765 56899999999999999888874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=221.68 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=195.8
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 266 (468)
..+|.....|..|+|++. |..+++|++.-..........|..|.-.|+-+.||||+.++|.|..+.+..++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 356788899999999995 5667778776554444444679999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccc
Q 012213 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346 (468)
Q Consensus 267 L~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 346 (468)
|+..||+..+-..+..++.+++.+||+|++|||.... -|.---+.+..+++|++.+++|+= +-+++ +-....
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------sfqe~g 345 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVG 345 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee------eeeccc
Confidence 9999998887788889999999999999999998642 233446889999999999988751 11111 111122
Q ss_pred cccCccccCccccCCCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 347 VAGSYGYIAPEYAYTLKVD---EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 347 ~~gt~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
....+.||+||.+...+.+ .++|+|||++++||+.|...||.+...-.- ..+-.++......
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeglrv~i 410 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGLRVHI 410 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhccccccC
Confidence 3457899999998876544 579999999999999999999988543110 1111222222445
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+......+.+++.-|+++||.+||.+..|+-.||+++
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 5566777888999999999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=227.28 Aligned_cols=132 Identities=25% Similarity=0.355 Sum_probs=111.6
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-----C---CCccceeEEEe--
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----H---RNIVRLKAFCS-- 250 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~-- 250 (468)
.+|-..++||.|.|++||++.+. ..+.||+|+.+.... ..+....||++|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh---YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH---YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH---HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 56777899999999999999884 567899998765432 2356788999999884 3 36999999885
Q ss_pred --cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 012213 251 --NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319 (468)
Q Consensus 251 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 319 (468)
...+.+||+|++ |.+|..++....-+.++...+.+|+.||+.||.|||.+++ |||-||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 456889999999 7899999987776779999999999999999999999874 99999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=230.11 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=196.8
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecC
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK 252 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 252 (468)
..+.+.|...++||.|.|++||++.+. ..+.||+|.+...+.. .++.+|++.|..+ .+.||+++.+++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 344677888999999999999999874 4678999998654332 5588999999999 489999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGL 331 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl 331 (468)
+...+|+||+++..-.++... ++......++..+..||+++|..| ||||||||+|+|.+. -+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999988888753 667888999999999999999888 999999999999986 46789999999
Q ss_pred cccccccC-------------CC-----------------------------ccccccccCccccCccccCC-CCCCcch
Q 012213 332 AKYLQDTG-------------AS-----------------------------ECMSAVAGSYGYIAPEYAYT-LKVDEKS 368 (468)
Q Consensus 332 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 368 (468)
|...+... .. ......+||+||.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97321000 00 00012469999999998875 4578999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc-------------------------cC---
Q 012213 369 DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ-------------------------RL--- 420 (468)
Q Consensus 369 Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-------------------------~~--- 420 (468)
||||-||+++.+++++.||-....+...+.+.+...............+. ..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999996543333333333221111110000000000 00
Q ss_pred -------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 421 -------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 421 -------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..........++++..+|+..+|.+|-|++|.++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0001112236789999999999999999999876
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=262.03 Aligned_cols=196 Identities=16% Similarity=0.159 Sum_probs=138.8
Q ss_pred CCCC-CCccceeEEE-------ecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 012213 236 KIRH-RNIVRLKAFC-------SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307 (468)
Q Consensus 236 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 307 (468)
.++| +||+++++++ ...+..+.++||+ +++|.+++... ...+++.++..++.||++||.|||+.+ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5888888877 2334567778887 67999999743 345899999999999999999999877 99
Q ss_pred ecCCCCCcEEEcC-------------------CCceEEeeccccccccccCC--------------CccccccccCcccc
Q 012213 308 HRDVKSNNILLNS-------------------DFEAHVADFGLAKYLQDTGA--------------SECMSAVAGSYGYI 354 (468)
Q Consensus 308 H~dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~ 354 (468)
||||||+|||++. ++.+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566666776654211000 00011245788999
Q ss_pred CccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHH
Q 012213 355 APEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFV 434 (468)
Q Consensus 355 aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l 434 (468)
|||++.+..++.++|||||||+||||++|.+|+..... ....+.. .... ............+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~-----------~~~~----~~~~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRH-----------RVLP----PQILLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHH-----------hhcC----hhhhhcCHHHHHH
Confidence 99999999999999999999999999999888643110 0000000 0011 1111123345677
Q ss_pred HHhhcccCCCCCCCHHHHHH
Q 012213 435 AMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 435 ~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.+|++.+|.+||+|.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=204.80 Aligned_cols=168 Identities=21% Similarity=0.193 Sum_probs=126.6
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|+|.++++. .+..+++.+++.++.||+.||+|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 789999974 3446999999999999999999999754 999999999999999 9999865421
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.........+..+....... +.......
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---------DPRDRSNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---------CccccccH
Confidence 12578999999999999999999999999999999999999965332111111211111000 00000111
Q ss_pred HHHHH--HHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 425 LSEAM--QVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 425 ~~~~~--~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..... .+.+++..|++.+|++||++.|+++.+....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 12222 5889999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=222.34 Aligned_cols=197 Identities=26% Similarity=0.279 Sum_probs=162.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC------CCCccceeEEEecCCe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR------HRNIVRLKAFCSNKET 254 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~ 254 (468)
..|......|+|-|++|..|.+. -|+.||||++....... +.=..|+++|++|. --|+++++-.|...++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 45666677899999999999984 47899999997544322 33467999999995 2489999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeecccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLA 332 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla 332 (468)
.|||+|-+ ..+|.++|..-. .-.+....+..++.|+.-||..|-..+ |+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999988 579999997432 225778889999999999999999888 9999999999999885 56899999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
....... .+...-+-.|.|||++.+..|+...|+||.||+|||+.||+.-|.+
T Consensus 585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 7654221 1222234579999999999999999999999999999999998876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=211.91 Aligned_cols=166 Identities=23% Similarity=0.205 Sum_probs=127.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC--CCcEEEEEEecccCC---CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--NGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
...|...+.||+|+||+||+|.++ +++.||||++..... .......+.+|++++.+++|+|+++.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 456888999999999999999874 577789998753211 11223568999999999999999863322 2457
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCceEEeecccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV-KSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgla~~ 334 (468)
++||||+++++|... . .. . ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||+|+.
T Consensus 94 ~LVmE~~~G~~L~~~-~-~~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R-PH----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHHh-C-cc----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 999999999999632 1 11 1 1467889999999999877 999999 99999999999999999999998
Q ss_pred ccccCCCcc------ccccccCccccCccccCC
Q 012213 335 LQDTGASEC------MSAVAGSYGYIAPEYAYT 361 (468)
Q Consensus 335 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 361 (468)
+...+.... .....+++.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 764432221 135678889999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=203.94 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=191.9
Q ss_pred ccCCcceEcccCCcceEEEEcCCC--cEEEEEEecccCCCCCchhHHHHHHHHHhCCCC----CCccceeEEE-ecCCee
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPNG--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH----RNIVRLKAFC-SNKETN 255 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~ 255 (468)
.|...+.||+|+||.||++.+.+. ..+|+|.......... ..+..|+.++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 688899999999999999998654 4788887654332222 257788888888863 5888888888 477788
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CceEEeecc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-----FEAHVADFG 330 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg 330 (468)
++||+.+ |.||.++........++..+.++++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999988 889999886555567999999999999999999999888 9999999999999765 469999999
Q ss_pred ccc--cccccCCC----c-c-ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHH
Q 012213 331 LAK--YLQDTGAS----E-C-MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 331 la~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 402 (468)
+++ .+...... . . .....||..|.++....+...+.+.|+||++.++.|++.|..||....... .......
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-~~~~~~~ 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-LKSKFEK 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-hHHHHHH
Confidence 998 33222111 1 1 123569999999999999999999999999999999999999996533111 0111111
Q ss_pred HhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 403 MQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
... ...... .... ....+.++...+-..+...+|....+...|++....
T Consensus 252 ~~~-------~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPR-------KLLTDR-FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred Hhh-------hhcccc-ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000 000000 1111 223344455555557888999999999998766443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-22 Score=192.30 Aligned_cols=263 Identities=28% Similarity=0.362 Sum_probs=196.5
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCC-chhHHHHHHHHHhCCCCC-CccceeEEEecCCeeEEEEec
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS-HDNGLSAEIRTLGKIRHR-NIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 261 (468)
|...+.||.|+||.||++.+. ..+++|.+........ ....+.+|+..+..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 445678999999999999987 7889998876544432 356799999999999988 799999999777778999999
Q ss_pred cCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccccccccC
Q 012213 262 MPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDTG 339 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 339 (468)
+.++++.+++..... ..+.......++.+++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977653322 25888999999999999999999887 99999999999999998 79999999998654332
Q ss_pred CCc----cccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 340 ASE----CMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 340 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
... ......|+..|+|||.... ..+....|+||+|++++++++|..||............+......... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 3466789999999999987 578899999999999999999999976533210001111111111100 00
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
..... ..........+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 00001223567788899999999999999887763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=181.71 Aligned_cols=201 Identities=24% Similarity=0.353 Sum_probs=169.8
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 259 (468)
-.|+.++.||+|+||..+.|.. -+++.||||.-. ......++..|.+..+.+. .+.|..++-|.....+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP----rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP----RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc----ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4688899999999999999985 678999999532 2223356888998888884 689998888888888889999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CceEEeecccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-----FEAHVADFGLAKY 334 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgla~~ 334 (468)
|.+ |.||+|++. -.+..++..++..+|+|+..-++|+|++. +|.|||||+|+||..- ..+.++|||+|+.
T Consensus 104 dLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 998 889999876 44556999999999999999999999877 9999999999999643 4589999999998
Q ss_pred ccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 012213 335 LQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFG 391 (468)
Q Consensus 335 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 391 (468)
+.+.... .......||.+||+-....+.+.+.+.|+-|+|-++++.|-|..||.+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 8754432 23356679999999999999999999999999999999999999998844
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=174.06 Aligned_cols=200 Identities=25% Similarity=0.342 Sum_probs=166.5
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC-CCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 259 (468)
..|...+.||.|+||.+|.|.. .+|+.||+|.-...... .++..|.++...+++ ..|..+..|..+.....+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4577789999999999999986 68999999986544444 347788899888875 67777888888888899999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEeecccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAKYLQ 336 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~ 336 (468)
+.+ |.||++++.-- ...++..+.+-++-|+..-++|+|..+ ++||||||+|+|..-+ ..+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 998 88999988632 234788999999999999999999888 9999999999999654 458899999999875
Q ss_pred ccCC-----CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 337 DTGA-----SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 337 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+... ........||.+|.+-....+...+.+.|+-|+|.+|.+..-|..||.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 4322 22334567999999988888888889999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=178.20 Aligned_cols=142 Identities=18% Similarity=0.203 Sum_probs=108.8
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCc-------hh-----------------HHHHHHHHHhCCCCCCc
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH-------DN-----------------GLSAEIRTLGKIRHRNI 242 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------~~-----------------~~~~e~~~l~~l~h~ni 242 (468)
...||+|+||.||+|.+.+|+.||||+++........ .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999989999999998754221111 01 12348999999988776
Q ss_pred cceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCcEEEcCC
Q 012213 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL-HHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 243 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~~~ 321 (468)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44433322 234899999998877654321 23588999999999999999999 6777 99999999999998 4
Q ss_pred CceEEeecccccccc
Q 012213 322 FEAHVADFGLAKYLQ 336 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~ 336 (468)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=213.99 Aligned_cols=256 Identities=20% Similarity=0.218 Sum_probs=183.9
Q ss_pred CCcceEcccCCcceEEEEcC-CCcEEEEEEecccC-CCC---CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 185 KDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGIT-KGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
....++|.|++|.|+..... .....+.|.+.... ... .....+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45688999999988877653 33334455432110 111 11122556777778889999988877766666666669
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++ +|..++... ..+....+-.+++|+..|+.|+|..| |.|||+|++|++++.++.+||+|||.+....-..
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999998643 35778888999999999999999888 9999999999999999999999999998765433
Q ss_pred CC--ccccccccCccccCccccCCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 340 AS--ECMSAVAGSYGYIAPEYAYTLKVDE-KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 340 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
.. .......|+..|+|||...+..|.+ ..||||.|++++.|.+|+.||..-..+.....+ ... ....-+
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~--~~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNY--SDQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcc--cccccc
Confidence 33 4556788999999999999999886 589999999999999999999652222111100 000 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......-.....+...++.++++.+|.+|-|+++|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001111233455677889999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-23 Score=213.24 Aligned_cols=259 Identities=21% Similarity=0.216 Sum_probs=186.5
Q ss_pred ccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHH--HhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT--LGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+...+.+|.+.|=.|.+|++++|. |+||++......-. ...|.++++- ....+|||.+++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~s-L~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTIS-LRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCC-chHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556688999999999999999888 89999865432211 1334433332 455589999999888777777788889
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc--ccc
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL--QDT 338 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~--~~~ 338 (468)
|.. -+|+|.+. .+..+...+..-|+.|+..|+..+|+.+ |.|||||.+|||+++-..+.|+||.--+.. ..+
T Consensus 102 yvk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 985 59999884 4556788888889999999999999888 999999999999999999999999866432 211
Q ss_pred CC---CccccccccCccccCccccCCC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHH
Q 012213 339 GA---SECMSAVAGSYGYIAPEYAYTL----------K-VDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKM 403 (468)
Q Consensus 339 ~~---~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 403 (468)
+. .....+...-.+|+|||.+... . .+++-||||+||++.|+++ |++||.- .++..+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhcc
Confidence 11 1122333455689999976531 1 5678999999999999999 7888842 122222221
Q ss_pred hhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 404 QTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
........++++-| ..+..+++.|++.||++|-++++.++.-.+...++.|
T Consensus 251 ~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yF 301 (1431)
T KOG1240|consen 251 NADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYF 301 (1431)
T ss_pred CccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHH
Confidence 10000001122222 2456799999999999999999999987777666543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=178.29 Aligned_cols=174 Identities=14% Similarity=0.144 Sum_probs=132.2
Q ss_pred hhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCc-hh------HHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH-DN------GLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~------~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
+..+|+..+++|.|+||.||.+.. ++..+|||.+......... .. .+.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 356788899999999999999766 6778999998754432221 11 268899999999999999998886533
Q ss_pred --------CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCce
Q 012213 253 --------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324 (468)
Q Consensus 253 --------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 324 (468)
...+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||++|+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999988742 222 24568999999999888 99999999999999988 9
Q ss_pred EEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 012213 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382 (468)
Q Consensus 325 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 382 (468)
+|+|||........... ..+.....+..++|+||||+++.....
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988654211110 012333456678999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=171.50 Aligned_cols=141 Identities=23% Similarity=0.241 Sum_probs=110.7
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCc------------------------hhHHHHHHHHHhCCCCCCc
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH------------------------DNGLSAEIRTLGKIRHRNI 242 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 242 (468)
...||+|++|.||+|.+.+|+.||||++......... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998754221100 1123578899999999987
Q ss_pred cceeEEEecCCeeEEEEeccCCCChhhh-cccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcC
Q 012213 243 VRLKAFCSNKETNLLVYEYMPNGSLGEV-LHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNS 320 (468)
Q Consensus 243 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~ 320 (468)
.....+... ..++||||++++++... +.. ..++.....+++.+++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655444333 24899999998865433 322 346788899999999999999998 77 99999999999999
Q ss_pred CCceEEeecccccccc
Q 012213 321 DFEAHVADFGLAKYLQ 336 (468)
Q Consensus 321 ~~~~kl~Dfgla~~~~ 336 (468)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=190.71 Aligned_cols=218 Identities=23% Similarity=0.395 Sum_probs=163.9
Q ss_pred HhCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 012213 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313 (468)
Q Consensus 234 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 313 (468)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.|.+.. ....++|.-...++.+|+.||+|+|+. +-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 4567999999999999999999999999999999999975 445689999999999999999999973 3349999999
Q ss_pred CcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCC-------CCcchhhHHHHHHHHHHHhCCCC
Q 012213 314 NNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK-------VDEKSDVYSFGVVLLELITGRRP 386 (468)
Q Consensus 314 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s~G~~l~elltg~~p 386 (468)
+|.++|....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999998764211111112222356799999887631 46789999999999999999999
Q ss_pred CCCCCCCC--cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 387 VGDFGEEG--LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 387 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
|....... ..+..++.. .. ...+-+...... +....+..++..||.++|++||++++|-..++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~---~~----~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---GG----SNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh---cC----CCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 98733222 223333221 01 111111111111 2333688899999999999999999999999887653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=164.39 Aligned_cols=187 Identities=16% Similarity=0.065 Sum_probs=138.8
Q ss_pred CcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCC--chhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEecc
Q 012213 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
....|++|+||+||.+.. .+.+++.+.+.....-.. ....+.+|+++|+++. |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 678888777654322111 0124789999999995 5889999886 3469999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV-KSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+|.+|.+.+.. ....++.+++.+|.++|..| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998764421 11357789999999999888 999999 799999999999999999999865432210
Q ss_pred c---c--------ccccccCccccCccccCCC-CCC-cchhhHHHHHHHHHHHhCCCCCCC
Q 012213 342 E---C--------MSAVAGSYGYIAPEYAYTL-KVD-EKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 342 ~---~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
. . ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..|...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 1122367788888754322 233 577889999999999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.3e-22 Score=193.77 Aligned_cols=226 Identities=24% Similarity=0.268 Sum_probs=173.8
Q ss_pred EcccCCcceEEEEc----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEeccCC
Q 012213 190 IGRGGAGVVYRGVT----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 190 ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+|+|+||.|+.+.. ..|.-+|.|.++..............|..++..++ ||.+|++.-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998653 34677888887665443333234566788888886 99999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
|.|...+.... .+.......+...+|-|++++|+.+ ++|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 99988875433 3566666777788999999999888 9999999999999999999999999998764221
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 424 (468)
..+||..|||||+.. ....++|.||||++.+||+||..||.. + ....+.... ...+
T Consensus 152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~-----------------~~~~Il~~~-~~~p 207 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D-----------------TMKRILKAE-LEMP 207 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H-----------------HHHHHhhhc-cCCc
Confidence 128999999999988 567899999999999999999999975 0 111111111 2234
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 425 LSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 425 ~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
.+....+..++......+|..|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 4555556666667777777777544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=171.32 Aligned_cols=234 Identities=21% Similarity=0.273 Sum_probs=149.3
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCC----------CCccceeEE--
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRH----------RNIVRLKAF-- 248 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h----------~niv~l~~~-- 248 (468)
.+..++.||.|+++.||.+++. .|+.+|||.+....... ...+++++|.-....+.+ -.++--++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4456789999999999999995 48999999886554322 234567777655555432 112111121
Q ss_pred -------EecCC--------eeEEEEeccCCCChhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 012213 249 -------CSNKE--------TNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308 (468)
Q Consensus 249 -------~~~~~--------~~~lv~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 308 (468)
..... +.+++|+-+ .++|.+++.. .....+....++.+..|+.+.+++||..| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11111 236777777 5788877531 11123445667778899999999999888 999
Q ss_pred cCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCC--------CCCCcchhhHHHHHHHHHH
Q 012213 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT--------LKVDEKSDVYSFGVVLLEL 380 (468)
Q Consensus 309 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el 380 (468)
+||+|+|++++.+|.++|+||+....... .. .....+..|.+||.... ..++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE---EE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc---ee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988765432 11 11234578999997643 3578899999999999999
Q ss_pred HhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCC
Q 012213 381 ITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVER 446 (468)
Q Consensus 381 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~R 446 (468)
+++..||+....+..... .+.... +.++.+..++...++.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999976432211100 122223 567778889999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-20 Score=170.02 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=171.5
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-C-----------------------------------cEEEEEEecccCCCCCch
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-G-----------------------------------EQVAVKKLLGITKGSSHD 224 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~-----------------------------------~~vavK~~~~~~~~~~~~ 224 (468)
.++|++++.||+|....||.|..++ | -+.|+|.+.....++...
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 5778999999999999999987532 0 034677665544433221
Q ss_pred h---HHHHHH--------------HHHhC--------CCCCCccceeEEEec---------------------------C
Q 012213 225 N---GLSAEI--------------RTLGK--------IRHRNIVRLKAFCSN---------------------------K 252 (468)
Q Consensus 225 ~---~~~~e~--------------~~l~~--------l~h~niv~l~~~~~~---------------------------~ 252 (468)
. .+-+|. ...+. -+|||||++.++|.+ +
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 1 111111 11111 269999999887632 2
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCC--ceEEee
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL--NSDF--EAHVAD 328 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~D 328 (468)
...|+||.-.+ .+|.+++..+. .+.....-++.|+.+|+.|||+++ |.|||+|++|||+ |+|. ...|+|
T Consensus 316 ~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 316 KTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred ceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcc
Confidence 34588887664 58988886443 445566678899999999999888 9999999999998 3443 468999
Q ss_pred ccccccccccCCC----ccccccccCccccCccccCCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHH
Q 012213 329 FGLAKYLQDTGAS----ECMSAVAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIV 398 (468)
Q Consensus 329 fgla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 398 (468)
||.+-.....+-. .-.-...|....||||+....+ --.|+|.|+.|.+.||+++..-||...++...+..
T Consensus 389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r 468 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR 468 (598)
T ss_pred cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh
Confidence 9988643322211 1112345778899999876432 12689999999999999999999977443322222
Q ss_pred HHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 399 QWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
.+ ....+...+......+.+++...++.||++||+..-....|
T Consensus 469 ~Y---------------qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 469 TY---------------QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hh---------------hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 21 11223334455666778899999999999999877655544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=160.57 Aligned_cols=138 Identities=18% Similarity=0.256 Sum_probs=105.0
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-----CCCCccceeEEEecCC---ee
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-----RHRNIVRLKAFCSNKE---TN 255 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~ 255 (468)
++..+.||+|+||.||. +++....+||++..... ...+.+.+|+..++.+ .||||++++|++.++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 54434447998754322 2336789999999999 5799999999998874 33
Q ss_pred -EEEEec--cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCcEEEcC----CCceEEe
Q 012213 256 -LLVYEY--MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL-SYLHHDCSPLIIHRDVKSNNILLNS----DFEAHVA 327 (468)
Q Consensus 256 -~lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~ 327 (468)
.+|+|| +++|+|.+++... .+++. ..++.+++.++ +|||+.+ |+||||||+|||++. +..++|+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 378999 5679999999642 25544 35677888777 9999887 999999999999974 3479999
Q ss_pred e-ccccc
Q 012213 328 D-FGLAK 333 (468)
Q Consensus 328 D-fgla~ 333 (468)
| ||...
T Consensus 152 Dg~G~~~ 158 (210)
T PRK10345 152 DNIGEST 158 (210)
T ss_pred ECCCCcc
Confidence 9 45443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=188.95 Aligned_cols=195 Identities=19% Similarity=0.235 Sum_probs=157.2
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC---CCCccceeEEEecCCeeEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 258 (468)
+.|.+.+.||+|+||+||+|...+|+.||+|.=+.... ++ |.--.+++.+|+ -+.|..+..++.-.+.-++|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---ee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 45677889999999999999998899999997543221 11 222233344444 24455566666667788999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------CCceEEeeccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-------DFEAHVADFGL 331 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~Dfgl 331 (468)
+||.+.|+|.+++. ....++|.....++.++++.+++||..+ ||||||||+|++|.. ..-++|+|||.
T Consensus 773 ~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 99999999999997 4456999999999999999999999888 999999999999943 34589999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 386 (468)
+..+.--.........++|-.+-.+|+..+...+..+|.|.++.+++-||.|++-
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9876543444566778889999999999999999999999999999999999753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=156.54 Aligned_cols=136 Identities=22% Similarity=0.371 Sum_probs=113.5
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCC------chhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
+.||+|++|.||+|.+ .|..+++|+......... ....+..|+..+..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999987 678899998654322111 113577899999999999998888887777888999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
++|++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998532 12 78899999999999999877 99999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=156.24 Aligned_cols=144 Identities=19% Similarity=0.200 Sum_probs=108.5
Q ss_pred cCCcceEcccCCcceEEEE--cCCCcEEEEEEecccCCCCC----------------------chhHHHHHHHHHhCCCC
Q 012213 184 VKDNNVIGRGGAGVVYRGV--TPNGEQVAVKKLLGITKGSS----------------------HDNGLSAEIRTLGKIRH 239 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h 239 (468)
|.+.+.||+|+||.||+|. ..+|+.||+|++........ ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567899999999999998 56899999999865321100 01235679999999875
Q ss_pred CC--ccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 240 RN--IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 240 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
.. +.+++++ ...++||||+++++|....... ......+...++.+|+.++++||+.+. ++||||||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEE
Confidence 33 3344443 2358999999998887765322 235556678999999999999995542 999999999999
Q ss_pred EcCCCceEEeecccccccc
Q 012213 318 LNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~ 336 (468)
++ ++.++|+|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=153.73 Aligned_cols=138 Identities=21% Similarity=0.186 Sum_probs=107.3
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCC--------------------chhHHHHHHHHHhCCCCCC--
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS--------------------HDNGLSAEIRTLGKIRHRN-- 241 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~h~n-- 241 (468)
+...+.||+|+||.||++..++|+.||||++........ ....+..|+..+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 455688999999999999998899999998754221100 0123567888888887774
Q ss_pred ccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 012213 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 242 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 321 (468)
+...++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ ++||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 4444442 345899999999999776431 234678899999999999877 9999999999999999
Q ss_pred CceEEeecccccccc
Q 012213 322 FEAHVADFGLAKYLQ 336 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~ 336 (468)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=153.00 Aligned_cols=132 Identities=23% Similarity=0.393 Sum_probs=107.0
Q ss_pred eEcccCCcceEEEEcCCCcEEEEEEecccCCCCC------chhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
.||+|+||.||+|.+ ++..|++|.......... ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998654322111 1245678999999999887766666666677789999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
+|++|.+++.... ..++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875321 078999999999999877 99999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=172.62 Aligned_cols=139 Identities=22% Similarity=0.325 Sum_probs=111.5
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecc-cCCCC-----CchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLG-ITKGS-----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
..+...+.||+|+||+||+|.+... .+++|+... ..... .....+.+|++++..++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445678999999999999987544 444444321 11111 1124578999999999999999888888877788
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999998874 35678999999999999877 9999999999999 6789999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-19 Score=172.22 Aligned_cols=174 Identities=23% Similarity=0.344 Sum_probs=131.1
Q ss_pred eeEEEEeccCCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
..++.|+++...+|.+|+.. ......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 46799999999999999963 445578899999999999999999 55 899999999999999999999999999
Q ss_pred ccccccC----CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 333 KYLQDTG----ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 333 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
....... .....+...||..||+||.+.+..|+.++||||+|++|+|+++ =..++....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------------- 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------------- 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------------
Confidence 8765433 2334567789999999999999999999999999999999998 222322100
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREV 452 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev 452 (468)
...++-|..+.+.....-..-..+..+++.+.|.+||++.++
T Consensus 468 ---t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 ---TLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---hhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 111222222221111112223467788999999999955443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.5e-18 Score=175.75 Aligned_cols=111 Identities=32% Similarity=0.604 Sum_probs=100.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|.|+|.+|.++++|++|+.|+|++|+|+|.+|.++++|++|+.|||++|+|+|.+|+.+++|++|+.|+|++|+|+|
T Consensus 425 L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g 504 (623)
T PLN03150 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504 (623)
T ss_pred CCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-ccc-ccccCcccccCCCCCCCCC-CCCCC
Q 012213 81 EIPE-FGQ-YSFFNSTSFTGNPHLCGSY-LNPCN 111 (468)
Q Consensus 81 ~~p~-~~~-~~~~~~~~~~~n~~lcg~~-~~~c~ 111 (468)
.+|. ++. +..+..+++.+|+.+|+.. ...|.
T Consensus 505 ~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 505 RVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred cCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 9996 443 2456678999999999865 34563
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=142.49 Aligned_cols=138 Identities=22% Similarity=0.270 Sum_probs=97.3
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHH----------------------HHHHHHHhCCCCCC--c
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGL----------------------SAEIRTLGKIRHRN--I 242 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--i 242 (468)
.+.||+|+||+||+|.+.+|+.||||++............+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999999889999999886533221111111 34555555554332 3
Q ss_pred cceeEEEecCCeeEEEEeccCCCChhhh-cccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcC
Q 012213 243 VRLKAFCSNKETNLLVYEYMPNGSLGEV-LHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNS 320 (468)
Q Consensus 243 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~ 320 (468)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 334433 245899999998554321 21110 11 5677899999999999997 66 99999999999999
Q ss_pred CCceEEeecccccccc
Q 012213 321 DFEAHVADFGLAKYLQ 336 (468)
Q Consensus 321 ~~~~kl~Dfgla~~~~ 336 (468)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-17 Score=169.23 Aligned_cols=209 Identities=22% Similarity=0.219 Sum_probs=136.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
...|+..+.|..|+||.||..+++. -+.+|.| +.+. .. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq---~l----ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ---NL----ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-cccc---ch----hhhc--cccccCCccee----------------
Confidence 3457778999999999999998864 4567774 3211 10 1110 22222334333
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|+-...++... .++.. .+.+++|||+.+ |+|||+||.|.+++.-|++|++|||+++......
T Consensus 136 -----gDc~tllk~~g--~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -----chhhhhcccCC--CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 33334443211 22222 277899999777 9999999999999999999999999997542111
Q ss_pred C-------------CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 340 A-------------SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 340 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .-....++||+.|.|||++....|...+|.|++|+++||.+-|+.||.+...+. .......
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-----lfg~vis 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFGQVIS 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-----HHhhhhh
Confidence 0 011234689999999999999999999999999999999999999997632211 1111111
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP 447 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP 447 (468)
+..++ .+.......++.+++...++.+|..|-
T Consensus 273 d~i~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIEW---------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhccc---------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11111 112223345566777788888888884
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.6e-16 Score=132.46 Aligned_cols=134 Identities=22% Similarity=0.218 Sum_probs=112.9
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC--CCccceeEEEecCCeeEEEEeccCC
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++++....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4679999999999999854 7899998754322 3568899999999976 5889999988888889999999998
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
+.+..+ +......++.+++.+++++|.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4567778899999999999976445699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.4e-18 Score=173.00 Aligned_cols=255 Identities=24% Similarity=0.272 Sum_probs=188.0
Q ss_pred ccCCcceEcccCCcceEEEEcCCC--cEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPNG--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 259 (468)
.|...+.||+|+|+.|-....... ..+|+|.+...............|..+-..+. |+|++.+++.....+..++.+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 345556799999999988876433 34566655433322222234445676666665 999999999999999999999
Q ss_pred eccCCCChhhhc-ccCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCcEEEcCCC-ceEEeecccccccc
Q 012213 260 EYMPNGSLGEVL-HGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQ 336 (468)
Q Consensus 260 e~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~ 336 (468)
+|..++++.+-+ +... ...+....-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999988 4332 23556667788999999999999 777 99999999999999999 99999999999887
Q ss_pred c-cCCCcccccccc-CccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 337 D-TGASECMSAVAG-SYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 337 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
. .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|........
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence 6 566666666778 9999999998884 4568899999999999999999999764433333333332211100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVV 453 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~ 453 (468)
............++..+++..+|..|.+.+++.
T Consensus 252 -------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 -------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 000112233455667778889999999888764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-15 Score=139.52 Aligned_cols=139 Identities=21% Similarity=0.223 Sum_probs=105.9
Q ss_pred CcceEc-ccCCcceEEEEcCCCcEEEEEEecccC------C-----CCCchhHHHHHHHHHhCCCCCCc--cceeEEEec
Q 012213 186 DNNVIG-RGGAGVVYRGVTPNGEQVAVKKLLGIT------K-----GSSHDNGLSAEIRTLGKIRHRNI--VRLKAFCSN 251 (468)
Q Consensus 186 ~~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~ 251 (468)
....|| .||.|+||++... +..++||++.... . .......+.+|++.+..++|+++ +..+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 346798 8999999999874 7789999874311 0 11223467889999999998875 667776543
Q ss_pred CCe----eEEEEeccCC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 252 KET----NLLVYEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 252 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
... .++|+||+++ .+|.+++... .++.. .+.+|+.++.+||+.| |+||||||.|||++.++.++|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 222 2599999997 6898887532 24433 3568999999999888 999999999999999999999
Q ss_pred eeccccccc
Q 012213 327 ADFGLAKYL 335 (468)
Q Consensus 327 ~Dfgla~~~ 335 (468)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.9e-15 Score=145.86 Aligned_cols=151 Identities=19% Similarity=0.237 Sum_probs=102.9
Q ss_pred chhhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCC------------------------c----------
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------------------------H---------- 223 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~---------- 223 (468)
++++..|+ .+.||.|++|.||+|++++|+.||||+.+......- .
T Consensus 114 ~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 192 (437)
T TIGR01982 114 EELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK 192 (437)
T ss_pred HHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence 44455555 378999999999999999999999999754311000 0
Q ss_pred ----hhHHHHHHHHHhCC----CCCCccceeEEE-ecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHH-
Q 012213 224 ----DNGLSAEIRTLGKI----RHRNIVRLKAFC-SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK- 293 (468)
Q Consensus 224 ----~~~~~~e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~- 293 (468)
+-.|..|...+.++ +|.+-+.+-..+ ......+|||||++|++|.++...... .. .+.+++..++.
T Consensus 193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARS 268 (437)
T ss_pred HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHH
Confidence 00133444444443 232223322222 234457999999999999987643211 12 23456666666
Q ss_pred HHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 294 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
.+..+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 467889777 9999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=136.29 Aligned_cols=252 Identities=23% Similarity=0.201 Sum_probs=181.3
Q ss_pred hhccCCcceEcc--cCCcceEEEEc---CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGR--GGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 254 (468)
...+.....+|. |.+|.||.+.. .++..+|+|+-+.....+.....-.+|+....++ .|+|.++....+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345667788999 99999999986 4688899998554444333334445677777777 49999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeec
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADF 329 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df 329 (468)
.++-+|++ +.+|.++.+.. ...++....+....+... |+.++|... ++|-|+||.||+...+ ..++++||
T Consensus 193 lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999998 57888888743 334666777777777777 999999666 9999999999999999 88999999
Q ss_pred cccccccccCCCc---cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 330 GLAKYLQDTGASE---CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 330 gla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
|+...+....-.. ......|...|++||...+ .++..+|+|++|.++.+..++..+....-.. .|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W~~---- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-----SWSQ---- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-----Cccc----
Confidence 9998876443221 1122357788999998766 5789999999999999999987765431000 1211
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+ .++...-..++..++..+++++|..|++.+.+..
T Consensus 338 -----~r~~~ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----LRQGYIP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----cccccCc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111111 0011111233444788899999999999887754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=137.07 Aligned_cols=153 Identities=16% Similarity=0.170 Sum_probs=96.3
Q ss_pred ccchhhhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCC--------------------C------------C
Q 012213 176 GSDDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG--------------------S------------S 222 (468)
Q Consensus 176 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------~------------~ 222 (468)
..++++..|+. +.||.|++|.||+|++++ |+.||||+....... + +
T Consensus 114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 34556677776 899999999999999987 999999998643110 0 0
Q ss_pred chh------HHHHHHHHHhCCC----CCCccceeEEEe-cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHH
Q 012213 223 HDN------GLSAEIRTLGKIR----HRNIVRLKAFCS-NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291 (468)
Q Consensus 223 ~~~------~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i 291 (468)
..+ .+..|...+.+++ +.+.+.+-.++. .....+|||||++|+.+.++-.-.. ...+.. .++...
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~---~la~~~ 268 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMK---LLAERG 268 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHH---HHHHHH
Confidence 001 1333444333332 333333333332 2456789999999999987422111 112211 122222
Q ss_pred HH-HHHHhhhcCCCCeeecCCCCCcEEEcCCC----ceEEeecccccccc
Q 012213 292 AK-GLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVADFGLAKYLQ 336 (468)
Q Consensus 292 a~-~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~~~~ 336 (468)
+. -+..+...| ++|+|++|.||+++.++ .++++|||++..+.
T Consensus 269 v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 269 VEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 21 123344456 99999999999999988 99999999998664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-13 Score=124.99 Aligned_cols=204 Identities=21% Similarity=0.290 Sum_probs=138.0
Q ss_pred HHHHhCCCCCCccceeEEEecCC-----eeEEEEeccCCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 012213 231 IRTLGKIRHRNIVRLKAFCSNKE-----TNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCS 303 (468)
Q Consensus 231 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 303 (468)
..-+-++-|.|+|++..|+.+.. ...+++|||+.|++.++|+... ...+......+|+-||..||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455567999999999886543 4689999999999999997533 33566777789999999999999976 6
Q ss_pred CCeeecCCCCCcEEEcCCCceEEeecccccccc--ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 012213 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ--DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 381 (468)
Q Consensus 304 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ell 381 (468)
++|+|+++..+-|++..++-+|+.--.-...-. +...........+.++|.|||+-...+.+.++|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999888874321111000 000111122334678999999998888899999999999999998
Q ss_pred hCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 382 TGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 382 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
-+..--... +..-..+ ......+..+-++.. ...+..|++..|..||+|++.+.
T Consensus 277 ilEiq~tns--eS~~~~e------e~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNS--ESKVEVE------ENIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCC--cceeehh------hhhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 876432110 1000000 000000011111111 12566799999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.2e-12 Score=126.69 Aligned_cols=234 Identities=18% Similarity=0.190 Sum_probs=154.7
Q ss_pred cCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHH
Q 012213 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE 282 (468)
Q Consensus 203 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~ 282 (468)
..++.+|.|...+.... .......+.++.|+.+|||||++++..+..++..|+|+|-+. -|..++.... ..
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KE 104 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HH
Confidence 34688888888764433 334567888999999999999999999999999999999873 4555664322 34
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCC
Q 012213 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362 (468)
Q Consensus 283 ~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 362 (468)
...-.+.||+.||.|||+.+. ++|++|.-.-|+++..|+.||++|-++......+. ......---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 455567899999999997664 99999999999999999999999988865432111 01111112245556543322
Q ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccC
Q 012213 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEH 442 (468)
Q Consensus 363 ~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~ 442 (468)
. -..|.|.||++++|++.|..+-.........+. .......-..+...+..... .++.+..|....
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ip-----------k~~~~~~~k~~~~~~~~r~n-~~~~~~~~~~~~ 246 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIP-----------KALIELYCKKLGATELKRPN-KLRFILECRLLG 246 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccc-----------hhHHHHHHHHhccccccccc-hhhHHHHHHhcc
Confidence 2 346999999999999999333221110000000 00111111111111111222 566777888888
Q ss_pred CCCCCCHHHHHHHHHhccCCC
Q 012213 443 GVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 443 P~~RPt~~ev~~~L~~~~~~~ 463 (468)
+-.|=.+-+++..|++++-++
T Consensus 247 gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 247 GFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred ccccchHHHHHHHHHhcccCc
Confidence 888888999999998876544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-12 Score=113.47 Aligned_cols=130 Identities=21% Similarity=0.120 Sum_probs=95.7
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCcc-ceeEEEecCCeeEEEEeccCCCC
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEYMPNGS 266 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 266 (468)
+.++.|.++.||++... +..|++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 56899999999999875 78899998653321 113467889999888665544 445443 334589999999988
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 267 L~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
+.+.- .....++.+++++++.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76531 011245678999999999765 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-13 Score=149.75 Aligned_cols=103 Identities=36% Similarity=0.560 Sum_probs=96.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+++|.+|..++++++|+.|+|++|+++|.+|.++.+|++|++|+|++|.++|.+|..|..+++|+.|+|++|+++|
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-cccccccCcccccCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLC 103 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lc 103 (468)
.+|. +..+..+..+++++|+..+
T Consensus 562 ~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 562 EIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred cCChhHhcCcccCEEeccCCccee
Confidence 9995 7788889999999997654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-13 Score=112.99 Aligned_cols=77 Identities=32% Similarity=0.571 Sum_probs=59.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
||+|+|+ .+|+.|..|.+|++|++++|+++ .+|.++.+|++|+.|+++-|++. .+|..|+.++.|+.|||++|+|+.
T Consensus 40 LSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e 116 (264)
T KOG0617|consen 40 LSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE 116 (264)
T ss_pred cccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccc
Confidence 5788887 77778888888888888888888 77888887777777777777777 677777777777777777776654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.2e-11 Score=106.21 Aligned_cols=138 Identities=14% Similarity=0.166 Sum_probs=98.2
Q ss_pred ceEcccCCcceEEEEcCC-------CcEEEEEEecccCC----------C----------CCchhHHH----HHHHHHhC
Q 012213 188 NVIGRGGAGVVYRGVTPN-------GEQVAVKKLLGITK----------G----------SSHDNGLS----AEIRTLGK 236 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------~----------~~~~~~~~----~e~~~l~~ 236 (468)
..||.|.=+.||.|...+ +..+|||..+.... + ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998753 47999997643110 0 01112233 78889988
Q ss_pred CCC--CCccceeEEEecCCeeEEEEeccCCCChhh-hcccCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCC
Q 012213 237 IRH--RNIVRLKAFCSNKETNLLVYEYMPNGSLGE-VLHGKRGSFLKWEMRLKIAIEAAKGLSYL-HHDCSPLIIHRDVK 312 (468)
Q Consensus 237 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk 312 (468)
+.. -++..++++ ...++||||+.+..+.. .+.. ..++..+...+..+++.++..| |+.+ ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 456666654 45689999997654422 2221 1244456677889999999999 7777 9999999
Q ss_pred CCcEEEcCCCceEEeecccccccc
Q 012213 313 SNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 313 ~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+.||+++ ++.++|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.2e-13 Score=112.05 Aligned_cols=97 Identities=26% Similarity=0.389 Sum_probs=53.2
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCccc-ccCCcccccccccccccccCcccCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN-ASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
++|+|+ .+|.+++.++.|++|+++-|+|. .+|..||+++.|+.|||++|+++ -.+|..|.-++.|+.|+|++|.|.=
T Consensus 64 ~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~ 141 (264)
T KOG0617|consen 64 SNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEI 141 (264)
T ss_pred ccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCccc
Confidence 455555 55555555555555555555555 55555555555555555555554 2345555555555555555555554
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
.+|+.+++.+++.+++.+|.
T Consensus 142 lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 142 LPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred CChhhhhhcceeEEeeccCc
Confidence 44455555555555555553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.7e-11 Score=108.53 Aligned_cols=143 Identities=21% Similarity=0.261 Sum_probs=110.3
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCC--CccceeEEEecCC---eeEEEEecc
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR--NIVRLKAFCSNKE---TNLLVYEYM 262 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 262 (468)
+.|+.|.++.||++...+|+.+++|........ .....+..|++++..+++. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999999877789999986543221 1235688999999998763 4567777776543 568999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC---------------------------------------- 302 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------- 302 (468)
++.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988876632 24677788888899999999998521
Q ss_pred -------------CCCeeecCCCCCcEEEcC--CCceEEeecccccc
Q 012213 303 -------------SPLIIHRDVKSNNILLNS--DFEAHVADFGLAKY 334 (468)
Q Consensus 303 -------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~ 334 (468)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.1e-11 Score=100.81 Aligned_cols=133 Identities=24% Similarity=0.366 Sum_probs=101.6
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEe-cccCCCCCch-----hHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKL-LGITKGSSHD-----NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
..+++|+-+.+|.+.+. |.++++|.- .+....+... .+..+|..++.+++--.|...+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 445666643 2222233222 3456788899888766666666677788888999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
++|-.|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888643 2566777888888999888 99999999999998875 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.5e-12 Score=124.66 Aligned_cols=248 Identities=22% Similarity=0.186 Sum_probs=170.8
Q ss_pred hhccCCcceEcccCCcceEEEEc--CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT--PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
...|.....||.|.|+.|++... .++..|++|.+............-..|+.+...+ .|.+++++...+...+..++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 34566778899999999998764 3578899997765433322222234455555555 58899998887777778889
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeecccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQ 336 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~ 336 (468)
--||++++++.... .....++...++++..+++.++.++|... ++|+|+||+||++..+ +..++.|||.+..+.
T Consensus 344 p~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred chhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc
Confidence 99999999887665 22334777888999999999999999666 9999999999999886 888999999986432
Q ss_pred ccCCCccccccccCccc-cCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGY-IAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
-. .......+..| .+++......+..+.|+||||..+.|.+++..--... .+| ..+
T Consensus 419 ~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~------------~~i 475 (524)
T KOG0601|consen 419 FS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQS------------LTI 475 (524)
T ss_pred ee----cccccccccccccchhhccccccccccccccccccccccccCcccCccc-------ccc------------eee
Confidence 11 01111123333 3566666777889999999999999999976432110 011 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
........+. ....+..+......+++..||.+.+.....+
T Consensus 476 ~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 RSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111111111 1255556677788999999999988766544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=98.38 Aligned_cols=145 Identities=23% Similarity=0.263 Sum_probs=107.7
Q ss_pred CcceEcccCCcceEEEEcCCCcEEEEEEe-cccCCCCCc-----hhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKL-LGITKGSSH-----DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
...+|-||+-+.|+++.+ +|+...||.- .+..+.+.. ..+..+|.+.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 5787777743 222222221 145678999999887666655555666777778999
Q ss_pred eccCC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---ceEEeecccccc
Q 012213 260 EYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKY 334 (468)
Q Consensus 260 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~ 334 (468)
||+++ .++.+++...............++..|.+.+.-||..+ |+||||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47788876544433333444788899999999999877 99999999999997655 368999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.5e-11 Score=125.94 Aligned_cols=84 Identities=32% Similarity=0.556 Sum_probs=79.5
Q ss_pred CCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCC-cccccccCccccc
Q 012213 19 LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFT 97 (468)
Q Consensus 19 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~ 97 (468)
.++.|+|++|.|+|.+|.++++|++|+.|+|++|.|+|.+|+.++.+++|+.|||++|+|+|.+|+ ++.+.+|+.++++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 478999999999999999999999999999999999999999999999999999999999999995 8899999999999
Q ss_pred CCCCC
Q 012213 98 GNPHL 102 (468)
Q Consensus 98 ~n~~l 102 (468)
+|...
T Consensus 499 ~N~l~ 503 (623)
T PLN03150 499 GNSLS 503 (623)
T ss_pred CCccc
Confidence 99643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=101.19 Aligned_cols=143 Identities=19% Similarity=0.140 Sum_probs=100.3
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCC---------CCchhHHHHHHHHHhCCCCCC--ccceeEEEec-----
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG---------SSHDNGLSAEIRTLGKIRHRN--IVRLKAFCSN----- 251 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 251 (468)
+.+-.-....|++... +|+.|.||+....... ......+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455667655 6788999976432210 010124778988888885433 3345555543
Q ss_pred CCeeEEEEeccCCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------CCc
Q 012213 252 KETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-------DFE 323 (468)
Q Consensus 252 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 323 (468)
....++|+|++++. +|.+++........+...+..++.+++..+.-||+.| |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23468999999886 8988875322234556777899999999999999888 999999999999975 468
Q ss_pred eEEeecccccc
Q 012213 324 AHVADFGLAKY 334 (468)
Q Consensus 324 ~kl~Dfgla~~ 334 (468)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.8e-11 Score=112.43 Aligned_cols=98 Identities=33% Similarity=0.592 Sum_probs=84.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCc--------------------
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-------------------- 60 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-------------------- 60 (468)
|++|+++ -+|..++.+++|+.|+|++|-|. .+|.+++.+.+|+.||||.|+|. .+|.
T Consensus 419 lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 419 LSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred hhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 3566665 88999999999999999999999 89999999999999999998876 4553
Q ss_pred ---c-cccccccccccccCcccCCCCCCcccccccCcccccCCCC
Q 012213 61 ---E-MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 61 ---~-~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 101 (468)
. +.+|.+|..|||.+|.+...+|.+|++.++..+.+.|||.
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred cChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 2 7788899999999999997777899999999999999975
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-08 Score=96.97 Aligned_cols=263 Identities=14% Similarity=0.174 Sum_probs=156.8
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEE------EecCCe-e
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAF------CSNKET-N 255 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~~~-~ 255 (468)
...+..||+|+-+.+|..-.- +. .+.|+.+...... -...++.|... .||-+-.=+.| ..+... .
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchh-hc-hhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 445678999999999964221 11 3446554332211 12233444444 46544331211 112222 5
Q ss_pred EEEEeccCCCC-hhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 256 LLVYEYMPNGS-LGEVLHG----KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 256 ~lv~e~~~~gs-L~~~l~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
.+.|..+++.. +..+... ..-...+|+-.++.+..+|.+-+.||+.| .+-||+.++|+|+.+++.+.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccc
Confidence 67787776642 2222221 11235889999999999999999999988 8889999999999999999999855
Q ss_pred ccccccccCCCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCC---CCcCHH-HH
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITG-RRPVGDFGE---EGLDIV-QW 400 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~---~~~~~~-~~ 400 (468)
.-... .........+|...|.+||.-. +-.-+...|-|.+|+++++++.| ++||.+... ....+. +.
T Consensus 163 sfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 163 SFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 43332 2223334567889999999654 33456789999999999999995 999987321 111111 00
Q ss_pred HHHhhcccccchhhhccccCCCCC-HHHHHHHHHHHHhhcccC--CCCCCCHHHHHHHHHhcc
Q 012213 401 TKMQTNSSKEGVVKILDQRLSNTP-LSEAMQVFFVAMLCVQEH--GVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 401 ~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~~l~~~c~~~~--P~~RPt~~ev~~~L~~~~ 460 (468)
........++. ..-..+.....+ ......+..+...|+... |.-|||++.++..|..+.
T Consensus 240 a~g~f~ya~~~-~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 240 AHGRFAYASDQ-RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hcceeeechhc-cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 00000000000 000000001111 122345666777888753 568999999998887654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.8e-11 Score=113.31 Aligned_cols=95 Identities=27% Similarity=0.478 Sum_probs=77.4
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCcccc-ccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
.+|+|. .+| +|+.|..|..|+++.|++. .+|.++. +|.+|.+|||..|+++ +.|++++.+++|..||+|+|.+++
T Consensus 214 ~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 214 RRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS 289 (565)
T ss_pred hhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc
Confidence 345555 555 5555555666666666666 6666665 8899999999999999 899999999999999999999999
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.++++|++ .+..+.+.|||.
T Consensus 290 Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 290 LPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred CCcccccc-eeeehhhcCCch
Confidence 99999999 888899999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.1e-09 Score=101.30 Aligned_cols=169 Identities=19% Similarity=0.316 Sum_probs=129.0
Q ss_pred CCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe----cCCeeEEEEeccCC-CCh
Q 012213 194 GAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS----NKETNLLVYEYMPN-GSL 267 (468)
Q Consensus 194 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL 267 (468)
--.+.||+.. .||..|++|+++....... .....-++.++++.|+|+|++.+++. .....++||+|.|+ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3467899876 5899999999965443322 22345678899999999999988775 34467899999986 677
Q ss_pred hhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 268 GEVLHG-------------KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 268 ~~~l~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++-.. ..+...++...|.++.|++.||.++|+.| +.-+-|.+++|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceee
Confidence 665321 12235778999999999999999999888 99999999999999999999999888877
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 386 (468)
+...... -+ .--.+-|.-.||.+++.+.||..-
T Consensus 443 l~~d~~~----------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 LQEDPTE----------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecCCCCc----------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 6533201 01 122567999999999999998643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.3e-11 Score=116.70 Aligned_cols=99 Identities=28% Similarity=0.406 Sum_probs=89.1
Q ss_pred CCCccc-ccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcc-cccccccccccccCcccC
Q 012213 2 SRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 2 ~~N~l~-g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~ 79 (468)
.+|+|. ..||.+|.+|..|++||||+|+|+ ..|..+..-+++-+|+||+|++. +||.. |.+|+.|-.||||+|+|.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence 456664 368999999999999999999999 89999999999999999999998 78875 578999999999999999
Q ss_pred CCCCCcccccccCcccccCCCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~~l 102 (468)
..+|....+..++.+.+++||..
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhh
Confidence 99998889999999999999863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.6e-09 Score=92.28 Aligned_cols=127 Identities=26% Similarity=0.331 Sum_probs=81.4
Q ss_pred ceEEEEcCCCcEEEEEEecccCCC-----------C---------Cc----hhHHHHHHHHHhCCCCC--CccceeEEEe
Q 012213 197 VVYRGVTPNGEQVAVKKLLGITKG-----------S---------SH----DNGLSAEIRTLGKIRHR--NIVRLKAFCS 250 (468)
Q Consensus 197 ~Vy~~~~~~~~~vavK~~~~~~~~-----------~---------~~----~~~~~~e~~~l~~l~h~--niv~l~~~~~ 250 (468)
.||.|...+|..+|||..+..... . .. .....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999999999999977532110 0 00 12357899999999765 456666553
Q ss_pred cCCeeEEEEeccC--CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 012213 251 NKETNLLVYEYMP--NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY-LHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 251 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
...+||||++ |..+..+.... ++......++.+++..+.. +|..| |+|||+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4589999998 54454433211 1123445667777776655 46666 9999999999999988 99999
Q ss_pred eccccccc
Q 012213 328 DFGLAKYL 335 (468)
Q Consensus 328 Dfgla~~~ 335 (468)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.6e-10 Score=80.29 Aligned_cols=60 Identities=35% Similarity=0.477 Sum_probs=53.7
Q ss_pred CCCCEEEccCCcccccCC-ccccccccccEeeccCCcccccCCcccccccccccccccCccc
Q 012213 18 LLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 18 ~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l 78 (468)
++|++|+|++|+|+ .+| ..|.++++|++|+|++|.++..-|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999 565 5889999999999999999965566899999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.1e-10 Score=119.51 Aligned_cols=249 Identities=20% Similarity=0.215 Sum_probs=157.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.+.+.+.+-+|.++.++.+.-.. |...+.|.......- ....+....+-.++-..++|-+++...-+.-.....|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3445556678889999988775432 322333322111110 00001111222222223445555544444445677899
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
++|..+++|...|+... ..+.+.....+..+..+++|||... +.|+|++|.|.+...++..+++|||......-.
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999998544 2444445556667888999999654 899999999999999999999999844322100
Q ss_pred ----C-------------------------CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 339 ----G-------------------------ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 339 ----~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
+ .........||+.|.+||...+......+|.|+.|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00112345689999999999999999999999999999999999999976
Q ss_pred CCCCCcCHHHHHHHhhcccccchhhhcccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 012213 390 FGEEGLDIVQWTKMQTNSSKEGVVKILDQR--LSNTPLSEAMQVFFVAMLCVQEHGVERPTMR 450 (468)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ 450 (468)
..... ....+.... ....+........+++..-+..+|.+|-.|.
T Consensus 1038 ~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 22111 111111111 1233444555566677777778888886654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.7e-10 Score=97.58 Aligned_cols=96 Identities=25% Similarity=0.381 Sum_probs=40.1
Q ss_pred CCCCcccccCCcccc-cCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCccc-ccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIG-HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~-~~l~~L~~l~ls~N~l 78 (468)
|++|+|+ .|. .++ .|.+|+.||||+|+|+ .++ .+..|++|+.|+|++|.++ .+++.+ ..+++|+.|++++|++
T Consensus 26 L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I 100 (175)
T PF14580_consen 26 LRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKI 100 (175)
T ss_dssp ------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS--
T ss_pred ccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcC
Confidence 5678887 664 566 5889999999999999 676 6888999999999999999 676666 3689999999999998
Q ss_pred CCC--CCCcccccccCcccccCCCC
Q 012213 79 SGE--IPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 79 ~~~--~p~~~~~~~~~~~~~~~n~~ 101 (468)
... +-.+..++++..+++.|||.
T Consensus 101 ~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 101 SDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CChHHhHHHHcCCCcceeeccCCcc
Confidence 742 22355677788889999864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-08 Score=92.21 Aligned_cols=135 Identities=23% Similarity=0.216 Sum_probs=94.3
Q ss_pred CcceEcccCCcceEEEEcCCCcEEEEEEeccc-------C---------CCCC----chhHHHHHHHHHhCCCCC--Ccc
Q 012213 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGI-------T---------KGSS----HDNGLSAEIRTLGKIRHR--NIV 243 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-------~---------~~~~----~~~~~~~e~~~l~~l~h~--niv 243 (468)
+++.||-|.-+.||.|.+++|.++|||--... . .+.+ .....++|.+.|.++... .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 45899999999999999999999999943210 0 0001 012457789999888654 666
Q ss_pred ceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 012213 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323 (468)
Q Consensus 244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 323 (468)
+.+++ +...+||||++|-.|...-- +....-.++..|.+-+.-+-..| +||||+++-||+++++|.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 66664 34589999998866654321 12223334444555554444556 999999999999999999
Q ss_pred eEEeecccccc
Q 012213 324 AHVADFGLAKY 334 (468)
Q Consensus 324 ~kl~Dfgla~~ 334 (468)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999965543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.7e-08 Score=85.02 Aligned_cols=140 Identities=18% Similarity=0.122 Sum_probs=103.0
Q ss_pred EcccCCcceEEEEcCCCcEEEEEEecccCCC----CCchhHHHHHHHHHhCCCCC--CccceeEEEe-cC----CeeEEE
Q 012213 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKG----SSHDNGLSAEIRTLGKIRHR--NIVRLKAFCS-NK----ETNLLV 258 (468)
Q Consensus 190 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv 258 (468)
-|+||-+.|+.... +|..+-+|+-...-.. +.-...|.+|+..+.++..- .+.+.. ++. .. -.-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 37788889999766 3557999976521111 23346799999999888532 244444 332 11 124799
Q ss_pred EeccCC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--eEEeecccccc
Q 012213 259 YEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVADFGLAKY 334 (468)
Q Consensus 259 ~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~ 334 (468)
+|-+++ -+|.+++......+.+...+..+..+++.++.-||+.+ +.|+|+.+.||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 58888886544445677888899999999999999888 999999999999986666 99999976653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6e-10 Score=109.94 Aligned_cols=97 Identities=26% Similarity=0.316 Sum_probs=86.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCccc--
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF-- 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l-- 78 (468)
||.|+|. .+|..+-++.+|+.|+||+|+|+ .+....+...+|++|+||.|+|+ .+|+.++.|+.|+.|.+++|+|
T Consensus 229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 6889998 88999999999999999999999 78888889999999999999999 7999999999999999999964
Q ss_pred CCCCCCcccccccCcccccCCC
Q 012213 79 SGEIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 79 ~~~~p~~~~~~~~~~~~~~~n~ 100 (468)
.|.+..+|.+..+..+..++|.
T Consensus 306 eGiPSGIGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 306 EGIPSGIGKLIQLEVFHAANNK 327 (1255)
T ss_pred cCCccchhhhhhhHHHHhhccc
Confidence 5666678888888888888775
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.3e-08 Score=87.71 Aligned_cols=106 Identities=22% Similarity=0.312 Sum_probs=83.1
Q ss_pred hHHHHHHHHHhCCCCC--CccceeEEEecCC----eeEEEEeccCCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHH
Q 012213 225 NGLSAEIRTLGKIRHR--NIVRLKAFCSNKE----TNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297 (468)
Q Consensus 225 ~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~ 297 (468)
....+|...+..+... ...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4577888887777533 3455666665532 347999999874 79998864222 5566778999999999999
Q ss_pred hhhcCCCCeeecCCCCCcEEEcCCC---ceEEeeccccccc
Q 012213 298 LHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKYL 335 (468)
Q Consensus 298 LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~ 335 (468)
||+.| |+|+|++++|||++.+. .+.++||+-++..
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99888 99999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.7e-10 Score=113.47 Aligned_cols=98 Identities=30% Similarity=0.417 Sum_probs=81.4
Q ss_pred CCCCcccccCCc-ccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPV-EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|. ++|+ .+.++..|+.|+||+|+|+ .+|..+.+|..|++|...+|+|. .+| ++..++.|+.+|||.|+|+
T Consensus 390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 6788886 7774 6678888888899999988 88888999999999999999888 688 8899999999999999987
Q ss_pred C-CCCCcccccccCcccccCCCCC
Q 012213 80 G-EIPEFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 80 ~-~~p~~~~~~~~~~~~~~~n~~l 102 (468)
- .+|.-...++++.++++||.++
T Consensus 466 ~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 466 EVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhhhCCCcccceeeccCCccc
Confidence 4 3454444478999999999974
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.1e-09 Score=106.08 Aligned_cols=150 Identities=18% Similarity=0.304 Sum_probs=101.9
Q ss_pred HHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc-------cccccccCccccCccccCCC
Q 012213 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-------CMSAVAGSYGYIAPEYAYTL 362 (468)
Q Consensus 290 ~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 362 (468)
+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+.......... ..........|.|||++...
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45589999997 4569999999999999999999999999886544211100 00112345689999999998
Q ss_pred CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhccc
Q 012213 363 KVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQE 441 (468)
Q Consensus 363 ~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~ 441 (468)
..+.++|+||+|+++|.+.. |+.-++..+.. ....... ...+-.......+...++.+-+.+.+..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~~-----------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFSR-----------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCc--chhhhhh-----------cccccccccccccCcHHHHHHHHHHhcC
Confidence 89999999999999999995 55555432211 1111100 1111111222234456667777788999
Q ss_pred CCCCCCCHHHHHH
Q 012213 442 HGVERPTMREVVQ 454 (468)
Q Consensus 442 ~P~~RPt~~ev~~ 454 (468)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998877654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-09 Score=106.42 Aligned_cols=98 Identities=32% Similarity=0.465 Sum_probs=77.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|+|+ .+|.+++.+..|..||.|.|.+. .+|..++.|.+|+.|.+..|++. .+|++++.|+ |..||+|+|+++-
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis~ 225 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKISY 225 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCceee
Confidence 4678887 78888887778888888888888 78888888888888888888887 6888887665 7888888888884
Q ss_pred CCCCcccccccCcccccCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~l 102 (468)
.+-.|-.+..|+.+.+.+||..
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC
Confidence 3336778888888888888754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.6e-09 Score=104.81 Aligned_cols=99 Identities=25% Similarity=0.264 Sum_probs=59.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCC-cccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~ 79 (468)
||.|+|...-+..+.-+.+|.+||||+|+|+..-|.+|..|..|+.|+|+.|.++ .|- ..|..+++|+.|||++|.|+
T Consensus 300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls 378 (873)
T KOG4194|consen 300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELS 378 (873)
T ss_pred cchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEE
Confidence 5677777444677777777777777777777333445666666666666666655 232 23555666666666666666
Q ss_pred CCCCC----cccccccCcccccCCC
Q 012213 80 GEIPE----FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~----~~~~~~~~~~~~~~n~ 100 (468)
+.|.+ |..+.++..+.+.||+
T Consensus 379 ~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 379 WCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred EEEecchhhhccchhhhheeecCce
Confidence 65553 3334455555555554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.1e-08 Score=96.60 Aligned_cols=153 Identities=20% Similarity=0.251 Sum_probs=97.7
Q ss_pred ccchhhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCC--------------------C--------chh--
Q 012213 176 GSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS--------------------S--------HDN-- 225 (468)
Q Consensus 176 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~--------~~~-- 225 (468)
.-++.+..|+. +.|+.++-|.||+|++++|+.||||+.++.-... . ..+
T Consensus 120 ~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 120 PIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred CHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 34455555553 7899999999999999999999999875321100 0 000
Q ss_pred --------HHHHHHHHHhCC----C-CCCccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHH
Q 012213 226 --------GLSAEIRTLGKI----R-HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292 (468)
Q Consensus 226 --------~~~~e~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia 292 (468)
.+..|..-+.++ + .+++.--.-|+.......|+|||++|-.+.+...-+. ...+.. .++..++
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~ 274 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLV 274 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHH
Confidence 123333333333 1 2222222223334567799999999998888743222 234433 3333333
Q ss_pred HH-HHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 293 KG-LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 293 ~~-l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
++ +..+-..| ++|.|..|.||+++.++.+.+.|||+...+.
T Consensus 275 ~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 275 RAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 33 23333355 9999999999999999999999999998765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.4e-09 Score=97.17 Aligned_cols=99 Identities=19% Similarity=0.221 Sum_probs=87.4
Q ss_pred cCC-cccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCC-Ccc
Q 012213 9 IIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIP-EFG 86 (468)
Q Consensus 9 ~~p-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p-~~~ 86 (468)
.-| .-|..|++|+.|+|++|++++.-+.+|..+..|+.|.|..|+|...--..|.++.+|+.|+|.+|+++..-| .|.
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~ 343 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ 343 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence 334 357899999999999999998889999999999999999999984334568999999999999999998877 588
Q ss_pred cccccCcccccCCCCCCCCCC
Q 012213 87 QYSFFNSTSFTGNPHLCGSYL 107 (468)
Q Consensus 87 ~~~~~~~~~~~~n~~lcg~~~ 107 (468)
.+.++..+.+-+||+.|.|.+
T Consensus 344 ~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 344 TLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred ccceeeeeehccCcccCccch
Confidence 888999999999999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.4e-08 Score=70.05 Aligned_cols=54 Identities=33% Similarity=0.444 Sum_probs=47.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL 54 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l 54 (468)
|++|+|+...+..|.++++|++|+|++|+++..-|..|.++++|++|+|++|+|
T Consensus 8 l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 8 LSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp ETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 578999944457889999999999999999966667899999999999999986
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-06 Score=79.90 Aligned_cols=132 Identities=14% Similarity=0.127 Sum_probs=84.0
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC--ccceeEEEecCCeeEEEEeccCCC
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
..||+|..+.||+. .|..+++|...... ......+|.+.++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 35567888764321 2245788999998886433 466788877777788999999886
Q ss_pred C-hhhhcccCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHhhh-cCCC
Q 012213 266 S-LGEVLHGKRGSFLKWEMRLKIAIEAAKGL---------------------------------------SYLHH-DCSP 304 (468)
Q Consensus 266 s-L~~~l~~~~~~~l~~~~~~~i~~~ia~~l---------------------------------------~~LH~-~~~~ 304 (468)
. +...+.. +......++..+|+.+ .+|.. ....
T Consensus 80 ~~~~~~~~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 80 RSFSRIISD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred cchhhhhcC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 3 2211110 0011111111111111 22211 1234
Q ss_pred CeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 305 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.9e-08 Score=63.26 Aligned_cols=40 Identities=30% Similarity=0.473 Sum_probs=28.4
Q ss_pred CCCCEEEccCCcccccCCccccccccccEeeccCCcccccCC
Q 012213 18 LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59 (468)
Q Consensus 18 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p 59 (468)
++|++|+|++|+|+ .+|+.+++|++|+.|+|++|.++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 46778888888888 67777778888888888888777 443
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-07 Score=82.29 Aligned_cols=77 Identities=22% Similarity=0.297 Sum_probs=39.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccc-cccccccEeeccCCcccccCC--cccccccccccccccCcc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP--KEMGNMKSLTSADFSHNN 77 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~-~~l~~L~~l~ls~N~l~g~~p--~~~~~l~~L~~l~ls~N~ 77 (468)
|++|+|+ .++ .+..|++|+.|+|++|+++ .++..+ ..+++|+.|+|++|++. .+- ..+..+++|+.|++.+|.
T Consensus 49 Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NP 124 (175)
T PF14580_consen 49 LSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNP 124 (175)
T ss_dssp -TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-TT-G
T ss_pred CCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeeccCCc
Confidence 6899999 676 5888999999999999999 787666 47999999999999997 343 357789999999999999
Q ss_pred cCCC
Q 012213 78 FSGE 81 (468)
Q Consensus 78 l~~~ 81 (468)
++..
T Consensus 125 v~~~ 128 (175)
T PF14580_consen 125 VCEK 128 (175)
T ss_dssp GGGS
T ss_pred ccch
Confidence 9843
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-06 Score=76.95 Aligned_cols=138 Identities=24% Similarity=0.233 Sum_probs=90.1
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCch-------hH---------------HHHHHHHHhCCC--CCCcc
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD-------NG---------------LSAEIRTLGKIR--HRNIV 243 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------~~---------------~~~e~~~l~~l~--h~niv 243 (468)
..|+.|.-+.||+|...++..+|||+++.....-... .. ...|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677888889999998889999999886432211100 00 134555555552 23333
Q ss_pred ceeEEEecCCeeEEEEeccCCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCC
Q 012213 244 RLKAFCSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 244 ~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~ 321 (468)
+-+++. ...|||||+... .-.-.|.. -.+.......+..++.+.+.-|.. .+ +||+||+.-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence 444432 347999999653 11112221 122333566677788888888776 45 99999999999999 8
Q ss_pred CceEEeecccccccc
Q 012213 322 FEAHVADFGLAKYLQ 336 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~ 336 (468)
+.+.++|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999887654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.1e-08 Score=89.08 Aligned_cols=64 Identities=25% Similarity=0.277 Sum_probs=38.6
Q ss_pred ccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 13 EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
.+.....|+.||||+|.++ .|..++.-++.++.|+||+|.++ .+- +++.+++|+.||||+|.|+
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls 342 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA 342 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH
Confidence 3334445666666666666 56666666666666666666665 332 3566666666666666655
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.2e-08 Score=95.36 Aligned_cols=97 Identities=19% Similarity=0.118 Sum_probs=42.9
Q ss_pred CCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCC
Q 012213 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEI 82 (468)
Q Consensus 3 ~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~ 82 (468)
.|+++..--..+.+|+.|+.||||.|.+..-=+.++.-+.+|+.||||+|+|+.--|..|..|..|+.|+|++|.++-.-
T Consensus 278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~ 357 (873)
T KOG4194|consen 278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLA 357 (873)
T ss_pred cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHH
Confidence 34444322334444444444444444444222444444444555555555544222223444444445555555444221
Q ss_pred C-CcccccccCcccccCC
Q 012213 83 P-EFGQYSFFNSTSFTGN 99 (468)
Q Consensus 83 p-~~~~~~~~~~~~~~~n 99 (468)
. .|..++++..++++.|
T Consensus 358 e~af~~lssL~~LdLr~N 375 (873)
T KOG4194|consen 358 EGAFVGLSSLHKLDLRSN 375 (873)
T ss_pred hhHHHHhhhhhhhcCcCC
Confidence 1 1334445555555555
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2e-08 Score=80.68 Aligned_cols=90 Identities=21% Similarity=0.276 Sum_probs=68.6
Q ss_pred cCCccc---ccCCCCCEEEccCCcccccCCccccccc-cccEeeccCCcccccCCcccccccccccccccCcccCCCCCC
Q 012213 9 IIPVEI---GHCLLLTYLDLSQNHLSGPIPVQITQIH-ILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE 84 (468)
Q Consensus 9 ~~p~~~---~~l~~L~~L~l~~n~l~g~~p~~~~~l~-~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 84 (468)
.|+... .....|+..+|++|.|. .+|..|.... .+++|+|++|.|+ .+|.+++.++.|+.||++.|.|...+-.
T Consensus 41 ~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~v 118 (177)
T KOG4579|consen 41 YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRV 118 (177)
T ss_pred HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHH
Confidence 455433 34455666799999999 8888887664 8899999999998 7999999999999999999999866555
Q ss_pred cccccccCcccccCCC
Q 012213 85 FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 85 ~~~~~~~~~~~~~~n~ 100 (468)
+..+.++..++..+|.
T Consensus 119 i~~L~~l~~Lds~~na 134 (177)
T KOG4579|consen 119 IAPLIKLDMLDSPENA 134 (177)
T ss_pred HHHHHhHHHhcCCCCc
Confidence 6566666666655554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.4e-08 Score=96.14 Aligned_cols=92 Identities=33% Similarity=0.448 Sum_probs=44.1
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
.+|.|. .||..+.+|..|+.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|++++.+..|..||+|.|++...
T Consensus 106 y~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~sl 181 (722)
T KOG0532|consen 106 YHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSL 181 (722)
T ss_pred Hhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhc
Confidence 344454 55555555555555555555555 4554444443 444555555554 4454444444444555555544444
Q ss_pred CCCcccccccCccccc
Q 012213 82 IPEFGQYSFFNSTSFT 97 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~ 97 (468)
++.++.+.++..++..
T Consensus 182 psql~~l~slr~l~vr 197 (722)
T KOG0532|consen 182 PSQLGYLTSLRDLNVR 197 (722)
T ss_pred hHHhhhHHHHHHHHHh
Confidence 4444444433333333
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.2e-07 Score=96.30 Aligned_cols=69 Identities=25% Similarity=0.440 Sum_probs=29.8
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+|+
T Consensus 207 s~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 207 DNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS 275 (754)
T ss_pred cCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC
Confidence 445554 4444332 24555555555555 3444332 23444444444444 3443332 23444444444444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.9e-07 Score=96.17 Aligned_cols=32 Identities=25% Similarity=0.407 Sum_probs=15.5
Q ss_pred cccccccCcccCCCCC-CcccccccCcccccCCC
Q 012213 68 LTSADFSHNNFSGEIP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 68 L~~l~ls~N~l~~~~p-~~~~~~~~~~~~~~~n~ 100 (468)
|+.|++++|+|+ .+| .+..+..+..+++++|+
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~ 456 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 456 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence 344444444444 233 34445555555555554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.3e-06 Score=75.47 Aligned_cols=104 Identities=24% Similarity=0.242 Sum_probs=81.9
Q ss_pred HHHHHHHhCCCC-CCccceeEEEecCCeeEEEEeccCCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 012213 228 SAEIRTLGKIRH-RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305 (468)
Q Consensus 228 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 305 (468)
..|.-++..+++ +++.+++|+|. .++|+||.+.+++...-.. ..-...+|..|.+||.++++.+.++++.-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 69999999994 4789999987765421000 01113689999999999999999999865455
Q ss_pred eeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 306 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.9e-08 Score=100.30 Aligned_cols=96 Identities=28% Similarity=0.398 Sum_probs=76.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+++ ..|..+..+..|+.|+++.|-+. .+|.+..++.+|++|+|.+|.+. .+|.++..+.+|+.|++|.|+|.-
T Consensus 52 lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~ 128 (1081)
T KOG0618|consen 52 LSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGP 128 (1081)
T ss_pred ccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCC
Confidence 5778886 88988999999999999999998 88889999999999999999998 799999999999999999999874
Q ss_pred CCCCcccccccCcccccCC
Q 012213 81 EIPEFGQYSFFNSTSFTGN 99 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n 99 (468)
.++-+..+.......+++|
T Consensus 129 ~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 129 IPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred CchhHHhhhHHHHHhhhcc
Confidence 4434444444444444444
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.32 E-value=1e-05 Score=72.03 Aligned_cols=136 Identities=16% Similarity=0.158 Sum_probs=81.9
Q ss_pred ccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCch-------hHHHHHHHHHhCCCC---CCccceeEEEe--
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD-------NGLSAEIRTLGKIRH---RNIVRLKAFCS-- 250 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~h---~niv~l~~~~~-- 250 (468)
+|+..+++-......|.+-.. +|..+.+|.........+.. ....+++..+.+++. -....++.+..
T Consensus 32 ~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 344444555444444544433 67889999765433221110 112233333333322 22333232222
Q ss_pred ---cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 012213 251 ---NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 251 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
-....+++|||++|..|.+... ++. .++..++.++.-+|+.| ++|+|..|+|++++.++ ++++
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEE
Confidence 2234578999999988877642 222 24456778899999888 99999999999998654 9999
Q ss_pred eccccc
Q 012213 328 DFGLAK 333 (468)
Q Consensus 328 Dfgla~ 333 (468)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.2e-07 Score=97.19 Aligned_cols=89 Identities=22% Similarity=0.347 Sum_probs=55.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.
T Consensus 311 Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~ 381 (754)
T PRK15370 311 VQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN 381 (754)
T ss_pred hcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC
Confidence 4677777 4665443 56777777777777 4676654 57777777777776 5666542 467777777777774
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
.++.+. ..+..+++++|.
T Consensus 382 LP~~l~--~sL~~LdLs~N~ 399 (754)
T PRK15370 382 LPENLP--AALQIMQASRNN 399 (754)
T ss_pred CCHhHH--HHHHHHhhccCC
Confidence 433332 234555555554
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.6e-07 Score=60.26 Aligned_cols=37 Identities=35% Similarity=0.537 Sum_probs=33.2
Q ss_pred ccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 42 HILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 42 ~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
++|++|+|++|+++ .+|+.+++|++|+.|++++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 57999999999999 79988999999999999999998
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.7e-07 Score=96.37 Aligned_cols=62 Identities=29% Similarity=0.303 Sum_probs=48.2
Q ss_pred CCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCC
Q 012213 18 LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE 84 (468)
Q Consensus 18 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 84 (468)
++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+ .||..+.++++|+.|+|++|+|+|.+|.
T Consensus 402 s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 402 SELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 34556666666666 45543 245778888888888 7999999999999999999999998774
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.1e-08 Score=97.62 Aligned_cols=99 Identities=30% Similarity=0.397 Sum_probs=75.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+++.. - .+-.|+.|.+|||+.|+|+ .+|. +...+. |+.|.|++|.++ ++ -.+.+|++|..||||+|-|+
T Consensus 194 LshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL-~gie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 194 LSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TL-RGIENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred cchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hh-hhHHhhhhhhccchhHhhhh
Confidence 577888732 2 6777888888888888888 6765 455565 888888888887 45 36889999999999999887
Q ss_pred CCC--CCcccccccCcccccCCCCCCCC
Q 012213 80 GEI--PEFGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 80 ~~~--p~~~~~~~~~~~~~~~n~~lcg~ 105 (468)
+-- ..+..++.+..+.+.|||.-|-+
T Consensus 268 ~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 268 EHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 642 23566778888999999987754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=75.03 Aligned_cols=138 Identities=17% Similarity=0.143 Sum_probs=82.9
Q ss_pred EcccCC-cceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEeccCCCCh
Q 012213 190 IGRGGA-GVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPNGSL 267 (468)
Q Consensus 190 ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 267 (468)
|-.|.. ..||+.... +..+.||...... ...+.+|++++..+. +--+.+++++....+..++|||+++|.++
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444555 788999764 4788888764332 234678888887774 33455677777766678999999998777
Q ss_pred hhhc-------------------ccCCC--CCCC--HHHHHHHHH--------------------HHHHHHHHhhh----
Q 012213 268 GEVL-------------------HGKRG--SFLK--WEMRLKIAI--------------------EAAKGLSYLHH---- 300 (468)
Q Consensus 268 ~~~l-------------------~~~~~--~~l~--~~~~~~i~~--------------------~ia~~l~~LH~---- 300 (468)
.... |.... .... ......... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11110 0111 000000000 01111112211
Q ss_pred cCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 301 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
...+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 113458999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.1e-07 Score=91.65 Aligned_cols=97 Identities=32% Similarity=0.481 Sum_probs=70.8
Q ss_pred CCCCcccccCCcccccCC-CCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
+.+|+++ .||...+.+. +|+.|++++|++. .+|..++++++|+.|++++|+++ .+|...+.++.|+.|++++|+++
T Consensus 123 l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~ 199 (394)
T COG4886 123 LDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199 (394)
T ss_pred cCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc
Confidence 4567777 7777777774 7888888888888 77777888888888888888887 67776667778888888888887
Q ss_pred CCCCCcccccccCcccccCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~ 100 (468)
-.++.......+..+.+++|.
T Consensus 200 ~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 200 DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCchhhhhhhhhhhhhhcCCc
Confidence 333333344457777777774
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=74.15 Aligned_cols=142 Identities=25% Similarity=0.261 Sum_probs=82.3
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCC--CccceeEEEec---CCeeEEEEecc
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR--NIVRLKAFCSN---KETNLLVYEYM 262 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~ 262 (468)
+.++.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+... ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 578999999999999877 68999986432 2235677888888777433 35566664432 33468999999
Q ss_pred CCCChhh----------------h---cccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHhh
Q 012213 263 PNGSLGE----------------V---LHGK--RGSFLKWEM---------RLKI------------AIEAAK-GLSYLH 299 (468)
Q Consensus 263 ~~gsL~~----------------~---l~~~--~~~~l~~~~---------~~~i------------~~~ia~-~l~~LH 299 (468)
++..+.. . +|.. ......+.. .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887777 1 1111 111111111 0000 111222 233333
Q ss_pred h----cCCCCeeecCCCCCcEEEc-CCCceEEeecccccc
Q 012213 300 H----DCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKY 334 (468)
Q Consensus 300 ~----~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~ 334 (468)
. .....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1345599999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=8.2e-08 Score=90.29 Aligned_cols=99 Identities=24% Similarity=0.268 Sum_probs=68.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccC-CcccccCCc-ccccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSW-NQLNASLPK-EMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~-N~l~g~~p~-~~~~l~~L~~l~ls~N~l 78 (468)
|..|+|+...|..|+.+.+|+.||||+|+|+..-|..|..|.+|..|-+-+ |+|+ .+|. .|++|.+|+.|.+.-|++
T Consensus 74 LdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i 152 (498)
T KOG4237|consen 74 LDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHI 152 (498)
T ss_pred eccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhh
Confidence 457888844446788888888888888888866677888888877765544 7787 5665 467777888888877777
Q ss_pred CCCCCC-cccccccCcccccCCC
Q 012213 79 SGEIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 79 ~~~~p~-~~~~~~~~~~~~~~n~ 100 (468)
.-...+ +..+.++..+++-+|.
T Consensus 153 ~Cir~~al~dL~~l~lLslyDn~ 175 (498)
T KOG4237|consen 153 NCIRQDALRDLPSLSLLSLYDNK 175 (498)
T ss_pred cchhHHHHHHhhhcchhcccchh
Confidence 744432 5555555555555553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-07 Score=76.48 Aligned_cols=79 Identities=28% Similarity=0.407 Sum_probs=71.0
Q ss_pred CCCCcccccCCcccccC-CCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHC-LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l-~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|.|. ..|..|... +.++.|+|++|+|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|..|+..+|.+.
T Consensus 60 ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 60 LSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 6899998 788777654 58999999999999 89999999999999999999999 68999999999999999999886
Q ss_pred CCCC
Q 012213 80 GEIP 83 (468)
Q Consensus 80 ~~~p 83 (468)
.||
T Consensus 137 -eid 139 (177)
T KOG4579|consen 137 -EID 139 (177)
T ss_pred -cCc
Confidence 555
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=6e-06 Score=83.30 Aligned_cols=157 Identities=20% Similarity=0.195 Sum_probs=95.0
Q ss_pred cccccchhhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCC-----------------------------Cc
Q 012213 173 LDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS-----------------------------SH 223 (468)
Q Consensus 173 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------~~ 223 (468)
+...-++++..|+ .+.||.-+.|.|++|+.++|+.||||+-++.-... +.
T Consensus 153 lG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~ 231 (538)
T KOG1235|consen 153 LGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEI 231 (538)
T ss_pred hCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHH
Confidence 3444455566554 47899999999999999999999999754321110 00
Q ss_pred hh------HHHHHHHHHhCC----CCCCc---cceeEE-EecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHH
Q 012213 224 DN------GLSAEIRTLGKI----RHRNI---VRLKAF-CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289 (468)
Q Consensus 224 ~~------~~~~e~~~l~~l----~h~ni---v~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 289 (468)
.+ .|..|.+-..++ +|-+. |.+=.+ +.-...+.|+||||+|..+.|.-.-.. ..++......-+.
T Consensus 232 ~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~ 310 (538)
T KOG1235|consen 232 AKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLV 310 (538)
T ss_pred HhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHH
Confidence 00 133343333222 34441 112222 233456799999999988877643111 2244443333333
Q ss_pred HHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCceEEeecccccccc
Q 012213 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEAHVADFGLAKYLQ 336 (468)
Q Consensus 290 ~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgla~~~~ 336 (468)
++..-+-+ ..| ++|+|=.|.||+++. ++.+.+-|||+...+.
T Consensus 311 ~~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 311 EAYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 32221222 234 999999999999984 6789999999998664
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.3e-05 Score=69.56 Aligned_cols=132 Identities=20% Similarity=0.251 Sum_probs=91.5
Q ss_pred CCcceEcccCCcceEEEEcCCCcEEEEEEecccC--------------CCCCchhHHHHHHHHHhCCC------CCCccc
Q 012213 185 KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT--------------KGSSHDNGLSAEIRTLGKIR------HRNIVR 244 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~ 244 (468)
+....||+|+.-.||. +++.....||+..... .......+..+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456899999999995 6777778999887655 01112355667776655554 789999
Q ss_pred eeEEEecCCeeEEEEeccCC------CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 012213 245 LKAFCSNKETNLLVYEYMPN------GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 245 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 318 (468)
++|+..++....+|+|.+.+ -+|.+++... .++. ...+.+.++ ..||-+.. |+.+|++|+||++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 99999999999999998754 3567777432 2444 334444444 44555544 9999999999999
Q ss_pred cCC--C--ceEEee
Q 012213 319 NSD--F--EAHVAD 328 (468)
Q Consensus 319 ~~~--~--~~kl~D 328 (468)
... + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 643 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-07 Score=84.78 Aligned_cols=95 Identities=17% Similarity=0.203 Sum_probs=82.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
||+|.|+ .|..++.-++.++.|+||.|.++ .+. ++..|.+|+.||||+|.|+ .+-.+=..+-+.+.|+|+.|.+.
T Consensus 291 LS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE- 365 (490)
T KOG1259|consen 291 LSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE- 365 (490)
T ss_pred ccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-
Confidence 6899998 89999999999999999999999 665 4999999999999999998 67777677888999999999887
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
.+..++.+=++..+++++|.
T Consensus 366 ~LSGL~KLYSLvnLDl~~N~ 385 (490)
T KOG1259|consen 366 TLSGLRKLYSLVNLDLSSNQ 385 (490)
T ss_pred hhhhhHhhhhheeccccccc
Confidence 45556777778888888885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.8e-07 Score=90.51 Aligned_cols=181 Identities=19% Similarity=0.142 Sum_probs=128.8
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC-ccceeEEEecCCeeEEEEeccCCC-
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLLVYEYMPNG- 265 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g- 265 (468)
+-.++|+++.+||.+....+...++.+... ....-++++|.+++||| .++.++-+..+...+++++++..+
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 457899999999987644343444433211 33566889999999999 777777777777788999999876
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 345 (468)
+-..... .....+...+...+...-+++++|+|... =+|+| ||+..+ ...+..||+....+.... ...
T Consensus 321 s~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 321 SSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred cccccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 3222221 11112333344455566778899999653 48998 776655 678999999988775332 234
Q ss_pred ccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 012213 346 AVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387 (468)
Q Consensus 346 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 387 (468)
...+++.|+|||......+....|+|+.|+--.++--|-+|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 567899999999999999999999999998777777777664
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.1e-06 Score=96.87 Aligned_cols=98 Identities=16% Similarity=0.135 Sum_probs=60.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|. .+|..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|.....+|..+.++++|+.|++++|..-+
T Consensus 618 L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~ 695 (1153)
T PLN03210 618 MQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE 695 (1153)
T ss_pred CcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC
Confidence 3455565 556666666667777776655444565 36666777777776665445677777777777777777654334
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
.+|....+.++..+.+++|.
T Consensus 696 ~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 696 ILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred ccCCcCCCCCCCEEeCCCCC
Confidence 55543355666666666554
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1e-06 Score=88.03 Aligned_cols=100 Identities=25% Similarity=0.361 Sum_probs=86.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|+.+..+..|..|.+++|++.-
T Consensus 147 l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~ 223 (394)
T COG4886 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE 223 (394)
T ss_pred ccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCccee
Confidence 5789998 88889999999999999999999 89999889999999999999999 899987777789999999997654
Q ss_pred CCCCcccccccCcccccCCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHLC 103 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~lc 103 (468)
.+..+..+.++..+.+.+|+..+
T Consensus 224 ~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 224 LLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred cchhhhhcccccccccCCceeee
Confidence 66667777777777777776544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.3e-05 Score=82.62 Aligned_cols=80 Identities=15% Similarity=0.288 Sum_probs=56.7
Q ss_pred cceEcccCCcceEEEEcCCC---cEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCc--cceeEEEecC---CeeEE
Q 012213 187 NNVIGRGGAGVVYRGVTPNG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNI--VRLKAFCSNK---ETNLL 257 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~l 257 (468)
...++.|.+..+|+....++ ..+++|+....... .....+.+|+++++.+. |.++ .+++.+|.+. +..++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 46789999999999877554 46777775432211 12246889999999985 6654 7778888664 35789
Q ss_pred EEeccCCCCh
Q 012213 258 VYEYMPNGSL 267 (468)
Q Consensus 258 v~e~~~~gsL 267 (468)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 468 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-18 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-116
Identities = 119/279 (42%), Positives = 162/279 (58%), Gaps = 14/279 (5%)
Query: 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+ N++GRGG G VY+G +G VAVK+L + + E+ + HRN++RL
Sbjct: 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS--FLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ FC LLVY YM NGS+ L + S L W R +IA+ +A+GL+YLH C
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
P IIHRDVK+ NILL+ +FEA V DFGLAK L D + +AV G+ G+IAPEY T K
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDF----GEEGLDIVQWTK-MQTNSSKEGVVKILDQ 418
EK+DV+ +GV+LLELITG+R D ++ + ++ W K + E +V D
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEALV---DV 267
Query: 419 RL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
L N E Q+ VA+LC Q +ERP M EVV+ML
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-110
Identities = 100/278 (35%), Positives = 148/278 (53%), Gaps = 17/278 (6%)
Query: 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGKIRHRNI 242
+IG G G VY+GV +G +VA+K+ T SS G+ EI TL RH ++
Sbjct: 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRR---TPESSQ--GIEEFETEIETLSFCRHPHL 97
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF--LKWEMRLKIAIEAAKGLSYLHH 300
V L FC + +L+Y+YM NG+L L+G + WE RL+I I AA+GL YLH
Sbjct: 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
IIHRDVKS NILL+ +F + DFG++K + + + V G+ GYI PEY
Sbjct: 158 RA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRPV-GDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419
++ EKSDVYSFGVVL E++ R + E +++ +W N+ + + +I+D
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ--LEQIVDPN 272
Query: 420 L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
L + A+ C+ +RP+M +V+ L
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-108
Identities = 100/274 (36%), Positives = 153/274 (55%), Gaps = 12/274 (4%)
Query: 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGKIRHRNIV 243
N +G GG GVVY+G N VAVKKL + ++ EI+ + K +H N+V
Sbjct: 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHENLV 93
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDC 302
L F S+ + LVY YMPNGSL + L G+ L W MR KIA AA G+++LH +
Sbjct: 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
IHRD+KS NILL+ F A ++DFGLA+ + + S + G+ Y+APE
Sbjct: 154 ---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRG 209
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422
++ KSD+YSFGVVLLE+ITG V D E ++ + + ++ + +D+++++
Sbjct: 210 EITPKSDIYSFGVVLLEIITGLPAV-DEHREPQLLLDIKE-EIEDEEKTIEDYIDKKMND 267
Query: 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ ++ VA C+ E +RP +++V Q+L
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-83
Identities = 70/317 (22%), Positives = 124/317 (39%), Gaps = 38/317 (11%)
Query: 173 LDFGSDDI---LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA 229
+D G++++ ++ V RG G V++ E VAVK
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAVKIFP-----IQDKQSWQN 65
Query: 230 E--IRTLGKIRHRNIVRLKAFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
E + +L ++H NI++ + L+ + GSL + L + W
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNE 122
Query: 284 RLKIAIEAAKGLSYLHHD-------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
IA A+GL+YLH D P I HRD+KS N+LL ++ A +ADFGLA +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 337 DTGASECMSAVAGSYGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGRRPVGDFG 391
++ G+ Y+APE + + D+Y+ G+VL EL +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 392 EEGLDIVQWTKMQTNSSKEGVVKILDQRL------SNTPLSEAMQVFF-VAMLCVQEHGV 444
+E + + ++ + S E + +++ + M + C
Sbjct: 243 DEYMLPFEE-EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 445 ERPTMREVVQMLAQAQK 461
R + V + + Q Q+
Sbjct: 302 ARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-69
Identities = 83/280 (29%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG G G V+R +G VAVK L+ + N E+ + ++RH NIV
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ +V EY+ GSL +LH L RL +A + AKG++YLH+ +P I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HR++KS N+L++ + V DFGL++ T S + AG+ ++APE +E
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL---SNT 423
KSDVYSFGV+L EL T ++P + L+ Q V +RL N
Sbjct: 219 KSDVYSFGVILWELATLQQP---W--GNLNPAQVVAA---------VGFKCKRLEIPRNL 264
Query: 424 P--LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
++ ++ C +RP+ ++ +L K
Sbjct: 265 NPQVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 7e-68
Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 38/281 (13%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
V+GRG GVV + + VA+K++ + S E+R L ++ H NIV+L
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
C N LV EY GSL VLHG + + ++ ++G++YLH +
Sbjct: 69 ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 307 IHRDVKSNNILLNSDFE-AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
IHRD+K N+LL + + DFG A +Q M+ GS ++APE
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYS 181
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL---SN 422
EK DV+S+G++L E+IT R+P + ++ + + R N
Sbjct: 182 EKCDVFSWGIILWEVITRRKP-------------FDEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 423 TP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
P + M C + +RP+M E+V+++ +
Sbjct: 229 LPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 8e-67
Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+IG GG G VYR G++VAVK S + E + ++H NI+ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ C + LV E+ G L VL GKR + ++ + A++ A+G++YLH +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 306 IIHRDVKSNNILLNSDFEAH--------VADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
IIHRD+KS+NIL+ E + DFGLA+ T + AG+Y ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPE 184
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
+ SDV+S+GV+L EL+TG P F G+D + V +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP---F--RGIDGLAVAYG---------VAMNK 230
Query: 418 QRL---SNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
L S P ++ M+ C RP+ ++ L
Sbjct: 231 LALPIPSTCPEPFAKLME------DCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-66
Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 45/287 (15%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLL-----GITKGSSHDNGLSAEIRTLGKIRHRN 241
IG+GG G+V++G + VA+K L+ G T+ E+ + + H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
IV+L N +V E++P G L L K +KW ++L++ ++ A G+ Y+ +
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN- 140
Query: 302 CSPLIIHRDVKSNNILL-----NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
+P I+HRD++S NI L N+ A VADFGL++ + +S + G++ ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAP 195
Query: 357 E--YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414
E A EK+D YSF ++L ++TG P F + + + +++
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP---F--DEYSYGKIKFI-------NMIR 243
Query: 415 ILDQRL---SNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
R + P L ++ LC +RP +V+ L
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-64
Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 43/286 (15%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+ +G +++G G + VK L + + E L H N++ +
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 248 FCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
C + + +MP GSL VLH + +K A++ A+G+++LH PL
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE---YAYTL 362
I + S +++++ D A ++ + Q G + ++APE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPEALQKKPED 186
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL-- 420
+D++SF V+L EL+T P F L ++ +K+ + L
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP---F--ADLSNMEI-----------GMKVALEGLRP 230
Query: 421 ---SNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
+S+ M+ +C+ E +RP +V +L + Q
Sbjct: 231 TIPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-64
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 25/277 (9%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
IG G G VY+G +G+ VAVK L E+ L K RH NI+ +
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ +V ++ SL LH + + + IA + A+G+ YLH + IIHR
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE---YAYTLKVDE 366
D+KSNNI L+ D + DFGLA S ++GS ++APE +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV--KILDQRLSNTP 424
+SDVY+FG+VL EL+TG+ P ++ + +V L LS
Sbjct: 205 QSDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
+ ++ + C+++ ERP+ ++ + + +
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 63/288 (21%), Positives = 110/288 (38%), Gaps = 34/288 (11%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+IG+G G VY G +GE VA++ + E+ + RH N+V
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
C + ++ +L V+ + L +IA E KG+ YLH + I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAK---YLQDTGASECMSAVAGSYGYIAPE------- 357
H+D+KS N+ + + + + DFGL LQ + + G ++APE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 358 --YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415
L + SDV++ G + EL P + + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP-------------FKTQPAEAIIWQMGTG 258
Query: 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463
+ LS + + + + + C ERPT +++ ML + K N
Sbjct: 259 MKPNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-60
Identities = 65/306 (21%), Positives = 116/306 (37%), Gaps = 44/306 (14%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAE--IRTLGKIRHRNIVRL 245
+IGRG G VY+G + + VAVK ++ E I + + H NI R
Sbjct: 19 ELIGRGRYGAVYKG-SLDERPVAVKVFS-----FANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 246 KAFC----SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
++ LV EY PNGSL + L W ++A +GL+YLH
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHT 129
Query: 301 D------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE------CMSAVA 348
+ P I HRD+ S N+L+ +D ++DFGL+ L +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 349 GSYGYIAPEYA-------YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE-EGLDIVQW 400
G+ Y+APE ++ D+Y+ G++ E+ + +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 401 TKMQTNSSKEGVVKILDQR-----LSNTPLSEAMQVFFVAML---CVQEHGVERPTMREV 452
T++ + + E + ++ + ++ V + C + R T +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
Query: 453 VQMLAQ 458
+ +A+
Sbjct: 310 EERMAE 315
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-57
Identities = 67/291 (23%), Positives = 116/291 (39%), Gaps = 39/291 (13%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR 240
+ V+G+G G + GE + +K+L+ + + E++ + + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHP 67
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
N+++ + + EY+ G+L ++ S W R+ A + A G++YLH
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLH- 125
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS------------ECMSAVA 348
S IIHRD+ S+N L+ + VADFGLA+ + D + V
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 349 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408
G+ ++APE DEK DV+SFG+VL E+I D + +
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD----------YLPRTMDF- 232
Query: 409 KEGVVKILDQRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
G+ N P F + + C +RP+ ++ L
Sbjct: 233 --GLNVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-57
Identities = 79/310 (25%), Positives = 120/310 (38%), Gaps = 29/310 (9%)
Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
I + ++ IG+G G V+ G GE+VAVK + S EI +RH
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF---RETEIYQTVLMRH 90
Query: 240 RNIVRLKAFC---SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
NI+ A + T L L+ +Y NGSL + L L + LK+A + GL
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGL 147
Query: 296 SYLH-----HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE--CMSAVA 348
+LH P I HRD+KS NIL+ + +AD GLA +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 349 GSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402
G+ Y+ PE + +D+YSFG++L E+ G E L
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 403 MQTNSSK-EGVVKILDQRLS--NTPLSEAMQVFFVAML--CVQEHGVERPTMREVVQMLA 457
+ +V I R S N S+ ++ C + R T V + LA
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 458 QAQKPNTFQM 467
+ + ++
Sbjct: 328 KMSESQDIKL 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-57
Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 37/297 (12%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G+G G V+RG + GE VAVK + S E+ +RH NI+ A
Sbjct: 14 ECVGKGRYGEVWRG-SWQGENVAVKIFSSRDEKSWF---RETELYNTVMLRHENILGFIA 69
Query: 248 FC---SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-- 301
+ T L L+ Y GSL + L L L+I + A GL++LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 302 ---CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE--CMSAVAGSYGYIAP 356
P I HRD+KS NIL+ + + +AD GLA + + G+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 357 E------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE-----EGLDIVQWTKMQT 405
E ++ D+++FG+VL E+ G + + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 406 NSSKEGVVKILDQRLS--NTPLSEAMQVFFVAML--CVQEHGVERPTMREVVQMLAQ 458
VV + QR + N S+ ++ C ++ R T + + L +
Sbjct: 247 ----RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 29/310 (9%)
Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
I + IG+G G V+RG GE+VAVK + S AEI +RH
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRH 95
Query: 240 RNIVRLKAFC---SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
NI+ A + T L LV +Y +GSL + L+ + E +K+A+ A GL
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGL 152
Query: 296 SYLHHD-----CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC--MSAVA 348
++LH + P I HRD+KS NIL+ + +AD GLA + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 349 GSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402
G+ Y+APE + +++D+Y+ G+V E+ G + L
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 403 MQTNSSK-EGVVKILDQRLS--NTPLSEAMQVFFVAML--CVQEHGVERPTMREVVQMLA 457
+ + VV R + N S ++ C +G R T + + L+
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 458 QAQKPNTFQM 467
Q + +M
Sbjct: 333 QLSQQEGIKM 342
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
K + IGRG VY+G+ T +VA +L S E L ++H NIV
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 244 R-LKAFCSNKETNLLVY---EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
R ++ S + + E M +G+L L KR +K ++ + KGL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 300 HDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
+P IIHRD+K +NI + + D GLA + + A V G+ ++APE
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEM 201
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y K DE DVY+FG+ +LE+ T P
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-43
Identities = 51/127 (40%), Positives = 69/127 (54%), Gaps = 2/127 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
MS N SG IP EIG L L+L N +SG IP ++ + LN L++S N+L+ +P+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
M + LT D S+NN SG IPE GQ+ F F NP LCG L C+ S+
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADG--Y 756
Query: 121 QNGNKSH 127
+ +SH
Sbjct: 757 AHHQRSH 763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-24
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N F+G IP + +C L L LS N+LSG IP + + L L + N L +P+
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
E+ +K+L + N+ +GEIP N T+
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPS----GLSNCTN 491
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 34/130 (26%), Positives = 57/130 (43%), Gaps = 4/130 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N+ +G IP + +C L ++ LS N L+G IP I ++ L L +S N + ++P
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
E+G+ +SL D + N F+G IP + F + + G +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPA----AMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588
Query: 121 QNGNKSHVPG 130
GN G
Sbjct: 589 GAGNLLEFQG 598
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-22
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N SG IP +G L L L N L G IP ++ + L L + +N L +P
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 61 EMGNMKSLTSADFSHNNFSGEIP-EFGQYS 89
+ N +L S+N +GEIP G+
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-22
Identities = 29/84 (34%), Positives = 47/84 (55%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N G IP E+ + L L L N L+G IP ++ LN++++S N+L +PK
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+G +++L S+N+FSG IP
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-22
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 6/97 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+S NNFSG I + L L L N +G IP ++ L L++S+N L+ ++
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
P +G++ L N GEIP+ +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQ----ELMYVKT 467
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-21
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLP 59
+S N+F G +P G C LL L LS N+ SG +P+ + ++ L L++S+N+ + LP
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 60 KEMGNMK-SLTSADFSHNNFSGEIP-EFGQYSFFN 92
+ + N+ SL + D S NNFSG I Q
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-21
Identities = 36/96 (37%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 2 SRNNFSGIIPVEI-GHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N F+G IP + G C LT LDLS NH G +P +L L +S N + LP
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 61 EM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
+ M+ L D S N FSGE+PE S N ++
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPE----SLTNLSA 368
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-20
Identities = 35/85 (41%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S NNFS IP +G C L +LD+S N LSG I+ L LN+S NQ +P
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEF 85
+KSL + N F+GEIP+F
Sbjct: 266 L--PLKSLQYLSLAENKFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-19
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 3/90 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQN--HLSGPIPVQITQIHILNYLNVSWNQLNASL 58
++ N +G V I + + + N G Q+ ++ N N++
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIP-EFGQ 87
N S+ D S+N SG IP E G
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-18
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPK 60
S N F G IP L YL L++N +G IP ++ L L++S N ++P
Sbjct: 255 SSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
G+ L S S NNFSGE+P
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPM 336
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-18
Identities = 28/90 (31%), Positives = 37/90 (41%), Gaps = 6/90 (6%)
Query: 2 SRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQ---IHILNYLNVSWNQLNAS 57
S N V G L L LDLS N +SG V L +L +S N+++
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGD 193
Query: 58 LPKEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ + +L D S NNFS IP G
Sbjct: 194 VD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP--VQITQIHILNYLNVSWNQLNASL 58
+S ++ +G + LT LDLS+N LSGP+ + L +LNVS N L+
Sbjct: 84 LSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142
Query: 59 PKEMG-NMKSLTSADFSHNNFSGEIPE 84
G + SL D S N+ SG
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVV 169
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-17
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 1 MSRNNFSGIIP--VEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNAS 57
+SRN+ SG + +G C L +L++S N L P V +++ L L++S N ++ +
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 58 LPKEM---GNMKSLTSADFSHNNFSGEIP 83
L S N SG++
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 16/82 (19%), Positives = 29/82 (35%), Gaps = 3/82 (3%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP--KE 61
N + + L L LS +H++G + L L++S N L+ +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 62 MGNMKSLTSADFSHNNFSGEIP 83
+G+ L + S N
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGK 143
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 20 LTYLDLSQNHLS---GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN 76
+T +DLS L+ + + + L L +S + +N S+ SLTS D S N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110
Query: 77 NFSGEIPEFGQ 87
+ SG +
Sbjct: 111 SLSGPVTTLTS 121
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 8/61 (13%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 44 LNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSF-----FNSTSFTG 98
++ + N +++ + ++ L S S+++ +G + F + + S +G
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSG 114
Query: 99 N 99
Sbjct: 115 P 115
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-41
Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 49/290 (16%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA---EIRTLGKI 237
E + IGRG G V+ G + VAVK + + + + E R L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQY 169
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
H NIVRL C+ K+ +V E + G L G+ L+ + L++ +AA G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEY 228
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI--- 354
L S IHRD+ + N L+ ++DFG+++ D + A +G +
Sbjct: 229 LE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVPVK 280
Query: 355 --APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411
APE + +SDV+SFG++L E + G P L Q
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-----PNLSNQQ------------ 323
Query: 412 VVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ +++ RL P VF + C +RP+ + Q L
Sbjct: 324 TREFVEKGGRLPCPELCP----DAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 43/286 (15%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR 240
+ + +G G G VY GV VAVK L + + E + +I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
N+V+L C+ + ++ E+M G+L + L + + L +A + + + YL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY--IAPEY 358
IHR++ + N L+ + VADFGL++ + + + APE
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPES 390
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
K KSDV++FGV+L E+ T G P G+D+ Q V ++L+
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQ------------VYELLE 433
Query: 418 Q--RL---SNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ R+ P + E M C Q + +RP+ E+ Q
Sbjct: 434 KDYRMERPEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAF 473
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E ++ +G+G G V+ G +VA+K L G+ E + + K+RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+L A S +E +V EYM GSL + L G+ G +L+ + +A + A G++Y+
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD---TGASECMSAVAGSYGYIAPEY 358
+HRD+++ NIL+ + VADFGLA+ ++D T + + APE
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEA 352
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
A + KSDV+SFG++L EL T GR P + M V+ ++
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP-------------YPGM----VNREVLDQVE 395
Query: 418 Q--RL---SNTPLSEAMQVFFVAML-CVQEHGVERPTMREVVQML 456
+ R+ P + M C ++ ERPT + L
Sbjct: 396 RGYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK- 246
IG G G + +G+ + K+L + + L +E+ L +++H NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 247 AFCSNKETNL-LVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLH--HD 301
T L +V EY G L V+ K +L E L++ + L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
++HRD+K N+ L+ + DFGLA+ L + G+ Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNR 190
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421
+ +EKSD++S G +L EL P F S KE KI + +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP---F-------------TAFSQKELAGKIREGKFR 234
Query: 422 NTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
P S+ + ML ++++ RP++ E+++
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDY--HRPSVEEILEN 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 79/293 (26%), Positives = 120/293 (40%), Gaps = 34/293 (11%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
+K +G G G V GEQVAVK L + G +H L EI L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRN 79
Query: 237 IRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
+ H NIV+ K C+ N L+ E++P+GSL E L + + LK A++ KG
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-LKYAVQICKG 138
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
+ YL S +HRD+ + N+L+ S+ + + DFGL K ++ +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET----DKEYYTVKDDRDS 191
Query: 355 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408
APE K SDV+SFGV L EL+T I T +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 409 KEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+V L + RL N P +V+ + C + R + + +++
Sbjct: 252 ---LVNTLKEGKRLPCPPNCP----DEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 30/272 (11%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
IG G G T +G Q +K+ + ++ + E+ L ++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE--SRREVAVLANMKHPNIVQY 88
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ + +V +Y G L + ++ ++G + + L ++ L ++H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
I+HRD+KS NI L D + DFG+A+ L T E A G+ Y++PE +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYN 203
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP- 424
KSD+++ G VL EL T + F + S K V+KI+
Sbjct: 204 NKSDIWALGCVLYELCTLKHA---F-------------EAGSMKNLVLKIISGSFPPVSL 247
Query: 425 -LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
S ++ + +RP++ +++
Sbjct: 248 HYSYDLRSLVSQLFKRNPR--DRPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 30/275 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
IGRG VYR +G VA+KK + + + + + EI L ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKY 97
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
A +V E G L ++ K+ + K ++ L ++H S
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
++HRD+K N+ + + + D GL ++ + ++ G+ Y++PE +
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENG 212
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423
+ KSD++S G +L E+ + P F + +++ KI
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSL-----------CKKIEQCDYPPL 258
Query: 424 P---LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
P SE ++ + +RP + V +
Sbjct: 259 PSDHYSEELRQLVNMCINPDPE--KRPDVTYVYDV 291
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 76/293 (25%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
+K + +G+G G V G VAVK+L G EI+ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKA 80
Query: 237 IRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
+ IV+ + LV EY+P+G L + L R + L + + KG
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-LLYSSQICKG 139
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
+ YL S +HRD+ + NIL+ S+ +ADFGLAK L + V G
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL----DKDYYVVREPGQS 192
Query: 355 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408
APE +SDV+SFGVVL EL T + E + + S
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 409 KEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
++++L++ RL P +V + LC +RP+ + L
Sbjct: 253 ---LLELLEEGQRLPAPPACP----AEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E ++ +G+G G V+ G +VA+K L G+ E + + K+RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+L A S +E +V EYM GSL + L G+ G +L+ + +A + A G++Y+
Sbjct: 324 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 380
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD---TGASECMSAVAGSYGYIAPEY 358
+HRD+++ NIL+ + VADFGLA+ ++D T + + APE
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEA 435
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
A + KSDV+SFG++L EL T GR P + M V+ ++
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVP-------------YPGM----VNREVLDQVE 478
Query: 418 Q--RL---SNTPLSEAMQVFFVAML-CVQEHGVERPTMREVVQML 456
+ R+ P + M C ++ ERPT + L
Sbjct: 479 RGYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
+ +K IG+G G V G G +VAVK + K + AE + ++RH N
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 75
Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
+V+L ++ L +V EYM GSL + L + S L + LK +++ + + YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGASECMSAVAGSYGYI---- 354
+HRD+ + N+L++ D A V+DFGL K G +
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------------GKLPVKW 180
Query: 355 -APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
APE K KSDV+SFG++L E+ + GR P
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E +K +G G G V+ +VAVK + GS AE + ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 244
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+L A + KE ++ E+M GSL + L GS + + + A+G++++
Sbjct: 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI---APEY 358
IHRD+++ NIL+++ +ADFGLA+ ++D +A G+ I APE
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEA 356
Query: 359 AYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
KSDV+SFG++L+E++T GR P
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-38
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 1/110 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+SRN G V G + L++N L+ + ++ LN L++ N++ +LP+
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPC 110
+ +K L S + S NN GEIP+ G F+ +++ N LCGS L C
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
NN G IP I L YL ++ ++SG IP ++QI L L+ S+N L+ +LP
Sbjct: 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
+ ++ +L F N SG IP+ S+ + +
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPD----SYGSFSK 174
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N SG IP + L LD S N LSG +P I+ + L + N+++ ++P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 61 EMGNMKSLTSA-DFSHNNFSGEIP-EFGQYSF 90
G+ L ++ S N +G+IP F +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNL 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVS-WNQLNASL 58
+ G++ + LDLS +L PIP + + LN+L + N L +
Sbjct: 34 CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEF 85
P + + L +H N SG IP+F
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDF 120
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
+ IG G G+V+ G N ++VA+K + +G+ + E + K+ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 64
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--H 299
+V+L C + LV E+M +G L + L +RG F + L + ++ +G++YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA 123
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI---AP 356
+IHRD+ + N L+ + V+DFG+ +++ D + ++ G+ + +P
Sbjct: 124 C-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASP 174
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
E + KSDV+SFGV++ E+ + G+ P
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E +K +G G G V+ G +VAVK L +GS + AE + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+VRL A + +E ++ EYM NGSL + L G L L +A + A+G++++
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----AP 356
IHRD+++ NIL++ +ADFGLA+ ++D A AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EYTAREGAKFPIKWTAP 179
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
E KSDV+SFG++L E++T GR P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-38
Identities = 58/284 (20%), Positives = 105/284 (36%), Gaps = 42/284 (14%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD---NGLSAEIRTLGKIRHRN--I 242
IG GG+ V++ + + A+K + + + + EI L K++ + I
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKY---VNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
+RL + + +V E N L L K+ S WE + + + +H H
Sbjct: 91 IRLYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERK-SYWKNMLEAVHTIHQHG 147
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE---- 357
I+H D+K N L+ + DFG+A +Q S + G+ Y+ PE
Sbjct: 148 ----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 358 -------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
K+ KSDV+S G +L + G+ P Q +K+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIIDPN 256
Query: 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
++ D + +Q L +R ++ E++
Sbjct: 257 HEIEFPDI------PEKDLQDVLKCCLKRDPK--QRISIPELLA 292
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 60/286 (20%), Positives = 117/286 (40%), Gaps = 50/286 (17%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+IG GG G V++ +G+ +K+ + + + E++ L K+ H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN--EKAER-EVKALAKLDHVNIVHYN 70
Query: 247 AF---------------CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIE 290
+K L + E+ G+L + + +RG L + L++ +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
KG+ Y+H S +I+RD+K +NI L + + DFGL L++ G + G+
Sbjct: 131 ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGT 184
Query: 351 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
Y++PE + ++ D+Y+ G++L EL+ E
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFT----------- 229
Query: 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ D +S+ + + +L + +RP E+++ L
Sbjct: 230 ---DLRDGIISDI-FDKKEKTLLQKLLSKKPE--DRPNTSEILRTL 269
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 52/292 (17%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
E V N ++G G G VY GV GE VAVK + + +S E + +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS-EAVIMKNL 70
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
H +IV+L +E ++ E P G LG L + S + + +++ K ++Y
Sbjct: 71 DHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAY 128
Query: 298 L--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI- 354
L + +HRD+ NIL+ S + DFGL++Y++D S +
Sbjct: 129 LESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLP 177
Query: 355 ----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSK 409
+PE + SDV+ F V + E+++ G++P + + N
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP-------------FFWL-ENKD- 222
Query: 410 EGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
V+ +L++ RL P ++ + C +RP E+V L
Sbjct: 223 --VIGVLEKGDRLPKPDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
V+G+G G+VY G N ++A+K+ I + S L EI ++H+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKE---IPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 247 AFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLK-IAIEAAKGLSYLHHDCSP 304
++ + ++ E +P GSL +L K G E + + +GL YLH +
Sbjct: 86 G-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 305 LIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE----- 357
I+HRD+K +N+L+N+ + + +DFG +K L + C G+ Y+APE
Sbjct: 143 -IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDKG 198
Query: 358 -YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393
Y +D++S G ++E+ TG+ P + GE
Sbjct: 199 PRGYGK----AADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR 240
+ + +G G G VY GV VAVK L + + E + +I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
N+V+L C+ + ++ E+M G+L + L + + L +A + + + YL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---YGYIAPE 357
IHRD+ + N L+ + VADFGL++ + + +A AG+ + APE
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPE 182
Query: 358 YAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
K KSDV++FGV+L E+ T G P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
+ +K IG+G G V G G +VAVK + K + AE + ++RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL-H 299
+V+L ++ L +V EYM GSL + L + S L + LK +++ + + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI----- 354
++ +HRD+ + N+L++ D A V+DFGL K + G +
Sbjct: 308 NNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEA----------SSTQDTGKLPVKWT 353
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
APE K KSDV+SFG++L E+ + GR P
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
+ + +G G GVV G VA+K + +GS ++ E + + + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEK 80
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--H 299
+V+L C+ + ++ EYM NG L L R F ++ L++ + + + YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESK 139
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI---AP 356
+HRD+ + N L+N V+DFGL++Y+ D ++ GS + P
Sbjct: 140 Q-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPP 190
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
E K KSD+++FGV++ E+ + G+ P
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 58/281 (20%), Positives = 103/281 (36%), Gaps = 36/281 (12%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRL 245
IG GG+ V++ + + A+K + + + EI L K++ I+RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSP 304
+ + +V E N L L K+ S WE + + + +H H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 128
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE------- 357
I+H D+K N L+ + DFG+A +Q S + G+ Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 358 ----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
K+ KSDV+S G +L + G+ P Q +K+ +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIIDPNHEI 240
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ D + +Q L +R ++ E++
Sbjct: 241 EFPDI------PEKDLQDVLKCCLKRDPK--QRISIPELLA 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-37
Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 46/296 (15%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
+G GG V +G A+K+ I D E H NI+RL
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKR---ILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
A+C + L+ + G+L + +G+FL + L + + +GL +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT--GASECMS-----AVAGSYGY 353
+ HRD+K NILL + + + D G G+ + ++ A + Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 354 IAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409
APE ++ +DE++DV+S G VL ++ G P +
Sbjct: 210 RAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP---YDMV------------FQKG 253
Query: 410 EGVVKILDQRLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462
+ V + +LS + S A+ +M+ +RP + ++ L Q P
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMM--TVDPHQRPHIPLLLSQLEALQPP 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 59/281 (20%), Positives = 104/281 (37%), Gaps = 36/281 (12%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRL 245
IG GG+ V++ + + A+K + + + EI L K++ I+RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSP 304
+ + +V E N L L K+ S WE + + + +H H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE------- 357
I+H D+K N L+ D + DFG+A +Q S + G+ Y+ PE
Sbjct: 176 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 358 ----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
K+ KSDV+S G +L + G+ P Q +K+ +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIIDPNHEI 287
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ D + +Q L +R ++ E++
Sbjct: 288 EFPDI------PEKDLQDVLKCCLKRDPK--QRISIPELLA 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 19/232 (8%)
Query: 161 NSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITK 219
N + +D+ + + + +GRG G V+R G Q AVKK+
Sbjct: 37 NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV----- 91
Query: 220 GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL 279
+ E+ + IV L + E + GSLG+++ + G
Sbjct: 92 --RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLP 148
Query: 280 KWEMRLK-IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQD 337
E R +A +GL YLH I+H DVK++N+LL+SD A + DFG A LQ
Sbjct: 149 --EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203
Query: 338 TGASECMSA---VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G + + + G+ ++APE D K D++S ++L ++ G P
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV---TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
+ +IG G +G V G + VA+K L + LS E +G+
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS-EASIMGQF 107
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
H NI+RL+ + ++V EYM NGSL L G F ++ + + G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-VGMLRGVGAGMRY 166
Query: 298 L--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI- 354
L +HRD+ + N+L++S+ V+DFGL++ L+D + +A + G I
Sbjct: 167 LSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED----DPDAAYTTTGGKIP 217
Query: 355 ----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
APE SDV+SFGVV+ E++ G RP
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E + +G G GVV G VAVK + +GS ++ E +T+ K+ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+ CS + +V EY+ NG L L ++ L++ + +G+++L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-LEMCYDVCEGMAFLE-- 121
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----AP 356
S IHRD+ + N L++ D V+DFG+ +Y+ D V+ AP
Sbjct: 122 -SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSVGTKFPVKWSAP 174
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
E + K KSDV++FG+++ E+ + G+ P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 47/296 (15%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKL-LGITKGSSHDNGLSAEIRTLGK 236
+ ++ +G G GVV RG P+G+ VAVK L + + E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
+ HRN++RL +V E P GSL + L +G FL + + A++ A+G+
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMG 135
Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS---Y 351
YL IHRD+ + N+LL + + DFGL + L + +
Sbjct: 136 YLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPF 188
Query: 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
+ APE T SD + FGV L E+ T G+ P W + S
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------------WIGL-NGSQ-- 232
Query: 411 GVVKILDQ---RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460
++ +D+ RL + P ++ V + C +RPT + L +AQ
Sbjct: 233 -ILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 28/220 (12%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGEQ---VAVKKLLGITKGSSHDNGLS--AEIRTL 234
CV VIG G G VY+G+ T +G++ VA+K L G + + E +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIM 100
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
G+ H NI+RL+ S + +++ EYM NG+L + L K G F ++ + + A G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAG 159
Query: 295 LSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
+ YL + +HRD+ + NIL+NS+ V+DFGL++ L+D + + S G
Sbjct: 160 MKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTTSGG 210
Query: 353 YI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
I APE K SDV+SFG+V+ E++T G RP
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-36
Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 31/209 (14%)
Query: 189 VIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
I GG G +Y + NG V +K L+ S D A E + L ++ H +I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLV-----HSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 243 VRLKAF-----CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
V++ F +V EY+ SL K L + +E LSY
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSY 197
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
LH +++ D+K NI+L + + + D G + G + G+ G+ APE
Sbjct: 198 LHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPE 247
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
T +D+Y+ G L L
Sbjct: 248 IVRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 79/305 (25%), Positives = 135/305 (44%), Gaps = 54/305 (17%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLS--AEIRTLG 235
+ + V+G G G V G P+ + VA+K L G + E +G
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMG 101
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
+ H NI+RL+ + + ++V EYM NGSL L F ++ + + A G+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGM 160
Query: 296 SYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
YL +HRD+ + NIL+NS+ V+DFGL + L+D + +A G
Sbjct: 161 KYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEAAYTTRGGK 211
Query: 354 I-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNS 407
I +PE K SDV+S+G+VL E+++ G RP + +N
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--------------SNQ 257
Query: 408 SKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ-AQK 461
V+K +D+ RL + P + ++ + + C Q+ RP ++V +L + +
Sbjct: 258 D---VIKAVDEGYRLPPPMDCPAA----LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 462 PNTFQ 466
P + +
Sbjct: 311 PGSLK 315
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 49/283 (17%)
Query: 190 IGRGGAGVVYRGV--TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G G G V +GV + VA+K L T+ + + + E + + ++ + IVRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLDNPYIVRLI 76
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HHDCSP 304
C E +LV E G L + L GKR + ++ + + G+ YL +
Sbjct: 77 GVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN---- 130
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----APEYA 359
+HRD+ + N+LL + A ++DFGL+K L + A S G APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGA----DDSYYTARSAGKWPLKWYAPECI 185
Query: 360 YTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
K +SDV+S+GV + E ++ G++P + KM V+ ++Q
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP-------------YKKM-KGPE---VMAFIEQ 228
Query: 419 --RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
R+ P +++ + C +RP V Q +
Sbjct: 229 GKRMECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 76/294 (25%), Positives = 119/294 (40%), Gaps = 36/294 (12%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITK--GSSHDNGLSAEIRTL 234
+K +G+G G V GE VAVKKL + H EI L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEIL 65
Query: 235 GKIRHRNIVRLKAFC--SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
++H NIV+ K C + + L+ EY+P GSL + L + + L+ +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQIC 124
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
KG+ YL + IHRD+ + NIL+ ++ + DFGL K L + G
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ----DKEFFKVKEPG 177
Query: 353 YI-----APEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407
APE K SDV+SFGVVL EL T E + ++ K
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 408 SKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
++++L RL P +++ + C + +RP+ R++ +
Sbjct: 238 VFH-LIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
++GRGG G VY VA+K + ++ S D E RT G+++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM---SETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ F + + L +L ++G L + I + L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGP-LAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
HRDVK NIL+++D A++ DFG+A D ++ + G+ Y+APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESH 211
Query: 364 VDEKSDVYSFGVVLLELITGRRP-VGD 389
++D+Y+ VL E +TG P GD
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGD 238
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 188 NVIGRGGAGVVYRGV-TPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
V+G G G VY+G+ P GE VA+K+L T ++ L E + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHV 79
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HH 300
RL C T L+ + MP G L + + + + + + L ++ AKG++YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY------- 353
++HRD+ + N+L+ + + DFGLAK L Y
Sbjct: 138 -----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEKEYHAEGGKV 181
Query: 354 ----IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSS 408
+A E +SDV+S+GV + EL+T G +P + + S
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-------------YDGI-PASE 227
Query: 409 KEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
+ IL++ RL + V+ + C RP RE++ ++
Sbjct: 228 ---ISSILEKGERLPQPPICT----IDVYMIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 52/293 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK- 246
+GRGG GVV+ + A+K++ + + E++ L K+ H IVR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 247 AF--------CSNKETNLLVY---EYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKG 294
A+ + +Y + +L + ++G+ + + L I ++ A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG----------ASECM 344
+ +LH S ++HRD+K +NI D V DFGL + A
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404
+ G+ Y++PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-------------------YPFS 228
Query: 405 TNSSKEGVV-KILDQRLSNTPL--SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
T + + + + + V ML ERP +++
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPM--ERPEAINIIE 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G GG VY T +VA+K + E+ ++ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
+ + LV EY+ +L E + G L + + + G+ + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP-LSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
I+HRD+K NIL++S+ + DFG+AK L +T ++ + V G+ Y +PE A
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEAT 189
Query: 365 DEKSDVYSFGVVLLELITGRRP-VGD 389
DE +D+YS G+VL E++ G P G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
E ++ IG G G V++G+ +P VA+K T S + L E T+ +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ-EALTMRQF 73
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
H +IV+L + + ++ E G L L ++ S + + A + + L+Y
Sbjct: 74 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAY 131
Query: 298 L-HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-- 354
L +HRD+ + N+L++S+ + DFGL++Y++D+ + S G +
Sbjct: 132 LESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPI 181
Query: 355 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
APE + SDV+ FGV + E++ G +P
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 76/294 (25%), Positives = 118/294 (40%), Gaps = 36/294 (12%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITK--GSSHDNGLSAEIRTL 234
+K +G+G G V GE VAVKKL + H EI L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEIL 96
Query: 235 GKIRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
++H NIV+ K C + L+ EY+P GSL + L + + L+ +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQIC 155
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
KG+ YL + IHRD+ + NIL+ ++ + DFGL K L + G
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ----DKEYYKVKEPG 208
Query: 353 YI-----APEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407
APE K SDV+SFGVVL EL T E + ++ K
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 408 SKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
++++L RL P +++ + C + +RP+ R++ +
Sbjct: 269 VFH-LIELLKNNGRLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 53/314 (16%), Positives = 114/314 (36%), Gaps = 76/314 (24%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLS--AEI 231
E + N +G+G +++GV + +V +K L + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL----DKAHRNYSESFFEAA 63
Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
+ K+ H+++V C + N+LV E++ GSL L + + +L++A +
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQL 122
Query: 292 AKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAH--------VADFGLAKYLQDTGAS 341
A + +L + +IH +V + NILL + + ++D G++ +
Sbjct: 123 AAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--- 174
Query: 342 ECMSAVAGSYGYI-----APE-YAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEG 394
PE ++ +D +SFG L E+ + G +P
Sbjct: 175 --------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------- 218
Query: 395 LDIVQWTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTM 449
+ + + ++ + +L L+ + C+ RP+
Sbjct: 219 -----LSAL-DSQR---KLQFYEDRHQLPAPKAAELANLI------NNCMDYEPDHRPSF 263
Query: 450 REVVQMLAQAQKPN 463
R +++ L P+
Sbjct: 264 RAIIRDLNSLFTPD 277
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 82/307 (26%), Positives = 122/307 (39%), Gaps = 46/307 (14%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSA---EIRT 233
+K +G G G V GE VAVK L K + S EI
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL----KADAGPQHRSGWKQEIDI 86
Query: 234 LGKIRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
L + H +I++ K C + LV EY+P GSL + L + L A +
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQI 143
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS- 350
+G++YLH + IHRD+ + N+LL++D + DFGLAK + + + S
Sbjct: 144 CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 351 ---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTN 406
Y APE K SDV+SFGV L EL+T + I T
Sbjct: 201 VFWY---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 407 SSKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA---- 457
+ ++L++ RL P +V+ + C + RPT ++ +L
Sbjct: 258 LR---LTELLERGERLPRPDKCP----AEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
Query: 458 --QAQKP 462
Q Q P
Sbjct: 311 KYQGQAP 317
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGS-SHDNGLSA----EIRTLGKIRHRNIV 243
+G GG V+ + VAVK L + + D E + + H IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 244 RL----KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
+ +A +V EY+ +L +++H G + + +++ +A + L++ H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP-MTPKRAIEVIADACQALNFSH 133
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM-SAVAGSYGYIAPEY 358
+ IIHRDVK NI++++ V DFG+A+ + D+G S +AV G+ Y++PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRP-VGD 389
A VD +SDVYS G VL E++TG P GD
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV---TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
+ VIG+G GVVY G Q A+K L IT+ + L E + +
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR-EGLLMRGL 79
Query: 238 RHRNIVRLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
H N++ L E ++ YM +G L + + + + ++ + ++ A+G+
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGME 138
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-- 354
YL +HRD+ + N +L+ F VADFGLA+ + D E S + +
Sbjct: 139 YLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR---EYYSVQQHRHARLPV 192
Query: 355 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
A E T + KSDV+SFGV+L EL+T G P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 51/285 (17%)
Query: 189 VIGRGGAGVVYRGV--TPNGE-QVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
+G G G V +G VAVK L + D L+ E + ++ + IVR
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVR 82
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HHDC 302
+ C E+ +LV E G L + L ++ +K + +++ + + G+ YL +
Sbjct: 83 MIGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----APE 357
+HRD+ + N+LL + A ++DFGL+K L+ + A ++G APE
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA----DENYYKAQTHGKWPVKWYAPE 190
Query: 358 YAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416
K KSDV+SFGV++ E + G++P + M S V +L
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-------------YRGM-KGSE---VTAML 233
Query: 417 DQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
++ R+ P +++ + LC RP V L
Sbjct: 234 EKGERMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 85/293 (29%), Positives = 120/293 (40%), Gaps = 49/293 (16%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
V N VIGRG G VY G +G+ AVK L IT L+ E +
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDF 83
Query: 238 RHRNIVRLKAFCSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
H N++ L C E + L V YM +G L + + + ++ + ++ AKG+
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 142
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-- 354
YL S +HRD+ + N +L+ F VADFGLA+ + D E S + +
Sbjct: 143 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK---EYYSVHNKTGAKLPV 196
Query: 355 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
A E T K KSDV+SFGV+L EL+T G P D +
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----------------NTF 239
Query: 411 GVVKILDQ--RLS---NTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ L Q RL P L E M + C RP+ E+V +
Sbjct: 240 DITVYLLQGRRLLQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRI 286
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV-TPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
++ V+G G G V++GV P GE V +K + + S + +G
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGS 71
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
+ H +IVRL C + LV +Y+P GSL + + RG+ L ++ L ++ AKG+
Sbjct: 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMY 129
Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
YL H ++HR++ + N+LL S + VADFG+A L + S
Sbjct: 130 YLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-----QLLYSEAKT 179
Query: 355 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
A E + K +SDV+S+GV + EL+T G P
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
V N VIGRG G VY G +G+ AVK L IT L+ E +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDF 147
Query: 238 RHRNIVRLKAFCSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
H N++ L C E + L V YM +G L + + + ++ + ++ AKG+
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 206
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-- 354
+L S +HRD+ + N +L+ F VADFGLA+ + D E S + +
Sbjct: 207 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK---EFDSVHNKTGAKLPV 260
Query: 355 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
A E T K KSDV+SFGV+L EL+T G P
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 69/287 (24%), Positives = 121/287 (42%), Gaps = 41/287 (14%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
+ + +G G G V +GV + VA+K L T+ + + + E + + ++
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLD 394
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ IVRL C E +LV E G L + L GKR + ++ + + G+ YL
Sbjct: 395 NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL 452
Query: 299 --HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-- 354
+ +HR++ + N+LL + A ++DFGL+K L +A + +
Sbjct: 453 EEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKW 505
Query: 355 -APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412
APE K +SDV+S+GV + E ++ G++P + KM V
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------------YKKM-KGPE---V 548
Query: 413 VKILDQ--RLSNTPLSEAMQVFFVAML-CVQEHGVERPTMREVVQML 456
+ ++Q R+ P E + M C +RP V Q +
Sbjct: 549 MAFIEQGKRMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 27/216 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
++G+G V+RG G+ A+K S E L K+ H+NIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKV---FNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 246 KAFCSNKETNL--LVYEYMPNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
A T L+ E+ P GSL VL L L + + G+++L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 303 SPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGASECMSAVAGSYGYIAPE- 357
I+HR++K NI+ + + DFG A+ L+D E ++ G+ Y+ P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDM 186
Query: 358 -------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ K D++S GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
V+G+G G V + + A+KK I + + +E+ L + H+ +VR A
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 248 F----------CSNKETNLLVY---EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
+ + ++ EY NG+L +++H + + ++ + +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA 128
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT------------GASE 342
LSY+H S IIHRD+K NI ++ + DFGLAK + + G+S+
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 343 CMSAVAGSYGYIAPE-YAYTLKVDEKSDVYSFGVVLLELITG 383
+++ G+ Y+A E T +EK D+YS G++ E+I
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 188 NVIGRGGAGVVYRGV-TPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
V+G G G VY+G+ P GE VA+K+L T ++ L E + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHV 79
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
RL C T L+ + MP G L + + + + + + L ++ AKG++YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----APE 357
++HRD+ + N+L+ + + DFGLAK L G + A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALE 189
Query: 358 YAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
+SDV+S+GV + EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 31/300 (10%), Positives = 70/300 (23%), Gaps = 50/300 (16%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
+ G VV+ E A+K + S + L ++ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 247 AFC-------------------------SNKETNLLVYEYMPNGSLGEVL-----HGKRG 276
N L+ + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
+ + + + L ++H +N+ + D + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 337 DTGASECMSAVAGSYGYIAPEY--AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG 394
G + Y E+ A T + + G+ + + P G
Sbjct: 246 TRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ ++ + S TPL + ++ L R E ++
Sbjct: 301 KGSWKRPSLRVPGTDSLAFG------SCTPLPDFVKTLIGRFLNFDRR--RRLLPLEAME 352
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
VIG G VV P E+VA+K++ + K + + L EI+ + + H NIV
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--SY 78
Query: 248 FCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK---IAI---EAAKGLSYLH 299
+ S + L LV + + GS+ +++ L IA E +GL YLH
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA---VAGSYGYIAP 356
+ IHRDVK+ NILL D +ADFG++ +L G G+ ++AP
Sbjct: 139 KNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 357 E-----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y D K+D++SFG+ +EL TG P
Sbjct: 196 EVMEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 59/303 (19%), Positives = 103/303 (33%), Gaps = 45/303 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
++G+G V+RG G+ A+K S E L K+ H+NIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKV---FNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 246 KAFCSNKETNL--LVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
A T L+ E+ P GSL VL + E + + G+++L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLR-- 129
Query: 302 CSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
I+HR++K NI+ + + DFG A+ L+D E ++ G+ Y+ P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPD 185
Query: 358 --------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409
+ K D++S GV TG P F + K+ T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 410 EGVVKILDQRLS--------------NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
+ + + L + +L + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KCWGFDQFFAE 303
Query: 456 LAQ 458
+
Sbjct: 304 TSD 306
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRL 245
+V+G G G + + VAVK++L + E++ L + H N++R
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPNVIRY 83
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+++ + E +L E + K + L E + + GL++LH S
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138
Query: 306 IIHRDVKSNNILL-----NSDFEAHVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAPEY- 358
I+HRD+K +NIL+ + +A ++DFGL K L S S V G+ G+IAPE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 359 --AYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399
D++S G V +I+ G P G + +I+
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 64/212 (30%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
+G GG G V R + GEQVA+K+ + S N EI+ + K+ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 246 KAF------CSNKETNLLVYEYMPNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYL 298
+ + + LL EY G L + L+ LK + + + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIA 355
H IIHRD+K NI+L + + D G AK L E + G+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLA 191
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387
PE K D +SFG + E ITG RP
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGEQ--VAVKKLLGITKGSSHDNGLS---AEIRTL 234
E ++ IG G G V++G+ +P VA+K K + D+ E T+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQEALTM 445
Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
+ H +IV+L + + ++ E G L L ++ S + + A + +
Sbjct: 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASL-ILYAYQLSTA 503
Query: 295 LSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
L+YL +HRD+ + N+L++S+ + DFGL++Y++D+ + S G
Sbjct: 504 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGK 553
Query: 354 I-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
+ APE + SDV+ FGV + E++ G +P
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 76/290 (26%), Positives = 138/290 (47%), Gaps = 20/290 (6%)
Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGI 217
++ LT QK+ DD E + +G G GVV++ P+G +A K + +
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKIS---ELGAGNGGVVFKVSHKPSGLVMARKLIH-L 68
Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKR 275
+ N + E++ L + IV AF + + + E+M GSL +VL K+
Sbjct: 69 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL--KK 124
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
+ ++ K++I KGL+YL I+HRDVK +NIL+NS E + DFG++ L
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
Query: 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
D+ A ++ G+ Y++PE +SD++S G+ L+E+ GR P+ + L
Sbjct: 183 IDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 396 DIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEA---MQVFFVAMLCVQEH 442
+++ +++ ++++ R N ++ M +F + V E
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 72/308 (23%), Positives = 122/308 (39%), Gaps = 66/308 (21%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+ +G G G V+ N VAVK L T + D E L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLT 72
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKW 281
++H +IV+ C + + ++V+EYM +G L + L L
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 282 EMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
L IA + A G+ YL H +HRD+ + N L+ ++ + DFG+++ + T
Sbjct: 133 SQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 340 ASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEE 393
G + + PE K +SDV+SFGV+L E+ T G++P
Sbjct: 188 YYR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP------- 235
Query: 394 GLDIVQWTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPT 448
W ++ S V++ + Q L P +V+ V + C Q +R
Sbjct: 236 ------WFQL----SNTEVIECITQGRVLERPRVCP----KEVYDVMLGCWQREPQQRLN 281
Query: 449 MREVVQML 456
++E+ ++L
Sbjct: 282 IKEIYKIL 289
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 167 LTAFQKLDFGSDDILECVKDN----NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGS 221
+ + KL + + ++ IGRG G V + V P+G+ +AVK++ T
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDE 61
Query: 222 SHDNGLSAEIRTLGK-IRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF 278
L ++ + + IV+ A +E + + E M + S +
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDCWICMELM-STSFDKFYKYVYSVL 118
Query: 279 LKW--EMRL-KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
E L KI + K L++L + IIHRD+K +NILL+ + DFG++ L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 336 QDTGASECMSAVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
D+ A + AG Y+APE A D +SDV+S G+ L EL TGR P
Sbjct: 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 61/311 (19%), Positives = 113/311 (36%), Gaps = 71/311 (22%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSA---EIR 232
V+ +G G VY+G VA+K L K + E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL----KDKAEGPLREEFRHEAM 64
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSF 278
+++H N+V L + + +++ Y +G L E L + S
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 279 LKWEMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
L+ + + + A G+ YL HH ++H+D+ + N+L+ ++D GL + +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 337 DTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDF 390
+ + APE K SD++S+GVVL E+ + G +P
Sbjct: 180 AADYYK-----LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---- 230
Query: 391 GEEGLDIVQWTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVE 445
+ S + VV+++ L + P V+ + + C E
Sbjct: 231 ---------YCGY----SNQDVVEMIRNRQVLPCPDDCPAW----VYALMIECWNEFPSR 273
Query: 446 RPTMREVVQML 456
RP +++ L
Sbjct: 274 RPRFKDIHSRL 284
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 70/302 (23%), Positives = 106/302 (35%), Gaps = 59/302 (19%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+ + +G G G VY G QVAVK L + + L E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALIIS 88
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIE 290
K H+NIVR ++ E M G L L R S L L +A +
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 291 AAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHV---ADFGLAKYLQDTGASECMS 345
A G YL +H IHRD+ + N LL V DFG+A+ +
Sbjct: 149 IACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--- 200
Query: 346 AVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399
G + PE K+D +SFGV+L E+ + G P
Sbjct: 201 --KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------------- 245
Query: 400 WTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ S + V++ + R+ N P V+ + C Q +RP +++
Sbjct: 246 YPSK----SNQEVLEFVTSGGRMDPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILE 297
Query: 455 ML 456
+
Sbjct: 298 RI 299
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 53/226 (23%), Positives = 85/226 (37%), Gaps = 31/226 (13%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
+ ++G G G V G + +VAVK + +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 238 RHRNIVRLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIA 288
H N++RL C + +++ +M G L L R + + LK
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 289 IEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
++ A G+ YL + +HRD+ + N +L D VADFGL+K +
Sbjct: 154 VDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---- 204
Query: 347 VAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
G + A E KSDV++FGV + E+ T G P
Sbjct: 205 -QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 31/218 (14%)
Query: 188 NVIGRGGA--GVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
VIG+G V P GE V V+++ + L E+ H NIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV- 89
Query: 245 LKAFCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLH 299
+ + L +V +M GS +++ + E L IA K L Y+H
Sbjct: 90 -PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-E--LAIAYILQGVLKALDYIH 145
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA-----SECMSAVAGSYGYI 354
H +HR VK+++IL++ D + +++ + G + ++
Sbjct: 146 HMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 355 APE------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+PE Y D KSD+YS G+ EL G P
Sbjct: 203 SPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 32/227 (14%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
+ ++G+G G V + VAVK L SS E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 238 RHRNIVRLKAFCSNKETN------LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKI 287
H ++ +L +++ +M +G L L R L + ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 288 AIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
++ A G+ YL + IHRD+ + N +L D VADFGL++ +
Sbjct: 143 MVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--- 194
Query: 346 AVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
G + A E SDV++FGV + E++T G+ P
Sbjct: 195 --QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 70/307 (22%), Positives = 114/307 (37%), Gaps = 65/307 (21%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+ +G G G V+ N VAVK L ++ + D E L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLT 98
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR----------- 284
++H++IVR C+ L+V+EYM +G L L
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 285 --LKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
L +A + A G+ YL H +HRD+ + N L+ + DFG+++ + T
Sbjct: 159 QLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 341 SECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEG 394
G + PE K +SDV+SFGVVL E+ T G++P
Sbjct: 214 YR-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------- 260
Query: 395 LDIVQWTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTM 449
W ++ S + + Q L P +V+ + C Q +R ++
Sbjct: 261 -----WYQL----SNTEAIDCITQGRELERPRACP----PEVYAIMRGCWQREPQQRHSI 307
Query: 450 REVVQML 456
++V L
Sbjct: 308 KDVHARL 314
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
E + + +G+G G+VY GV +VA+K + L+ E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASVMK 83
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR--------LKI 287
+ ++VRL S + L++ E M G L L R + + +++
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
A E A G++YL+ + +HRD+ + N ++ DF + DFG+ + + +T
Sbjct: 144 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----YR 195
Query: 348 AGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
G G + +PE SDV+SFGVVL E+ T +P
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 20/234 (8%)
Query: 162 SNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKG 220
++S + + D E IG+G G V++G+ + VA+K + + +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEA 60
Query: 221 SSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSF 278
+ EI L + + K + S K+T L ++ EY+ GS ++L + G
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVT--KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPL 116
Query: 279 LKWEMRLKIAI---EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
+IA E KGL YLH + IHRD+K+ N+LL+ E +ADFG+A L
Sbjct: 117 ----DETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169
Query: 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
DT + G+ ++APE D K+D++S G+ +EL G P +
Sbjct: 170 TDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 70/305 (22%), Positives = 105/305 (34%), Gaps = 65/305 (21%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLS---AEIR 232
+ + +G G G VY G QVAVK L + E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEAL 126
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKI 287
+ K H+NIVR ++ E M G L L R S L L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 288 AIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHV---ADFGLAKYLQDTGASE 342
A + A G YL +H IHRD+ + N LL V DFG+A+ + G
Sbjct: 187 ARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 343 CMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396
G + PE K+D +SFGV+L E+ + G P
Sbjct: 242 -----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---------- 286
Query: 397 IVQWTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMRE 451
+ S + V++ + R+ N P V+ + C Q +RP
Sbjct: 287 ---YPSK----SNQEVLEFVTSGGRMDPPKNCP----GPVYRIMTQCWQHQPEDRPNFAI 335
Query: 452 VVQML 456
+++ +
Sbjct: 336 ILERI 340
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 58/240 (24%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ---VAVKKLLGITKGSSHDNGLSA---EIRTLG 235
+K +VIG G G V + A+K++ K + + E+ L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYASKDDHRDFAGELEVLC 80
Query: 236 KI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLK 280
K+ H NI+ L C ++ L EY P+G+L + L R S L
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK----YLQ 336
+ L A + A+G+ YL IHRD+ + NIL+ ++ A +ADFGL++ Y++
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197
Query: 337 DTGASECMSAVAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
T G + A E YT SDV+S+GV+L E+++ G P
Sbjct: 198 KTM------------GRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVSLGGTP 241
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 28/236 (11%), Positives = 64/236 (27%), Gaps = 42/236 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-------- 238
V+G+ GE V + S+ + E+ L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 239 -----------------HRNIVRLKAFCSNKE-TNLLVYEYMPNGSLGEVL-----HGKR 275
+ ++R++ + + +L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
L RL++ ++ + L+ LHH ++H ++ +I+L+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 336 QDTGASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRP 386
+ S A + D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 66/318 (20%), Positives = 122/318 (38%), Gaps = 65/318 (20%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
++ +G G G V +VAVK L K ++H + A E++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMSELK 101
Query: 233 TLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR------------GSFL 279
+ + +H NIV L C++ L++ EY G L L K S
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
L + + A+G+++L S IHRDV + N+LL + A + DFGLA+ + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 340 ASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEE 393
+ + APE + +SDV+S+G++L E+ + G P
Sbjct: 219 N-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP------- 266
Query: 394 GLDIVQWTKMQTNSSKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVERPT 448
+ + N K++ ++ + P ++ + C RPT
Sbjct: 267 ------YPGILVN---SKFYKLVKDGYQMAQPAFAPK----NIYSIMQACWALEPTHRPT 313
Query: 449 MREVVQMLAQAQKPNTFQ 466
+++ L + + + +
Sbjct: 314 FQQICSFLQEQAQEDRRE 331
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 73/312 (23%), Positives = 122/312 (39%), Gaps = 69/312 (22%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
+ +G G G V + VAVK L K S+H A E++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----KPSAHLTEREALMSELK 78
Query: 233 TLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------- 284
L + H NIV L C+ L++ EY G L L KR SF+ +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 285 ---------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
L + + AKG+++L S IHRD+ + NILL + DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 336 QDTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGD 389
++ + APE + +SDV+S+G+ L EL + G P
Sbjct: 196 KNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--- 247
Query: 390 FGEEGLDIVQWTKMQTNSSKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGV 444
+ M + K++ + R+ + P +++ + C +
Sbjct: 248 ----------YPGMPVD---SKFYKMIKEGFRMLSPEHAPA----EMYDIMKTCWDADPL 290
Query: 445 ERPTMREVVQML 456
+RPT +++VQ++
Sbjct: 291 KRPTFKQIVQLI 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 39/274 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
+G G G V++ +G AVK+ + +G AE+ + K+ +H VRL+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
L E SL + G+ L + L++LH S +
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQGL 178
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-----YAYT 361
+H DVK NI L + DFGL L G G Y+APE Y
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQGSY--- 232
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421
+DV+S G+ +LE+ G EG W ++ L +
Sbjct: 233 ---GTAADVFSLGLTILEVACNMELP--HGGEG-----WQQL--------RQGYLPPEFT 274
Query: 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
LS ++ V ML + R T ++ +
Sbjct: 275 AG-LSSELRSVLVMML--EPDPKLRATAEALLAL 305
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G+GG + E A K + K EI + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKI---VPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
F + + +V E SL E+ +R + + E R + G YLH +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEAR-YYLRQIVLGCQYLHRNR-- 161
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
+IHRD+K N+ LN D E + DFGLA ++ G E + G+ YIAPE
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGH 218
Query: 365 DEKSDVYSFGVVLLELITGRRP 386
+ DV+S G ++ L+ G+ P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 173 LDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEI 231
++ +DD LE + +GRG GVV + P+G+ +AVK++ T S L ++
Sbjct: 2 MEVKADD-LEPIM---ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDL 56
Query: 232 RTLGK-IRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHG--KRGSFLKWEMRL- 285
+ + V A +E ++ + E M + SL + +G + E L
Sbjct: 57 DISMRTVDCPFTVTFYGALF--REGDVWICMELM-DTSLDKFYKQVIDKGQTIP-EDILG 112
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
KIA+ K L +LH S +IHRDVK +N+L+N+ + + DFG++ YL D A
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KD 167
Query: 346 AVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
AG Y+APE KSD++S G+ ++EL R P
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 23/225 (10%)
Query: 171 QKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAE 230
Q+ +D+ ++ +G G G V++ V K + + + + +
Sbjct: 18 QRYQAEINDL----ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 231 IRTLGK-IRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRL-K 286
+ + K IV+ F T++ + E M ++ +G E L K
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELM-GTCAEKLKKRMQGPIP--ERILGK 128
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
+ + K L YL +IHRDVK +NILL+ + + DFG++ L D A
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDR 183
Query: 347 VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
AG Y+APE D ++DV+S G+ L+EL TG+ P
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 15/202 (7%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G+GG + E A K + K EI + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKI---VPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
F + + +V E SL E+ +R + + E R + G YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEAR-YYLRQIVLGCQYLH---RN 134
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
+IHRD+K N+ LN D E + DFGLA ++ G E + G+ YIAPE
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGH 192
Query: 365 DEKSDVYSFGVVLLELITGRRP 386
+ DV+S G ++ L+ G+ P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP 214
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 64/306 (20%), Positives = 109/306 (35%), Gaps = 55/306 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-HRNIVRL 245
V+ GG VY +G + A+K+ + + E+ + K+ H NIV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKR---LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 246 KAFCS-------NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-LKIAIEAAKGLSY 297
+ S + L+ + G L E L LKI + + + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL----------QDTGASECMSAV 347
+H P IIHRD+K N+LL++ + DFG A + Q E
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 348 AGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM 403
+ Y PE Y+ + EK D+++ G +L L + P F +
Sbjct: 211 NTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP---FED----------- 255
Query: 404 QTNSSKEGVVKILDQRLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460
++I++ + S + AML Q + ER ++ EVV L +
Sbjct: 256 ------GAKLRIVNGKYSIPPHDTQYTVFHSLIRAML--QVNPEERLSIAEVVHQLQEIA 307
Query: 461 KPNTFQ 466
Sbjct: 308 AARNVN 313
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 63/310 (20%), Positives = 121/310 (39%), Gaps = 54/310 (17%)
Query: 176 GSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+ V ++G G +G V + G VAVK++L + EI+ L
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLT 63
Query: 236 KI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK- 293
+ H N++R + + E N +L +++ K + ++L+
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESK--NVSDENLKLQKEYNPISL 120
Query: 294 ------GLSYLHHDCSPLIIHRDVKSNNILLNS-------------DFEAHVADFGLAKY 334
G+++LH S IIHRD+K NIL+++ + ++DFGL K
Sbjct: 121 LRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 335 LQDTGASEC--MSAVAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIT-GR 384
L +S ++ +G+ G+ APE ++ D++S G V +++ G+
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 385 RPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGV 444
P FG++ ++N + + L + L M+
Sbjct: 238 HP---FGDK-------YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL-- 285
Query: 445 ERPTMREVVQ 454
+RPT +V++
Sbjct: 286 KRPTAMKVLR 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVR-- 244
++G G G VY+G G+ A+K + + + EI L K HRNI
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKV---MDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 245 ---LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSY 297
+K + L LV E+ GS+ +++ +G+ LK E IA E +GLS+
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE---WIAYICREILRGLSH 144
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
LH +IHRD+K N+LL + E + DFG++ L T + G+ ++APE
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPE 199
Query: 358 YAYTLKV-----DEKSDVYSFGVVLLELITGRRPVGD 389
+ D KSD++S G+ +E+ G P+ D
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 19/235 (8%)
Query: 157 KFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLL 215
+ + + D + E +G G G VY+ + G+ VA+K++
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV- 62
Query: 216 GITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGK 274
S + EI + + ++V+ K T+L +V EY GS+ +++ +
Sbjct: 63 ---PVESDLQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 275 RGSFLKWEMRLKIAI---EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
+ + E IA KGL YLH IHRD+K+ NILLN++ A +ADFG+
Sbjct: 119 NKTLTEDE----IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
A L DT A + V G+ ++APE + + +D++S G+ +E+ G+ P
Sbjct: 172 AGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 74/321 (23%), Positives = 125/321 (38%), Gaps = 68/321 (21%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
+ +K +GRG G V T VAVK L K + + A E++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALMSELK 82
Query: 233 TLGKI-RHRNIVRLKAFCSNKET-NLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------ 284
L I H N+V L C+ +++ E+ G+L L KR F+ +++
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 285 --------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
+ + + AKG+ +L S IHRD+ + NILL+ + DFGLA+ +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 337 DTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDF 390
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 200 KDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---- 250
Query: 391 GEEGLDIVQWTKMQTNSSKEGVVKILDQ--RL---SNTPLSEAMQVFFVAMLCVQEHGVE 445
+ ++ + E + L + R+ T +++ + C +
Sbjct: 251 ---------YPGVKID---EEFCRRLKEGTRMRAPDYTTP----EMYQTMLDCWHGEPSQ 294
Query: 446 RPTMREVVQMLAQAQKPNTFQ 466
RPT E+V+ L + N Q
Sbjct: 295 RPTFSELVEHLGNLLQANAQQ 315
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G+G VYR G +VA+K I K + + G+ E++ +++H +I+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKM---IDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
L + + LV E NG + L + F + E R + + G+ YLH S
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH---SH 131
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
I+HRD+ +N+LL + +ADFGLA L+ E + G+ YI+PE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAH 189
Query: 365 DEKSDVYSFGVVLLELITGRRP 386
+SDV+S G + L+ GR P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
+G+G G VY + +A+K L + K L E+ +RH NI+R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
L + + L+ EY P G++ L K F + E A LSY H S
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTA-TYITELANALSYCH---SK 128
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-CMSAVAGSYGYIAPEYAYTLK 363
+IHRD+K N+LL S E +ADFG + + + ++ C G+ Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEMIEGRM 183
Query: 364 VDEKSDVYSFGVVLLELITGRRP 386
DEK D++S GV+ E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 44/237 (18%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLSA---E 230
+ + +G G G V VAVK L K + + LS E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSE 90
Query: 231 IRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-------------- 275
+ + I +H+NI+ L C+ ++ EY G+L E L +R
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
+ ++ + + A+G+ YL S IHRD+ + N+L+ + +ADFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 336 QDTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP 386
+ + G + APE + +SDV+SFGV++ E+ T G P
Sbjct: 208 NNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 29/220 (13%), Positives = 72/220 (32%), Gaps = 27/220 (12%)
Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHR 240
+++G G VY N ++ +K + + + + L
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV---QKPANPWEFYIGTQLMERLKPSMQH 127
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSY 297
++ + + ++LV E G+L ++ + + + + A+ +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAH-----------VADFGLAKYLQDTGASECMSA 346
+H IIH D+K +N +L + F + D G + ++ +A
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 347 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ G+ E + + D + + ++ G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 69/323 (21%), Positives = 116/323 (35%), Gaps = 82/323 (25%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
E ++ V+G G G V T QVAVK L K + + A E++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSEREALMSELK 100
Query: 233 TLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------- 284
+ ++ H NIV L C+ L++EY G L L KR F + E+
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 285 --------------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330
L A + AKG+ +L +HRD+ + N+L+ + DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 331 LAKYLQDTGASECMSAVAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELI 381
LA+ + V + APE YT KSDV+S+G++L E+
Sbjct: 218 LARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYT----IKSDVWSYGILLWEIF 268
Query: 382 T-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ--RL---SNTPLSEAMQVFFVA 435
+ G P + + + K++ ++ +++ +
Sbjct: 269 SLGVNP-------------YPGIPVD---ANFYKLIQNGFKMDQPFYATE----EIYIIM 308
Query: 436 MLCVQEHGVERPTMREVVQMLAQ 458
C +RP+ + L
Sbjct: 309 QSCWAFDSRKRPSFPNLTSFLGC 331
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 69/319 (21%), Positives = 121/319 (37%), Gaps = 79/319 (24%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSA---EIR 232
++ IG G G V++ P VAVK L K + + + E
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAA 102
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------- 284
+ + + NIV+L C+ + L++EYM G L E L +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 285 --------------LKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
L IA + A G++YL +HRD+ + N L+ + +AD
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIAD 217
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT- 382
FGL++ + A I PE + + +SDV+++GVVL E+ +
Sbjct: 218 FGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 383 GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ--RLS---NTPLSEAMQVFFVAML 437
G +P + M + E V+ + L+ N PL +++ + L
Sbjct: 273 GLQP-------------YYGM----AHEEVIYYVRDGNILACPENCPL----ELYNLMRL 311
Query: 438 CVQEHGVERPTMREVVQML 456
C + +RP+ + ++L
Sbjct: 312 CWSKLPADRPSFCSIHRIL 330
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSA---EIR 232
+ + +G G G V + + + VAVK L K ++ + L E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFN 78
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------- 284
L ++ H ++++L CS LL+ EY GSL L R +
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 285 --------------LKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
+ A + ++G+ YL ++HRD+ + NIL+ + ++D
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISD 193
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLE 379
FGL++ + + S V S G I A E + YT +SDV+SFGV+L E
Sbjct: 194 FGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWE 244
Query: 380 LIT-GRRP 386
++T G P
Sbjct: 245 IVTLGGNP 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 81/342 (23%), Positives = 138/342 (40%), Gaps = 47/342 (13%)
Query: 156 RKFRKNSNSWKLTAFQKLDFGSDDILECVKDN--------NVIGRGGAGVVYRGV-TPNG 206
+S L L + K + +G G G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
+ A+K + + +S ++ L E+ L + H NI++L F +K LV E G
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFE 323
L + + R F + + I + G++YLH I+HRD+K N+LL S D
Sbjct: 123 LFDEII-HRMKFNEVDAA-VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 383
+ DFGL+ ++ + M G+ YIAPE K DEK DV+S GV+L L+ G
Sbjct: 178 IKIVDFGLSAVFEN---QKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233
Query: 384 RRPVGDFGEEGL-----------DIVQWTKMQTNSSKEGVVKIL----DQRLSNTPLSEA 428
P G ++ + D +W + + +K+ + ++L +R+S A
Sbjct: 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQMLQFDSQRRIS------A 286
Query: 429 MQV----FFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466
Q + M +E G+E P++ ++ + + Q
Sbjct: 287 QQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 68/311 (21%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLSA---E 230
+ + +G G G V VAVK L K + + LS E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSE 136
Query: 231 IRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-------------- 275
+ + I +H+NI+ L C+ ++ EY G+L E L +R
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
+ ++ + + A+G+ YL S IHRD+ + N+L+ + +ADFGLA+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 336 QDTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRRP-VG 388
+ + G + APE + +SDV+SFGV++ E+ T G P G
Sbjct: 254 NNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 389 DFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS---NTPLSEAMQVFFVAMLCVQEHGVE 445
EE ++ KEG R+ N +++ + C +
Sbjct: 309 IPVEELFKLL----------KEG------HRMDKPANCTN----ELYMMMRDCWHAVPSQ 348
Query: 446 RPTMREVVQML 456
RPT +++V+ L
Sbjct: 349 RPTFKQLVEDL 359
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 44/227 (19%), Positives = 89/227 (39%), Gaps = 42/227 (18%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKL----LGITKGSSHDNGLSA-----------EIRT 233
+ +G + + + A+KK L + + N E++
Sbjct: 38 TLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL-------GEVLHGKRGSFLKWEMRLK 286
+ I++ + + +N + ++YEYM N S+ + ++
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-C 155
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
I SY+H++ + I HRDVK +NIL++ + ++DFG ++Y+ D + +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKG 209
Query: 347 VAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+Y ++ PE Y K D++S G+ L + P
Sbjct: 210 SRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVP 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 65/257 (25%), Positives = 102/257 (39%), Gaps = 48/257 (18%)
Query: 166 KLTAFQKLDFGSDDILE----CVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKK 213
L + + D E + +G G G V +VAVK
Sbjct: 49 MLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 108
Query: 214 LLGITKGSSHDNGLSA---EIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGE 269
L K + + LS E+ + I +H+NI+ L C+ ++ EY G+L E
Sbjct: 109 L----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 270 VLHGKRGSFLKWEMR--------------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
L +R L++ + A + A+G+ YL S IHRD+ + N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221
Query: 316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----APEYAYTLKVDEKSDV 370
+L+ D +ADFGLA+ + + G + APE + +SDV
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 371 YSFGVVLLELIT-GRRP 386
+SFGV+L E+ T G P
Sbjct: 277 WSFGVLLWEIFTLGGSP 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
IG+G +G VY + G++VA++++ + + EI + + ++ NIV L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 248 FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ L +V EY+ GSL +V+ + + E + L +LH S +
Sbjct: 86 YL--VGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
IHRD+KS+NILL D + DFG + + S + G+ ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGP 195
Query: 367 KSDVYSFGVVLLELITGRRP 386
K D++S G++ +E+I G P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G G G VY+ G A K + ++ D EI L H IV+L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLL 82
Query: 247 AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHDC 302
+ L ++ E+ P G++ ++ + + I + + + L++LH
Sbjct: 83 G-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----IQVVCRQMLEALNFLH--- 134
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S IIHRD+K+ N+L+ + + +ADFG++ T + G+ ++APE
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCE 192
Query: 363 KV-----DEKSDVYSFGVVLLELITGRRP 386
+ D K+D++S G+ L+E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 56/248 (22%), Positives = 86/248 (34%), Gaps = 55/248 (22%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
IG+G GVV + A+K K+ I + E+R + K+ H NI
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER--IKTEVRLMKKLHHPNI 90
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI------------- 289
RL +++ LV E G L + L+ +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 290 ------------------EAAK-------GLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
+ L YLH + I HRD+K N L +++
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207
Query: 325 HV--ADFGLAKYLQ--DTGASECMSAVAGSYGYIAPE--YAYTLKVDEKSDVYSFGVVLL 378
+ DFGL+K + G M+ AG+ ++APE K D +S GV+L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 379 ELITGRRP 386
L+ G P
Sbjct: 268 LLLMGAVP 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
IG G G+V +G QVAVK + + L E+ + +H N+V K+
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 248 FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ L ++ E++ G+L +++ R L E + + L+YLH + +
Sbjct: 111 YL--VGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH---AQGV 162
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
IHRD+KS++ILL D ++DFG + ++ G+ ++APE
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYAT 220
Query: 367 KSDVYSFGVVLLELITGRRP 386
+ D++S G++++E++ G P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 52/297 (17%), Positives = 105/297 (35%), Gaps = 66/297 (22%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
IG G G V++ V +G A+K+ GS + E+ + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 247 AFCSNKETNLLVY-EYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+ ++ ++L+ EY GSL + + + + S+ K + ++ +GL Y+H S
Sbjct: 78 S-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 304 PLIIHRDVKSNNILLNSDFEAHV-------------------ADFGLAKYLQDTGASECM 344
++H D+K +NI ++ + D G + E
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 345 SAVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQ 399
G ++A E Y + K+D+++ + ++
Sbjct: 192 ----GDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL------------- 230
Query: 400 WTKMQTNSSKEGVVKILDQRLSNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ + +I RL P LS+ M+ RP+ +V+
Sbjct: 231 ------PRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPE--RRPSAMALVK 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 32/242 (13%), Positives = 68/242 (28%), Gaps = 53/242 (21%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-------- 238
V+G+ GE V + S+ + E+ L +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 239 -----------------HRNIVRLKA-FCSNKETNLLVYEYMPNGSLGEVL-----HGKR 275
+ ++R++ + +L H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
L RL++ ++ + L+ LHH ++H ++ +I+L+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 336 QDTGASECMSAVAGSYGYIAPEY-----------AYTLKVDEKSDVYSFGVVLLELITGR 384
S + S G+ PE + D ++ G+V+ +
Sbjct: 257 GARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 385 RP 386
P
Sbjct: 311 LP 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 80/301 (26%), Positives = 135/301 (44%), Gaps = 37/301 (12%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
V+G+G G V G++ AVK K K L E++ L ++ H NI+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--LLREVQLLKQLDHPNIM 89
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+L F +K LV E G L + + R F + + +I + G++Y+H +
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAA-RIIRQVLSGITYMHKNK- 146
Query: 304 PLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
I+HRD+K N+LL S D + DFGL+ + + S+ M G+ YIAPE
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAPE-VL 200
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNSSK 409
DEK DV+S GV+L L++G P E + ++ QW K+ + S+K
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV-SESAK 259
Query: 410 EGVVKIL----DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465
+ + K+L R+S +A+ ++ ++ V+ P++ + + Q Q
Sbjct: 260 DLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKL 316
Query: 466 Q 466
Sbjct: 317 A 317
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G+G G VY N +A+K L + K L EI +RH NI+R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ +++ L+ E+ P G L + L K G F + + E A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFME-ELADALHYCH---ERK 134
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAPEYAYTLKV 364
+IHRD+K N+L+ E +ADFG + + C G+ Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIEGKTH 189
Query: 365 DEKSDVYSFGVVLLELITGRRP 386
DEK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
IG G G VY N E VA+KK+ + + + E+R L K+RH N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHD 301
+ C +E LV EY GS ++L + + E IA A +GL+YLH
Sbjct: 120 RG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE----IAAVTHGALQGLAYLH-- 171
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ--DTGASECMSAVAGSYGYIAPEYA 359
S +IHRDVK+ NILL+ + DFG A + ++ G+ ++APE
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--------FVGTPYWMAPEVI 222
Query: 360 YTLKV---DEKSDVYSFGVVLLELITGRRPVGD 389
+ D K DV+S G+ +EL + P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 32/251 (12%)
Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDN--------NVIGRGGAGVVYRGV-TPNGEQV 209
+S+ + FQ + + + +G G G V +
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 210 AVK-----KLLGITKGSSHDNG------LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
A+K + + N + EI L + H NI++L +K+ LV
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
E+ G L E + R F + + I + G+ YLH I+HRD+K NILL
Sbjct: 125 TEFYEGGELFEQII-NRHKFDECDAA-NIMKQILSGICYLHKHN---IVHRDIKPENILL 179
Query: 319 NS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 375
+ + DFGL+ + + G+ YIAPE K +EK DV+S GV
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGV 235
Query: 376 VLLELITGRRP 386
++ L+ G P
Sbjct: 236 IMYILLCGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 39/302 (12%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
++G+G G V + ++ AVK + + + + + E+ L K+ H NI++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ + +V E G L + + KR F + + +I + G++Y+H I
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAA-RIIKQVFSGITYMHKHN---I 142
Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
+HRD+K NILL S D + + DFGL+ Q + M G+ YIAPE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE-VLRGT 198
Query: 364 VDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-----------DIVQWTKMQTNSSKEGV 412
DEK DV+S GV+L L++G P E + D+ QW + ++ +K+ +
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-SDDAKDLI 257
Query: 413 VKIL----DQRLSNTPLSEAMQVF----FVAMLCVQEHGVERPTMREVVQMLAQAQKPNT 464
K+L R++ A Q + P++ + + Q Q
Sbjct: 258 RKMLTFHPSLRIT------ATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKK 311
Query: 465 FQ 466
Sbjct: 312 LA 313
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 38/219 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
VIG+G VV R + G+Q AVK + L E ++H +IV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
L S+ +V+E+M L V G E A+ L
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-EA------VASHYMRQILEAL 143
Query: 296 SYLH-HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSY 351
Y H ++ IIHRDVK + +LL S + + FG+A L ++G G+
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTP 197
Query: 352 GYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
++APE Y + DV+ GV+L L++G P
Sbjct: 198 HFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLP 232
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVR 244
++G+G G V + ++ AVK I K + + + E+ L K+ H NI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKV---INKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
L + + +V E G L + + KR F + + +I + G++Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAA-RIIKQVFSGITYMH---KH 140
Query: 305 LIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPE---Y 358
I+HRD+K NILL S + + DFGL+ Q M G+ YIAPE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
Y K DV+S GV+L L++G P E +
Sbjct: 198 TYDEKC----DVWSAGVILYILLSGTPPFYGKNEYDI 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 28/216 (12%), Positives = 56/216 (25%), Gaps = 45/216 (20%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
G ++ + T QVA+ + + + L +I +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDP---QGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
R+ + L+V E++ GSL EV ++ A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
+ + + ++ D + +A +
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD------- 178
Query: 364 VDEKSDVYSFGVVLLELITGRRP-VGDFGEEGLDIV 398
+ + D+ G L L+ R P GL
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVR 244
+G+G VV R V G + A K I + L E R K++H NIVR
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
L + + LV++ + G L E + R + + + + + ++Y H S
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADAS-HCIQQILESIAYCH---SN 124
Query: 305 LIIHRDVKSNNILLNSDFE-AHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE---- 357
I+HR++K N+LL S + A V ADFGLA + D SE AG+ GY++PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKK 181
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y+ V D+++ GV+L L+ G P
Sbjct: 182 DPYSKPV----DIWACGVILYILLVGYPP 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 58/242 (23%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
+ + G+G G V G G VA+KK++ + ++ L +
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--------QDPRFRNRELQIMQDLAVLH 77
Query: 239 HRNIVRLK-AFCSNKETNL------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
H NIV+L+ F + E + +V EY+P + LH + R ++A
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLH----RCCRNYYRRQVAPPP 128
Query: 292 A----------KGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQDTGA 340
+ + LH S + HRD+K +N+L+N +D + DFG AK L +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 341 SECMSAVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF-GEEG 394
+ ++ + Y Y APE YT V D++S G + E++ G P+ F G+
Sbjct: 188 N--VAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLG-EPI--FRGDNS 237
Query: 395 LD 396
Sbjct: 238 AG 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHD--NGLSAEIRTLGKI-RH 239
++GRG + VV R + P ++ AVK + + E+ L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
NI++LK LV++ M G L + L ++ + + E R KI + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETR-KIMRALLEVICALH 141
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-- 357
I+HRD+K NILL+ D + DFG + L E + V G+ Y+APE
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEII 195
Query: 358 ----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
++ D++S GV++ L+ G P
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDN-GLSAEIRTLGKIRHRN 241
+G G G V ++VA++ K + + + EI L K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
I+++K F ++ + V E M G L + + + + + + YLH
Sbjct: 202 IIKIKNFFDAEDYYI-VLELMEGGELFDKV-VGNKRLKEATCK-LYFYQMLLAVQYLH-- 256
Query: 302 CSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPE- 357
IIHRD+K N+LL+S E + DFG +K L +T M + G+ Y+APE
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEV 312
Query: 358 ------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE 393
Y V D +S GV+L ++G P F E
Sbjct: 313 LVSVGTAGYNRAV----DCWSLGVILFICLSGYPP---FSEH 347
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 46/249 (18%), Positives = 86/249 (34%), Gaps = 38/249 (15%)
Query: 221 SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFL 279
S + S +IR + +N V S K + + +L + +
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
+ + L I I+ A+ + +LH S ++HRD+K +NI D V DFGL +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 340 ----------ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
A + G+ Y++PE + K D++S G++L EL
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL--------- 269
Query: 390 FGEEGLDIVQWTKMQTNSSKEGVVKIL-DQRLSNTPL--SEAMQVFFVAMLCVQEHGVER 446
T + ++ + + + + ML ER
Sbjct: 270 ----------LYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT--ER 317
Query: 447 PTMREVVQM 455
P ++++
Sbjct: 318 PEATDIIEN 326
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 27/208 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
IGRG G V V + A KK I K D + EI + + H NI+RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ LV E G L E + + F + + +I + ++Y H +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAA-RIMKDVLSAVAYCH---KLNV 127
Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-----Y 358
HRD+K N L + D + DFGLA + + M G+ Y++P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVLEGLY 184
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ D +S GV++ L+ G P
Sbjct: 185 ------GPECDEWSAGVMMYVLLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
+G G G V+ +G + +K I K S + AEI L + H NI+++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 246 KAFCSNKETNLLVYEYMPNGSLGE---VLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ +V E G L E + + + + ++ + L+Y H
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFH--- 141
Query: 303 SPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPE-- 357
S ++H+D+K NIL + DFGLA+ + E + AG+ Y+APE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVF 198
Query: 358 -YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
K D++S GVV+ L+TG P
Sbjct: 199 KRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 36/214 (16%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
+G+G VV R V G + A K + K S+ D L E R K++H NIVRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
+ + LV++ + G L E + R + E +A+ ++Y H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIV-AREFYS--EA------DASHCIQQILESIAYCH 145
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
S I+HR++K N+LL S + +ADFGLA + D SE AG+ GY++P
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSP 199
Query: 357 E----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y+ V D+++ GV+L L+ G P
Sbjct: 200 EVLKKDPYSKPV----DIWACGVILYILLVGYPP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK----KLLGITKGSSHD--NGLSAEIRTLGKIR-HR 240
VIGRG + VV R V G + AVK ++ + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
+I+ L + LV++ M G L + L ++ + + E R I + +S+LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETR-SIMRSLLEAVSFLH- 217
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE--- 357
+ I+HRD+K NILL+ + + ++DFG + +L+ E + + G+ GY+APE
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILK 272
Query: 358 ---YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
++ D+++ GV+L L+ G P
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN-GLSAEIRTLGKIRHRNIVRLK 246
+G+G VV R V G++ A + K S+ D+ L E R ++H NIVRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIIN-TKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
S + + L+++ + G L E + R + + + + + + + H +
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADAS-HCIQQILEAVLHCH---QMGV 131
Query: 307 IHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPE----YA 359
+HR++K N+LL S + +ADFGLA ++ + AG+ GY++PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDP 189
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRP 386
Y V D+++ GV+L L+ G P
Sbjct: 190 YGKPV----DLWACGVILYILLVGYPP 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
V+G G V+ G+ A+K I K + + L EI L KI+H NIV L+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKC---IKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ LV + + G L + + +RG + + + + + + YLH I
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRIL-ERGVYTEKDAS-LVIQQVLSAVKYLH---ENGI 127
Query: 307 IHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPE----YA 359
+HRD+K N+L + E + DFGL+K Q+ MS G+ GY+APE
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKP 183
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
Y+ V D +S GV+ L+ G P + E L
Sbjct: 184 YSKAV----DCWSIGVITYILLCGYPPFYEETESKL 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 75/241 (31%), Positives = 108/241 (44%), Gaps = 62/241 (25%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
D VIG G GVVY+ +GE VA+KK+L E++ + K+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----------QDKRFKNRELQIMRKLD 105
Query: 239 HRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
H NIVRL+ F S+ E LV +Y+P E ++ + R K +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVY----RVARHYSRAKQTLPVI 156
Query: 293 ----------KGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGAS 341
+ L+Y+H S I HRD+K N+LL+ D + DFG AK L +
Sbjct: 157 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 342 ECMSAVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF-GEEGL 395
+S + Y Y APE YT + DV+S G VL EL+ G +P+ F G+ G+
Sbjct: 214 --VSYICSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLG-QPI--FPGDSGV 263
Query: 396 D 396
D
Sbjct: 264 D 264
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG+G V G +VA+K + + L E+R + + H NIV+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
++T L+ EY G + + V HG+ +K + + + Y H I
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD- 365
+HRD+K+ N+LL++D +ADFG + + A G+ Y APE K D
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 366 EKSDVYSFGVVLLELITGRRP 386
+ DV+S GV+L L++G P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 26/208 (12%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
+G G G V V E VAVK ++ + + + EI + H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
L EY G L + + +A + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP-DAQRFFHQLMAGVVYLH 122
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
I HRD+K N+LL+ ++DFGLA + ++ + G+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 360 YTLKVD-EKSDVYSFGVVLLELITGRRP 386
+ E DV+S G+VL ++ G P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 22/244 (9%)
Query: 151 AIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQV 209
+ + + WK Q ++ D +L+ + +G G GVV+R G
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 210 AVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
A K + D + EI+T+ +RH +V L + +++YE+M G L
Sbjct: 186 AAKF---VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
E + + E A+E + GL ++H +H D+K NI+ +
Sbjct: 243 EKVADEHNKMS--E---DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSN 294
Query: 325 HV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 382
+ DFGL +L + + G+ + APE A V +D++S GV+ L++
Sbjct: 295 ELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 383 GRRP 386
G P
Sbjct: 352 GLSP 355
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 8e-24
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
IG G G V++ E VA+K++ + D G+ + EI L +++H+NI
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
VRL + + LV+E+ L + G ++ + KGL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGFCHSRN 121
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY---- 358
++HRD+K N+L+N + E +A+FGLA+ C SA + Y P+
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGA 176
Query: 359 -AYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y+ + D++S G + EL RP
Sbjct: 177 KLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLK 246
+G G + + V + + AVK I+K + EI L H NIV+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEAN--TQKEITALKLCEGHPNIVKLH 72
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
++ LV E + G L E + K+ F + E I + +S++H +
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIK-KKKHFSETEAS-YIMRKLVSAVSHMH---DVGV 127
Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE----YA 359
+HRD+K N+L + E + DFG A+ + + + Y APE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNG 185
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRP 386
Y DE D++S GV+L +++G+ P
Sbjct: 186 Y----DESCDLWSLGVILYTMLSGQVP 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
++G G G V + + + AVK L + + + + + EI+ L ++RH+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 246 KAFCSNKETN--LLVYEYMPNGS---LGEVLHGKRGSFLKWEMRLKIAIEAAK------- 293
N+E +V EY G L V R + +A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPVC-QAHGYFCQLID 120
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
GL YLH S I+H+D+K N+LL + ++ G+A+ L A + GS +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 354 IAPEYAYTLKVDE--KSDVYSFGVVLLELITGRRP 386
PE A L K D++S GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 27/238 (11%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-HRNIVRL 245
V+G G V + ++ AVK I K H + + E+ L + + HRN++ L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKI---IEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F ++ LV+E M GS+ +H KR F + E + + A L +LH +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEAS-VVVQDVASALDFLH---NKG 131
Query: 306 IIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTG-----ASECMSAVAGSYGYIAPE 357
I HRD+K NIL + + DF L ++ G ++ + GS Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 358 -----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
D++ D++S GV+L L++G P F W + + + +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCGSDCGWDRGEACPACQ 246
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
+G G GVVY+ G VA+K++ + + D G+ + EI L ++ H NIV
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI----RLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
L ++ LV+E+M L +VL + +++ + +G+++ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK-IYLYQLLRGVAHCHQHR- 139
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY----- 358
I+HRD+K N+L+NSD +ADFGLA+ + + Y AP+
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGR 384
Y+ V D++S G + E+ITG+
Sbjct: 196 KYSTSV----DIWSIGCIFAEMITGK 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 26/208 (12%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
+G G G V V E VAVK ++ + + + EI + H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
L EY G L + + +A + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP-DAQRFFHQLMAGVVYLH 122
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
I HRD+K N+LL+ ++DFGLA + ++ + G+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 360 YTLKVD-EKSDVYSFGVVLLELITGRRP 386
+ E DV+S G+VL ++ G P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
IG G GVVY+ GE A+KK+ + D G+ + EI L +++H NIV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+L K+ +LV+E++ L ++L G + ++ G++Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDRR- 120
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-----Y 358
++HRD+K N+L+N + E +ADFGLA+ + + Y AP+
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGR 384
Y+ + D++S G + E++ G
Sbjct: 177 KYSTTI----DIWSVGCIFAEMVNGT 198
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 34/217 (15%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNG-LSAEIRTLGKIRHRN 241
+G G G V ++VA+K K + + + EI L K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
I+++K F ++ + V E M G L + V + + + + YLH
Sbjct: 77 IIKIKNFFDAEDYYI-VLELMEGGELFDKVV---GNKRLKEATCK-LYFYQMLLAVQYLH 131
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
IIHRD+K N+LL+S E + DFG +K L +T M + G+ Y+AP
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAP 185
Query: 357 E-------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y V D +S GV+L ++G P
Sbjct: 186 EVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 33/216 (15%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH----DNGLSA-----EIRTLGKIRH 239
I G G V GV G VA+K++ + EIR L H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 240 RNIVRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
NI+ L+ F +E + LV E M L +V+H +R ++ G
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILLG 146
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA-VAGSYGY 353
L LH ++HRD+ NILL + + + DF LA+ + A + V + Y
Sbjct: 147 LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRW-Y 199
Query: 354 IAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
APE +T V D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
+L+ ++ IG G G+V VA+KKL N A E+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-----FQNQTHAKRAYRELV 76
Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGK----RGSFLKWE 282
+ + H+NI+ L F K +V E M +L +V+ + R S+L ++
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
M G+ +LH S IIHRD+K +NI++ SD + DFGLA+ G S
Sbjct: 136 M--------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 181
Query: 343 CMSA-VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384
M+ V Y Y APE + E D++S G ++ E+I G
Sbjct: 182 MMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+GRG +VYR + A+K + K + + EI L ++ H NI++LK
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKV---LKK-TVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLHH 300
LV E + G L + + ++G + E +AA ++YLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV-EKGYYS--ER------DAADAVKQILEAVAYLH- 165
Query: 301 DCSPLIIHRDVKSNNILLNS-DFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
I+HRD+K N+L + +A + ADFGL+K ++ M V G+ GY APE
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPE 220
Query: 358 ----YAYTLKVDEKSDVYSFGVVLLELITGRRP-VGDFGEEGL 395
AY +V D++S G++ L+ G P + G++ +
Sbjct: 221 ILRGCAYGPEV----DMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+GRG G+V+R V T + + K + + + EI L RHRNI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKF---VKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDCS 303
+ E ++++E++ + E ++ E + + L +LH S
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELN--E---REIVSYVHQVCEALQFLH---S 120
Query: 304 PLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
I H D++ NI+ + + + +FG A+ L+ + + + Y APE
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQH 177
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP 386
V +D++S G ++ L++G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G +V + G++ A K +L +G S + + E+ L +IRH NI
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-IEREVNILREIRHPNI 70
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
+ L NK +L+ E + G L + L ++ S E A + K G+ YL
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLA-EKESLT--E---DEATQFLKQILDGVHYL 124
Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
H S I H D+K NI+L + + + DFG+A ++ + G+ ++
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEFV 178
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
APE + ++D++S GV+ L++G P
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK-IRHRNIVRL 245
IG G V R + + AVK I K S D + EI L + +H NI+ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKI---IDK-SKRDP--TEEIEILLRYGQHPNIITL 81
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
K + + +V E M G L + + ++ F + E + K + YLH +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREAS-AVLFTITKTVEYLH---AQG 136
Query: 306 IIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGASECMSAVAGSYGYIAPE---- 357
++HRD+K +NIL + + DFG AK L+ + + ++APE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLER 194
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y D++S GV+L ++TG P
Sbjct: 195 QGYDAAC----DIWSLGVLLYTMLTGYTP 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 35/221 (15%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNG-LSAEIRTLGKIRHRNI 242
+G G G V+ V ++V VK K+L G ++ EI L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGE-----VLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
+++ N+ LV E +G + H + L + I + + Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
L IIHRD+K NI++ DF + DFG A YL+ + G+ Y APE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCGTIEYCAPE 199
Query: 358 ------YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE 392
Y + +++S GV L L+ P + E
Sbjct: 200 VLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 45/212 (21%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHR--N 241
++G GG G VY G+ + VA+K + + + + E+ L K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGE-----VLHGKRGSFLKWEMRLKIAIEAAKGLS 296
++RL + ++ +L+ E + G L+ E+ + + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGA----LQEELARSFFWQVLEAVR 163
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
+ H + ++HRD+K NIL++ + E + DFG L+DT ++ G+ Y
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSP 216
Query: 356 PEYAYTLKVD-EKSDVYSFGVVLLELITGRRP 386
PE+ + + V+S G++L +++ G P
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 61/240 (25%)
Query: 185 KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRH 239
+ VIG G GVV++ ++VA+KK+L E++ + ++H
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----------QDKRFKNRELQIMRIVKH 91
Query: 240 RNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA- 292
N+V LK F SN + LV EY+P E ++ + +LK +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVY----RASRHYAKLKQTMPMLL 142
Query: 293 ---------KGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASE 342
+ L+Y+H S I HRD+K N+LL+ + DFG AK L +
Sbjct: 143 IKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN- 198
Query: 343 CMSAVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF-GEEGLD 396
+S + Y Y APE YT + D++S G V+ EL+ G +P+ F GE G+D
Sbjct: 199 -VSYICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQG-QPL--FPGESGID 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G G G V G G +VAVK + + + EI+ L RH +I++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKI---LNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
L S +V EY+ G L + HG R++ EA + +
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEM-EARRLFQQILSAV 124
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGY 353
Y H +++HRD+K N+LL++ A +ADFGL+ + D + C GS Y
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNY 176
Query: 354 IAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRP 386
APE + D++S GV+L L+ G P
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 49/228 (21%)
Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
++ + +G G G V + +GE+VA+KKL + + A E+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-----FQSEIFAKRAYRELL 75
Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGK----RGSFLKWE 282
L ++H N++ L F LV +M L +++ K + +L ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ 134
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
M KGL Y+H S ++HRD+K N+ +N D E + DFGLA+ A
Sbjct: 135 M--------LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADA 178
Query: 343 CMSA-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
M+ V + Y APE Y V D++S G ++ E++TG+
Sbjct: 179 EMTGYVVTRW-YRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G +V + G + A K + +G S + + E+ L ++ H N+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-IEREVSILRQVLHHNV 77
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
+ L N+ +L+ E + G L + L ++ S E + A K G++YL
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLS--E---EEATSFIKQILDGVNYL 131
Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
H + I H D+K NI+L + + + DFGLA ++D + G+ ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFV 185
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
APE + ++D++S GV+ L++G P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIR---- 238
++G+GG G V+ G + QVA+K ++LG + S E+ L K+
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKVGAGGG 96
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGE-----VLHGKRGSFLKWEMRLKIAIEAAK 293
H ++RL + +E +LV E + G L +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP----LGEGPSRCFFGQVVA 150
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
+ + H S ++HRD+K NIL++ A + DFG L D + G+
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRV 203
Query: 353 YIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRP 386
Y PE+ + + V+S G++L +++ G P
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 64/212 (30%), Positives = 83/212 (39%), Gaps = 37/212 (17%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG G GV E VAVK I +G++ D + EI +RH NIVR K
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKY---IERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
++ EY G L E G R EA G+SY H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG----------RFSED-EARFFFQQLLSGVSYCH 133
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAH--VADFGLAKYLQDTGA--SECMSAVAGSYGYIA 355
S I HRD+K N LL+ + DFG +K S G+ YIA
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIA 185
Query: 356 PEYAYTLKVD-EKSDVYSFGVVLLELITGRRP 386
PE + D + +DV+S GV L ++ G P
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 23/167 (13%)
Query: 229 AEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
E++ + + H +V L +F E ++ +V + + G L L + F + ++L
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLF 120
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
I E L YL + IIHRD+K +NILL+ H+ DF +A L ++
Sbjct: 121 IC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITT 173
Query: 347 VAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+AG+ Y+APE Y+ V D +S GV EL+ GRRP
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 52/239 (21%), Positives = 91/239 (38%), Gaps = 28/239 (11%)
Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGI 217
+ + WK Q ++ + + +G G GVV+R V G K I
Sbjct: 28 KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF---I 84
Query: 218 TKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG 276
D + EI + ++ H ++ L +K +L+ E++ G L + + +
Sbjct: 85 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144
Query: 277 SFLKWEMRLKIAIEAAK-------GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--A 327
E E GL ++H I+H D+K NI+ + + V
Sbjct: 145 KMS--EA------EVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
DFGLA L E + + + APE V +D+++ GV+ L++G P
Sbjct: 194 DFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G +V + G + A K + +G + + E+ L ++ H NI
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-IEREVSILRQVLHPNI 77
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
+ L N+ +L+ E + G L + L ++ S E + A K G++YL
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLS--E---EEATSFIKQILDGVNYL 131
Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
H + I H D+K NI+L + + + DFGLA ++D + G+ ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFV 185
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
APE + ++D++S GV+ L++G P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 39/214 (18%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
++G G G+V + G VA+KK S D + EI+ L ++RH N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
V L C K+ LV+E++ + ++ + L ++ K + G+ + H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCHSHN 144
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG-------YIA 355
IIHRD+K NIL++ + DFG A+ L G Y Y A
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---------EVYDDEVATRWYRA 192
Query: 356 PE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
PE Y V DV++ G ++ E+ G
Sbjct: 193 PELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
++ +D +G G G V V G +VA+KKL + L A E+R
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-----FQSELFAKRAYRELR 76
Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
L +RH N++ L F ++ + LV +M LG+++ ++ L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LGEDRIQF 132
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
+ + KGL Y+H + IIHRD+K N+ +N D E + DFGLA+ A M+
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTG 184
Query: 347 -VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
V + Y APE YT V D++S G ++ E+ITG+
Sbjct: 185 YVVTRW-YRAPEVILNWMRYTQTV----DIWSVGCIMAEMITGK 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+G G VV + G Q A K + +G S ++ + E+ L +I+H N+
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQHPNV 76
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
+ L NK +L+ E + G L + L ++ S E + A E K G+ YL
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLA-EKESLT--E---EEATEFLKQILNGVYYL 130
Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
H S I H D+K NI+L + + + DFGLA + + G+ ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFV 184
Query: 355 APEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
APE + ++D++S GV+ L++G P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRN 241
+ IG G G+V N +VA+KK+ S ++ EI+ L + RH N
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 242 IVRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
I+ + + + +V + M L ++L + L + + +GL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILRGLK 142
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK-YLQDTGASECMSA-VAGSYGYI 354
Y+H S ++HRD+K +N+LLN+ + + DFGLA+ D + ++ VA + Y
Sbjct: 143 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW-YR 198
Query: 355 APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
APE YT + D++S G +L E+++ R
Sbjct: 199 APEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 44/230 (19%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVK-----KLL---------------GITKGSSHDNGLS 228
IG+G GVV + A+K KL+ G G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 229 A----EIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWE 282
EI L K+ H N+V+L E +L +V+E + G + EV K L +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSED 137
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
+ KG+ YLH IIHRD+K +N+L+ D +ADFG++ + + A
Sbjct: 138 QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL- 193
Query: 343 CMSAVAGSYGYIAPEYAYTLKVDEK------SDVYSFGVVLLELITGRRP 386
+S G+ ++APE +L K DV++ GV L + G+ P
Sbjct: 194 -LSNTVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR-NIVRLK 246
+GRG VV + + G++ A K L +G + EI L + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDC 302
N +L+ EY G + + + + E I K G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-E---NDVIRLIKQILEGVYYLH--- 148
Query: 303 SPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA 359
I+H D+K NILL+S + + DFG+++ + + + + G+ Y+APE
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEIL 205
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRP 386
+ +D+++ G++ L+T P
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRN 241
V ++G G G V++ T G ++A K I D + EI + ++ H N
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKI---IKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSY 297
+++L +K +LV EY+ G L + + + + + + I K G+ +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-----TILFMKQICEGIRH 202
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIA 355
+H I+H D+K NIL + + DFGLA+ + E + G+ ++A
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLA 256
Query: 356 PE---YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
PE Y + V +D++S GV+ L++G P
Sbjct: 257 PEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
IG G GVV++ G+ VA+KK S D + EIR L +++H N+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
V L K LV+EY + ++ L + + ++ I + + +++ H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCHKHN 122
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE----- 357
IHRDVK NIL+ + DFG A+ L TG S+ + Y +PE
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELLVGD 177
Query: 358 YAYTLKVDEKSDVYSFGVVLLELITGR 384
Y V DV++ G V EL++G
Sbjct: 178 TQYGPPV----DVWAIGCVFAELLSGV 200
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 50/221 (22%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNI 242
+ +G G VY+ + VA+KK+ + S +G+ +A EI+ L ++ H NI
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ L +K LV+++M L ++ ++ + +GL YLH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK-AYMLMTLQGLEYLHQHW 132
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG---------- 352
I+HRD+K NN+LL+ + +ADFGLAK S+G
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAK----------------SFGSPNRAYTHQV 173
Query: 353 ----YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y APE Y + V D+++ G +L EL+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
+L+ ++ IG G G+V VA+KKL N A E+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-----FQNQTHAKRAYRELV 113
Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGK----RGSFLKWE 282
+ + H+NI+ L F K LV E M +L +V+ + R S+L ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ 172
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
M G+ +LH S IIHRD+K +NI++ SD + DFGLA+ G S
Sbjct: 173 M--------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 218
Query: 343 CMSA-VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384
M+ V Y Y APE + E D++S G ++ E++ +
Sbjct: 219 MMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G G G V G G +VAVK + + + EI+ L RH +I++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKI---LNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
L S +V EY+ G L + +G RL E+ + G+
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEK-ESRRLFQQILSGV 129
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGY 353
Y H +++HRD+K N+LL++ A +ADFGL+ + D + C GS Y
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNY 181
Query: 354 IAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRP 386
APE + D++S GV+L L+ G P
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 51/225 (22%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
++G G GVV P GE VA+KK+ D L A EI+ L +H NI
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFALRTLREIKILKHFKHENI 71
Query: 243 VRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAA 292
+ + + N ++ E M L V+ + S + ++ L+
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT-LR------ 123
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY- 351
+ LH +IHRD+K +N+L+NS+ + V DFGLA+ + ++ A S
Sbjct: 124 -AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 352 -GYI------APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
++ APE Y+ + DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 60/226 (26%), Positives = 88/226 (38%), Gaps = 53/226 (23%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSA--EI---RTLGKIRHR 240
IG G G VY+ +G VA+K + + G +S E+ R L H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 241 NIVRLKAFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
N+VRL C+ T+ LV+E++ L L L E + + +GL
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG--- 352
+LH +C I+HRD+K NIL+ S +ADFGLA+ Y
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI----------------YSYQM 174
Query: 353 ----------YIAPEY----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y APE Y V D++S G + E+ +
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 45/219 (20%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
+G G G VY+ + T E VA+K++ + + G+ E+ L +++HRNI
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ LK+ + L++EY N L + + K ++ + G+++ H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMD-KNPDVSMRVIK-SFLYQLINGVNFCH--- 149
Query: 303 SPLIIHRDVKSNNILLNSDFEAH-----VADFGLAKYLQDTGASECMSAVAGSYG----- 352
S +HRD+K N+LL+ + + DFGLA+ +
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---------FGIPIRQFTHEIIT 200
Query: 353 --YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y PE Y+ V D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 59/226 (26%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGL--SA--EIRTLGKIRHRN 241
+G G VY+G+ G VA+K++ L + G +A EI + +++H N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHEN 64
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL----KIAIEAAKGLSY 297
IVRL + LV+E+M N L + + + + L + +GL++
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG----- 352
H + I+HRD+K N+L+N + + DFGLA+ ++G
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR----------------AFGIPVNT 164
Query: 353 ---------YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y AP+ Y+ +D ++S G +L E+ITG+
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSID----IWSCGCILAEMITGK 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 40/214 (18%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
+G G G V ++VA+K I++ + + EI L +RH +I++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKF---ISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
L + ++V EY G L + V R+ E + +
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTED-EGRRFFQQIICAI 121
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGY 353
Y H I+HRD+K N+LL+ + +ADFGL+ + D + C GS Y
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNY 173
Query: 354 IAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRP 386
APE + DV+S G+VL ++ GR P
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 40/215 (18%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRN 241
+ +G G G V T G +VAVKKL + + A E+R L ++H N
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-----FQSIIHAKRTYRELRLLKHMKHEN 89
Query: 242 IVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
++ L F + LV M L ++ ++ L + + + +GL
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK---LTDDHVQFLIYQILRGL 145
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA-VAGSYGYI 354
Y+H S IIHRD+K +N+ +N D E + DFGLA+ ++ M+ VA + Y
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRW-YR 196
Query: 355 APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
APE Y V D++S G ++ EL+TGR
Sbjct: 197 APEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNI 242
+ +G G VY+G + VA+K++ H+ G +A E+ L ++H NI
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIR-----LEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
V L +++ LV+EY+ L + L ++ + +GL+Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-LFLFQLLRGLAYCHRQK 120
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY---- 358
++HRD+K N+L+N E +ADFGLA+ ++ + Y P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGS 175
Query: 359 -AYTLKVDEKSDVYSFGVVLLELITGR 384
Y+ ++ D++ G + E+ TGR
Sbjct: 176 TDYSTQI----DMWGVGCIFYEMATGR 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 59/228 (25%)
Query: 188 NVIGRGGAGVVYRG--VTPNGEQVAVKKLLGITKGSSHDNGL--SA--EI---RTLGKIR 238
IG G G V++ + G VA+K++ + + + G+ S E+ R L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 239 HRNIVRLK----AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
H N+VRL +++ET L LV+E++ L L + E + + +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG- 352
GL +LH ++HRD+K NIL+ S + +ADFGLA+ Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI----------------YSF 172
Query: 353 ------------YIAPEY----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y APE +Y V D++S G + E+ +
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
V+G+GG G V V G+ A KKL + KG + E + L K+ R +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM---ALNEKQILEKVNSRFVV 247
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
L K+ LV M G L ++ + F + A E GL LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLH--- 303
Query: 303 SPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE--- 357
I++RD+K NILL D H+ +D GLA ++ + + + G+ GY+APE
Sbjct: 304 RERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVK 358
Query: 358 -YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
YT D ++ G +L E+I G+ P
Sbjct: 359 NERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 5e-20
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKI---RHR 240
+IGRGG G VY G+ A+K L + + +G + E L +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NERIMLSLVSTGDCP 252
Query: 241 NIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
IV + + + L + + M G L L + G F + +MR A E GL ++H
Sbjct: 253 FIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAA-EIILGLEHMH 309
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
+ +++RD+K NILL D HV +D GLA A G++GY+APE
Sbjct: 310 ---NRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 360
Query: 358 -----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
AY D +S G +L +L+ G P
Sbjct: 361 VLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 84/277 (30%)
Query: 176 GSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
G + + +G G G+V +G++ A+KK+L + + E+ +
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR------ELDIM 54
Query: 235 GKIRHRNIVRLK-AFCSNKETNL------------------------------------- 256
+ H NI++L F + +
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA----------KGLSYLHHDCSPLI 306
++ EY+P + LH LK +R +I + + ++H S I
Sbjct: 115 VIMEYVP-----DTLH----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI 162
Query: 307 IHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-----YAY 360
HRD+K N+L+NS D + DFG AK L + S ++ + + Y APE Y
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRF-YRAPELMLGATEY 219
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRPVGDF-GEEGLD 396
T + D++S G V ELI G +P+ F GE +D
Sbjct: 220 TPSI----DLWSIGCVFGELILG-KPL--FSGETSID 249
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 8e-20
Identities = 65/213 (30%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
V+GRGG G V+ + G+ A KKL L KG E + L K+ R IV
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG---AMVEKKILAKVHSRFIV 248
Query: 244 RLKAFCSNKETNL-LVYEYMPNGSLG---EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
L + +T+L LV M G + + F + A + GL +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH 306
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357
II+RD+K N+LL D + +V +D GLA L+ AG+ G++APE
Sbjct: 307 ---QRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 358 ----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y V D ++ GV L E+I R P
Sbjct: 360 LLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 49/210 (23%), Positives = 77/210 (36%), Gaps = 23/210 (10%)
Query: 186 DNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIV 243
V+G G G V G++ A+K + S E+ + +IV
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD--SPK--ARQEVDHHWQASGGPHIV 85
Query: 244 RLKAFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
+ N L++ E M G L + + +I + + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 300 HDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
I HRDVK N+L S D + DFG AK + + Y+AP
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAP 198
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E K D+ D++S GV++ L+ G P
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 43/222 (19%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNI 242
IG+G G V++ G++VA+KK+ + G +A EI+ L ++H N+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENV 78
Query: 243 VRLKAFCSNKETNL--------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
V L C K + LV+++ + L +L F E++ ++ G
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNG 136
Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG-- 352
L Y+H + I+HRD+K+ N+L+ D +ADFGLA+ S ++ Y
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF-----SLAKNSQPNRYTNR 188
Query: 353 -----YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 384
Y PE Y + D++ G ++ E+ T
Sbjct: 189 VVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 189 VIGRGGAGVVYRGVT--PNGEQVAVKKL--LGITKGS--SHDNGLSAEIRTLGKIRHRNI 242
++G G V + A+K L I K + + E + ++ H
Sbjct: 37 ILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVT---RERDVMSRLDHPFF 92
Query: 243 VRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
V+L F + L Y NG L + + K GSF + R A E L YLH
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALEYLHGK 149
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
IIHRD+K NILLN D + DFG AK L ++ G+ Y++PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRP 386
+ SD+++ G ++ +L+ G P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 47/228 (20%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
D +G GG G+V+ V ++VA+KK+ + S EI+ + ++
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-------VLTDPQSVKHALREIKIIRRLD 66
Query: 239 HRNIVRLK-------AFCSNKETNL-------LVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
H NIV++ + ++ +L +V EYM L VL L E
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LLEEHA 122
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYL-QDTGASE 342
+ +GL Y+H S ++HRD+K N+ +N+ D + DFGLA+ +
Sbjct: 123 RLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 343 CMSA-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
+S + + Y +P YT + D+++ G + E++TG+
Sbjct: 180 HLSEGLVTKW-YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 63/250 (25%), Positives = 96/250 (38%), Gaps = 45/250 (18%)
Query: 156 RKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKK 213
+ ++ K + DF +IL VIGRG G V + + A+K
Sbjct: 57 EWAKPFTSKVKQMRLHREDF---EIL------KVIGRGAFGEVAVVKLKN-ADKVFAMKI 106
Query: 214 L----LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSL 267
L + ++ E L + I L AF + NL LV +Y G L
Sbjct: 107 LNKWEMLKRAETACFR---EERDVLVNGDSKWITTLHYAFQD--DNNLYLVMDYYVGGDL 161
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV- 326
+L + R +A E + +H +HRD+K +NIL+ D H+
Sbjct: 162 LTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILM--DMNGHIR 215
Query: 327 -ADFGLAKYLQDTGASECMSAVAGSYGYIAPE---------YAYTLKVDEKSDVYSFGVV 376
ADFG L + G + AV G+ YI+PE Y + D +S GV
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPEC----DWWSLGVC 270
Query: 377 LLELITGRRP 386
+ E++ G P
Sbjct: 271 MYEMLYGETP 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 52/214 (24%), Positives = 81/214 (37%), Gaps = 36/214 (16%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
V+G G G V + E+ A+K + E+ + + +IVR+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKM---LQDCPK----ARREVELHWRASQCPHIVRIV 121
Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA-------KGL 295
N L+V E + G L + + E EA+ + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER------EASEIMKSIGEAI 174
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYG 352
YLH S I HRDVK N+L S + DFG AK ++ +
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPY 228
Query: 353 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y+APE K D+ D++S GV++ L+ G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 172 KLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAE 230
+++G+ D + V+ +GRG V+ + N E+V VK L K E
Sbjct: 29 VVEWGNQDDYQLVR---KLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKR-E 80
Query: 231 IRTLGKIR-HRNIVRLKAFC--SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
I+ L +R NI+ L T LV+E++ N ++ +++ M
Sbjct: 81 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY--- 137
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDTGASECMSA 346
E K L Y H S I+HRDVK +N++++ + + + D+GLA++ + +
Sbjct: 138 --EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNV 189
Query: 347 -VAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
VA Y + PE Y Y+L D++S G +L +I + P
Sbjct: 190 RVASRY-FKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 67/249 (26%), Positives = 100/249 (40%), Gaps = 46/249 (18%)
Query: 156 RKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKK 213
+++ N + + D+ +++ VIGRG G V R + + A+K
Sbjct: 52 SRYKDTINKIRDLRMKAEDY---EVV------KVIGRGAFGEVQLVRHKS-TRKVYAMKL 101
Query: 214 L----LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSL 267
L + S+ E + +V+L AF ++ L +V EYMP G L
Sbjct: 102 LSKFEMIKRSDSAFFW---EERDIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDL 156
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV- 326
V + R A E L +H S IHRDVK +N+LL D H+
Sbjct: 157 --VNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLL--DKSGHLK 208
Query: 327 -ADFGLAKYLQDTGASECMSAVAGSYGYIAPE--------YAYTLKVDEKSDVYSFGVVL 377
ADFG + G C +AV G+ YI+PE Y + D +S GV L
Sbjct: 209 LADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFL 263
Query: 378 LELITGRRP 386
E++ G P
Sbjct: 264 YEMLVGDTP 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 52/231 (22%)
Query: 185 KDNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKI 237
+ +GRG G VY+ + + A+K++ G+S EI L ++
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLREL 75
Query: 238 RHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA--- 292
+H N++ L+ F S+ + + L+++Y + L ++ R S + + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK---ANKKPVQLPRGMVK 131
Query: 293 -------KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQD---T 338
G+ YLH + ++HRD+K NIL+ + +AD G A+
Sbjct: 132 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 339 GASECMSAVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 384
A V + Y APE YT + D+++ G + EL+T
Sbjct: 189 LADLDPVVVT--FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 51/234 (21%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
+IGRG G VY + VA+KK+ + ++ + EI L +++ I
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-----FEDLIDCKRILREITILNRLKSDYI 87
Query: 243 VRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
+RL + +V E + L ++ K FL E I G ++
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF--KTPIFLTEEHIKTILYNLLLGENF 144
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG----- 352
+H IIHRD+K N LLN D V DFGLA+ + + ++ + +
Sbjct: 145 IH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 353 ---------------YIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y APE YT + D++S G + EL+ +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQS 251
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 61/213 (28%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 189 VIGRGGAGVVY--RGVTPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
VIGRG V + G+ A+K + + K E L R I +
Sbjct: 68 VIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLKRGEVSCFR-EERDVLVNGDRRWITQ 125
Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEM-RLKIAIEAAKGLSYLHHDC 302
L F E L LV EY G L +L K G + EM R +A E + +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA-EIVMAIDSVH--- 179
Query: 303 SPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
+HRD+K +NILL D H+ ADFG L+ G + AV G+ Y++PE
Sbjct: 180 RLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 361 TLKVDEKSDVY-------SFGVVLLELITGRRP 386
+ + Y + GV E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 49/247 (19%), Positives = 85/247 (34%), Gaps = 56/247 (22%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
+IG G G V VA+KK+L + ++ + EI L ++ H ++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-----EDLIDCKRILREIAILNRLNHDHV 114
Query: 243 VRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
V++ +V E + ++ + +L + G+ Y
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTELHIKTLLYNLLVGVKY 171
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG----- 352
+H S I+HRD+K N L+N D V DFGLA+ + ++
Sbjct: 172 VH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 353 --------------------YIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRRPV 387
Y APE YT + DV+S G + EL+ +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMIKEN 284
Query: 388 GDFGEEG 394
+ +
Sbjct: 285 VAYHADR 291
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 52/246 (21%)
Query: 172 KLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA- 229
++D +L + +G+G G+V++ + GE VAVKK+ N A
Sbjct: 2 RVDR---HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-----FQNSTDAQ 53
Query: 230 ----EIRTLGKIR-HRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWE 282
EI L ++ H NIV L ++ + ++ LV++YM L V+ L+
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI---LEPV 109
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
+ + + K + YLH S ++HRD+K +NILLN++ VADFGL++ +
Sbjct: 110 HKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 343 CMSAVAGSYG-------------------YIAPE-----YAYTLKVDEKSDVYSFGVVLL 378
++ + Y APE YT + D++S G +L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG 222
Query: 379 ELITGR 384
E++ G+
Sbjct: 223 EILCGK 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 50/165 (30%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
E R L RH + LK + L V EY G L L + F + R
Sbjct: 197 TENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYG 254
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMS 345
A E L YLH + + +++RD+K N++L D + H+ DFGL K + M
Sbjct: 255 A-EIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCK--EGIKDGATMK 307
Query: 346 AVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ Y+APE Y V D + GVV+ E++ GR P
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 9/96 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHL--------SGPIPVQITQIHILNYLNVSWN 52
+ +P + + ++++ N + + + +N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 53 QLNA-SLPKEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
L + + MK L + +N G++P FG
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS 351
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 21/107 (19%), Positives = 39/107 (36%), Gaps = 15/107 (14%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-------PIPVQITQIHILNYLNVSWNQ 53
+S N S L+ ++L N L+ ++L +++ +N+
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 54 LNASLPKE--MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTG 98
L L + + L D S+N+FS P NS++ G
Sbjct: 500 LT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPT----QPLNSSTLKG 540
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 15/92 (16%), Positives = 34/92 (36%), Gaps = 8/92 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLN---- 55
++ N + I G + L + N L P + +++ ++ S+N++
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 56 ---ASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
L +++S + S+N S E
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 10/88 (11%), Positives = 24/88 (27%), Gaps = 7/88 (7%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
NN + + + L + + + N + Q +
Sbjct: 190 QLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICE-----AWENENSEYAQQYKTEDL 243
Query: 61 EMGNMKSLTSADFSHNNFSGEIP-EFGQ 87
+ N+K LT + + ++P
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 17/100 (17%), Positives = 32/100 (32%), Gaps = 14/100 (14%)
Query: 1 MSRNNFSGI-------IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ 53
S N + + + ++ ++LS N +S + L+ +N+ N
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468
Query: 54 LN-------ASLPKEMGNMKSLTSADFSHNNFSGEIPEFG 86
L + N LTS D N + +F
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 18/90 (20%), Positives = 27/90 (30%), Gaps = 9/90 (10%)
Query: 2 SRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQI------TQIHILNYLNVSWNQL 54
N + + L +DLS N S P Q I N + N+
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 55 NASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
P+ + SLT N+ + E
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNE 583
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 10/91 (10%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYL------DLSQNHLSGPIPVQITQIHILNYLNVSWNQL 54
+S N+FS P + + L D N P IT L L + N +
Sbjct: 520 LSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 55 NASLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
+ +++ +++ D N +
Sbjct: 579 R-KVNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 5/89 (5%)
Query: 1 MSRNNF-SGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
+ NN + + + L L+ N L G +P L LN+++NQ+ +P
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIP 369
Query: 60 KEM-GNMKSLTSADFSHNNFSGEIPEFGQ 87
G + + + F+HN IP
Sbjct: 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFD 397
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 9/103 (8%), Positives = 29/103 (28%), Gaps = 13/103 (12%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL------- 54
++ + LT +++ +P + + + +NV+ N+
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292
Query: 55 -NASLPKEMGNMKSLTSADFSHNNF-SGEIPEFGQYSFFNSTS 95
+ + + + +NN + + S
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVET----SLQKMKK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 20/135 (14%), Positives = 37/135 (27%), Gaps = 7/135 (5%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL----NAS 57
+ + V + +T L L SG +P I Q+ L L + +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 58 LPKEMGNMKSLTSADFSHNNFSGEIPE---FGQYSFFNSTSFTGNPHLCGSYLNPCNYSS 114
PK + S ++ + +S +P +
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 115 TTPIHNQNGNKSHVP 129
T I + N + V
Sbjct: 185 DTQIGQLSNNITFVS 199
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 12/77 (15%), Positives = 24/77 (31%), Gaps = 3/77 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N P I C LT L + N + + +IT ++ L++ N +
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP--NISVLDIKDNPNISIDLS 605
Query: 61 EMGNMKSLTSADFSHNN 77
+ ++
Sbjct: 606 YVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 9/100 (9%), Positives = 22/100 (22%), Gaps = 11/100 (11%)
Query: 2 SRNNFSG----IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILN--YLNVSWNQLN 55
+ P I + + H + + ++ +
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 56 ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
S+ K T NN + + + + T
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITF-VSK----AVMRLTK 207
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
V+G+G G V+ + + A+K K + E L ++ H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDILVEVNHPF 87
Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
IV+L + E L L+ +++ G L L K F + +++ +A E A L +LH
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLA-ELALALDHLH- 143
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGASECMSAVAGSYGYIA 355
S II+RD+K NILL D E H+ DFGL+K + S C G+ Y+A
Sbjct: 144 --SLGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKAYSFC-----GTVEYMA 194
Query: 356 PE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
PE +T D +SFGV++ E++TG P
Sbjct: 195 PEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
+G G G V +G A+K L + K H E R L + +V
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRILQAVNFPFLV 104
Query: 244 RLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
+L+ F +NL +V EY+ G + L + G F + R A + YLH D
Sbjct: 105 KLE-FSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA-QIVLTFEYLHSLD 161
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE-- 357
+I+RD+K N+L+ D + ++ DFG AK ++ + C G+ +APE
Sbjct: 162 ----LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEII 210
Query: 358 --YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y V D ++ GV++ E+ G P
Sbjct: 211 LSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 51/166 (30%), Positives = 74/166 (44%), Gaps = 26/166 (15%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
E L + H I+R+ + ++ +Y+ G L +L K F +
Sbjct: 55 DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYA 112
Query: 288 AIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECM 344
A E L YLH D II+RD+K NILL D H+ DFG AKY+ D + C
Sbjct: 113 A-EVCLALEYLHSKD----IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDVTYTLC- 164
Query: 345 SAVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ YIAPE Y + D +SFG+++ E++ G P
Sbjct: 165 ----GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 51/166 (30%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLH-GKRGSFLKWEMRLK 286
E R L RH + LK + L V EY G L H + F + R
Sbjct: 54 TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECM 344
A E L YLH S +++RD+K N++L D + H+ DFGL K + M
Sbjct: 111 GA-EIVSALEYLH---SRDVVYRDIKLENLML--DKDGHIKITDFGLCK--EGISDGATM 162
Query: 345 SAVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
G+ Y+APE Y V D + GVV+ E++ GR P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNI 242
V+G+GG G V+ G+ A+K L I + + AE L +++H I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 243 VRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
V L + L L+ EY+ G L L + G F++ +A E + L +LH
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA-EISMALGHLHQK 140
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPE- 357
II+RD+K NI+L + + HV DFGL K + G+ Y+APE
Sbjct: 141 G----IIYRDLKPENIML--NHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEI 192
Query: 358 ---YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ V D +S G ++ +++TG P
Sbjct: 193 LMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 26/103 (25%), Positives = 39/103 (37%), Gaps = 3/103 (2%)
Query: 1 MSRNNFSG-IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
M+ N+F +P LT+LDLSQ L P + L LN+S N +
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF--TGNP 100
+ SL D+S N+ + Q+ + T N
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 13/95 (13%), Positives = 27/95 (28%), Gaps = 4/95 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N + L LDLS+ + + L+ L ++ N + +
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
+ SL N + + +
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENF----PIGHLKT 125
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 21/98 (21%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+SR I L+ L L+ N + + + L L L +
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 61 EMGNMKSLTSADFSHNNF-SGEIPEFGQYSFFNSTSFT 97
+G++K+L + +HN S ++PE F N T+
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPE----YFSNLTNLE 152
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
+S N + L +LD ++L + + L YL++S +
Sbjct: 380 LSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 60 KEMGNMKSLTSADFSHNNFSGEIP 83
+ SL + N+F
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 1/84 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S+ + P L L++S N+ ++ L L+ S N + S +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 61 EMGNM-KSLTSADFSHNNFSGEIP 83
E+ + SL + + N+F+
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 12/101 (11%)
Query: 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM 62
+F G L YLDLS N + + + L +L+ + L +
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 63 -GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
++++L D SH + F G L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNG----------IFNGLSSL 447
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 17/125 (13%), Positives = 35/125 (28%), Gaps = 10/125 (8%)
Query: 1 MSRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY----LNVSWNQLN 55
++ N +P + L +LDLS N + + +H + L++S N +N
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 56 ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSST 115
+ L +N S + + + + L
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMK----TCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 116 TPIHN 120
Sbjct: 246 FDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 3/84 (3%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASLP 59
+ + G L +LDLS+N LS G L YL++S+N + ++
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389
Query: 60 KEMGNMKSLTSADFSHNNFSGEIP 83
++ L DF H+N
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 14/83 (16%), Positives = 25/83 (30%), Gaps = 10/83 (12%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
LDLS N L L L++S ++ ++ L++ + N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 80 GEIPEFGQYSFFNSTSFTGNPHL 102
+F+G L
Sbjct: 90 SLALG----------AFSGLSSL 102
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 14/96 (14%), Positives = 29/96 (30%), Gaps = 13/96 (13%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+ + +L+L Q + + + +++
Sbjct: 290 VSVTIERVKD--FSYNFGWQHLELVNCKFG-----QFPTLKLKSLKRLTFTSNKGGNAFS 342
Query: 62 MGNMKSLTSADFSHN--NFSGEIPEFGQYSFFNSTS 95
++ SL D S N +F G + S F +TS
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQ----SDFGTTS 374
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 8/83 (9%), Positives = 22/83 (26%), Gaps = 5/83 (6%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
+ + I ++ L + + +L + + ++
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 64 NMKSLTSADFSHNNFSGEIPEFG 86
++K L F+ N E
Sbjct: 326 SLKRL---TFTSNKGGNAFSEVD 345
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 4/77 (5%)
Query: 1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQ--ITQIHILNYLNVSWNQLNAS 57
S N+ E+ H L +L+L+QN + Q + I L V ++ +
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584
Query: 58 LPKEMGNMKSLTSADFS 74
P + + S + +
Sbjct: 585 TPSDKQG-MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 12/83 (14%), Positives = 24/83 (28%), Gaps = 5/83 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQL---NA 56
+S N + I P + L L L N S + I + L + +
Sbjct: 184 LSLNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 57 SLPKEMGNMKSLTSADFSHNNFS 79
+ ++ L + +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLA 265
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 13/136 (9%), Positives = 29/136 (21%), Gaps = 17/136 (12%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLS------GPIPVQITQIHILNYLNVSWNQLNAS 57
N + + L L + + L+ I + ++ ++ +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 58 LPKEMGNMKSLTSADFSHNNFSGEIPE---------FGQYSFFNSTSFTGNPHLCGSYLN 108
+ + F F N+ S P L L+
Sbjct: 298 KDF--SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 109 PCNYSSTTPIHNQNGN 124
S +
Sbjct: 356 RNGLSFKGCCSQSDFG 371
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVKKLLGITKGS--SHDNGLS---AEIRTLGKIRH 239
V+G G G V+ G+ A+K L K + E + L IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 240 RN-IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
+V L + ET L L+ +Y+ G L L +R F + E+++ + E L +
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVG-EIVLALEH 174
Query: 298 LH-HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK----YLQDTGASECMSAVAGS 350
LH II+RD+K NILL D HV DFGL+K + C G+
Sbjct: 175 LHKLG----IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFC-----GT 223
Query: 351 YGYIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y+AP+ + V D +S GV++ EL+TG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 37/250 (14%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKA 247
IG G G +Y G GE+VA+K + + L E + ++ I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72
Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ + N++V E + G SL ++ + F LK L +A + + Y+H S
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIH---SKN 125
Query: 306 IIHRDVKSNNILL---NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA--Y 360
IHRDVK +N L+ ++ DFGLAK +D + + YA
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 361 TLKVDEKS---DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
T E+S D+ S G VL+ G P W ++ + ++ +I +
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLP-------------WQGLKAATKRQKYERISE 232
Query: 418 QRLSNTPLSE 427
+++S TP+
Sbjct: 233 KKMS-TPIEV 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
V+G+G G V +G E AVK L K + E R L +
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ +L C L V EY+ G L + + G F + A E A GL +L
Sbjct: 402 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFL 458
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
S II+RD+K +N++L D E H+ ADFG+ K ++ G+ YIAP
Sbjct: 459 Q---SKGIIYRDLKLDNVML--DSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAP 511
Query: 357 E----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y V D ++FGV+L E++ G+ P
Sbjct: 512 EIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 42/217 (19%)
Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGK-IRH 239
++G+G G V ++ + A+K L K + E R L H
Sbjct: 24 MLGKGSFGKVFLAEFKK---TNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ + + NL V EY+ G L + F A E GL +L
Sbjct: 78 PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAA-EIILGLQFL 134
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGASECMSAVAGSYGY 353
H S I++RD+K +NILL D + H+ ADFG+ K + C G+ Y
Sbjct: 135 H---SKGIVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDAKTNTFC-----GTPDY 184
Query: 354 IAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
IAPE Y V D +SFGV+L E++ G+ P
Sbjct: 185 IAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 65/217 (29%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
V+G+G G V +G E AVK L K + E R L +
Sbjct: 27 VLGKGSFGKVMLSERKG---TDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ +L C L V EY+ G L + + G F + A E A GL +L
Sbjct: 81 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFL 137
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGASECMSAVAGSYGY 353
S II+RD+K +N++L D E H+ ADFG+ K + T + C G+ Y
Sbjct: 138 Q---SKGIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFC-----GTPDY 187
Query: 354 IAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
IAPE Y V D ++FGV+L E++ G+ P
Sbjct: 188 IAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 56/170 (32%), Positives = 76/170 (44%), Gaps = 30/170 (17%)
Query: 229 AEIRTLGK-IRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
+E L K ++H +V L F L V +Y+ G L L + FL E R +
Sbjct: 87 SERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFL--EPRAR 142
Query: 287 I-AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGA 340
A E A L YLH S I++RD+K NILL D + H+ DFGL K T +
Sbjct: 143 FYAAEIASALGYLH---SLNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 341 SECMSAVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
+ C G+ Y+APE Y V D + G VL E++ G P
Sbjct: 198 TFC-----GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 64/265 (24%), Positives = 100/265 (37%), Gaps = 65/265 (24%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKA 247
IG G G + G E VA+K + S L E R ++ I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F + N +V E + G SL ++ +F LK L IAI+ + Y+H S
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVH---SKN 125
Query: 306 IIHRDVKSNNILL-----NSDFEAHVADFGLAKYLQD---------------TGASECMS 345
+I+RDVK N L+ + H+ DF LAK D TG + MS
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 346 AVAGSYGYIAPEYAYTLKVDEKS---DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402
+ G E+S D+ + G + + + G P W
Sbjct: 186 -INTHLGK------------EQSRRDDLEALGHMFMYFLRGSLP-------------WQG 219
Query: 403 MQTNSSKEGVVKILDQRLSNTPLSE 427
++ ++ KE KI D + + TP+
Sbjct: 220 LKADTLKERYQKIGDTKRA-TPIEV 243
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 61/214 (28%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
V+G+G G V + G+ AVK L K + E R L H
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNH 83
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+ +L C L V E++ G L + K F + R A E L +L
Sbjct: 84 PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAA-EIISALMFL 140
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
H II+RD+K +N+LL D E H ADFG+ K + + G+ YIAP
Sbjct: 141 H---DKGIIYRDLKLDNVLL--DHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 357 E----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y V D ++ GV+L E++ G P
Sbjct: 194 EILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 189 VIGRGGAG----VVYRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
VIGRG V + A+K + K +D+ + E + H
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVV---KKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+V L C E+ L V EY+ G L + ++ + R A E + L+YL
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYL 126
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
H II+RD+K +N+LL D E H+ D+G+ K + + S G+ YIAP
Sbjct: 127 H---ERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 179
Query: 357 E----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y V D ++ GV++ E++ GR P
Sbjct: 180 EILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 15/106 (14%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS-------GPIPVQITQIHILNYLNVSWNQ 53
+S N ++ + LS N ++ P ++L +++ +N+
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739
Query: 54 LNASLPKEM--GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
L SL + + L++ D S+N FS P NS+
Sbjct: 740 LT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPT----QPLNSSQLK 779
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 10/92 (10%), Positives = 26/92 (28%), Gaps = 9/92 (9%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N I I L + + + + + +Y + +
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELSWS 488
Query: 64 NMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
N+K LT + + ++P+ ++
Sbjct: 489 NLKDLTDVELYNCPNMTQLPD----FLYDLPE 516
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 18/105 (17%), Positives = 32/105 (30%), Gaps = 17/105 (16%)
Query: 1 MSRNNFSGI---------IPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVS 50
++ N + + + + N+L P + ++ L L+
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 51 WNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
N++ L G LT +N EIPE F T
Sbjct: 582 HNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPE----DFCAFTD 619
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 16/92 (17%), Positives = 31/92 (33%), Gaps = 11/92 (11%)
Query: 1 MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQI------TQIHILNYLNVSWN 52
+ N + + + L L+ +D+S N S P Q I + + N
Sbjct: 735 LRFNKLTSL-SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 53 QLNASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
++ P + SL N+ ++ E
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIR-KVDE 823
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 15/92 (16%), Positives = 32/92 (34%), Gaps = 8/92 (8%)
Query: 1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQL---- 54
+ N I P + + L S N L P ++++ ++ S+N++
Sbjct: 602 LDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660
Query: 55 -NASLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
N S + + ++ S+N E
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 12/96 (12%), Positives = 28/96 (29%), Gaps = 13/96 (13%)
Query: 1 MSRNNFSGIIP-----VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN 55
S N ++ + + + LS N + ++ + +S N +
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
Query: 56 A-------SLPKEMGNMKSLTSADFSHNNFSGEIPE 84
+ N LT+ D N + + +
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSD 745
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 12/105 (11%), Positives = 29/105 (27%), Gaps = 2/105 (1%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+ G +P IG L L + + + + + +++ K
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 62 -MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGS 105
+ + L +D + + PE + S +
Sbjct: 391 FLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGNLT 434
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 14/107 (13%), Positives = 32/107 (29%), Gaps = 9/107 (8%)
Query: 2 SRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILN-----YLNVSWNQLN 55
S N I ++ +D S N + + + +S+N++
Sbjct: 627 SHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 56 ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ +++ S+N + IPE ++ L
Sbjct: 687 KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK--DGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 10/77 (12%), Positives = 22/77 (28%), Gaps = 3/77 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N P I C L L + N + + ++ L L+++ N +
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVT 845
Query: 61 EMGNMKSLTSADFSHNN 77
+ ++
Sbjct: 846 SVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 11/84 (13%), Positives = 27/84 (32%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ + V++ + +T L L+ G +P I Q+ L L+ + S
Sbjct: 306 KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRL 365
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+ ++ + +
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 11/86 (12%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLS-----GPIPVQITQIHILNYLNVSWNQLNASL 58
+ + + L DL Q+ ++ PI + N++ +
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FI 440
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPE 84
K + + L F+++ F+ +
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIA 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 19/102 (18%), Positives = 33/102 (32%), Gaps = 10/102 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N + LT LD+ N +S P ++ +L LN+ N+L+ K
Sbjct: 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK 91
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+LT N+ F +L
Sbjct: 92 TFAFCTNLTELHLMSNSIQKIKNN----------PFVKQKNL 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 17/84 (20%), Positives = 30/84 (35%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N S + C LT L L N + + L L++S N L+++
Sbjct: 80 LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+++L S+N E
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSE 163
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 20/105 (19%), Positives = 33/105 (31%), Gaps = 2/105 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ ++ G + L L+L N + L +++ N LN
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF--TGNPHLC 103
N SL S + N + + +F N T NP C
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 5/114 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N F I L +DL N+L+ L LN+ N + S+ K
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI-TSVEK 601
Query: 61 EM--GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNY 112
++ ++LT D N F + + + + T P L YL CN
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL--CNT 653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 8/93 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--------GPIPVQITQIHILNYLNVSWN 52
+S NN + I + L LDL N+L+ G + + L+ LN+ N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 53 QLNASLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
+ + ++ L D NN +
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 5/89 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+S N + E+ L L+LS N + P I L L ++ QL SL
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211
Query: 59 PKEMG---NMKSLTSADFSHNNFSGEIPE 84
+++ S+ + S++ S
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 17/104 (16%), Positives = 32/104 (30%), Gaps = 3/104 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+S + S LT LDLS N+L+ + L Y + +N +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ + ++ + + I + SF L
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSI-SLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 13/81 (16%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLP 59
+++N S I L LDL N + + Q + + + +S+N+
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 60 KEMGNMKSLTSADFSHNNFSG 80
+ SL
Sbjct: 448 NSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 5/89 (5%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI---LNYLNVSWNQLNASL 58
S N P L L L+ L + ++ + L++S +QL+ +
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 59 PKEMGNMK--SLTSADFSHNNFSGEIPEF 85
+K +LT D S+NN + +
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 17/94 (18%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 1 MSRNNFSGI--IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN--- 55
+ R + P LT LDLS N+++ + + L L++ N L
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520
Query: 56 -----ASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
+ + L + N F E
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 23/99 (23%), Positives = 32/99 (32%), Gaps = 6/99 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N+ I L LDLS N LS Q+ L L +S N++ A +
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 61 EMGNMK--SLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
E+ SL + S N P F
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPG----CFHAIGRLF 198
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 14/104 (13%), Positives = 33/104 (31%), Gaps = 9/104 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHI--------LNYLNVSW 51
+ NN + + + YL+L ++ I + + +I L +LN+
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 52 NQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
N + + +L S++ S + +
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 17/105 (16%), Positives = 39/105 (37%), Gaps = 16/105 (15%)
Query: 4 NNFSGIIPVEIGHCL-----LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
N+F+ + + + L L+L++N +S + + L L++ N++ L
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 59 PKEM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ ++++ S+N + SF P L
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRN----------SFALVPSL 456
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 13/101 (12%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S + + P ++ +T L+L+ N L T+ L L+V +N ++ P+
Sbjct: 12 SHLKLTQV-PDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ L + HN S + +F +L
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDK----------TFAFCTNL 99
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 22/90 (24%), Positives = 28/90 (31%), Gaps = 17/90 (18%)
Query: 20 LTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF 78
D S L+ +P + T + LN++ NQL LTS D N
Sbjct: 6 HEVADCSHLKLTQ-VPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 79 SGEIPEFGQYSFFNSTSFTGNPHLCGSYLN 108
S PE P L LN
Sbjct: 62 SKLEPE----------LCQKLPML--KVLN 79
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 14/143 (9%)
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
S+ + + + + + E FL E + + + AKG+ +L S IHR
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHR 217
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI-----APEYAYTLKV 364
D+ + NILL+ + DFGLA+ + V + APE +
Sbjct: 218 DLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVY 272
Query: 365 DEKSDVYSFGVVLLELIT-GRRP 386
+SDV+SFGV+L E+ + G P
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 40/171 (23%), Positives = 59/171 (34%), Gaps = 18/171 (10%)
Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
+ +K +GRG G V T VAVK L S L +E++ L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILI 80
Query: 236 KI-RHRNIVRLKAFCS-NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
I H N+V L C+ +++ E+ G+L L KR F+ K
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP---------YKTK 131
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
G + I D+K + S + + F K L D E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 189 VIGRGGAG----VVYRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
VIGRG V + A++ + K +D+ + E + H
Sbjct: 59 VIGRGSYAKVLLVRLKK---TDRIYAMRVV---KKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
+V L C E+ L V EY+ G L + ++ + R A E + L+YL
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYL 169
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
H II+RD+K +N+LL D E H+ D+G+ K + + S G+ YIAP
Sbjct: 170 H---ERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222
Query: 357 E----YAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E Y V D ++ GV++ E++ GR P
Sbjct: 223 EILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 65/265 (24%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKA 247
IG G GV++ G N +QVA+K S L E RT + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F N+LV + + G SL ++L F +K A + + +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIH---EKS 126
Query: 306 IIHRDVKSNNILLNSDFEA-----HVADFGLAKYLQD---------------TGASECMS 345
+++RD+K +N L+ +V DFG+ K+ +D +G + MS
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 346 AVAGSYGYIAPEYAYTLKVDEKS---DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTK 402
+ G E+S D+ + G V + + G P W
Sbjct: 187 -INTHLGR------------EQSRRDDLEALGHVFMYFLRGSLP-------------WQG 220
Query: 403 MQTNSSKEGVVKILDQRLSNTPLSE 427
++ ++K+ +I +++ S TPL E
Sbjct: 221 LKAATNKQKYERIGEKKQS-TPLRE 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 58/250 (23%), Positives = 103/250 (41%), Gaps = 37/250 (14%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKA 247
IG G G +Y G E+VA+K + + L E + ++ I ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
F + N+LV + + G SL ++ + LK L +A + + ++H S
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVH---SKS 123
Query: 306 IIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA--Y 360
+HRD+K +N L+ A+ + DFGLAK +DT + + YA
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 361 TLKVDEKS---DVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417
T E+S D+ S G VL+ + G P W ++ + K+ KI +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP-------------WQGLKAGTKKQKYEKISE 230
Query: 418 QRLSNTPLSE 427
++++ T +
Sbjct: 231 KKVA-TSIEA 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 55/222 (24%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIRHR----- 240
VIG+G G V + + VA+K + + H EIR L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK----MVRNEKRFHRQAAE-EIRILEHLRKQDKDNT 158
Query: 241 -NIVRLKAF-------CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIE 290
N++ + C + +E + + +L E++ K+ F + + L K A
Sbjct: 159 MNVIHMLENFTFRNHIC-------MTFELL-SMNLYELI--KKNKFQGFSLPLVRKFAHS 208
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH--VADFGLAKYLQDTGASECMSAVA 348
+ L LH IIH D+K NILL + V DFG + Y
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---------- 255
Query: 349 GSYGYI------APEYAYTLKVDEKSDVYSFGVVLLELITGR 384
Y YI APE + D++S G +L EL+TG
Sbjct: 256 -VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 178 DDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTL 234
+ ++ + +++IG+G G V + E VA+K I K + E+R L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQI-EVRLL 104
Query: 235 GKIRHR------NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--K 286
+ IV LK + LV+E + + +L ++L + +F + L K
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL--RNTNFRGVSLNLTRK 161
Query: 287 IAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFEAH--VADFGLAKYLQDTGASEC 343
A + L +L + S IIH D+K NILL + + + DFG + L
Sbjct: 162 FAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----- 214
Query: 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384
+ S Y +PE + D D++S G +L+E+ TG
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 39/221 (17%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIR-------- 238
+G G V+ N VA+K I +G + EI+ L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 239 ---HRNIVRLK---AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAI 289
+I++L ++ +V+E + +L ++ K+ + +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI--KKYEHRGIPLIYVKQISK 138
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH------VADFGLAKYLQDTGASEC 343
+ GL Y+H C IIH D+K N+L+ +AD G A E
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEH 191
Query: 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 384
+ + Y +PE +D++S ++ ELITG
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 47/215 (21%), Positives = 73/215 (33%), Gaps = 59/215 (27%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
V+G G G V + E+ A+K + E+ + + +IVR+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKM---LQDCPK----ARREVELHWRASQCPHIVRIV 77
Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA-------KGL 295
N L+V E + G L + + E EA+ + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER------EASEIMKSIGEAI 130
Query: 296 SYLH-HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSY 351
YLH + I HRDVK N+L S + DFG AK Y
Sbjct: 131 QYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------GEKY 175
Query: 352 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
D+ D++S GV++ L+ G P
Sbjct: 176 -------------DKSCDMWSLGVIMYILLCGYPP 197
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 2/75 (2%)
Query: 10 IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT 69
P + L ++ + L +P + Q L L ++ N L +LP + ++ L
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLR 153
Query: 70 SADFSHNNFSGEIPE 84
E+PE
Sbjct: 154 ELSIRACPELTELPE 168
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 12/85 (14%), Positives = 29/85 (34%), Gaps = 3/85 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLS-QNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
+ P G L L L ++L +P+ I ++ L L++ + LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
+ + + + ++ +
Sbjct: 295 SLIAQLPANCIILVP-PHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 13/77 (16%), Positives = 23/77 (29%), Gaps = 5/77 (6%)
Query: 10 IPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKS 67
+ L+L L P Q ++ L ++ + L LP M
Sbjct: 71 TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAG 128
Query: 68 LTSADFSHNNFSGEIPE 84
L + + N +P
Sbjct: 129 LETLTLARNPLR-ALPA 144
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 16/85 (18%), Positives = 26/85 (30%), Gaps = 3/85 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSW-NQLNASLP 59
+ + S + I H L LDL P L L + + L +LP
Sbjct: 213 IRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLP 270
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
++ + L D +P
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI---------LNYLNVSW 51
++RN +P I L L + +P + L L + W
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 52 NQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
+ SLP + N+++L S ++ S +
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 1/85 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN-ASLP 59
++ N P L L + L+ I Q+ L LNV+ N ++ LP
Sbjct: 87 LTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP 146
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
N+ +L D S+N
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQTITVN 171
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 22/86 (25%), Positives = 32/86 (37%), Gaps = 1/86 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLL-LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
M+ N+F + LT+LDLS+ L +H L LN+S N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEF 85
+ SL++ D S N
Sbjct: 515 SHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 15/102 (14%), Positives = 30/102 (29%), Gaps = 10/102 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N + + L +LDLS+ + +H L+ L ++ N + + P
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ SL + + L
Sbjct: 99 SFSGLTSLENLVAVETKLASLESF----------PIGQLITL 130
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 18/103 (17%), Positives = 31/103 (30%), Gaps = 11/103 (10%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLP 59
+S N I+ L +LD + L + L YL++S+
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ SL + + N+F S F +L
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTL---------SNVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 17/79 (21%), Positives = 34/79 (43%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S+ I L L++S N+L Q++ L+ L+ S+N++ S
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 61 EMGNMKSLTSADFSHNNFS 79
KSL + ++N+ +
Sbjct: 540 LQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASL 58
++ N S L+YLDLS+N LS G + L +L++S+N +
Sbjct: 335 LTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IM 391
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIP 83
++ L DF H+
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 15/121 (12%), Positives = 34/121 (28%), Gaps = 10/121 (8%)
Query: 2 SRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILN----YLNVSWNQLNA 56
+ N +P + L ++DLS N++ + + L++S N ++
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194
Query: 57 SLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTT 116
+ + L N S I + + + + L
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMK----TCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 117 P 117
Sbjct: 251 E 251
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 11/86 (12%), Positives = 27/86 (31%), Gaps = 5/86 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N V+ ++ + L+ + + + L++ QL P
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLK-QFPT 324
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFG 86
++ L S + N S +
Sbjct: 325 --LDLPFLKSLTLTMNKGSISFKKVA 348
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 19/101 (18%), Positives = 33/101 (32%), Gaps = 13/101 (12%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S + P +I +DLS N L + L +L++S ++ K
Sbjct: 19 MDQKLSKV-PDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ L++ + N P SF+G L
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPG----------SFSGLTSL 106
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 50/267 (18%), Positives = 89/267 (33%), Gaps = 51/267 (19%)
Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNG-LSAEIR---------------T 233
IG+GG G +Y + E V + K DNG L E++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVV-KVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 234 LGKIRHRNIVRLKAF----CSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKI 287
K+++ + + + K ++ + G L ++ F K L++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRK--TVLQL 157
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMS 345
++ L Y+H +H D+K++N+LLN V D+GLA G + +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 346 AVAGSYGYIAPEYA--YTLKVDEKS---DVYSFGVVLLELITGRRPVGDFGEEGLDIVQW 400
A E+ S D+ G +++ +TG P W
Sbjct: 215 ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP-------------W 261
Query: 401 TKMQTNSSKEGVVKILDQRLSNTPLSE 427
+ KI R + L +
Sbjct: 262 EDNLKDPKYVRDSKIRY-RENIASLMD 287
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 14/92 (15%), Positives = 27/92 (29%), Gaps = 9/92 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT----QIHILNYLNVSWNQLNA 56
+++ + ++ L+ LDLS N G + + L L + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME- 214
Query: 57 SLPKEM----GNMKSLTSADFSHNNFSGEIPE 84
+ L D SHN+
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 6/81 (7%)
Query: 1 MSRNNFSGIIPVEI-GHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
+S N+ L L+LS L +P + L+ L++S+N+L+ P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNP 290
Query: 60 KEMGNMKSLTSADFSHNNFSG 80
+ + + N F
Sbjct: 291 SP-DELPQVGNLSLKGNPFLD 310
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 30/171 (17%), Positives = 56/171 (32%), Gaps = 26/171 (15%)
Query: 190 IGRGGAGVVYRGV---------TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIR--- 232
R G++Y P ++ ++K L + ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 233 TLGKIRHRNIVRLKAFCSNKET-NLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIE 290
L I F +++ LV + G SL L L L++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTG 339
L +LH +H +V + NI ++ + ++ V A +G A +G
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 17/85 (20%), Positives = 27/85 (31%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
S N I + LT+LDL++ + H L+ L ++ N L
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEF 85
+ K+L F S
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIP 124
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 20/83 (24%), Positives = 29/83 (34%), Gaps = 1/83 (1%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
++ F I L LDL+ HLS +P + + L L +S N+
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 62 MGNMKSLTSADFSHNNFSGEIPE 84
N SLT N E+
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 13/84 (15%), Positives = 28/84 (33%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N + + L +L Q +S + + L L + N +++
Sbjct: 88 LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+ + L DF +N E
Sbjct: 148 KGFPTEKLKVLDFQNNAIHYLSKE 171
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 16/96 (16%), Positives = 28/96 (29%), Gaps = 4/96 (4%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+R I L L L+ N L ++ L +L +++
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
+ N K+L S N+ S F +
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLP----KGFPTEKLK 156
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 19/103 (18%), Positives = 35/103 (33%), Gaps = 10/103 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ + S + P + L L LS N + + L +L++ N L
Sbjct: 285 LTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 61 EM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
N+++L D SH++ S + HL
Sbjct: 344 GCLENLENLRELDLSHDDIET--------SDCCNLQLRNLSHL 378
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 21/111 (18%), Positives = 43/111 (38%), Gaps = 13/111 (11%)
Query: 1 MSRNNFSGIIPVEIG---HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNAS 57
+ N+F + L L LS LS T + ++N++++S N+L +S
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 58 LPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS-----FTGNPHLC 103
+ + ++K + + + N+ S +P + NP C
Sbjct: 516 SIEALSHLKGIY-LNLASNHISIILPS----LLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 15/104 (14%), Positives = 31/104 (29%), Gaps = 13/104 (12%)
Query: 1 MSRNNFSGIIPVEIGHC--LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+ I P + + ++L +++ L L+++ L+ L
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
P + + +L S N F S + P L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFEN----------LCQISASNFPSL 327
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 2/101 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ S I + + + L L L NH+S + L L+ N ++ +
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 61 EMGNMKSLTSA--DFSHNNFSGEIPEFGQYSFFNSTSFTGN 99
+M +++ T+ + + N+ +G P + F S +F G
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 18/105 (17%), Positives = 37/105 (35%), Gaps = 13/105 (12%)
Query: 1 MSRNN--FSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+S ++ S +++ + L L+LS N + L L++++ +L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 59 PKE-MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ N+ L + SH+ + F G P L
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDI----------SSEQLFDGLPAL 451
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 15/89 (16%), Positives = 25/89 (28%), Gaps = 4/89 (4%)
Query: 1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL---NA 56
++ L LL L+LS + L + L +LN+ N N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
Query: 57 SLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
+ + L S + S
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 15/112 (13%)
Query: 1 MSRNNFSGIIPVEIGHC--LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
N + ++ L+L+ N ++G I + LN Q +
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI 218
Query: 59 PKEMGN--MKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLN 108
K + N ++SL F + + F G + +N
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDED----------ISPAVFEGLCEMSVESIN 260
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 10/97 (10%), Positives = 28/97 (28%), Gaps = 10/97 (10%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP-----VQITQIHILNYLNVSWNQLNASL 58
N I + L+ I I + + + ++ ++ ++
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
+ + M S+ S + + F +F +
Sbjct: 248 FEGLCEM-SVESINLQKHYFFNISSN----TFHCFSG 279
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 11/83 (13%), Positives = 26/83 (31%), Gaps = 3/83 (3%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+ I P + + L+ S N L +++ L +L+++ Q+
Sbjct: 20 ENLGLNEI-PGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 62 MGNMKSLTSADFSHNNFSGEIPE 84
+ L + + N
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAET 99
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 38/175 (21%), Positives = 68/175 (38%), Gaps = 37/175 (21%)
Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG-LSAEIRTL------------- 234
IG GG G++Y T E+ A + K +NG L +E++
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH----VVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 235 --GKIRHRNIVRLKAF----CSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLK 286
++ + I + +V E + G L + + G+ G+F L+
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDL-QKISGQNGTFKKS--TVLQ 155
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVADFGLAKYLQDTG 339
+ I L Y+H + +H D+K+ N+LL ++AD+GL+ G
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 8/84 (9%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
N +PV L L +S N L+ +P+ + L L+V NQL LP+ +
Sbjct: 230 GNRLTSLPVLPSE---LKELMVSGNRLTS-LPMLPSG---LLSLSVYRNQL-TRLPESLI 281
Query: 64 NMKSLTSADFSHNNFSGEIPEFGQ 87
++ S T+ + N S + +
Sbjct: 282 HLSSETTVNLEGNPLSERTLQALR 305
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 13/84 (15%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N + + P L L N L+ +P+ + L L+VS NQL SLP
Sbjct: 148 VSDNQLASL-PALPSE---LCKLWAYNNQLTS-LPMLPSG---LQELSVSDNQLA-SLPT 198
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+ L + +N + +P
Sbjct: 199 LPSELYKLWA---YNNRLT-SLPA 218
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 21/83 (25%), Positives = 30/83 (36%), Gaps = 13/83 (15%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S N + +PV L L+ HL P + L L + NQL SLP
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-SLPVL 139
Query: 62 MGNMKSLTSADFSHNNFSGEIPE 84
++ L S N + +P
Sbjct: 140 PPGLQEL---SVSDNQLA-SLPA 158
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 20/90 (22%)
Query: 13 EIGHCLL--LTYLDLSQNHLSG-P--IPVQITQIHI--------------LNYLNVSWNQ 53
++ CL L++ ++ L+ P +P IT + I L L VS NQ
Sbjct: 33 KMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQ 92
Query: 54 LNASLPKEMGNMKSLTSADFSHNNFSGEIP 83
L SLP + L+ +
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 13/84 (15%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N + + P+ L L +S N L+ +P ++++ L N N+L SLP
Sbjct: 168 AYNNQLTSL-PMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYN---NRLT-SLPA 218
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
+K L S N + +P
Sbjct: 219 LPSGLKEL---IVSGNRLT-SLPV 238
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 21/96 (21%), Positives = 32/96 (33%), Gaps = 18/96 (18%)
Query: 1 MSRNNFSGIIPVEIG-----------HCLL--LTYLDLSQNHLSGPIPVQITQIHILNYL 47
+ + + P G CL L+L+ LS +P L L
Sbjct: 41 NAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESL 96
Query: 48 NVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIP 83
S N L LP+ ++KSL + + S P
Sbjct: 97 VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 8/82 (9%)
Query: 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM 62
NN +P E+ + L +D+ N L +P L ++ NQL LP E+
Sbjct: 139 SNNQLEKLP-ELQNSSFLKIIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELP-EL 191
Query: 63 GNMKSLTSADFSHNNFSGEIPE 84
N+ LT+ +N+ ++P+
Sbjct: 192 QNLPFLTAIYADNNSLK-KLPD 212
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 7/84 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N +P E+ + LT + N L +P + LN + N L LP+
Sbjct: 222 AGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRD---NYLT-DLPE 274
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
++ L ++ + S P
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 13/84 (15%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N FSG+ + L YL+ S N + + L LNVS N+L LP
Sbjct: 284 VSENIFSGL-SELPPN---LYYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI-ELPA 334
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
++ L S N+ + E+PE
Sbjct: 335 LPPRLERL---IASFNHLA-EVPE 354
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 20/84 (23%), Positives = 31/84 (36%), Gaps = 13/84 (15%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
S N + L L++S N L +P + L L S+N L +P+
Sbjct: 304 ASSNEIRSL-CDLPPS---LEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 354
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
N+K L +N E P+
Sbjct: 355 LPQNLKQL---HVEYNPLR-EFPD 374
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 14/84 (16%), Positives = 30/84 (35%), Gaps = 11/84 (13%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N+ + P L + N L ++ + L + N L +LP
Sbjct: 202 ADNNSLKKL-PDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
++++L + N + ++PE
Sbjct: 255 LPPSLEAL---NVRDNYLT-DLPE 274
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 12/89 (13%), Positives = 29/89 (32%), Gaps = 16/89 (17%)
Query: 9 IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGN---- 64
I P + + L ++L+ +PV+ + +W++ + P G
Sbjct: 3 INPRNVSNTFLQE-PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 65 ---------MKSLTSADFSHNNFSGEIPE 84
+ + ++ S +PE
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPE 88
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 23/83 (27%), Positives = 41/83 (49%), Gaps = 12/83 (14%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+R N S +P + +T L+++QN L +P L YL+ N+L+ +LP+
Sbjct: 67 NRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPEL 118
Query: 62 MGNMKSLTSADFSHNNFSGEIPE 84
++K L D +N + +PE
Sbjct: 119 PASLKHL---DVDNNQLT-MLPE 137
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 9/81 (11%)
Query: 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIH----ILNYLNVSWNQLNASL 58
RNN +P L LD+S N L +P + H + N++ +
Sbjct: 168 RNNQLTFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THI 222
Query: 59 PKEMGNMKSLTSADFSHNNFS 79
P+ + ++ + N S
Sbjct: 223 PENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 13/84 (15%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N + ++P L Y++ N L+ +P T L L+V NQL LP+
Sbjct: 127 VDNNQLT-MLPELPAL---LEYINADNNQLTM-LPELPTS---LEVLSVRNNQLT-FLPE 177
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
++++L D S N +P
Sbjct: 178 LPESLEAL---DVSTNLLE-SLPA 197
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 10/80 (12%), Positives = 24/80 (30%), Gaps = 6/80 (7%)
Query: 3 RNNFSGIIPVEIGHCL----LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
N +P + +N ++ IP I + + + N L+ S
Sbjct: 188 STNLLESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS-SR 245
Query: 59 PKEMGNMKSLTSADFSHNNF 78
+E + ++ +
Sbjct: 246 IRESLSQQTAQPDYHGPRIY 265
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 2e-08
Identities = 40/257 (15%), Positives = 66/257 (25%), Gaps = 68/257 (26%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKL------LGITKGSSHDNGLS 228
++ + C K IG G G V++ + VA+K + L +
Sbjct: 17 LPTEKLQRCEK----IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 229 AEIRTLGKI---------RHRNIVRLKAFC------------------------------ 249
EI ++ R + L +
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
+ +V E+ G E + K S I + L+ HR
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEASLR--FEHR 186
Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSD 369
D+ N+LL + K S G YTL E+
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDG 235
Query: 370 --VYSFGVVLLELITGR 384
V+ + +L TG
Sbjct: 236 IVVFCDVSMDEDLFTGD 252
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLP 59
++ N + + ++ G + YLDL N + L +LN+ +N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVK 185
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
++ L + D S N + PEF
Sbjct: 186 GQV-VFAKLKTLDLSSNKLAFMGPEFQS 212
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 4/79 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N + ++ L LDLS N L+ + + + ++++ N+L + K
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 61 EMGNMKSLTSADFSHNNFS 79
+ ++L D N F
Sbjct: 232 ALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ ++ + + LDLS N LS + L LN+S N L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
++ ++ +L + D ++N E+
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 9/68 (13%), Positives = 21/68 (30%), Gaps = 1/68 (1%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
++ + L + + L++S N L+ ++ L + S N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 80 GEIPEFGQ 87
E +
Sbjct: 72 -ETLDLES 78
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 11/85 (12%), Positives = 32/85 (37%), Gaps = 5/85 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
+ NN S + G + L+ N ++ + + YL++ N+++ +
Sbjct: 106 AANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
+ + +L + +N ++
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 11/78 (14%), Positives = 23/78 (29%), Gaps = 3/78 (3%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S N + + E +T++ L N L I + L + ++ N +
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CGTLR 255
Query: 62 MGNMKSLTSADFSHNNFS 79
K+ +
Sbjct: 256 DFFSKNQRVQTVAKQTVK 273
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 16/87 (18%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ NN S I P + L L N +S + + +N+L+ NQ++ L
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQIS-DLT- 369
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ N+ +T + ++ +
Sbjct: 370 PLANLTRITQLGLNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 7/87 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N I P I + LTYL L N++S P ++ + L L N++ S
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVS 347
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ N+ ++ HN S +
Sbjct: 348 SLANLTNINWLSAGHNQISD-LTPLAN 373
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 13/105 (12%), Positives = 27/105 (25%), Gaps = 25/105 (23%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPI----------------------PVQI 38
N S + P + + +T L L+ + P I
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATI 417
Query: 39 TQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIP 83
+ +++WN + + + FSG +
Sbjct: 418 SDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N S I + L L + N +S P + + L+ L+++ NQL
Sbjct: 184 ISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIG 237
Query: 61 EMGNMKSLTSADFSHNNFSGEIP 83
+ ++ +LT D ++N S P
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 16/86 (18%), Positives = 32/86 (37%), Gaps = 7/86 (8%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
R I + + LT ++ S N L+ P + + L + ++ NQ+
Sbjct: 54 DRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITP 107
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ N+ +LT +N + I
Sbjct: 108 LANLTNLTGLTLFNNQITD-IDPLKN 132
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 18/87 (20%), Positives = 37/87 (42%), Gaps = 7/87 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N I + LT LDL+ N +S P ++ + L L + NQ++ ++
Sbjct: 228 LNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NIS- 281
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ + +LT+ + + N I
Sbjct: 282 PLAGLTALTNLELNENQLED-ISPISN 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 16/118 (13%), Positives = 36/118 (30%), Gaps = 8/118 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N S + + + + +L N +S P + + + L ++ + P
Sbjct: 338 FYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPV 392
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI 118
S+ + + + T N SY N +Y+ + P+
Sbjct: 393 NYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP---SYTNEVSYTFSQPV 447
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 21/87 (24%), Positives = 37/87 (42%), Gaps = 8/87 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N + I P + + L L+LS N +S ++ + L L+ NQ+ P
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP- 172
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ N+ +L D S N S +I +
Sbjct: 173 -LANLTTLERLDISSNKVS-DISVLAK 197
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 10/84 (11%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
+ I L + +++ + T + + L + + +
Sbjct: 12 TPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVE 65
Query: 64 NMKSLTSADFSHNNFSGEIPEFGQ 87
+ +LT +FS+N + I
Sbjct: 66 YLNNLTQINFSNNQLTD-ITPLKN 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N S I + L L++ N +S + + LN L ++ NQL +
Sbjct: 250 IGTNQISDINA--VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDME 305
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+G + +LT+ S N+ + I
Sbjct: 306 VIGGLTNLTTLFLSQNHITD-IRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 13/87 (14%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N + I P + + + LT L + N ++ + + L L ++ + + S
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNI--SDIS 126
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ N+ + S + N+ ++
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPLSN 153
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 7e-07
Identities = 16/87 (18%), Positives = 32/87 (36%), Gaps = 7/87 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N + I P + + L L + N ++ P + + L +L + NQ+ S
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDIN 259
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ ++ L + N S +I
Sbjct: 260 AVKDLTKLKMLNVGSNQIS-DISVLNN 285
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 8e-07
Identities = 16/86 (18%), Positives = 35/86 (40%), Gaps = 7/86 (8%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+ + I I + L YL+L+ N ++ P ++ + L L + N++ +
Sbjct: 52 AGEKVASIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISA 105
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ N+ +L + +N S I
Sbjct: 106 LQNLTNLRELYLNEDNISD-ISPLAN 130
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 17/79 (21%), Positives = 31/79 (39%), Gaps = 4/79 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N S I + + L L L+ N L I + L L +S N + +
Sbjct: 272 VGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIR- 327
Query: 61 EMGNMKSLTSADFSHNNFS 79
+ ++ + SADF++
Sbjct: 328 PLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 14/86 (16%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
N+ + + + L YL ++++ + P I + L L++++NQ+
Sbjct: 140 GANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SP 194
Query: 62 MGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ ++ SL N + I
Sbjct: 195 LASLTSLHYFTAYVNQITD-ITPVAN 219
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 7/68 (10%), Positives = 24/68 (35%), Gaps = 5/68 (7%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
L + ++ + ++ + L V+ ++ S+ + + +L + + N +
Sbjct: 24 GIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT 79
Query: 80 GEIPEFGQ 87
I
Sbjct: 80 D-ISPLSN 86
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 17/85 (20%), Positives = 30/85 (35%), Gaps = 1/85 (1%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
++ N + L L + +L+ I + L LNV+ N + + LP
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
+ N+ +L D S N
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCT 167
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 15/86 (17%), Positives = 26/86 (30%), Gaps = 2/86 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N + L LDLS+ + + L+ L ++ N + SL
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLAL 93
Query: 61 EM-GNMKSLTSADFSHNNFSGEIPEF 85
+ SL N +
Sbjct: 94 GAFSGLSSLQKLVAVETNLASLENFP 119
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
+N + + L L YLD+S H + L L ++ N +
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 60 KEM-GNMKSLTSADFSHNNFSGEIPE 84
++ +++LT D S ++
Sbjct: 463 PDIFTELRNLTFLDLSQCQLE-QLSP 487
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASL 58
+ N L +LDLS+N LS G L YL++S+N + ++
Sbjct: 332 FTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFG 86
++ L DF H+N ++ EF
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLK-QMSEFS 415
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 3/81 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
+S + L L ++ N I T++ L +L++S QL L
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS 486
Query: 60 KEM-GNMKSLTSADFSHNNFS 79
++ SL + + N
Sbjct: 487 PTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 16/106 (15%)
Query: 1 MSRN--NFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+SRN +F G L YLDLS N + + + L +L+ + L +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QM 411
Query: 59 PKE--MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ ++++L D SH + + F G L
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHT----------RVAFNGIFNGLSSL 447
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/85 (16%), Positives = 26/85 (30%), Gaps = 2/85 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLP 59
+S N + L +LD ++L + L YL++S +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
+ SL + N+F
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 20/124 (16%), Positives = 39/124 (31%), Gaps = 15/124 (12%)
Query: 1 MSRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY----LNVSWNQLN 55
++ N +P + L +LDLS N + + +H + L++S N +N
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 56 ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSST 115
+ L +N S + + T G L L + +
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMK---------TCIQGLAGLEVHRLVLGEFRNE 240
Query: 116 TPIH 119
+
Sbjct: 241 GNLE 244
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ ++ + + LDLS N LS + L LN+S N L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
++ ++ +L + D ++N E+
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 22/166 (13%), Positives = 50/166 (30%), Gaps = 8/166 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N + ++ L LDLS N L+ + + + ++++ N+L + K
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE--FGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI 118
+ ++L D N F F + + + L G C +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 119 HNQ--NGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNS 162
+ + L L S + ++ + +
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 9/68 (13%), Positives = 21/68 (30%), Gaps = 1/68 (1%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
++ + L + + L++S N L+ ++ L + S N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 80 GEIPEFGQ 87
E +
Sbjct: 72 -ETLDLES 78
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 11/85 (12%), Positives = 32/85 (37%), Gaps = 5/85 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
+ NN S + G + L+ N ++ + + YL++ N+++ +
Sbjct: 106 AANNNISRV-SCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPE 84
+ + +L + +N ++
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 54/232 (23%), Positives = 79/232 (34%), Gaps = 55/232 (23%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIRHR----- 240
+G G G V N + AVK + + + E L KI++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKI-EADILKKIQNDDINNN 96
Query: 241 NIVRLKAF-------CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEA 291
NIV+ C L++E + SL E++ R ++ + + IE
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEII--TRNNYNGFHIEDIKLYCIEI 146
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA--- 348
K L+YL S + H D+K NILL+ + +
Sbjct: 147 LKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 349 ---GS--------YGYI------APEYAYTLKVDEKSDVYSFGVVLLELITG 383
G I APE L D SD++SFG VL EL TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 47/233 (20%), Positives = 78/233 (33%), Gaps = 61/233 (26%)
Query: 189 VIGRGGAGVVYRGV--TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIRHR---- 240
+G G G V + QVA+K I + + EI L KI+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARL-EINVLKKIKEKDKEN 80
Query: 241 --NIVRLKAF-------CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAI 289
V + + C + +E + + E L K +F + + +A
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELL-GKNTFEFL--KENNFQPYPLPHVRHMAY 130
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA-------------------DFG 330
+ L +LH + + H D+K NIL + + DFG
Sbjct: 131 QLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 383
A + E + + + Y PE L + DV+S G +L E G
Sbjct: 188 SATF-----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 3/84 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N I+ L L +S N L + + I L L++S N L + +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 312
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
L + HN+ +
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKL 335
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 16/103 (15%), Positives = 31/103 (30%), Gaps = 12/103 (11%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ + + + L+L+ + H + L + +N + LP
Sbjct: 52 FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPP 110
Query: 61 EM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ N+ LT N+ S +P F P L
Sbjct: 111 HVFQNVPLLTVLVLERNDLS-SLPR---------GIFHNTPKL 143
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 3/84 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S N I+ L L +S N L + + I L L++S N L + +
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 318
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
L + HN+ +
Sbjct: 319 NQPQFDRLENLYLDHNSIV-TLKL 341
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 19/95 (20%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI--------LNYLNVSWN 52
+S N + I ++ C L L L + +I I L +L++S N
Sbjct: 33 LSFNKITYIGHGDLRACANLQVLILKSS--------RINTIEGDAFYSLGSLEHLDLSDN 84
Query: 53 QLNASLPKEM-GNMKSLTSADFSHNNFSGEIPEFG 86
L+ SL G + SL + N + +
Sbjct: 85 HLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTS 117
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 22/103 (21%), Positives = 33/103 (32%), Gaps = 10/103 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
+ + + I L +LDLS NHLS + L YLN+ N +
Sbjct: 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
N+ +L + + EI F G L
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRR---------IDFAGLTSL 150
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 16/88 (18%), Positives = 31/88 (35%), Gaps = 9/88 (10%)
Query: 16 HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG-NMKSLTSADFS 74
+ + L + Q +L + + + + + V +++ +P ++KSL D S
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342
Query: 75 HNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
N E NS P L
Sbjct: 343 ENLMVEEY-------LKNSACKGAWPSL 363
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 12/105 (11%), Positives = 31/105 (29%), Gaps = 11/105 (10%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ + + + + + + + + L +L++S N + K
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 61 EM---GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
G SL + S N+ + + G+ +L
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLR-SMQKTGE-------ILLTLKNL 389
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
LT LD+S+N P+P + +LN+S + + ++L D S+NN
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD 444
Query: 80 GEIPEF 85
F
Sbjct: 445 -SFSLF 449
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 1e-06
Identities = 21/102 (20%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ + + + + LL+T+LDLS N L +P + + L L S N L ++
Sbjct: 448 LAHKDLTVLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD- 502
Query: 61 EMGNMKSLTSADFSHNNFSG--EIPEFGQYSFFNSTSFTGNP 100
+ N+ L +N I + GN
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 4e-04
Identities = 16/87 (18%), Positives = 34/87 (39%), Gaps = 4/87 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
R+ F V + L L+ L+ ++ Q+ ++ +L++S N+L +LP
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLR-ALPP 480
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
+ ++ L S N +
Sbjct: 481 ALAALRCLEVLQASDNALE-NVDGVAN 506
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 51/226 (22%), Positives = 81/226 (35%), Gaps = 47/226 (20%)
Query: 189 VIGRGGAGVVYRGV--TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIRHR---- 240
+G G G V + G VAVK I K + S EI+ L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK----IVKNVDRYCEAARS-EIQVLEHLNTTDPNS 75
Query: 241 --NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLS 296
V++ + + +V+E + S + + K FL + + K+A + K ++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFI--KENGFLPFRLDHIRKMAYQICKSVN 132
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVA-------------------DFGLAKYLQD 337
+LH + H D+K NIL DFG A Y +
Sbjct: 133 FLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 383
S + + Y APE L + DV+S G +L+E G
Sbjct: 190 H-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 48/252 (19%), Positives = 78/252 (30%), Gaps = 90/252 (35%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIR--------HRNIVRLK-AF------ 248
+ VA+K + K + H + EIR L +R +V+L F
Sbjct: 61 GKKFVAMK----VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116
Query: 249 ----CSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
C +V+E + G L + + L KI + +GL YLH C
Sbjct: 117 GTHIC-------MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR 167
Query: 304 PLIIHRDVKSNNILLNSD------------------------------------------ 321
IIH D+K NILL+ +
Sbjct: 168 --IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL 225
Query: 322 -------FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFG 374
+ +AD G A ++ + + Y + E + +D++S
Sbjct: 226 EPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTA 280
Query: 375 VVLLELITGRRP 386
+ EL TG
Sbjct: 281 CMAFELATGDYL 292
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 13/86 (15%), Positives = 34/86 (39%), Gaps = 2/86 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ + + P I L L + ++ ++ + L L++S + + S+
Sbjct: 73 INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFG 86
++ + + S D S+N +I
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLK 156
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+ N + + +E + + L ++ H + P I+ + L L + + +
Sbjct: 52 ANINVTDLTGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPN 107
Query: 62 MGNMKSLTSADFSHNNFSGEIPE 84
+ + SLT D SH+ I
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILT 130
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 20/82 (24%), Positives = 30/82 (36%), Gaps = 3/82 (3%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPI--PVQITQIHILNYLNVSWNQLNA-S 57
+ + + P L L L LS + + L L++S NQ+ +
Sbjct: 80 LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 58 LPKEMGNMKSLTSADFSHNNFS 79
L G + SL S DFS N
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 18/86 (20%), Positives = 33/86 (38%), Gaps = 8/86 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLL-LTYLDLSQNHLSGPIPVQITQIHI-----LNYLNVSWNQL 54
+++N FS + L L L +N L ++ L L ++ N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 55 NASLPKEM-GNMKSLTSADFSHNNFS 79
N SLP + ++ +L + N +
Sbjct: 493 N-SLPPGVFSHLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 18/125 (14%), Positives = 38/125 (30%), Gaps = 13/125 (10%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S + L L+L+ N ++ + L LN+S+N L
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNS-----------TSFTGNPHLCGSYLNP 109
+ + D N+ + I + + F T+ P + +L+
Sbjct: 333 NFYGLPKVAYIDLQKNHIA-IIQD-QTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSG 390
Query: 110 CNYSS 114
+
Sbjct: 391 NKLVT 395
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 10/83 (12%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
+ +LDLS + + L LN+++N++N + + +L + S+N
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL- 326
Query: 80 GEIPEFGQYSFFNSTSFTGNPHL 102
S++F G P +
Sbjct: 327 ---------GELYSSNFYGLPKV 340
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 11/84 (13%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF 78
L LS N++ + L L + ++ KE N+ +L D +
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 79 SGEIPEFGQYSFFNSTSFTGNPHL 102
F + +F G HL
Sbjct: 86 ----------YFLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 13/104 (12%), Positives = 28/104 (26%), Gaps = 11/104 (10%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
+S N + L L+L + I + + L L++ +++ L
Sbjct: 31 LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLH 89
Query: 60 KEM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
+ + L S + + F L
Sbjct: 90 PDAFQGLFHLFELRLYFCGLSDAVLK--------DGYFRNLKAL 125
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 24/104 (23%), Positives = 38/104 (36%), Gaps = 12/104 (11%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASL 58
+ N + LT L LS N LS G L YL++S+N + ++
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITM 93
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
++ L DF H+N ++ EF F +L
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLK-QMSEFS--------VFLSLRNL 128
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 30/151 (19%), Positives = 50/151 (33%), Gaps = 10/151 (6%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+S+N S + +I L L +S N + L YL++S N+L +
Sbjct: 28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKISC 86
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT----GNPHLCGSYLNPCNYSSTT 116
+L D S N F +P F N + HL S + P + + +
Sbjct: 87 --HPTVNLKHLDLSFNAFD-ALPICK--EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141
Query: 117 PIHNQNGNKSHVPGKYKLLFALGLLLCSLVF 147
+ G + L +VF
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 25/81 (30%), Positives = 36/81 (44%), Gaps = 9/81 (11%)
Query: 1 MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
MS N + I CL + LDL N + IP Q+ ++ L LNV+ NQL S+
Sbjct: 406 MSSNILTDTIF----RCLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL-KSV 459
Query: 59 PKEM-GNMKSLTSADFSHNNF 78
P + + SL N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 22/106 (20%), Positives = 44/106 (41%), Gaps = 13/106 (12%)
Query: 1 MSRNNFSGIIPVEIGHCLL-LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
+S+N+ S L L++S N L+ I + + L++ N++ S+P
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIP 437
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT-----GNP 100
K++ +++L + + N +P+ F TS NP
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVPDG---IFDRLTSLQKIWLHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 20/86 (23%), Positives = 32/86 (37%), Gaps = 4/86 (4%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
+ + + + +LD S N L+ + + L L + NQL L K
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKI 366
Query: 62 MG---NMKSLTSADFSHNNFSGEIPE 84
MKSL D S N+ S + +
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 3/60 (5%)
Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF 78
+ LDL N + IP +T + L LNV+ NQL S+P + + SL N +
Sbjct: 452 VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 37/186 (19%), Positives = 61/186 (32%), Gaps = 35/186 (18%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI--------LNYLNVSWN 52
+S+N+ S + +I L L LS N +I + L YL+VS N
Sbjct: 59 LSQNSISELRMPDISFLSELRVLRLSHN--------RIRSLDFHVFLFNQDLEYLDVSHN 110
Query: 53 QLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNY 112
+L ++ M SL D S N+F +P + F L ++L
Sbjct: 111 RL-QNIS--CCPMASLRHLDLSFNDFD-VLPVCKE--------FGNLTKL--TFLGL--- 153
Query: 113 SSTTPIHNQN-GNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQ 171
S + +H+ LL + + L I T + L + Q
Sbjct: 154 -SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 172 KLDFGS 177
+
Sbjct: 213 VNMSVN 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 23/119 (19%), Positives = 38/119 (31%), Gaps = 6/119 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N + + + L L LS N +S + L L+++ N+L +P
Sbjct: 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPG 257
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIH 119
+ + K + +NN I G F T G L N I
Sbjct: 258 GLADHKYIQVVYLHNNN----ISAIGSNDFCPPGYNTKKASYSGVSLFS-NPVQYWEIQ 311
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 16/102 (15%), Positives = 38/102 (37%), Gaps = 12/102 (11%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
S + + + L LT L ++ +L+ + + + L +LN+S+N + +++
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGS 266
Query: 62 M-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
M + L + + +F G +L
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEP---------YAFRGLNYL 298
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 20/106 (18%), Positives = 41/106 (38%), Gaps = 5/106 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
++ N + + + + H + L +L+LS N +S + ++ L + + QL A +
Sbjct: 231 ITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEP 289
Query: 61 EM-GNMKSLTSADFSHNNFSGEIPE--FGQYSFFNSTSFTGNPHLC 103
+ L + S N + + E F + NP C
Sbjct: 290 YAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 25/120 (20%), Positives = 41/120 (34%), Gaps = 9/120 (7%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
+ N I ++ L L L N + I + + L L++ N+L + +P
Sbjct: 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKL-SRVP 257
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYL--NPCNYSSTTP 117
+ ++K L NN I + G F + G L NP Y P
Sbjct: 258 AGLPDLKLLQVVYLHTNN----ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 19/76 (25%), Positives = 32/76 (42%), Gaps = 6/76 (7%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
+ I +++ LT LD S N ++ + ++Q +LN LN N + L +
Sbjct: 156 HLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LN 209
Query: 64 NMKSLTSADFSHNNFS 79
LT D S N +
Sbjct: 210 QNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 21/120 (17%), Positives = 39/120 (32%), Gaps = 22/120 (18%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ NN + + ++ LTYL N L+ + +T + L YLN N+L L
Sbjct: 71 CTSNNITTL---DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD- 122
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
+ LT + + N + + N L + + +
Sbjct: 123 -VSQNPLLTYLNCARNTLT-------------EIDVSHNTQLTELDCHLNKKITKLDVTP 168
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 14/84 (16%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 4 NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
I +++ H L LD ++ + ++Q L YL ++ +L L +
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VS 336
Query: 64 NMKSLTSADFSHNNFSGEIPEFGQ 87
+ L S + + + G+
Sbjct: 337 HNTKLKSLSCVNAHIQ-DFSSVGK 359
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.61 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.58 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.58 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.57 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.56 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.52 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.52 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.52 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.5 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.46 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.45 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.45 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.44 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.44 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.44 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.43 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.42 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.42 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.41 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.4 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.39 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.39 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.38 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.38 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.38 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.36 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.36 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.36 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.35 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.35 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.34 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.33 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.33 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.32 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.32 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.32 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.32 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.31 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.31 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.3 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.29 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.28 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.27 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.27 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.26 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.25 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.25 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.25 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.25 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.24 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.24 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.22 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.22 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.2 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.2 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.2 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.2 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.19 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.18 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.17 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.15 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.1 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.1 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.1 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.09 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.09 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.05 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.05 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.04 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.03 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.03 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.02 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.02 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.02 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.02 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.02 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.97 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.96 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.91 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.91 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.87 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.85 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.84 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.83 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.82 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.81 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.77 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.75 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.75 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.74 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.74 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.73 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.65 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.65 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.31 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.99 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.8 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.77 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.5 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.48 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.43 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.42 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.31 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.2 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.51 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.3 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.06 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 92.97 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 91.35 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 90.89 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.87 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.98 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 89.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 89.31 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.48 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.76 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.35 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-59 Score=442.28 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=214.9
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
..++..+.||+|+||+||+|.+. +++.||||+++.... ....++|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34556688999999999999862 467899999875432 33346799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 012213 256 LLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 321 (468)
+||||||++|+|.++|.... ...++|.++++|+.|||+||+|||+.+ ||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 99999999999999996432 235899999999999999999999877 9999999999999999
Q ss_pred CceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHH
Q 012213 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQW 400 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 400 (468)
+.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... ++.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~-- 257 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVV-- 257 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHH--
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHH--
Confidence 9999999999997764444444556789999999999999999999999999999999999 89999764311 111
Q ss_pred HHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 401 TKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 401 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..+.+......+..++..+.+++..||+.||++||||.||++.|+.+.
T Consensus 258 ------------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 ------------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111222223344556677889999999999999999999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=444.67 Aligned_cols=260 Identities=24% Similarity=0.406 Sum_probs=214.1
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
++|...+.||+|+||+||+|.+. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 45677889999999999999864 47789999986432 23346799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCce
Q 012213 256 LLVYEYMPNGSLGEVLHGKR-----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 324 (468)
+||||||++|+|.++|+... ...++|.++++++.|||+||+|||+.+ |+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 99999999999999997532 346999999999999999999999877 9999999999999999999
Q ss_pred EEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHH
Q 012213 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKM 403 (468)
Q Consensus 325 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 403 (468)
||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~------ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV------ 239 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HH------
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH------
Confidence 9999999987654433334445679999999999999999999999999999999999 99999764311 11
Q ss_pred hhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 404 QTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
+..+........+...+.++.+++..||+.||++||||+||++.|+++.+.
T Consensus 240 --------~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 240 --------IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp --------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111222222333445567788999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=437.98 Aligned_cols=263 Identities=29% Similarity=0.389 Sum_probs=207.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.+...+.||+|+||+||+|.+++ .||||+++.........+.|.+|+.++++++|||||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4566778999999999999998853 59999987554444445779999999999999999999999865 56899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
||++|+|.++|+.. ...++|.++.+|+.|||.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.......
T Consensus 112 y~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999743 346999999999999999999999877 99999999999999999999999999987754444
Q ss_pred CccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 341 SECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.... ......... ....
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----~~~~~~~~~------~~~~ 256 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----DQIIFMVGR------GYAS 256 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHT------TCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhc------CCCC
Confidence 444566789999999999853 46899999999999999999999999763321 111111111 1112
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+.+...+...+..+.+++..||+.||++||||.||++.|+.++.
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 22233344556778899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=443.84 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=205.3
Q ss_pred hccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
+++...+.||+|+||+||+|.++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45666789999999999999864 47889999986432 23346799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 256 LLVYEYMPNGSLGEVLHGKR-------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
+||||||++|+|.++++... ...++|.++++|+.|||+||+|||+.+ |+||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 99999999999999997532 236999999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 401 (468)
.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~-- 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAID-- 271 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHH--
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHH--
Confidence 999999999997754444444456789999999999999999999999999999999999 99999763311 1111
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.+........+...+..+.+++.+||+.||++||||+||++.|+.+..
T Consensus 272 ------------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 ------------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ------------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 111111223344456778899999999999999999999999998854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-57 Score=432.92 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=207.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46788999999999999999997 46899999999755444444567999999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.......+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999998666667899999999999999999999887 999999999999999999999999999876421
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+ ..+. +.++....
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~-----------~~~i~~~~ 241 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNL-----------VLKIISGS 241 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH-----------HHHHHHTC
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHH-----------HHHHHcCC
Confidence 122345679999999999999999999999999999999999999997532 1111 11222222
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....+......+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22223344567888999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=417.45 Aligned_cols=272 Identities=27% Similarity=0.337 Sum_probs=202.7
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC----eeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 257 (468)
+.+...+.||+|+||+||+|.+ +|+.||||++.... .....++.|+..+.+++|||||+++|+|.+++ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 3466778999999999999998 58999999985422 21233455677778899999999999997654 5799
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
||||+++|+|.++++.. .++|..+.+++.|+|+||+|||+.+ .++|+||||||+|||++.++++||+|||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999999753 4899999999999999999999761 335999999999999999999999999999
Q ss_pred ccccccCCC--ccccccccCccccCccccCCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc---------
Q 012213 333 KYLQDTGAS--ECMSAVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--------- 395 (468)
Q Consensus 333 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--------- 395 (468)
+........ .......||+.|||||++.+. .++.++|||||||++|||+||++||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 877533222 122346799999999998754 467899999999999999999888754221111
Q ss_pred -CHHHHHHHhhcccccchhhhccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCccC
Q 012213 396 -DIVQWTKMQTNSSKEGVVKILDQRLSN--TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQM 467 (468)
Q Consensus 396 -~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 467 (468)
....+..... ....++.+.. ...+....+.+++.+||+.||++||||.||+++|+++...+..+|
T Consensus 236 ~~~~~~~~~~~-------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ik~ 303 (303)
T 3hmm_A 236 PSVEEMRKVVC-------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 303 (303)
T ss_dssp CCHHHHHHHHT-------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred chHHHHHHHHh-------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 1111111111 1111222211 123566778899999999999999999999999999977665543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=418.45 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=209.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||+||+|.++ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456777889999999999999985 689999999965433 23366899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|||++|+|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 223 (346)
T 4fih_A 151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223 (346)
T ss_dssp CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence 999999999999743 4899999999999999999999888 999999999999999999999999999877532
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+. ..... .. .+.....
T Consensus 224 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~--~i---------~~~~~~~ 289 (346)
T 4fih_A 224 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK--MI---------RDNLPPR 289 (346)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH--HH---------HHSSCCC
T ss_pred -CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH--HH---------HcCCCCC
Confidence 2234567899999999999999999999999999999999999999975321 11111 10 0000011
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
..........+.+++.+|++.||++|||++|+++ .+.+..
T Consensus 290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 1112234567788999999999999999999987 455443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=416.55 Aligned_cols=253 Identities=26% Similarity=0.301 Sum_probs=203.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||+||+|.++ +|+.||||++.... ...+|+.+++.++|||||++++++.+++..+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456777889999999999999974 68999999986422 1347999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeecccccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDT 338 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~ 338 (468)
||+++|+|.++++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 130 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999743 35999999999999999999999777 99999999999999987 6999999999987543
Q ss_pred CCCc---cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASE---CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
+... .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+...... ..... ...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~---~~~------- 272 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIA---SEP------- 272 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHHH---HSC-------
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHH---cCC-------
Confidence 2221 22346799999999999999999999999999999999999999976432221 11110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
......+......+.+++.+||+.||++|||+.|+++.|..+
T Consensus 273 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 273 --PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 001112234456778899999999999999999999887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=426.59 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=213.0
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC-CCccceeEEEecC-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNK- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~- 252 (468)
.++|+..+.||+|+||+||+|.+.. ++.||||++..... ....+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 4678888999999999999998642 35799999864332 2234578999999999965 8999999999764
Q ss_pred CeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 318 (468)
+..++|||||++|+|.++|+... ...++|.++..++.|||+||+|||+.+ ||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 56899999999999999997532 235899999999999999999999877 9999999999999
Q ss_pred cCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCH
Q 012213 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDI 397 (468)
Q Consensus 319 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~ 397 (468)
++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..... .+
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~ 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 9999999999999997764444444556789999999999999999999999999999999998 999997643211 11
Q ss_pred HHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.. .+.+......+.....++.+++..||+.||++||||.||++.|+++...
T Consensus 298 ~~--------------~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 298 CR--------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH--------------HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11 1111111223334556788899999999999999999999999887543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=413.83 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=208.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++..... .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35688889999999999999997 4689999999864321 223346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999643 35999999999999999999999888 999999999999999999999999999987644
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.........+||+.|||||++.+..|+.++||||+||++|||+||++||.+.+. .+. ..++...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~-----------~~~i~~~ 249 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLI-----------FAKIIKL 249 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH-----------HHHHHHT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHH-----------HHHHHcC
Confidence 444455678899999999999999999999999999999999999999975321 111 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVV 453 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~ 453 (468)
.. ..+.....++.+++.+|++.||++|||++|++
T Consensus 250 ~~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 EY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC-CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 12223345678899999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=406.20 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=197.1
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec----CCeeEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 258 (468)
++..+.||+|+||+||+|.+. ++..||||++..........+.|.+|++++++++|||||++++++.+ +...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 355678999999999999974 58899999997654444445679999999999999999999999865 3457899
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeeccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQD 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~ 337 (468)
||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999643 45899999999999999999999653 34999999999999985 79999999999985431
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... ............ .
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~~--------~ 247 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGV--------K 247 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTC--------C
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcCC--------C
Confidence 23346789999999998865 699999999999999999999999975321 111111111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ ...+.....++.+++.+||+.||++|||++|+++
T Consensus 248 ~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 P--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011112345778999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=419.57 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=210.9
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+.|+..+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++..+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 3567888899999999999999984 689999999964432 3346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||||++|+|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 227 mEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999999643 4899999999999999999999888 999999999999999999999999999877532
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+... ..... . +......
T Consensus 301 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~---~--------i~~~~~~ 365 (423)
T 4fie_A 301 --VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK---M--------IRDNLPP 365 (423)
T ss_dssp --CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH---H--------HHHSCCC
T ss_pred --CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH---H--------HHcCCCC
Confidence 2234567899999999999999999999999999999999999999975321 11111 1 0010111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQK 461 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~ 461 (468)
.+ .........+.+++.+||..||++|||+.|+++ .|.+..+
T Consensus 366 ~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 366 RL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp CC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 11 111223456788999999999999999999987 4555443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=396.57 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=190.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+|+..+.||+|+||+||+|.+ .+|+.||||++..... .......+.+|+.++++++|||||++++++.+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45788899999999999999997 4689999999865432 223346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+ +|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 9999 68999998643 35999999999999999999999887 999999999999999999999999999876432
Q ss_pred CCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.+ ......... .
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~-----------~ 226 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNIS-----------N 226 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH-----------H
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHH-----------c
Confidence 22345789999999999998876 579999999999999999999997522 111111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ...+......+.+++.+|++.||++|||++|+++
T Consensus 227 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 GV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 1112233456788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=407.36 Aligned_cols=249 Identities=24% Similarity=0.270 Sum_probs=197.2
Q ss_pred hccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
++|+..+.||+|+||+||+|+.. .++.||||++............+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56888999999999999999862 46789999986543322333468899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999643 35899999999999999999999887 99999999999999999999999999986542
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. .......+||+.|||||++.+..|+.++||||+||++|||+||++||.+.+. .+... .+..
T Consensus 179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~-----------~i~~ 240 (304)
T 3ubd_A 179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMT-----------MILK 240 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-----------HHHH
T ss_pred C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHH-----------HHHc
Confidence 2 2234567899999999999999999999999999999999999999975321 11111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
.. ...+.....++.+++.+|++.||++||| ++|+++
T Consensus 241 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 AK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 1122334566788999999999999998 467664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=394.58 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=190.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe-----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET----- 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 254 (468)
.++|+..+.||+|+||+||+|.++ +|+.||||++.... .....+.+.+|+.++++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 456788899999999999999974 68999999986432 22233578899999999999999999999865443
Q ss_pred -------eEEEEeccCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 255 -------NLLVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 255 -------~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
.++||||+++|+|.+++..... ...++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 6899999999999999975432 24667888999999999999999887 999999999999999999999
Q ss_pred eeccccccccccCCC----------ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcC
Q 012213 327 ADFGLAKYLQDTGAS----------ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD 396 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 396 (468)
+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~ 233 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ER 233 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HH
Confidence 999999887533221 12234679999999999999999999999999999999996 775311 00
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.. .+..+.+...............+++.+|++.||++|||+.|+++ .++++
T Consensus 234 ~~------------~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 234 VR------------TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HH------------HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HH------------HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 00 01111111111111233345678999999999999999999987 45444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=372.82 Aligned_cols=275 Identities=36% Similarity=0.576 Sum_probs=232.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||+||+|.+++++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 67899999999999999999999889999999876432 2334678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 261 YMPNGSLGEVLHGKRG--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999975432 35899999999999999999999887 999999999999999999999999999875433
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF-GEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
..........||+.|+|||++.+..++.++||||||+++|||+||+.||... ..+......|........ .+...++
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 270 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG--QLEQIVD 270 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT--CCCSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc--cHHHhcC
Confidence 3333334556899999999998889999999999999999999999999763 334456667765544333 4455555
Q ss_pred ccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 418 QRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 418 ~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
... ..........+.+++.+|++.||++|||+.||++.|+.+...
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 555 345677888999999999999999999999999999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=384.65 Aligned_cols=272 Identities=22% Similarity=0.299 Sum_probs=203.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec------CC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------KE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 253 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 45688899999999999999997 468999999997554433444678899999999999999999998754 35
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..+||||||+ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 7899999643 46999999999999999999999888 9999999999999999999999999998
Q ss_pred cccccC--CCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 334 YLQDTG--ASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 334 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
.+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+... .+............+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChH
Confidence 764321 22334567899999999998765 56999999999999999999999997633110 000000000000000
Q ss_pred --------chhhhccccC--CCCCH-----HHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 411 --------GVVKILDQRL--SNTPL-----SEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 411 --------~~~~~~d~~~--~~~~~-----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.....+.... ...+. .....+.+++.+|+..||++|||+.|+++ .+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0000000000 01111 12346788999999999999999999987 44443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=370.98 Aligned_cols=281 Identities=40% Similarity=0.677 Sum_probs=232.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||.||+|.+.+|+.||||++....... ....+.+|+++++.++||||+++++++...+..++|||
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 67899999999999999999998889999999987543322 22468999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 261 YMPNGSLGEVLHGKRG--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+...++|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 9999999999975432 35999999999999999999999882224999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD---FGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.........||+.|+|||++.+..++.++||||||+++|||+||+.||.. .........+|........ .....
T Consensus 188 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 264 (326)
T 3uim_A 188 -DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--KLEAL 264 (326)
T ss_dssp -SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC--CSTTS
T ss_pred -cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch--hhhhh
Confidence 23334456699999999999888899999999999999999999999963 2334455666665544443 45555
Q ss_pred ccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 416 LDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 416 ~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
.+..+ ......+...+.+++..|++.||++|||+.||++.|++....+.+
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 56555 455678889999999999999999999999999999987655543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=377.07 Aligned_cols=200 Identities=28% Similarity=0.413 Sum_probs=170.0
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
++.+.|+..+.||+|+||+||+|.++ .++.||||++... ....++.+|++++..+ +||||+++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 44677999999999999999999863 4678999998543 2235688999999988 6999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeecccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLA 332 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla 332 (468)
..++||||+++|+|.+++. .+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999999984 3889999999999999999999888 9999999999999887 79999999999
Q ss_pred ccccccCC--------------------------CccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCC
Q 012213 333 KYLQDTGA--------------------------SECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRR 385 (468)
Q Consensus 333 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~ 385 (468)
+....... .......+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86542211 1112345799999999998765 58999999999999999999999
Q ss_pred CCCCC
Q 012213 386 PVGDF 390 (468)
Q Consensus 386 p~~~~ 390 (468)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=394.72 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=206.5
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+.+.++|+..+.||+|+||.||+|.++ +|+.||+|++.... ....+.+.+|+.+|+.++|||||++++++.+....+
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 445678999999999999999999984 68999999986432 222356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CceEEeecccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD--FEAHVADFGLAKY 334 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~ 334 (468)
+|||||++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999999998643 345899999999999999999999888 9999999999999864 8999999999997
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+.. .......+||+.|||||++.+..|+.++||||+||++|||++|++||.+.... +.........
T Consensus 307 ~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~~i~~~~------ 372 (573)
T 3uto_A 307 LDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVKSCD------ 372 (573)
T ss_dssp CCT---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTC------
T ss_pred ccC---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHhCC------
Confidence 753 22345568999999999999999999999999999999999999999763311 1111100000
Q ss_pred hccccCC-CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLS-NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~-~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+. .........+.+++.+|++.||++|||+.|+++
T Consensus 373 ---~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 ---WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ---CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 001122456778999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=390.89 Aligned_cols=251 Identities=23% Similarity=0.263 Sum_probs=199.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHH---HHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLS---AEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++|+..+.||+|+||+||+|+++ +|+.||||++..... .......+. .++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 567888999999999999999985 689999999864221 111112233 346777888999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
+|||||++||+|.++|... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.+|++||+|||+|+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999643 45899999999999999999999877 999999999999999999999999999876
Q ss_pred cccCCCccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
... .....+||+.|||||++. +..|+.++||||+||++|||++|++||.+.... +.......
T Consensus 343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~----------- 405 (689)
T 3v5w_A 343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRM----------- 405 (689)
T ss_dssp SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHH-----------
T ss_pred CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHh-----------
Confidence 532 234568999999999986 457999999999999999999999999753221 11111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
..... ...+......+.+++..|++.||++|++ ++||.+
T Consensus 406 i~~~~-~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 406 TLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHCC-CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred hcCCC-CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111 1122334566788999999999999998 677754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=352.13 Aligned_cols=268 Identities=37% Similarity=0.604 Sum_probs=221.8
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
++.||+|+||.||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 48999999999999987 688999999865432 223346789999999999999999999999999999999999999
Q ss_pred CChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCcc
Q 012213 265 GSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343 (468)
Q Consensus 265 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 343 (468)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...........
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 99999986432 346899999999999999999999887 99999999999999999999999999987654333333
Q ss_pred ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
.....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .+..+..... .....+...++..+...
T Consensus 192 ~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 192 TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIE-DEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHHH-TTSCCHHHHSCSSCSCC
T ss_pred ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHhh-hhhhhhhhhcccccccc
Confidence 345678999999998765 58899999999999999999999998643222 2223332222 22234566777777777
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+......+.+++..|++.+|++|||+.||++.|+++..
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 88888999999999999999999999999999998864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.39 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=212.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.+.|+..+.||+|+||.||+|.+. ++..||||++.... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467888899999999999999852 35679999986432 122335689999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999997543 235899999999999999999999887 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~ 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987654333333445567889999999999999999999999999999999 99999764321 1
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+.. .+........+......+.+++..||+.||++||++.|+++.|+++.
T Consensus 314 ~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LFK--------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHH--------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 11111112233345567889999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.41 Aligned_cols=268 Identities=25% Similarity=0.319 Sum_probs=208.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe----eE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET----NL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~ 256 (468)
.+.|+..+.||+|+||+||+|.+. ++.||||++.... .....+..|+.++++++||||+++++++..... .+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 467888999999999999999885 7899999985332 223456678999999999999999999987543 69
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------CCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-------CSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. .+++|+||||||+||+++.++.+||+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999999753 389999999999999999999976 0113999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-C-------
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-D------- 396 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-~------- 396 (468)
|+++.+.............||+.|+|||++.+. .++.++|||||||++|||+||+.||........ .
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999877644333334456799999999998763 466789999999999999999999976332211 1
Q ss_pred ---HHHHHHHhhcccccchhhhccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 397 ---IVQWTKMQTNSSKEGVVKILDQRLSN--TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 397 ---~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
..++........ ..+.+.. ........+.+++.+||+.||++|||+.||++.|++++..
T Consensus 256 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEVVVHKK-------KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHTTSC-------CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhccc-------CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111110000 0011110 1234567799999999999999999999999999988643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=358.92 Aligned_cols=264 Identities=31% Similarity=0.429 Sum_probs=204.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||+||+|.+ +|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 56788889999999999999987 58899999987554433444678899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 261 YMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST- 192 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-
Confidence 9999999999974332 24899999999999999999999653 23999999999999999999999999999865422
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........||+.|+|||++.+..++.++||||||+++|||+||+.||...... +....... ...
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~~~~~~~----------~~~ 256 (309)
T 3p86_A 193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QVVAAVGF----------KCK 256 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHH----------SCC
T ss_pred -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh----------cCC
Confidence 12234567899999999999999999999999999999999999999753311 11111000 011
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
....+......+.+++..||+.||++|||+.|+++.|+.+....
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11223344567889999999999999999999999999886554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=356.84 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=209.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|...+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 456788899999999999999984 6889999988532 2233467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp ECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999753 345899999999999999999999887 9999999999999999999999999998764322
Q ss_pred CCc------------cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 340 ASE------------CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 340 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
... ......||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------- 234 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------- 234 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence 111 112457999999999999999999999999999999999999998763322111000
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
......+... +......+.+++..|++.||++|||+.|+++.|+.++
T Consensus 235 ---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 235 ---NVRGFLDRYC---PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---CHHHHHHHTC---CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hhhccccccC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 1122345778999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=349.46 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=211.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 46788889999999999999999888899999986432 233678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-Q 158 (268)
T ss_dssp CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT-C
T ss_pred ccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh-h
Confidence 99999999999643 335899999999999999999999887 999999999999999999999999999876532 2
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .... ......
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~-----------~~~~~~ 222 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVL-----------KVSQGH 222 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHH-----------HHHTTC
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHH-----------HHHcCC
Confidence 222234456778999999998889999999999999999999 99999753311 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
....+......+.+++..|++.+|++|||+.|+++.|+.++..+
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11112223456888999999999999999999999999998765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=349.60 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=211.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||+||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 45678889999999999999999889999999986432 223679999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 160 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-Q 160 (269)
T ss_dssp CCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-H
T ss_pred eCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc-c
Confidence 99999999999743 345899999999999999999999887 999999999999999999999999999866422 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +... .+....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~-----------~~~~~~ 224 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVE-----------DISTGF 224 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH-----------HHHTTC
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHH-----------HHhcCc
Confidence 112234456788999999998899999999999999999999 99999753311 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
....+......+.+++..|++.+|++|||+.|+++.|+++..
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111222335668889999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=376.70 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=214.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||+||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 56788889999999999999999888999999986432 23477999999999999999999999986 567899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN-E 338 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-H
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-c
Confidence 999999999997554446889999999999999999999887 999999999999999999999999999876421 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||++....++.++||||||+++|||+| |+.||.+.... +... .+....
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~-----------~i~~~~ 402 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR-----------ALERGY 402 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHH-----------HHHHTC
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH-----------HHHcCC
Confidence 111233456789999999998899999999999999999999 99999763311 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCcc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 466 (468)
....+......+.+++..||+.||++|||+++|++.|+++......+
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 11223345567889999999999999999999999999997655443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=351.02 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=206.8
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+.|+..+.||+|+||+||+|.+ .+++.||||++...... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 467789999999999999999997 56899999998654332 236689999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999754 4899999999999999999999887 999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .......||+.|+|||++.+..++.++||||||+++|||+||+.||...... ........... .
T Consensus 170 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~---------~ 234 (297)
T 3fxz_A 170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIATNGT---------P 234 (297)
T ss_dssp T--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHHCS---------C
T ss_pred c--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC---------C
Confidence 2 2234567999999999999999999999999999999999999999753211 01111000000 0
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....+......+.+++..|++.||++|||+.|+++
T Consensus 235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01122334566788999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=357.99 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=207.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
..+|+..+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 56788899999999999999997 57899999999765444444567889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999998643 34899999999999999999999887 999999999999999999999999999866422
Q ss_pred CCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.......||+.|+|||++.+..+. .++|||||||++|||++|+.||.+.+ ..+...... ..
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~-----------~~ 229 (328)
T 3fe3_A 168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVL-----------RG 229 (328)
T ss_dssp --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH-----------HC
T ss_pred --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHH-----------hC
Confidence 234566799999999999887765 79999999999999999999997532 111111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...+......+.+++.+|++.||.+|||++|+++
T Consensus 230 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 K-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp C-CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 1122234456778999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=369.81 Aligned_cols=260 Identities=26% Similarity=0.368 Sum_probs=208.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|...+.||+|+||.||+|.+. +++.||||.+.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 456788899999999999999985 78999999986432 1222346889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999999742 345899999999999999999999887 9999999999999999999999999998643211
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.........+++.|+|||.+.+..++.++||||||+++|||+| |..||...... ....+. ...
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~--------------~~~ 331 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFV--------------EKG 331 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHH--------------HTT
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH--------------HcC
Confidence 1111122335778999999998889999999999999999999 99999763311 011110 001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.....+......+.+++..||+.||++|||++++++.|+++..
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1112233345678889999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.25 Aligned_cols=260 Identities=24% Similarity=0.392 Sum_probs=208.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|+..+.||+|+||+||+|.+. .+..||||++.... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 567888899999999999999984 34569999986432 2223357899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 127 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999643 345899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCC-CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGA-SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... +.. ..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~-----------~~ 266 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVI-----------SS 266 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHH-----------HH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHH-----------HH
Confidence 3222 112233456788999999998899999999999999999999 99999653311 111 11
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+........+......+.+++..||+.||++|||+.||++.|+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111122233455678899999999999999999999999998743
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.09 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=198.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||.||+|.+. ++..||||++.... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 567889999999999999999875 57789999986432 2223457899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.++++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999743 346899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~----------- 262 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKA----------- 262 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHH-----------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-----------
Confidence 32211 11222345778999999999999999999999999999998 9999975331 111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+........+......+.+++..||+.||++||++.||+++|+++.
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1111112223345567889999999999999999999999998874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.01 Aligned_cols=263 Identities=29% Similarity=0.414 Sum_probs=209.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 46678889999999999999999888899999986433 223679999999999999999999999876 67899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++....+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-E 334 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC-c
Confidence 999999999997554556899999999999999999999887 999999999999999999999999999876532 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||.+....++.++||||||+++|||+| |+.||.+.... +... .+....
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~-----------~i~~~~ 398 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-----------QVERGY 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH-----------HHHTTC
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH-----------HHHcCC
Confidence 222234456789999999998899999999999999999999 99999753311 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCccC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQM 467 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 467 (468)
....+......+.+++..||+.||++|||++++++.|+++......+.
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 122233455678899999999999999999999999999876655444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=358.34 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=212.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||.||+|.+. +++.||||.+.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 567888999999999999999974 34789999986432 22234578999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR----------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 312 (468)
.++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 999999999999999997532 146899999999999999999999887 9999999
Q ss_pred CCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 012213 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFG 391 (468)
Q Consensus 313 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 391 (468)
|+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987653333333345668899999999998899999999999999999999 999997532
Q ss_pred CCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 392 EEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
. .+.. ..+.+......+......+.+++..||+.||++||++.|+++.|+++....
T Consensus 282 ~-----~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 H-----EEVI-----------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H-----HHHH-----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred h-----HHHH-----------HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 1111 111112222233344567889999999999999999999999999986543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=353.46 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=205.9
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
+.++|+..+.||+|+||+||+|.+. +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4678899999999999999999975 789999999854322 22235688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999999643 35899999999999999999999887 999999999999999999999999999876544
Q ss_pred CCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
..........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............|... ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~~--------- 226 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KT--------- 226 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT---CT---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc---cc---------
Confidence 33333456789999999999987765 779999999999999999999997644332222222111 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...........+.+++.+|++.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111223456678999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=354.04 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=195.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN- 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 255 (468)
.++|+..+.||+|+||+||+|.+.... .||||++..........+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 567888999999999999999986433 799999875544444557799999999999999999999999877665
Q ss_pred -----EEEEeccCCCChhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 256 -----LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 256 -----~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999985432 225899999999999999999999887 999999999999999999999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------- 247 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----------- 247 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----------
Confidence 99999987654333333344557889999999999999999999999999999999 999997643211
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
....+........+......+.+++..|++.||++|||+.|+++.|+++.
T Consensus 248 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 248 -----IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp -----HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111112222223344567889999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=373.30 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=214.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+.++++++||||++++++|......++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4567888999999999999999864 7899999986432 23467999999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 371 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD- 371 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC-
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC-
Confidence 9999999999998666667999999999999999999999887 999999999999999999999999999876422
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.........++..|+|||.+....++.++||||||+++|||+| |+.||...... .+... +..
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~---------------~~~ 434 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL---------------LEK 434 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH---------------HHT
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH---------------HHc
Confidence 2222234456789999999998899999999999999999999 99999764321 11111 111
Q ss_pred c-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 419 R-LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 419 ~-~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
. ....+......+.+++..||+.||++|||+.||++.|+.+....
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 1 11223345567888999999999999999999999999885443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=350.67 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=212.3
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|...+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 56788889999999999999986 345789999986432 22334678899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRG----------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 312 (468)
.++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999975432 34899999999999999999999887 9999999
Q ss_pred CCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 012213 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFG 391 (468)
Q Consensus 313 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 391 (468)
|+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654333333344567889999999998889999999999999999999 999997643
Q ss_pred CCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 392 EEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
... +... +........+......+.+++..|++.||++||++.|+++.|+++..
T Consensus 258 ~~~--~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PER--LFNL--------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGG--HHHH--------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--HHHH--------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 211 1111 11111122233445678899999999999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=366.20 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=208.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-eeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.++++++||||+++++++.... ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467788899999999999999885 7899999986432 3367999999999999999999999987665 689999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999998655556899999999999999999999887 999999999999999999999999999854321
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ... .+...
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~--------------~i~~~ 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP--------------RVEKG 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH--------------HHHTT
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH--------------HHHcC
Confidence 122356889999999999999999999999999999999 999997643221 111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.....+......+.+++..||+.||++|||+.|+++.|+.+...
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11223334567788999999999999999999999999988644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=361.26 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=212.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.++|...+.||+|+||+||+|.+. ++..||||++.... .......+.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 467888899999999999999852 34579999986432 222335688999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999997543 235899999999999999999999887 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987754433334445567899999999999999999999999999999999 9999975321
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+...... .......+......+.+++..||+.||++|||+.||++.|+++.
T Consensus 300 -~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 300 -EELFKLLK-----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp -HHHHHHHH-----------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHH-----------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111 11111222334567888999999999999999999999998874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=353.60 Aligned_cols=258 Identities=25% Similarity=0.430 Sum_probs=201.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcE----EEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++|+..+.||+|+||+||+|.+. +++. ||+|.+.... .......+.+|+.++++++||||++++++|.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 456788899999999999999964 3443 5888775432 2233467999999999999999999999998754 7
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 89999999999999997533 45899999999999999999999887 999999999999999999999999999877
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... +. .
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~---------------~ 230 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS---------------S 230 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH---------------H
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HH---------------H
Confidence 54443333344567889999999999999999999999999999999 999997643211 11 1
Q ss_pred hccc-cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 415 ILDQ-RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 415 ~~d~-~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.+.. .....+......+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111 1122233455678889999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=361.80 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=210.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467888899999999999999843 46789999986332 22233568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---ceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 326 (468)
.++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997533 235899999999999999999999887 99999999999999555 5999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~--- 297 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLE--- 297 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHH---
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---
Confidence 99999987654444344445668999999999998899999999999999999998 9999975321 11111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+........+......+.+++..||+.||++|||+.||++.|+.+.
T Consensus 298 --------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 298 --------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11111111222334556888999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.90 Aligned_cols=269 Identities=22% Similarity=0.299 Sum_probs=204.5
Q ss_pred chhhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+.+.++|+..+.||+|+||+||+|.+.+|+.||||++............+.+|++++++++||||+++++++.+.+..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34578899999999999999999999889999999997554444444678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 97 VFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999997 5888887643 345899999999999999999999887 99999999999999999999999999987642
Q ss_pred cCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh-
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI- 415 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 415 (468)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..................
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGT
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhh
Confidence 2 222344578999999998876 568999999999999999999999997643221 11111111111110000000
Q ss_pred -----ccccC---CCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 -----LDQRL---SNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 -----~d~~~---~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+... ...+ .....++.+++..|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 1111 112346788999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.38 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=209.6
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 57788899999999999999973 356789999986432 122235689999999999 7899999999998765
Q ss_pred e-eEEEEeccCCCChhhhcccCCC--------------------------------------------------------
Q 012213 254 T-NLLVYEYMPNGSLGEVLHGKRG-------------------------------------------------------- 276 (468)
Q Consensus 254 ~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 276 (468)
. .++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5 8999999999999999975432
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccc
Q 012213 277 --------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348 (468)
Q Consensus 277 --------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 348 (468)
..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.............
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 12899999999999999999999887 9999999999999999999999999998765443333445567
Q ss_pred cCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHH
Q 012213 349 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427 (468)
Q Consensus 349 gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 427 (468)
||+.|+|||++.+..++.++||||||+++|||+| |+.||....... .... . +........+...
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~--~------------~~~~~~~~~~~~~ 321 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR--R------------LKEGTRMRAPDYT 321 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHH--H------------HHHTCCCCCCTTC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHH--H------------HHcCCCCCCCCCC
Confidence 8999999999999999999999999999999999 999997643211 0100 0 0011111222234
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 428 AMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 428 ~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
...+.+++..|++.||++|||+.|+++.|+++..
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 4568889999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=345.97 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=207.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||+||+|.+.++..||||++.... ...+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 56788889999999999999999988899999986432 223678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 100 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999999753 235899999999999999999999887 9999999999999999999999999998664221
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +.. ..+....
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~-----------~~~~~~~ 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETA-----------EHIAQGL 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHH-----------HHHHTTC
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHH-----------HHHhccc
Confidence 112233456788999999998899999999999999999999 99999763311 111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
....+......+.+++..|++.+|++|||+.|+++.|+++..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 111222334568889999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=344.57 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=202.4
Q ss_pred hhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhC--CCCCCccceeEEEec----CC
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK--IRHRNIVRLKAFCSN----KE 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~ 253 (468)
+.++|+..+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 356788999999999999999988 6899999998532 22445556665554 799999999998654 34
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEEcCCCceE
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH--------HDCSPLIIHRDVKSNNILLNSDFEAH 325 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~k 325 (468)
..++||||+++|+|.++++. ..+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 57899999999999999953 35899999999999999999999 666 99999999999999999999
Q ss_pred EeeccccccccccCCCc--cccccccCccccCccccCCC------CCCcchhhHHHHHHHHHHHhC----------CCCC
Q 012213 326 VADFGLAKYLQDTGASE--CMSAVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELITG----------RRPV 387 (468)
Q Consensus 326 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~elltg----------~~p~ 387 (468)
|+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998765332211 12334799999999998876 455799999999999999999 8888
Q ss_pred CCCCCCCcCHHHHHHHhhcccccchhhhccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 388 GDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS--NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
..................... ...... .........+.+++..||+.||++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQ-------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSC-------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccC-------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 664333333333222211111 001111 11235678899999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=348.42 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=206.0
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
..+.+.|+..+.||+|+||.||+|.+. +|+.||||.+....... ...+.+.+|+.++..++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 345677889999999999999999985 68999999987544322 1236789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----ceEEee
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVAD 328 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 328 (468)
...++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999999643 45899999999999999999999887 99999999999998877 799999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
||++..+... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+...
T Consensus 163 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~------ 228 (361)
T 2yab_A 163 FGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLA------ 228 (361)
T ss_dssp CSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHH------
T ss_pred cCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------
Confidence 9999876532 223456799999999999998999999999999999999999999975321 11111
Q ss_pred ccchhhhccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+..... ..+. .....+.+++..|+..||++|||+.|+++
T Consensus 229 -----~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 229 -----NITAVSY-DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -----HHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----HHHhcCC-CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111110 1111 12356778999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.30 Aligned_cols=263 Identities=29% Similarity=0.420 Sum_probs=198.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
...|+..+.||+|+||+||+|.+.. .||||++..........+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4568889999999999999998753 599999875544444456789999999999999999999965 4566899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999643 346899999999999999999999887 99999999999999999999999999986653333
Q ss_pred CccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 341 SECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~-------~~~ 244 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIEMVGRG-------SLS 244 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----HHHHHHHHHT-------SCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----HHHHHHhccc-------ccC
Confidence 33344567999999999886 567889999999999999999999999763321 1111111110 011
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.............+.+++..|++.+|++|||+.|++++|+++..
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11122223445678899999999999999999999999998864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=340.71 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=207.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+..+.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 567888999999999999999974 68899999986543322 2235788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999643 35899999999999999999999887 999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.........||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ................
T Consensus 165 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~~----- 233 (294)
T 4eqm_A 165 -SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIKHIQDSVPNVT----- 233 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHHHHSSCCCCHH-----
T ss_pred -cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhhccCCCcc-----
Confidence 22223446789999999999999999999999999999999999999975321 1111111111100000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHhccCCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-TMREVVQMLAQAQKPN 463 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-t~~ev~~~L~~~~~~~ 463 (468)
..........+.+++.+|++.||++|| +++++.+.|+.+...+
T Consensus 234 --~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 --TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp --HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred --hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 001122345678899999999999998 9999999999875443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.29 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=210.4
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+ .++..||||.+..... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 56788899999999999999986 2456899999874322 23346799999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRG---------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 312 (468)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999975432 23799999999999999999999887 9999999
Q ss_pred CCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 012213 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFG 391 (468)
Q Consensus 313 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 391 (468)
|+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987764443333445567889999999988899999999999999999998 999997643
Q ss_pred CCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 392 EEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
... ....... . ......+......+.+++..||+.||.+|||+.|+++.|+.+....
T Consensus 280 ~~~-~~~~~~~----~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDA-NFYKLIQ----N----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSH-HHHHHHH----T----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHH-HHHHHHh----c----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 211 1111100 0 0011122234567888999999999999999999999999886543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=348.62 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=204.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.++ +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467888899999999999999975 689999999864321 223346688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999998643 35899999999999999999999887 999999999999999999999999999864322
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....... ...
T Consensus 159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i-----------~~~ 220 (337)
T 1o6l_A 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELI-----------LME 220 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH-----------HHC
T ss_pred --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHH-----------HcC
Confidence 2234556799999999999999999999999999999999999999975321 1111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
. ...+......+.+++..|++.||++|| +++|+++
T Consensus 221 ~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 E-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1 112223456678899999999999999 8999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=345.56 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=202.4
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
.|+..+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 3556679999999999999986 799999999864332 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 124 ~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 195 (321)
T 2c30_A 124 LQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-- 195 (321)
T ss_dssp CCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--
Confidence 999999999864 24899999999999999999999887 9999999999999999999999999998765322
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+........ .....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~--------~~~~~- 261 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRDS--------PPPKL- 261 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS--------SCCCC-
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcC--------CCCCc-
Confidence 223456799999999999999999999999999999999999999965321 1111110000 00011
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.........+.+++.+|++.||++|||+.|+++
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111223456788999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.11 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=203.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcE----EEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+.|+..+.||+|+||+||+|.+. +++. ||+|.+..... ......+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 456788899999999999999974 3443 78887754322 222355788999999999999999999986 4568
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 90 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 8999999999999999743 346889999999999999999999887 999999999999999999999999999987
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.............++..|+|||++.+..++.++||||||+++|||+| |+.||...... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~------------ 231 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLE------------ 231 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHH------------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHH------------
Confidence 64444444455678889999999998899999999999999999999 99999763321 1111110
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.......+......+.+++..||+.||++||++.|+++.|+.+..
T Consensus 232 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 --KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp --TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred --cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001111122233456789999999999999999999999988753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.31 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=208.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+. ++.||||++..........+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 567888899999999999999985 88999999876544444446789999999999999999999999887 778999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++.......+++..++.++.|++.||+|||+.+ .+++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 99999999999998766557999999999999999999999643 339999999999999999999999999876432
Q ss_pred CCCccccccccCccccCccccCCCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDE---KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.....||+.|+|||.+.+..++. ++||||||+++|||+||+.||..... .+.......
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~--------- 225 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVAL--------- 225 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHH---------
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHh---------
Confidence 12346799999999988765444 89999999999999999999975331 111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.......+......+.+++..|++.||++|||++|+++.|+++..
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 -EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011112223345678889999999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.28 Aligned_cols=268 Identities=28% Similarity=0.386 Sum_probs=205.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--E 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 253 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 56788889999999999999983 468899999986332 22335788999999999999999999998653 4
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 5899999999999999997543 35899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---
Q 012213 334 YLQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK--- 409 (468)
Q Consensus 334 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 409 (468)
........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+.... ..+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMIGNDKQGQM 236 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH------HHHHHHHCTTCCTHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh------HHHHhhhcCccccch
Confidence 76533221 22234457788999999999999999999999999999999999986421 011110000000
Q ss_pred ---cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 410 ---EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 410 ---~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.....+........+......+.+++..||+.||++|||+.|+++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 001111111122334455677889999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.30 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=210.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 456788899999999999999998889999999864332 23678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~ 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-Q 158 (267)
T ss_dssp CCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-H
T ss_pred CCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-c
Confidence 99999999999754 345899999999999999999999887 999999999999999999999999999865421 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||...+..++.++||||||+++|||++ |+.||..... ...... +....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~-----------i~~~~ 222 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED-----------ISTGF 222 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH-----------HHTTC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHH-----------HhcCC
Confidence 112233456789999999998899999999999999999999 8999975321 111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
....+......+.+++..|++.||++||++.|+++.|+++...
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1112223356678899999999999999999999999988643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=339.56 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=196.5
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCC--CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG--SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888899999999999999985 889999988654332 22346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--------CCceEEeecc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--------DFEAHVADFG 330 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg 330 (468)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35899999999999999999999876555899999999999986 6789999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~---- 228 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGVAM---- 228 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHT----
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHhhhc----
Confidence 998654321 22456899999999999989999999999999999999999999753311 00000000
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.......+......+.+++..|++.||++|||+.|+++.|+++
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011122233456788999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=341.36 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=213.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+.. +..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 5678888999999999999999864 788999998632 233467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++.......+++..+..++.+++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC-
Confidence 9999999999998766667999999999999999999999888 999999999999999999999999999876532
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~--------------~~~ 228 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL--------------EKD 228 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH--------------HTT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH--------------hcc
Confidence 2223344557889999999998899999999999999999999 99999764321 111111 001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.....+......+.+++..|++.||++|||+.|+++.|+.+.
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 111222334567889999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=345.81 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=204.5
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
++.+.|+..+.||+|+||+||+|.+. +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 34678889999999999999999985 5788999988532 2333568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCceEEeeccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--DFEAHVADFGLAKYL 335 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~ 335 (468)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.+
T Consensus 79 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999999643 345899999999999999999999887 999999999999987 789999999999876
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+... .+
T Consensus 155 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~-----------~i 215 (321)
T 1tki_A 155 KPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIE-----------NI 215 (321)
T ss_dssp CTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH-----------HH
T ss_pred CCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHH-----------HH
Confidence 522 223456789999999999988899999999999999999999999975321 11111 11
Q ss_pred ccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... .+. .....+.+++.+|+..||++|||+.|+++
T Consensus 216 ~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 216 MNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTCCC-CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HcCCCC-CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111110 111 12456788999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=341.12 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=197.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|+..+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+..+++++||||+++++++. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 5678889999999999999998743 4569999876432 2223356889999999999999999999984 56789
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999999743 345899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .... .+
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~--------------~i 230 (281)
T 1mp8_A 168 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG--------------RI 230 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH--------------HH
T ss_pred ccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHH--------------HH
Confidence 322 222234456789999999998899999999999999999997 99999764321 1111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
........+......+.+++..|++.||++|||+.|+++.|+++..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111122233445678889999999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=375.08 Aligned_cols=263 Identities=29% Similarity=0.414 Sum_probs=214.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 46678889999999999999999888899999986433 223679999999999999999999999876 67899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++....+..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+... .
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-E 417 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-H
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-c
Confidence 999999999997554556899999999999999999999887 999999999999999999999999999876421 1
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||.+....++.++||||||+++|||+| |+.||.+.... +... .+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~-----------~i~~~~ 481 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-----------QVERGY 481 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHH-----------HHHTTC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-----------HHHcCC
Confidence 111233456789999999998899999999999999999999 99999763311 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCccC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQM 467 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 467 (468)
....+......+.+++..||+.||++|||+++|+++|+++......+.
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 112233445678889999999999999999999999999876655544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.91 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=212.3
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++..... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46788889999999999999984 3567899999864322 22346789999999999 9999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRG----------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999975432 24899999999999999999999887 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... .
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-K 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-H
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-H
Confidence 99999999999999987764433333345567889999999998899999999999999999999 999997643221 1
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
...... .... ...+......+.+++..|++.||++|||+.|+++.|+++..
T Consensus 257 ~~~~~~-----------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 FYKMIK-----------EGFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHH-----------HTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhc-----------cCCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111100 0000 11122345678889999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.25 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=208.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+++++.++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 46788889999999999999999888899999986432 23467899999999999999999999986 456899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...... .
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E 163 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc-c
Confidence 999999999997544346899999999999999999999887 999999999999999999999999999876532 2
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..... ....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~-----------~~~~ 227 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNL-----------ERGY 227 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH-----------HTTC
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHHHHH-----------hccc
Confidence 222234456789999999988889999999999999999999 9999975321 1111111 0111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
....+......+.+++..|++.+|++|||+.++++.|+++.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11122234567888999999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=339.26 Aligned_cols=273 Identities=22% Similarity=0.276 Sum_probs=212.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC--eeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--TNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 257 (468)
.+.|...+.||+|+||+||+|.+. +++.||||++...... ...+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467888999999999999999985 4899999998754322 22466889999999999999999999997765 6799
Q ss_pred EEeccCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCceEEeecccc
Q 012213 258 VYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFGLA 332 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla 332 (468)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999975433 24899999999999999999999887 9999999999999 78888999999999
Q ss_pred ccccccCCCccccccccCccccCccccC--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAY--------TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
+.+.... ......||+.|+|||++. +..++.++|||||||++|||+||+.||.................
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 8765322 223456899999999875 56789999999999999999999999976433222211111111
Q ss_pred hccc---ccchhhhcc------ccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 405 TNSS---KEGVVKILD------QRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 405 ~~~~---~~~~~~~~d------~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.... ...+.+... ..+ ..........+.+++..|++.||++|||++|+++-..+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1110 000000000 011 2344677788899999999999999999999999887653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=341.85 Aligned_cols=256 Identities=22% Similarity=0.257 Sum_probs=205.8
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
+.+.+.|+..+.||+|+||.||+|.+. +|+.||||.+....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 455678899999999999999999985 68999999987543322 1246789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----ceEEee
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVAD 328 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 328 (468)
...++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred CEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999999643 45899999999999999999999887 99999999999999887 899999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.........
T Consensus 162 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~ 233 (326)
T 2y0a_A 162 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANVSAVN 233 (326)
T ss_dssp CTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHTC
T ss_pred CCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHhcC
Confidence 9999876422 123456799999999999988999999999999999999999999965321 11111000000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... ........+.+++..|++.||++|||+.|+++
T Consensus 234 ~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEFEDE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCCHH--------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCcc--------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00112356778999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=347.79 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=203.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
...|...+.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 56788899999999999999997 5789999999864321 122235789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 78999988643 35899999999999999999999888 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.......||+.|+|||.+.+..+ ++++||||||+++|||++|+.||.+..... ..+.+.
T Consensus 162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~~~~i~ 221 (336)
T 3h4j_B 162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------LFKKVN 221 (336)
T ss_dssp ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------CBCCCC
T ss_pred ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------HHHHHH
Confidence 22345679999999999988775 789999999999999999999997632111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+......+.+++..|++.||.+|||++|+++
T Consensus 222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111223334566788999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.94 Aligned_cols=266 Identities=24% Similarity=0.315 Sum_probs=202.4
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
++|+..+.||+|+||+||+|.+. +++.||||++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 45778899999999999999985 68899999997655545445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 9975 666655432 345899999999999999999999887 999999999999999999999999999876422
Q ss_pred CccccccccCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc---hhhhc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG---VVKIL 416 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 416 (468)
........||+.|+|||++.+.. ++.++||||||+++|||++|..||.........+............+. ..+..
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 22234567899999999987765 899999999999999999988886442211111111111111110000 00000
Q ss_pred c----------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 D----------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d----------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ ..+..........+.+++..|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0001112234566788999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=344.07 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=198.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe--
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-- 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 254 (468)
.+.|...+.||+|+||.||+|.+. .+..||||++..........+.+.+|+.++++++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 567888899999999999999864 34579999986544333334678999999999999999999999977653
Q ss_pred ---eEEEEeccCCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 012213 255 ---NLLVYEYMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 255 ---~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
.++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 49999999999999998432 3346999999999999999999999777 9999999999999999999999
Q ss_pred eccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~------- 260 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYD------- 260 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH-------
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHH-------
Confidence 9999987653332233344567889999999999999999999999999999999 99999763321 1111
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+........+......+.+++..|++.||++|||+.++++.|+++.
T Consensus 261 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 -------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111112223334567889999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=358.09 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=204.6
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.+.|+..+.||+|+||+||+|.+ .+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 4567889999999999999999987 468899999986544333334668899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~ 334 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 88 v~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999998644 35899999999999999999999887 99999999999998 467899999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.... ........||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+. ...........
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~------ 229 (444)
T 3soa_A 163 VEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIKAGA------ 229 (444)
T ss_dssp CCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTC------
T ss_pred ecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhCC------
Confidence 6532 2223456799999999999999999999999999999999999999965321 11111100000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.. ..........+.+++..|++.||++|||+.|+++
T Consensus 230 -~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 -YDFP-SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CCCC-TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCC-ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 0011123456788999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=342.58 Aligned_cols=260 Identities=18% Similarity=0.231 Sum_probs=207.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+ .+++.||||.+..... ...+..|+.+++++ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 45688889999999999999996 5789999998864322 24588999999999 999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----eEEeeccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-----AHVADFGLAK 333 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~ 333 (468)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999 99999999753 346999999999999999999999887 999999999999999887 9999999998
Q ss_pred cccccCCCc-----cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 334 YLQDTGASE-----CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 334 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~~ 236 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGDTK 236 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHhhh
Confidence 765332211 1245679999999999999999999999999999999999999998743221 111111100000
Q ss_pred c-cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 409 K-EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 409 ~-~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
. ..... +.. ... .+.+++..|++.||.+||++.+|.+.|+++.
T Consensus 237 ~~~~~~~-----~~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 237 RATPIEV-----LCE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHSCHHH-----HTT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCHHH-----Hhc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 00000 000 112 7888999999999999999999999998763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=345.02 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=199.3
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---- 254 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 254 (468)
+.++|+..+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3677889999999999999999985 78999999986433 23344679999999999999999999999865432
Q ss_pred -----------------------------------------------------eEEEEeccCCCChhhhcccCCC-CCCC
Q 012213 255 -----------------------------------------------------NLLVYEYMPNGSLGEVLHGKRG-SFLK 280 (468)
Q Consensus 255 -----------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~-~~l~ 280 (468)
.++||||+++|+|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 7899999999999999975432 3467
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC----------ccccccccC
Q 012213 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS----------ECMSAVAGS 350 (468)
Q Consensus 281 ~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt 350 (468)
+..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7789999999999999999887 999999999999999999999999999877533211 122345799
Q ss_pred ccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHH
Q 012213 351 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQ 430 (468)
Q Consensus 351 ~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 430 (468)
+.|+|||++.+..++.++||||||+++|||++|..|+... .. ....................
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~-----------~~~~~~~~~~~~~~~~~~~~ 301 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VR-----------IITDVRNLKFPLLFTQKYPQ 301 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HH-----------HHHHHHTTCCCHHHHHHCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HH-----------HHHHhhccCCCcccccCChh
Confidence 9999999999999999999999999999999987774210 00 01111111111112334456
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHH
Q 012213 431 VFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 431 ~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.+++..|++.||++|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 788999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=348.95 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=209.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.+.|+..+.||+|+||.||+|.+. ++..||||++.... .......+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 467888899999999999999863 46789999986432 222335688999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRG--------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
.+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975432 24899999999999999999999887 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999999987654333233344567889999999988889999999999999999999 9999975321
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+..... ........+......+.+++..|++.+|.+|||+.|+++.|+++.
T Consensus 266 -~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 -EELFKLL-----------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -HHHHHHH-----------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHH-----------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111 011111222334567888999999999999999999999998773
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=350.10 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=205.3
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.+.|+..+.||+|+||.||+|.+. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44678899999999999999999874 68999999987544333344678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---ceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~ 334 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++..
T Consensus 106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999998643 45899999999999999999999887 99999999999998654 599999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. ...........
T Consensus 181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~~~~------ 246 (362)
T 2bdw_A 181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGA------ 246 (362)
T ss_dssp CTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTC------
T ss_pred ecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCC------
Confidence 6522 223456799999999999998999999999999999999999999975321 11111100000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+. ...........+.+++.+|++.||++|||+.|+++
T Consensus 247 -~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 -YDY-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCC-CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCC-CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00001123456788999999999999999999876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=338.38 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=199.5
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
++|+..+.||+|+||+||+|.+.+|+.||||++............+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 45778899999999999999998899999999865443333346788999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--V 154 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--c
Confidence 974 999988643 345899999999999999999999887 999999999999999999999999999876422 1
Q ss_pred ccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---cchhh--h
Q 012213 342 ECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---EGVVK--I 415 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~ 415 (468)
.......||+.|+|||++.+ ..++.++||||||+++|||+||+.||....... .+............ ....+ .
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccc
Confidence 22334568999999999875 458999999999999999999999997633110 11111110000000 00000 0
Q ss_pred ccccCC--------CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLS--------NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~--------~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.... .........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011110 011123456788999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.43 Aligned_cols=270 Identities=20% Similarity=0.242 Sum_probs=206.9
Q ss_pred hhccCCcceEccc--CCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRG--GAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
..+|+..+.||+| +||+||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5678889999999 99999999985 68999999997654444444678889999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998765567999999999999999999999887 99999999999999999999999999876532
Q ss_pred cCCC-----ccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc---
Q 012213 338 TGAS-----ECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS--- 407 (468)
Q Consensus 338 ~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 407 (468)
.+.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...... +..........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCCcccc
Confidence 2211 11233478999999999987 6799999999999999999999999976432211 10000000000
Q ss_pred -----c------------ccchhhhcc----------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 -----S------------KEGVVKILD----------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 -----~------------~~~~~~~~d----------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. .......+. ......+......+.+++.+|++.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 000000000 0000112223456889999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=336.44 Aligned_cols=264 Identities=17% Similarity=0.230 Sum_probs=209.2
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+..+..+ +|+|++++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 45688899999999999999996 5789999998854322 24588999999999 799999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----eEEeeccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-----AHVADFGLAK 333 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~ 333 (468)
|||+ +++|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||+++
T Consensus 85 ~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999 99999999743 345899999999999999999999777 999999999999988776 9999999998
Q ss_pred cccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 334 YLQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 334 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHHHhhcc
Confidence 77543221 123456799999999999999999999999999999999999999987432211 111111000000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
....... .......+.+++..|++.||++||++++|++.|+++...
T Consensus 239 ~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 239 STPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CccHHHH--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000000 112345688899999999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.28 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=211.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||.||+|.+. +++.||||.+.... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 567888999999999999999864 36789999986432 12223568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
.++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 999999999999999986422 135789999999999999999999887 999999999999999999999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+...
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~--- 251 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLR--- 251 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHHH---
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----HHHHH---
Confidence 99999987653333233344557889999999998899999999999999999999 8999975321 11111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.+........+......+.+++..|++.||++|||+.|+++.|+++..+
T Consensus 252 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 252 --------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111122222334456688899999999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=333.62 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=203.5
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCch-----hHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHD-----NGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++.......... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 45678889999999999999997 478999999986544332221 56889999999999999999999987655
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----eEEeec
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-----AHVADF 329 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Df 329 (468)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999988643 346899999999999999999999653 33999999999999988776 999999
Q ss_pred cccccccccCCCccccccccCccccCcccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYA--YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
|+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........ .+.......
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~ 245 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI---KFINMIREE 245 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH---HHHHHHHHS
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH---HHHHHHhcc
Confidence 99975431 23456789999999998 455678999999999999999999999976442221 111111111
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
. .....+......+.+++..|++.||++|||+.|+++.|+++
T Consensus 246 ~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 G----------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C----------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 01122234456788999999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=350.24 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=196.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC--CCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||++.+.+++.||||++..........+.+.+|+.++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45688889999999999999999899999999987544433334678899999999976 9999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||+ .+|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 88 ~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 588999999753 35899999999999999999999887 99999999999997 578999999999877543
Q ss_pred CCCccccccccCccccCccccCC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYT-----------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~--------- 228 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---IS--------- 228 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HH---------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HH---------
Confidence 33333445679999999999854 67899999999999999999999999753211 11
Q ss_pred cccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....++... ...+......+.+++..|++.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 229 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1111222111 1122223356778999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.24 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=195.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC------------------------CchhHHHHHHHHHh
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS------------------------SHDNGLSAEIRTLG 235 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~ 235 (468)
.+.|+..+.||+|+||.||+|.+ .+++.||||++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788889999999999999987 468899999986432211 11256889999999
Q ss_pred CCCCCCccceeEEEec--CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 012213 236 KIRHRNIVRLKAFCSN--KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313 (468)
Q Consensus 236 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 313 (468)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999986 5678999999999999987643 35899999999999999999999887 99999999
Q ss_pred CcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 314 NNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 314 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+||+++.++.+||+|||+++..... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999876432 22234567999999999987665 478999999999999999999999652
Q ss_pred CCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 391 GEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...+........ .. ..........+.+++.+|++.||++|||+.|+++
T Consensus 244 ~-----~~~~~~~~~~~~-------~~---~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R-----IMCLHSKIKSQA-------LE---FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S-----HHHHHHHHHHCC-------CC---CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c-----HHHHHHHHhccc-------CC---CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 111111111110 00 0011123456788999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=344.60 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=200.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcE----EEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++|+..+.||+|+||+||+|.+. +++. ||+|.+.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 456888899999999999999974 4443 5777765432 2334467999999999999999999999998754 7
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred eEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 89999999999999997543 45899999999999999999999887 999999999999999999999999999877
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~------------- 232 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL------------- 232 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH-------------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH-------------
Confidence 54333333344567889999999999999999999999999999999 999997643221 11111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
........+......+.+++..||+.||++||++.|+++.|+++..
T Consensus 233 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 233 -EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0111122233345578889999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=348.89 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=204.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 567888999999999999999975 578899999864321 223346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999743 45899999999999999999999887 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .......
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~------------ 231 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHT------------ 231 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHH------------
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHH------------
Confidence 23456789999999999864 458999999999999999999999997533221 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-MREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-~~ev~~ 454 (468)
+.......+......+.+++..|++.||++||+ ++++.+
T Consensus 232 ~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111112223344567888999999999999998 676654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=341.39 Aligned_cols=272 Identities=26% Similarity=0.323 Sum_probs=205.8
Q ss_pred hhhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC--CCCCccceeEEEecC----
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI--RHRNIVRLKAFCSNK---- 252 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~---- 252 (468)
.+.+.|+..+.||+|+||.||+|.+. ++.||||++.... ...+..|.+++... +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 34678899999999999999999885 8999999985321 23455566665554 899999999999877
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCceEEe
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6789999999999999999643 4899999999999999999999761 1139999999999999999999999
Q ss_pred eccccccccccCCCc--cccccccCccccCccccCCCCCCcc------hhhHHHHHHHHHHHhC----------CCCCCC
Q 012213 328 DFGLAKYLQDTGASE--CMSAVAGSYGYIAPEYAYTLKVDEK------SDVYSFGVVLLELITG----------RRPVGD 389 (468)
Q Consensus 328 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~~l~elltg----------~~p~~~ 389 (468)
|||+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764322211 1234579999999999987766654 9999999999999999 666655
Q ss_pred CCCCCcCHHHHHHHhhcccccchhhhccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCcc
Q 012213 390 FGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS--NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466 (468)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 466 (468)
..........+........ ...... .........+.+++..||+.||++|||+.||++.|+++.....++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKK-------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSC-------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred hcCCCCchhhhHHHHhhhc-------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence 3322222222222111110 011111 012367788999999999999999999999999999997766543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.44 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=199.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||+||+|.++ +++.||||+++..... ......+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 567888899999999999999975 5788999998754332 22235578899998876 89999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999998643 35899999999999999999999887 99999999999999999999999999985332
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc---CHHHHHHHhhcccccchhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL---DIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 414 (468)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...++ +.+
T Consensus 206 --~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~-----------~~~ 272 (396)
T 4dc2_A 206 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY-----------LFQ 272 (396)
T ss_dssp --TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH-----------HHH
T ss_pred --CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH-----------HHH
Confidence 22234567899999999999999999999999999999999999999975321110 00111 111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
.+.......+......+.+++..|++.||++||++
T Consensus 273 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11111112233345677889999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.52 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=202.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccC---CCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGIT---KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|+..+.||+|+||+||+|.+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 567888999999999999999874 68999999985422 11223467899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---eEEeeccc
Q 012213 257 LVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFGL 331 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl 331 (468)
+||||+++|+|.+++... .+..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887543 2335899999999999999999999887 999999999999987655 99999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+ +
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--~----------- 241 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RL--F----------- 241 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HH--H-----------
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HH--H-----------
Confidence 9876532 2223456799999999999999999999999999999999999999975210 00 1
Q ss_pred hhhhccccCCCCC---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVKILDQRLSNTP---LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~~~~~---~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+........+ ......+.+++.+|++.||++|||+.|+++
T Consensus 242 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 -EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111110000 112456788999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=350.42 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=193.4
Q ss_pred cCCcceEcccCCcceEEEEcC--CC--cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCeeEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP--NG--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 258 (468)
|...+.||+|+||+||+|.+. ++ ..||||.+.... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 556789999999999999864 22 358999876432 23334678999999999999999999998754 4577999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999974 3345889999999999999999999887 999999999999999999999999999876432
Q ss_pred CCC--ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 339 GAS--ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 339 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... .......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||...... +.....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~-------------- 309 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL-------------- 309 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHH--------------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHH--------------
Confidence 211 12234457889999999999999999999999999999999 78888654322 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
........+......+.+++..||+.||++|||+.|+++.|+++.
T Consensus 310 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 310 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111122334567888999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=331.17 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=207.5
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
+.++|+..+.||+|+||.||+|.+. +++.||||.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3577888999999999999999985 689999999864332 23346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+...
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999999643 45899999999999999999999887 999999999999999999999999999876533
Q ss_pred CCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
..........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............|... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~--------- 226 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KT--------- 226 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT---CT---------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc---cc---------
Confidence 33333445678999999999987765 679999999999999999999997644332222222110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...........+.+++..|++.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00011223456778999999999999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.21 Aligned_cols=269 Identities=26% Similarity=0.360 Sum_probs=211.5
Q ss_pred hhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhC--CCCCCccceeEEEecCC----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK--IRHRNIVRLKAFCSNKE---- 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---- 253 (468)
+.+.|+..+.||+|+||.||+|.+ +|+.||||++... ....+..|++++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 356788999999999999999998 5899999998532 23557788888776 79999999999998876
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEEcCCCceE
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH--------HDCSPLIIHRDVKSNNILLNSDFEAH 325 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~k 325 (468)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999643 4899999999999999999999 566 99999999999999999999
Q ss_pred EeeccccccccccCCCc--cccccccCccccCccccCCC------CCCcchhhHHHHHHHHHHHhC----------CCCC
Q 012213 326 VADFGLAKYLQDTGASE--CMSAVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELITG----------RRPV 387 (468)
Q Consensus 326 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~elltg----------~~p~ 387 (468)
|+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||+|| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999998765332211 22445789999999998765 234789999999999999999 7788
Q ss_pred CCCCCCCcCHHHHHHHhhcccccchhhhccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 388 GDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN--TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
............+........ ....+.. ........+.+++..||+.||++|||+.||++.|+++......
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQK-------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSC-------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred cccCcCcccHHHHHHHHHHHH-------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 664433333333333221111 1111111 1236677899999999999999999999999999999877765
Q ss_pred cC
Q 012213 466 QM 467 (468)
Q Consensus 466 ~~ 467 (468)
+|
T Consensus 341 ~~ 342 (342)
T 1b6c_B 341 KM 342 (342)
T ss_dssp --
T ss_pred CC
Confidence 53
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=353.07 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=197.2
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC--CCCccceeEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 259 (468)
..|+..+.||+|+||.||+|.+.+++.||||++............+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458888999999999999999988999999998654433334467899999999996 599999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999997543 5889999999999999999999877 99999999999995 5899999999998775433
Q ss_pred CCccccccccCccccCccccCC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-----------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~--------- 275 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----IS--------- 275 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HH---------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----HH---------
Confidence 3333445679999999998864 46889999999999999999999999753211 11
Q ss_pred ccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+..+++... ...+......+.+++..||+.||++|||+.|+++
T Consensus 276 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 276 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp --HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1112222211 1112222456788999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=343.50 Aligned_cols=247 Identities=21% Similarity=0.258 Sum_probs=193.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+. +|+.||||++............+..|+..+.++ +||||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 567888999999999999999986 789999999865443333334455666655555 899999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+ +++|.+++... ...++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 77999988643 345999999999999999999999887 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.......||+.|+|||++.+ .++.++||||||+++|||++|..|+... ..|........ ..
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~~~~--------~~ 271 (311)
T 3p1a_A 211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQQLRQGYL--------PP 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHHHHTTTCC--------CH
T ss_pred ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHhccCC--------Cc
Confidence 22345569999999998876 7999999999999999999997765431 11211111000 00
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. .+......+.+++..|++.||++|||+.|+++
T Consensus 272 ~---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 E---FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 01123456888999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.09 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=205.0
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
..+.+.|+..+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 445678899999999999999999885 68899999885432 122356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCceEEeecccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--DFEAHVADFGLAKY 334 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~ 334 (468)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999998743 345899999999999999999999887 999999999999974 47799999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+..........
T Consensus 201 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~i~~~~~----- 267 (387)
T 1kob_A 201 LNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDW----- 267 (387)
T ss_dssp CCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHCCC-----
T ss_pred cCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC-----
Confidence 6532 223345789999999999999999999999999999999999999975321 111111110000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+ ..........+.+++..|++.||++|||+.|+++
T Consensus 268 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 268 EFD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 1111233456788999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=349.28 Aligned_cols=269 Identities=16% Similarity=0.213 Sum_probs=205.0
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCC---------chhHHHHHHHHHhCCCCCCccce
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSS---------HDNGLSAEIRTLGKIRHRNIVRL 245 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l 245 (468)
.+.|+..+.||+|+||.||+|.+.+ ++.||||++........ ....+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999998865 47899999754321000 00123455667778899999999
Q ss_pred eEEEecC----CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--
Q 012213 246 KAFCSNK----ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-- 319 (468)
Q Consensus 246 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-- 319 (468)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 9998764 4479999999 99999999753 346999999999999999999999887 99999999999999
Q ss_pred CCCceEEeeccccccccccCCCc-----cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 012213 320 SDFEAHVADFGLAKYLQDTGASE-----CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG 394 (468)
Q Consensus 320 ~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 394 (468)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 88999999999998765332211 123455999999999999999999999999999999999999999753221
Q ss_pred cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.....+..... ...+..+++..+.. ......+.+++..||+.+|++||++.++++.|+++.
T Consensus 268 ~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 268 PKYVRDSKIRY---RENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHHHHHH---HHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHh---hhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 11222222111 12344444444321 122456788999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=339.08 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=203.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467888899999999999999985 689999999864321 122335688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999999743 35899999999999999999999777 99999999999999999999999999986542
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ... ...+...
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~-----------~~~i~~~ 218 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKT-----------YEKILNA 218 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH-----------HHHHHHC
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHH-----------HHHHHhC
Confidence 12356799999999999999999999999999999999999999975321 111 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.. ..+......+.+++..|++.||++|| +++|+++
T Consensus 219 ~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 EL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11 11223345678899999999999999 8888874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=350.49 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=198.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||+||+|.++ +|+.||||++..... .......+..|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467888899999999999999975 589999999864321 122335678899999887 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999643 34899999999999999999999887 99999999999999999999999999985432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +. ...+..
T Consensus 177 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~-----------~~~i~~ 238 (353)
T 3txo_A 177 --NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DL-----------FEAILN 238 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH-----------HHHHHH
T ss_pred --CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HH-----------HHHHHc
Confidence 222345568999999999999888999999999999999999999999753211 11 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM------REVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~------~ev~~ 454 (468)
... ..+......+.+++..|++.||++||++ +|+++
T Consensus 239 ~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111 1222344567889999999999999998 67654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.63 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=203.5
Q ss_pred hhccCCcc-eEcccCCcceEEEEc---CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNN-VIGRGGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|...+ .||+|+||+||+|.+ .+++.||||++..........+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34566666 999999999999954 3468899999876544444456799999999999999999999999 566789
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999753 34899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... +....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~----------- 232 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVTAM----------- 232 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH-----------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH-----------
Confidence 33221 11223446789999999988889999999999999999999 99999763311 11111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+........+......+.+++..|++.||++||++.|+++.|+++-
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 233 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111112223344567889999999999999999999999998763
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=347.22 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=209.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCC------CcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.+.|+..+.||+|+||.||+|.+.. ...||+|.+.... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4668888999999999999998743 2479999986432 222346688999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 321 (468)
..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999986432 235799999999999999999999887 9999999999999999
Q ss_pred CceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHH
Q 012213 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQW 400 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 400 (468)
+.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||.+..... .....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHH
Confidence 9999999999987654433333445567889999999988899999999999999999999 999997633211 11111
Q ss_pred HHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 401 TKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 401 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
... ... ...+......+.+++..|++.||.+|||+.||++.|+++.
T Consensus 280 ~~~-----------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 280 VKD-----------GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHH-----------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hhc-----------CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 110 000 1112223456788999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.73 Aligned_cols=259 Identities=30% Similarity=0.462 Sum_probs=201.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+.|+..+.||+|+||.||+|.+.. +..||||.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 4567778999999999999998743 2359999986432 222335688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999743 345899999999999999999999887 999999999999999999999999999876
Q ss_pred cccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 336 QDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 336 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +.. .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~-----------~ 261 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVM-----------K 261 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-----------H
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----HHH-----------H
Confidence 532211 11223346789999999998899999999999999999999 99999653211 111 1
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+.+......+......+.+++..||+.+|++||++.|+++.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111223344567889999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=336.39 Aligned_cols=260 Identities=29% Similarity=0.408 Sum_probs=201.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCC----cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe-cCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNG----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-NKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~ 255 (468)
...|+..+.||+|+||+||+|.+.++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++. ..+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34577789999999999999986432 358999886432 2223356889999999999999999999865 45577
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999974 3345899999999999999999999887 999999999999999999999999999876
Q ss_pred cccCC--CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 336 QDTGA--SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 336 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
..... ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... ...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~------------- 243 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITV------------- 243 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHH-------------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHH-------------
Confidence 43221 122334567889999999999899999999999999999999 666665533211 111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
..........+......+.+++..|++.+|++|||+.|++++|+++..
T Consensus 244 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 244 -YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111111122334568889999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=342.05 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=204.3
Q ss_pred cchhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCC------chhHHHHHHHHHhCCCCCCccceeEEE
Q 012213 177 SDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFC 249 (468)
Q Consensus 177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~ 249 (468)
..++.+.|+..+.||+|+||+||+|.+ .+++.||||++........ ....+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345678899999999999999999986 5688999999875433221 224578899999999999999999999
Q ss_pred ecCCeeEEEEeccCCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 012213 250 SNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328 (468)
Q Consensus 250 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 328 (468)
.+.+..++||||+.+| +|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999999777 999998643 35899999999999999999999887 99999999999999999999999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
||++...... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 174 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------- 235 (335)
T 3dls_A 174 FGSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------- 235 (335)
T ss_dssp CTTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------
T ss_pred cccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------
Confidence 9999876532 22344678999999999988776 7899999999999999999999965211
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
...... ..+......+.+++..|++.||++|||+.|+++.
T Consensus 236 -------~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -------TVEAAI-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------GTTTCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------HHhhcc-CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1111234567889999999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=332.72 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=205.8
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.++|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.+....++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 44678899999999999999999874 58899999987554444444678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---eEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~ 334 (468)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 83 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999888643 35899999999999999999999887 999999999999987655 99999999976
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~------ 223 (284)
T 3kk8_A 158 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGA------ 223 (284)
T ss_dssp CCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTC------
T ss_pred cccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHHHHhcc------
Confidence 5422 223456789999999999999999999999999999999999999965321 11111100000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ............+.+++..|++.||++|||+.|+++
T Consensus 224 -~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 -YD-YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CC-CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cc-CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 001111223456788999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.81 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=206.5
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec------
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------ 251 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 251 (468)
.+...|+..+.||+|+||.||+|.+. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34577889999999999999999985 78999999986432 457899999999999999999998854
Q ss_pred ----------CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 012213 252 ----------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321 (468)
Q Consensus 252 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 321 (468)
....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 345789999999999999997665567999999999999999999999887 9999999999999999
Q ss_pred CceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHH
Q 012213 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 322 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 401 (468)
+.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~ 228 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFF 228 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHH
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHH
Confidence 999999999998765322 223456899999999999989999999999999999999999886421 0111
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
..+.+.... ......+.+++..|++.||++|||+.|+++.|+.+....
T Consensus 229 -----------~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 -----------TDLRDGIIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -----------HHHHTTCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -----------HHhhccccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111111111 122345678999999999999999999999999887554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=367.99 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=198.8
Q ss_pred eEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.||+|+||.||+|.+. ++..||||+++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 7999999999999874 466799999875432 2334679999999999999999999999976 5689999999999
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC-ccc
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-ECM 344 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~ 344 (468)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 421 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 421 PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp BHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred cHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 999999743 446899999999999999999999887 999999999999999999999999999876432211 112
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNT 423 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 423 (468)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .+... +........
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~--------------i~~~~~~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF--------------IEQGKRMEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHH--------------HHTTCCCCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHH--------------HHcCCCCCC
Confidence 23345689999999998999999999999999999998 99999764321 11111 111111223
Q ss_pred CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 424 PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 424 ~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
+......+.+++..||+.+|++||++.+|++.|+.+
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 344567788999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=336.62 Aligned_cols=269 Identities=27% Similarity=0.376 Sum_probs=207.2
Q ss_pred hhccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--E 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 253 (468)
.+.|+..+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 45578889999999999999983 4688999999875432 33346789999999999999999999999876 5
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 6799999999999999996432 45899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc-cc--
Q 012213 334 YLQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS-SK-- 409 (468)
Q Consensus 334 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~-- 409 (468)
........ .......||..|+|||.+.+..++.++||||||+++|||+||+.|+.... ..+....... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMT 248 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccC
Confidence 76533221 22344568889999999998899999999999999999999999864310 0000000000 00
Q ss_pred -cc-hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 410 -EG-VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 410 -~~-~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.. ...+........+......+.+++..|++.||++|||+.|++++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00 0111111112233345567889999999999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=344.57 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=188.6
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
+.+.|+..+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3567888999999999999999986 57889999986432 225588999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEeeccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYL 335 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~ 335 (468)
|||+++|+|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+++..
T Consensus 127 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp ECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999643 45899999999999999999999887 999999999999975 889999999999865
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.... .... ..
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~i~-~~~~----~~ 270 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFRRIL-NCEY----YF 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHHHH-TTCC----CC
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHHHHH-hCCC----cc
Confidence 422 22345678999999999999999999999999999999999999997533211 0111110 0000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...........+.+++.+|++.||++|||+.|+++
T Consensus 271 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111234456788999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.35 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=197.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||+||+|.+. ++.||||++.. ....+.+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 456788899999999999999885 78899998753 2334678999999999999999999998864 4799999
Q ss_pred ccCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-eEEeecccccccccc
Q 012213 261 YMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-AHVADFGLAKYLQDT 338 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~ 338 (468)
|+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999975432 24789999999999999999999833244999999999999998887 799999999765421
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||......... ..|... ..
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-------------~~ 220 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVH-------------NG 220 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHH-------------TT
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHh-------------cC
Confidence 22346899999999999999999999999999999999999999764322111 111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
............+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111112233456788999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.33 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=205.4
Q ss_pred hccCCcc-eEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNN-VIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
++|...+ .||+|+||.||+|.+. ++..||||++.... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 3445544 8999999999999863 57789999986532 223346788999999999999999999999 4566899
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999643 345899999999999999999999887 99999999999999999999999999987653
Q ss_pred cCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..... +
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~--------------i 226 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF--------------I 226 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH--------------H
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH--------------H
Confidence 2221 11233456889999999988889999999999999999999 99999763321 11111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
........+......+.+++..|++.+|++||++.|+++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111112223345567889999999999999999999999998774
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=340.97 Aligned_cols=251 Identities=24% Similarity=0.279 Sum_probs=200.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||.||+|.++ +++.||+|++....... .....+..|+.++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 567888899999999999999985 58899999997543322 2235578899999887 89999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999998643 35899999999999999999999887 99999999999999999999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc---CHHHHHHHhhcccccchhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL---DIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 414 (468)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... ...
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----------~~~ 230 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL----------FQV 230 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH----------HHH
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH----------HHH
Confidence 2 2234556899999999999999999999999999999999999999975321110 000000 011
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
+... ....+......+.+++.+|++.||++||++
T Consensus 231 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1111 112233345677889999999999999995
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=342.47 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=209.8
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++..... ......+.+|+.++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 56788899999999999999974 3568899999864322 22235688999999999 7999999999987755
Q ss_pred -eeEEEEeccCCCChhhhcccCCCC--------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKRGS--------------FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~~~--------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 318 (468)
..++||||+++|+|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEE
Confidence 489999999999999999754421 2889999999999999999999887 9999999999999
Q ss_pred cCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCH
Q 012213 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDI 397 (468)
Q Consensus 319 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~ 397 (468)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-HH
Confidence 9999999999999987654333333445567899999999999899999999999999999998 999997633211 01
Q ss_pred HHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
. .. +........+......+.+++..|++.||++|||+.|+++.|+.+...
T Consensus 261 ~---~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 261 C---RR-----------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp H---HH-----------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HH-----------hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1 00 000111112223445688899999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=343.08 Aligned_cols=247 Identities=21% Similarity=0.229 Sum_probs=203.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 567888899999999999999985 689999999864321 223346688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999999743 34899999999999999999999887 999999999999999999999999999876421
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. ..+...
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~-----------~~i~~~ 253 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIY-----------EKIVSG 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-----------HHHHHC
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHH-----------HHHHcC
Confidence 2346799999999999999999999999999999999999999975321 1111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
.. ..+......+.+++..|++.||++||+ ++||++
T Consensus 254 ~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 KV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 122234566788999999999999998 888865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=344.43 Aligned_cols=268 Identities=28% Similarity=0.404 Sum_probs=205.6
Q ss_pred cCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC--CeeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNL 256 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 256 (468)
|+..+.||+|+||+||++.+ .+++.||||++.... .......+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 47889999999999998864 268899999986432 223345689999999999999999999999874 5678
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 112 lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999996543 899999999999999999999887 9999999999999999999999999998775
Q ss_pred ccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
..... .......+|..|+|||.+.+..++.++||||||+++|||+||+.||............+...... .....+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 263 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT--VLRLTEL 263 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH--HHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh--HHHHHHH
Confidence 33221 12334567888999999998889999999999999999999999986421100000000000000 0011111
Q ss_pred cccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 416 LDQR-LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 416 ~d~~-~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
++.. ....+......+.+++..||+.||++|||+.|+++.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 12233445677889999999999999999999999998774
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=334.19 Aligned_cols=257 Identities=27% Similarity=0.383 Sum_probs=201.8
Q ss_pred ccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee-EE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-LL 257 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l 257 (468)
.|...+.||+|+||+||+|.+.+ +..||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35566899999999999998632 23699999864322 22336788999999999999999999999876665 99
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 101 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999974 3456899999999999999999999887 99999999999999999999999999986543
Q ss_pred cC--CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 338 TG--ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP-VGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 338 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
.. .........+++.|+|||...+..++.++||||||+++|||++|..| |..... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~------------- 241 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFL------------- 241 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHH-------------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHh-------------
Confidence 22 11223345678999999999999999999999999999999995555 433221 1111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
........+......+.+++..|++.||.+|||++|+++.|+++.
T Consensus 242 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 242 -AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111222334457888999999999999999999999998874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=343.33 Aligned_cols=270 Identities=16% Similarity=0.181 Sum_probs=201.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC----CCcEEEEEEecccCCCCC---------chhHHHHHHHHHhCCCCCCccceeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSS---------HDNGLSAEIRTLGKIRHRNIVRLKA 247 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~ 247 (468)
.++|...+.||+|+||.||+|.+. ++..||||++........ ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457888999999999999999985 578899998864322100 1134667888999999999999999
Q ss_pred EEec----CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-
Q 012213 248 FCSN----KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF- 322 (468)
Q Consensus 248 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~- 322 (468)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9987 67889999999 999999997543 6899999999999999999999887 99999999999999887
Q ss_pred -ceEEeeccccccccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcC
Q 012213 323 -EAHVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD 396 (468)
Q Consensus 323 -~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 396 (468)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||+||+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876532211 1124557999999999999989999999999999999999999999642211111
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
................... .. .......+.+++..||+.||++||++++|++.|+++..+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKW----AP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHH----SC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred HHHHHHhhcccccHHHHhh----cc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1111111111110001100 00 012345688899999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=346.41 Aligned_cols=249 Identities=24% Similarity=0.279 Sum_probs=201.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||.||+|.++ +|+.||||++..... .......+..|..++..+ +||||+++++++.+.+..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 567888899999999999999985 588999999865321 122335678889888876 89999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 96 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999643 34899999999999999999999887 99999999999999999999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ...... +..
T Consensus 171 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~-----------i~~ 232 (345)
T 1xjd_A 171 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHS-----------IRM 232 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-----------HHH
T ss_pred C--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH-----------HHh
Confidence 1 2224567899999999999999999999999999999999999999975321 111110 100
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMR-EVV 453 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~-ev~ 453 (468)
.. ...+......+.+++.+|++.||++||++. |++
T Consensus 233 ~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 DN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 112223445678899999999999999997 654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.58 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=199.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-CeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-ETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 259 (468)
.+.|+..+.||+|+||+||+|.+. |+.||||.+... ...+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 567888999999999999999874 889999998532 2336789999999999999999999997654 4689999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999997544344889999999999999999999887 999999999999999999999999999765422
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ... ..+...
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~--------------~~~~~~ 230 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV--------------PRVEKG 230 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHH--------------HHHTTT
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH--------------HHHhcC
Confidence 123357889999999998899999999999999999998 99999763321 111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.....+......+.+++..|++.||++|||+.|+++.|++++.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1112233445678889999999999999999999999998864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=353.02 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=204.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
...|...+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456888899999999999999985 789999999864321 122335789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999964 345899999999999999999999877 999999999999999999999999999876432
Q ss_pred CCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.... .. ..++.+
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~-----------~~~i~~ 230 (476)
T 2y94_A 170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TL-----------FKKICD 230 (476)
T ss_dssp ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HH-----------HHHHHT
T ss_pred ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HH-----------HHHHhc
Confidence 22345679999999999988765 68999999999999999999999753211 11 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ..+......+.+++..|++.||++|||+.|+++
T Consensus 231 ~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 231 GIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111 112223456788999999999999999999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=333.95 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=202.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||+||+|.+.+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 5678888999999999999998643 3359999886432 22234678999999999999999999999865 4568
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999999643 345899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... ........+++.|+|||...+..++.++||||||+++|||+| |+.||...... .......
T Consensus 165 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~------------- 228 (281)
T 3cc6_A 165 DED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLE------------- 228 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHH-------------
T ss_pred ccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHh-------------
Confidence 322 222334557889999999998899999999999999999998 99999753321 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.......+......+.+++..|++.||++|||+.|+++.|+++.
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 229 -KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11111122234466888999999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=343.82 Aligned_cols=251 Identities=13% Similarity=0.129 Sum_probs=203.8
Q ss_pred hhccCCcceEcccCCcceEEEE------cCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC---CCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 251 (468)
.+.|...+.||+|+||+||+|. ..+++.||||++... ...++..|+.++..++ |+|++++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4668888999999999999994 356889999998532 2356788888888886 8999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--------
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGK---RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-------- 320 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------- 320 (468)
.+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999632 3446999999999999999999999877 999999999999998
Q ss_pred ---CCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCH
Q 012213 321 ---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI 397 (468)
Q Consensus 321 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 397 (468)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999987654444445566789999999999999999999999999999999999999985422110
Q ss_pred HHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCC-CCHHHHHHHHHhcc
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVER-PTMREVVQMLAQAQ 460 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~R-Pt~~ev~~~L~~~~ 460 (468)
.. ++..+...+ ....+.+++..|++.+|.+| |+++++.+.|+++.
T Consensus 293 ------------~~----~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 ------------CK----PEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ------------EE----ECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ------------ee----echhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 01 111111111 23455678889999999999 68888888887763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=339.87 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=194.0
Q ss_pred hhccCCcceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.+.|+..+.||+|+||.||++.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 56788899999999999999987 4789999999875432 12223557889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999643 34889999999999999999999887 99999999999999999999999999976
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... ..
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~-----------~~ 232 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTI-----------DK 232 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH-----------HH
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHH-----------HH
Confidence 43221 223456799999999999998999999999999999999999999975321 1111 11
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
+..... ..+......+.+++.+|++.||++|| ++.|+++
T Consensus 233 i~~~~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 233 ILKCKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHTCC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHhCCC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111 12223346678899999999999999 7778765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=335.13 Aligned_cols=266 Identities=20% Similarity=0.290 Sum_probs=201.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+|+..+.||+|+||.||+|.+ .+|+.||||++...... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 56788899999999999999987 57899999998753322 22345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 259 YEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
|||+++|+|.+++.. .....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 23446899999999999999999999887 9999999999999999999999999998764
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.......
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--------- 253 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQC--------- 253 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHHHTT---------
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHhhcc---------
Confidence 322 122345689999999999999999999999999999999999999975321 222222211111
Q ss_pred cccCCC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 417 DQRLSN-TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 417 d~~~~~-~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
.... ........+.+++..|++.||++|||+.||++.|+++.+..+.
T Consensus 254 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 254 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp --CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1111 1123345688899999999999999999999999998765543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=334.02 Aligned_cols=248 Identities=19% Similarity=0.314 Sum_probs=202.0
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
.+.+.|+..+.||+|+||+||+|.+. +++.||||++............+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34677889999999999999999985 789999999876544444556788999999998 9999999999999999999
Q ss_pred EEEeccCCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--------------
Q 012213 257 LVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-------------- 320 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------------- 320 (468)
+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999997532 245899999999999999999999887 999999999999984
Q ss_pred -----CCceEEeeccccccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 012213 321 -----DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEG 394 (468)
Q Consensus 321 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 394 (468)
...+||+|||.+...... ....||+.|+|||.+.+. .++.++||||||+++|||++|.+|+....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 447999999999876432 223589999999998765 56689999999999999999998764311
Q ss_pred cCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 395 LDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.|.. +........+......+.+++..|++.||++|||+.|+++
T Consensus 236 ----~~~~------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----QWHE------------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHHH------------HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHH------------HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111 1111222222334567888999999999999999999976
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=330.53 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=184.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+ .+|+.||||.+..... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 56788899999999999999997 5789999999854321 122236789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999743 346899999999999999999999887 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~ 227 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----------------TLNKVVLA 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS
T ss_pred C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----------------HHHHHhhc
Confidence 2 12234568999999999998889999999999999999999999997633111 00111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...+......+.+++.+|++.||++|||++|+++
T Consensus 228 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 D-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1 1112233456788999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.84 Aligned_cols=274 Identities=22% Similarity=0.277 Sum_probs=212.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC--eeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--TNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 257 (468)
.+.|...+.||+|+||+||+|.+. +|+.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467888999999999999999985 489999999875332 222466789999999999999999999998765 6799
Q ss_pred EEeccCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCceEEeecccc
Q 012213 258 VYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFGLA 332 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla 332 (468)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999975432 24899999999999999999999887 9999999999999 77888999999999
Q ss_pred ccccccCCCccccccccCccccCccccCC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYT--------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.................
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 876432 22345679999999998764 4678899999999999999999999976433222222222211
Q ss_pred hcccccch---hhhcc------ccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 405 TNSSKEGV---VKILD------QRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 405 ~~~~~~~~---~~~~d------~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.......+ ....+ ..+ ..........+.+++..|++.||++||++.|+++.++++-.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11110000 00000 011 22346677888899999999999999999999999988754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=342.31 Aligned_cols=251 Identities=25% Similarity=0.284 Sum_probs=192.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||++.+. +++.||||++..... ..+.+.+|+..++.++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 567888999999999999999985 789999999864322 2266889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--eEEeeccccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVADFGLAKYLQD 337 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~~~~ 337 (468)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++....
T Consensus 96 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 96 EYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999998643 34899999999999999999999887 999999999999988765 99999999975432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEK-SDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... ....... .+.
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~-----------~~~ 235 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQ-----------RIL 235 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHH-----------HHH
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHH-----------HHh
Confidence 122344579999999999988777665 899999999999999999997643211 1111111 111
Q ss_pred cccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ..........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1111 0111123456788999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=338.95 Aligned_cols=258 Identities=19% Similarity=0.292 Sum_probs=204.3
Q ss_pred chhhhccCCc-ceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCe
Q 012213 178 DDILECVKDN-NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET 254 (468)
Q Consensus 178 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 254 (468)
+.+.+.|... +.||+|+||.||+|.+. +++.||||++............+.+|+.++..++ ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3345556665 88999999999999875 6899999998765554444567899999999994 6999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEeeccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGL 331 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl 331 (468)
.++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999997666667999999999999999999999887 999999999999998 78999999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+....
T Consensus 181 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~------- 246 (327)
T 3lm5_A 181 SRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETYLNIS------- 246 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-------
T ss_pred ccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHH-------
Confidence 9876422 1224467899999999999999999999999999999999999999753211 0011100
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.................+.+++..|++.||++|||++|+++
T Consensus 247 --~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 --QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00000011112234556788999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=342.20 Aligned_cols=262 Identities=24% Similarity=0.282 Sum_probs=202.2
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccC---CCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGIT---KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
++.+.|+..+.||+|+||.||+|.+ .+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4567899999999999999999987 467889999986432 123445678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------------------------------------GSFLKWEMRLKIAIEAAKGLS 296 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~~l~ 296 (468)
.++||||+++|+|.+++.... ...+++..+..++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999999985210 112467788899999999999
Q ss_pred HhhhcCCCCeeecCCCCCcEEEcCCC--ceEEeeccccccccccCC--CccccccccCccccCccccCC--CCCCcchhh
Q 012213 297 YLHHDCSPLIIHRDVKSNNILLNSDF--EAHVADFGLAKYLQDTGA--SECMSAVAGSYGYIAPEYAYT--LKVDEKSDV 370 (468)
Q Consensus 297 ~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv 370 (468)
|||+.+ |+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++||
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999887 99999999999998776 899999999987643222 122345679999999999865 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC---CCCHHHHHHHHHHHHhhcccCCCCCC
Q 012213 371 YSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS---NTPLSEAMQVFFVAMLCVQEHGVERP 447 (468)
Q Consensus 371 ~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~~~~l~~~c~~~~P~~RP 447 (468)
||||+++|||++|+.||...... +. ...+...... .........+.+++..|++.||++||
T Consensus 260 wslG~il~el~~g~~pf~~~~~~-----~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDA-----DT-----------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH-----HH-----------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHCCCCCCCCChH-----HH-----------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999753311 11 1111111110 01112345678899999999999999
Q ss_pred CHHHHHH--HHHhc
Q 012213 448 TMREVVQ--MLAQA 459 (468)
Q Consensus 448 t~~ev~~--~L~~~ 459 (468)
++.|+++ .+++.
T Consensus 324 s~~~~l~hp~~~~~ 337 (345)
T 3hko_A 324 DAMRALQHPWISQF 337 (345)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhcChhhccC
Confidence 9999987 45544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=338.52 Aligned_cols=255 Identities=21% Similarity=0.365 Sum_probs=200.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-C-------cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-G-------EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
.++|...+.||+|+||+||+|.+.. + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4578888999999999999998753 3 4699999864332 3346789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--------e
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--------A 324 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~ 324 (468)
+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999753 334899999999999999999999887 999999999999998887 9
Q ss_pred EEeeccccccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCcCHHHHHH
Q 012213 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGR-RPVGDFGEEGLDIVQWTK 402 (468)
Q Consensus 325 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~~~~~~~~ 402 (468)
||+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|. +|+..... .....
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~ 229 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQ 229 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHH
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHH
Confidence 9999999875431 123457899999999887 67899999999999999999954 45443221 11111
Q ss_pred HhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 403 MQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
..... ...+......+.+++..|++.||++|||+.|+++.|+++..+...
T Consensus 230 ~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 230 FYEDR-------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHHTT-------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred Hhhcc-------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 00000 001111234567899999999999999999999999999776543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.56 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=200.0
Q ss_pred ceEcccCCcceEEEEc---CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||.||+|.+ ..++.||||+++.........+.+.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999965 346789999997654444445779999999999999999999999965 558899999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC-Ccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA-SEC 343 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~ 343 (468)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999643 35899999999999999999999887 99999999999999999999999999987653222 122
Q ss_pred ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +.. ..+.......
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~-----------~~i~~~~~~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVT-----------AMLEKGERMG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHH-----------HHHHTTCCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-----------HHHHcCCCCC
Confidence 233456789999999999999999999999999999999 99999764321 111 1111111122
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.+......+.+++..||+.||++||++.+|+++|+++
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3334567788999999999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.13 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=191.3
Q ss_pred hhhccCCc-ceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHH-hCCCCCCccceeEEEec----C
Q 012213 180 ILECVKDN-NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTL-GKIRHRNIVRLKAFCSN----K 252 (468)
Q Consensus 180 ~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~ 252 (468)
+.+.|... +.||+|+||+||++.+. +++.||||++... ..+.+|+.++ +..+||||+++++++.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 35556554 78999999999999975 6889999998521 4577888886 44589999999998865 5
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEeec
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADF 329 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 329 (468)
...++||||+++|+|.+++.......+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 56899999999999999998655557999999999999999999999887 999999999999998 789999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--CHHHHHHHhhcc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--DIVQWTKMQTNS 407 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~ 407 (468)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ ..
T Consensus 209 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--~~ 283 (400)
T 1nxk_A 209 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--GQ 283 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--TC
T ss_pred ccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--Cc
Confidence 999865422 223456789999999999999999999999999999999999999976432211 11111110 00
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ... ..........+.+++..|++.||++|||+.|+++
T Consensus 284 ~-----~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 284 Y-----EFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp C-----CCC----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-----cCC----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000 0011223456788999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=341.73 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=204.2
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 56788899999999999999984 357789999986332 22233568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRG-----SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl 326 (468)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 35899999999999999999999887 999999999999994 456999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~-- 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEF-- 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH--
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHHHHH--
Confidence 99999986653333333345567899999999988899999999999999999998 9999975321 111111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+........+......+.+++..|++.||++||++.|+++.|+.+.
T Consensus 258 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 ---------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1111111122334567888999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=339.71 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=178.8
Q ss_pred cceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEeccCC
Q 012213 187 NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
.+.||+|+||+||+|.+. +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999985 6899999998532 2356889999999997 99999999999999999999999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---ceEEeeccccccccccCCC
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~ 341 (468)
|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+++..... .
T Consensus 91 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~ 163 (325)
T 3kn6_A 91 GELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N 163 (325)
T ss_dssp CBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--C
Confidence 9999999754 45899999999999999999999887 99999999999998765 8999999999865422 2
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--CcCHHHHHHHhhcccccchhhhcccc
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE--GLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. ..+....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----------~~i~~~~ 232 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----------KKIKKGD 232 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-----------HHHTTTC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-----------HHHHcCC
Confidence 2234566899999999999999999999999999999999999999763321 11111111 1111111
Q ss_pred CCCCC---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTP---LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~---~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..... ......+.+++..|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111 123466889999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=342.32 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=202.4
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||.||+|.++. ++.||||++..... .......+..|..++..+ +||+|+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678888999999999999999864 78899999865321 122335688899999988 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999643 34899999999999999999999887 99999999999999999999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .... ..+..
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~-----------~~i~~ 235 (353)
T 2i0e_A 174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF-----------QSIME 235 (353)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-----------HHHHH
T ss_pred C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHH-----------HHHHh
Confidence 1 2234566899999999999999999999999999999999999999975321 1111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
... ..+......+.+++..|++.||++||+ ++|+++
T Consensus 236 ~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 HNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111 122234567888999999999999995 466654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.86 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=203.0
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
++.+.|+..+.||+|+||.||+|.+. ++..||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 45678899999999999999999985 4678999998654332 34679999999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~ 334 (468)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999988643 34899999999999999999999887 9999999999999 7889999999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+... .......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... +.. ..
T Consensus 159 ~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~-----------~~ 218 (277)
T 3f3z_A 159 FKPG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVM-----------LK 218 (277)
T ss_dssp CCTT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH-----------HH
T ss_pred ccCc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHH-----------HH
Confidence 6422 223455789999999988764 899999999999999999999999753211 111 11
Q ss_pred hccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+..... ..+. .....+.+++..|++.||++|||+.|+++
T Consensus 219 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 219 IREGTF-TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHCCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHhCCC-CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 1111 12456788999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.09 Aligned_cols=248 Identities=20% Similarity=0.251 Sum_probs=194.0
Q ss_pred CCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccC
Q 012213 185 KDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
...+.||+|+||.||+|.+ .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3457899999999999987 4689999999864322 234678999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCCceEEeeccccccccccCCC
Q 012213 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL--NSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 264 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 170 ~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-- 243 (373)
T 2x4f_A 170 GGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-- 243 (373)
T ss_dssp TCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--
Confidence 99999988643 335899999999999999999999887 9999999999999 567899999999998765322
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 421 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........... ....
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~----~~~~--- 310 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AETLNNILACRWD----LEDE--- 310 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCC----SCSG---
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCC----CChh---
Confidence 22345699999999999988999999999999999999999999975321 1111111110000 0000
Q ss_pred CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 422 ~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........+.+++.+|++.||++|||+.|+++
T Consensus 311 -~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 -EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01123456788999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=351.37 Aligned_cols=251 Identities=23% Similarity=0.246 Sum_probs=201.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.++ +++.||+|++..... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 567888999999999999999985 588999999864211 112224588999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 148 ~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp ECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999643 4899999999999999999999887 999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+. ... ..+
T Consensus 222 -~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~-----------~~~ 284 (410)
T 3v8s_A 222 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGT-----------YSK 284 (410)
T ss_dssp -SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH-----------HHH
T ss_pred -CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhH-----------HHH
Confidence 222334678999999999987655 78999999999999999999999975321 111 111
Q ss_pred hcccc--C-CCCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 012213 415 ILDQR--L-SNTPLSEAMQVFFVAMLCVQEHGVE--RPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~--~-~~~~~~~~~~~~~l~~~c~~~~P~~--RPt~~ev~~ 454 (468)
++... + ..........+.+++..|+..+|++ ||+++||++
T Consensus 285 i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11100 0 0011123456778999999999988 999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.58 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=188.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 456888899999999999999975 588999999865432 223366889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 260 EYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
||++ |+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 69999886422 235899999999999999999999887 999999999999999999999999999876
Q ss_pred cccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---cc
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---EG 411 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 411 (468)
... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+............ ..
T Consensus 159 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGG
T ss_pred CCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhh
Confidence 422 122345578999999999876 468999999999999999999999997633110 01001000000000 00
Q ss_pred hhhhc--cccC----CC---------CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVKIL--DQRL----SN---------TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~~~--d~~~----~~---------~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.. .... .. ........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 0000 00 00122356889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.09 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=205.9
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCC----chhHHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
..+.+.|+..+.||+|+||.||+|.+. +|+.||||.+........ ..+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345677899999999999999999975 689999999875443221 246789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----ceEEee
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVAD 328 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 328 (468)
...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999999643 35899999999999999999999887 99999999999999888 799999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
||++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.........
T Consensus 163 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 234 (321)
T 2a2a_A 163 FGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITSVS 234 (321)
T ss_dssp CTTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTC
T ss_pred CccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcc
Confidence 9999876532 223455689999999999999999999999999999999999999965321 11111110000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. . .+... .......+.+++..|++.||++|||+.|+++
T Consensus 235 ~-~----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y-D----FDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C-C----CCHHH---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c-c----cChhh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0 00000 0112356788999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=338.79 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=204.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcE--EEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQ--VAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||.||+|.+. ++.. +|||.+..... ......+.+|++++.++ +||||+++++++.+.+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 467888899999999999999975 4554 49998864322 22335689999999999 8999999999999999999
Q ss_pred EEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 257 LVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997543 346899999999999999999999887 99999999999999999
Q ss_pred ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 401 (468)
.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+..
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~ 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELY 251 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHH
Confidence 9999999999754321 11233456889999999988889999999999999999998 9999975321 1111
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
.. +........+......+.+++..|++.||++|||+.|+++.|+++...
T Consensus 252 ~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 EK-----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HH-----------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HH-----------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 111111122233456788999999999999999999999999877433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=334.78 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=197.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+. +|+.||||++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 456888899999999999999985 5899999998654433333466889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999988643 34899999999999999999999887 9999999999999999999999999998764222
Q ss_pred CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc--------
Q 012213 340 ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE-------- 410 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 410 (468)
.......||..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ..............
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHT
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhccccccccccccc
Confidence 22345578999999998875 568999999999999999999999997633211 11100000000000
Q ss_pred --chh--hhccccCCC----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 --GVV--KILDQRLSN----TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 --~~~--~~~d~~~~~----~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ...+..... ........+.+++..|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000000000 00123455788999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=336.96 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=206.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe--cCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 257 (468)
.++|+..+.||+|+||.||+|.+. +++.||+|.+..........+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 567888899999999999999985 6899999998754433344467899999999999999999999874 4567899
Q ss_pred EEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 258 VYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999643 2345899999999999999999999765 2349999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
..... ........|++.|+|||.+.+..++.++||||||+++|||+||+.||..... .+.. .
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-----------~ 226 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELA-----------G 226 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-----------H
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHH-----------H
Confidence 76422 1122345689999999999988999999999999999999999999975321 1111 1
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.+........+......+.+++..|++.||++||++.|+++.+....
T Consensus 227 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 227 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred HHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 11111112223334567888999999999999999999998765544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=353.77 Aligned_cols=257 Identities=21% Similarity=0.203 Sum_probs=202.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-CcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+++ ++.||||++..... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 5678899999999999999999864 78899999864211 111224588999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 153 ~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp ECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999742 345899999999999999999999887 999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 339 GASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
........+||+.|+|||++. ...++.++|||||||++|||++|+.||...+.. ..+.... ..
T Consensus 229 -~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----~~~~~i~-~~------ 296 (437)
T 4aw2_A 229 -GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGKIM-NH------ 296 (437)
T ss_dssp -SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-TH------
T ss_pred -CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh----HHHHhhh-hc------
Confidence 222334568999999999986 567899999999999999999999999753211 0111100 00
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVE--RPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~--RPt~~ev~~ 454 (468)
.....+..........+.+++.+|+..+|++ ||+++|+++
T Consensus 297 -~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 -KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000111111123456778899998888887 999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=331.58 Aligned_cols=248 Identities=27% Similarity=0.352 Sum_probs=199.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+. +++.||||++..... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 677888999999999999999875 567899999854321 112235688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999998643 34899999999999999999999777 999999999999999999999999998654321
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...... .
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-----------~- 221 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRIS-----------R- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH-----------H-
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHH-----------h-
Confidence 22345789999999999999999999999999999999999999975321 11111000 0
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....+......+.+++..|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001122233456778999999999999999999997
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.78 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=195.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+ .+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46788899999999999999997 4688999999865321 222235678899999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999998643 358999999999999999999997 67 99999999999999999999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .........
T Consensus 302 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~----------- 363 (446)
T 4ejn_A 302 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILM----------- 363 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH-----------
T ss_pred C--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHHh-----------
Confidence 2 2233557899999999999999999999999999999999999999965321 111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.. ...+......+.+++..|++.||++|| +++|+++
T Consensus 364 ~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 EE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 112223446678899999999999999 9999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=334.40 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=199.9
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCC---CCchhHHHHHHHHHhCCC---CCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG---SSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||+||+|.+ .+++.||||++...... ......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56788999999999999999997 56889999998643321 112245777888777664 999999999997765
Q ss_pred -----eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEee
Q 012213 254 -----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328 (468)
Q Consensus 254 -----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 328 (468)
..++||||++ |+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 4789999996 69999998766666999999999999999999999888 99999999999999999999999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||....... .+...........
T Consensus 164 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~ 239 (308)
T 3g33_A 164 FGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPP 239 (308)
T ss_dssp CSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred CccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9999866422 22345678999999999998899999999999999999999999997633111 0111111000000
Q ss_pred ccchh---hhccccC---CCC-----CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVV---KILDQRL---SNT-----PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~---~~~d~~~---~~~-----~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+... ......+ ... .......+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 0000000 000 0123456788999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=330.94 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=198.6
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
++.+.|...+.||+|+||.||++.+. ++..||+|++..... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 34678889999999999999999974 688999999875443 2334678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeecccc
Q 012213 258 VYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLA 332 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla 332 (468)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999988542 2356899999999999999999999887 9999999999999 45688999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
..+... .......||+.|+|||.+. ..++.++||||||+++|||++|+.||..... .+........
T Consensus 175 ~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~----- 240 (285)
T 3is5_A 175 ELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQKATYK----- 240 (285)
T ss_dssp CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC-----
T ss_pred eecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhhhccC-----
Confidence 876432 2234566899999999876 4689999999999999999999999975321 1111111000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..............+.+++..|++.||++|||+.|+++
T Consensus 241 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 ----EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111111112456778999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=342.71 Aligned_cols=264 Identities=16% Similarity=0.169 Sum_probs=206.6
Q ss_pred hhccCCcceEcccCCcceEEEEcCC---------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccc-------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN---------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR------- 244 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------- 244 (468)
.+.|+..+.||+|+||.||+|.+.. ++.||||.+... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3678889999999999999999864 789999998532 35889999999999999987
Q ss_pred --------eeEEEec-CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 012213 245 --------LKAFCSN-KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315 (468)
Q Consensus 245 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 315 (468)
+++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777765 67889999999 999999998654567999999999999999999999887 9999999999
Q ss_pred EEEcCCC--ceEEeeccccccccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 012213 316 ILLNSDF--EAHVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVG 388 (468)
Q Consensus 316 ill~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 388 (468)
|+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999876533221 11234579999999999999999999999999999999999999997
Q ss_pred CCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 389 DFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
........+........... ..+.+.... .......+.+++..|++.||++|||++|+++.|+++..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKP----GPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSC----CCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCCh----hhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 64322222222221111111 111111100 01224668889999999999999999999999988753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=346.25 Aligned_cols=273 Identities=26% Similarity=0.315 Sum_probs=208.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe--cCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~ 253 (468)
.+.|+..+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 45788889999999999999983 468899999986432 223356899999999999999999999886 455
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6889999999999999997432 35899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 334 YLQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 334 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
........ .......||..|+|||.+.+..++.++||||||+++|||++|+.||.....+.. ..+............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccccccHHHH
Confidence 76533221 122345678889999999988899999999999999999999999864211000 000000000000011
Q ss_pred hhhc-cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 413 VKIL-DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 413 ~~~~-d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.+.+ .......+......+.+++..|++.||++|||+.|+++.|+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 111123344556778899999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=358.84 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=207.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999985 689999999864321 122335688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997655556999999999999999999999887 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .+..
T Consensus 340 ---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~------------~i~~ 403 (576)
T 2acx_A 340 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER------------LVKE 403 (576)
T ss_dssp ---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHH------------HHHH
T ss_pred ---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHH------------Hhhc
Confidence 22344589999999999999899999999999999999999999997643211 1111111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.....+......+.+++..|++.||++|| +++||++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11112233456778899999999999999 7788875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=327.01 Aligned_cols=262 Identities=20% Similarity=0.252 Sum_probs=202.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEE-ecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 258 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++...... ..+..|+.++..++|++++..+.++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 56788999999999999999997 57889999986543322 3488999999999988877776665 667778999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeeccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYL 335 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~ 335 (468)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 99999998743 335899999999999999999999887 9999999999999 78899999999999877
Q ss_pred cccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-CcCHHHHHHHhhcccc
Q 012213 336 QDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEE-GLDIVQWTKMQTNSSK 409 (468)
Q Consensus 336 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 409 (468)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-
Confidence 543221 1223567899999999999999999999999999999999999999874322 111111111000000
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
..... .......+.+++..|++.||++|||++||++.|+++..
T Consensus 238 -~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 -PIEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -CHHHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -hhhhh--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00000 01123568889999999999999999999999988754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=343.98 Aligned_cols=252 Identities=24% Similarity=0.252 Sum_probs=194.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHH-HhCCCCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRT-LGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||.||+|.++ +++.||||++...... ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467888899999999999999985 5788999998654332 2223446667766 577899999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999643 35889999999999999999999887 99999999999999999999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+. ...++.
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~-----------~~~i~~ 253 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEM-----------YDNILN 253 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHH-----------HHHHHH
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHH-----------HHHHHh
Confidence 2 2234567899999999999999999999999999999999999999975321 111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L 456 (468)
... ..+......+.+++..|++.||++||++.+.++.+
T Consensus 254 ~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 254 KPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp SCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 111 11222345678899999999999999986444433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=341.68 Aligned_cols=250 Identities=28% Similarity=0.344 Sum_probs=199.9
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
..+.|+..+.||+|+||+||+|.+ .+++.||||++....... .....+.+|++++++++||||+++++++...+..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 356688889999999999999997 578999999986543322 223568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 132 v~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999997 6888887532 245899999999999999999999887 99999999999999999999999999986542
Q ss_pred cCCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 338 TGASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...........
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~------ 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNE------ 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSC------
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC------
Confidence 1 3456899999999874 56789999999999999999999999965321 11111111110
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
.. ..........+.+++..||+.||++|||++|+++.
T Consensus 270 --~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 --SP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 11112234567789999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=336.58 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=196.9
Q ss_pred chhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
+.+.++|+..+.||+|+||.||+|.+ .+++.||||++....... .....+.+|+.++.+++||||+++++++......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34467889999999999999999997 578899999987543322 2235688999999999999999999998765543
Q ss_pred ----EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 256 ----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 256 ----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 9999999999999999643 35899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 332 AKYLQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 332 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++.+...... .......||+.|+|||++.+..++.++||||||+++|||+||+.||..... .............
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~ 237 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPI 237 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCC
Confidence 9876533221 223345689999999999999999999999999999999999999975321 1111111111100
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH-HHHHhc
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVV-QMLAQA 459 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~-~~L~~~ 459 (468)
... .........+.+++.+|++.||++||++.+++ ..|...
T Consensus 238 ~~~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 PPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHH--------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Ccc--------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000 00011345678899999999999999766555 455544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=346.81 Aligned_cols=205 Identities=28% Similarity=0.452 Sum_probs=164.4
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCC--e
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE--T 254 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 254 (468)
.+.++|+..+.||+|+||.||+|.+ .+|+.||||++............+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567889999999999999999987 46899999998654444444466889999999997 999999999997544 6
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||++ |+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 799999997 6899988643 5899999999999999999999887 99999999999999999999999999987
Q ss_pred ccccC-------------------CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 335 LQDTG-------------------ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 335 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 64211 1112344679999999999876 67899999999999999999999999763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=327.36 Aligned_cols=264 Identities=20% Similarity=0.247 Sum_probs=206.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEE-ecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.++..++|++++..+.++ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 56788899999999999999997 6789999998864332 24588999999999998877766655 566778999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeeccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYL 335 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~ 335 (468)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999 99999999733 345899999999999999999999887 9999999999999 47899999999999876
Q ss_pred cccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CCcCHHHHHHHhhcccc
Q 012213 336 QDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE-EGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 336 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~ 409 (468)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-
Confidence 543221 122456799999999999999999999999999999999999999986432 2112221111100000
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
.... ........+.+++..|++.||++|||+.||++.|+++....
T Consensus 238 -~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 238 -PIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -CHHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -chHH--------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0000 00122356888999999999999999999999999875443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.39 Aligned_cols=198 Identities=29% Similarity=0.332 Sum_probs=174.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-----CCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----HRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~ 254 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++... ......+..|+.+++.++ ||||+++++++...+.
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 56788999999999999999998 46889999998532 222355778999998886 9999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--------------
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-------------- 320 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------------- 320 (468)
.++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 999999998766667999999999999999999999887 999999999999975
Q ss_pred -----------CCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 321 -----------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 321 -----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999864421 2345789999999999999999999999999999999999999976
Q ss_pred C
Q 012213 390 F 390 (468)
Q Consensus 390 ~ 390 (468)
.
T Consensus 262 ~ 262 (360)
T 3llt_A 262 H 262 (360)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=336.77 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=205.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe----cCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS----NKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~ 255 (468)
.++|+..+.||+|+||.||++.+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45688899999999999999997 578999999885422 233467889999999999999999999986 34467
Q ss_pred EEEEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999998642 3456899999999999999999999887 9999999999999999999999999987
Q ss_pred cccccCCC-------ccccccccCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHH
Q 012213 334 YLQDTGAS-------ECMSAVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM 403 (468)
Q Consensus 334 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 403 (468)
........ .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-- 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-- 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh--
Confidence 65321111 0112345799999999987654 68999999999999999999999854111111111100
Q ss_pred hhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 404 QTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
...............+.+++..|++.||.+|||+.|+++.|+.+..+..-
T Consensus 261 ------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 261 ------------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ------------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ------------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00000111223346788899999999999999999999999999776543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=334.61 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=199.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 567888999999999999999975 68899999986543322 2235688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999743 35899999999999999999999887 999999999999999999999999999866432
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . .......... .
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-~~~~~~~~~~--------~ 252 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----S-VMGAHINQAI--------P 252 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----H-HHHHHHHSCC--------C
T ss_pred c-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----H-HHHHHhccCC--------C
Confidence 1 2223345689999999999998999999999999999999999999975221 1 1111111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHhccCCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-TMREVVQMLAQAQKPN 463 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-t~~ev~~~L~~~~~~~ 463 (468)
............+.+++.+|++.||++|| +++++++.|+.+....
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00111122345677899999999999999 9999999999875443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=342.87 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=192.2
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC------CCchhHHHHHHHHHhCCCCCCccceeEEEe
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG------SSHDNGLSAEIRTLGKIRHRNIVRLKAFCS 250 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 250 (468)
..+.+.|...+.||+|+||+||+|.+. +++.||||++...... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345678899999999999999999874 5789999998653211 112235889999999999999999999985
Q ss_pred cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEe
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVA 327 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~ 327 (468)
. +..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4 5679999999999999998643 45899999999999999999999887 9999999999999754 459999
Q ss_pred eccccccccccCCCccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|||+||+.||....... .+.....
T Consensus 285 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~-- 358 (419)
T 3i6u_A 285 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT-- 358 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHH--
T ss_pred ecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHh--
Confidence 9999987642 222345679999999999853 568899999999999999999999997633221 1111111
Q ss_pred hcccccchhhhccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 405 TNSSKEGVVKILDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 405 ~~~~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........ .....+.+++.+|++.||++|||+.|+++
T Consensus 359 -------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 -------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00001111 12456788999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=336.25 Aligned_cols=262 Identities=19% Similarity=0.293 Sum_probs=205.5
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCch---------------hHHHHHHHHHhCCCCCCccce
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD---------------NGLSAEIRTLGKIRHRNIVRL 245 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~h~niv~l 245 (468)
.++|+..+.||+|+||.||+|.+ +++.||||++.......... +.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57788999999999999999999 89999999986543222111 678999999999999999999
Q ss_pred eEEEecCCeeEEEEeccCCCChhhh------cccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEE
Q 012213 246 KAFCSNKETNLLVYEYMPNGSLGEV------LHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 246 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill 318 (468)
++++.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999999 665446679999999999999999999998 77 9999999999999
Q ss_pred cCCCceEEeeccccccccccCCCccccccccCccccCccccCCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCcC
Q 012213 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDE-KSDVYSFGVVLLELITGRRPVGDFGEEGLD 396 (468)
Q Consensus 319 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 396 (468)
+.++.+||+|||++...... ......|+..|+|||...+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence 99999999999999876422 33456789999999999877 6666 999999999999999999999763321 11
Q ss_pred HHHHHHHhhcccccch---hhhcc----ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 397 IVQWTKMQTNSSKEGV---VKILD----QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~---~~~~d----~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... .......... ..... .............+.+++..|++.||.+|||+.|+++
T Consensus 261 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111100000 00000 0000001234567889999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=338.51 Aligned_cols=271 Identities=24% Similarity=0.333 Sum_probs=194.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHH--HhCCCCCCccceeEEEec-----CC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT--LGKIRHRNIVRLKAFCSN-----KE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~ 253 (468)
.+.|+..+.||+|+||.||+|.+ +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 56788899999999999999977 68999999985322 1334444444 556899999999986532 23
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCceEEe
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------SPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
..++||||+++|+|.+++.... .++..+..++.||+.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 5689999999999999996443 589999999999999999999770 0139999999999999999999999
Q ss_pred eccccccccccCC------CccccccccCccccCccccCC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 012213 328 DFGLAKYLQDTGA------SECMSAVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG 394 (468)
Q Consensus 328 Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 394 (468)
|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||+||..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653211 122234579999999999876 456679999999999999999977764422111
Q ss_pred cCHHHHHHHhhc-ccccchhhhc-----cccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 395 LDIVQWTKMQTN-SSKEGVVKIL-----DQRL---SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 395 ~~~~~~~~~~~~-~~~~~~~~~~-----d~~~---~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.....+...... ...+.....+ ...+ ..........+.+++..||+.||++|||+.|+++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 000000000000 0000000000 0111 1122346678999999999999999999999999998763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=329.38 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=204.0
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC--CCCchhHHHHHHHHHhCCCCCCccceeEEEe--cCCe
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKET 254 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 254 (468)
+.++|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3567899999999999999999984 688999999864321 1233467899999999999999999999984 4557
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||++++ |.+++.......+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 777776655667999999999999999999999887 99999999999999999999999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
..............||+.|+|||+..+.. ++.++||||||+++|||++|+.||.... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~------ 227 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGK------ 227 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhc------
Confidence 65433333445567899999999987644 4789999999999999999999997522 1111111100
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccC
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQK 461 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~ 461 (468)
. ....+......+.+++.+|++.||++|||++|+++ .+.+...
T Consensus 228 -----~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 228 -----G-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -----C-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -----C-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 0 01112234456778999999999999999999996 4554433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.03 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=205.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+ .+++.||||.+..... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 46688889999999999999987 4688999999865432 233467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999864 35899999999999999999999887 9999999999999999999999999998765321
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... ..
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-----------~~ 235 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIPK-----------NN 235 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH-----------SC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHHHHhhc-----------CC
Confidence 223456789999999999999999999999999999999999999975321 111111000 11
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
....+......+.+++..|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111122334567889999999999999999999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=348.56 Aligned_cols=256 Identities=21% Similarity=0.183 Sum_probs=200.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||++.++ +|+.||||++..... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 567888999999999999999984 689999999864211 112224588999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 140 mE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 9999999999999743 235899999999999999999999887 999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccC-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAY-------TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
. .......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+.. ..+.... ..
T Consensus 216 ~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~-~~---- 285 (412)
T 2vd5_A 216 G-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA----ETYGKIV-HY---- 285 (412)
T ss_dssp S-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-TH----
T ss_pred C-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH----HHHHHHH-hc----
Confidence 2 22234568999999999887 456899999999999999999999999753211 0111110 00
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCC---CCHHHHHH
Q 012213 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVER---PTMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~R---Pt~~ev~~ 454 (468)
... ..+...+......+.+++.+|+. +|++| |+++|+++
T Consensus 286 -~~~--~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 -KEH--LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHH--CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -ccC--cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 00111112234567889999999 99998 68999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.92 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=205.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|...+.||+|+||.||+|.++ +|+.||+|++..... .......+..|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 466788899999999999999985 689999999864321 122335688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 259 YEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986543 346999999999999999999999887 9999999999999999999999999998764
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...........
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~----------- 406 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVL----------- 406 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHH-----------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHh-----------
Confidence 322 2234458999999999999999999999999999999999999999764321 11111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM-----REVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~-----~ev~~ 454 (468)
.. ....+......+.+++..|++.||++||++ +||++
T Consensus 407 ~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 EQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11 111223345677889999999999999975 56653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=348.26 Aligned_cols=260 Identities=25% Similarity=0.313 Sum_probs=195.9
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----- 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 253 (468)
+.++|+..+.||+|+||+||+|.+. +++.||||++..........+++.+|+.+++.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3577889999999999999999874 6889999999754333444567889999999999999999999996553
Q ss_pred -eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 56999999975 56666642 3889999999999999999999887 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc----
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS---- 408 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 408 (468)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. ...|......-+
T Consensus 212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~----~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 212 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCP 284 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCH
T ss_pred eecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCH
Confidence 87642 2233556799999999999999999999999999999999999999976331 111211111000
Q ss_pred ------ccchhhhcc---------------ccCCCC-C---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 ------KEGVVKILD---------------QRLSNT-P---LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ------~~~~~~~~d---------------~~~~~~-~---~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......++ ..+... . ......+.+++.+|+..||++|||++|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000111111 111000 0 112567889999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.57 Aligned_cols=268 Identities=28% Similarity=0.393 Sum_probs=207.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-----CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC--
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-- 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 253 (468)
.+.|+..+.||+|+||.||++.+ .+++.||||++... .......+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 45678889999999999999983 46889999998643 2333467899999999999999999999987654
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 6799999999999999997543 45899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---
Q 012213 334 YLQDTGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK--- 409 (468)
Q Consensus 334 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 409 (468)
........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+.... ..+.........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMIGNDKQGQM 267 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHHHCTTCCTHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHhhccccchhh
Confidence 76533221 11233456788999999988889999999999999999999999975311 011110000000
Q ss_pred --cchhhhccc-cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 410 --EGVVKILDQ-RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 410 --~~~~~~~d~-~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..+.+.+.. .....+......+.+++..||+.||++|||+.|+++.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111111 112223345567889999999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=332.93 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=195.4
Q ss_pred hhccCC-cceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKD-NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.+.|.. .+.||+|+||+||+|.+. +++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 455666 478999999999999974 68999999986543 23346789999999885 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---eEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~ 334 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999999753 35899999999999999999999887 999999999999998776 99999999986
Q ss_pred ccccCC-----CccccccccCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 335 LQDTGA-----SECMSAVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 335 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||......... |....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~ 240 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---WDRGE 240 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---C----
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---ccccc
Confidence 542211 111234568999999999865 45889999999999999999999999764322110 10000
Q ss_pred hcc--cccchhhhccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 405 TNS--SKEGVVKILDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 405 ~~~--~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... .......+.... ...+. .....+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000 000001111111 11111 12456889999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=341.73 Aligned_cols=256 Identities=23% Similarity=0.257 Sum_probs=202.3
Q ss_pred hhccCCcceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.++..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46788899999999999999987 4789999999864321 112234577899999999 6999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999743 35899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ...........
T Consensus 208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~----- 280 (355)
T 1vzo_A 208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILK----- 280 (355)
T ss_dssp ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHH-----
T ss_pred ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhc-----
Confidence 664222 222345679999999999885 347899999999999999999999997533221 12222111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 012213 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQM 455 (468)
Q Consensus 412 ~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~~ 455 (468)
.....+......+.+++.+|++.||++|| +++|+++.
T Consensus 281 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 -------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11122233455678899999999999999 99999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.80 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=203.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+.|+..+.||+|+||.||+|.+. +++.||||.+....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456888899999999999999986 68999999987543322 1246789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----ceEEeeccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVADFGL 331 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 331 (468)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999643 35899999999999999999999887 99999999999998877 899999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.......... .
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-~ 229 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----QETLTNISAVNY-D 229 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCC-C
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----HHHHHHhHhccc-C
Confidence 98764221 22345689999999999988999999999999999999999999975321 111110000000 0
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 412 ~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
.... ........+.+++.+|++.||++|||+.|+++ .++.+.
T Consensus 230 ----~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 230 ----FDEE---YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp ----CCHH---HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred ----Ccch---hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000 00112356788999999999999999999997 455543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=352.83 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=155.5
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-----CC
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-----KE 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 253 (468)
+.++|+..+.||+|+||+||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3567888999999999999999875 68999999986544333444678899999999999999999999843 35
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 689999998 57999998643 45899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCC-------------------------ccccccccCccccCcccc-CCCCCCcchhhHHHHHHHHHHHhC
Q 012213 334 YLQDTGAS-------------------------ECMSAVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELITG 383 (468)
Q Consensus 334 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg 383 (468)
........ .......||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422111 123456789999999975 566799999999999999999993
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.46 Aligned_cols=265 Identities=17% Similarity=0.242 Sum_probs=192.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+ .+++.||||++............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 67788999999999999999986 46889999998655444433456789999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-----CCCceEEeecccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-----SDFEAHVADFGLAKY 334 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfgla~~ 334 (468)
||++ |+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 59999986543 4899999999999999999999887 99999999999994 455699999999987
Q ss_pred ccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch-
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV- 412 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 412 (468)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...............
T Consensus 187 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 187 FGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTST
T ss_pred cCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhhh
Confidence 6422 2223445689999999998774 4899999999999999999999999753211 011111111000000000
Q ss_pred --hh---hcc--ccCCCCCH------HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 --VK---ILD--QRLSNTPL------SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 --~~---~~d--~~~~~~~~------~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ... ........ .....+.+++..|++.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000 00000011 12356789999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.42 Aligned_cols=255 Identities=22% Similarity=0.264 Sum_probs=199.8
Q ss_pred cchhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCe
Q 012213 177 SDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKET 254 (468)
Q Consensus 177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 254 (468)
...+.+.|+..+.||+|+||.||++.++ +|+.||||.+..... ...+|++++.++ +||||+++++++.+.+.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 3455778999999999999999999985 588999999864322 245688888777 79999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CceEEeecc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFG 330 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg 330 (468)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++.++ +.+||+|||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999999999998643 35899999999999999999999887 9999999999998543 359999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+ ...+..........
T Consensus 166 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~- 240 (342)
T 2qr7_A 166 FAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKF- 240 (342)
T ss_dssp TCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCC-
T ss_pred CcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCc-
Confidence 998765322 2234567899999999998888999999999999999999999999753211 11111111111100
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ...........+.+++..|++.||++|||+.|+++
T Consensus 241 ------~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ------SL-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------CC-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------cc-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 01111234456788999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=328.79 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=201.9
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.+.|...+.||+|+||+||++.+. +|+.||+|.+...... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 45678889999999999999999985 6899999998743322 23568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~ 334 (468)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 84 VMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999998643 34899999999999999999999887 9999999999999 7889999999999975
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~------ 223 (304)
T 2jam_A 159 EQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKIKEGY------ 223 (304)
T ss_dssp CCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHCC------
T ss_pred cCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCC------
Confidence 432 122345689999999999999999999999999999999999999975321 11111100000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ............+.+++..|++.||++|||+.|+++
T Consensus 224 -~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 -YE-FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CC-CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CC-CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 001111233466888999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=327.99 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=206.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|...+.||+|+||.||+|.+. +++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 567888999999999999999985 5788999988654322 22345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999988643 35899999999999999999999887 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..+... ...
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~------------~~~ 230 (294)
T 2rku_A 169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRI------------KKN 230 (294)
T ss_dssp T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH------------HTT
T ss_pred c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH------------hhc
Confidence 2 2234467899999999999989999999999999999999999999753211 011111 000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
. ...+......+.+++.+|++.||++|||++|+++ .+.+.
T Consensus 231 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 231 E-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred c-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 0 1112233456778999999999999999999997 44443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=350.08 Aligned_cols=254 Identities=25% Similarity=0.328 Sum_probs=198.6
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.+.|+..+.||+|+||+||+|.+. ++..||||++............+.+|+.+++.++||||+++++++.+....++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678899999999999999999985 68899999987654444445778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~ 334 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||++..
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999988643 34899999999999999999999887 9999999999999764 5599999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+... .......||+.|+|||++. ..++.++||||+||++|+|++|++||..... .+.......... .
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~----~ 255 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEKGKY----T 255 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC----C
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC----C
Confidence 6532 2234567999999999886 4699999999999999999999999976321 111111110000 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+.. ......+.+++..|++.||++|||+.|+++
T Consensus 256 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000000 123456778999999999999999999885
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=326.10 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=205.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+. +++.||||.+..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 567888899999999999999985 577899999854321 122335789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999643 34899999999999999999999777 999999999999999999999999999765421
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+... .+...
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~-----------~~~~~ 227 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHR-----------RIVNV 227 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH-----------HHHTT
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHH-----------HHhcc
Confidence 22345789999999999999999999999999999999999999975321 11111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.. ..+......+.+++..|++.||.+||++.|+++ .++..
T Consensus 228 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 DL-KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred cc-CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 11 112233456788999999999999999999987 44443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.50 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=200.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+. +|+.||||++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 677889999999999999999985 4899999998655443333456789999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998887533 34899999999999999999999887 9999999999999999999999999998764322
Q ss_pred CCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc---------c
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS---------K 409 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~ 409 (468)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ..+........... .
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhHhhhc
Confidence 223445689999999998775 7899999999999999999999999763311 01111110000000 0
Q ss_pred cchhhhccccC-CCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 EGVVKILDQRL-SNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~~~~~~~d~~~-~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
........+.. ...+ ......+.+++..|++.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000111 0111 123466889999999999999999999886
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=326.15 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=198.1
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.+....+||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3455567999999999999997 468899999986543 2334678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCceEEeecccccccccc
Q 012213 261 YMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 338 (468)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9999999999975432 35678999999999999999999887 999999999999988 899999999999876422
Q ss_pred CCCccccccccCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
. .......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........ .......
T Consensus 177 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~----------- 240 (295)
T 2clq_A 177 N--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGM----------- 240 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHH-----------
T ss_pred C--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcc-----------
Confidence 1 2234457899999999987643 78999999999999999999999965321110 0000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.......+......+.+++..|++.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111222334566788999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.19 Aligned_cols=259 Identities=24% Similarity=0.300 Sum_probs=205.2
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.+.+.|+..+.||+|+||+||+|.+. +++.||||++............+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 45788999999999999999999985 68999999986544333445678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~ 334 (468)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999988643 35899999999999999999999887 99999999999995 456799999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+... .+.........
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~------ 238 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGK------ 238 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTC------
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC------
Confidence 6422 22345679999999999876 599999999999999999999999975321 11111110000
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.... ..........+.+++..|++.||++|||+.|+++ .+++.
T Consensus 239 -~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 239 -YAFD-LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -CCSC-SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -CCCC-CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 0000 0001123456788999999999999999999997 34443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=333.06 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=208.3
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|...+.||+|+||.||++.+. +++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 567888899999999999999985 4788999988654322 22345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988643 35899999999999999999999887 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
. .......||..|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... ..
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~-~~----------- 256 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIK-KN----------- 256 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-HT-----------
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHh-cC-----------
Confidence 2 2234567899999999999889999999999999999999999999653210 0111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPN 463 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~ 463 (468)
. ...+......+.+++.+|++.||++|||+.|+++ .+.....++
T Consensus 257 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 257 E-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred C-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 0 0111223456778999999999999999999997 455544443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=329.48 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=187.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++............+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 56788899999999999999997 57889999998654332222233445555688889999999999999999999999
Q ss_pred eccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 260 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
||++ |+|.+++.. .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588887753 2345699999999999999999999987 7 9999999999999999999999999998764
Q ss_pred ccCCCccccccccCccccCcccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 337 DTGASECMSAVAGSYGYIAPEYA----YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
.. .......||+.|+|||.+ .+..++.++||||||+++|||+||+.||...... ......
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---------- 225 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---FQQLKQ---------- 225 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---HHHHHH----------
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---HHHHHH----------
Confidence 32 122344689999999995 5667899999999999999999999999753321 111111
Q ss_pred hhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.... ..........+.+++..|++.||++|||+.|+++
T Consensus 226 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 226 --VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111 1111233456788999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.18 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=201.0
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.+.|+..+.||+|+||.||+|.+.+ .||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 5678889999999999999998854 59999987654444444668899999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC-
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG- 339 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 339 (468)
|+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++ ++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999743 346899999999999999999999887 99999999999998 6799999999987653211
Q ss_pred --CCccccccccCccccCccccCC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 340 --ASECMSAVAGSYGYIAPEYAYT---------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 340 --~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.....+ .........
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~- 258 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGTG- 258 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHHHTT-
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhccC-
Confidence 1122234568999999998864 45789999999999999999999999753311 111110000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
...... .......+.+++..|++.||++|||+.|++++|+++....
T Consensus 259 -------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 -------MKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -------CCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -------CCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111 1122345778999999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=334.51 Aligned_cols=268 Identities=19% Similarity=0.268 Sum_probs=200.9
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-------- 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 251 (468)
..+|+..+.||+|+||+||+|.+ .+|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 56788999999999999999998 578999999986654444444678899999999999999999999876
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
.+..++||||++ |+|.+.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 346799999997 47777775432 35899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccC--CCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 332 AKYLQDTG--ASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 332 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
++.+.... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 98765222 1222345678999999998876 458999999999999999999999997633110 0111111000000
Q ss_pred ccchhhh-----ccc----cCCCCC-HHH------HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKI-----LDQ----RLSNTP-LSE------AMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~-----~d~----~~~~~~-~~~------~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+..... .+. ...... ... ...+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000 000 000011 111 244789999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.84 Aligned_cols=252 Identities=28% Similarity=0.391 Sum_probs=198.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec----CCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 255 (468)
...|...+.||+|+||+||+|.+. ++..||+|.+..........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345677789999999999999874 67889999987654444445678999999999999999999998865 3457
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCceEEeecccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKY 334 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~ 334 (468)
++||||+++|+|.+++... ..+++..+..++.+++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999999643 34899999999999999999999653 2399999999999998 789999999999975
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ............
T Consensus 182 ~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~------ 246 (290)
T 1t4h_A 182 KRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGV------ 246 (290)
T ss_dssp CCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTC------
T ss_pred ccc----cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHHhccC------
Confidence 432 12234568999999998764 589999999999999999999999975321 111111111110
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ...+......+.+++..|++.||++|||++|+++
T Consensus 247 --~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 --KP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --Cc--cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00 0011112346788999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=324.20 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=195.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|...+.||+|+||.||+|.+. +|+.||||.+..... .......+.+|+..++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888899999999999999985 789999999864321 223345788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999643 34899999999999999999999888 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ....... .
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~------------~ 224 (276)
T 2h6d_A 165 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKI------------R 224 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH------------H
T ss_pred ---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHh------------h
Confidence 12234568999999999987765 5899999999999999999999965321 1111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+......+.+++..|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 225 GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0111112223456788999999999999999999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.38 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=197.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC--CCc--EEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--NGE--QVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++|+..+.||+|+||+||+|.+. +++ .||||++..... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457888899999999999999853 333 689998865432 2233467899999999999999999999998765 8
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++|+||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 8999999999999999743 245899999999999999999999887 999999999999999999999999999876
Q ss_pred cccCCCc-cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 336 QDTGASE-CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 336 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
....... ......+|+.|+|||...+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~----- 241 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEG----- 241 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSC-----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccC-----
Confidence 5332211 2234567889999999988889999999999999999999 9999975331 11111111110
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
.....+......+.+++..|++.||++|||+.++++.|+++.+.+
T Consensus 242 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 242 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 011122334567889999999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.23 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=201.6
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCC------chhHHHHHHHHHhCC-CCCCccceeEEEe
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKI-RHRNIVRLKAFCS 250 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 250 (468)
.+.+.|+..+.||+|+||.||+|.+. +|+.||||++........ ....+.+|+.++.++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34567888999999999999999985 799999999865432211 124578899999998 7999999999999
Q ss_pred cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
.....++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999999643 35899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYT------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
++..+... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 246 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~~- 316 (365)
T 2y7j_A 246 FSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----ILMLRM- 316 (365)
T ss_dssp TCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-
T ss_pred cccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----HHHHHH-
Confidence 99876532 22345679999999998753 3588999999999999999999999965321 111110
Q ss_pred hcccccchhhhccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 405 TNSSKEGVVKILDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 405 ~~~~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+..... ..+. .....+.+++.+|++.||++|||+.|+++
T Consensus 317 ----------i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 ----------IMEGQY-QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----------HHHTCC-CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----------HHhCCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 0111 12345788999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=343.05 Aligned_cols=263 Identities=19% Similarity=0.277 Sum_probs=205.4
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC-CCccceeEEEecCCeeEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l 257 (468)
+.+.|+..+.||+|+||.||+|.+ .+++.||||++...... .++..|++++..++| +++..+..++...+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 356788999999999999999997 56899999987643322 348899999999987 555566667778888899
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeecccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKY 334 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~ 334 (468)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 vme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999 99999999743 345899999999999999999999887 9999999999999 6889999999999987
Q ss_pred ccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 335 LQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 335 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVA 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHHhhcccc
Confidence 7543221 122356799999999999999999999999999999999999999987442211 1111111000000
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
..+..+. . ....++.+++..||+.+|++||++.+|+++|+++.
T Consensus 235 ~~~~~l~----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 235 TSIEALC----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp SCHHHHH----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHHHh----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0111110 1 12356888999999999999999999999998874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=337.05 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=198.0
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----- 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 253 (468)
+.+.|+..+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 356788889999999999999997 46899999998654333333467889999999999999999999997653
Q ss_pred -eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999875 34899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc-
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE- 410 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 410 (468)
+..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+... .+............+
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 875421 244578999999998876 679999999999999999999999997632110 000000000000000
Q ss_pred -------chhhhc-------cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 411 -------GVVKIL-------DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 411 -------~~~~~~-------d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
.....+ ...+..........+.+++.+|+..||++|||+.|+++ .+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000000 00111111233466888999999999999999999988 454443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.25 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=193.2
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|...+.||+|+||+||+|.+. +++.||||++....... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 45778899999999999999985 68899999986433221 11235579999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|++ |+|.+++... +..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 153 (324)
T ss_dssp CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence 997 6999888743 346899999999999999999999887 999999999999999999999999999865422
Q ss_pred CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc--
Q 012213 341 SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD-- 417 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 417 (468)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..... .+............+.......
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcch
Confidence 222344568999999998876 568999999999999999999999997633110 0111111100000000011000
Q ss_pred -------ccCCC-----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 -------QRLSN-----TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 -------~~~~~-----~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..... ........+.+++..|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 01122356788999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=345.51 Aligned_cols=243 Identities=15% Similarity=0.179 Sum_probs=190.2
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHH---HHHhCCCCCCcccee-------EE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEI---RTLGKIRHRNIVRLK-------AF 248 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 248 (468)
.+.|+..+.||+|+||+||+|.+ .+|+.||||++..... .....+.+.+|+ ..++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999997 5689999999875422 233446788999 566666899999998 77
Q ss_pred EecCCe-----------------eEEEEeccCCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 012213 249 CSNKET-----------------NLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306 (468)
Q Consensus 249 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 306 (468)
+.+++. .++||||+ +|+|.+++.... ...+++..++.++.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665543 78999999 689999997422 123446888999999999999999887 9
Q ss_pred eecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCC-----------CCCcchhhHHHHH
Q 012213 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-----------KVDEKSDVYSFGV 375 (468)
Q Consensus 307 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~ 375 (468)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998532 12345567 999999999877 7999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 376 VLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 376 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
++|||+||+.||....... ....+.. ... .....+.+++..||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~----------------~~~~~~~-~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG----------------GSEWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------C----------------CSGGGGS-SCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccccc----------------chhhhhh-hcc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999997533111 1111111 111 22356778999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.51 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=199.8
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-----------CchhHHHHHHHHHhCCCCCCcccee
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-----------SHDNGLSAEIRTLGKIRHRNIVRLK 246 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~ 246 (468)
.+.+.|...+.||+|+||+||+|.+. +++.||||++....... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45678899999999999999999985 57899999986543221 2346788999999999999999999
Q ss_pred EEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---c
Q 012213 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---E 323 (468)
Q Consensus 247 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~ 323 (468)
+++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999988643 34899999999999999999999887 99999999999998876 6
Q ss_pred eEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHH
Q 012213 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM 403 (468)
Q Consensus 324 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 403 (468)
+||+|||++..+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+... .+....
T Consensus 188 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~ 258 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDIIKK 258 (504)
T ss_dssp EEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred EEEEECCCCEEcCCC---CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 999999999876532 22345679999999999874 699999999999999999999999976321 111111
Q ss_pred hhcccccchhhhccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 404 QTNSSKEGVVKILDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+..... ..+. .....+.+++..|++.||.+|||+.|+++
T Consensus 259 -----------i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 -----------VEKGKY-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----------HHHCCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----------HHcCCC-CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111 0111 12356788999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=337.66 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=202.5
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 467888999999999999999985 68899999986432 2223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||+++|+|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999996433 489999999999999999999985 7 999999999999999999999999999765422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHH------------HH-----
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQ------------WT----- 401 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~------------~~----- 401 (468)
......||+.|+|||++.+..++.++||||||+++|||+||+.||............ +.
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 123457899999999999999999999999999999999999999753311100000 00
Q ss_pred ------HHhh---cccccchhhhccccCCCC-CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 402 ------KMQT---NSSKEGVVKILDQRLSNT-PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 402 ------~~~~---~~~~~~~~~~~d~~~~~~-~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ....+....+........ .......+.+++..|++.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 000000011111111111 1123456889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=343.15 Aligned_cols=203 Identities=26% Similarity=0.359 Sum_probs=168.5
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----C
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----E 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 253 (468)
+.++|+..+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3577889999999999999999974 578899999975444334446788999999999999999999999766 5
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||++ |+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 6899999996 699999964 345899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCC--------------------ccccccccCccccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 012213 334 YLQDTGAS--------------------ECMSAVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELITGRRPVG 388 (468)
Q Consensus 334 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 388 (468)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76532211 123567899999999985 56679999999999999999998665554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=327.05 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=199.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEec--CCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSN--KETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~ 256 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46788899999999999999986 57899999998532 2367899999999997 9999999999987 56789
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYL 335 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~ 335 (468)
+||||+++++|.+++.. +++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999999852 789999999999999999999887 99999999999999776 8999999999876
Q ss_pred cccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh----------
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ---------- 404 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~---------- 404 (468)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.......
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 5322 2344578999999999877 6789999999999999999999999965322111111111100
Q ss_pred --hcccccchhhhcccc--------C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 405 --TNSSKEGVVKILDQR--------L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 405 --~~~~~~~~~~~~d~~--------~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.........+..... . ..........+.+++..|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000000 0 1111123567889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=349.67 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=204.3
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.+.|+..+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34678889999999999999999985 7899999998654332 334467899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCceEEeeccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAK 333 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~ 333 (468)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999998643 35899999999999999999999887 9999999999999 567899999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
.+... .......||+.|+|||++.+ .++.++||||+||++|+|++|++||..... .+.........
T Consensus 178 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~----- 243 (484)
T 3nyv_A 178 HFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDILKKVEKGK----- 243 (484)
T ss_dssp HBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-----
T ss_pred Ecccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCC-----
Confidence 76532 22345579999999999876 699999999999999999999999976321 11111100000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ..........+.+++..|++.+|++|||+.|+++
T Consensus 244 --~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 244 --YTFE-LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --CCCC-SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCC-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000 0001123456788999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=329.64 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=195.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC--CCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||++.+.+++.||||++..........+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4568889999999999999999988999999998654433334467899999999997 59999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++ +.+||+|||++..+...
T Consensus 107 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred Ee-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 99 5688999999754 35899999999999999999999887 999999999999965 89999999999876543
Q ss_pred CCCccccccccCccccCccccCC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYT-----------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
..........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~-------- 248 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK-------- 248 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHH--------
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---HHH--------
Confidence 33323345578999999999865 46889999999999999999999999753211 111
Q ss_pred cccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....++... ...+......+.+++..|++.||++||++.|+++
T Consensus 249 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 249 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111 1112222456788999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=334.94 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=193.6
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC-----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----- 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 253 (468)
+.+.|+..+.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3577889999999999999999874 6889999998754333333466889999999999999999999997665
Q ss_pred -eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
..++||||++ |+|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999996 578888752 3889999999999999999999887 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK--- 409 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 409 (468)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. ...|.........
T Consensus 175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCH
T ss_pred cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 865421 223456789999999999999999999999999999999999999976331 1112211110000
Q ss_pred -------c---------------chhhhccccC-CCC---CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 -------E---------------GVVKILDQRL-SNT---PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 -------~---------------~~~~~~d~~~-~~~---~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...+.+.... ... .......+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0000010000 000 1223567889999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.27 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=198.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+. +|+.||||.+.... ....+.+|+.++..++||||+++++++...+..++||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 567888899999999999999985 58999999986432 2366899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 99999999999863 2345899999999999999999999887 999999999999999999999999999876432
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~~~ 244 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPTNP--------PPT 244 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSC--------CCC
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCC--------Ccc
Confidence 12234456899999999999989999999999999999999999999753211 1000000000 000
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+......+.+++..|++.||++|||+.|+++
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112223466888999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=324.87 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=196.3
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC------CCCchhHHHHHHHHHhCCCCCCccceeEEEec
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK------GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN 251 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 251 (468)
.+.+.|...+.||+|+||.||+|.+. +++.||||.+..... .......+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 44678889999999999999999874 578999999864321 11222458899999999999999999999876
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---eEEee
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVAD 328 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 328 (468)
.. .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred Cc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 55 8999999999999999864 345899999999999999999999887 999999999999987664 99999
Q ss_pred ccccccccccCCCccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhh
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
||++..... ........||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+........
T Consensus 161 fg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~ 236 (322)
T 2ycf_A 161 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGK 236 (322)
T ss_dssp CTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTC
T ss_pred Cccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCc
Confidence 999987542 12223456899999999863 5678899999999999999999999997643221 1221111100
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..... .......+.+++..|++.||++|||+.|+++
T Consensus 237 ~~---~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YN---FIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC---CCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc---cCchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 00000 0112456788999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=327.99 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=197.9
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3677889999999999999999985 58899999986433 23346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999988642 335899999999999999999999887 999999999999999999999999998643211
Q ss_pred CCCccccccccCccccCcccc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 339 GASECMSAVAGSYGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
........||+.|+|||++ ....++.++||||||+++|||++|+.||..... ...........
T Consensus 171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~----- 238 (302)
T 2j7t_A 171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSD----- 238 (302)
T ss_dssp --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSC-----
T ss_pred --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHhccC-----
Confidence 1112345689999999987 466789999999999999999999999975331 11111110000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......+......+.+++..|++.||++|||+.|+++
T Consensus 239 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 ----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001112234456888999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.61 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=204.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 257 (468)
.++|+..+.||+|+||.||+|.+. +++.||||++..... .......+..|..++..+ +||+|+++++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 456888899999999999999975 578899999864321 222335678899999988 79999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999753 35899999999999999999999887 99999999999999999999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .+. ...+..
T Consensus 495 ~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~-----------~~~i~~ 556 (674)
T 3pfq_A 495 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DEL-----------FQSIME 556 (674)
T ss_dssp T--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH-----------HHHHHS
T ss_pred C--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHH-----------HHHHHh
Confidence 2 2234567899999999999999999999999999999999999999976321 111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM-----REVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~-----~ev~~ 454 (468)
.. ...+......+.+++..|++.||++||++ +||++
T Consensus 557 ~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11 12233445678889999999999999998 66654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=328.96 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=197.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC---CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|+..+.||+|+||.||+|.+. +|+.||||++....... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 567888999999999999999985 58999999986432211 11246889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 99999975 888888643 345888999999999999999999888 9999999999999999999999999998764
Q ss_pred ccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh--
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV-- 413 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 413 (468)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|.+||.+.... ..+............+...
T Consensus 164 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 164 SPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp SCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSST
T ss_pred CCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhhh
Confidence 322 223456789999999998654 5889999999999999999999998753211 0111111110000000000
Q ss_pred -hhcc----ccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 012213 414 -KILD----QRLSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455 (468)
Q Consensus 414 -~~~d----~~~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~ 455 (468)
...+ ......+ ......+.+++..|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0001111 1234678899999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.88 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=203.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.+.|+..+.||+|+||.||+|.+.. +..||||++.... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4567778999999999999998743 4579999875432 2222367899999999999999999999985 45689
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999999743 345899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.... +.. ..+
T Consensus 543 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~-----------~~i 605 (656)
T 2j0j_A 543 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVI-----------GRI 605 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-----------HHH
T ss_pred CCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHH-----------HHH
Confidence 322 222234456789999999998899999999999999999997 99999763311 111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
........+......+.+++..||+.||++|||+.|+++.|+++..
T Consensus 606 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111122233445678889999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=326.88 Aligned_cols=266 Identities=21% Similarity=0.258 Sum_probs=202.0
Q ss_pred hhccCCcceEcccCCcceEEEEc--CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC---CCCCccceeEEEe-----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT--PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCS----- 250 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----- 250 (468)
.+.|+..+.||+|+||.||+|.+ .+|+.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46788899999999999999997 4678899999875443333334577788777666 8999999999987
Q ss_pred cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
.....++||||++ |+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567899999997 69999998666666999999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
+++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||...... ..+............+
T Consensus 166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred ccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCcc
Confidence 99865422 2234567899999999999989999999999999999999999999763211 0000110000000000
Q ss_pred chh-------hhcc----ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVV-------KILD----QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~-------~~~d----~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ..+. .............+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 0001111233456788999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.11 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=195.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec------C
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN------K 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~ 252 (468)
.+.|+..+.||+|+||.||+|.+ .+++.||||++.... .....+.+|+.++.++ +||||+++++++.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 67788999999999999999998 478999999986432 2236789999999998 79999999999976 4
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
...++||||+++|+|.+++.......+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 67899999999999999998665567899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
....... .......||+.|+|||++. +..++.++||||||+++|||++|+.||...... .-.......
T Consensus 177 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~ 249 (326)
T 2x7f_A 177 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLIPRN 249 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHS
T ss_pred eecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHHhhcC
Confidence 8664221 1223456899999999986 567889999999999999999999999653311 000000000
Q ss_pred cccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. .... ........+.+++..|++.||++||++.|+++
T Consensus 250 ~--------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 P--------APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp C--------CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c--------cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0001 11123456788999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=339.01 Aligned_cols=201 Identities=25% Similarity=0.302 Sum_probs=172.7
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC------CCCCccceeEEEe
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI------RHRNIVRLKAFCS 250 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~ 250 (468)
+.+..+|+..+.||+|+||+||+|.+. +++.||||++... ......+..|+.++..+ .|+||+++++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 344567889999999999999999875 5889999998632 12234567788777666 5779999999999
Q ss_pred cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--eEEee
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVAD 328 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~D 328 (468)
.....++||||+. ++|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEee
Confidence 9999999999995 79999998766667999999999999999999999888 999999999999999987 99999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
||+++.... ......||+.|+|||++.+..++.++|||||||++|||+||++||...
T Consensus 246 FG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 246 FGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999975432 123457899999999999999999999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=336.93 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=183.8
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK----- 252 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 252 (468)
++.++|+..+.||+|+||.||+|.+ .+|+.||||++............+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 4457888999999999999999986 5688999999865433333346788999999999999999999998654
Q ss_pred -CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 253 -ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 253 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
...++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 7899998864 35899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.. ..+............+
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAE 252 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9865421 234678999999999876 67899999999999999999999999763311 0011111100000000
Q ss_pred --------chhhhcccc--CCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 --------GVVKILDQR--LSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 --------~~~~~~d~~--~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....+... ..... ......+.+++.+|+..||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000111000 00111 112356788999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=319.55 Aligned_cols=260 Identities=24% Similarity=0.303 Sum_probs=206.6
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
..+.+.|+..+.||+|+||.||+|.+. +++.||||++............+.+|+.++++++||||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 455778999999999999999999985 6899999998765544455577999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CceEEeeccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAK 333 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~ 333 (468)
+|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999988643 34899999999999999999999887 9999999999999764 469999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+.........
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~----- 238 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGK----- 238 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-----
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC-----
Confidence 664221 1233458899999998876 489999999999999999999999975321 11111111000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
..... .........+.+++..|++.||++|||+.|+++ .+++.
T Consensus 239 --~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 239 --YAFDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp --CCCCS-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred --CCCCc-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 00000 000123456788999999999999999999997 45544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.40 Aligned_cols=269 Identities=26% Similarity=0.398 Sum_probs=186.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+..+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457888899999999999999874 688999998754322 222356889999999999999999999999999999999
Q ss_pred eccCCCChhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 260 EYMPNGSLGEVLHG------KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 260 e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
||+++++|.+++.. .....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999863 12346899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCC---CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 334 YLQDTGA---SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 334 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. .. ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~--~~-~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VL--ML-TLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH--HH-HHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HH--HH-HhccCC
Confidence 7643221 112234568999999998865 568999999999999999999999997643221 11 00 111110
Q ss_pred cchh-hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccC
Q 012213 410 EGVV-KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQK 461 (468)
Q Consensus 410 ~~~~-~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~ 461 (468)
.... ...+... .......+.+++..|++.||++|||+.|+++ .+.+.+.
T Consensus 245 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 245 PSLETGVQDKEM---LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CCTTC-----CC---CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred Cccccccccchh---hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 0110 0111111 1123356778999999999999999999987 4444443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=334.31 Aligned_cols=262 Identities=20% Similarity=0.178 Sum_probs=201.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC--------CCCccceeEEEe-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR--------HRNIVRLKAFCS- 250 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~- 250 (468)
.++|+..+.||+|+||+||+|.+ .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46788899999999999999987 46789999998532 223356889999998885 788999999987
Q ss_pred ---cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCC----
Q 012213 251 ---NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDF---- 322 (468)
Q Consensus 251 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~---- 322 (468)
.....++||||+ +++|.+++.......+++..+..++.||+.||+|||+. + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556789999999 66777776655555699999999999999999999987 7 99999999999999775
Q ss_pred ---------------------------------------------ceEEeeccccccccccCCCccccccccCccccCcc
Q 012213 323 ---------------------------------------------EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE 357 (468)
Q Consensus 323 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 357 (468)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999876422 23457899999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcC--HHHHHHH--hhccccc-------chhhhccc--------
Q 012213 358 YAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD--IVQWTKM--QTNSSKE-------GVVKILDQ-------- 418 (468)
Q Consensus 358 ~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~--~~~~~~~--~~~~~~~-------~~~~~~d~-------- 418 (468)
++.+..++.++|||||||++|||+||+.||......... ....... ....... .....+..
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999989999999999999999999999999764432211 0000000 0000000 00000000
Q ss_pred ------------cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 ------------RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ------------~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.....+......+.+++.+|++.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234667788999999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=332.40 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=193.8
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------- 252 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 252 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 56788899999999999999987 5789999999864322 234799999999999999999998443
Q ss_pred -------------------------------CeeEEEEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhh
Q 012213 253 -------------------------------ETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLH 299 (468)
Q Consensus 253 -------------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH 299 (468)
...++||||++ |+|.+.+.. .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33789999997 588777753 23456999999999999999999999
Q ss_pred hcCCCCeeecCCCCCcEEEc-CCCceEEeeccccccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHH
Q 012213 300 HDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVL 377 (468)
Q Consensus 300 ~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l 377 (468)
+.+ |+||||||+||+++ .++.+||+|||+++.+.... ......||+.|+|||.+.+. .++.++||||+||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 777 99999999999998 68899999999998764322 23445689999999988765 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh-------ccccCCC------CCHHHHHHHHHHHHhhcccCCC
Q 012213 378 LELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI-------LDQRLSN------TPLSEAMQVFFVAMLCVQEHGV 444 (468)
Q Consensus 378 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~d~~~~~------~~~~~~~~~~~l~~~c~~~~P~ 444 (468)
|||++|+.||.+.... ..+............+.+... .-+.... .+......+.+++.+|++.||+
T Consensus 233 ~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999763311 111111111111100000000 0000000 1122345688999999999999
Q ss_pred CCCCHHHHHH
Q 012213 445 ERPTMREVVQ 454 (468)
Q Consensus 445 ~RPt~~ev~~ 454 (468)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=330.08 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=193.8
Q ss_pred hhhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCc---------hhHHHHHHHHHhCCCCCCccceeEEEe
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH---------DNGLSAEIRTLGKIRHRNIVRLKAFCS 250 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~ 250 (468)
+.+.|+..+.||+|+||.||+|.+.+|+.||||++......... .+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 36778899999999999999999988999999998654332221 256899999999999999999999984
Q ss_pred c-----CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceE
Q 012213 251 N-----KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH 325 (468)
Q Consensus 251 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 325 (468)
. ....++||||++ |+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEE
Confidence 3 335799999997 6888888743 346899999999999999999999887 99999999999999999999
Q ss_pred EeeccccccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 326 VADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 326 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
|+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.......
T Consensus 175 l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~ 250 (362)
T 3pg1_A 175 ICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNKIVEVV 250 (362)
T ss_dssp ECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred EEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHc
Confidence 9999999754322 22344578999999998876 678999999999999999999999997632110 000000000
Q ss_pred hccc--------ccchhhhccccCCC--------CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 405 TNSS--------KEGVVKILDQRLSN--------TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 405 ~~~~--------~~~~~~~~d~~~~~--------~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... .....+.+...... ........+.+++..|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000 00011111111110 01122456789999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=331.15 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=184.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEe--------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCS-------- 250 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------- 250 (468)
..+|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 346888899999999999999974 68999999885332 233356889999999996 999999999984
Q ss_pred cCCeeEEEEeccCCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
.....++||||++ |+|.+++.. .....+++..++.++.||+.||+|||+.+ ++|+||||||+||+++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3344789999995 799998864 22346999999999999999999999543 23999999999999999999999999
Q ss_pred cccccccccCCCc----------cccccccCccccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcC
Q 012213 330 GLAKYLQDTGASE----------CMSAVAGSYGYIAPEYA---YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLD 396 (468)
Q Consensus 330 gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 396 (468)
|+++......... ......||+.|+|||++ .+..++.++||||||+++|||+||+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998765322111 11244589999999998 56678999999999999999999999996532110
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
. ....... .........+.+++..|++.||++|||+.|+++.|+.+..
T Consensus 261 ---~-----------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ---I-----------VNGKYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---h-----------hcCcccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0000000 0011122346789999999999999999999999987753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.15 Aligned_cols=254 Identities=12% Similarity=0.038 Sum_probs=180.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHH---HHHHhCCCCCCcccee-------EE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAE---IRTLGKIRHRNIVRLK-------AF 248 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~l~-------~~ 248 (468)
...|+..+.||+|+||+||+|.+. +|+.||||++....... .....+.+| +..++. +|||+++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345778899999999999999974 78999999997644322 223456777 556666 799987754 55
Q ss_pred EecC-----------------CeeEEEEeccCCCChhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCC
Q 012213 249 CSNK-----------------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------LKIAIEAAKGLSYLHHDCSPL 305 (468)
Q Consensus 249 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ 305 (468)
+..+ ...++||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 5433 23799999998 89999997532 23455666 788899999999999887
Q ss_pred eeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhC
Q 012213 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITG 383 (468)
Q Consensus 306 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg 383 (468)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986532 1123456799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 384 RRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 384 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.||......... .|.. ........... ..........+.+++.+|++.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKG--SWKR-------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTT--CCCB-------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCccccc--chhh-------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999764321110 0000 00000001111 1111234567888999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=333.83 Aligned_cols=261 Identities=24% Similarity=0.297 Sum_probs=193.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET------ 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 254 (468)
...|+..+.||+|+||+||+|.+.++..||+|++..... ...+|+.+++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 456888999999999999999998888899999864322 12369999999999999999999865433
Q ss_pred eEEEEeccCCCChhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCceEEeecccc
Q 012213 255 NLLVYEYMPNGSLGEVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLA 332 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla 332 (468)
.++||||++++.+....+ ......+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 689999998654433322 122346899999999999999999999887 99999999999999 7999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.. ..+............+.
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 8764222 22345789999999988764 5899999999999999999999999763311 11111111111100000
Q ss_pred hhh----hccccC---CCC------CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VVK----ILDQRL---SNT------PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~~----~~d~~~---~~~------~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+.. ..+..+ ... .......+.+++.+|++.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000 000000 001 1123457889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=329.10 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=196.9
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee--
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-- 255 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-- 255 (468)
++.+.|...+.||+|+||+||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 34577888999999999999999874 688999999875443333346788999999999999999999999877765
Q ss_pred ----EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 256 ----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 256 ----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred ceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 688888742 3899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.. ..+............+
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTE 264 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHH
Confidence 9865421 234568999999999877 67999999999999999999999999763211 0011111000000000
Q ss_pred c--------hhhhcc---ccCCC----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 G--------VVKILD---QRLSN----TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~--------~~~~~d---~~~~~----~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...... ..... ........+.+++..|++.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 000000 00000 01123467889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=318.89 Aligned_cols=255 Identities=26% Similarity=0.311 Sum_probs=202.6
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-------CchhHHHHHHHHHhCCC-CCCccceeEEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-------SHDNGLSAEIRTLGKIR-HRNIVRLKAFC 249 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 249 (468)
.+.++|+..+.||+|+||.||+|.+. +|+.||||.+....... ...+.+.+|+.++.+++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678889999999999999999985 68899999986543211 11245788999999995 99999999999
Q ss_pred ecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999999643 35899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHH
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKM 403 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 403 (468)
|++...... .......|++.|+|||++. ...++.++||||||+++|||++|+.||..... ......
T Consensus 169 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRM 240 (298)
T ss_dssp TTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred cchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHHH
Confidence 999876422 2234457899999999874 45688999999999999999999999965321 111111
Q ss_pred hhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 404 QTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 404 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... . ............+.+++..|++.||++|||+.|+++
T Consensus 241 ~~~~~~-------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNY-------Q-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCC-------C-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCc-------c-cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 110000 0 001111234567889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=325.31 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=202.9
Q ss_pred hhhccCCcceEcccCCcceEEEEc--CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCC------CccceeEEEec
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT--PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR------NIVRLKAFCSN 251 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~ 251 (468)
+.++|+..+.||+|+||+||+|.+ .+++.||||++... ....+.+.+|+.++..++|+ +++++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 356788999999999999999986 36889999998532 12235688899998888665 49999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----------
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----------- 320 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----------- 320 (468)
.+..++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 899999998666567899999999999999999999887 999999999999987
Q ss_pred --------CCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 012213 321 --------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE 392 (468)
Q Consensus 321 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 392 (468)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999864321 2345789999999999998999999999999999999999999976332
Q ss_pred CCcCHHHHHHHhhcccccch---------------------------hhhcc--ccCCCCCHHHHHHHHHHHHhhcccCC
Q 012213 393 EGLDIVQWTKMQTNSSKEGV---------------------------VKILD--QRLSNTPLSEAMQVFFVAMLCVQEHG 443 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~d--~~~~~~~~~~~~~~~~l~~~c~~~~P 443 (468)
.. ........ ........ ..... .............+.+++.+|++.||
T Consensus 240 ~~-~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 240 KE-HLAMMERI-LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HH-HHHHHHHH-HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH-HHHHHHHH-hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11 00000000 00000000 00000 00012234567788999999999999
Q ss_pred CCCCCHHHHHH
Q 012213 444 VERPTMREVVQ 454 (468)
Q Consensus 444 ~~RPt~~ev~~ 454 (468)
++|||+.|+++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=327.30 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=196.9
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe----
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---- 254 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 254 (468)
+.+.|...+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3567888999999999999999974 68999999986543333334678899999999999999999999987654
Q ss_pred --eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 255 --NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 255 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
.++||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 688888742 3899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 333 KYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 333 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+... .+............+.
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEF 247 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 865421 234568999999998876 678999999999999999999999997633110 0000000000000000
Q ss_pred hh--------hhc-------cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 412 VV--------KIL-------DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 412 ~~--------~~~-------d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..+ ...+..........+.+++.+|++.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000 01111222344567889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=335.00 Aligned_cols=202 Identities=22% Similarity=0.365 Sum_probs=154.6
Q ss_pred hhccCC-cceEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe--cCCe
Q 012213 181 LECVKD-NNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKET 254 (468)
Q Consensus 181 ~~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 254 (468)
.+.|+. +++||+|+||+||+|.++ +++.||||++.... ....+.+|+.++++++||||+++++++. ....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 445555 568999999999999965 57889999985332 2256889999999999999999999995 4678
Q ss_pred eEEEEeccCCCChhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCc
Q 012213 255 NLLVYEYMPNGSLGEVLHGK-------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFE 323 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~ 323 (468)
.++||||++ |+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 899999996 5888777521 1224899999999999999999999887 9999999999999 67889
Q ss_pred eEEeeccccccccccCC-CccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 324 AHVADFGLAKYLQDTGA-SECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 324 ~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
+||+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999987653211 1223456789999999998874 5899999999999999999999999763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=334.03 Aligned_cols=266 Identities=26% Similarity=0.304 Sum_probs=194.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC----C--
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK----E-- 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~-- 253 (468)
...|+..+.||+|+||.||+|.+. +|+.||||++.... ....+|+++++.++||||+++++++... +
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 345788899999999999999985 58999999986432 1234799999999999999999988532 2
Q ss_pred eeEEEEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeecc
Q 012213 254 TNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFG 330 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 330 (468)
..++||||+++ ++.+.+.. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccch
Confidence 25689999975 66665542 23456899999999999999999999777 9999999999999965 568999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+............
T Consensus 203 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 203 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp TCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCH
T ss_pred hhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCH
Confidence 998764322 22345789999999998764 799999999999999999999999976331 1112222221111111
Q ss_pred cchhhh-------ccccCCC------CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 410 EGVVKI-------LDQRLSN------TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 410 ~~~~~~-------~d~~~~~------~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
+.+.+. .-+.... ........+.+++.+|++.||++|||+.|+++ .++++.
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 111110 0000000 11123467889999999999999999999986 444443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.68 Aligned_cols=265 Identities=20% Similarity=0.279 Sum_probs=199.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----Ce
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 254 (468)
...|+..+.||+|+||.||+|.+. +++.||||++.... .......+.+|++++.+++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 457889999999999999999874 67889999986422 222235688999999999999999999999655 36
Q ss_pred eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 799999997 6999988643 4899999999999999999999887 99999999999999999999999999987
Q ss_pred ccccCC-CccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 335 LQDTGA-SECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 335 ~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
...... ........||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+............+..
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDL 256 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence 653222 11234567999999999765 4558999999999999999999999997643211 11111110000000000
Q ss_pred hh--------hccccC--CCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 413 VK--------ILDQRL--SNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 413 ~~--------~~d~~~--~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ...... ...+ ......+.+++.+|++.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000 0011 122356789999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=326.06 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=173.3
Q ss_pred hhhccCC-cceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHH-HHHhCCCCCCccceeEEEec----C
Q 012213 180 ILECVKD-NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEI-RTLGKIRHRNIVRLKAFCSN----K 252 (468)
Q Consensus 180 ~~~~~~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~----~ 252 (468)
+.++|.. .++||+|+||+||+|.+. +|+.||||++... .....|+ ..+..++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 3566777 457999999999999985 6899999998532 2233333 34566799999999999875 4
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEeec
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADF 329 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 329 (468)
...++||||+++|+|.+++.......+++.++..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 45789999999999999998666567999999999999999999999887 999999999999986 455999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
|+++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ...
T Consensus 176 g~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~------- 243 (336)
T 3fhr_A 176 GFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKR------- 243 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHH-------
Confidence 999865421 22345689999999999888899999999999999999999999976332111000 000
Q ss_pred cchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 EGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+.. ..... ..........+.+++..|++.||++|||+.|+++
T Consensus 244 -~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 244 -RIRL-GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -hhhc-cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00000 1111234566788999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=324.51 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=177.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHH-HHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.+.|+..+.||+|+||.||+|.+. +|+.||||++..... .....++..|+. +++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 467888899999999999999984 688999999864322 122234555665 77888999999999999999999999
Q ss_pred EeccCCCChhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 259 YEYMPNGSLGEVLHG---KRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
|||++ |+|.+++.. .....+++..+..++.+++.||.|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99997 488777652 2345689999999999999999999987 7 99999999999999999999999999987
Q ss_pred ccccCCCccccccccCccccCcccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYA----YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------- 237 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------- 237 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------
T ss_pred ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------------
Confidence 64321 12334689999999998 456789999999999999999999999976321100
Q ss_pred chhhhcccc---C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVVKILDQR---L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~~~~d~~---~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
......... + ..........+.+++..|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111 1 1111234567888999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.86 Aligned_cols=269 Identities=22% Similarity=0.293 Sum_probs=188.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe-----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET----- 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 254 (468)
.++|+..+.||+|+||+||+|.+. +|+.||||++..... ....+.+++..+..++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 677889999999999999999984 689999998854322 22456778888888999999999999865443
Q ss_pred --eEEEEeccCCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCCcEEEcC-CCceEEe
Q 012213 255 --NLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLH--HDCSPLIIHRDVKSNNILLNS-DFEAHVA 327 (468)
Q Consensus 255 --~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~~~~kl~ 327 (468)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999976 55444332 23446889999999999999999999 777 999999999999997 8999999
Q ss_pred eccccccccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
|||+++.+.... ......||+.|+|||++.+. .++.++||||||+++|||+||+.||...... ..+.........
T Consensus 175 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~ 250 (360)
T 3e3p_A 175 DFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLGC 250 (360)
T ss_dssp CCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred eCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcCC
Confidence 999998765322 22345689999999988654 4899999999999999999999999763311 111111111111
Q ss_pred ccccchhhh---------cc-------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 407 SSKEGVVKI---------LD-------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 407 ~~~~~~~~~---------~d-------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
...+....+ .+ ..+..........+.+++..|++.||++|||+.|+++ .+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 100000000 00 0011122234677889999999999999999999987 455543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.62 Aligned_cols=278 Identities=21% Similarity=0.298 Sum_probs=195.5
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe-------
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS------- 250 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~------- 250 (468)
++..+|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 44577888999999999999999986 48899999886432 233467889999999999999999999874
Q ss_pred -------cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCC
Q 012213 251 -------NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDF 322 (468)
Q Consensus 251 -------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~ 322 (468)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDL 158 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence 3467799999997 699999863 34889999999999999999999887 99999999999997 567
Q ss_pred ceEEeeccccccccccCC-CccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHH
Q 012213 323 EAHVADFGLAKYLQDTGA-SECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQW 400 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 400 (468)
.+||+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||+||+.||....... .....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~ 237 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLI 237 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 999999999987643211 112234567899999998765 678999999999999999999999997633110 00000
Q ss_pred HHHhhcccccchhh-------hccccC--CCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCCC
Q 012213 401 TKMQTNSSKEGVVK-------ILDQRL--SNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPNT 464 (468)
Q Consensus 401 ~~~~~~~~~~~~~~-------~~d~~~--~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~~ 464 (468)
.........+...+ .+.... ...+ ......+.+++..|++.||++|||+.|+++ .+.....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 00000000000000 000000 0001 123456889999999999999999999987 5666655554
Q ss_pred cc
Q 012213 465 FQ 466 (468)
Q Consensus 465 ~~ 466 (468)
.|
T Consensus 318 ~~ 319 (320)
T 2i6l_A 318 EP 319 (320)
T ss_dssp --
T ss_pred CC
Confidence 33
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.99 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=191.1
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-------
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------- 251 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 251 (468)
+.++|+..+.||+|+||.||+|.+ .+++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 457788899999999999999997 47899999998532 2233568899999999999999999998865
Q ss_pred ------CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceE
Q 012213 252 ------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH 325 (468)
Q Consensus 252 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 325 (468)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 34678999999999999999743 345788999999999999999999887 99999999999999999999
Q ss_pred EeeccccccccccC------------CCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 012213 326 VADFGLAKYLQDTG------------ASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGE 392 (468)
Q Consensus 326 l~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 392 (468)
|+|||++....... .........||+.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998664221 01222345689999999998764 68999999999999999998 553210
Q ss_pred CCcCHHHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 393 EGLDIVQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
............ .... ...+......+.+++..|++.||++|||+.|+++
T Consensus 233 ---~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---ERVNILKKLRSV---------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHHHHHHST---------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hHHHHHHhcccc---------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111110000 0011 1223344566788999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=323.90 Aligned_cols=203 Identities=26% Similarity=0.324 Sum_probs=170.7
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CC-----CccceeEEEe
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HR-----NIVRLKAFCS 250 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~ 250 (468)
+.+.++|+..+.||+|+||+||+|.+. +++.||||++... ......+..|+.++..++ |+ +++++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 344678999999999999999999875 6788999998632 122355677888887774 44 4999999999
Q ss_pred cCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCceEEee
Q 012213 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--SDFEAHVAD 328 (468)
Q Consensus 251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~D 328 (468)
..+..++||||++ |+|.+++.......+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999996 6999999866656699999999999999999999942 12399999999999995 478899999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDF 390 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 390 (468)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876421 23467899999999999999999999999999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=323.62 Aligned_cols=272 Identities=22% Similarity=0.281 Sum_probs=200.0
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----C
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----E 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 253 (468)
+.++|+..+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4567888999999999999999975 68899999985332 222235678999999999999999999988654 6
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 7899999996 699998864 34899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCCc--------cccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHh
Q 012213 334 YLQDTGASE--------CMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404 (468)
Q Consensus 334 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 404 (468)
......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+... .+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 239 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGII 239 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHh
Confidence 765322111 1233578999999998654 678999999999999999999999997633110 000000000
Q ss_pred hccccc---------chhhhcccc--CCCC-----CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 405 TNSSKE---------GVVKILDQR--LSNT-----PLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 405 ~~~~~~---------~~~~~~d~~--~~~~-----~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
.....+ ...+.+... .... .......+.+++.+|++.||++|||+.|+++ .++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000000 000000000 0000 0123456788999999999999999999987 455443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.54 Aligned_cols=243 Identities=21% Similarity=0.354 Sum_probs=197.3
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCC--CCCccceeEEEecC
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNK 252 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 252 (468)
+.+.|+..+.||+|+||.||+|.+ .+++.||||++....... .....+..|+.++++++ |+|++++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 356788899999999999999986 568899999987543322 11245678999999986 59999999999999
Q ss_pred CeeEEEEeccCC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCceEEeecc
Q 012213 253 ETNLLVYEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFG 330 (468)
Q Consensus 253 ~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg 330 (468)
+..++|+||+.+ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ +++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999976 8999998643 35899999999999999999999887 99999999999999 78999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~--------- 255 (320)
T 3a99_A 196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI--------- 255 (320)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH---------
T ss_pred cccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh---------
Confidence 99876522 2234568999999999877665 688999999999999999999996411 00
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..... ..+......+.+++.+|++.||++|||+.|+++
T Consensus 256 ------~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 ------IRGQV-FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------HHCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hcccc-cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 011123456778999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.96 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=179.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||.||+|.+. +|+.||||++............+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 567888899999999999999985 6899999998654322222233445556788889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||+ ++.+..+.. .....+++..+..++.+++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 455555443 3334689999999999999999999985 7 999999999999999999999999999766432
Q ss_pred CCCccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 339 GASECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
. ......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ...+... .....
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~-~~~~~---- 247 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLTKV-LQEEP---- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHH-HHSCC----
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHHHH-hccCC----
Confidence 1 223456899999999984 456889999999999999999999999753211 1111111 11100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..........+.+++..|++.||.+||++.|+++
T Consensus 248 ----~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PL-LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CC-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CC-CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 0111123456788999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.78 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=186.5
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.+...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 345557889999999998777778999999998532 225578899999876 89999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCC-----CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-------------C
Q 012213 261 YMPNGSLGEVLHGKRGSF-----LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-------------F 322 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~ 322 (468)
|++ |+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 995 69999997543211 123345789999999999999887 9999999999999754 4
Q ss_pred ceEEeeccccccccccCCC--ccccccccCccccCccccCC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 012213 323 EAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIT-GRRPVGDFGE 392 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 392 (468)
.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999877532221 12234579999999999865 678999999999999999999 9999965321
Q ss_pred CCcCHHHHHHHhhcccccchhhhccc-cC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 393 EGLDIVQWTKMQTNSSKEGVVKILDQ-RL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~d~-~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..... ...+. .. ..........+.+++.+|++.||++|||+.||++
T Consensus 246 ~~---~~i~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RE---SNIIR-----------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH---HHHHH-----------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH---HHHhc-----------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 10 11100 00000 01 1123456678899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.94 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=189.9
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC----CchhHHHHHHHHHhCC----CCCCccceeEEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKI----RHRNIVRLKAFC 249 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~~ 249 (468)
.+.++|+..+.||+|+||.||+|.+ .+++.||||++....... .....+..|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3466788999999999999999987 468899999986443211 1123456788888888 899999999999
Q ss_pred ecCCeeEEEEec-cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCceEEe
Q 012213 250 SNKETNLLVYEY-MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVA 327 (468)
Q Consensus 250 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 327 (468)
...+..++|+|| +++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ .++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999 7899999999753 35899999999999999999999888 99999999999999 88999999
Q ss_pred eccccccccccCCCccccccccCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhc
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 406 (468)
|||++...... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||.... .
T Consensus 183 dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~------- 244 (312)
T 2iwi_A 183 DFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E------- 244 (312)
T ss_dssp CCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H-------
T ss_pred EcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H-------
Confidence 99999876532 22445689999999998776665 58999999999999999999996411 0
Q ss_pred ccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 407 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+.. ...+......+.+++.+|++.||++|||+.|+++
T Consensus 245 --------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 --------ILEAE-LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --------HHHTC-CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------Hhhhc-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0112233456788999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=325.88 Aligned_cols=266 Identities=19% Similarity=0.224 Sum_probs=201.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-----------CCCccceeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----------HRNIVRLKAF 248 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 248 (468)
.+.|+..+.||+|+||+||+|.+ .+++.||||++... ......+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 45788889999999999999997 56889999998532 122356788999988876 8999999999
Q ss_pred EecCC----eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEc----
Q 012213 249 CSNKE----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLN---- 319 (468)
Q Consensus 249 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~---- 319 (468)
+...+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+. + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 87654 678999999 89999999866666699999999999999999999987 7 99999999999994
Q ss_pred --CCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--
Q 012213 320 --SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL-- 395 (468)
Q Consensus 320 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-- 395 (468)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999876422 2345689999999999999999999999999999999999999976332110
Q ss_pred ---CHHHHHHHhhccccc-------chhhhcc--------------------ccCCCCCHHHHHHHHHHHHhhcccCCCC
Q 012213 396 ---DIVQWTKMQTNSSKE-------GVVKILD--------------------QRLSNTPLSEAMQVFFVAMLCVQEHGVE 445 (468)
Q Consensus 396 ---~~~~~~~~~~~~~~~-------~~~~~~d--------------------~~~~~~~~~~~~~~~~l~~~c~~~~P~~ 445 (468)
.+....... ...+. .....++ ......+......+.+++..|++.||++
T Consensus 246 ~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 246 DDDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred hHHHHHHHHHhc-CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 011100000 00000 0000000 0112345677888999999999999999
Q ss_pred CCCHHHHHH--HHHhc
Q 012213 446 RPTMREVVQ--MLAQA 459 (468)
Q Consensus 446 RPt~~ev~~--~L~~~ 459 (468)
|||+.|+++ .+.+.
T Consensus 325 Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDT 340 (373)
T ss_dssp CBCHHHHHTCGGGTTC
T ss_pred cCCHHHHhhChhhhcc
Confidence 999999987 44443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=321.61 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=199.9
Q ss_pred hhhccCCcceEcccCCcceEEEEcC-CC-cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC------ccceeEEEec
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVTP-NG-EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN------IVRLKAFCSN 251 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~ 251 (468)
+.++|+..+.||+|+||+||+|.+. ++ +.||||++... ......+..|+.+++.++|++ ++.+.+++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3567889999999999999999974 34 68999998532 223356788999998887665 8999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-------------
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL------------- 318 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill------------- 318 (468)
.+..++||||+ ++++.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 99999999999 678878776655567999999999999999999999777 9999999999999
Q ss_pred ------cCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 012213 319 ------NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGE 392 (468)
Q Consensus 319 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 392 (468)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999864321 2345789999999999999999999999999999999999999976331
Q ss_pred CCcCHHHHHHHhhcccccch-------hhhcc----------------------ccCCCCCHHHHHHHHHHHHhhcccCC
Q 012213 393 EGLDIVQWTKMQTNSSKEGV-------VKILD----------------------QRLSNTPLSEAMQVFFVAMLCVQEHG 443 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~-------~~~~d----------------------~~~~~~~~~~~~~~~~l~~~c~~~~P 443 (468)
. ................. ..... .........+...+.+++.+|++.||
T Consensus 245 ~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 245 R--EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp H--HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred H--HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1 00110000000000000 00000 00011233456688899999999999
Q ss_pred CCCCCHHHHHH
Q 012213 444 VERPTMREVVQ 454 (468)
Q Consensus 444 ~~RPt~~ev~~ 454 (468)
++|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=329.61 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=186.1
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 260 (468)
..|...+.||+|+||+||.....+++.||||++.... ...+.+|+.+++++ +||||+++++++.+....++|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4577789999999999766556689999999985322 13467899999998 79999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCceEEeeccccccc
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----DFEAHVADFGLAKYL 335 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~ 335 (468)
|++ |+|.+++..... ...+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.+
T Consensus 99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 996 699999975442 3444566789999999999999887 999999999999953 346889999999876
Q ss_pred cccCC-CccccccccCccccCccccC---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 336 QDTGA-SECMSAVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 336 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
..... ........||+.|+|||++. ...++.++|||||||++|||+| |..||...... ........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~~~~~~--- 244 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QANILLGA--- 244 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHHHHTTC---
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHHHHhcc---
Confidence 53221 12334567999999999987 4567889999999999999999 99999642211 00000000
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...............+.+++.+|++.||++|||+.||++
T Consensus 245 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 -----CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 001111122345566789999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.63 Aligned_cols=270 Identities=28% Similarity=0.316 Sum_probs=201.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec------CC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------KE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 253 (468)
...|+..+.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 56789999999999999999998 468899999876432 22334568899999999999999999998765 66
Q ss_pred eeEEEEeccCCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---eEEeec
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADF 329 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 329 (468)
..++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 7799999999999999997533 235889999999999999999999887 999999999999997765 999999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
|++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....|.........
T Consensus 169 G~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC----
T ss_pred ccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccc
Confidence 999876532 22345678999999999999999999999999999999999999996521 11222111110000
Q ss_pred cc--hhhhcc------cc---CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHH-----HHHHHHhccC
Q 012213 410 EG--VVKILD------QR---LSNTPLSEAMQVFFVAMLCVQEHGVERPTMRE-----VVQMLAQAQK 461 (468)
Q Consensus 410 ~~--~~~~~d------~~---~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~e-----v~~~L~~~~~ 461 (468)
.. ..+... .. ...........+.+++..|++.||++|||+.| +.+.++++..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 000000 01 11233456778899999999999999999987 5556655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=301.52 Aligned_cols=235 Identities=23% Similarity=0.303 Sum_probs=183.7
Q ss_pred chhhhccCCc-ceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHH-hCCCCCCccceeEEEec---
Q 012213 178 DDILECVKDN-NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTL-GKIRHRNIVRLKAFCSN--- 251 (468)
Q Consensus 178 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~--- 251 (468)
.++.+.|... +.||+|+||.||+|.+ .+++.||+|++.. ...+.+|+.++ +..+||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3446667665 7899999999999987 5688999999853 14577888887 66699999999999876
Q ss_pred -CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEe
Q 012213 252 -KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVA 327 (468)
Q Consensus 252 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 327 (468)
....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEe
Confidence 667899999999999999998766667999999999999999999999887 999999999999998 7889999
Q ss_pred eccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
|||++.... +..++.++||||||+++|||+||+.||........ ..
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~ 208 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SP 208 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------C
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hH
Confidence 999986542 12467899999999999999999999975321100 00
Q ss_pred cccchhhhccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 408 SKEGVVKILDQRLSNTP----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 408 ~~~~~~~~~d~~~~~~~----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.....+.......+ ......+.+++..|++.||++|||+.|+++ .+.+.
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 209 ---GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ---CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ---HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00011111111111 123466888999999999999999999997 44443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.21 Aligned_cols=233 Identities=15% Similarity=0.093 Sum_probs=183.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
..+|+..+.||+|+||.||+|.+. +++.||||++....... .....+.+|+..+.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 456888899999999999999985 48999999986543322 2236789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++++|.+++... ....+..+++.|++.||+|||+.+ |+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999532 355678899999999999999887 9999999999999999999998543
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
|++ .++.++||||||+++|||+||+.||.+....... ....+.+..
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------------~~~~~~~~~ 220 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------------APAERDTAG 220 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------EECCBCTTS
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------HHHHHHhcc
Confidence 333 3689999999999999999999999864321100 000000000
Q ss_pred cCC---CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 419 RLS---NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 419 ~~~---~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
... .........+.+++.+||+.||++| |+.|+++.|+++...+
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000 0011234567889999999999999 9999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=338.89 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=190.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC--CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---- 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 254 (468)
.+.|+..+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 467889999999999999999985 58999999886422 22233568899999999999999999999987665
Q ss_pred -eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 255 -NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 255 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+.+ |+||||||+||+++.+ .+||+|||+++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999988753 5899999999999999999999887 9999999999999986 89999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
..... ....||+.|+|||++.+. ++.++|||||||++|||++|.+||.........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 76422 345689999999998765 489999999999999999999988642111000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHHHh
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-MREVVQMLAQ 458 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-~~ev~~~L~~ 458 (468)
. ..........+.+++.+|++.||++||+ ++++.+.|..
T Consensus 286 ---~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ---E---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---T---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---c---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 0000122356778999999999999995 6666666654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=320.85 Aligned_cols=243 Identities=16% Similarity=0.162 Sum_probs=180.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCC-CCccc---------eeE-
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRH-RNIVR---------LKA- 247 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~---------l~~- 247 (468)
...|...+.||+|+||+||+|.+ .+|+.||||++..... .....+.+.+|+.++..++| +|... ...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999996 5789999999874332 22334679999999999987 32211 111
Q ss_pred -----------EEec-----CCeeEEEEeccCCCChhhhcc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 012213 248 -----------FCSN-----KETNLLVYEYMPNGSLGEVLH-----GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306 (468)
Q Consensus 248 -----------~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 306 (468)
++.. ....+++|+++ +++|.+++. ......+++..++.++.||+.||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111 22346777765 689999884 233446889999999999999999999887 9
Q ss_pred eecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCcccc----------CCCCCCcchhhHHHHHH
Q 012213 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYA----------YTLKVDEKSDVYSFGVV 376 (468)
Q Consensus 307 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~~ 376 (468)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865422 344567 999999998 55668899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 377 LLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 377 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+|||+||+.||....... .....+... .. ....+.+++..||+.||++||++.|+++
T Consensus 307 l~elltg~~Pf~~~~~~~----------------~~~~~~~~~-~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG----------------GSEWIFRSC-KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS----------------CSGGGGSSC-CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhh----------------hHHHHHhhc-cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999997632111 111111111 11 2356888999999999999999777643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=299.62 Aligned_cols=241 Identities=15% Similarity=0.148 Sum_probs=183.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCC------CCCchhHHHHHHHHHhCCC---------CCCccce
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITK------GSSHDNGLSAEIRTLGKIR---------HRNIVRL 245 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~l 245 (468)
.++|+..+.||+|+||+||+|.+ +|+.||||++..... .....+.+.+|+.++++++ |||++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 689999999975432 1222366889999988885 7777777
Q ss_pred eEEEe-----------------c-------------CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 012213 246 KAFCS-----------------N-------------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295 (468)
Q Consensus 246 ~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l 295 (468)
.+.+. + .+..++||||+++|++.+.+.. ..+++..+..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 66542 2 6788999999999987776643 3589999999999999999
Q ss_pred HHhh-hcCCCCeeecCCCCCcEEEcCCC--------------------ceEEeeccccccccccCCCccccccccCcccc
Q 012213 296 SYLH-HDCSPLIIHRDVKSNNILLNSDF--------------------EAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354 (468)
Q Consensus 296 ~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 354 (468)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+.... ....||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence 9999 888 99999999999999887 899999999987652 1347899999
Q ss_pred CccccCCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC---CCCCHHHHHH
Q 012213 355 APEYAYTLKVDEKSDVYSFGVV-LLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL---SNTPLSEAMQ 430 (468)
Q Consensus 355 aPE~~~~~~~~~~~Dv~s~G~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~---~~~~~~~~~~ 430 (468)
|||++.+.. +.++||||+|++ .+++++|..||.. ..|...... .+.+...... ..........
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTD----KMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHH----HHHHTCCCSSCCCSHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHH----hhhhhhccCcccchhhhhhcCHH
Confidence 999998766 899999998777 7788889999742 122111110 0000000000 1112356778
Q ss_pred HHHHHHhhcccCCCCCCCHHHHH
Q 012213 431 VFFVAMLCVQEHGVERPTMREVV 453 (468)
Q Consensus 431 ~~~l~~~c~~~~P~~RPt~~ev~ 453 (468)
+.+++.+|++.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999965 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-31 Score=273.54 Aligned_cols=186 Identities=19% Similarity=0.116 Sum_probs=128.4
Q ss_pred EcccCCcceEEEEc-CCCcEEEEEEecccCCCC--------CchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeEEEE
Q 012213 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS--------SHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 190 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.+.|+.|.+..++. .-|+.+|||.+....... ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 44555555544332 347889999986543211 1124689999999999 6999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||++|++|.++|... .+++.. +|+.||+.||+|+|+.| ||||||||+|||+++++.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999643 345543 58899999999999888 9999999999999999999999999998765322
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 386 (468)
......+||++|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 23345679999999999876 467889999999998877665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=253.77 Aligned_cols=187 Identities=18% Similarity=0.206 Sum_probs=147.6
Q ss_pred CcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCc------hhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH------DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
..+.||+|+||+||+|.. .++.+++|+.......... .+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 5788999987543222111 234789999999999999997777777788889999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++++|.+++.. +..++.|++.||+|||+.+ |+||||||+|||++. .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999964 5689999999999999887 999999999999999 99999999999775321
Q ss_pred CCc-----cccccccCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 012213 340 ASE-----CMSAVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRRPVG 388 (468)
Q Consensus 340 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~ 388 (468)
... ......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 111 1235679999999999876 568889999999999999888887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=205.10 Aligned_cols=145 Identities=16% Similarity=0.097 Sum_probs=115.1
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCC----------------CchhHHHHHHHHHhCCCCCCccceeE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS----------------SHDNGLSAEIRTLGKIRHRNIVRLKA 247 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~l~~ 247 (468)
|...+.||+|+||.||+|.+.+|+.||||.+....... .....+.+|+.++++++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 44558999999999999999779999999986432111 02346889999999999 5 66666
Q ss_pred EEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEe
Q 012213 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327 (468)
Q Consensus 248 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 327 (468)
++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ ++.+||+
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred EEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 5543 55699999999999998 531 123479999999999999887 99999999999999 9999999
Q ss_pred eccccccccccCCCccccccccCccccCccccC
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 360 (468)
|||+++. +..++|||++.
T Consensus 235 DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE---------------TTSTTHHHHHH
T ss_pred ECCCCeE---------------CCCCCHHHHHH
Confidence 9999863 33467888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=172.34 Aligned_cols=138 Identities=21% Similarity=0.187 Sum_probs=105.0
Q ss_pred cCCcceEcccCCcceEEEEc-CCCcE--EEEEEecccCCCCC----------------------chhHHHHHHHHHhCCC
Q 012213 184 VKDNNVIGRGGAGVVYRGVT-PNGEQ--VAVKKLLGITKGSS----------------------HDNGLSAEIRTLGKIR 238 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 238 (468)
++..+.||+|+||.||+|.+ .+|+. ||||+++....... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34568999999999999998 78989 99998754311100 0125788999999998
Q ss_pred CCCc--cceeEEEecCCeeEEEEeccCC-C----ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecC
Q 012213 239 HRNI--VRLKAFCSNKETNLLVYEYMPN-G----SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRD 310 (468)
Q Consensus 239 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~d 310 (468)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8764 334432 356899999942 4 56655432 224466789999999999999 888 99999
Q ss_pred CCCCcEEEcCCCceEEeeccccccc
Q 012213 311 VKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 311 lk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=192.98 Aligned_cols=113 Identities=43% Similarity=0.709 Sum_probs=108.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+|.+|.+|+++++|+.|+|++|+|+|.+|.+|++|++|+.||||+|+++|.+|..+..+++|+.|||++|+|+|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccccCcccccCCCCCCCCCCCCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS 113 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~lcg~~~~~c~~~ 113 (468)
.||..+.+..+...+|.||+++||.+..+|...
T Consensus 719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 719 PIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp ECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred cCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 999989999999999999999999887788643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=159.32 Aligned_cols=139 Identities=12% Similarity=0.075 Sum_probs=98.6
Q ss_pred cCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCC------------CCchhH--------HHHHHHHHhCCCCCCcc
Q 012213 184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG------------SSHDNG--------LSAEIRTLGKIRHRNIV 243 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~--------~~~e~~~l~~l~h~niv 243 (468)
|++.+.||+|++|.||+|.+.+|+.||||.++..... ...... ...|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 6778999999999999999999999999987532110 000001 12355555555433332
Q ss_pred ceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-
Q 012213 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF- 322 (468)
Q Consensus 244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~- 322 (468)
...-+.. ...+|||||+++++|.++... +....++.|++.+|.|||+.| ||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 2111111 124799999999998776532 123567899999999999888 99999999999998876
Q ss_pred ---------ceEEeeccccccc
Q 012213 323 ---------EAHVADFGLAKYL 335 (468)
Q Consensus 323 ---------~~kl~Dfgla~~~ 335 (468)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=151.82 Aligned_cols=109 Identities=31% Similarity=0.465 Sum_probs=99.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++.+|..++++++|+.|+|++|++++.+|. +..+++|++|+|++|.++|.+|..|..+++|+.|+|++|+++|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 578888888888889999999999999999976665 8899999999999999999999999999999999999999999
Q ss_pred CCCCcccccccCcccccCCCCCCCCCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHLCGSYLNPC 110 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~lcg~~~~~c 110 (468)
.+|..+.+..+..+++.+|+++||.+...|
T Consensus 283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 283 EIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 999988999999999999999999876666
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=8.6e-16 Score=136.09 Aligned_cols=105 Identities=26% Similarity=0.396 Sum_probs=92.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|.|++..|..|..+++|+.|+|++|+|++
T Consensus 38 L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~ 116 (193)
T 2wfh_A 38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV 116 (193)
T ss_dssp CCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCe
Confidence 5789998 888999999999999999999997666789999999999999999997666689999999999999999997
Q ss_pred CCCC-cccccccCcccccCCCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
.++. +..+.++..+++++|++.|.+.
T Consensus 117 ~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 117 VPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred eChhhhhcCccccEEEeCCCCeecCCc
Confidence 7664 7788899999999999988764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.61 E-value=8.3e-16 Score=136.10 Aligned_cols=105 Identities=21% Similarity=0.319 Sum_probs=92.0
Q ss_pred CCCCcccccCCc-ccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPV-EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~-~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|. .++++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 36 l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 115 (192)
T 1w8a_A 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 578999855553 4899999999999999999888999999999999999999999877777999999999999999999
Q ss_pred CCCCC-cccccccCcccccCCCCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
+.+|. +..+.++..+++++|++.|.+
T Consensus 116 ~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 116 CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred eeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 98874 788889999999999988765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=137.39 Aligned_cols=99 Identities=16% Similarity=0.114 Sum_probs=46.7
Q ss_pred CCCCcccccCC-cccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..| ..|+++++|+.|+|++|+|++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|+|+
T Consensus 39 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 118 (220)
T 2v70_A 39 LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT 118 (220)
T ss_dssp CCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCC
T ss_pred cCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCC
Confidence 34555554333 22445555555555555555333334555555555555555554333333444555555555555555
Q ss_pred CCCCC-cccccccCcccccCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGN 99 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n 99 (468)
+.+|. +..+.++..+++++|
T Consensus 119 ~~~~~~~~~l~~L~~L~L~~N 139 (220)
T 2v70_A 119 CVGNDSFIGLSSVRLLSLYDN 139 (220)
T ss_dssp CBCTTSSTTCTTCSEEECTTS
T ss_pred eECHhHcCCCccCCEEECCCC
Confidence 44432 444444444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.58 E-value=3.2e-15 Score=129.53 Aligned_cols=102 Identities=19% Similarity=0.243 Sum_probs=91.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus 16 ~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~ 92 (170)
T 3g39_A 16 CSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS 92 (170)
T ss_dssp CTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred eCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCE
Confidence 5789998 7898774 899999999999998778899999999999999999996445557899999999999999998
Q ss_pred CCCC-cccccccCcccccCCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
.+|. +..+.++..+++++|++.|.+
T Consensus 93 ~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 93 IPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred eCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 8885 888999999999999998875
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.5e-15 Score=129.75 Aligned_cols=101 Identities=20% Similarity=0.261 Sum_probs=90.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCc-ccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~ 79 (468)
+++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++ +|+ .|..+++|+.|+|++|+|+
T Consensus 19 ~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~l~ 94 (174)
T 2r9u_A 19 CQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLK 94 (174)
T ss_dssp CCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC
T ss_pred eCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCccc
Confidence 5789997 8998775 899999999999998778899999999999999999996 655 4689999999999999999
Q ss_pred CCCCC-cccccccCcccccCCCCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
+.++. +..+.++..+++++|++.|.+
T Consensus 95 ~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 95 SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred eeCHHHhccccCCCEEEeCCCCccccc
Confidence 88776 888999999999999988765
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-17 Score=167.72 Aligned_cols=99 Identities=20% Similarity=0.226 Sum_probs=86.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCcccc-ccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..++++++|+.|+|++|+|++.+|..+. ++++|+.|+|++|.|++ +|+ +..+++|+.|+|++|+|+
T Consensus 127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~ 204 (487)
T 3oja_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA 204 (487)
T ss_dssp CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc-ccc-cccCCCCCEEECCCCCCC
Confidence 578999988888999999999999999999988888886 79999999999999986 443 446899999999999999
Q ss_pred CCCCCcccccccCcccccCCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~~ 101 (468)
+.+|.+..+.++..+++++|..
T Consensus 205 ~~~~~~~~l~~L~~L~Ls~N~l 226 (487)
T 3oja_A 205 FMGPEFQSAAGVTWISLRNNKL 226 (487)
T ss_dssp EECGGGGGGTTCSEEECTTSCC
T ss_pred CCCHhHcCCCCccEEEecCCcC
Confidence 8888888888999999998854
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4.5e-15 Score=134.36 Aligned_cols=99 Identities=24% Similarity=0.262 Sum_probs=55.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcc-cccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|.|+ .+|+. |..+++|+.|+|++|+|+
T Consensus 39 l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~ 117 (220)
T 2v9t_B 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117 (220)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCC
Confidence 3556666444445666666666666666666555556666666666666666665 34333 455555666666666655
Q ss_pred CCCCC-cccccccCcccccCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~ 100 (468)
+.+|. +..+.++..+++++|.
T Consensus 118 ~~~~~~~~~l~~L~~L~L~~N~ 139 (220)
T 2v9t_B 118 CLRVDAFQDLHNLNLLSLYDNK 139 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSC
T ss_pred EeCHHHcCCCCCCCEEECCCCc
Confidence 55442 4455555555555553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=7.1e-15 Score=157.76 Aligned_cols=99 Identities=27% Similarity=0.510 Sum_probs=95.2
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
+.|.++|.+|..++++++|+.|||++|+|+|.+|.+|++|++|+.|||++|+++|.+|..|+++++|+.|||++|+|+|.
T Consensus 616 ~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ 695 (768)
T 3rgz_A 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695 (768)
T ss_dssp TSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEC
T ss_pred ccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCc
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-cccccccCcccccCCC
Q 012213 82 IPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 ~p~-~~~~~~~~~~~~~~n~ 100 (468)
+|. +..+.++..+++++|+
T Consensus 696 ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 696 IPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp CCGGGGGCCCCSEEECCSSE
T ss_pred CChHHhCCCCCCEEECcCCc
Confidence 995 8889999999999885
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=130.84 Aligned_cols=101 Identities=15% Similarity=0.135 Sum_probs=73.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+.
T Consensus 47 Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~ 126 (229)
T 3e6j_A 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE 126 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS
T ss_pred cCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccc
Confidence 57788887777778888888888888888873333456778888888888888875444456777888888888888874
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.++.+..+.++..+++++|..
T Consensus 127 lp~~~~~l~~L~~L~L~~N~l 147 (229)
T 3e6j_A 127 LPRGIERLTHLTHLALDQNQL 147 (229)
T ss_dssp CCTTGGGCTTCSEEECCSSCC
T ss_pred cCcccccCCCCCEEECCCCcC
Confidence 434566777777777777743
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.6e-14 Score=124.65 Aligned_cols=104 Identities=17% Similarity=0.205 Sum_probs=71.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..++++++|++|+|++|+|++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|++++|++++
T Consensus 35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 114 (177)
T 2o6r_A 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS 114 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred eCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE
Confidence 46677775445556777777777777777774444456777777777777777775444456777777777777777776
Q ss_pred CCCC-cccccccCcccccCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCG 104 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg 104 (468)
.++. +..+.++..+++++|++.|.
T Consensus 115 ~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 115 VPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred eCHHHhcCCcccCEEEecCCCeecc
Confidence 5554 45667777777777766654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=3.4e-14 Score=137.87 Aligned_cols=103 Identities=17% Similarity=0.154 Sum_probs=90.5
Q ss_pred CCC-cccccCCcccccCCCCCEEEccC-CcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 2 SRN-NFSGIIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 2 ~~N-~l~g~~p~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
++| +|+ .||. |+.+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|+
T Consensus 16 ~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 93 (347)
T 2ifg_A 16 TRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (347)
T ss_dssp CSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc
Confidence 455 898 6998 99999999999996 9999766688999999999999999999988888999999999999999999
Q ss_pred CCCCCcccccccCcccccCCCCCCCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
+.+|.......+..+.+.+|++.|.|.
T Consensus 94 ~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 94 SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred eeCHHHcccCCceEEEeeCCCccCCCc
Confidence 887764333348999999999998763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=127.18 Aligned_cols=101 Identities=16% Similarity=0.168 Sum_probs=75.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|+|++
T Consensus 66 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 66 LDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc
Confidence 56788887666777888888888888888885555667788888888888888885444446778888888888888887
Q ss_pred CCC-CcccccccCcccccCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
.+| .+..+.++..+++++|..
T Consensus 146 ~~~~~~~~l~~L~~L~L~~N~l 167 (251)
T 3m19_A 146 IPAGAFDKLTNLQTLSLSTNQL 167 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cCHHHcCcCcCCCEEECCCCcC
Confidence 666 367777777777777753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-13 Score=122.71 Aligned_cols=101 Identities=19% Similarity=0.194 Sum_probs=71.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..+..++++++|++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|..+++|+.|++++|++++
T Consensus 35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 114 (208)
T 2o6s_A 35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS 114 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred cCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc
Confidence 56777875545556778888888888888874434456778888888888888875434446777788888888888776
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 115 ~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 115 LPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cCHhHhccCCcCCEEECCCCcc
Confidence 6664 56677777777777743
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=128.45 Aligned_cols=100 Identities=20% Similarity=0.223 Sum_probs=66.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..++++++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+..+++|+.|++++|++++
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence 46677775555556777777777777777775555556777777777777777775444445677777777777777776
Q ss_pred CCCC-cccccccCcccccCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~ 100 (468)
.+|. +..+.++..+++++|.
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 172 LPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSC
T ss_pred cCHHHhcCCccCCEEECCCCc
Confidence 5554 4566666667776664
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.45 E-value=4e-14 Score=135.32 Aligned_cols=101 Identities=29% Similarity=0.542 Sum_probs=94.2
Q ss_pred CCCCcccc--cCCcccccCCCCCEEEccC-CcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcc
Q 012213 1 MSRNNFSG--IIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNN 77 (468)
Q Consensus 1 l~~N~l~g--~~p~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~ 77 (468)
|++|+|+| .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|.++|.+|..|..+++|+.|++++|+
T Consensus 57 L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 136 (313)
T 1ogq_A 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence 46899999 8999999999999999995 99999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCC-cccccccCcccccCCCC
Q 012213 78 FSGEIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 78 l~~~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
+++.+|. +..+.++..+++++|..
T Consensus 137 l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 137 LSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCC
T ss_pred cCCcCChHHhcCCCCCeEECcCCcc
Confidence 9998884 88899999999998853
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=9.7e-14 Score=145.45 Aligned_cols=106 Identities=25% Similarity=0.311 Sum_probs=94.2
Q ss_pred CCCCcc-cccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNF-SGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l-~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|++ .+.+|..|..+++|++|||++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|+.|||++|+|+
T Consensus 476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 555 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 555 (635)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred hhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence 467764 4457888999999999999999999888999999999999999999999877778999999999999999999
Q ss_pred CCCCC-cccc-cccCcccccCCCCCCCCC
Q 012213 80 GEIPE-FGQY-SFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 80 ~~~p~-~~~~-~~~~~~~~~~n~~lcg~~ 106 (468)
+.+|. +..+ .++..+++++||+.|.|.
T Consensus 556 ~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 556 TSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp BCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99885 6666 578999999999999874
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=129.19 Aligned_cols=100 Identities=19% Similarity=0.179 Sum_probs=70.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++
T Consensus 84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 5677777 677777777778888888888775445667777777777777777775444446677777777777777775
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 163 l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 163 LPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cCHHHhcCcCCCCEEECCCCcC
Confidence 5554 45666677777766643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=123.70 Aligned_cols=104 Identities=18% Similarity=0.286 Sum_probs=73.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..|.++++|++|+|++|+|+ .+|. .|.++++|++|+|++|.+++..|..|..+++|+.|+|++|+|+
T Consensus 63 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 63 LSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 4677777666777777777777777777777 4444 3567777777777777777655666777777777777777777
Q ss_pred CCCCC-cccccccCcccccCCCCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
+.++. +..+.++..+++++|++.|.+
T Consensus 142 ~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 142 TIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred EECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 66664 666667777777777777654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.8e-13 Score=123.71 Aligned_cols=105 Identities=15% Similarity=0.184 Sum_probs=80.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|+.|+|++|+|++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|+|++
T Consensus 64 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 143 (220)
T 2v70_A 64 FSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143 (220)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC
T ss_pred CCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE
Confidence 56788886666678888888888888888886555567888888888888888887667778888888888888888887
Q ss_pred CCC-CcccccccCcccccCCCCCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~lcg~ 105 (468)
.+| .+..+.++..+++++|++.|.+
T Consensus 144 ~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 144 VAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp BCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred ECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 766 4677777788888888877764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=8.8e-14 Score=123.00 Aligned_cols=105 Identities=24% Similarity=0.358 Sum_probs=86.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++
T Consensus 61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 68999998889999999999999999999998788889999999999999999999889999999999999999999998
Q ss_pred CCCCcccccccCcccccCCCCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~lcg~ 105 (468)
..+-..-...+....+.++...|+.
T Consensus 141 ~c~l~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 141 NCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cCcchHHHHHHHHcCCCCCCCCCCC
Confidence 7763111112222344445455543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=4e-13 Score=125.50 Aligned_cols=99 Identities=17% Similarity=0.264 Sum_probs=52.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..+..+.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|+.|++++|++++
T Consensus 92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171 (270)
T ss_dssp CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence 34566654334445556666666666666664444445555566666666655553222235555555555555555555
Q ss_pred CCCC-cccccccCcccccCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGN 99 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n 99 (468)
.++. +..+.++..+++++|
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 172 VPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSS
T ss_pred eChhHhccCCCcCEEECCCC
Confidence 4442 444555555555555
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.5e-13 Score=122.65 Aligned_cols=93 Identities=22% Similarity=0.247 Sum_probs=43.6
Q ss_pred CCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCC-cccccccccccccccCcccCCC
Q 012213 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 3 ~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
+|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++ +| ..|..+++|+.|+|++|+|++.
T Consensus 28 ~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~l 103 (229)
T 3e6j_A 28 SKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVL 103 (229)
T ss_dssp TSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-cChhhcccCCCcCEEECCCCcCCcc
Confidence 34443 4444332 445555555555554444445555555555555555542 32 2334455555555555555544
Q ss_pred CCC-cccccccCcccccCC
Q 012213 82 IPE-FGQYSFFNSTSFTGN 99 (468)
Q Consensus 82 ~p~-~~~~~~~~~~~~~~n 99 (468)
++. +..+.++..+++++|
T Consensus 104 ~~~~~~~l~~L~~L~Ls~N 122 (229)
T 3e6j_A 104 PSAVFDRLVHLKELFMCCN 122 (229)
T ss_dssp CTTTTTTCTTCCEEECCSS
T ss_pred ChhHhCcchhhCeEeccCC
Confidence 432 344444455555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.41 E-value=9.4e-14 Score=117.40 Aligned_cols=98 Identities=14% Similarity=0.138 Sum_probs=87.9
Q ss_pred CCCCccc-ccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~-g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+++ |.+|..++.+++|+.|+|++|++++. ..++++++|++|+|++|.+++.+|..+..+++|+.|++++|+++
T Consensus 24 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~ 101 (149)
T 2je0_A 24 LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101 (149)
T ss_dssp CTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred ccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence 5789998 89999999999999999999999954 78999999999999999999778888888999999999999999
Q ss_pred CCC--CCcccccccCcccccCCC
Q 012213 80 GEI--PEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~--p~~~~~~~~~~~~~~~n~ 100 (468)
+.. +.+..++++..+++++|+
T Consensus 102 ~~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 102 DLSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp SHHHHGGGGGCTTCCEEECTTCG
T ss_pred ChHHHHHHhhCCCCCEEeCcCCc
Confidence 843 467888899999999885
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=135.35 Aligned_cols=103 Identities=19% Similarity=0.226 Sum_probs=48.6
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
++|+|++..|..|+++++|++|+|++|++++..|..+.++++|++|+|++|.+++..|..|..+++|+.|++++|++++.
T Consensus 307 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC
Confidence 34444444444444444444444444444443344444445555555555555444444444455555555555555443
Q ss_pred CCC-cccccccCcccccCCCCCCC
Q 012213 82 IPE-FGQYSFFNSTSFTGNPHLCG 104 (468)
Q Consensus 82 ~p~-~~~~~~~~~~~~~~n~~lcg 104 (468)
++. +..+.++..+++++|+..|.
T Consensus 387 ~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 387 PDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CHhHhccCCcccEEEccCCCcccC
Confidence 332 34444445555555544444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.39 E-value=1.9e-13 Score=117.98 Aligned_cols=99 Identities=16% Similarity=0.174 Sum_probs=85.3
Q ss_pred CCCCccc-ccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~-g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|+ |.+|..+..+++|+.|+|++|++++ + ..+..+++|++|+|++|.+++.+|..+..+++|+.|++++|+++
T Consensus 31 l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 108 (168)
T 2ell_A 31 LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108 (168)
T ss_dssp CCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC
T ss_pred CCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC
Confidence 5788998 8899888999999999999999995 4 78899999999999999999778887878999999999999998
Q ss_pred CCC--CCcccccccCcccccCCCC
Q 012213 80 GEI--PEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~--p~~~~~~~~~~~~~~~n~~ 101 (468)
+.+ +.+..+.++..+++++|+.
T Consensus 109 ~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 109 DISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp SSGGGGGGSSCSCCCEEECCSSGG
T ss_pred cchhHHHHhcCCCCCEEEeeCCcC
Confidence 754 4577888888899988853
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.1e-13 Score=141.82 Aligned_cols=71 Identities=11% Similarity=0.171 Sum_probs=55.5
Q ss_pred cccccCCccccccccccEeeccCCccccc-----------------CCcccc--cccccccccccCcccCCCCCC-cccc
Q 012213 29 HLSGPIPVQITQIHILNYLNVSWNQLNAS-----------------LPKEMG--NMKSLTSADFSHNNFSGEIPE-FGQY 88 (468)
Q Consensus 29 ~l~g~~p~~~~~l~~L~~l~ls~N~l~g~-----------------~p~~~~--~l~~L~~l~ls~N~l~~~~p~-~~~~ 88 (468)
+|+| ||.+|+++++|++|+|++|.|+|. +|+.++ ++++|+.|++++|+++|.+|. ++.+
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4555 788888888888888888888875 888877 888888888888888887774 7777
Q ss_pred cccCcccccCCC
Q 012213 89 SFFNSTSFTGNP 100 (468)
Q Consensus 89 ~~~~~~~~~~n~ 100 (468)
.++..+++++|.
T Consensus 273 ~~L~~L~Ls~n~ 284 (636)
T 4eco_A 273 PEMQLINVACNR 284 (636)
T ss_dssp SSCCEEECTTCT
T ss_pred CCCCEEECcCCC
Confidence 778888887775
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.3e-13 Score=138.20 Aligned_cols=96 Identities=21% Similarity=0.298 Sum_probs=89.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +|. +++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|++ +| .++.+++|+.|+|++|+|++
T Consensus 448 Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~ 522 (567)
T 1dce_A 448 LAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQ 522 (567)
T ss_dssp CTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCS
T ss_pred ecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCC
Confidence 68999995 886 999999999999999999 999999999999999999999996 88 89999999999999999999
Q ss_pred CC-C-CcccccccCcccccCCCC
Q 012213 81 EI-P-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~-p-~~~~~~~~~~~~~~~n~~ 101 (468)
.+ | .++.++++..+++++|+.
T Consensus 523 ~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 523 SAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp SSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCcHHHhcCCCCCEEEecCCcC
Confidence 85 5 688999999999999964
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.38 E-value=8.4e-13 Score=121.89 Aligned_cols=101 Identities=15% Similarity=0.160 Sum_probs=90.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|+|++
T Consensus 42 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 121 (251)
T 3m19_A 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS 121 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCC
Confidence 67899998888889999999999999999998777789999999999999999996666678999999999999999998
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 122 ~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 122 LPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cChhHhccCCcccEEECcCCcC
Confidence 7775 67889999999999854
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3.9e-13 Score=126.58 Aligned_cols=100 Identities=17% Similarity=0.172 Sum_probs=58.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|++++..|..+.++++|++|+|++|++++..+..+.++++|+.|+|++|.+++..+..|..+++|+.|++++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 45666665555666666666666666666664334446666666666666666664333345666666666666666665
Q ss_pred CCC-CcccccccCcccccCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~ 100 (468)
.+| .+..+.++..+++++|.
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSC
T ss_pred cCHhHccCcccccEeeCCCCc
Confidence 544 35555555556655553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.4e-13 Score=128.92 Aligned_cols=97 Identities=16% Similarity=0.208 Sum_probs=58.7
Q ss_pred CCCcccccCCccccc---------CCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCccccccccccccc
Q 012213 2 SRNNFSGIIPVEIGH---------CLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSAD 72 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~---------l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ 72 (468)
++|++.|.+|..++. +++|++|+|++|+|+ .+|.+++++++|+.|+|++|.+++ +|+.+..+++|+.|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence 345555566655543 666666666666666 566666666666666666666663 555566666666666
Q ss_pred ccCcccCCCCCC-cccccccCcccccCCC
Q 012213 73 FSHNNFSGEIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 73 ls~N~l~~~~p~-~~~~~~~~~~~~~~n~ 100 (468)
+++|++.+.+|. ++.+.++..+++++|.
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 264 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCS 264 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCT
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCC
Confidence 666666666553 5555666666666554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=8.1e-13 Score=132.44 Aligned_cols=104 Identities=25% Similarity=0.331 Sum_probs=91.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++
T Consensus 192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 5778887 677 58888999999999999998778899999999999999999998778889999999999999999997
Q ss_pred CCCC-cccccccCcccccCCCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
.++. +..+.++..+++++|++.|.|.
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred cChhHhccccCCCEEEcCCCCccCCCC
Confidence 7775 6788899999999999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-12 Score=119.67 Aligned_cols=144 Identities=15% Similarity=0.076 Sum_probs=110.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 259 (468)
...|+....++.|+.+.||++... ++.+++|......... ...+.+|++.++.+. +..+.++++++...+..++||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 345666677888888999999764 6889999886432222 245889999998884 677888999998888899999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-------------------------------------- 301 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------- 301 (468)
||++|.+|.+.+.. ......++.++++++..||..
T Consensus 90 e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999876421 122347788999999999981
Q ss_pred ------------------CCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 302 ------------------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 302 ------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
....++|+|++|.||+++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114489999999999998765667999987753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=115.49 Aligned_cols=98 Identities=21% Similarity=0.287 Sum_probs=88.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++
T Consensus 17 ~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~ 92 (193)
T 2wfh_A 17 CSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92 (193)
T ss_dssp CTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred cCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE
Confidence 4789998 8897764 68999999999999 899999999999999999999997666789999999999999999998
Q ss_pred CCCC-cccccccCcccccCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~l 102 (468)
.+|. +..+.++..+++++|...
T Consensus 93 i~~~~f~~l~~L~~L~L~~N~l~ 115 (193)
T 2wfh_A 93 IPPRTFDGLKSLRLLSLHGNDIS 115 (193)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC
T ss_pred eCHHHhCCCCCCCEEECCCCCCC
Confidence 8884 888999999999999643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=6.1e-13 Score=138.88 Aligned_cols=106 Identities=24% Similarity=0.242 Sum_probs=62.1
Q ss_pred CCCCcccc-cCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSG-IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g-~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|++++ .+|..++++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|..|..+++|+.|++++|+|+
T Consensus 455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 34555555 24555566666666666666666555555666666666666666666555666666666666666666666
Q ss_pred CCCCCccccc-ccCcccccCCCCCCCCC
Q 012213 80 GEIPEFGQYS-FFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 80 ~~~p~~~~~~-~~~~~~~~~n~~lcg~~ 106 (468)
..++.+..+. ++..+++++|++.|.+.
T Consensus 535 ~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 535 TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 3333444444 36666666666666553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=116.36 Aligned_cols=104 Identities=19% Similarity=0.234 Sum_probs=53.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..+..|.++++|++|+|++|+|++..+..+.++++|++|+|++|.+++..|..|..+++|+.|++++|++++
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 138 (208)
T 2o6s_A 59 LGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce
Confidence 34555553333344555555555555555553333334555555555555555553333334555555555555555554
Q ss_pred CCCC-cccccccCcccccCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCG 104 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg 104 (468)
.++. +..+.++..+++++|++.|.
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred eCHHHhccCCCccEEEecCCCeecC
Confidence 4443 44455555555555555443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.35 E-value=8.7e-13 Score=125.51 Aligned_cols=101 Identities=20% Similarity=0.227 Sum_probs=82.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccc-cCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g-~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|++++..|..++++++|++|+|++|++++ .+|..+..+++|+.|+|++|.+++..|..|..+++|+.|++++|+++
T Consensus 133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (306)
T 2z66_A 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212 (306)
T ss_dssp CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence 56788887778888888888888888888886 57888888888888888888888766778888888888888888888
Q ss_pred CCCC-CcccccccCcccccCCCC
Q 012213 80 GEIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
+..+ .+..+.++..+++++|..
T Consensus 213 ~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 213 SLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp BCCSGGGTTCTTCCEEECTTSCC
T ss_pred ccChhhccCcccCCEeECCCCCC
Confidence 7666 466777888888888754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.35 E-value=4.8e-13 Score=143.72 Aligned_cols=102 Identities=17% Similarity=0.239 Sum_probs=82.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEc-cCCccccc----------------------------------------------
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDL-SQNHLSGP---------------------------------------------- 33 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l-~~n~l~g~---------------------------------------------- 33 (468)
|++|+|+|.+|++|++|++|++||| ++|.++|.
T Consensus 330 Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~ 409 (876)
T 4ecn_A 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409 (876)
T ss_dssp CTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred CccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhh
Confidence 5788888888888888888888888 77766555
Q ss_pred ------------------------------CCccccccccccEeeccCCcccc-----------------cCCcccc--c
Q 012213 34 ------------------------------IPVQITQIHILNYLNVSWNQLNA-----------------SLPKEMG--N 64 (468)
Q Consensus 34 ------------------------------~p~~~~~l~~L~~l~ls~N~l~g-----------------~~p~~~~--~ 64 (468)
||.+|++|++|++|+|++|.|+| .+|+.++ +
T Consensus 410 ~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~ 489 (876)
T 4ecn_A 410 RNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489 (876)
T ss_dssp TCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG
T ss_pred hCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhcc
Confidence 78888888888888888888887 4888877 8
Q ss_pred ccccccccccCcccCCCCCC-cccccccCcccccCCCCC
Q 012213 65 MKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 65 l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~l 102 (468)
+++|+.|+|++|++.|.+|. ++.+.++..+++++|..+
T Consensus 490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~l 528 (876)
T 4ecn_A 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528 (876)
T ss_dssp CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTS
T ss_pred CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCc
Confidence 88888888888888888884 777888888888888633
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.35 E-value=7.3e-13 Score=127.36 Aligned_cols=100 Identities=15% Similarity=0.199 Sum_probs=92.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..++.+++|+.|++++|++.+
T Consensus 190 L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267 (328)
T ss_dssp EEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred CcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence 4678998 89999999999999999999999 588899999999999999999999999999999999999999999999
Q ss_pred CCC-CcccccccCcccccCCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~l 102 (468)
.+| .+..+.++..+++++|+.+
T Consensus 268 ~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 268 TLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp BCCTTGGGCTTCCEEECTTCTTC
T ss_pred hcchhhhcCCCCCEEeCCCCCch
Confidence 999 4888999999999998654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=131.45 Aligned_cols=104 Identities=21% Similarity=0.286 Sum_probs=91.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|.+++..|..|..+++|+.|+|++|+|++
T Consensus 203 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 203 LGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp CTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence 5778888 455 58888999999999999998788899999999999999999998888889999999999999999997
Q ss_pred CCCC-cccccccCcccccCCCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
.++. +..+.++..+++++|++.|.|.
T Consensus 281 ~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 281 LPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred cChHHhccccCCCEEEccCCCcCCCCC
Confidence 7775 6778899999999999999874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=112.97 Aligned_cols=85 Identities=24% Similarity=0.239 Sum_probs=75.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.++.
T Consensus 37 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 68999998889999999999999999999996555567999999999999999996445569999999999999999998
Q ss_pred CCCCc
Q 012213 81 EIPEF 85 (468)
Q Consensus 81 ~~p~~ 85 (468)
..+.+
T Consensus 117 ~c~~l 121 (170)
T 3g39_A 117 ACSDI 121 (170)
T ss_dssp TBGGG
T ss_pred CchhH
Confidence 77653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=138.71 Aligned_cols=98 Identities=31% Similarity=0.358 Sum_probs=84.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..+++|++|++|+|++|+|+ .||.+|++|++|++|||++|.|+ .||..|++|++|+.|+|++|.|+.
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc
Confidence 6788888 88888888999999999999998 88988999999999999999998 789889999999999999998874
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.++.++.+.+|..+++++|+.
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCC
T ss_pred cChhhhcCCCccEEeCCCCcc
Confidence 444688888888888888864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=134.11 Aligned_cols=106 Identities=18% Similarity=0.243 Sum_probs=80.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCccc-ccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~-g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|++++.+|..++++++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++..|..|..+++|+.|++++|+++
T Consensus 428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 507 (570)
T 2z63_A 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507 (570)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence 4667777777777777777888888888776 567777788888888888888888766777778888888888888888
Q ss_pred CCCCC-cccccccCcccccCCCCCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
+.+|. +..+.++..+++++|++.|.+.
T Consensus 508 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 508 SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 77664 6677777778888887776643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.33 E-value=2.6e-12 Score=120.07 Aligned_cols=99 Identities=20% Similarity=0.223 Sum_probs=77.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +| .++++++|++|+|++|++++..|..+.++++|++|+|++|.+++..|..|..+++|+.|++++|++++
T Consensus 70 l~~n~l~~-~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 147 (272)
T 3rfs_A 70 LGGNKLHD-IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS 147 (272)
T ss_dssp CTTSCCCC-CG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCC-ch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc
Confidence 56788875 43 78888888888888888886556667888888888888888886555567888888888888888887
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.+|. +..+.++..+++++|..
T Consensus 148 ~~~~~~~~l~~L~~L~l~~n~l 169 (272)
T 3rfs_A 148 LPKGVFDKLTNLTELDLSYNQL 169 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cCHHHhccCccCCEEECCCCCc
Confidence 7665 57778888888888753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.32 E-value=8.8e-13 Score=113.77 Aligned_cols=98 Identities=16% Similarity=0.190 Sum_probs=87.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCC--cccccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP--KEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p--~~~~~l~~L~~l~ls~N~l 78 (468)
|++|+|++. ..++.+++|++|+|++|++++.+|..+.++++|++|+|++|.+++ +| ..+..+++|+.|++++|++
T Consensus 56 l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 56 LINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp EESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGG
T ss_pred CcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcC
Confidence 468999854 789999999999999999998799999999999999999999995 55 7899999999999999999
Q ss_pred CCCCC----CcccccccCcccccCCCC
Q 012213 79 SGEIP----EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 79 ~~~~p----~~~~~~~~~~~~~~~n~~ 101 (468)
++.++ .+..++++..+++++|..
T Consensus 133 ~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 133 TNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp GTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred cchHHHHHHHHHhCccCcEecCCCCCh
Confidence 98877 477888999999988854
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=113.55 Aligned_cols=84 Identities=25% Similarity=0.406 Sum_probs=74.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCCc-ccccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l 78 (468)
|++|+|++..|..|+++++|+.|+|++|+|++ +|. .|.++++|++|+|++|+|++ +|+ .|..+++|+.|+|++|.+
T Consensus 40 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~L~~N~~ 117 (174)
T 2r9u_A 40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNNPW 117 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCB
T ss_pred eCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCccce-eCHHHhccccCCCEEEeCCCCc
Confidence 68999998889999999999999999999995 555 57899999999999999995 555 599999999999999999
Q ss_pred CCCCCCcc
Q 012213 79 SGEIPEFG 86 (468)
Q Consensus 79 ~~~~p~~~ 86 (468)
+...+.+.
T Consensus 118 ~c~~~~~~ 125 (174)
T 2r9u_A 118 DCECRDIM 125 (174)
T ss_dssp CTTBGGGH
T ss_pred ccccccHH
Confidence 97666543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-12 Score=136.00 Aligned_cols=101 Identities=15% Similarity=0.061 Sum_probs=88.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|.+|.+|++|++|||++|+|++..|..|.+|++|++|+|++|+|++..|..|.++++|+.|+|++|+|++
T Consensus 59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~ 138 (635)
T 4g8a_A 59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 138 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC
T ss_pred eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC
Confidence 68999996667789999999999999999996556689999999999999999996444568999999999999999998
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. ++.+.+++.+++++|..
T Consensus 139 l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 139 LENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp STTCCCTTCTTCCEEECCSSCC
T ss_pred CChhhhhcCcccCeeccccCcc
Confidence 7774 88889999999998864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=115.95 Aligned_cols=97 Identities=13% Similarity=0.113 Sum_probs=70.6
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
++|+++ . +..++.+++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+..+++|+.|++++|++.+.
T Consensus 74 ~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~ 151 (197)
T 4ezg_A 74 NNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151 (197)
T ss_dssp ESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC
T ss_pred cCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc
Confidence 456554 2 34677777888888888888776777777888888888888888776777777778888888888874445
Q ss_pred CCCcccccccCcccccCCC
Q 012213 82 IPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~~n~ 100 (468)
+|.+..++++..+++++|.
T Consensus 152 ~~~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 152 IMPLKTLPELKSLNIQFDG 170 (197)
T ss_dssp CGGGGGCSSCCEEECTTBC
T ss_pred cHhhcCCCCCCEEECCCCC
Confidence 5666777777777777764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.31 E-value=6.9e-13 Score=112.02 Aligned_cols=95 Identities=19% Similarity=0.170 Sum_probs=82.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCccccc-CCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNAS-LPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~-~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++. ..++++++|++|+|++|++++.+|..+.++++|++|+|++|.+++. .|..+..+++|+.|++++|+++
T Consensus 49 l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 49 TINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 678999955 7899999999999999999987999999999999999999999962 3488999999999999999999
Q ss_pred CCCC----CcccccccCccccc
Q 012213 80 GEIP----EFGQYSFFNSTSFT 97 (468)
Q Consensus 80 ~~~p----~~~~~~~~~~~~~~ 97 (468)
+.++ .+..++++..++++
T Consensus 127 ~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 127 NLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp GSTTHHHHHHHHCTTCCEETTB
T ss_pred chHHHHHHHHHHCCCcccccCC
Confidence 8776 36667777776654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-12 Score=120.43 Aligned_cols=98 Identities=22% Similarity=0.326 Sum_probs=75.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +|.. +.+++|++|+|++|+|+ .+|..+.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++
T Consensus 62 L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 62 LDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp CTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred CCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence 56788874 4433 77888888888888888 788888888888888888888885445668888888888888888887
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCC
T ss_pred cChhhcccccCCCEEECCCCcC
Confidence 6664 56777888888887754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.5e-13 Score=139.91 Aligned_cols=99 Identities=11% Similarity=0.098 Sum_probs=89.6
Q ss_pred CCcccccCCcccccCCCCCEEEccCCccccc-----------------CCcccc--ccccccEeeccCCcccccCCcccc
Q 012213 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGP-----------------IPVQIT--QIHILNYLNVSWNQLNASLPKEMG 63 (468)
Q Consensus 3 ~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~-----------------~p~~~~--~l~~L~~l~ls~N~l~g~~p~~~~ 63 (468)
+|+|+| ||..++++++|++|+|++|+|+|. +|.+++ ++++|++|+|++|.++|.+|+.|+
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 689998 999999999999999999999986 999999 999999999999999999999999
Q ss_pred cccccccccccCcc-cCC-CCCC-cccc------cccCcccccCCCCC
Q 012213 64 NMKSLTSADFSHNN-FSG-EIPE-FGQY------SFFNSTSFTGNPHL 102 (468)
Q Consensus 64 ~l~~L~~l~ls~N~-l~~-~~p~-~~~~------~~~~~~~~~~n~~l 102 (468)
++++|+.|++++|+ ++| .+|. ++.+ .+++.+++++|...
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 99999999999998 998 7774 6655 78889999888643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.5e-12 Score=124.29 Aligned_cols=102 Identities=21% Similarity=0.145 Sum_probs=86.8
Q ss_pred CCCCcccccCCcccc-cCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIG-HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..+..+. ++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 46 Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 125 (361)
T 2xot_A 46 LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125 (361)
T ss_dssp CCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCccc
Confidence 688999976666776 8999999999999999666678999999999999999999655567899999999999999999
Q ss_pred CCCC-CcccccccCcccccCCCCC
Q 012213 80 GEIP-EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 80 ~~~p-~~~~~~~~~~~~~~~n~~l 102 (468)
+..| .+..+.++..+++++|...
T Consensus 126 ~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 126 VVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCC
T ss_pred EECHHHhCCcccCCEEECCCCcCC
Confidence 8766 4788889999999988643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.9e-12 Score=123.96 Aligned_cols=97 Identities=22% Similarity=0.196 Sum_probs=63.3
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCcccc-ccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
++|+|+ .+|..+. ..|+.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus 26 ~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~ 102 (361)
T 2xot_A 26 SKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102 (361)
T ss_dssp CSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCc
Confidence 566666 5666553 3467777777777754444555 67777777777777775444557777777777777777776
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 103 ~~~~~~~~l~~L~~L~L~~N~i 124 (361)
T 2xot_A 103 LDEFLFSDLQALEVLLLYNNHI 124 (361)
T ss_dssp ECTTTTTTCTTCCEEECCSSCC
T ss_pred CCHHHhCCCcCCCEEECCCCcc
Confidence 5553 56666777777776643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=4.2e-12 Score=130.80 Aligned_cols=83 Identities=19% Similarity=0.206 Sum_probs=77.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccC-CcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL-PKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~-p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+++|++|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|+
T Consensus 470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 6899999 999999999999999999999995 88 9999999999999999999765 999999999999999999999
Q ss_pred CCCCCcc
Q 012213 80 GEIPEFG 86 (468)
Q Consensus 80 ~~~p~~~ 86 (468)
+.+|...
T Consensus 547 ~~~~~~~ 553 (567)
T 1dce_A 547 QEEGIQE 553 (567)
T ss_dssp GSSSCTT
T ss_pred CCccHHH
Confidence 9888643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=6.5e-12 Score=117.54 Aligned_cols=105 Identities=17% Similarity=0.294 Sum_probs=64.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccc-cCCccccccccccEeeccCCcccccCCcccccc--------------
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLPKEMGNM-------------- 65 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g-~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l-------------- 65 (468)
|++|++++..+..++++++|++|+|++|++++ .+|..+.++++|+.|+|++|.+++..|..+..+
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~ 186 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence 35566664444456666666666666666664 256666666666666666666664333333333
Q ss_pred -------------cccccccccCcccCCCCCC-cccccccCcccccCCCCCCCC
Q 012213 66 -------------KSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 66 -------------~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
.+|+.|++++|++++.++. +..+.++..+++++|++.|.+
T Consensus 187 n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 187 NPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp SCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred CcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 3566667777777655554 456667777777777777664
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.2e-12 Score=130.08 Aligned_cols=89 Identities=19% Similarity=0.317 Sum_probs=51.7
Q ss_pred cccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCC-cccccccC
Q 012213 14 IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFN 92 (468)
Q Consensus 14 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~ 92 (468)
+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|+.+..+++|+.|+|++|+|++.++. +..+..+.
T Consensus 424 ~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~ 500 (562)
T 3a79_B 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500 (562)
T ss_dssp CCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCC
T ss_pred hcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCC
Confidence 33344444444444444443333332 46666666666666 5666666667777777777777744444 56666666
Q ss_pred cccccCCCCCCCC
Q 012213 93 STSFTGNPHLCGS 105 (468)
Q Consensus 93 ~~~~~~n~~lcg~ 105 (468)
.+++++|++.|.|
T Consensus 501 ~L~l~~N~~~c~c 513 (562)
T 3a79_B 501 YIWLHDNPWDCTC 513 (562)
T ss_dssp CEECCSCCBCCCH
T ss_pred EEEecCCCcCCCc
Confidence 7777777766654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=2e-12 Score=140.11 Aligned_cols=101 Identities=19% Similarity=0.212 Sum_probs=80.4
Q ss_pred CCCccc-----ccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCc
Q 012213 2 SRNNFS-----GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN 76 (468)
Q Consensus 2 ~~N~l~-----g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N 76 (468)
++|+|+ +..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|
T Consensus 459 s~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N 536 (844)
T 3j0a_A 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN 536 (844)
T ss_dssp ESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEE
T ss_pred CCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCC
Confidence 456665 33445678888999999999999977777889999999999999999864444443 78999999999
Q ss_pred ccCCCCCCcccccccCcccccCCCCCCCCC
Q 012213 77 NFSGEIPEFGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 77 ~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
+|++.+|.. +.++..+++++|++.|.|.
T Consensus 537 ~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 537 QLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred cCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 999988853 4578889999999999775
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=5.6e-12 Score=126.79 Aligned_cols=102 Identities=20% Similarity=0.155 Sum_probs=93.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|++++.+|..++++++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|++++
T Consensus 282 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 361 (455)
T 3v47_A 282 LSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred ecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence 57899998899999999999999999999998888899999999999999999998778889999999999999999998
Q ss_pred CCC-CcccccccCcccccCCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~l 102 (468)
.+| .+..+.++..+++++|...
T Consensus 362 ~~~~~~~~l~~L~~L~L~~N~l~ 384 (455)
T 3v47_A 362 LGDQSFLGLPNLKELALDTNQLK 384 (455)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCS
T ss_pred cChhhccccccccEEECCCCccc
Confidence 877 4888999999999998643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=3.9e-12 Score=132.79 Aligned_cols=93 Identities=22% Similarity=0.246 Sum_probs=54.5
Q ss_pred cccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCC-cccccc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSF 90 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~ 90 (468)
..++.+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+..+++| .|++++|++++.+|. +..+..
T Consensus 470 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~ 548 (606)
T 3t6q_A 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548 (606)
T ss_dssp CGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHT
T ss_pred hhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCC
Confidence 345555555555555555555455555566666666666666665555556666666 666666666655553 455556
Q ss_pred cCcccccCCCCCCCC
Q 012213 91 FNSTSFTGNPHLCGS 105 (468)
Q Consensus 91 ~~~~~~~~n~~lcg~ 105 (468)
+..+++++|++.|.|
T Consensus 549 L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 549 QRTINLRQNPLDCTC 563 (606)
T ss_dssp SSEEECTTCCEECSG
T ss_pred CCEEeCCCCCccccC
Confidence 666666777666654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.6e-12 Score=113.04 Aligned_cols=96 Identities=18% Similarity=0.190 Sum_probs=84.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+| .+..+++|++|+|++|+++ . +..+.++++|++|+|++|.+++..|..++.+++|+.|++++|++++
T Consensus 51 l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~ 126 (197)
T 4ezg_A 51 LANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126 (197)
T ss_dssp EESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBG
T ss_pred ccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCc
Confidence 4678888 788 7999999999999999776 3 4589999999999999999998889999999999999999999998
Q ss_pred CCC-CcccccccCcccccCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~ 100 (468)
..| .+..+.++..+++++|.
T Consensus 127 ~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 127 SILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp GGHHHHTTCSSCCEEECCSCT
T ss_pred HhHHHHhhCCCCCEEEccCCC
Confidence 666 47888899999999886
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=107.04 Aligned_cols=98 Identities=17% Similarity=0.191 Sum_probs=83.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|+++ .+|..+. ++|+.|+|++|++++..|..+.++++|++|+|++|.+++..|..|..+++|+.|++++|+|++
T Consensus 14 ~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 90 (177)
T 2o6r_A 14 CNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90 (177)
T ss_dssp CCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccc
Confidence 4678898 7886554 799999999999996555668999999999999999996445567999999999999999998
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 91 ~~~~~~~~l~~L~~L~l~~N~l 112 (177)
T 2o6r_A 91 LPNGVFDKLTQLKELALDTNQL 112 (177)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cCHHHhhCCcccCEEECcCCcc
Confidence 8875 68889999999999854
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.8e-12 Score=118.86 Aligned_cols=101 Identities=20% Similarity=0.254 Sum_probs=87.4
Q ss_pred CCCCcccccCC-cccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccc-cCCcccccccccccccccCccc
Q 012213 1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g-~~p~~~~~l~~L~~l~ls~N~l 78 (468)
|++|++++..+ ..+.++++|++|+|++|++++..|..+.++++|+.|+|++|.+++ .+|..+..+++|+.|++++|++
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 57889985544 578899999999999999998888889999999999999999986 5788899999999999999999
Q ss_pred CCCCC-CcccccccCcccccCCCC
Q 012213 79 SGEIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 79 ~~~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
++.+| .+..+.++..+++++|..
T Consensus 188 ~~~~~~~~~~l~~L~~L~L~~N~l 211 (306)
T 2z66_A 188 EQLSPTAFNSLSSLQVLNMSHNNF 211 (306)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCC
T ss_pred CCcCHHHhcCCCCCCEEECCCCcc
Confidence 98877 477888899999998864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=115.62 Aligned_cols=101 Identities=15% Similarity=0.072 Sum_probs=77.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..+..|+++++|++|+|++|++++..|..+.++++|++|+|++|.+++..|..|..+++|+.|++++|++++
T Consensus 35 ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 114 (276)
T 2z62_A 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114 (276)
T ss_dssp CTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred CCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc
Confidence 56788886556678888888888888888885555678888888888888888886666778888888888888888887
Q ss_pred CCC-CcccccccCcccccCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
..+ .++.+.++..+++++|..
T Consensus 115 ~~~~~~~~l~~L~~L~l~~n~l 136 (276)
T 2z62_A 115 LENFPIGHLKTLKELNVAHNLI 136 (276)
T ss_dssp STTCCCTTCTTCCEEECCSSCC
T ss_pred cCchhcccCCCCCEEECcCCcc
Confidence 666 477777788888877743
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=9.1e-12 Score=127.51 Aligned_cols=101 Identities=20% Similarity=0.252 Sum_probs=50.9
Q ss_pred CCCcccccCCcc-cccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 2 SRNNFSGIIPVE-IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 2 ~~N~l~g~~p~~-~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
++|+|++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+.|||++|+++ .+|..+..+++|+.|++++|+|++
T Consensus 382 s~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 458 (520)
T 2z7x_B 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458 (520)
T ss_dssp CSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc
Confidence 344444333332 33444444444444444444443332 45555555555555 455555566666666666666664
Q ss_pred CCCC-cccccccCcccccCCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
.++. +..+.++..+++++|++.|.|
T Consensus 459 l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 459 VPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCHHHhccCCcccEEECcCCCCcccC
Confidence 3333 455555666666666655543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.7e-12 Score=128.23 Aligned_cols=105 Identities=19% Similarity=0.298 Sum_probs=93.3
Q ss_pred CCCCcccccCC-cccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|+ .+| ..+.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|+
T Consensus 231 l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 309 (477)
T 2id5_A 231 ITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309 (477)
T ss_dssp EESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS
T ss_pred CcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc
Confidence 4578888 455 67899999999999999999777778999999999999999999888999999999999999999999
Q ss_pred CCCCC-cccccccCcccccCCCCCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
+.++. +..+.++..+++++|++.|.|.
T Consensus 310 ~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 310 TLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp CCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred eeCHhHcCCCcccCEEEccCCCccCccc
Confidence 87774 6788899999999999998864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=114.39 Aligned_cols=101 Identities=17% Similarity=0.149 Sum_probs=83.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+...+..|.++++|++|+|++|++++..+..+.++++|++|+|++|.+++..|..|..+++|+.|++++|++++
T Consensus 68 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 147 (270)
T 2o6q_A 68 LNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS 147 (270)
T ss_dssp CCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc
Confidence 57889984444456889999999999999995555567899999999999999997666678899999999999999997
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
.++. +..+.++..+++++|..
T Consensus 148 ~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 148 LPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSSCC
T ss_pred cCHhHccCCcccceeEecCCcC
Confidence 7665 77888899999988854
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.23 E-value=5e-12 Score=109.95 Aligned_cols=97 Identities=15% Similarity=0.208 Sum_probs=80.5
Q ss_pred CCCCcccccCCcccccCC-CCCEEEccCCcccccCCccccccccccEeeccCCcccccCCccc-ccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~-~~l~~L~~l~ls~N~l 78 (468)
|++|+|+ .+|. +..+. +|++|+|++|+|++ + ..+.++++|++|+|++|.+++ +|+.+ ..+++|+.|++++|++
T Consensus 26 l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i 100 (176)
T 1a9n_A 26 LRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSL 100 (176)
T ss_dssp CTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCC
T ss_pred eeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcC
Confidence 6789998 6664 66655 99999999999995 4 689999999999999999995 66554 8999999999999999
Q ss_pred CCCCC--CcccccccCcccccCCCCC
Q 012213 79 SGEIP--EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 79 ~~~~p--~~~~~~~~~~~~~~~n~~l 102 (468)
+..++ .+..+.++..+++++|+..
T Consensus 101 ~~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 101 VELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CcchhhHhhhcCCCCCEEEecCCCCC
Confidence 75443 4777888999999999754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=115.36 Aligned_cols=101 Identities=20% Similarity=0.212 Sum_probs=87.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCc-ccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ-LNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~-l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|. ++...|..|..+++|+.|++++|+++
T Consensus 39 l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~ 118 (285)
T 1ozn_A 39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118 (285)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred eeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC
Confidence 57899997666789999999999999999997778899999999999999997 77544778999999999999999999
Q ss_pred CCCCC-cccccccCcccccCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
+.+|. +..+.++..+++++|..
T Consensus 119 ~~~~~~~~~l~~L~~L~l~~n~l 141 (285)
T 1ozn_A 119 ELGPGLFRGLAALQYLYLQDNAL 141 (285)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECHhHhhCCcCCCEEECCCCcc
Confidence 88774 77888899999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-11 Score=111.66 Aligned_cols=129 Identities=17% Similarity=0.094 Sum_probs=96.9
Q ss_pred cccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC--ccceeEEEecCCeeEEEEeccCCCChh
Q 012213 191 GRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAFCSNKETNLLVYEYMPNGSLG 268 (468)
Q Consensus 191 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~ 268 (468)
+.|..+.||++...+|+.+++|..... ....+..|+..++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 355669999998877888999986532 1145788999888885444 556888888877889999999998884
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------------
Q 012213 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC---------------------------------------------- 302 (468)
Q Consensus 269 ~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------------- 302 (468)
... .+ ...++.++++.+..||...
T Consensus 104 --~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 --SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp --TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred --cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 221 11 2356778888888888642
Q ss_pred ---------CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 303 ---------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 303 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.3e-12 Score=123.02 Aligned_cols=99 Identities=16% Similarity=0.165 Sum_probs=79.5
Q ss_pred CCCCcc-cccCCcccc-------cCCCCCEEEccCCcccccCCccc--cccccccEeeccCCcccccCCcccccc-----
Q 012213 1 MSRNNF-SGIIPVEIG-------HCLLLTYLDLSQNHLSGPIPVQI--TQIHILNYLNVSWNQLNASLPKEMGNM----- 65 (468)
Q Consensus 1 l~~N~l-~g~~p~~~~-------~l~~L~~L~l~~n~l~g~~p~~~--~~l~~L~~l~ls~N~l~g~~p~~~~~l----- 65 (468)
|++|+| ++.+|..+. ++++|++|+|++|+++|.+|..+ .++++|++|+|++|.+++. |+.+..+
T Consensus 70 L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~ 148 (312)
T 1wwl_A 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLK 148 (312)
T ss_dssp CCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCC
T ss_pred cccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhc
Confidence 467777 456777666 78888888888888888888876 8888888888888888864 7777777
Q ss_pred cccccccccCcccCCCCC-CcccccccCcccccCCC
Q 012213 66 KSLTSADFSHNNFSGEIP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 66 ~~L~~l~ls~N~l~~~~p-~~~~~~~~~~~~~~~n~ 100 (468)
++|+.|++++|++++.+| .++.+.++..+++++|.
T Consensus 149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 184 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184 (312)
T ss_dssp TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT
T ss_pred CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC
Confidence 788888888888887776 47788888888888886
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.9e-12 Score=137.71 Aligned_cols=93 Identities=17% Similarity=0.167 Sum_probs=81.1
Q ss_pred cCCcccc--cCCCCCEEEccCCcccccCCccccccccccEeeccCCc-ccc-cCCccccccc-------ccccccccCcc
Q 012213 9 IIPVEIG--HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ-LNA-SLPKEMGNMK-------SLTSADFSHNN 77 (468)
Q Consensus 9 ~~p~~~~--~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~-l~g-~~p~~~~~l~-------~L~~l~ls~N~ 77 (468)
.+|.+++ +|++|++|+|++|++.|.+|.+|++|++|+.|+|++|+ ++| .+|..++.++ +|+.|+|++|+
T Consensus 480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~ 559 (876)
T 4ecn_A 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559 (876)
T ss_dssp HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence 4999988 99999999999999999999999999999999999998 998 8998777776 89999999999
Q ss_pred cCCCCCC---cccccccCcccccCCCCC
Q 012213 78 FSGEIPE---FGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 78 l~~~~p~---~~~~~~~~~~~~~~n~~l 102 (468)
|+ .+|. ++.+.++..+++++|...
T Consensus 560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~ 586 (876)
T 4ecn_A 560 LE-EFPASASLQKMVKLGLLDCVHNKVR 586 (876)
T ss_dssp CC-BCCCHHHHTTCTTCCEEECTTSCCC
T ss_pred CC-ccCChhhhhcCCCCCEEECCCCCcc
Confidence 99 6665 788888888888888643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.22 E-value=1e-11 Score=107.98 Aligned_cols=86 Identities=13% Similarity=0.099 Sum_probs=71.7
Q ss_pred cccccCCCCCEEEccCCcccccCCccccccc-cccEeeccCCcccccCCcccccccccccccccCcccCCCCCCc-cccc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPIPVQITQIH-ILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEF-GQYS 89 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~-~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~ 89 (468)
..+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|.+++ + +.|..+++|+.|++++|++++.+|.+ ..+.
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 35678889999999999999 6764 66665 99999999999995 5 68899999999999999999766664 7888
Q ss_pred ccCcccccCCCC
Q 012213 90 FFNSTSFTGNPH 101 (468)
Q Consensus 90 ~~~~~~~~~n~~ 101 (468)
++..+++++|..
T Consensus 89 ~L~~L~L~~N~i 100 (176)
T 1a9n_A 89 DLTELILTNNSL 100 (176)
T ss_dssp TCCEEECCSCCC
T ss_pred CCCEEECCCCcC
Confidence 899999998864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=128.01 Aligned_cols=101 Identities=17% Similarity=0.149 Sum_probs=75.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|+.|++++|++++
T Consensus 39 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 118 (606)
T 3vq2_A 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccc
Confidence 56777776666677788888888888888886667777788888888888888876667777778888888888887776
Q ss_pred CCC-CcccccccCcccccCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
.+| .++.+.+++.+++++|..
T Consensus 119 ~~~~~~~~l~~L~~L~L~~n~l 140 (606)
T 3vq2_A 119 LESFPIGQLITLKKLNVAHNFI 140 (606)
T ss_dssp SSSSCCTTCTTCCEEECCSSCC
T ss_pred ccccccCCCCCCCEEeCCCCcc
Confidence 664 466777777777777653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-11 Score=116.50 Aligned_cols=98 Identities=17% Similarity=0.235 Sum_probs=57.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+++ .+|..+. ++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|++++|+++.
T Consensus 178 l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (330)
T 1xku_A 178 IADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 254 (330)
T ss_dssp CCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS
T ss_pred CCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCcc
Confidence 3456665 4554443 566666666666665555666666666666666666665444456666666666666666663
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.+..+..+..+..+++++|+.
T Consensus 255 lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 255 VPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp CCTTTTTCSSCCEEECCSSCC
T ss_pred CChhhccCCCcCEEECCCCcC
Confidence 333455555666666666543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.5e-11 Score=128.41 Aligned_cols=102 Identities=19% Similarity=0.105 Sum_probs=87.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|+.|++++|++++
T Consensus 40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 119 (606)
T 3t6q_A 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119 (606)
T ss_dssp CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence 67899997778899999999999999999997778889999999999999999998778889999999999999999987
Q ss_pred CCC-CcccccccCcccccCCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~l 102 (468)
..| .+..+.++..+++++|...
T Consensus 120 l~~~~~~~l~~L~~L~L~~n~l~ 142 (606)
T 3t6q_A 120 IDFIPLHNQKTLESLYLGSNHIS 142 (606)
T ss_dssp GGGSCCTTCTTCCEEECCSSCCC
T ss_pred CCcchhccCCcccEEECCCCccc
Confidence 644 4777888888888887543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.2e-11 Score=127.44 Aligned_cols=100 Identities=17% Similarity=0.158 Sum_probs=80.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|||++|.+++..|..|+++++|+.|++++|++++
T Consensus 33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 112 (549)
T 2z81_A 33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112 (549)
T ss_dssp CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence 57888887777888888888888888888887777788888888888888888886555568888888888888888885
Q ss_pred C-C-CCcccccccCcccccCCC
Q 012213 81 E-I-PEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~-~-p~~~~~~~~~~~~~~~n~ 100 (468)
. + +.++.+.+++.+++++|.
T Consensus 113 ~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 113 LGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp SCSSCSCTTCTTCCEEEEEESS
T ss_pred cchhhhhhccCCccEEECCCCc
Confidence 2 3 357778888888888775
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-11 Score=126.86 Aligned_cols=97 Identities=19% Similarity=0.234 Sum_probs=46.0
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcc-cccccccccccccCcccCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~~ 80 (468)
++|+|++..|..|+++++|+.|+|++|.|++..|..|+++++|++|+|++|.|++ +|+. |.++++|+.|+|++|.+++
T Consensus 83 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~Ls~N~l~~ 161 (597)
T 3oja_B 83 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLER 161 (597)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCC-CCHHHhccCCCCCEEEeeCCcCCC
Confidence 4444544444445555555555555555554334444555555555555555542 3332 3445555555555555554
Q ss_pred CCCC-cccccccCcccccCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGN 99 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n 99 (468)
.+|. ++.+.++..+++++|
T Consensus 162 ~~~~~~~~l~~L~~L~L~~N 181 (597)
T 3oja_B 162 IEDDTFQATTSLQNLQLSSN 181 (597)
T ss_dssp CCTTTTTTCTTCCEEECTTS
T ss_pred CChhhhhcCCcCcEEECcCC
Confidence 4442 444444444444444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.1e-11 Score=122.54 Aligned_cols=100 Identities=16% Similarity=0.085 Sum_probs=75.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|+.|+|++|+|++..|..|.++++|++|+|++|.|++..+..|..+++|+.|+|++|++++
T Consensus 82 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 161 (452)
T 3zyi_A 82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES 161 (452)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred CcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence 56788887777778888888888888888886666778888888888888888885444457778888888888888875
Q ss_pred CCC-CcccccccCcccccCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~ 100 (468)
.++ .+..+.++..+++++|.
T Consensus 162 ~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 162 IPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp ECTTTTTTCTTCCEEECCCCT
T ss_pred eCHhHHhcCCcccEEeCCCCC
Confidence 555 36667777777777654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.3e-11 Score=125.28 Aligned_cols=101 Identities=23% Similarity=0.313 Sum_probs=62.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccc------------------cccccccEeeccCCcccccCCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI------------------TQIHILNYLNVSWNQLNASLPKEM 62 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~------------------~~l~~L~~l~ls~N~l~g~~p~~~ 62 (468)
|++|+|+ .+|..++.+++|++|+|++|+++ .+|..+ .++++|++|+|++|+|+ .||+ .
T Consensus 394 Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~ 469 (549)
T 2z81_A 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-A 469 (549)
T ss_dssp CTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-G
T ss_pred CCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-c
Confidence 4566666 56666666666666666666655 333322 25666666666666666 5665 4
Q ss_pred ccccccccccccCcccCCCCCC-cccccccCcccccCCCCCCCC
Q 012213 63 GNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 63 ~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
..+++|+.|+|++|+|++.+|. +..+.++..+++++|++.|.+
T Consensus 470 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 5666777777777777766664 566667777777777766654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.6e-11 Score=116.65 Aligned_cols=79 Identities=19% Similarity=0.209 Sum_probs=37.4
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
++|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++.
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence 344444333344444444455555555444333334444445555555555444 4444444444455555555444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-11 Score=131.54 Aligned_cols=81 Identities=27% Similarity=0.417 Sum_probs=78.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..|++|++|++|+|++|+|+ .||.+|++|++|++|+|++|.|+ .||..|++|++|+.|+|++|+|+|
T Consensus 254 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 254 LNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp CTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred eeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence 6899999 99999999999999999999999 89999999999999999999998 899999999999999999999999
Q ss_pred CCCC
Q 012213 81 EIPE 84 (468)
Q Consensus 81 ~~p~ 84 (468)
.+|.
T Consensus 331 ~~p~ 334 (727)
T 4b8c_D 331 QFLK 334 (727)
T ss_dssp HHHH
T ss_pred CChH
Confidence 9886
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.7e-12 Score=119.72 Aligned_cols=99 Identities=13% Similarity=0.146 Sum_probs=82.2
Q ss_pred CCCCcccccCCccc--ccCCCCCEEEccCCcccccCCcccccc-----ccccEeeccCCcccccCCcccccccccccccc
Q 012213 1 MSRNNFSGIIPVEI--GHCLLLTYLDLSQNHLSGPIPVQITQI-----HILNYLNVSWNQLNASLPKEMGNMKSLTSADF 73 (468)
Q Consensus 1 l~~N~l~g~~p~~~--~~l~~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l 73 (468)
|++|+|+|.+|..+ +.+++|++|+|++|++++. |..++++ ++|++|+|++|.+++..|..|+.+++|+.|++
T Consensus 102 L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 180 (312)
T 1wwl_A 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180 (312)
T ss_dssp EEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEEC
T ss_pred ccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEEC
Confidence 46788988888877 8899999999999999965 8888888 89999999999998766688999999999999
Q ss_pred cCcccCCCC---CCc--ccccccCcccccCCC
Q 012213 74 SHNNFSGEI---PEF--GQYSFFNSTSFTGNP 100 (468)
Q Consensus 74 s~N~l~~~~---p~~--~~~~~~~~~~~~~n~ 100 (468)
++|+++|.+ +.+ ..+.++..+++++|.
T Consensus 181 s~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~ 212 (312)
T 1wwl_A 181 SDNPELGERGLISALCPLKFPTLQVLALRNAG 212 (312)
T ss_dssp CSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred CCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence 999987752 233 677888888888874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.4e-11 Score=123.03 Aligned_cols=100 Identities=21% Similarity=0.240 Sum_probs=79.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCc-ccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..|.++++|++|+|++|++++..|..|.+|++|++|+|++|.+++ +|. .|.++++|+.|+|++|+++
T Consensus 39 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~ 117 (477)
T 2id5_A 39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIV 117 (477)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCTTSSTTCTTCCEEECTTSCCC
T ss_pred CCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc-cCcccccCCCCCCEEECCCCccc
Confidence 57788887777788888888888888888887778888888888888888888884 544 5778888888888888888
Q ss_pred CCCC-CcccccccCcccccCCCC
Q 012213 80 GEIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
+.+| .+..+.++..+++++|..
T Consensus 118 ~~~~~~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 118 ILLDYMFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp EECTTTTTTCTTCCEEEECCTTC
T ss_pred cCChhHccccccCCEEECCCCcc
Confidence 7776 367777888888877753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.5e-11 Score=125.92 Aligned_cols=97 Identities=25% Similarity=0.252 Sum_probs=74.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|||++|+++ .+|.. .+++|+.|++++|++++
T Consensus 28 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~ 104 (520)
T 2z7x_B 28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDA 104 (520)
T ss_dssp CCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSS
T ss_pred CCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCcccc
Confidence 5677887666677888888888888888888666778888888888888888887 57766 77888888888888876
Q ss_pred -CCC-CcccccccCcccccCCC
Q 012213 81 -EIP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 -~~p-~~~~~~~~~~~~~~~n~ 100 (468)
.+| .++.+.++..+++++|.
T Consensus 105 ~~~p~~~~~l~~L~~L~L~~n~ 126 (520)
T 2z7x_B 105 LPICKEFGNMSQLKFLGLSTTH 126 (520)
T ss_dssp CCCCGGGGGCTTCCEEEEEESS
T ss_pred ccchhhhccCCcceEEEecCcc
Confidence 455 47777777777777765
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.17 E-value=6.3e-13 Score=118.06 Aligned_cols=97 Identities=15% Similarity=0.211 Sum_probs=86.9
Q ss_pred CCCCcccccCCc------ccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCccccccccccccccc
Q 012213 1 MSRNNFSGIIPV------EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFS 74 (468)
Q Consensus 1 l~~N~l~g~~p~------~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls 74 (468)
|++|.|+|.+|. .++++++|++|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++|+.|+++
T Consensus 25 l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~ 101 (198)
T 1ds9_A 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS 101 (198)
T ss_dssp CSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEE
T ss_pred hheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECc
Confidence 467888888887 89999999999999999995 88 9999999999999999999 799888888999999999
Q ss_pred CcccCCCCCCcccccccCcccccCCCC
Q 012213 75 HNNFSGEIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 75 ~N~l~~~~p~~~~~~~~~~~~~~~n~~ 101 (468)
+|++++ +|.+..+.++..+++++|..
T Consensus 102 ~N~l~~-l~~~~~l~~L~~L~l~~N~i 127 (198)
T 1ds9_A 102 YNQIAS-LSGIEKLVNLRVLYMSNNKI 127 (198)
T ss_dssp EEECCC-HHHHHHHHHSSEEEESEEEC
T ss_pred CCcCCc-CCccccCCCCCEEECCCCcC
Confidence 999997 56777888899999998853
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.5e-11 Score=112.59 Aligned_cols=100 Identities=10% Similarity=0.101 Sum_probs=81.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCc-ccccCCccccccccccEeeccC-CcccccCCcccccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNH-LSGPIPVQITQIHILNYLNVSW-NQLNASLPKEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l~~L~~l~ls~-N~l~g~~p~~~~~l~~L~~l~ls~N~l 78 (468)
|++|+|++..+..|+++++|++|+|++|+ +++..|..|.++++|++|+|++ |.+++..|..|.++++|+.|++++|++
T Consensus 38 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l 117 (239)
T 2xwt_C 38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117 (239)
T ss_dssp EESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECC
T ss_pred EeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCC
Confidence 46788986666688899999999999997 8844445789999999999998 999864456788899999999999999
Q ss_pred CCCCCCcccccccC---cccccCCCC
Q 012213 79 SGEIPEFGQYSFFN---STSFTGNPH 101 (468)
Q Consensus 79 ~~~~p~~~~~~~~~---~~~~~~n~~ 101 (468)
++ +|.+..+..+. .+++++|+.
T Consensus 118 ~~-lp~~~~l~~L~~L~~L~l~~N~~ 142 (239)
T 2xwt_C 118 KM-FPDLTKVYSTDIFFILEITDNPY 142 (239)
T ss_dssp CS-CCCCTTCCBCCSEEEEEEESCTT
T ss_pred cc-ccccccccccccccEEECCCCcc
Confidence 87 66677777777 888888843
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-11 Score=116.85 Aligned_cols=99 Identities=20% Similarity=0.226 Sum_probs=80.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCcccc-ccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..++.+++|++|+|++|++++..|..+. ++++|++|+|++|.+++ +|. ...+++|+.|++++|+++
T Consensus 127 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp CCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCC
Confidence 578999877777888899999999999999977677764 78889999999998884 543 345888888888888888
Q ss_pred CCCCCcccccccCcccccCCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~~ 101 (468)
+.+|.+..+.++..+++++|..
T Consensus 205 ~l~~~~~~l~~L~~L~L~~N~l 226 (317)
T 3o53_A 205 FMGPEFQSAAGVTWISLRNNKL 226 (317)
T ss_dssp EECGGGGGGTTCSEEECTTSCC
T ss_pred cchhhhcccCcccEEECcCCcc
Confidence 7777777888888888888854
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.4e-11 Score=128.24 Aligned_cols=98 Identities=22% Similarity=0.186 Sum_probs=77.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ |..++.+++|+.|+|++|++++.+|..|+++++|+.|+|++|.+++ +|..+..+++|+.|+|++|++++
T Consensus 239 L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~ 315 (597)
T 3oja_B 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315 (597)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC
T ss_pred CCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc
Confidence 56788885 3678888888888888888888778888888888888888888885 77777778888888888888886
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.++.+..+.++..+++++|..
T Consensus 316 i~~~~~~l~~L~~L~L~~N~l 336 (597)
T 3oja_B 316 VERNQPQFDRLENLYLDHNSI 336 (597)
T ss_dssp CGGGHHHHTTCSEEECCSSCC
T ss_pred cCcccccCCCCCEEECCCCCC
Confidence 555677777788888887754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.3e-11 Score=131.85 Aligned_cols=100 Identities=13% Similarity=0.141 Sum_probs=54.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccC-CccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPI-PVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..|+++++|++|||++|.+.+.+ |..|.+|++|++|+|++|.+++..|..|.++++|+.|+|++|.++
T Consensus 31 Ls~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 110 (844)
T 3j0a_A 31 LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110 (844)
T ss_dssp EESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCS
T ss_pred CCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCC
Confidence 3456666555555555555555555555444444 445555555555555555555544555555555555555555555
Q ss_pred CCCCC---cccccccCcccccCCC
Q 012213 80 GEIPE---FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~---~~~~~~~~~~~~~~n~ 100 (468)
+.+|. +..+.+++.+++++|.
T Consensus 111 ~~~~~~~~~~~L~~L~~L~Ls~N~ 134 (844)
T 3j0a_A 111 DAVLKDGYFRNLKALTRLDLSKNQ 134 (844)
T ss_dssp SCCSTTCCCSSCSSCCEEEEESCC
T ss_pred cccccCccccccCCCCEEECCCCc
Confidence 54332 4444555555555443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-11 Score=124.87 Aligned_cols=98 Identities=27% Similarity=0.286 Sum_probs=75.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|||++|.++ .+|.. .+++|+.|++++|++++
T Consensus 59 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~ 135 (562)
T 3a79_B 59 LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDV 135 (562)
T ss_dssp CCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSB
T ss_pred CCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccc
Confidence 5678887666677888888888888888888666777888888888888888887 67766 77888888888888876
Q ss_pred C-CC-CcccccccCcccccCCCC
Q 012213 81 E-IP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~-~p-~~~~~~~~~~~~~~~n~~ 101 (468)
. +| .++.+.++..+++++|..
T Consensus 136 l~~p~~~~~l~~L~~L~L~~n~l 158 (562)
T 3a79_B 136 LPVCKEFGNLTKLTFLGLSAAKF 158 (562)
T ss_dssp CCCCGGGGGCTTCCEEEEECSBC
T ss_pred cCchHhhcccCcccEEecCCCcc
Confidence 3 34 477777788888877753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=2.7e-11 Score=117.64 Aligned_cols=96 Identities=24% Similarity=0.270 Sum_probs=52.1
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
++|.|+ .+|..+. ++|++|+|++|++++..+..+.++++|++|+|++|.+++..|..|.++++|+.|++++|++++.
T Consensus 39 ~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 115 (353)
T 2z80_A 39 SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNL 115 (353)
T ss_dssp CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSC
T ss_pred CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcC
Confidence 445555 5555443 3556666666666533333555566666666666665544444555555666666666665544
Q ss_pred CCC-cccccccCcccccCCC
Q 012213 82 IPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 ~p~-~~~~~~~~~~~~~~n~ 100 (468)
++. +..+.++..+++++|.
T Consensus 116 ~~~~~~~l~~L~~L~L~~n~ 135 (353)
T 2z80_A 116 SSSWFKPLSSLTFLNLLGNP 135 (353)
T ss_dssp CHHHHTTCTTCSEEECTTCC
T ss_pred CHhHhCCCccCCEEECCCCC
Confidence 433 4555555555555553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.8e-11 Score=120.62 Aligned_cols=98 Identities=22% Similarity=0.184 Sum_probs=79.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|++++. ..++++++|+.|+|++|++++..|..+.++++|+.|+|++|.+++ +|..+..+++|+.|++++|++++
T Consensus 233 l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~ 309 (390)
T 3o6n_A 233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH 309 (390)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC
T ss_pred CCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee
Confidence 567888753 478888888888888888887778888888888888888888884 77777888888888888888886
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.++.+..+..+..+++++|+.
T Consensus 310 ~~~~~~~l~~L~~L~L~~N~i 330 (390)
T 3o6n_A 310 VERNQPQFDRLENLYLDHNSI 330 (390)
T ss_dssp CGGGHHHHTTCSEEECCSSCC
T ss_pred cCccccccCcCCEEECCCCcc
Confidence 665677777888888888753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=2.5e-11 Score=115.65 Aligned_cols=98 Identities=15% Similarity=0.094 Sum_probs=65.1
Q ss_pred CCCCccccc--CC--cccccCCCCCEEEccCCcccccCCcc----ccccccccEeeccCCcccccCCcccccc---cccc
Q 012213 1 MSRNNFSGI--IP--VEIGHCLLLTYLDLSQNHLSGPIPVQ----ITQIHILNYLNVSWNQLNASLPKEMGNM---KSLT 69 (468)
Q Consensus 1 l~~N~l~g~--~p--~~~~~l~~L~~L~l~~n~l~g~~p~~----~~~l~~L~~l~ls~N~l~g~~p~~~~~l---~~L~ 69 (468)
|++|+++|. +| ..++++++|++|+|++|+++ .+|.. +.++++|++|||++|.+++.+|+.+..+ ++|+
T Consensus 176 Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~ 254 (310)
T 4glp_A 176 LSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALN 254 (310)
T ss_dssp CCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCC
T ss_pred CCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCC
Confidence 567777652 22 22367777888888888876 34432 4677788888888888877667776666 5778
Q ss_pred cccccCcccCCCCCCcccccccCcccccCCCC
Q 012213 70 SADFSHNNFSGEIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 70 ~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.|+|++|+|+ .+|... ..++..+++++|..
T Consensus 255 ~L~Ls~N~l~-~lp~~~-~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 255 SLNLSFAGLE-QVPKGL-PAKLRVLDLSSNRL 284 (310)
T ss_dssp CEECCSSCCC-SCCSCC-CSCCSCEECCSCCC
T ss_pred EEECCCCCCC-chhhhh-cCCCCEEECCCCcC
Confidence 8888888877 444311 25777777777753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.15 E-value=5.6e-11 Score=114.34 Aligned_cols=97 Identities=22% Similarity=0.245 Sum_probs=54.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.++ .+|..+. ++|+.|++++|++++
T Consensus 61 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~ 137 (332)
T 2ft3_A 61 LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRK 137 (332)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCC
T ss_pred CCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCc
Confidence 3455555444455556666666666666666544555666666666666666655 4555444 555666666666654
Q ss_pred CCCC-cccccccCcccccCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~ 100 (468)
.++. +..+.++..+++++|.
T Consensus 138 ~~~~~~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 138 VPKGVFSGLRNMNCIEMGGNP 158 (332)
T ss_dssp CCSGGGSSCSSCCEEECCSCC
T ss_pred cCHhHhCCCccCCEEECCCCc
Confidence 4443 4555555555555553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=5.4e-11 Score=119.10 Aligned_cols=101 Identities=17% Similarity=0.106 Sum_probs=76.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++
T Consensus 71 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 150 (440)
T 3zyj_A 71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES 150 (440)
T ss_dssp CCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred ccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc
Confidence 56788887667788888888888888888886556778888888888888888884334467888888888888888886
Q ss_pred CCC-CcccccccCcccccCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
.++ .+..+.++..+++++|..
T Consensus 151 ~~~~~~~~l~~L~~L~l~~~~~ 172 (440)
T 3zyj_A 151 IPSYAFNRIPSLRRLDLGELKR 172 (440)
T ss_dssp ECTTTTTTCTTCCEEECCCCTT
T ss_pred cCHHHhhhCcccCEeCCCCCCC
Confidence 555 366777777777776543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=2.9e-10 Score=110.59 Aligned_cols=142 Identities=15% Similarity=0.227 Sum_probs=105.6
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEec--ccCCCCCchhHHHHHHHHHhCCC--CCCccceeEEEecC---CeeEEEE
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNK---ETNLLVY 259 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 259 (468)
.+.++.|.++.||+....+ ..+++|+.. .... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4678999999999998754 678888764 2211 111245788999998886 45678889988776 3479999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------------------------------------- 302 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------- 302 (468)
||++|..+.+... ..++...+..++.+++++|+.||...
T Consensus 121 e~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999988754221 23678888899999999999999731
Q ss_pred ------------------CCCeeecCCCCCcEEEcCCCc--eEEeecccccc
Q 012213 303 ------------------SPLIIHRDVKSNNILLNSDFE--AHVADFGLAKY 334 (468)
Q Consensus 303 ------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~ 334 (468)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999998753 68999998864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.13 E-value=4.7e-11 Score=115.62 Aligned_cols=80 Identities=19% Similarity=0.123 Sum_probs=69.7
Q ss_pred CCC-CcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSR-NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~-N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|||++|+|++ +|+.+.....|+.|+|++|.|.
T Consensus 38 l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116 (347)
T ss_dssp CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred ccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCceEEEeeCCCcc
Confidence 575 99997777899999999999999999998888899999999999999999995 6655444334999999999998
Q ss_pred CC
Q 012213 80 GE 81 (468)
Q Consensus 80 ~~ 81 (468)
..
T Consensus 117 c~ 118 (347)
T 2ifg_A 117 CS 118 (347)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.1e-11 Score=115.86 Aligned_cols=97 Identities=15% Similarity=0.209 Sum_probs=51.6
Q ss_pred CCcccccCCcc-cccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 3 RNNFSGIIPVE-IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 3 ~N~l~g~~p~~-~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
+|.++ .+|.. +.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|+.|++++|+++..
T Consensus 54 ~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l 132 (390)
T 3o6n_A 54 NSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132 (390)
T ss_dssp SCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcC
Confidence 44454 33332 45555555566655555544444555555555555555555544444455555555555555555543
Q ss_pred CCC-cccccccCcccccCCC
Q 012213 82 IPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 ~p~-~~~~~~~~~~~~~~n~ 100 (468)
++. +..+.++..+++++|.
T Consensus 133 ~~~~~~~l~~L~~L~L~~n~ 152 (390)
T 3o6n_A 133 PRGIFHNTPKLTTLSMSNNN 152 (390)
T ss_dssp CTTTTTTCTTCCEEECCSSC
T ss_pred CHHHhcCCCCCcEEECCCCc
Confidence 333 3455555555555553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.1e-10 Score=120.87 Aligned_cols=101 Identities=15% Similarity=0.072 Sum_probs=77.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|+.|++++|++++
T Consensus 35 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 114 (570)
T 2z63_A 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114 (570)
T ss_dssp CCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred ccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccccccc
Confidence 57788886667788888888888888888886556678888888888888888886556778888888888888888876
Q ss_pred CCC-CcccccccCcccccCCCC
Q 012213 81 EIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
..+ .++.+.++..+++++|..
T Consensus 115 l~~~~~~~l~~L~~L~L~~n~l 136 (570)
T 2z63_A 115 LENFPIGHLKTLKELNVAHNLI 136 (570)
T ss_dssp STTCSCTTCTTCCEEECCSSCC
T ss_pred CCCccccccccccEEecCCCcc
Confidence 555 467777777777777743
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.7e-11 Score=114.43 Aligned_cols=98 Identities=17% Similarity=0.126 Sum_probs=62.8
Q ss_pred CCCcccccCCccc--ccCCCCCEEEccCCcccccCC----ccccccccccEeeccCCcccccCCcccccccccccccccC
Q 012213 2 SRNNFSGIIPVEI--GHCLLLTYLDLSQNHLSGPIP----VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSH 75 (468)
Q Consensus 2 ~~N~l~g~~p~~~--~~l~~L~~L~l~~n~l~g~~p----~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~ 75 (468)
++|++++.+|..+ +++++|++|+|++|++++.+| ..+..+++|++|+|++|.+++..|..|..+++|+.|+|++
T Consensus 99 ~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 178 (310)
T 4glp_A 99 EDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSD 178 (310)
T ss_dssp ESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCS
T ss_pred eCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCC
Confidence 5667776777666 667777777777777776554 3345667777777777777665556667777777777777
Q ss_pred cccCC---CCCC--cccccccCcccccCC
Q 012213 76 NNFSG---EIPE--FGQYSFFNSTSFTGN 99 (468)
Q Consensus 76 N~l~~---~~p~--~~~~~~~~~~~~~~n 99 (468)
|++++ .++. ++.++++..+++++|
T Consensus 179 N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N 207 (310)
T 4glp_A 179 NPGLGERGLMAALCPHKFPAIQNLALRNT 207 (310)
T ss_dssp CTTCHHHHHHTTSCTTSSCCCCSCBCCSS
T ss_pred CCCccchhhhHHHhhhcCCCCCEEECCCC
Confidence 76654 2222 245556666666665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=9.9e-11 Score=123.87 Aligned_cols=100 Identities=19% Similarity=0.223 Sum_probs=74.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCc-ccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..|..|+++++|++|+|++|++++..|..+++|++|++|+|++|.+++ +|+ .|+++++|+.|++++|+++
T Consensus 32 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~ 110 (680)
T 1ziw_A 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQ 110 (680)
T ss_dssp CCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCC
T ss_pred CCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc-cChhhhccCCCCCEEECCCCccC
Confidence 56778876556678888888888888888887777778888888888888888874 554 5777888888888888877
Q ss_pred CCCC-CcccccccCcccccCCCC
Q 012213 80 GEIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
+.+| .++.+.++..+++++|..
T Consensus 111 ~~~~~~~~~l~~L~~L~Ls~n~l 133 (680)
T 1ziw_A 111 KIKNNPFVKQKNLITLDLSHNGL 133 (680)
T ss_dssp CCCSCTTTTCTTCCEEECCSSCC
T ss_pred ccChhHccccCCCCEEECCCCcc
Confidence 6665 367777777777777743
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.4e-10 Score=109.74 Aligned_cols=99 Identities=15% Similarity=0.252 Sum_probs=73.5
Q ss_pred CCCCccc--ccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCccc
Q 012213 1 MSRNNFS--GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~--g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l 78 (468)
|++|+++ |..|..+.++++|+.|++++|+++ .+|..+. ++|+.|+|++|.+++..|..|..+++|+.|++++|++
T Consensus 152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 228 (330)
T 1xku_A 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228 (330)
T ss_dssp CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC
T ss_pred CCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence 4567774 356677778888888888888887 5776664 7788888888888876677778888888888888888
Q ss_pred CCCCC-CcccccccCcccccCCCCC
Q 012213 79 SGEIP-EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 79 ~~~~p-~~~~~~~~~~~~~~~n~~l 102 (468)
++.+| .+..+.++..+++++|...
T Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 229 SAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp CEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ceeChhhccCCCCCCEEECCCCcCc
Confidence 77666 4667777777777777543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=123.57 Aligned_cols=99 Identities=21% Similarity=0.194 Sum_probs=86.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|++++..|..|+++++|++|+|++|+++ .+|. .|+++++|++|+|++|.+++..|..|+++++|+.|++++|+++
T Consensus 56 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 134 (680)
T 1ziw_A 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134 (680)
T ss_dssp CCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccc
Confidence 5789999888889999999999999999999 5655 6999999999999999998655678999999999999999999
Q ss_pred CCCCC-cccccccCcccccCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~ 100 (468)
+.+|. ++.+.++..+++++|.
T Consensus 135 ~~~~~~~~~l~~L~~L~L~~n~ 156 (680)
T 1ziw_A 135 STKLGTQVQLENLQELLLSNNK 156 (680)
T ss_dssp CCCCCSSSCCTTCCEEECCSSC
T ss_pred ccCchhhcccccCCEEEccCCc
Confidence 88774 7788888888888875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.08 E-value=6.8e-11 Score=112.97 Aligned_cols=96 Identities=13% Similarity=0.108 Sum_probs=56.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccc-cccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG-NMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..+. .+++|+.|+|++|++++..|..++.+++|++|+|++|.+++..|..+. .+++|+.|++++|+++
T Consensus 106 l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp CCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 345566543332 245666666666666655555666666666666666666655555543 5666666666666666
Q ss_pred CCCCCcccccccCcccccCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~ 100 (468)
+. |....+.++..+++++|.
T Consensus 183 ~~-~~~~~l~~L~~L~Ls~N~ 202 (317)
T 3o53_A 183 DV-KGQVVFAKLKTLDLSSNK 202 (317)
T ss_dssp EE-ECCCCCTTCCEEECCSSC
T ss_pred cc-ccccccccCCEEECCCCc
Confidence 44 333345566666666664
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.8e-12 Score=113.85 Aligned_cols=97 Identities=22% Similarity=0.261 Sum_probs=86.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +| .++++++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+++ +| .+..+++|+.|++++|++++
T Consensus 55 ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 55 LSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp CSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 57899995 88 9999999999999999999 899999999999999999999995 77 68999999999999999996
Q ss_pred CCC--CcccccccCcccccCCCCC
Q 012213 81 EIP--EFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p--~~~~~~~~~~~~~~~n~~l 102 (468)
..+ .+..+.++..+++++|+..
T Consensus 130 ~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 130 WGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHHHHTTTTTCSEEEECSCHHH
T ss_pred hhHHHHHhcCCCCCEEEecCCccc
Confidence 443 5778889999999998653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.4e-10 Score=106.03 Aligned_cols=63 Identities=13% Similarity=0.208 Sum_probs=28.7
Q ss_pred cccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 14 IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 14 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+..+++|+.|+|++|+++ .+| .+..+++|+.|+|++|.+++ +|+ +..+++|+.|++++|++++
T Consensus 37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~ 99 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN 99 (263)
T ss_dssp HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC
T ss_pred hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC
Confidence 444444444444444444 344 34444444444444444442 332 4444444444444444443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.8e-10 Score=111.72 Aligned_cols=99 Identities=19% Similarity=0.225 Sum_probs=88.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcc-cccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..+..++++++|++|+|++|++++..|..|.++++|++|+|++|.+++ +|+. |..+++|+.|++++|+++
T Consensus 59 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~ 137 (353)
T 2z80_A 59 LSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK 137 (353)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCS
T ss_pred CCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCc
Confidence 67899996656689999999999999999998778889999999999999999995 6665 899999999999999999
Q ss_pred CCCC--CcccccccCcccccCCC
Q 012213 80 GEIP--EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p--~~~~~~~~~~~~~~~n~ 100 (468)
+.++ .+..+.++..+++++|.
T Consensus 138 ~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 138 TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp SSCSSCSCTTCTTCCEEEEEESS
T ss_pred ccCchhhhccCCCCcEEECCCCc
Confidence 6655 37888999999999884
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.03 E-value=3e-10 Score=105.38 Aligned_cols=92 Identities=18% Similarity=0.205 Sum_probs=60.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+| .++.+++|+.|+|++|+|+ .+|. +.++++|+.|+|++|++++ +|... . ++|+.|++++|++++
T Consensus 48 l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~ 120 (263)
T 1xeu_A 48 GDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD 120 (263)
T ss_dssp CTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB
T ss_pred CcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEccCCccCC
Confidence 4667776 566 6777777777777777777 3444 7777777777777777773 55432 2 666666666666664
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
+|.+..+.++..+++++|.
T Consensus 121 -~~~l~~l~~L~~L~Ls~N~ 139 (263)
T 1xeu_A 121 -TDSLIHLKNLEILSIRNNK 139 (263)
T ss_dssp -SGGGTTCTTCCEEECTTSC
T ss_pred -ChhhcCcccccEEECCCCc
Confidence 3445556666666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.3e-10 Score=106.77 Aligned_cols=94 Identities=15% Similarity=0.284 Sum_probs=74.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +|. ++++++|+.|+|++|++++ +| .+.++++|+.|+|++|.+++ + +.+..+++|+.|++++|++++
T Consensus 75 L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~ 148 (291)
T 1h6t_A 75 LNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD 148 (291)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC
T ss_pred ccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc
Confidence 57888885 444 8888889999999998884 55 48888888888888888884 5 467888888888888888886
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
. +.+..+.++..+++++|..
T Consensus 149 ~-~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 149 I-TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp C-GGGGGCTTCSEEECCSSCC
T ss_pred c-hhhccCCCCCEEEccCCcc
Confidence 5 6677778888888887753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.2e-10 Score=106.52 Aligned_cols=99 Identities=12% Similarity=0.158 Sum_probs=84.1
Q ss_pred CCCCc-ccccCCcccccCCCCCEEEccC-CcccccCCccccccccccEeeccCCcccccCCcccccccccc---cccccC
Q 012213 1 MSRNN-FSGIIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT---SADFSH 75 (468)
Q Consensus 1 l~~N~-l~g~~p~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~---~l~ls~ 75 (468)
|++|+ +++..|..|+++++|++|+|++ |+|++..|..|.++++|++|+|++|.+++ +|+ |..+++|+ .|++++
T Consensus 62 l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~ 139 (239)
T 2xwt_C 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITD 139 (239)
T ss_dssp EECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEES
T ss_pred CCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCC
Confidence 46786 8855556899999999999998 99996555789999999999999999995 887 88888888 999999
Q ss_pred c-ccCCCCCC-cccccccC-cccccCCCC
Q 012213 76 N-NFSGEIPE-FGQYSFFN-STSFTGNPH 101 (468)
Q Consensus 76 N-~l~~~~p~-~~~~~~~~-~~~~~~n~~ 101 (468)
| ++++.++. +..+.++. .+++++|..
T Consensus 140 N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp CTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CcchhhcCcccccchhcceeEEEcCCCCC
Confidence 9 99877664 78888888 999988853
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.02 E-value=3.6e-10 Score=107.51 Aligned_cols=94 Identities=16% Similarity=0.278 Sum_probs=69.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +| .++++++|++|+|++|++++ +|. +.++++|+.|+|++|.+++ +|+ +..+++|+.|++++|++++
T Consensus 92 L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC
T ss_pred ccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC
Confidence 56788874 44 67788888888888888884 553 7888888888888888874 544 7777888888888888876
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
..+ +..+.++..+++++|..
T Consensus 166 ~~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 166 LTP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp CGG-GTTCTTCCEEECCSSCC
T ss_pred Chh-hcCCCCCCEEECCCCcc
Confidence 444 66777777777777743
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-10 Score=117.87 Aligned_cols=97 Identities=12% Similarity=0.095 Sum_probs=81.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccc-cccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG-NMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++..+. .+++|+.|+|++|+|++..|..++++++|++|+|++|.+++.+|..+. .+++|+.|+|++|.|+
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 467777754443 467899999999999988888999999999999999999998888886 7999999999999999
Q ss_pred CCCCCcccccccCcccccCCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~~ 101 (468)
+.+ ....++++..+++++|..
T Consensus 183 ~~~-~~~~l~~L~~L~Ls~N~l 203 (487)
T 3oja_A 183 DVK-GQVVFAKLKTLDLSSNKL 203 (487)
T ss_dssp EEE-CCCCCTTCCEEECCSSCC
T ss_pred ccc-ccccCCCCCEEECCCCCC
Confidence 774 445688899999998854
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3.3e-10 Score=106.83 Aligned_cols=94 Identities=21% Similarity=0.271 Sum_probs=81.4
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|.++ .+| .+..+++|++|+|++|++++ +|. +.++++|++|+|++|.+++ +| .+..+++|+.|++++|++++
T Consensus 53 l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~ 126 (291)
T 1h6t_A 53 ANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD 126 (291)
T ss_dssp CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC
T ss_pred ccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC
Confidence 5788888 566 48999999999999999995 555 9999999999999999985 65 49999999999999999996
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
++.+..+.++..+++++|..
T Consensus 127 -~~~l~~l~~L~~L~l~~n~l 146 (291)
T 1h6t_A 127 -INGLVHLPQLESLYLGNNKI 146 (291)
T ss_dssp -CGGGGGCTTCCEEECCSSCC
T ss_pred -ChhhcCCCCCCEEEccCCcC
Confidence 47788888999999998854
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.02 E-value=3.8e-10 Score=107.33 Aligned_cols=93 Identities=14% Similarity=0.203 Sum_probs=69.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+++ .+| .+..+++|+.|+|++|+++ .+|. +.++++|++|+|++|.+++ +| .+..+++|+.|++++|++++
T Consensus 48 l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~ 121 (308)
T 1h6u_A 48 AFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD 121 (308)
T ss_dssp CTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC
T ss_pred eeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC
Confidence 4677777 566 5778888888888888888 4555 8888888888888888874 54 57788888888888888876
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
. |.+..+.++..+++++|.
T Consensus 122 ~-~~l~~l~~L~~L~l~~n~ 140 (308)
T 1h6u_A 122 V-TPLAGLSNLQVLYLDLNQ 140 (308)
T ss_dssp C-GGGTTCTTCCEEECCSSC
T ss_pred c-hhhcCCCCCCEEECCCCc
Confidence 3 446777777777777774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.98 E-value=4.3e-10 Score=108.67 Aligned_cols=95 Identities=22% Similarity=0.350 Sum_probs=65.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+++ .+|. +..+++|++|+|++|++++ + ..+..+++|+.|+|++|.+++ +| .+..+++|+.|++++|++++
T Consensus 228 l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 228 IGNNKIT-DLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCG
T ss_pred ccCCccC-CCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCC
Confidence 4677777 3443 7777777777777777773 4 357777777777777777774 43 46777777777777777776
Q ss_pred CCCC-cccccccCcccccCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
..|. +..+.++..+++++|+.
T Consensus 302 ~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 302 EDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp GGHHHHHTCTTCSEEECCSSSC
T ss_pred cChhHhhccccCCEEEccCCcc
Confidence 6653 56666777777777754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.3e-10 Score=107.53 Aligned_cols=187 Identities=19% Similarity=0.181 Sum_probs=119.5
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCC--ccceeEEEecCC---eeEEEEe
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRN--IVRLKAFCSNKE---TNLLVYE 260 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 260 (468)
.+.++.|.+..||+.. ..+++|..... .....+.+|.+.++.+. +.. +.+++.+..... ..++||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3568999999999863 56889975422 22356889999998773 332 334554443333 3478999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD--------------------------------------- 301 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------------- 301 (468)
+++|.++.+... ..++..++..++.++++.++.||..
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988865332 1256777788888888888888851
Q ss_pred ----------------CCCCeeecCCCCCcEEEcC--CCceEEeeccccccccccCCCccccc------------cccCc
Q 012213 302 ----------------CSPLIIHRDVKSNNILLNS--DFEAHVADFGLAKYLQDTGASECMSA------------VAGSY 351 (468)
Q Consensus 302 ----------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt~ 351 (468)
....++|+|++|.||++++ ...+.|+||+.+..-.....-..... ....+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1245899999999999998 45678999999865321000000000 00000
Q ss_pred cccC-ccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 012213 352 GYIA-PEYAYTLKVDEKSDVYSFGVVLLELITGRRPV 387 (468)
Q Consensus 352 ~y~a-PE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 387 (468)
+... |+.... .....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 111110 112368999999999999998876
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.97 E-value=7.1e-10 Score=114.95 Aligned_cols=92 Identities=16% Similarity=0.316 Sum_probs=48.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++..| ++.|++|+.|+|++|+|+ .+| .+.+|++|+.|+|++|.|++ +| .+..|++|+.|+|++|+|++
T Consensus 72 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~ 145 (605)
T 1m9s_A 72 LNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITD 145 (605)
T ss_dssp CTTSCCCCCGG--GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCC
T ss_pred eeCCCCCCChh--hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCC
Confidence 45566653322 555666666666666655 233 45555555555555555553 32 35555555555555555554
Q ss_pred CCCCcccccccCcccccCC
Q 012213 81 EIPEFGQYSFFNSTSFTGN 99 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n 99 (468)
. +.+..+.+|..+++++|
T Consensus 146 l-~~l~~l~~L~~L~Ls~N 163 (605)
T 1m9s_A 146 I-TVLSRLTKLDTLSLEDN 163 (605)
T ss_dssp C-GGGGSCTTCSEEECCSS
T ss_pred c-hhhcccCCCCEEECcCC
Confidence 3 44444455555555544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.96 E-value=5.9e-10 Score=115.55 Aligned_cols=94 Identities=16% Similarity=0.284 Sum_probs=70.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +| .++.|++|+.|+|++|+|++ + ..+.+|++|+.|+|++|.|++ + +.+..+++|+.|+|++|+|++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCC
Confidence 56788873 45 67888888888888888884 4 357788888888888888874 4 567778888888888888887
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.+| +..+.+|..+++++|..
T Consensus 168 ~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 168 IVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp CGG-GTTCTTCCEEECCSSCC
T ss_pred chh-hccCCCCCEEECcCCCC
Confidence 666 67777777777777743
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.92 E-value=1e-09 Score=112.60 Aligned_cols=86 Identities=27% Similarity=0.308 Sum_probs=57.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|+|+
T Consensus 127 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~- 193 (571)
T 3cvr_A 127 VDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE- 193 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-
T ss_pred CCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-
Confidence 56777774 665 56777788888887774 775 56777778888887775 776 55 67777777777777
Q ss_pred CCCCccccccc-------CcccccCCCC
Q 012213 81 EIPEFGQYSFF-------NSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~-------~~~~~~~n~~ 101 (468)
.+|.+.. ++ ..+++++|..
T Consensus 194 ~lp~~~~--~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 194 SLPAVPV--RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SCCCCC----------CCEEEECCSSCC
T ss_pred chhhHHH--hhhcccccceEEecCCCcc
Confidence 4444333 45 6666776643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.9e-09 Score=108.21 Aligned_cols=90 Identities=19% Similarity=0.233 Sum_probs=67.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +| .++.+++|++|+|++|+|++ +| ++++++|++|+|++|.+++ +| ++.+++|+.|++++|++++
T Consensus 49 Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~ 120 (457)
T 3bz5_A 49 CHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK 120 (457)
T ss_dssp CCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC
T ss_pred ccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe
Confidence 56788874 45 68888888888888888885 55 7788888888888888875 44 7778888888888888876
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
. | ++.+.++..+++++|.
T Consensus 121 l-~-~~~l~~L~~L~l~~N~ 138 (457)
T 3bz5_A 121 L-D-VSQNPLLTYLNCARNT 138 (457)
T ss_dssp C-C-CTTCTTCCEEECTTSC
T ss_pred e-c-CCCCCcCCEEECCCCc
Confidence 3 4 6667777777777764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.91 E-value=9.8e-10 Score=110.77 Aligned_cols=93 Identities=25% Similarity=0.356 Sum_probs=53.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|++++ +|. +..+++|+.|+|++|++++ +|. +.++++|+.|+|++|.+++..| +..+++|+.|++++|++++
T Consensus 272 l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 272 LGANQISN-ISP-LAGLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CCSSCCCC-CGG-GTTCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCccCc-ccc-ccCCCccCeEEcCCCcccC-chh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 45666664 332 6666666666666666664 332 5666666666666666664333 5555666666666666554
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
. +.+..+.++..+++++|.
T Consensus 346 ~-~~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 346 V-SSLANLTNINWLSAGHNQ 364 (466)
T ss_dssp C-GGGTTCTTCCEEECCSSC
T ss_pred c-hhhccCCCCCEEeCCCCc
Confidence 3 445555555555555553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.7e-09 Score=110.98 Aligned_cols=86 Identities=28% Similarity=0.451 Sum_probs=47.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +|..+. ++|+.|+|++|+|+ .|| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|++|+|++
T Consensus 66 Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~ 134 (571)
T 3cvr_A 66 LNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM 134 (571)
T ss_dssp CCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC
T ss_pred eCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC
Confidence 45666664 565552 55666666666666 555 345566666666666664 555 443 55566666666555
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
+|. .+.++..+++++|.
T Consensus 135 -lp~--~l~~L~~L~Ls~N~ 151 (571)
T 3cvr_A 135 -LPE--LPALLEYINADNNQ 151 (571)
T ss_dssp -CCC--CCTTCCEEECCSSC
T ss_pred -CCC--cCccccEEeCCCCc
Confidence 333 34455555555553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.9e-10 Score=115.39 Aligned_cols=55 Identities=15% Similarity=0.048 Sum_probs=30.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccc-------------cEeeccCCcccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHIL-------------NYLNVSWNQLNA 56 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L-------------~~l~ls~N~l~g 56 (468)
|++|+| |.+|.+|++|++|++|+|++|+++|.+|.+++++.+| +.|++++|.+++
T Consensus 18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~ 85 (454)
T 1jl5_A 18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS 85 (454)
T ss_dssp -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC
T ss_pred cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc
Confidence 467888 7999999999999999999999998999888877654 556666666553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.85 E-value=4.4e-09 Score=105.46 Aligned_cols=74 Identities=28% Similarity=0.473 Sum_probs=35.4
Q ss_pred CCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCCcccccccCcccccC
Q 012213 19 LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTG 98 (468)
Q Consensus 19 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~ 98 (468)
+|++|+|++|++++ +| +++++++|++|+|++|++++ +|..+ .+|+.|++++|++++ +|.++.+..+..+++++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADN 204 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCS
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCC
Confidence 45555555555553 44 35555555555555555553 44332 244455555555544 33444444444444444
Q ss_pred C
Q 012213 99 N 99 (468)
Q Consensus 99 n 99 (468)
|
T Consensus 205 N 205 (454)
T 1jl5_A 205 N 205 (454)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.84 E-value=3.9e-09 Score=106.40 Aligned_cols=91 Identities=21% Similarity=0.328 Sum_probs=45.1
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
++|++++ ++ .+..+++|+.|+|++|++++..| +.++++|+.|+|++|.+++ +|+ +..+++|+.|++++|++++.
T Consensus 229 ~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~ 302 (466)
T 1o6v_A 229 NGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDI 302 (466)
T ss_dssp CSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCC
T ss_pred CCCCccc-ch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCc
Confidence 4555552 32 45555555555555555553222 5555555555555555553 332 44555555555555555543
Q ss_pred CCCcccccccCcccccCC
Q 012213 82 IPEFGQYSFFNSTSFTGN 99 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~~n 99 (468)
+| +..+.++..+++++|
T Consensus 303 ~~-~~~l~~L~~L~L~~n 319 (466)
T 1o6v_A 303 SP-ISNLKNLTYLTLYFN 319 (466)
T ss_dssp GG-GGGCTTCSEEECCSS
T ss_pred hh-hcCCCCCCEEECcCC
Confidence 33 444444444555444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.83 E-value=4.8e-09 Score=105.35 Aligned_cols=74 Identities=23% Similarity=0.286 Sum_probs=65.6
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +| ++.+++|+.|+|++|++++ + .++++++|+.|+|++|++++ +| +..+++|+.|++++|++++
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 57899995 66 8899999999999999995 4 48999999999999999996 77 8899999999999999998
Q ss_pred CCC
Q 012213 81 EIP 83 (468)
Q Consensus 81 ~~p 83 (468)
.++
T Consensus 248 ~~~ 250 (457)
T 3bz5_A 248 LDV 250 (457)
T ss_dssp CCC
T ss_pred cCH
Confidence 765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.82 E-value=6.1e-10 Score=108.40 Aligned_cols=100 Identities=20% Similarity=0.093 Sum_probs=84.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCC----ccccccc-cccEeeccCCcccccCCcccccc-----ccccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP----VQITQIH-ILNYLNVSWNQLNASLPKEMGNM-----KSLTS 70 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p----~~~~~l~-~L~~l~ls~N~l~g~~p~~~~~l-----~~L~~ 70 (468)
|++|+++|.+|..+....+|++|||++|++++.-+ ..+.+++ +|+.|+|++|.+++..+..+..+ ++|+.
T Consensus 5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 84 (362)
T 3goz_A 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS 84 (362)
T ss_dssp CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence 68899999999888888889999999999996555 6788888 89999999999998777777776 89999
Q ss_pred ccccCcccCCCCCC-----cccc-cccCcccccCCC
Q 012213 71 ADFSHNNFSGEIPE-----FGQY-SFFNSTSFTGNP 100 (468)
Q Consensus 71 l~ls~N~l~~~~p~-----~~~~-~~~~~~~~~~n~ 100 (468)
|+|++|++++..+. +..+ ..+..+++++|.
T Consensus 85 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 120 (362)
T 3goz_A 85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120 (362)
T ss_dssp EECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC
T ss_pred EECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCc
Confidence 99999999987764 3333 678889998885
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.81 E-value=6e-09 Score=100.57 Aligned_cols=95 Identities=20% Similarity=0.327 Sum_probs=79.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|.++ .+| .+..+++|++|+|++|+++ .+|. +.++++|++|+|++|.++. +| .+..+++|+.|++++|++++
T Consensus 51 l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~ 124 (347)
T 4fmz_A 51 VAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISD 124 (347)
T ss_dssp CCSSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCC
T ss_pred EeCCccc-cch-hhhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccC
Confidence 4678887 666 4889999999999999999 5665 9999999999999999984 65 68999999999999999986
Q ss_pred CCCCcccccccCcccccCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~l 102 (468)
..+ +..+.++..+++++|...
T Consensus 125 ~~~-~~~l~~L~~L~l~~n~~~ 145 (347)
T 4fmz_A 125 ISP-LANLTKMYSLNLGANHNL 145 (347)
T ss_dssp CGG-GTTCTTCCEEECTTCTTC
T ss_pred chh-hccCCceeEEECCCCCCc
Confidence 544 778888888999888544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.77 E-value=7.6e-10 Score=106.40 Aligned_cols=99 Identities=14% Similarity=0.123 Sum_probs=78.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCccccc-CCccccccccccEeeccCCcccccCCcccccccccccccccCc-cc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGP-IPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN-NF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~-~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N-~l 78 (468)
|++|.+++.+| .+.++++|++|+|++|++++. +|..+.++++|+.|+|++|.+++.+|..++.+++|+.|++++| .+
T Consensus 77 l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l 155 (336)
T 2ast_B 77 CPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155 (336)
T ss_dssp CTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred cCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence 46788886555 466788899999999988866 8888888899999999999888888888888888999999988 67
Q ss_pred CCC-CCC-cccccccCcccccCCC
Q 012213 79 SGE-IPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 79 ~~~-~p~-~~~~~~~~~~~~~~n~ 100 (468)
++. +|. +..+.++..+++++|.
T Consensus 156 ~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 156 SEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp CHHHHHHHHHHCTTCCEEECCCCT
T ss_pred CHHHHHHHHhcCCCCCEEcCCCCC
Confidence 752 443 5667778888888773
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.77 E-value=5.2e-10 Score=109.89 Aligned_cols=100 Identities=16% Similarity=0.202 Sum_probs=69.1
Q ss_pred CCCCccc-ccCC---cccccCCCCCEEEccCCccc--c---cCCccccccccccEeeccCCccc----ccCCcccccccc
Q 012213 1 MSRNNFS-GIIP---VEIGHCLLLTYLDLSQNHLS--G---PIPVQITQIHILNYLNVSWNQLN----ASLPKEMGNMKS 67 (468)
Q Consensus 1 l~~N~l~-g~~p---~~~~~l~~L~~L~l~~n~l~--g---~~p~~~~~l~~L~~l~ls~N~l~----g~~p~~~~~l~~ 67 (468)
|++|+|+ +.+| ..+..+++|++|+|++|+++ | .+|..+.++++|+.|+|++|.++ +.+|..+..+++
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence 5677776 4555 46667777888888888777 3 34447777778888888888875 567777777777
Q ss_pred cccccccCcccCCC----CCC-c--ccccccCcccccCCC
Q 012213 68 LTSADFSHNNFSGE----IPE-F--GQYSFFNSTSFTGNP 100 (468)
Q Consensus 68 L~~l~ls~N~l~~~----~p~-~--~~~~~~~~~~~~~n~ 100 (468)
|+.|+|++|++++. +|. + +.+.++..+++++|.
T Consensus 246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285 (386)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCc
Confidence 88888888877754 332 2 335667777777764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.75 E-value=2.2e-09 Score=98.78 Aligned_cols=68 Identities=24% Similarity=0.283 Sum_probs=56.0
Q ss_pred ccCCCCCEEEccCCcccc--cCCccccccccccEeeccCCcccccCCccccccc--ccccccccCcccCCCCCC
Q 012213 15 GHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVSWNQLNASLPKEMGNMK--SLTSADFSHNNFSGEIPE 84 (468)
Q Consensus 15 ~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~--~L~~l~ls~N~l~~~~p~ 84 (468)
.++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++ + ..+..++ +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~-~-~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-E-RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS-G-GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC-c-hhhhhcccCCcceEEccCCcCccccCc
Confidence 568899999999999997 677788899999999999999985 3 3455555 889999999999887773
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.75 E-value=4.3e-10 Score=108.13 Aligned_cols=100 Identities=19% Similarity=0.236 Sum_probs=86.9
Q ss_pred CCCCccccc-CCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCC-cccc-cCCcccccccccccccccCc-
Q 012213 1 MSRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWN-QLNA-SLPKEMGNMKSLTSADFSHN- 76 (468)
Q Consensus 1 l~~N~l~g~-~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N-~l~g-~~p~~~~~l~~L~~l~ls~N- 76 (468)
|++|++++. +|..+.++++|++|+|++|++++.+|..++++++|++|+|++| .+++ .+|..+..+++|+.|++++|
T Consensus 100 L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 100 LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp CTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred ccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence 578889876 8889999999999999999999999999999999999999999 7886 37878899999999999999
Q ss_pred ccCCC-CCC-ccccc-ccCcccccCCC
Q 012213 77 NFSGE-IPE-FGQYS-FFNSTSFTGNP 100 (468)
Q Consensus 77 ~l~~~-~p~-~~~~~-~~~~~~~~~n~ 100 (468)
.+++. ++. +..++ ++..+++++|.
T Consensus 180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 180 DFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp TCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 89864 443 66777 88889888774
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.74 E-value=6.9e-09 Score=100.45 Aligned_cols=96 Identities=16% Similarity=0.123 Sum_probs=78.6
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCCc-cccccccccc-ccccCccc
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTS-ADFSHNNF 78 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~-l~ls~N~l 78 (468)
++|+|+ .||..+ .++|+.|+|++|+|+ .||. .|.+|++|++|+|++|.+.+.+|. .|.++++|.. +.+++|+|
T Consensus 17 ~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l 92 (350)
T 4ay9_X 17 QESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92 (350)
T ss_dssp ESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred cCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence 468888 889877 468999999999999 6765 689999999999999998877875 4678888765 66778999
Q ss_pred CCCCCC-cccccccCcccccCCCC
Q 012213 79 SGEIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 79 ~~~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
++..|. +..+.++..+++++|..
T Consensus 93 ~~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 93 LYINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp CEECTTSBCCCTTCCEEEEEEECC
T ss_pred cccCchhhhhcccccccccccccc
Confidence 977774 78888899999988854
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.74 E-value=5.8e-09 Score=100.94 Aligned_cols=98 Identities=14% Similarity=0.007 Sum_probs=77.6
Q ss_pred CCCCcccccCC-cccccCCCCCEEEccCCcccccCCc-cccccccccE-eeccCCcccccCCcccccccccccccccCcc
Q 012213 1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNY-LNVSWNQLNASLPKEMGNMKSLTSADFSHNN 77 (468)
Q Consensus 1 l~~N~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~-l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~ 77 (468)
|++|+|+ .|| ..|.+|++|++|+|++|++.+.+|. .|.+|++|.. ++++.|++++..|..|..+++|+.|++++|+
T Consensus 37 Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~ 115 (350)
T 4ay9_X 37 FVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 115 (350)
T ss_dssp EESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred ccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccc
Confidence 5789999 565 5799999999999999999878876 5789998875 6778899997667789999999999999999
Q ss_pred cCCCCCC-cccccccCcccccCC
Q 012213 78 FSGEIPE-FGQYSFFNSTSFTGN 99 (468)
Q Consensus 78 l~~~~p~-~~~~~~~~~~~~~~n 99 (468)
+++.++. +.....+..+.+.++
T Consensus 116 l~~~~~~~~~~~~~l~~l~l~~~ 138 (350)
T 4ay9_X 116 IKHLPDVHKIHSLQKVLLDIQDN 138 (350)
T ss_dssp CSSCCCCTTCCBSSCEEEEEESC
T ss_pred cccCCchhhcccchhhhhhhccc
Confidence 9976653 333334444555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-08 Score=105.40 Aligned_cols=74 Identities=30% Similarity=0.262 Sum_probs=33.8
Q ss_pred CCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCCcccccccCcccccC
Q 012213 19 LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTG 98 (468)
Q Consensus 19 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~ 98 (468)
+|+.|+|++|+|+ .+| ..+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+..++.+..+.++..+++++
T Consensus 222 ~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 222 GLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp TCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCS
T ss_pred CCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecC
Confidence 3444444444444 233 22344444444444444 3443 33445555555555552222344555555555555
Q ss_pred CC
Q 012213 99 NP 100 (468)
Q Consensus 99 n~ 100 (468)
|+
T Consensus 294 N~ 295 (622)
T 3g06_A 294 NP 295 (622)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.4e-09 Score=106.87 Aligned_cols=100 Identities=13% Similarity=0.208 Sum_probs=70.9
Q ss_pred CCCCcccc----cCCcccccC---------CCCCEEEccCCccc-ccCC---ccccccccccEeeccCCccc--c---cC
Q 012213 1 MSRNNFSG----IIPVEIGHC---------LLLTYLDLSQNHLS-GPIP---VQITQIHILNYLNVSWNQLN--A---SL 58 (468)
Q Consensus 1 l~~N~l~g----~~p~~~~~l---------~~L~~L~l~~n~l~-g~~p---~~~~~l~~L~~l~ls~N~l~--g---~~ 58 (468)
|++|+|++ .++..+..+ ++|++|+|++|+++ +.+| ..+.++++|+.|+|++|.++ | .+
T Consensus 129 L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~ 208 (386)
T 2ca6_A 129 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208 (386)
T ss_dssp CCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHH
T ss_pred CcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHH
Confidence 46677752 345556666 78888888888887 4566 46777888888888888887 3 34
Q ss_pred CcccccccccccccccCcccC----CCCCC-cccccccCcccccCCC
Q 012213 59 PKEMGNMKSLTSADFSHNNFS----GEIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 59 p~~~~~l~~L~~l~ls~N~l~----~~~p~-~~~~~~~~~~~~~~n~ 100 (468)
|..+..+++|+.|+|++|.++ +.+|. +..++++..+++++|.
T Consensus 209 ~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~ 255 (386)
T 2ca6_A 209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255 (386)
T ss_dssp HTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred HHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCC
Confidence 557778888888888888875 44553 5666777778887775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.65 E-value=3.8e-09 Score=102.73 Aligned_cols=101 Identities=27% Similarity=0.266 Sum_probs=81.5
Q ss_pred CCCCcccccCC----cccccCC-CCCEEEccCCcccccCCcccccc-----ccccEeeccCCcccccCCcccccc-----
Q 012213 1 MSRNNFSGIIP----VEIGHCL-LLTYLDLSQNHLSGPIPVQITQI-----HILNYLNVSWNQLNASLPKEMGNM----- 65 (468)
Q Consensus 1 l~~N~l~g~~p----~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~l~ls~N~l~g~~p~~~~~l----- 65 (468)
|++|+|++..+ ..+.+++ +|++|+|++|++++..+..+..+ ++|++|+|++|.+++..+..++..
T Consensus 29 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 108 (362)
T 3goz_A 29 LSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108 (362)
T ss_dssp CTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred ccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCC
Confidence 68899986555 6778888 89999999999998778888886 999999999999997666654443
Q ss_pred cccccccccCcccCCCCCC-cc----c-ccccCcccccCCCC
Q 012213 66 KSLTSADFSHNNFSGEIPE-FG----Q-YSFFNSTSFTGNPH 101 (468)
Q Consensus 66 ~~L~~l~ls~N~l~~~~p~-~~----~-~~~~~~~~~~~n~~ 101 (468)
++|+.|+|++|++++..+. +. . ...+..+++++|..
T Consensus 109 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred CCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 8999999999999876653 22 2 24788888888743
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.63 E-value=3.8e-08 Score=102.14 Aligned_cols=86 Identities=24% Similarity=0.214 Sum_probs=62.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|.|+ .+|..+. ++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|++++|++++
T Consensus 47 ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~ 115 (622)
T 3g06_A 47 VGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH 115 (622)
T ss_dssp CCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC
T ss_pred ecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC
Confidence 5678887 7887765 68888888888888 6776 5678888888888887 5776 56777788888887776
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
.++ .+.++..+++++|.
T Consensus 116 l~~---~l~~L~~L~L~~N~ 132 (622)
T 3g06_A 116 LPA---LPSGLCKLWIFGNQ 132 (622)
T ss_dssp CCC---CCTTCCEEECCSSC
T ss_pred CCC---CCCCcCEEECCCCC
Confidence 433 34555666666664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=2.9e-07 Score=85.38 Aligned_cols=135 Identities=19% Similarity=0.196 Sum_probs=95.6
Q ss_pred eEcccCCc-ceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGAG-VVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.+..|..| .||+.... ++..++||+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556665 58988764 4667899975422 2356788998887774 334677899999999999999999998
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------------
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------------------------------------------- 302 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------- 302 (468)
++.+..... ......+..+++..|..||...
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 877654321 1223345566666666666410
Q ss_pred ------------CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 303 ------------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 303 ------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.3e-06 Score=82.72 Aligned_cols=136 Identities=19% Similarity=0.190 Sum_probs=93.3
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCC---CccceeEEEe-cCCeeEEEEecc
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR---NIVRLKAFCS-NKETNLLVYEYM 262 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 262 (468)
.+.++.|....||+. |..++||.... ......+..|.+++..+.+. .+.+++.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888888899988 56788887421 12235688999999988652 3556677764 445578999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD----------------------------------------- 301 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------------- 301 (468)
+|..+.+.... .++..++..++.++++.|+.||..
T Consensus 96 ~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 96 QGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 99887653211 134444555555555555555532
Q ss_pred ----------------CCCCeeecCCCCCcEEEcC---CCc-eEEeecccccc
Q 012213 302 ----------------CSPLIIHRDVKSNNILLNS---DFE-AHVADFGLAKY 334 (468)
Q Consensus 302 ----------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgla~~ 334 (468)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2334799999999999987 455 48999998764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-07 Score=87.06 Aligned_cols=70 Identities=21% Similarity=0.208 Sum_probs=59.3
Q ss_pred CCCCcccc--cCCcccccCCCCCEEEccCCcccccCCccccccc--cccEeeccCCcccccCCc-------ccccccccc
Q 012213 1 MSRNNFSG--IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIH--ILNYLNVSWNQLNASLPK-------EMGNMKSLT 69 (468)
Q Consensus 1 l~~N~l~g--~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~--~L~~l~ls~N~l~g~~p~-------~~~~l~~L~ 69 (468)
|++|+|++ .+|..++.+++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|. .+..+++|+
T Consensus 177 Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~ 254 (267)
T 3rw6_A 177 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLL 254 (267)
T ss_dssp CTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCC
T ss_pred CCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccC
Confidence 78999998 6678888999999999999999954 4566666 999999999999998874 367788888
Q ss_pred ccc
Q 012213 70 SAD 72 (468)
Q Consensus 70 ~l~ 72 (468)
.||
T Consensus 255 ~LD 257 (267)
T 3rw6_A 255 RLD 257 (267)
T ss_dssp EES
T ss_pred eEC
Confidence 776
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.2e-06 Score=84.66 Aligned_cols=83 Identities=6% Similarity=0.040 Sum_probs=55.9
Q ss_pred cceE-cccCCcceEEEEcC-------CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCC-C--CCccceeEEEecC--
Q 012213 187 NNVI-GRGGAGVVYRGVTP-------NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIR-H--RNIVRLKAFCSNK-- 252 (468)
Q Consensus 187 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 252 (468)
.+.| +.|....+|+.... +++.+++|....... .......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998764 267788887543220 0001134778888888774 2 3567788887655
Q ss_pred -CeeEEEEeccCCCChhh
Q 012213 253 -ETNLLVYEYMPNGSLGE 269 (468)
Q Consensus 253 -~~~~lv~e~~~~gsL~~ 269 (468)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.31 E-value=2.5e-08 Score=100.09 Aligned_cols=100 Identities=14% Similarity=0.051 Sum_probs=71.6
Q ss_pred CCCCccccc----CCcccccCCCCCEEEccCCcccccCCcccccc-----ccccEeeccCCccccc----CCcccccccc
Q 012213 1 MSRNNFSGI----IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQI-----HILNYLNVSWNQLNAS----LPKEMGNMKS 67 (468)
Q Consensus 1 l~~N~l~g~----~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~l~ls~N~l~g~----~p~~~~~l~~ 67 (468)
|++|+|++. +|..+.++++|++|+|++|++++.-+..+... ++|+.|+|++|.+++. +|..+..+++
T Consensus 263 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 342 (461)
T 1z7x_W 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSS
T ss_pred CcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCC
Confidence 567888754 67778888899999999998886555555443 6888888888888754 5666777788
Q ss_pred cccccccCcccCCCCCC-ccc-----ccccCcccccCCC
Q 012213 68 LTSADFSHNNFSGEIPE-FGQ-----YSFFNSTSFTGNP 100 (468)
Q Consensus 68 L~~l~ls~N~l~~~~p~-~~~-----~~~~~~~~~~~n~ 100 (468)
|+.|++++|++++..+. +.. ...+..+++++|.
T Consensus 343 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred ccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 88888888887754332 221 4467777777774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.19 E-value=1.9e-07 Score=93.64 Aligned_cols=101 Identities=13% Similarity=0.073 Sum_probs=78.1
Q ss_pred CCCCcccccCCcccccC-----CCCCEEEccCCccccc----CCccccccccccEeeccCCcccccCCccccc-----cc
Q 012213 1 MSRNNFSGIIPVEIGHC-----LLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNASLPKEMGN-----MK 66 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l-----~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~-----l~ 66 (468)
|++|+|++..+..+... ++|+.|+|++|++++. +|..+.++++|+.|||++|.+++..+..+.. .+
T Consensus 291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 370 (461)
T 1z7x_W 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370 (461)
T ss_dssp CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence 57788876555455433 6899999999999865 6777888899999999999998655555543 67
Q ss_pred ccccccccCcccCC----CCCC-cccccccCcccccCCCC
Q 012213 67 SLTSADFSHNNFSG----EIPE-FGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 67 ~L~~l~ls~N~l~~----~~p~-~~~~~~~~~~~~~~n~~ 101 (468)
+|+.|++++|++++ .+|. +..++.+..+++++|+.
T Consensus 371 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 371 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred ceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 89999999999985 5553 56678888899998853
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.6e-07 Score=91.33 Aligned_cols=84 Identities=14% Similarity=0.092 Sum_probs=44.1
Q ss_pred CCCCCEEEccCCcccc----cCCccccccccccEeeccCCcccc----cCCcccccccccccccccCcccCCCCC-----
Q 012213 17 CLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKSLTSADFSHNNFSGEIP----- 83 (468)
Q Consensus 17 l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~l~ls~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~~~~p----- 83 (468)
.++|+.|+|++|+|+. .++..+..+++|++|||++|.|+. .++..+..+++|+.|+|++|.|+..-.
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~ 233 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR 233 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence 4556666666666652 234444556666666666666652 123445555566666666666653211
Q ss_pred CcccccccCcccccCCC
Q 012213 84 EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 84 ~~~~~~~~~~~~~~~n~ 100 (468)
.+.....+..+++++|+
T Consensus 234 ~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 234 AAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHCSSCCEEECTTSS
T ss_pred HHHhCCCCCEEeccCCC
Confidence 01223455556666553
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.5e-05 Score=78.27 Aligned_cols=77 Identities=17% Similarity=0.171 Sum_probs=49.3
Q ss_pred cceEcccCCcceEEEEcC-CCcEEEEEEecccCC--C---CCchhHHHHHHHHHhCCCC--CC-ccceeEEEecCCeeEE
Q 012213 187 NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK--G---SSHDNGLSAEIRTLGKIRH--RN-IVRLKAFCSNKETNLL 257 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 257 (468)
.+.||.|.++.||++... +++.++||....... . .....++..|.+.+..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 468899998653221 0 1123456778888876632 33 3355544 3455689
Q ss_pred EEeccCCC
Q 012213 258 VYEYMPNG 265 (468)
Q Consensus 258 v~e~~~~g 265 (468)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.3e-05 Score=75.01 Aligned_cols=139 Identities=17% Similarity=0.247 Sum_probs=78.5
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-----CCCCcccee-E--EEecCCeeEEEE
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-----RHRNIVRLK-A--FCSNKETNLLVY 259 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~ 259 (468)
+.|+.|..+.||+....+| .+++|+.... ...+..|..++..+ ..|.++... | +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566677899999987554 5899987531 13344455554444 234444311 1 123456778999
Q ss_pred eccCCCChhh--------------hcccCC-----C-------CCCCHHHHH----------------------------
Q 012213 260 EYMPNGSLGE--------------VLHGKR-----G-------SFLKWEMRL---------------------------- 285 (468)
Q Consensus 260 e~~~~gsL~~--------------~l~~~~-----~-------~~l~~~~~~---------------------------- 285 (468)
+|++|..+.. .+|... . ....|....
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9999865530 112100 0 012332211
Q ss_pred ---HHHHHHHHHHHHhhh----------cCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 286 ---KIAIEAAKGLSYLHH----------DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 286 ---~i~~~ia~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
.+...+..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123445666653 124569999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.05 E-value=4.5e-05 Score=71.94 Aligned_cols=137 Identities=16% Similarity=0.147 Sum_probs=91.9
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC---CCCccceeEEEecCCeeEEEEeccC
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKETNLLVYEYMP 263 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 263 (468)
.+.|+.|....+|+... ++..++||+.... ....+..|.+.|+.+. ...+.++++++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 46789999999999987 4678899976432 2356888988888773 3568888998888888999999999
Q ss_pred CCChhh-----------hcccCCC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 012213 264 NGSLGE-----------VLHGKRG-S-------------------FLKWEMRL---KIAI----------------EAAK 293 (468)
Q Consensus 264 ~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~ia~ 293 (468)
+..+.. .||.... . .-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876531 1232111 0 12455321 1111 1111
Q ss_pred H-HHHhhh-cCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 294 G-LSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 294 ~-l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223421 2356799999999999999887 8899974
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=6.1e-07 Score=87.27 Aligned_cols=80 Identities=21% Similarity=0.272 Sum_probs=64.5
Q ss_pred CCCCcccc----cCCcccccCCCCCEEEccCCcccc----cCCccccccccccEeeccCCcccc----cCCccccccccc
Q 012213 1 MSRNNFSG----IIPVEIGHCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKSL 68 (468)
Q Consensus 1 l~~N~l~g----~~p~~~~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~l~ls~N~l~g----~~p~~~~~l~~L 68 (468)
|++|+|+. .++..+..+++|++|||++|+|++ .++..+..+++|+.|||++|.|+. .++..+..+++|
T Consensus 162 Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L 241 (372)
T 3un9_A 162 LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241 (372)
T ss_dssp CCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSC
T ss_pred CCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCC
Confidence 57788864 245556788999999999999984 346678888999999999999984 344556677899
Q ss_pred ccccccCcccCC
Q 012213 69 TSADFSHNNFSG 80 (468)
Q Consensus 69 ~~l~ls~N~l~~ 80 (468)
+.|||++|.|+.
T Consensus 242 ~~L~Ls~N~i~~ 253 (372)
T 3un9_A 242 ELLHLYFNELSS 253 (372)
T ss_dssp CEEECTTSSCCH
T ss_pred CEEeccCCCCCH
Confidence 999999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.2e-05 Score=72.25 Aligned_cols=77 Identities=17% Similarity=0.143 Sum_probs=54.9
Q ss_pred CCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCC---CccceeEEEecCCeeEEEEec
Q 012213 185 KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR---NIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 185 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~ 261 (468)
.....+|.|..+.||+....||+.|+||+...... .....|..|.+.|+.+... -+.+++++. ..++||||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 34577899999999999999999999997643322 2224578899888877422 344555542 34789999
Q ss_pred cCCCCh
Q 012213 262 MPNGSL 267 (468)
Q Consensus 262 ~~~gsL 267 (468)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.82 E-value=1e-06 Score=91.29 Aligned_cols=88 Identities=13% Similarity=0.052 Sum_probs=54.0
Q ss_pred ccccCCCCCEEEccCC--cccccCCccccc-cccccEeeccCCcccc-cCCcccccccccccccccCcccCCC-CCC-cc
Q 012213 13 EIGHCLLLTYLDLSQN--HLSGPIPVQITQ-IHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNFSGE-IPE-FG 86 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n--~l~g~~p~~~~~-l~~L~~l~ls~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~-~p~-~~ 86 (468)
.+.++++|+.|+|+.| .+++..+..++. +++|++|+|++|.+++ .+|..+..+++|+.|++++|.+++. ++. ..
T Consensus 431 ~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 510 (592)
T 3ogk_B 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVT 510 (592)
T ss_dssp HHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHH
T ss_pred HHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHH
Confidence 3555666666666532 355555555544 6777777777777764 3455556677777777777776543 232 23
Q ss_pred cccccCcccccCCC
Q 012213 87 QYSFFNSTSFTGNP 100 (468)
Q Consensus 87 ~~~~~~~~~~~~n~ 100 (468)
.++++..+++++|.
T Consensus 511 ~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 511 KLPSLRYLWVQGYR 524 (592)
T ss_dssp HCSSCCEEEEESCB
T ss_pred hcCccCeeECcCCc
Confidence 45667777777665
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00011 Score=72.61 Aligned_cols=80 Identities=15% Similarity=0.087 Sum_probs=47.5
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCC---CCCcchhhHHHHHHHHH
Q 012213 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLE 379 (468)
Q Consensus 303 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~e 379 (468)
...++|||+++.||+++.++ ++|+||+.+..-... .........-...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45599999999999998876 999999988753210 00000000012345666554311 11224555677778887
Q ss_pred HHhCC
Q 012213 380 LITGR 384 (468)
Q Consensus 380 lltg~ 384 (468)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.79 E-value=2.4e-05 Score=74.60 Aligned_cols=80 Identities=19% Similarity=0.221 Sum_probs=53.2
Q ss_pred CCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCC-cccccccccc-cccccCcccCCCCC-CcccccccC
Q 012213 17 CLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLP-KEMGNMKSLT-SADFSHNNFSGEIP-EFGQYSFFN 92 (468)
Q Consensus 17 l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~-~l~ls~N~l~~~~p-~~~~~~~~~ 92 (468)
+++|+.|+|++|+++ .||. .|.+|.+|+.|+|++| ++ .|+ ..|.+|++|+ .+++++ +++...+ .|..+.+++
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCC
Confidence 677777777777777 5554 5777777777777777 65 344 3577777777 777777 5553322 366666677
Q ss_pred cccccCCC
Q 012213 93 STSFTGNP 100 (468)
Q Consensus 93 ~~~~~~n~ 100 (468)
.+.+.+|.
T Consensus 301 ~l~l~~n~ 308 (329)
T 3sb4_A 301 YVLATGDK 308 (329)
T ss_dssp EEEECSSC
T ss_pred EEEeCCCc
Confidence 77765553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.77 E-value=2.2e-06 Score=74.61 Aligned_cols=88 Identities=13% Similarity=0.134 Sum_probs=51.0
Q ss_pred ccccCCCCCEEEccCC-ccccc----CCccccccccccEeeccCCcccc----cCCcccccccccccccccCcccCCC--
Q 012213 13 EIGHCLLLTYLDLSQN-HLSGP----IPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKSLTSADFSHNNFSGE-- 81 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n-~l~g~----~p~~~~~l~~L~~l~ls~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~~~-- 81 (468)
.+...+.|++|+|++| +++.. +...+...++|++|+|++|.+.. .+...+...++|+.|+|++|+++..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3445667777777777 66532 33445566777777777777652 1333445556677777777776532
Q ss_pred --CC-CcccccccCcccc--cCCC
Q 012213 82 --IP-EFGQYSFFNSTSF--TGNP 100 (468)
Q Consensus 82 --~p-~~~~~~~~~~~~~--~~n~ 100 (468)
+. .+.....+..+++ ++|.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~ 134 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQP 134 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSC
T ss_pred HHHHHHHHhCCCceEEEecCCCCC
Confidence 11 1233345666666 4453
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00035 Score=66.50 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=71.5
Q ss_pred ceEcccCCcc-eEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC--CCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGV-VYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.|+.|.... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+..+.+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 3465555444 6777664477787775432210 224456666655532 23556676643333 789999977
Q ss_pred CChhhhcccCC---------------------C---CCCCHHHHH-------H-------------HHHHHHHHHHHhh-
Q 012213 265 GSLGEVLHGKR---------------------G---SFLKWEMRL-------K-------------IAIEAAKGLSYLH- 299 (468)
Q Consensus 265 gsL~~~l~~~~---------------------~---~~l~~~~~~-------~-------------i~~~ia~~l~~LH- 299 (468)
..+.+++.... . ..++..... . ....+...+..+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654332110 0 011111100 0 0001111222221
Q ss_pred --hcCCCCeeecCCCCCcEEEcCC----CceEEeecccccc
Q 012213 300 --HDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKY 334 (468)
Q Consensus 300 --~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~ 334 (468)
......++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1124469999999999999875 6799999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.48 E-value=1.5e-05 Score=69.16 Aligned_cols=100 Identities=11% Similarity=0.128 Sum_probs=72.4
Q ss_pred CCCC-cccc----cCCcccccCCCCCEEEccCCccccc----CCccccccccccEeeccCCccccc----CCcccccccc
Q 012213 1 MSRN-NFSG----IIPVEIGHCLLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKS 67 (468)
Q Consensus 1 l~~N-~l~g----~~p~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~ 67 (468)
|++| +|+. .+...+...++|++|+|++|+|+.. +...+...++|++|+|++|.++.. +...+...++
T Consensus 43 L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~ 122 (185)
T 1io0_A 43 LNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTS 122 (185)
T ss_dssp CTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSS
T ss_pred ecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCC
Confidence 4566 6653 2345566788999999999999742 445567778999999999999843 5667888889
Q ss_pred cccccc--cCcccCCCCC-----CcccccccCcccccCCC
Q 012213 68 LTSADF--SHNNFSGEIP-----EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 68 L~~l~l--s~N~l~~~~p-----~~~~~~~~~~~~~~~n~ 100 (468)
|+.|+| ++|.++..-. .+.....+..+++++|.
T Consensus 123 L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 123 LIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp CCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred ceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 999999 8898874311 12233567778887764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.48 E-value=4.4e-05 Score=78.85 Aligned_cols=75 Identities=13% Similarity=0.022 Sum_probs=60.5
Q ss_pred CCCCccccc----CCcccccCCCCCEEEccCCccc----ccCCccccccccccEeeccCCcccccCCccccccccccccc
Q 012213 1 MSRNNFSGI----IPVEIGHCLLLTYLDLSQNHLS----GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSAD 72 (468)
Q Consensus 1 l~~N~l~g~----~p~~~~~l~~L~~L~l~~n~l~----g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ 72 (468)
|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+..+++|+.|+
T Consensus 171 L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~ 249 (592)
T 3ogk_B 171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFC 249 (592)
T ss_dssp CTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEE
T ss_pred CccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhc
Confidence 567777765 4555678899999999999997 4566677889999999999999885 788888888888888
Q ss_pred ccCc
Q 012213 73 FSHN 76 (468)
Q Consensus 73 ls~N 76 (468)
++++
T Consensus 250 l~~~ 253 (592)
T 3ogk_B 250 GGSL 253 (592)
T ss_dssp ECBC
T ss_pred cccc
Confidence 8753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00012 Score=59.33 Aligned_cols=52 Identities=21% Similarity=0.341 Sum_probs=24.8
Q ss_pred EEEccCCccc-ccCCccccccccccEeeccCCcccccCCc-ccccccccccccccCc
Q 012213 22 YLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHN 76 (468)
Q Consensus 22 ~L~l~~n~l~-g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N 76 (468)
.++.+++.|+ ..+|..+. .+|+.|+|++|+|+ .||. .|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N 65 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGAN 65 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSS
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCC
Confidence 5566666654 24554332 24555555555555 3433 2344444444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.42 E-value=7.5e-06 Score=84.70 Aligned_cols=64 Identities=20% Similarity=0.216 Sum_probs=29.4
Q ss_pred ccCCCCCEEEccCCcccccCCccccc-cccccEeeccCCcccccCCccc-ccccccccccccCcccC
Q 012213 15 GHCLLLTYLDLSQNHLSGPIPVQITQ-IHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNFS 79 (468)
Q Consensus 15 ~~l~~L~~L~l~~n~l~g~~p~~~~~-l~~L~~l~ls~N~l~g~~p~~~-~~l~~L~~l~ls~N~l~ 79 (468)
.++++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.++
T Consensus 429 ~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 429 EHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred hhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 3444444444443 344333333333 4555555555555543333222 34455555555555553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00072 Score=63.35 Aligned_cols=72 Identities=11% Similarity=0.080 Sum_probs=44.6
Q ss_pred CcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCc-cceeEEEecCCeeEEEEecc-C
Q 012213 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLVYEYM-P 263 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~ 263 (468)
..+.|+.|....+|+. +.+++|+....... ......|+..++.+....+ .+++++ +.+.-++++||+ +
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 3578999999999998 56888876532111 1224567777766643233 455554 344457899999 6
Q ss_pred CCCh
Q 012213 264 NGSL 267 (468)
Q Consensus 264 ~gsL 267 (468)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.34 E-value=2.8e-05 Score=80.38 Aligned_cols=86 Identities=12% Similarity=0.113 Sum_probs=53.9
Q ss_pred ccCCCCCEEEccCCcccccCCcccc-ccccccEeeccCC-ccccc-CCcccccccccccccccCcccCCCCCC-c----c
Q 012213 15 GHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWN-QLNAS-LPKEMGNMKSLTSADFSHNNFSGEIPE-F----G 86 (468)
Q Consensus 15 ~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~l~ls~N-~l~g~-~p~~~~~l~~L~~l~ls~N~l~~~~p~-~----~ 86 (468)
..+++|++|+|++|.+++..+..+. ++++|+.|+|++| .++.. ++..+.++++|+.|++++|.+++..+. + .
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3567777777777777766666665 5777777777777 44422 444445677777777777776654332 1 1
Q ss_pred cccccCcccccCCC
Q 012213 87 QYSFFNSTSFTGNP 100 (468)
Q Consensus 87 ~~~~~~~~~~~~n~ 100 (468)
.+.++..+++++|.
T Consensus 182 ~~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 182 TYTSLVSLNISCLA 195 (594)
T ss_dssp TCCCCCEEECTTCC
T ss_pred cCCcCcEEEecccC
Confidence 34456666666553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=62.81 Aligned_cols=141 Identities=14% Similarity=0.140 Sum_probs=79.8
Q ss_pred ceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCC--CccceeEE-----EecCCeeEEEEe
Q 012213 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR--NIVRLKAF-----CSNKETNLLVYE 260 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e 260 (468)
..++ |....||+....+|+.+++|...... .....+..|...+..+... .+.+++.. ....+..+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 88889999887778789999875321 1224566777777666321 23344432 122445678999
Q ss_pred ccCCCChhh-----h---------ccc----C---CCCCCCHHHH----HHH---------------HHHHHHHHHHhhh
Q 012213 261 YMPNGSLGE-----V---------LHG----K---RGSFLKWEMR----LKI---------------AIEAAKGLSYLHH 300 (468)
Q Consensus 261 ~~~~gsL~~-----~---------l~~----~---~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~ 300 (468)
|++|..+.. + +|. . .....++... ..+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754421 0 111 0 0111222211 001 0111112222221
Q ss_pred ----cCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 301 ----DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 301 ----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.....++|||+++.||+++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00072 Score=63.93 Aligned_cols=142 Identities=14% Similarity=0.094 Sum_probs=78.4
Q ss_pred cceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC--ccceeEE------EecCCeeEEE
Q 012213 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAF------CSNKETNLLV 258 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv 258 (468)
.+.|+.|....+|+....+| .+++|...... . ...+..|+.++..+.... +.+++.. ....+..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--E--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--C--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 35677888899999987655 68889875421 1 134566777766553211 2223211 1223567899
Q ss_pred EeccCCCChhhh--------------cccCC----C------CCCCHHHHHHH------------HHHHHHHHHHhhhc-
Q 012213 259 YEYMPNGSLGEV--------------LHGKR----G------SFLKWEMRLKI------------AIEAAKGLSYLHHD- 301 (468)
Q Consensus 259 ~e~~~~gsL~~~--------------l~~~~----~------~~l~~~~~~~i------------~~~ia~~l~~LH~~- 301 (468)
++|++|..+... +|... . ....|.....- ...+...+++++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999998654210 12100 0 00123321110 01134445555432
Q ss_pred ---CCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 302 ---CSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 302 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
....++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23459999999999999987666899998775
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00025 Score=57.48 Aligned_cols=60 Identities=20% Similarity=0.326 Sum_probs=42.4
Q ss_pred cEeeccCCccc-ccCCcccccccccccccccCcccCCCCCC-cccccccCcccccCCCCCCCCC
Q 012213 45 NYLNVSWNQLN-ASLPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 45 ~~l~ls~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
..+|.++++|+ ..+|..+. ++|+.|+|++|+|+...+. |..+.++..+.+.+|||.|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 46788888886 34775432 3577888888888865553 5667777788888888888764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.20 E-value=7e-05 Score=72.23 Aligned_cols=85 Identities=12% Similarity=0.055 Sum_probs=56.0
Q ss_pred cCCCCCEEEccC--Cccccc-----CCccc--cccccccEeeccCCcccccCCcccc---cccccccccccCcccCCC--
Q 012213 16 HCLLLTYLDLSQ--NHLSGP-----IPVQI--TQIHILNYLNVSWNQLNASLPKEMG---NMKSLTSADFSHNNFSGE-- 81 (468)
Q Consensus 16 ~l~~L~~L~l~~--n~l~g~-----~p~~~--~~l~~L~~l~ls~N~l~g~~p~~~~---~l~~L~~l~ls~N~l~~~-- 81 (468)
.+++|+.|+|+. |...|. +...+ ..+++|++|+|++|.++...+..+. .+++|+.|+|+.|.|+..
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 688999998863 332222 11122 3578999999999988754443333 578899999999988763
Q ss_pred --CCC-cccccccCcccccCCC
Q 012213 82 --IPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 --~p~-~~~~~~~~~~~~~~n~ 100 (468)
++. +..+..+..+++++|.
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBB
T ss_pred HHHHhhcccCCcceEEECCCCc
Confidence 332 2456777888887663
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00031 Score=66.83 Aligned_cols=90 Identities=17% Similarity=0.092 Sum_probs=64.4
Q ss_pred CCCCcccccCC-cccccCCCCCEEEccCCcccccCC-cccccccccc-EeeccCCcccccCCcccccccccccccccCcc
Q 012213 1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIP-VQITQIHILN-YLNVSWNQLNASLPKEMGNMKSLTSADFSHNN 77 (468)
Q Consensus 1 l~~N~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~-~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~ 77 (468)
|++|+++ .|| ..|.+|++|+.|+|++| ++ .|+ ..|.+|.+|+ .|+|++ +++..-+..|.+|++|+.|++++|+
T Consensus 233 L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~ 308 (329)
T 3sb4_A 233 ISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDK 308 (329)
T ss_dssp CTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSC
T ss_pred CCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCc
Confidence 4567787 554 57888888888888888 77 454 4688888888 888888 6663234678888888888888888
Q ss_pred cCCCCC-CcccccccCcc
Q 012213 78 FSGEIP-EFGQYSFFNST 94 (468)
Q Consensus 78 l~~~~p-~~~~~~~~~~~ 94 (468)
++...+ .|..+.++..+
T Consensus 309 i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 309 ITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CCEECTTTTCTTCCCCEE
T ss_pred cCccchhhhcCCcchhhh
Confidence 874444 25554444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00088 Score=66.19 Aligned_cols=72 Identities=18% Similarity=0.256 Sum_probs=48.1
Q ss_pred ceEcccCCcceEEEEcCC--------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCc-cceeEEEecCCeeEEE
Q 012213 188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLV 258 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 258 (468)
+.|+.|....+|+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+.+ .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 568888889999998653 578899986321 111345678888877743333 566766532 389
Q ss_pred EeccCCCCh
Q 012213 259 YEYMPNGSL 267 (468)
Q Consensus 259 ~e~~~~gsL 267 (468)
+||++|-++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0043 Score=59.94 Aligned_cols=140 Identities=17% Similarity=0.226 Sum_probs=82.1
Q ss_pred ceEcccCCcceEEEEcC--------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEE
Q 012213 188 NVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 258 (468)
+.+..|-...+|+.... +++.+++|+.-.. ......+.+|..+++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 46777888899998875 3578899875221 122345668888887774 2223566766543 399
Q ss_pred EeccCCCChhhh-----------------cccCC---CCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 012213 259 YEYMPNGSLGEV-----------------LHGKR---GSFLK--WEMRLKIAIEAAK-------------------GLSY 297 (468)
Q Consensus 259 ~e~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia~-------------------~l~~ 297 (468)
|||++|..|..- ||... +.... |.+..++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655311 12111 11222 4555555544322 1222
Q ss_pred h----hhc-CCCCeeecCCCCCcEEEcCC----CceEEeecccccc
Q 012213 298 L----HHD-CSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKY 334 (468)
Q Consensus 298 L----H~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~ 334 (468)
| ... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 221 23458999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0021 Score=62.02 Aligned_cols=73 Identities=10% Similarity=0.004 Sum_probs=42.4
Q ss_pred ceEcccCCcceEEEEcCC---------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC-ccceeEEEecCCeeEE
Q 012213 188 NVIGRGGAGVVYRGVTPN---------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLL 257 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l 257 (468)
..|+.|....+|+....+ ++.+++|...... ........|...+..+...+ ..++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 467788888999988654 2678888754321 11112467777777764333 34566544 2 378
Q ss_pred EEeccCCCCh
Q 012213 258 VYEYMPNGSL 267 (468)
Q Consensus 258 v~e~~~~gsL 267 (468)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0051 Score=53.78 Aligned_cols=103 Identities=17% Similarity=0.133 Sum_probs=66.6
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCccc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 344 (468)
-||.++|. ..+.+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 37888887 455679999999999999999877621110 0 1223457899999999998764 1110
Q ss_pred cccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 012213 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386 (468)
Q Consensus 345 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 386 (468)
.....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888764 3567899999999999998874444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.01 Score=58.95 Aligned_cols=74 Identities=14% Similarity=0.110 Sum_probs=46.9
Q ss_pred cceEcccCCcceEEEEcCC-CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCc-cceeEEEecCCeeEEEEeccCC
Q 012213 187 NNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 264 (468)
.+.|+.|-...+|+....+ +..+++|+..... .. .-....|..++..+...++ .++++++. + .+|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3578888889999998765 4778888763321 11 1123578888887765444 45777662 2 359999987
Q ss_pred CCh
Q 012213 265 GSL 267 (468)
Q Consensus 265 gsL 267 (468)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.014 Score=55.63 Aligned_cols=32 Identities=16% Similarity=0.345 Sum_probs=27.9
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 303 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34599999999999999888899999987764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00028 Score=67.99 Aligned_cols=85 Identities=9% Similarity=0.048 Sum_probs=58.2
Q ss_pred cCCCCCEEEccCCcccccCCcccc--ccccccEeeccC--Cccccc-----CCccc--ccccccccccccCcccCCCCCC
Q 012213 16 HCLLLTYLDLSQNHLSGPIPVQIT--QIHILNYLNVSW--NQLNAS-----LPKEM--GNMKSLTSADFSHNNFSGEIPE 84 (468)
Q Consensus 16 ~l~~L~~L~l~~n~l~g~~p~~~~--~l~~L~~l~ls~--N~l~g~-----~p~~~--~~l~~L~~l~ls~N~l~~~~p~ 84 (468)
.+++|+.|+|+.|.++...-..+. .+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.++...+.
T Consensus 191 ~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 378999999999988754444554 789999999964 222111 11222 3578999999999988743321
Q ss_pred ----cccccccCcccccCCC
Q 012213 85 ----FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 85 ----~~~~~~~~~~~~~~n~ 100 (468)
...++.+..++++.|.
T Consensus 271 ~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGV 290 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSC
T ss_pred HHHhCccCCCCCEEECCCCC
Confidence 1346678888888774
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.30 E-value=0.00066 Score=57.75 Aligned_cols=91 Identities=7% Similarity=0.090 Sum_probs=60.8
Q ss_pred cCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCc-ccccCCcccccc----cccccccccCc-ccCCC-
Q 012213 9 IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ-LNASLPKEMGNM----KSLTSADFSHN-NFSGE- 81 (468)
Q Consensus 9 ~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~-l~g~~p~~~~~l----~~L~~l~ls~N-~l~~~- 81 (468)
.+|.....-.+|+.||||++.++..=-..+.+|++|+.|+|+++. ++..==..++.+ ++|+.|+|+++ ++|-.
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 345443333479999999999885433467899999999999985 663211234443 47999999998 46531
Q ss_pred CCCcccccccCcccccCC
Q 012213 82 IPEFGQYSFFNSTSFTGN 99 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~~n 99 (468)
+-.+..+++++.+++++-
T Consensus 132 l~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HHHGGGCTTCCEEEEESC
T ss_pred HHHHhcCCCCCEEECCCC
Confidence 222455677777777654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0073 Score=58.97 Aligned_cols=83 Identities=13% Similarity=0.160 Sum_probs=38.8
Q ss_pred cccccCCCCCEEEccCCccc-----ccCCccccccccccEeeccCCcccccCC-cccccccccccccccCcccCCCCC--
Q 012213 12 VEIGHCLLLTYLDLSQNHLS-----GPIPVQITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNFSGEIP-- 83 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~-----g~~p~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p-- 83 (468)
..|.+|++|+.++|.+|.+. ---+..|.+|++|+.++|. |+++ .|+ ..|.+|++|+.++|.+| ++ .|+
T Consensus 265 ~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~ 340 (401)
T 4fdw_A 265 RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VT-QINFS 340 (401)
T ss_dssp TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CC-EECTT
T ss_pred hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-cc-EEcHH
Confidence 34455555555555555443 1112345555555555555 2344 333 23455555555555433 33 222
Q ss_pred CcccccccCcccccCC
Q 012213 84 EFGQYSFFNSTSFTGN 99 (468)
Q Consensus 84 ~~~~~~~~~~~~~~~n 99 (468)
.|..+ ++..+.+.+|
T Consensus 341 aF~~~-~L~~l~l~~n 355 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGT 355 (401)
T ss_dssp SSSSS-CCCEEEECCS
T ss_pred hCCCC-CCCEEEEcCC
Confidence 13344 4555555544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0016 Score=55.38 Aligned_cols=68 Identities=7% Similarity=0.037 Sum_probs=50.0
Q ss_pred cccccCCCCCEEEccCCc-ccccCCcccccc----ccccEeeccCCc-ccccCCcccccccccccccccCcc-cC
Q 012213 12 VEIGHCLLLTYLDLSQNH-LSGPIPVQITQI----HILNYLNVSWNQ-LNASLPKEMGNMKSLTSADFSHNN-FS 79 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l----~~L~~l~ls~N~-l~g~~p~~~~~l~~L~~l~ls~N~-l~ 79 (468)
..+.+|++|++|+|+++. ++..-=..++.+ ++|+.|+|+++. +|..==..+..+++|+.|+|++.. ++
T Consensus 79 ~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 79 DHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp GGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred HHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence 356789999999999995 774333345553 479999999974 763211357789999999999884 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.074 Score=52.06 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=81.9
Q ss_pred ceEcccCCcceEEEEcCC--------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC-ccceeEEEecCCeeEEE
Q 012213 188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLLV 258 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 258 (468)
+.+..|-...+|+....+ ++.+++|+..... ...-...+|..+++.+...+ ..++++.+. -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 467778888899988753 5788888753321 11122467888777774222 345565432 3789
Q ss_pred EeccCCCChhh--h---------------cccC-----------CCCCCCHHHHHHHHHHH-------------------
Q 012213 259 YEYMPNGSLGE--V---------------LHGK-----------RGSFLKWEMRLKIAIEA------------------- 291 (468)
Q Consensus 259 ~e~~~~gsL~~--~---------------l~~~-----------~~~~l~~~~~~~i~~~i------------------- 291 (468)
+||++|..|.. . +|.. ...+.-|.+..++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999865421 0 1110 01111244444443322
Q ss_pred HHHHHHhh---------------------hcCCCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 292 AKGLSYLH---------------------HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 292 a~~l~~LH---------------------~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
...+.+|. ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 11223322 111345899999999999 8888999999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.88 E-value=0.03 Score=54.59 Aligned_cols=82 Identities=12% Similarity=0.092 Sum_probs=55.0
Q ss_pred cccccCCCCCEEEccCCcccccC-CccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCC--Ccccc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPI-PVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIP--EFGQY 88 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p--~~~~~ 88 (468)
..|.++ +|+.++|.+ .++ .| +..|.+|.+|+.++|+.|+++ .||.....+.+|+.+.+.+| ++ .|+ .|..+
T Consensus 152 ~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~-~I~~~aF~~~ 225 (401)
T 4fdw_A 152 MAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LK-EIGSQAFLKT 225 (401)
T ss_dssp TTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CC-EECTTTTTTC
T ss_pred HhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hh-eehhhHhhCC
Confidence 345554 588888875 666 44 356788888888888888887 57766555678888888744 54 333 25566
Q ss_pred cccCcccccCC
Q 012213 89 SFFNSTSFTGN 99 (468)
Q Consensus 89 ~~~~~~~~~~n 99 (468)
.++..+.+..|
T Consensus 226 ~~L~~l~l~~~ 236 (401)
T 4fdw_A 226 SQLKTIEIPEN 236 (401)
T ss_dssp TTCCCEECCTT
T ss_pred CCCCEEecCCC
Confidence 66666666654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.61 E-value=0.011 Score=51.29 Aligned_cols=64 Identities=11% Similarity=0.093 Sum_probs=47.6
Q ss_pred cCCCCCEEEccCC-cccc----cCCccccccccccEeeccCCccccc----CCcccccccccccccccCcccC
Q 012213 16 HCLLLTYLDLSQN-HLSG----PIPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 16 ~l~~L~~L~l~~n-~l~g----~~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
+-+.|+.|+|++| +|.. .|-..+..-++|+.|+|++|.+... |-..+..-+.|+.|+|++|+|.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3467999999986 7762 2344567788999999999998722 2233445678999999999987
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=92.97 E-value=0.036 Score=47.93 Aligned_cols=66 Identities=17% Similarity=0.114 Sum_probs=48.5
Q ss_pred cccccCCCCCEEEccCCccccc----CCccccccccccEeeccCCccccc----CCcccccccccccccccCcc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNN 77 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~ 77 (468)
..+..-+.|+.|+|++|+|... |-..+..-++|+.|+|++|.|... |-..+..-+.|+.|+|++|.
T Consensus 64 ~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 64 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence 3445567899999999999832 334466778999999999999732 22335556679999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=91.35 E-value=0.38 Score=46.41 Aligned_cols=59 Identities=14% Similarity=0.334 Sum_probs=27.4
Q ss_pred cccccccccEeeccCCcccccCC-cccccccccccccccCcccCCCCCC--cccccccCcccccCC
Q 012213 37 QITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNFSGEIPE--FGQYSFFNSTSFTGN 99 (468)
Q Consensus 37 ~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p~--~~~~~~~~~~~~~~n 99 (468)
.|.+|.+|+.++|..| ++ .|. ..|.+|.+|+.+.+..+ ++ .|+. |..+.+|+.+.+.+|
T Consensus 306 aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 306 VFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp TTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred eecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 3455555555555433 33 232 23555555555555433 33 3332 444445555555444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=90.89 E-value=0.42 Score=45.77 Aligned_cols=63 Identities=14% Similarity=0.188 Sum_probs=27.4
Q ss_pred ccccCCCCCEEEccCCcccccC-CccccccccccEeeccCCcccccCCc-ccccccccccccccCcccC
Q 012213 13 EIGHCLLLTYLDLSQNHLSGPI-PVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~ 79 (468)
.+.++..|+.+.+..+ ++ .| ...+.++.+|+.+.+..+ ++ .++. .|.++++|+.+.+.+|.++
T Consensus 235 ~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~ 299 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE 299 (379)
T ss_dssp TTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCC
T ss_pred cccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccc
Confidence 3444555665555444 33 22 223444444554444332 22 2222 3444444444444444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.87 E-value=1.8 Score=37.67 Aligned_cols=124 Identities=7% Similarity=0.057 Sum_probs=82.5
Q ss_pred HHHHHhCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 012213 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309 (468)
Q Consensus 230 e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 309 (468)
|+..|.. .||+.+.. ..-.+.+...+.|+.-+ +..++-. -...+...+++++.+|+....+++. -+|-
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 4444433 68888866 45556666666565433 2333221 1237789999999999988866653 4688
Q ss_pred CCCCCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 310 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
-+.|+|++++.++.+++.=.|+...+. |. ..++..=.-.+=+++..+++++..|++
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 899999999999999998777543322 21 122223334577899999999999864
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.98 E-value=0.25 Score=47.70 Aligned_cols=63 Identities=14% Similarity=0.337 Sum_probs=50.9
Q ss_pred cccccCCCCCEEEccCCcccccCC-ccccccccccEeeccCCcccccCCc-ccccccccccccccCccc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l 78 (468)
..|.+|.+|+.++|..| ++ .|. ..|.+|.+|+.+.|..+ ++ .|+. .|.+|++|+.+++++|..
T Consensus 305 ~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 305 SVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred eeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 46778899999999865 66 554 47999999999999765 66 5654 689999999999998854
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=89.60 E-value=0.34 Score=46.72 Aligned_cols=59 Identities=15% Similarity=0.232 Sum_probs=29.3
Q ss_pred cccCCCCCEEEccCCcccccCC-ccccccccccEeeccCCcccccCC-cccccccccccccccCc
Q 012213 14 IGHCLLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHN 76 (468)
Q Consensus 14 ~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N 76 (468)
+..+.+|+.+.+..+ ++ .|+ ..|.+|.+|+.++|..+ ++ .|+ ..|.+|++|+.+++..|
T Consensus 293 F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred ccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence 344555555555433 33 332 24555566666665433 44 343 34555566666655544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=89.31 E-value=0.47 Score=45.38 Aligned_cols=83 Identities=13% Similarity=0.257 Sum_probs=60.3
Q ss_pred cccccCCCCCEEEccCCcccccCC-ccccccccccEeeccCCcccccCC-cccccccccccccccCcccCCCCCC--ccc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNFSGEIPE--FGQ 87 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p~--~~~ 87 (468)
..+.++.+|+.+.+..+ ++ .++ ..|.+|.+|+.+++.+|.++ .|+ ..|.+|.+|+.++|..| ++ .|+. |..
T Consensus 257 ~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~ 331 (379)
T 4h09_A 257 FLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKN 331 (379)
T ss_dssp TTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTT
T ss_pred cccceeehhcccccccc-ce-eccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhC
Confidence 35567888999988654 55 454 46888999999999988888 564 46888999999999765 54 4443 666
Q ss_pred ccccCcccccCC
Q 012213 88 YSFFNSTSFTGN 99 (468)
Q Consensus 88 ~~~~~~~~~~~n 99 (468)
..+|..+.+..+
T Consensus 332 C~~L~~i~ip~~ 343 (379)
T 4h09_A 332 CKALSTISYPKS 343 (379)
T ss_dssp CTTCCCCCCCTT
T ss_pred CCCCCEEEECCc
Confidence 667777776554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.98 E-value=0.36 Score=46.62 Aligned_cols=61 Identities=15% Similarity=0.224 Sum_probs=50.5
Q ss_pred cccccCCCCCEEEccCCcccccCC-ccccccccccEeeccCCcccccCC-cccccccccccccccCc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHN 76 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N 76 (468)
..|.+|++|+.++|.++ ++ .|+ ..|.+|.+|+.++|..| ++ .|+ ..|.+|++|+.+++..|
T Consensus 314 ~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 314 EAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG
T ss_pred hhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC
Confidence 56888999999999755 77 564 57999999999999887 66 564 47899999999999765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.48 E-value=0.22 Score=48.41 Aligned_cols=29 Identities=31% Similarity=0.546 Sum_probs=24.7
Q ss_pred eeecCCCCCcEEE------cCCCceEEeecccccc
Q 012213 306 IIHRDVKSNNILL------NSDFEAHVADFGLAKY 334 (468)
Q Consensus 306 ivH~dlk~~Nill------~~~~~~kl~Dfgla~~ 334 (468)
++|+|+.+.||++ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4466799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.76 E-value=4.6 Score=35.17 Aligned_cols=116 Identities=14% Similarity=0.140 Sum_probs=77.9
Q ss_pred CCCCccceeEEEecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeecCCCCCcE
Q 012213 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS-YLHHDCSPLIIHRDVKSNNI 316 (468)
Q Consensus 238 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~dlk~~Ni 316 (468)
.||++ -...-.+.+...+.++.-+++.=...+. .++...+++++.+|+.... +++. -+|--+.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 67777 4444466777777776553332222332 2678899999999988777 5653 57888999999
Q ss_pred EEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 012213 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389 (468)
Q Consensus 317 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 389 (468)
++|.++.+++.=.|+-..+ +|. ..++.-=.-.+=+++..++.++..|++
T Consensus 116 ~f~~~~~p~i~hRGi~~~l-------------------pP~-----e~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL-------------------PPD-----EWDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp EECTTCCEEESCCEETTTB-------------------SSC-----SCCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EEeCCCcEEEEEcCCcccC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999877754432 222 112222233477888899999888754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.35 E-value=0.083 Score=52.43 Aligned_cols=61 Identities=8% Similarity=-0.061 Sum_probs=16.7
Q ss_pred cceEcccCCcceEEEEcCC-CcEEEE------EEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEe
Q 012213 187 NNVIGRGGAGVVYRGVTPN-GEQVAV------KKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS 250 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 250 (468)
.+.+| ||.||+|.+.. ..+||| |..+......+....+.+|..++...+|||+++..++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34555 99999999854 367888 766543333333345778888888899999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 468 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.003 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-71
Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 21/277 (7%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG G G VY+G VAVK L E+ L K RH NI+
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ + + +V ++ SL LH F + + IA + A+G+ YLH II
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK---V 364
HRD+KSNNI L+ D + DFGLA S ++GS ++APE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 365 DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424
+SDVY+FG+VL EL+TG+ P + I + L LS
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----------GYLSPDLSKVR 235
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461
+ + + C+++ ERP +++ + +
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-65
Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 23/269 (8%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G G V+ G +VAVK + +GS + AE + +++H+ +VRL A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ + ++ EYM NGSL + L G L L +A + A+G++++ I
Sbjct: 76 VVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+++ NIL++ +ADFGLA+ ++D + APE K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 368 SDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427
SDV+SFG++L E++T R G +++Q + P +
Sbjct: 191 SDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQ--------------NLERGYRMVRPDNC 235
Query: 428 AMQVFFVAMLCVQEHGVERPTMREVVQML 456
+++ + LC +E +RPT + +L
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-62
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 23/275 (8%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
E ++ +G+G G V+ G +VA+K + G+ E + + K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+V+L A S + +V EYM GSL + L G+ G +L+ + +A + A G++Y+
Sbjct: 74 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
+HRD+++ NIL+ + VADFGLA+ ++D + + APE A
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY 188
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421
+ KSDV+SFG++L EL T R ++E + ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVERGYRM 233
Query: 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
P + + C ++ ERPT + L
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-62
Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG G G+V+ G N ++VA+K I +G+ + E + K+ H +V+L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
C + LV+E+M +G L + + E L + ++ +G++YL C +I
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+ + N L+ + V+DFG+ +++ D + + +PE + K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSK 182
Query: 368 SDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427
SDV+SFGV++ E+ + + + S+ E V I P
Sbjct: 183 SDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYKPRLA 227
Query: 428 AMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
+ V+ + C +E +RP +++ LA+
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-61
Identities = 77/301 (25%), Positives = 123/301 (40%), Gaps = 29/301 (9%)
Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
IG+G G V+RG GE+VAVK + AEI +RH NI+ A
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 249 CSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-- 302
+ LV +Y +GSL + L+ + E +K+A+ A GL++LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 303 ---SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGYIAPE 357
P I HRD+KS NIL+ + +AD GLA + G+ Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 358 YAYT------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS--- 408
+ +++D+Y+ G+V E+ G + L +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 409 KEGVVKILDQRLSNTPLS-EAMQVFF-VAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466
K + L + N S EA++V + C +G R T + + L+Q + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 467 M 467
M
Sbjct: 303 M 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 60/224 (26%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+ +G G GVV++ P+G +A K + K + + + E++ L + IV
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHECNSPYIVGFY 70
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ + E+M GSL +VL + + ++ K++I KGL+YL I
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HRDVK +NIL+NS E + DFG++ L D+ A+ + G+ Y++PE
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSV 182
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410
+SD++S G+ L+E+ GR P+ + L+++ +++ ++++
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G + +G+ + K+L + + L +E+ L +++H NIVR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 247 AFCSNKETNLL--VYEYMPNGSLGEVLH--GKRGSFLKWEMRLKIAIEAAKGLSYLH--H 300
++ L V EY G L V+ K +L E L++ + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
D ++HRD+K N+ L+ + DFGLA+ L + A G+ Y++PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMN 187
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420
+ +EKSD++S G +L EL P S KE KI + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQKELAGKIREGKF 231
Query: 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
P + ++ + + RP++ E+++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-60
Identities = 60/269 (22%), Positives = 112/269 (41%), Gaps = 23/269 (8%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G GVV G VA+K I +GS ++ E + + + H +V+L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
C+ + ++ EYM NG L L R F + + L++ + + + YL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLESKQ---FL 122
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+ + N L+N V+DFGL++Y+ D + + PE K K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 368 SDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSE 427
SD+++FGV++ E+ + + + + + + E + + L + +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMP------------YERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 428 AMQVFFVAMLCVQEHGVERPTMREVVQML 456
+ C E ERPT + ++ +
Sbjct: 230 VYT---IMYSCWHEKADERPTFKILLSNI 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-60
Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 29/270 (10%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG+G G V G G +VAVK + K + AE + ++RH N+V+L
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 248 FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
++ L +V EYM GSL + L + S L + LK +++ + + YL +
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HRD+ + N+L++ D A V+DFGL K T + APE K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFST 179
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLS 426
KSDV+SFG++L E+ + R K+ V ++ + P
Sbjct: 180 KSDVWSFGILLWEIYSFGRVP---------------YPRIPLKDVVPRVEKGYKMDAPDG 224
Query: 427 EAMQVFFVAMLCVQEHGVERPTMREVVQML 456
V+ V C RP+ ++ + L
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (495), Expect = 2e-59
Identities = 65/315 (20%), Positives = 124/315 (39%), Gaps = 51/315 (16%)
Query: 170 FQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSH 223
L++ ++ +E V+ IG G G V++ P VAVK L
Sbjct: 5 LLSLEYPRNN-IEYVR---DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF----- 278
+ E + + + NIV+L C+ + L++EYM G L E L
Sbjct: 61 AD-FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 279 -----------------LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
L +L IA + A G++YL +HRD+ + N L+ +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 381
+ADFGL++ + + A ++ PE + + +SDV+++GVVL E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 382 TGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQE 441
+ +G +++ + D + P + ++++ + LC +
Sbjct: 237 SYGLQP-YYGMAHEEVIY--------------YVRDGNILACPENCPLELYNLMRLCWSK 281
Query: 442 HGVERPTMREVVQML 456
+RP+ + ++L
Sbjct: 282 LPADRPSFCSIHRIL 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 1e-58
Identities = 74/300 (24%), Positives = 129/300 (43%), Gaps = 30/300 (10%)
Query: 174 DFGSDDILECVKDNNVIGRGGAGVVYRGV----TPNGEQVAVKKLLGITKGSSHDNGLSA 229
+F + + CVK VIG G G V G VA+K L + +
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLS 76
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
E +G+ H N++ L+ + +++ E+M NGSL L G F + +
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLR 135
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
A G+ YL +HRD+ + NIL+NS+ V+DFGL+++L+D + ++ G
Sbjct: 136 GIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 350 SYG---YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQT 405
+ APE K SDV+S+G+V+ E+++ G RP D
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---------------- 236
Query: 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA-QKPNT 464
++++ + I P+ + + + C Q+ RP ++V L + + PN+
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-58
Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 27/276 (9%)
Query: 186 DNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
++ +G G G V +G + VAVK L + + L AE + ++ + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
VR+ C E+ +LV E G L + L R +K + +++ + + G+ YL
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN 127
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAPEYAYT 361
+HRD+ + N+LL + A ++DFGL+K L+ D + + + APE
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 362 LKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420
K KSDV+SFGV++ E + G++P E +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----------------KGSEVTAMLEKGER 228
Query: 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
P +++ + LC RP V L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 5e-57
Identities = 66/299 (22%), Positives = 119/299 (39%), Gaps = 29/299 (9%)
Query: 170 FQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLS 228
+ K + DI + +G G G VY GV VAVK + + +
Sbjct: 9 YDKWEMERTDI----TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFL 61
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
E + +I+H N+V+L C+ + ++ E+M G+L + L + + L +A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
+ + + YL IHRD+ + N L+ + VADFGL++ + + +
Sbjct: 122 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAK 177
Query: 349 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408
+ APE K KSDV++FGV+L E+ T
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------------PYPGID 221
Query: 409 KEGVVKILDQRLSNT-PLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466
V ++L++ P +V+ + C Q + +RP+ E+ Q + ++
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-57
Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 28/274 (10%)
Query: 187 NNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+ IGRG VY+G+ T +VA +L S E L ++H NIVR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 246 KAFC----SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
K+ +LV E M +G+L L R +K ++ + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 302 CSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
P IIHRD+K +NI + + D GLA + + AV G+ ++APE Y
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420
K DE DVY+FG+ +LE+ T P + E + ++ + K+ +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ C++++ ER ++++++
Sbjct: 243 KE-----------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-57
Identities = 77/301 (25%), Positives = 117/301 (38%), Gaps = 29/301 (9%)
Query: 163 NSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV----TPNGEQVAVKKLLGIT 218
N + A Q + G ++ V N VIGRG G VY G AVK L IT
Sbjct: 10 NPELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-LLVYEYMPNGSLGEVLHGKRGS 277
E + H N++ L C E + L+V YM +G L
Sbjct: 68 DIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETH 125
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL-- 335
+ + ++ AKG+ S +HRD+ + N +L+ F VADFGLA+ +
Sbjct: 126 NPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL 395
++ + + ++A E T K KSDV+SFGV+L EL+T P +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDV 238
Query: 396 DIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
+ V +L R P ++ V + C RP+ E+V
Sbjct: 239 NTFDI-----------TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 456 L 456
+
Sbjct: 288 I 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-56
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 28/290 (9%)
Query: 171 QKLDFGSDDILECVKDNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHDNGL 227
+KL D++L + +G G G V +GV VA+K L T+ + + +
Sbjct: 1 KKLFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-M 56
Query: 228 SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
E + + ++ + IVRL C + +LV E G L + L GKR + ++
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE-IPVSNVAEL 114
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ-DTGASECMSA 346
+ + G+ YL +HRD+ + N+LL + A ++DFGL+K L D SA
Sbjct: 115 LHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 347 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406
+ APE K +SDV+S+GV + E ++ + +G +++
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMA------- 223
Query: 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
I + P +++ + C +RP V Q +
Sbjct: 224 -------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-56
Identities = 67/293 (22%), Positives = 112/293 (38%), Gaps = 43/293 (14%)
Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHR 240
+G G G V + VAVK L + + L +E++ L + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHM 87
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF----------------LKWEMR 284
NIV L C+ L++ EY G L L KR SF L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
L + + AKG+++L IHRD+ + NILL + DFGLA+ +++
Sbjct: 148 LSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 345 SAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQ 404
++APE + +SDV+S+G+ L EL +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYP 249
Query: 405 TNSSKEGVVKILDQRLSNT-PLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
K++ + P +++ + C ++RPT +++VQ++
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (477), Expect = 1e-56
Identities = 77/285 (27%), Positives = 122/285 (42%), Gaps = 31/285 (10%)
Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIR 232
F DD + D IG G G VY N E VA+KK+ K S+ + E+R
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
L K+RH N ++ + + T LV EY + + K+ L+ + A
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGAL 125
Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
+GL+YLH S +IHRDVK+ NILL+ + DFG A + ++ G+
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPY 176
Query: 353 YIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK 409
++APE + + D K DV+S G+ +EL + P M S+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-------------LFNMNAMSAL 223
Query: 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ + L + SE + F C+Q+ +RPT +++
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNF--VDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-56
Identities = 67/270 (24%), Positives = 114/270 (42%), Gaps = 30/270 (11%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G+G G VY + +A+K L + + ++ L E+ +RH NI+RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ + L+ EY P G++ L + E A LSY H S
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKR 126
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
+IHRD+K N+LL S E +ADFG + + + + + G+ Y+ PE D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHD 182
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP- 424
EK D++S GV+ E + G+ P + N+ +E +I +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP----------------FEANTYQETYKRISRVEFTFPDF 226
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
++E + +L +RP +REV++
Sbjct: 227 VTEGARDLISRLLKHNPS--QRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-56
Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 27/292 (9%)
Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ-----VAVKKLLGITKGSSHDNGLSAEIRTLGK 236
CV VIG G G VY+G+ VA+K L E +G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 65
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
H NI+RL+ S + +++ EYM NG+L + ++ + + A G+
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGM- 123
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-ASECMSAVAGSYGYIA 355
+ + +HRD+ + NIL+NS+ V+DFGL++ L+D A+ S + A
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415
PE K SDV+SFG+V+ E++T S+ E + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAI 226
Query: 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ-AQKPNTFQ 466
D TP+ ++ + M C Q+ RP ++V +L + + P++ +
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-56
Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 50/299 (16%)
Query: 189 VIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRN 241
V+G G G V T QVAVK L SS L +E++ + ++ H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHEN 102
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF---------------------LK 280
IV L C+ L++EY G L L KR F L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
+E L A + AKG+ +L +HRD+ + N+L+ + DFGLA+ +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQ 399
++APE + KSDV+S+G++L E+ + G P
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI--------- 270
Query: 400 WTKMQTNSSKEGVVKILDQRLS-NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457
K++ + P +++ + C +RP+ + L
Sbjct: 271 -------PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-55
Identities = 58/269 (21%), Positives = 99/269 (36%), Gaps = 22/269 (8%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+G G G V V E VAVK + + + + EI + H N+V+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
L EY G L + + G + + + G+ YLH I
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD- 365
HRD+K N+LL+ ++DFGLA + ++ + G+ Y+APE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425
E DV+S G+VL ++ G P + + W + +T + +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------WKKI 232
Query: 426 SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
A +L R T+ ++ +
Sbjct: 233 DSAPLALLHKILVENPS--ARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 2e-53
Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 25/293 (8%)
Query: 165 WKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSH 223
WK Q ++ D +L+ + +G G GVV+R G A K ++ T S
Sbjct: 9 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESD 66
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
+ EI+T+ +RH +V L + +++YE+M G L E + + + +
Sbjct: 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDE 125
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGAS 341
++ + KGL ++H + +H D+K NI+ + + DFGL +L
Sbjct: 126 AVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 179
Query: 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWT 401
+ + G+ + APE A V +D++S GV+ L++G P G GE + ++
Sbjct: 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--GENDDETLR-- 235
Query: 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ K + D S +SE + F +L + R T+ + ++
Sbjct: 236 -----NVKSCDWNMDDSAFSG--ISEDGKDFIRKLLLADPN--TRMTIHQALE 279
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-53
Identities = 72/279 (25%), Positives = 108/279 (38%), Gaps = 25/279 (8%)
Query: 188 NVIGRGGAGVVYRGV----TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNI 242
+G G GVV RG + VAVK L + E+ + + HRN+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+RL +V E P GSL + L +G FL + A++ A+G+ YL
Sbjct: 74 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR 131
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAPEYAYT 361
IHRD+ + N+LL + + DFGL + L M + + APE T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421
SD + FGV L E+ T + G G I+ + +RL
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDKE------------GERLP 235
Query: 422 NTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460
P ++ V + C +RPT + L +AQ
Sbjct: 236 R-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-53
Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 31/289 (10%)
Query: 172 KLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAE 230
D +D E + +G G G VY+ A K + TK E
Sbjct: 5 TRDLNPEDFWEIIG---ELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVE 59
Query: 231 IRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIE 290
I L H NIV+L + ++ E+ G++ V+ + L + +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQ 118
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
L+YLH IIHRD+K+ NIL D + +ADFG++ T + + G+
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGT 173
Query: 351 YGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT 405
++APE D K+DV+S G+ L+E+ P + + +++ K +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEP 232
Query: 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ + + S + F L R T +++Q
Sbjct: 233 PTLAQ-----------PSRWSSNFKDFLKKCLEKNVD--ARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-53
Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 26/280 (9%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
V+G G G VY+G+ P GE+ VA+K+L T ++ + E + + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHV 73
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
RL C T L+ + MP G L + + + + + L ++ AKG++YL
Sbjct: 74 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRR 131
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
++HRD+ + N+L+ + + DFGLAK L ++A E
Sbjct: 132 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422
+SDV+S+GV + EL+T D + E +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYD---------------GIPASEISSILEKGERLP 233
Query: 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462
P + V+ + + C RP RE++ ++ +
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-52
Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 168 TAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHD 224
T + LD+ +DI K +VIG G G V + A+K++ H
Sbjct: 2 TIYPVLDW--NDI----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 225 NGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGK--------- 274
+ + E+ L K+ H NI+ L C ++ L EY P+G+L + L
Sbjct: 56 D-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 275 -----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329
S L + L A + A+G+ + IHRD+ + NIL+ ++ A +ADF
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADF 171
Query: 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGD 389
GL++ + ++A E SDV+S+GV+L E+++
Sbjct: 172 GLSRGQEVYVKKTM---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-- 226
Query: 390 FGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTM 449
G+ + + K+ PL+ +V+ + C +E ERP+
Sbjct: 227 --YCGMTCAELYE-----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 273
Query: 450 REVVQML 456
+++ L
Sbjct: 274 AQILVSL 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 1e-51
Identities = 62/290 (21%), Positives = 117/290 (40%), Gaps = 33/290 (11%)
Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
+G+G G+VY GV +VA+K + E + + +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 84
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF--------LKWEMRLKIAIEAAK 293
+VRL S + L++ E M G L L R + +++A E A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
G++YL+ + +HRD+ + N ++ DF + DFG+ + + +T +
Sbjct: 145 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 354 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413
++PE SDV+SFGVVL E+ T Q S+++ +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGLSNEQVLR 246
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463
+++ L + P + +F + +C Q + RP+ E++ + + +P
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-51
Identities = 61/269 (22%), Positives = 110/269 (40%), Gaps = 27/269 (10%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG+G +G VY + G++VA++++ + + EI + + ++ NIV
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ +V EY+ GSL +V+ + E + L +LH + +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSNQ---V 137
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
IHRD+KS+NILL D + DFG + S + G+ ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 367 KSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP-L 425
K D++S G++ +E+I G P + + + L N L
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP-------------YLNENPLRALYLIATNGTPELQNPEKL 242
Query: 426 SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
S + F L + +R + +E++Q
Sbjct: 243 SAIFRDFLNRCLDMDVE--KRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-50
Identities = 57/278 (20%), Positives = 98/278 (35%), Gaps = 26/278 (9%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
++G G V + A+K L + ++ E + ++ H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ E Y NG L + + K GSF + R A + +S L +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA----EIVSALEYLHGKG 128
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
IIHRD+K NILLN D + DFG AK L ++ G+ Y++PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS-NTP 424
+ SD+++ G ++ +L+ G P + + KI+
Sbjct: 189 KSSDLWALGCIIYQLVAGLPP----------------FRAGNEYLIFQKIIKLEYDFPEK 232
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462
+ +L + +R E+ P
Sbjct: 233 FFPKARDLVEKLLVLDAT--KRLGCEEMEGYGPLKAHP 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-48
Identities = 59/274 (21%), Positives = 109/274 (39%), Gaps = 26/274 (9%)
Query: 189 VIGRGGAGVVYRGVTPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
IG G G V++G+ + E VA+K T S + E T+ + H +IV+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 72
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
L + ++ E G L L ++ S L + A + + L+YL
Sbjct: 73 LIGVITENPV-WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR-- 128
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
+HRD+ + N+L++S+ + DFGL++Y++D+ S ++APE +
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRF 186
Query: 365 DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424
SDV+ FGV + E++ Q + + + +I + P
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKP---------------FQGVKNNDVIGRIENGERLPMP 231
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQ 458
+ ++ + C RP E+ L+
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (424), Expect = 2e-48
Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 25/269 (9%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G GVV+R V G K + T + EI + ++ H ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+K +L+ E++ G L + + + + +A +GL ++H I+
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 308 HRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
H D+K NI+ + + V DFGLA L E + + + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVG 206
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPL 425
+D+++ GV+ L++G P GE+ L+ +Q + K + + S+ +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFA--GEDDLETLQ-------NVKRCDWEFDEDAFSS--V 255
Query: 426 SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
S + F +L + +R T+ + ++
Sbjct: 256 SPEAKDFIKNLLQKEPR--KRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-47
Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 38/297 (12%)
Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
+GRG G V T VAVK L S H +S + H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF--------------LKWEMRLK 286
+V L C+ L ++ E+ G+L L KR F L E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
+ + AKG+ +L IHRD+ + NILL+ + DFGLA+ +
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 347 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTN 406
++APE + +SDV+SFGV+L E+ + G+ I +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEFCR--- 248
Query: 407 SSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463
++ + P +++ + C +RPT E+V+ L + N
Sbjct: 249 -------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-46
Identities = 54/274 (19%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+GRG G+V+R V T + + K + + + EI L RHRNI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKF---VKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
+ E ++++E++ + E ++ L + + + L +LH S I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 308 HRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
H D++ NI+ + + + +FG A+ L+ + + + Y APE V
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP- 424
+D++S G ++ L++G P ++++ + I++ +
Sbjct: 182 TATDMWSLGTLVYVLLSGINP----------------FLAETNQQIIENIMNAEYTFDEE 225
Query: 425 ----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+S F +L + R T E +Q
Sbjct: 226 AFKEISIEAMDFVDRLLVKERK--SRMTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-46
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 48/295 (16%)
Query: 188 NVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGK 236
+G G G V +VAVK L K + + LS +E+ +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLSDLISEMEMMKM 74
Query: 237 I-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF--------------LKW 281
I +H+NI+ L C+ ++ EY G+L E L +R L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341
+ + A + A+G+ YL S IHRD+ + N+L+ D +ADFGLA+ +
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWT 401
+ + ++APE + +SDV+SFGV+L E+ T G+ + +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP----GVPVEELF 247
Query: 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQML 456
K + + + P + +++ + C +RPT +++V+ L
Sbjct: 248 K-----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 3e-46
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
++G GG V+ VAVK L + + S E + + H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 247 AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ +V EY+ +L +++H + + + +++ +A + L++ H +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG 131
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAPEYAYT 361
IIHRDVK NI++++ V DFG+A+ + D+G S +AV G+ Y++PE A
Sbjct: 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 362 LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLS 421
VD +SDVYS G VL E++TG P F + V + ++ + +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVRED--------PIPPSAR 237
Query: 422 NTPLSEAMQVFFVAMLCVQEHGVERP-TMREVVQMLAQAQ 460
+ LS + + L R T E+ L +
Sbjct: 238 HEGLSADLDAVVLKALAKNPE--NRYQTAAEMRADLVRVH 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 3e-44
Identities = 68/282 (24%), Positives = 114/282 (40%), Gaps = 36/282 (12%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLS-------AEIRTLGKIR- 238
++GRG + VV R + P ++ AVK + GS + E+ L K+
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
H NI++LK LV++ M G L + L K L + KI + + L
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 126
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY 358
H I+HRD+K NILL+ D + DFG + L E + V G+ Y+APE
Sbjct: 127 HKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEI 180
Query: 359 AYT------LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412
++ D++S GV++ L+ G P + + + +++ G
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHRKQMLMLRMI-------MSGN 231
Query: 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ + S+ ++ L VQ +R T E +
Sbjct: 232 YQFGSPEWDD--YSDTVKDLVSRFLVVQPQ--KRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 3e-44
Identities = 61/287 (21%), Positives = 109/287 (37%), Gaps = 36/287 (12%)
Query: 177 SDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
++DI + +V+G G V + VA+K + + + EI L
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLH 62
Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
KI+H NIV L + L+ + + G L + + K F ++ + +
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 120
Query: 296 SYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
YLH I+HRD+K N+L + D + ++DFGL+K +S G+ G
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPG 174
Query: 353 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412
Y+APE + D +S GV+ L+ G P + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----------------FYDENDAKLF 218
Query: 413 VKILDQRLSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+IL +S++ + F ++ +R T + +Q
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE--KRFTCEQALQ 263
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-42
Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 27/286 (9%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA---EIRTLGKIRHRNIV 243
+ +G G VY+ + VA+KK+ + + D EI+ L ++ H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
L +K LV+++M V+ L + +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
I+HRD+K NN+LL+ + +ADFGLAK + + Y APE + +
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGAR 176
Query: 364 V-DEKSDVYSFGVVLLELITGRRP-VGDFGEEGLDIV----------QWTKMQTNSSKEG 411
+ D+++ G +L EL+ GD + L + QW M +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 412 VVKILDQRLSN--TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM 455
L + + + + + R T + ++M
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC--ARITATQALKM 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (378), Expect = 3e-42
Identities = 61/273 (22%), Positives = 106/273 (38%), Gaps = 32/273 (11%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
+G G G V+ NG A+K L I + E L + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
+ + ++ +Y+ G L +L + + L + S
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
II+RD+K NILL+ + + DFG AKY+ D + G+ YIAPE T +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYN 179
Query: 366 EKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP- 424
+ D +SFG+++ E++ G P D +++ + KIL+ L P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYD----------------SNTMKTYEKILNAELRFPPF 223
Query: 425 LSEAMQVFFVAMLCV---QEHGVERPTMREVVQ 454
+E ++ ++ Q G + +V
Sbjct: 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 26/293 (8%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G GVVY+ GE VA+KK+ T+ + EI L ++ H NIV+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ LV+E++ + L + + + + + + +GL++ H +
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPE-YAYTLKVD 365
+HRD+K N+L+N++ +ADFGLA+ + + Y APE
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 366 EKSDVYSFGVVLLELITGRRP-VGDFGEEGLD-IVQWTKMQTNSSKEGVVKILDQRLSN- 422
D++S G + E++T R GD + L I + GV + D + S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 423 -----------TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQAQKP 462
PL E + ML + +R + + + KP
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPN--KRISAKAALAHPFFQDVTKP 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-41
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 37/297 (12%)
Query: 168 TAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG 226
T F++ + DD + + +G G VV + G Q A K + SS
Sbjct: 1 TVFRQENV--DDYYDTGE---ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 227 ----LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE 282
+ E+ L +I+H N++ L NK +L+ E + G L + L K L E
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEE 113
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKYLQDT 338
+ + G +++ S I H D+K NI+L + DFGLA +
Sbjct: 114 EATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP-VGDFGEEGLDI 397
+ + G+ ++APE + ++D++S GV+ L++G P +GD +E L
Sbjct: 171 NEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227
Query: 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
V + D+ SN S + F +L +R T+++ +Q
Sbjct: 228 V----------SAVNYEFEDEYFSN--TSALAKDFIRRLLVKDPK--KRMTIQDSLQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 60/267 (22%), Positives = 99/267 (37%), Gaps = 27/267 (10%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGK-IRHRNIVR 244
++G+G G V+ + A+K L + E R L H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
+ KE V EY+ G L + A E GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG-- 123
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV 364
I++RD+K +NILL+ D +ADFG+ K A + G+ YIAPE K
Sbjct: 124 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKY 180
Query: 365 DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTP 424
+ D +SFGV+L E++ G+ P G++ ++ +M +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWL------------ 226
Query: 425 LSEAMQVFFVAMLCVQEHGVERPTMRE 451
+ + V + + +R +R
Sbjct: 227 -EKEAKDLLVKLFVREPE--KRLGVRG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 59/272 (21%), Positives = 105/272 (38%), Gaps = 25/272 (9%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
V+G G G V + E+ A+K L E+ + + +IVR+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 71
Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
N L+V E + G L + + +I + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTL 362
S I HRDVK N+L S + + ++T + ++ + Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 363 KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422
K D+ D++S GV++ L+ G P + GL I K + + G + + S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRI---RMGQYEFPNPEWSE 243
Query: 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+SE +++ +L + +R T+ E +
Sbjct: 244 --VSEEVKMLIRNLLKTEPT--QRMTITEFMN 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 2e-41
Identities = 50/297 (16%), Positives = 100/297 (33%), Gaps = 42/297 (14%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLK 246
IG G GV++ G N +QVA+K S L E RT + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
F N+LV + + G E L G + A + + +H +
Sbjct: 68 YFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 307 IHRDVKSNNILLNSDFEAH-----VADFGLAKYLQDTGASEC-----MSAVAGSYGYIAP 356
++RD+K +N L+ + V DFG+ K+ +D + ++G+ Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 357 EYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416
+ + D+ + G V + + G W ++ ++K+ +I
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSL-------------PWQGLKAATNKQKYERIG 229
Query: 417 DQRLSNTP------LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQM 467
+++ S E + P + + ++ +
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYM--HYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (369), Expect = 3e-41
Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 22/281 (7%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG G GVVY+ GE A+KK+ + + EI L +++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
K+ +LV+E++ + + G L+ ++ G++Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEK 367
HRD+K N+L+N + E +ADFGLA+ + + + + K
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 368 SDVYSFGVVLLELITGRRPVGDFGEEGL--------------DIVQWTKMQTNSSKEGVV 413
D++S G + E++ G E + T++ V
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ L L E+ ML + + +R T ++ ++
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPN--QRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-40
Identities = 76/305 (24%), Positives = 112/305 (36%), Gaps = 38/305 (12%)
Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
D VIG G GVVY+ +GE VA+KK+L + E++ + K+ H NIV
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCNIV 76
Query: 244 RLKAFCSNKETN------LLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLS 296
RL+ F + LV +Y+P H R L + + L+
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAH-VADFGLAKYLQDTGASECMSAVAGSYGYIA 355
Y+H S I HRD+K N+LL+ D + DFG AK L +S + Y
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAP 191
Query: 356 PEYAYTLKVDEKSDVYSFGVVLLELITGRRP-VGDFGEEGLDIV----------QWTKMQ 404
DV+S G VL EL+ G+ GD G + L + Q +M
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 405 TNSSKEGVVKILDQRLSNTP---LSEAMQVFFVAMLCVQEHGVERPTMREVVQM--LAQA 459
N ++ +I + +L R T E +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT--ARLTPLEACAHSFFDEL 309
Query: 460 QKPNT 464
+ PN
Sbjct: 310 RDPNV 314
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 1e-40
Identities = 52/295 (17%), Positives = 103/295 (34%), Gaps = 40/295 (13%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLK 246
IG G G +Y G GE+VA+K + L E + ++ I ++
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ + N++V E + R + L +A + + Y+H S
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECM-----SAVAGSYGYIAPEY 358
IHRDVK +N L+ ++ DFGLAK +D + + + G+ Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 359 AYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418
++ + D+ S G VL+ G W ++ + ++ +I ++
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSL-------------PWQGLKAATKRQKYERISEK 231
Query: 419 RLSNTP------LSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQM 467
++S + ++ ++P + Q+ F
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFD--DKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (370), Expect = 1e-40
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNI 242
+IGRGG G VY G+ A+K L + + +G + + + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
V + + + + M G L L + A E GL ++H+
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT- 361
+++RD+K NILL+ ++D GLA + G++GY+APE
Sbjct: 128 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 180
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP 386
+ D +D +S G +L +L+ G P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-40
Identities = 56/296 (18%), Positives = 107/296 (36%), Gaps = 36/296 (12%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG+G G V++ G++VA+KK+L + EI+ L ++H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 247 AFCSNKETN--------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
C K + LV+++ + G + + L R+ + L+ L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAP 356
++ I+HRD+K+ N+L+ D +ADFGLA+ S + + Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 357 EYAYTLK-VDEKSDVYSFGVVLLELITGRRP----------------VGDFGEEGL-DIV 398
E + D++ G ++ E+ T G E ++
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 399 QWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ + +G + + RL +L + +R + +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA--QRIDSDDALN 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-40
Identities = 58/298 (19%), Positives = 101/298 (33%), Gaps = 34/298 (11%)
Query: 183 CVKDNN-----VIGRGGAGVVYRG--VTPNGEQVAVKKLLGITKGSSHDNGLSAEI---R 232
C D IG G G V++ + G VA+K++ T E+ R
Sbjct: 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN----GSLGEVLHGKRGSFLKWEMRLKIA 288
L H N+VRL C+ T+ + L L + E +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
+ +GL +LH ++HRD+K NIL+ S + +ADFGLA+ +++V
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVV 176
Query: 349 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--DIVQWTKMQTN 406
+ Y APE D++S G + E+ + + I+ +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 407 SSKEGVVKILDQRLSNTP----------LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
V + Q + + E + + L +R + +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA--KRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-39
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 32/290 (11%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+ IG G G+V N +VA+KK+ + L EI+ L + RH NI+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 72
Query: 247 AFCSNKETNLLVYEYMPNGSLG----EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
+ Y+ +G ++L + L + + +GL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH--- 126
Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAPEYAYT 361
S ++HRD+K +N+LLN+ + + DFGLA+ ++ + Y APE
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 362 LKVD-EKSDVYSFGVVLLELITGRRP----------------VGDFGEEGLDIVQWTKMQ 404
K + D++S G +L E+++ R +G +E L+ + K +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 405 TNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ ML H +R + + +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH--KRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-38
Identities = 56/276 (20%), Positives = 110/276 (39%), Gaps = 42/276 (15%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIR--HRN 241
++G GG G VY G+ + VA+K + + + + E+ L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
++RL + ++ +L+ E +RG+ L+ E+ + + + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 129
Query: 302 CSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEY-A 359
++HRD+K NIL++ + E + DFG L+DT + G+ Y PE+
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR 182
Query: 360 YTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419
Y + V+S G++L +++ G P E +I+ +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP----------------------FEHDEEIIRGQ 220
Query: 420 LSNTP-LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ +S Q L ++ +RPT E+
Sbjct: 221 VFFRQRVSSECQHLIRWCLALRPS--DRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-36
Identities = 52/201 (25%), Positives = 75/201 (37%), Gaps = 9/201 (4%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
++G+G G V G A+K L + E R L RH + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
K + V EY G L L R E E L + S
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSAL---EYLHSRD 125
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVD 365
+++RD+K N++L+ D + DFGL K GA+ G+ Y+APE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYG 183
Query: 366 EKSDVYSFGVVLLELITGRRP 386
D + GVV+ E++ GR P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-36
Identities = 59/283 (20%), Positives = 103/283 (36%), Gaps = 24/283 (8%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
IG G G V++ E VA+K++ + EI L +++H+NIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
+ + LV+E+ L E+ + KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDE 366
+HRD+K N+L+N + E +A+FGLA+ V +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYST 181
Query: 367 KSDVYSFGVVLLELITGRRPV--GDFGEEGLD-IVQWTKMQTNSSKEGVVKILDQRLSNT 423
D++S G + EL RP+ G+ ++ L I + T + K+ D +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 424 P------------LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
L+ + +L +R + E +Q
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPV--QRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-34
Identities = 69/290 (23%), Positives = 109/290 (37%), Gaps = 38/290 (13%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G G V V G +VA+KKL + E+R L +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 248 FCSNKETN------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+ ET LV +M + H K L + + + KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAA 140
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY- 360
IIHRD+K N+ +N D E + DFGLA+ M+ + Y APE
Sbjct: 141 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILN 192
Query: 361 TLKVDEKSDVYSFGVVLLELITGRRP----------------VGDFGEEGLDIVQWTKMQ 404
++ + D++S G ++ E+ITG+ G E + +Q + +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 405 TNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
++ D T S ML + +R T E +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE--QRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 8e-33
Identities = 44/203 (21%), Positives = 76/203 (37%), Gaps = 18/203 (8%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKIRHRNIV 243
+G G G V +G A+K + K E R L + +V
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
+L+ + +V EY+ G + L A + YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLK 363
+I+RD+K N+L++ V DFG AK ++ + G+ +APE +
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKG 214
Query: 364 VDEKSDVYSFGVVLLELITGRRP 386
++ D ++ GV++ E+ G P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-32
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 15/208 (7%)
Query: 188 NVIGRGGAGVVYRGV----TPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHR- 240
V+G G G V+ G+ A+K L I + + E + L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
+V L + L+ +Y+ G L L + + I + + L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEH 144
Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAY 360
II+RD+K NILL+S+ + DFGL+K +E G+ Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVR 203
Query: 361 TLK--VDEKSDVYSFGVVLLELITGRRP 386
D+ D +S GV++ EL+TG P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-31
Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 23/232 (9%)
Query: 160 KNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGIT 218
+ +++G+ D + V+ +GRG V+ + N E+V VK L
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVR---KLGRGKYSEVFEAINITNNEKVVVKILK--- 69
Query: 219 KGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNL--LVYEYMPNGSLGEVLHGKR 275
+ EI+ L +R NI+ L + + LV+E++ N ++
Sbjct: 70 --PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-- 125
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKY 334
L E K L Y H I+HRDVK +N++++ + + + D+GLA++
Sbjct: 126 ---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
E VA Y D D++S G +L +I + P
Sbjct: 180 YHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
IG G G+V VA+KKL + +H E+ + + H+NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 248 FCSNKETN------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+ ++T LV E M + E + + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
IIHRD+K +NI++ SD + DFGLA+ G S M+ + Y APE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP 386
+ E D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-30
Identities = 58/289 (20%), Positives = 110/289 (38%), Gaps = 34/289 (11%)
Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
+ +G G G V T G +VAVKKL + H E+R L ++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 247 AFCSNKET-----NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
+ + ++ + ++ L ++ ++ L + + + +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSA 140
Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYT 361
IIHRD+K +N+ +N D E + DFGLA++ D + +
Sbjct: 141 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 193
Query: 362 LKVDEKSDVYSFGVVLLELITGRRP----------------VGDFGEEGLDIVQWTKMQT 405
+ ++ D++S G ++ EL+TGR VG G E L + +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454
+ ++ + ML + +R T + +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD--KRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 2e-28
Identities = 42/214 (19%), Positives = 76/214 (35%), Gaps = 21/214 (9%)
Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
+G G V+ N VA+K + + EI+ L ++ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI---VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 248 FCSNKETNLLVY--EYMPNGSLGEV------------LHGKRGSFLKWEMRLKIAIEAAK 293
+N LL + PNG + + + +I+ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
GL Y+H C IIH D+K N+L+ D ++ +A E + +
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 353 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRP 386
Y +PE +D++S ++ ELITG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 7e-21
Identities = 29/163 (17%), Positives = 59/163 (36%), Gaps = 17/163 (10%)
Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKL-LGITKGSS-------HDNGLSAEIRTLGKIRH 239
++G G V+ + + VK +G T D S +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
R + +L+ K Y + N L E++ K ++ E ++ + ++ +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
H I+H D+ N+L+ S+ + DF + + + G E
Sbjct: 121 HRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE 159
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.0 bits (193), Expect = 6e-17
Identities = 24/66 (36%), Positives = 38/66 (57%)
Query: 45 NYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCG 104
N L++ N++ +LP+ + +K L S + S NN GEIP+ G F+ +++ N LCG
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 105 SYLNPC 110
S L C
Sbjct: 307 SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 37.4 bits (85), Expect = 0.003
Identities = 30/129 (23%), Positives = 57/129 (44%), Gaps = 4/129 (3%)
Query: 1 MSRNNFSGI--IPVEIGHCLLLTYLDLSQNH-LSGPIPVQITQIHILNYLNVSWNQLNAS 57
+S N IP + + L +L + + L GPIP I ++ L+YL ++ ++ +
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 58 LPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTT 116
+P + +K+L + DFS+N SG +P +F GN + ++S
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 117 PIHNQNGNK 125
+ N+
Sbjct: 177 TSMTISRNR 185
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 3e-09
Identities = 16/76 (21%), Positives = 31/76 (40%), Gaps = 6/76 (7%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ NN S I P + L L + N +S + + +N+L+ NQ++ P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWLSAGHNQISDLTP- 368
Query: 61 EMGNMKSLTSADFSHN 76
+ N+ +T +
Sbjct: 369 -LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.8 bits (133), Expect = 4e-09
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 4/68 (5%)
Query: 16 HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSH 75
+ LTYL L N++S P ++ + L L + N++ S + N+ ++ H
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGH 360
Query: 76 NNFSGEIP 83
N S P
Sbjct: 361 NQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 23/122 (18%), Positives = 42/122 (34%), Gaps = 7/122 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N S I P+ I L L L+ N L + + L L+++ NQ++ P
Sbjct: 204 ATNNQISDITPLGILTNL--DELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP- 258
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
+ + LT N S I + + N S ++ + ++
Sbjct: 259 -LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 121 QN 122
N
Sbjct: 317 NN 318
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.8 bits (120), Expect = 1e-07
Identities = 16/117 (13%), Positives = 32/117 (27%), Gaps = 2/117 (1%)
Query: 10 IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT 69
+P ++ LDL N ++ + L+ L + N+++ P + L
Sbjct: 25 VPKDLPPDT--ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 70 SADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKS 126
S N + + + S N N + S
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 19/129 (14%), Positives = 34/129 (26%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N + I + + L L L N +S P + L L +S NQL K
Sbjct: 38 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
++ L + + + I
Sbjct: 98 MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157
Query: 121 QNGNKSHVP 129
+ N + +P
Sbjct: 158 ADTNITTIP 166
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 22/183 (12%), Positives = 56/183 (30%), Gaps = 8/183 (4%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDL--SQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
+ N + + + ++L + SG + L+Y+ ++ + ++
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165
Query: 59 PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTP- 117
P+ G SLT N + + + + +
Sbjct: 166 PQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 223
Query: 118 IHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGS 177
+H N VPG + ++ L ++ I + F + K ++ + S
Sbjct: 224 LHLNNNKLVKVPGGLADHKYIQVV--YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 178 DDI 180
+ +
Sbjct: 282 NPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 27/142 (19%), Positives = 41/142 (28%), Gaps = 32/142 (22%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVS---------- 50
++ N + I G LT L L N ++ + ++ L L +S
Sbjct: 157 IADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213
Query: 51 ----------WNQLNASL---PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
+ N L P + + K + +NN S G F T
Sbjct: 214 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS----AIGSNDFCPPGYNT 269
Query: 98 GNPHLCGSYL--NPCNYSSTTP 117
G L NP Y P
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQP 291
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 1e-06
Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
N S I L L++S N L +P + L L S+N L +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEF 85
N+K L +N E P+
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 5e-04
Identities = 18/102 (17%), Positives = 29/102 (28%), Gaps = 10/102 (9%)
Query: 13 EIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTS 70
+ CL L+L+ LS +P L L S N L LP+ + L S
Sbjct: 31 RLRDCLDRQAHELELNNLGLSS-LPELPPH---LESLVASCNSLT-ELPELPQS---LKS 82
Query: 71 ADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNY 112
+NN + ++ +
Sbjct: 83 LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKI 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 3e-05
Identities = 17/103 (16%), Positives = 35/103 (33%), Gaps = 24/103 (23%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV---------------------QIT 39
++ + + + + LL+T+LDLS N L P +
Sbjct: 5 LAHKDLTVLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 40 QIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNFSGE 81
+ L L + N+L + + + + L + N+ E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 16/105 (15%), Positives = 36/105 (34%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ N S + L L L QN ++ P + L L + N L+A +
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGS 105
+ +++L + N + + +++ + + C
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 4/80 (5%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ NN S + + L YL L+ N L S +++ SLP+
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ 266
Query: 61 EMGNMKSLTSADFSHNNFSG 80
+ + N+ G
Sbjct: 267 RLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 2e-04
Identities = 17/115 (14%), Positives = 31/115 (26%), Gaps = 1/115 (0%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ R + P L YL L N L + L +L + N++++ +
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 61 EMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLCGSYLNPCNYSS 114
+ SL N + P F + N +
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 0.002
Identities = 21/117 (17%), Positives = 31/117 (26%), Gaps = 10/117 (8%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+ P L L L + L P + L YL + N L A
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTP 117
++ +LT N S +F G L L+ + P
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPER----------AFRGLHSLDRLLLHQNRVAHVHP 194
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 16/129 (12%), Positives = 39/129 (30%), Gaps = 3/129 (2%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLP 59
R+ + E + ++DLS + + + ++Q L L++ +L+ +
Sbjct: 30 CPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 88
Query: 60 KEMGNMKSLTSADFSHN-NFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI 118
+ +L + S FS + S + + + +
Sbjct: 89 NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 148
Query: 119 HNQNGNKSH 127
N S
Sbjct: 149 TITQLNLSG 157
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.002
Identities = 8/66 (12%), Positives = 23/66 (34%), Gaps = 2/66 (3%)
Query: 19 LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF 78
L LDL+ +L + ++ ++ + ++ L + + + D S++
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI 58
Query: 79 SGEIPE 84
Sbjct: 59 EVSTLH 64
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 1e-04
Identities = 7/70 (10%), Positives = 17/70 (24%), Gaps = 5/70 (7%)
Query: 20 LTYLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLN----ASLPKEMGNMKSLTSADFS 74
+ LD+ LS + + + + L + + +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 75 HNNFSGEIPE 84
N
Sbjct: 64 SNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 2e-04
Identities = 13/79 (16%), Positives = 26/79 (32%), Gaps = 9/79 (11%)
Query: 16 HCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNASLPKEMG-----NMK 66
+L L L+ +S + + H L L++S N L + ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 67 SLTSADFSHNNFSGEIPEF 85
L +S E+ +
Sbjct: 427 LLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (84), Expect = 0.004
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 9/75 (12%)
Query: 1 MSRNNFSGIIPVEIGHCLL----LTYLDLSQNHLSGPIPVQITQI-----HILNYLNVSW 51
++ + S + LL L LDLS N L +Q+ + +L L +
Sbjct: 376 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 435
Query: 52 NQLNASLPKEMGNMK 66
+ + + ++
Sbjct: 436 IYWSEEMEDRLQALE 450
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 5e-04
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 2/89 (2%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVSWNQLNASLP 59
R++ + + + + L L+LS N L + + + L LN+S N+L +
Sbjct: 49 RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108
Query: 60 KEMGNMKSLTSADFSHNNFSGEIPEFGQY 88
+ L N+ S + Y
Sbjct: 109 LDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.002
Identities = 20/109 (18%), Positives = 32/109 (29%), Gaps = 2/109 (1%)
Query: 2 SRNNFSGIIPVEIGHCLLLTYLDLS-QNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
+R+ + LT L + Q HL + + L L + + L P
Sbjct: 16 TRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNP 109
L+ + S N + Q +GNP C L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 12/53 (22%), Positives = 19/53 (35%), Gaps = 5/53 (9%)
Query: 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ 53
N S I P + L + L N +S P + L + ++ NQ
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.65 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.41 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.39 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.36 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.32 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.3 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.29 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.23 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.12 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.1 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.0 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.89 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.81 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.81 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.68 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.67 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.53 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.45 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.36 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.29 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.03 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.49 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.31 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.31 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.14 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.04 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.15 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.89 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.53 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.85 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.42 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-56 Score=415.24 Aligned_cols=263 Identities=29% Similarity=0.403 Sum_probs=206.2
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||+||+|+++ ..||||+++.........+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 456788899999999999999875 359999987655555566789999999999999999999998754 56899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.++++.. ...+++..+..++.|||+||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999743 345999999999999999999999877 99999999999999999999999999987764444
Q ss_pred CccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 341 SECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+..... ..... ... ....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~-~~~------~~~~ 228 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFM-VGR------GYLS 228 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHH-HHH------TSCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHH-Hhc------CCCC
Confidence 444566789999999999864 358999999999999999999999997643211 11010 000 0111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
+.+...+......+.+++.+||+.||++||||+||++.|+.+..
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122233445678889999999999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=410.38 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=199.8
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
++|+..+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 356778899999999999999998999999998642 23346799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++... ...++|..+++++.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.... .
T Consensus 82 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~ 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 156 (263)
T ss_dssp CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred cCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-c
Confidence 9999999998743 346899999999999999999999887 9999999999999999999999999998775332 2
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......||+.|+|||++.+..++.++|||||||++|||+|+ ++||.... ..+..... .....
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~i-----------~~~~~ 220 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDI-----------STGFR 220 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHHH-----------HHTCC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHHH-----------HhcCC
Confidence 223446789999999999999999999999999999999995 55554322 11111111 11111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
...+.....++.+++..||+.||++||||+||++.|+++.
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1223334567889999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=409.81 Aligned_cols=257 Identities=27% Similarity=0.366 Sum_probs=208.9
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 46778889999999999999999888999999986432 334679999999999999999999998854 56799999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.......++|..+++++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+... .
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-c
Confidence 999999999887655556999999999999999999999877 999999999999999999999999999987532 2
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
........||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+.. ..+.....
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~-----------~~i~~~~~ 228 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVI-----------QNLERGYR 228 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHH-----------HHHHTTCC
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHH-----------HHHHhcCC
Confidence 2334456789999999999988999999999999999999996555433111 11111 11111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
...+......+.+++.+||+.||++||||+||+++|+++-
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2223334567888999999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-55 Score=411.24 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=215.9
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++++|.+.+..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 456778899999999999999985 5888999998643 233467999999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.......+++..+..++.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 168 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence 9999999999998766678999999999999999999999887 999999999999999999999999999876532
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.........|++.|+|||++.+..++.++|||||||++|||++|..|+.... +... +.+.+...
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~------------~~~~i~~~ 232 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQ------------VYELLEKD 232 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHH------------HHHHHHTT
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHH------------HHHHHhcC
Confidence 2333344568999999999999999999999999999999999776654311 1111 11111111
Q ss_pred C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCc
Q 012213 420 L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTF 465 (468)
Q Consensus 420 ~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 465 (468)
. ...+......+.+++..||+.||++||||+||++.|+.+...+.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~ 279 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence 1 222334456788999999999999999999999999998665543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-54 Score=411.78 Aligned_cols=263 Identities=27% Similarity=0.461 Sum_probs=200.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-Cc---EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GE---QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||+||+|.++. ++ .||||++.... .....+.|.+|++++++++|||||+++|+|.+++..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 4567788999999999999998753 32 58888875332 2233457999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ...++|.++.+++.|||+||+|||+.+ |+||||||+|||++.++++||+|||+++.+.
T Consensus 104 iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999988743 345899999999999999999999877 9999999999999999999999999998775
Q ss_pred ccCCCc---cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 337 DTGASE---CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 337 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
...... ......||+.|+|||.+.+..++.++|||||||++|||+| |++||.+.... .+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~------------- 244 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVIN------------- 244 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH-------------
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHH-------------
Confidence 332221 1223457899999999999999999999999999999998 89999763311 1111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc-cCCCC
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA-QKPNT 464 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~-~~~~~ 464 (468)
.+........+.+....+.+++.+||+.||++||||.||++.|+++ +.++.
T Consensus 245 -~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 245 -AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence 1111111223344566788999999999999999999999999886 44443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=402.33 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=204.7
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.++ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 467888999999999999999984 689999999864332 222356899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 Ey~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 83 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999964 346999999999999999999999887 9999999999999999999999999999876444
Q ss_pred CCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
........+||+.|+|||++.+..+ +.++|||||||++|||+||++||............+ .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~~~---------- 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKT---------- 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTTCT----------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCCC----------
Confidence 4444556789999999999988776 578999999999999999999997633221111111 00000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...........+.+++.+|++.||++|||++|+++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111223456778999999999999999999965
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=398.51 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=212.0
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4677889999999999999999888899999987432 2346799999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.+++... ...+++..+.+++.|||+||+|||+.+ |+||||||+||++++++.+||+|||+++.+... ..
T Consensus 81 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~ 155 (258)
T d1k2pa_ 81 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EY 155 (258)
T ss_dssp CTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SC
T ss_pred cCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC-Cc
Confidence 9999999997643 345889999999999999999999887 999999999999999999999999999876533 22
Q ss_pred ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 342 ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.. ..+.....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~-----------~~i~~~~~ 219 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETA-----------EHIAQGLR 219 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHH-----------HHHHTTCC
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHH-----------HHHHhCCC
Confidence 23345678999999999999999999999999999999998 89999764321 111 11111111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
...+......+.+++.+||+.||++|||++||++.|.++
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 223334456788999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=404.49 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=196.4
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--CCeeEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLL 257 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 257 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|++++++++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 35688889999999999999987 468999999987654444444678999999999999999999999865 445789
Q ss_pred EEeccCCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 258 VYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 3456999999999999999999999864 2459999999999999999999999999999
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
.+... ........||+.|+|||++.+..++.++|||||||++|||+||++||.+.+. .+. ..
T Consensus 163 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~-----------~~ 224 (269)
T d2java1 163 ILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KEL-----------AG 224 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHH-----------HH
T ss_pred ecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHH-----------HH
Confidence 87532 2223457899999999999999999999999999999999999999975321 111 11
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.+........+.....++.+++.+||+.||++|||++|+++
T Consensus 225 ~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122222233344567888999999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=401.05 Aligned_cols=263 Identities=28% Similarity=0.363 Sum_probs=207.5
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
.++|+..+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 46788899999999999999999988899999986432 234679999999999999999999999854 56899999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++.......++|.+++.++.|||.||+|||+.+ |+||||||+|||+++++++||+|||+++.+... .
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-E 167 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC-C
Confidence 999999999987666667999999999999999999999887 999999999999999999999999999876532 2
Q ss_pred CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccC
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRL 420 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 420 (468)
........||+.|+|||++....++.++|||||||++|||+||..|+.... ...+...... ....
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~~~~~~~~i~-----------~~~~ 232 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVE-----------RGYR 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHH-----------TTCC
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----CHHHHHHHHH-----------hcCC
Confidence 233345678999999999999999999999999999999999766654322 1111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCcc
Q 012213 421 SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466 (468)
Q Consensus 421 ~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 466 (468)
...+.....++.+++.+||+.||++||||++|+++|++.......+
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 1223344567889999999999999999999999999876544443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=395.67 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=205.1
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|+++ +++.||+|++..... .......+.+|+.++++++|||||++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 456888899999999999999985 688999999864321 223346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999643 35899999999999999999999887 999999999999999999999999999865422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.+... .+... .+...
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~-----------~i~~~ 219 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYK-----------RISRV 219 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH-----------HHHTT
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHH-----------HHHcC
Confidence 23456799999999999999999999999999999999999999965321 11111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ...+......+.+++.+|++.||++|||++|+++
T Consensus 220 ~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 E-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 1122233456778999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=400.14 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=199.9
Q ss_pred ceEcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEeccCC
Q 012213 188 NVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 264 (468)
+.||+|+||+||+|.++ .++.||||+++.........++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 34679999997554444445679999999999999999999999965 457899999999
Q ss_pred CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC-cc
Q 012213 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-EC 343 (468)
Q Consensus 265 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~ 343 (468)
|+|.+++... ..+++.++++++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999743 35999999999999999999999877 999999999999999999999999999876533222 22
Q ss_pred ccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccccCCC
Q 012213 344 MSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQRLSN 422 (468)
Q Consensus 344 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 422 (468)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... ++.. .+.......
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~--------------~i~~~~~~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA--------------MLEKGERMG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH--------------HHHTTCCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHH--------------HHHcCCCCC
Confidence 334578999999999999999999999999999999998 89999763311 1111 111111222
Q ss_pred CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 423 TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 423 ~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.+...+.++.+++.+||+.||++||||+||+++|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 3334556788999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=399.63 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=205.7
Q ss_pred hccCCcce-EcccCCcceEEEEcC---CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 182 ECVKDNNV-IGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 182 ~~~~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+++...+. ||+|+||+||+|.++ ++..||||+++... .....++|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 34555564 999999999999864 35579999986432 22334679999999999999999999999875 46799
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
||||+++|+|.+++... ...+++..+.+++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999998643 346899999999999999999999877 99999999999999999999999999997754
Q ss_pred cCCC-ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 338 TGAS-ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 338 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ++.. .+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~--------------~i 225 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA--------------FI 225 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHH--------------HH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHH--------------HH
Confidence 3222 22234568999999999999999999999999999999998 99999764321 1111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
........+...+..+.+++..||+.||++||||.+|++.|+..
T Consensus 226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112223344556788999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=397.32 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=206.3
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 46789999999999999999997 46899999998644332 2367899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999988643 4899999999999999999999887 9999999999999999999999999998765322
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.... +......... ...
T Consensus 171 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~--------~~~ 235 (293)
T d1yhwa1 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNG--------TPE 235 (293)
T ss_dssp --CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHC--------SCC
T ss_pred --ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCC--------CCC
Confidence 2335567999999999999999999999999999999999999999653211 1111000000 000
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...+......+.+++.+|++.||++|||+.|+++
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112234566788999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=407.36 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=208.3
Q ss_pred hhccCCcceEcccCCcceEEEEcCCC------cEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNG------EQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||+||+|.+... ..||||++..... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 35678889999999999999987432 3699998865433 23336789999999988 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRG---------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 312 (468)
..++||||+++|+|.++++.... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999975432 35899999999999999999999877 9999999
Q ss_pred CCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 012213 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFG 391 (468)
Q Consensus 313 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 391 (468)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999988765444444456678999999999999999999999999999999998 899997643
Q ss_pred CCCcCHHHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 012213 392 EEGLDIVQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLA 457 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~ 457 (468)
... .+. +++.... ...+......+.+++.+||+.||++||||+||++.|.
T Consensus 272 ~~~-~~~---------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA-NFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH-HHH---------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-HHH---------------HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 111 1111111 1223344567889999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=397.92 Aligned_cols=260 Identities=28% Similarity=0.401 Sum_probs=201.1
Q ss_pred hhccCCcceEcccCCcceEEEEcCCC-----cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNG-----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++|+..++||+|+||+||+|.++.+ ..||||++.... ......+|.+|+.++++++|||||+++|++.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 34577889999999999999987542 369999986432 223335689999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++||||+++|++.+++... ...++|.++.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999987643 346999999999999999999999877 999999999999999999999999999877
Q ss_pred cccCC-CccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGA-SECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
..... ........||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+. ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~-----------~~~ 225 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEV-----------MKA 225 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH-----------HHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHH-----------HHH
Confidence 53322 2223345689999999999999999999999999999999996655543111 1111 111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+.+......+...+..+.+++.+||+.||++||||.||+++|+++.
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1122222334445677889999999999999999999999998863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=396.76 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=203.5
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
+.|+..+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 45777889999999999999974 68899999986432 3334678999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+++|+|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-- 163 (288)
T d2jfla1 90 FCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 163 (288)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence 99999999987643 345899999999999999999999887 999999999999999999999999999765422
Q ss_pred CccccccccCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 341 SECMSAVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
........||+.|+|||++. ...++.++|||||||++|||+||+.||.+..... .. .++
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~--------------~~i 227 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL--------------LKI 227 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH--------------HHH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH--------------HHH
Confidence 12234567999999999873 4568999999999999999999999997643211 11 111
Q ss_pred cccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQR--LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~--~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... ....+......+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 11122334567888999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-53 Score=400.17 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=212.2
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||+||+|.++ +++.||||++.... .....++|.+|+.++++++||||++++++|.+.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 567888999999999999999863 45789999986432 22334679999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR----------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 312 (468)
.+++|||+++|+|.+++.... ...+++..++.++.|+|.||+|||+.+ |+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999986422 224899999999999999999999877 9999999
Q ss_pred CCcEEEcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCC
Q 012213 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR-RPVGDFG 391 (468)
Q Consensus 313 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~ 391 (468)
|+|||++.++.+||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||++|. +||.+..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998776444444445677899999999999999999999999999999999985 6776532
Q ss_pred CCCcCHHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 392 EEGLDIVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.. + ....+.+......+...+.++.+++..||+.+|++||||.||+++|+++.
T Consensus 248 ~~-----e-----------~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE-----E-----------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH-----H-----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH-----H-----------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 1 11122222223334445567889999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=396.82 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=203.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 35688899999999999999998 4689999999864321 223346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999998643 35899999999999999999999887 999999999999999999999999999987644
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
..........||+.|+|||++.+..++.++|||||||++|||+||+.||...+. .+-. .++...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~-----------~~i~~~ 225 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIF-----------QKIIKL 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-----------HHHHTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHH-----------HHHHcC
Confidence 444444567899999999999999999999999999999999999999975321 1100 111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..+......+.+++.+|++.||++|||++|++.
T Consensus 226 ~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 EY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CC-CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11 122233456788999999999999999998643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=388.06 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=200.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 259 (468)
.++|+..+.||+|+||.||+|.++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ ++..++||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 456777899999999999999984 789999998532 233679999999999999999999999865 45679999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccC
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 339 (468)
||+++|+|.+++.......++|..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999997655456899999999999999999999877 999999999999999999999999999865422
Q ss_pred CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 340 ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 340 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....+|..|+|||++.+..+++++||||||+++|||+| |++||...... ++..+. ...
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i--------------~~~ 216 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV--------------EKG 216 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH--------------TTT
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH--------------HcC
Confidence 234467899999999999999999999999999999998 78887653221 222221 111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
.....+.....++.+++.+||+.||++||||.|++++|++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1222333445678899999999999999999999999998763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=386.51 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=195.8
Q ss_pred cCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec----CCeeEEE
Q 012213 184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLV 258 (468)
Q Consensus 184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 258 (468)
++..+.||+|+||+||+|.+. +++.||+|++..........+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 345568999999999999985 58899999987654444445678999999999999999999999865 3457899
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCceEEeeccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~ 337 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999643 35899999999999999999999653 3499999999999997 478999999999986432
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILD 417 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 417 (468)
.......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+... ............ .
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~~~--------~ 230 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGV--------K 230 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTC--------C
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHcCC--------C
Confidence 22345689999999998865 699999999999999999999999975321 111111111000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 418 QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ ...+.....++.+++.+|++.||++|||++|+++
T Consensus 231 ~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 P--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp C--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 0011112345778999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-52 Score=393.52 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=191.3
Q ss_pred chhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+++.+.|+..+.||+|+||+||+|.++ +|+.||||++....... ....+.+|+.++++++|||||++++++.+++..+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456677899999999999999999985 68899999986543322 2356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCceEEeeccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAK 333 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~ 333 (468)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++. +++.+||+|||+|+
T Consensus 84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999999643 45999999999999999999999887 99999999999995 57899999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||+||++||.+.... .+ +... ....
T Consensus 159 ~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~--~~~i-~~~~----- 225 (307)
T d1a06a_ 159 MEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KL--FEQI-LKAE----- 225 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH--HHHH-HTTC-----
T ss_pred EccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HH--HHHH-hccC-----
Confidence 65422 2234567999999999999999999999999999999999999999753211 11 1111 0000
Q ss_pred hhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
... ..........+.+++.+|++.||++|||++|+++
T Consensus 226 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 1111233456788999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=397.32 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=205.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 259 (468)
.++|+..+.||+|+||+||+|.+. +|+.||+|+++... ......++.+|+.++++++|||||+++++|.+++..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457888899999999999999974 68999999986533 2333467899999999999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999999643 3589999999999999999999974 6 999999999999999999999999999876532
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhh----------ccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT----------NSS 408 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~ 408 (468)
. ....+||+.|+|||++.+..++.++||||+||++|||+||+.||...+.............. ...
T Consensus 159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 23568999999999999999999999999999999999999999763322110000000000 000
Q ss_pred ------------c----cchhhhccccCCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHh
Q 012213 409 ------------K----EGVVKILDQRLSNTP-LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQ 458 (468)
Q Consensus 409 ------------~----~~~~~~~d~~~~~~~-~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~ 458 (468)
. +.............+ .....++.+++.+|++.||++|||++|+++ .+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 000000000000111 112356788999999999999999999987 4543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-52 Score=392.86 Aligned_cols=249 Identities=28% Similarity=0.340 Sum_probs=201.6
Q ss_pred hhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
+..+.|+..+.||+|+||+||+|.+ .+|+.||||++....... ...+.+.+|+.++++++|||||++++++.+++..+
T Consensus 12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 4456688889999999999999987 468889999986543322 22356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|..++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999999998766433 45899999999999999999999887 9999999999999999999999999998654
Q ss_pred ccCCCccccccccCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
. .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+... ...+..
T Consensus 167 ~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~----------- 225 (309)
T d1u5ra_ 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYH----------- 225 (309)
T ss_dssp S------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHH-----------
T ss_pred C------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHH-----------
Confidence 2 234579999999999854 4689999999999999999999999975321 111111
Q ss_pred hhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+..... ...+......+.+++.+||+.||++|||++|+++
T Consensus 226 -i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 -IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 1111223456888999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=385.42 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=197.8
Q ss_pred hhccCCcceEcccCCcceEEEEcCC----CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||.||+|.+.. +..||||++..... ....+.+.+|+.++++++|||||++++++. .+..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4578888999999999999998743 34688888754322 223457899999999999999999999986 46789
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999987643 346899999999999999999999887 9999999999999999999999999998765
Q ss_pred ccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 337 DTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 337 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.. .........||+.|+|||.+.+..++.++|||||||++|||+| |.+||...... .+. ..+
T Consensus 160 ~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~--------------~~i 222 (273)
T d1mp8a_ 160 DS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVI--------------GRI 222 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH--------------HHH
T ss_pred CC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHH--------------HHH
Confidence 32 2223345678999999999999999999999999999999998 89999764321 111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 416 LDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 416 ~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
........+...+..+.+++..||+.||++|||++||++.|+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1222222333455678899999999999999999999999988743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=392.70 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=201.9
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCc----EEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
.|+..+.||+|+||+||+|.+. +|+ +||||++.... .....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4778899999999999999874 343 58999886432 233446799999999999999999999999875 5678
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 337 (468)
++||+.+|+|.+++... ...+++..+++++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 88999999999988743 456899999999999999999999877 99999999999999999999999999998764
Q ss_pred cCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhhhc
Q 012213 338 TGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKIL 416 (468)
Q Consensus 338 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (468)
...........||+.|+|||++.+..++.++|||||||++|||+| |++||.+.... .+.... .
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i--------------~ 227 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL--------------E 227 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHH--------------H
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH--------------H
Confidence 444434445678999999999999999999999999999999999 89998764321 111111 1
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 417 DQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 417 d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.......+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11112233445567889999999999999999999999988763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-51 Score=396.21 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=206.9
Q ss_pred cchhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 177 SDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.+++.++|+..+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345678899999999999999999997 468999999986432 22336788999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCceEEeeccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--DFEAHVADFGLAK 333 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~ 333 (468)
++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 9999999999999998643 345999999999999999999999888 999999999999964 5789999999998
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
.+... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+. .+.......... ..
T Consensus 175 ~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~-~~- 244 (350)
T d1koaa2 175 HLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVKSCDW-NM- 244 (350)
T ss_dssp ECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC-CS-
T ss_pred ecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC-CC-
Confidence 76532 233456799999999999999999999999999999999999999975321 111111110000 00
Q ss_pred hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 414 KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 414 ~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ..........+.+++.+|++.||++|||++|+++
T Consensus 245 ---~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 ---D---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---C---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---C---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011123456788999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=385.96 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=203.1
Q ss_pred cceEcccCCcceEEEEcCCC----cEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec-CCeeEEEEec
Q 012213 187 NNVIGRGGAGVVYRGVTPNG----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVYEY 261 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 261 (468)
.++||+|+||+||+|.+.++ ..||||++.... .....++|.+|++++++++||||++++|++.+ +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 47899999999999997542 258999986432 23334679999999999999999999999875 5578999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+++|+|.++++. ....+++..+++++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 111 ~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 111 MKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred eecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999874 3445788999999999999999999877 999999999999999999999999999876533222
Q ss_pred --ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhcccc
Q 012213 342 --ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQR 419 (468)
Q Consensus 342 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 419 (468)
.......||+.|+|||.+.+..++.++||||||+++|||+||..||...... .++..+ +....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~--------------i~~g~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVY--------------LLQGR 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH--------------HHTTC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHH--------------HHcCC
Confidence 2233457899999999999999999999999999999999988887542211 111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCC
Q 012213 420 LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKP 462 (468)
Q Consensus 420 ~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 462 (468)
....+......+.+++.+||+.||++||+|.||++.|+++...
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1222233456788899999999999999999999999988644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=379.56 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=206.2
Q ss_pred chhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCCCCCccceeEEEecC
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK 252 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 252 (468)
+++.+.|+..+.||+|+||+||+|.+ .+|+.||||++....... ...+.+.+|+.++++++|||||++++++.++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 44567789999999999999999998 468999999986543322 2346789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----ceEEee
Q 012213 253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVAD 328 (468)
Q Consensus 253 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 328 (468)
+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+|++|
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred CEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999999643 35999999999999999999999887 99999999999998876 499999
Q ss_pred ccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 329 FGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 329 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
||++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.... ..+... ....
T Consensus 161 fG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i-~~~~ 232 (293)
T d1jksa_ 161 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANV-SAVN 232 (293)
T ss_dssp CTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH-HTTC
T ss_pred hhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----HHHHHH-HhcC
Confidence 9999876532 2234567899999999999999999999999999999999999999753211 001111 0000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
. ..... .+......+.+++.+|++.||++|||++|+++
T Consensus 233 ~-~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y-EFEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-CCCHH-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CCCch-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 00112356778999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-51 Score=393.31 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=206.8
Q ss_pred chhhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
..+.+.|+..+.||+|+||+||+|.+ .+|+.||||++.... ......+.+|+.++++++|||||++++++.+++..+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34567799999999999999999997 469999999986432 222356889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCceEEeecccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--SDFEAHVADFGLAKY 334 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~ 334 (468)
+||||+++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 103 ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 103 LILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence 99999999999988753 3446999999999999999999999888 99999999999998 578999999999987
Q ss_pred ccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 335 LQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
+... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.... .... .. ...
T Consensus 179 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~--~i-~~~------- 243 (352)
T d1koba_ 179 LNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQ--NV-KRC------- 243 (352)
T ss_dssp CCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH--HH-HHC-------
T ss_pred cCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHH--HH-HhC-------
Confidence 7532 2234567899999999999999999999999999999999999999753211 1110 10 000
Q ss_pred hccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 415 ILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 415 ~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+... ..........+.+++.+|++.||++|||++|+++
T Consensus 244 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 244 --DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001 1111234456788999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=383.79 Aligned_cols=259 Identities=26% Similarity=0.367 Sum_probs=196.9
Q ss_pred hccCCcceEcccCCcceEEEEcC--CC--cEEEEEEecccCCC-CCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP--NG--EQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 256 (468)
++|+..+.||+|+||.||+|.+. ++ ..||||++...... ....+.|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45778889999999999999863 22 36899988654332 2334679999999999999999999999976 4678
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 336 (468)
+||||+++|++.+++... ...+++..+++++.|||.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999988643 345999999999999999999999877 9999999999999999999999999999875
Q ss_pred ccCCCc-cccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 337 DTGASE-CMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 337 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
...... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+.. ....+. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i---~~~~------ 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKI---DKEG------ 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH---HTSC------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHH---HhCC------
Confidence 433322 2234567889999999999999999999999999999998 89999753311 111111 1110
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.....+...+..+.+++.+||+.||++||||+||.++|++++
T Consensus 232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 011222334467889999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=388.49 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=215.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCe
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET 254 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 254 (468)
.++|+..+.||+|+||+||+|.++ +++.||||+++... .......|.+|+.++++++||||++++++|...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 467788899999999999999873 35789999986432 22233568999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 012213 255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326 (468)
Q Consensus 255 ~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 326 (468)
.++||||+++|+|.+++.... ...+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999986422 235789999999999999999999877 999999999999999999999
Q ss_pred eeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcCHHHHHHHhh
Q 012213 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 327 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+|| ++||.+.. ..++
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----~~~~----- 244 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQV----- 244 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHH-----
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----HHHH-----
Confidence 999999987654444444556789999999999999999999999999999999998 47775432 1111
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCC
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPN 463 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 463 (468)
...+.+......+......+.+++.+||+.+|++||||+||+++|++...+.
T Consensus 245 ------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 245 ------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ------HHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1222233333334445567899999999999999999999999999876554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=384.88 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=198.8
Q ss_pred hhccCCcceEcccCCcceEEEEcC------CCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||.||+|.+. +++.||||+++.... ......+..|+..+.++ +|+||+.+++++...+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 456888899999999999999863 346899999864322 22235677788877776 6899999999987654
Q ss_pred -eeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 012213 254 -TNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318 (468)
Q Consensus 254 -~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 318 (468)
..++||||+++|+|.++++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 5799999999999999996542 235899999999999999999999877 9999999999999
Q ss_pred cCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcCH
Q 012213 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RRPVGDFGEEGLDI 397 (468)
Q Consensus 319 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~ 397 (468)
++++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+|| .+||....... .+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999999999877644444445567899999999999999999999999999999999996 56776533211 11
Q ss_pred HHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 398 VQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
.... .+......+.....++.+++.+||+.||++|||++||++.|+++-
T Consensus 247 ~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 CRRL--------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHH--------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH--------------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1110 011112223334567889999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=383.74 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=207.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCC--------CcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 251 (468)
.+.|+..+.||+|+||.||+|+... +..||||+++.... .....++.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4677888999999999999998632 34799999864322 22336688898888888 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
++..++||||+++|+|.+++.... ...+++.++++++.||+.||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999997543 235899999999999999999999887 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.+||+|||+++...............||+.|+|||.+.+..+++++||||||+++|||+| |++||.+.... .
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--H
Confidence 99999999999999998875555555566789999999999999999999999999999999998 78888653311 1
Q ss_pred HHHHHHHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+..+ +.+......+......+.+++.+||+.||++|||+.||+++|+++.
T Consensus 246 ~~~~--------------i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LFKL--------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHH--------------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH--------------HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1111 1111112223334567889999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=383.75 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=204.7
Q ss_pred hhccCCcceEcccCCcceEEEEcCC-Cc--EEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCCeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTPN-GE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 256 (468)
.++|+..+.||+|+||+||+|.+++ |. .||||++...... ...+.|.+|+++++++ +|||||+++|+|.+++..+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 4567788999999999999999854 33 4788887543322 2335799999999998 7999999999999999999
Q ss_pred EEEeccCCCChhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 012213 257 LVYEYMPNGSLGEVLHGK--------------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 322 (468)
+||||+++|+|.++++.. ....+++..+++++.|||.||.|||+.+ |+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCC
Confidence 999999999999999643 2357999999999999999999999877 99999999999999999
Q ss_pred ceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCcCHHHHH
Q 012213 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR-RPVGDFGEEGLDIVQWT 401 (468)
Q Consensus 323 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~~~~~~~ 401 (468)
.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+ ..+..
T Consensus 165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELY 236 (309)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHH
T ss_pred ceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHH
Confidence 99999999998654222 223456899999999999999999999999999999999965 5665432 11111
Q ss_pred HHhhcccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccC
Q 012213 402 KMQTNSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQK 461 (468)
Q Consensus 402 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 461 (468)
..+........+......+.+++.+||+.||++||||+||++.|+++..
T Consensus 237 -----------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 -----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -----------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111222334455678899999999999999999999999988753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=386.07 Aligned_cols=271 Identities=27% Similarity=0.328 Sum_probs=202.3
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC----eeEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNLL 257 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 257 (468)
+.+...+.||+|+||+||+|++ +|+.||||++.... .....++.|+..+..++||||++++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4556678899999999999987 68999999985322 11122344555667789999999999997654 5789
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCceEEeecccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSNNILLNSDFEAHVADFGLA 332 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 332 (468)
||||+++|+|.++++.. .++|..+++++.++|.||+|||..+ .++|+||||||+|||++.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999753 4899999999999999999999641 345999999999999999999999999999
Q ss_pred ccccccCCC--ccccccccCccccCccccCCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc---------
Q 012213 333 KYLQDTGAS--ECMSAVAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--------- 395 (468)
Q Consensus 333 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--------- 395 (468)
+.+...... .......||+.|+|||++.... ++.++|||||||++|||+||..|+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 887543322 1234567999999999987542 67899999999999999999988754221111
Q ss_pred -CHHHHHHHhhcccccchhhhccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhccCCCCcc
Q 012213 396 -DIVQWTKMQTNSSKEGVVKILDQRLSN--TPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQKPNTFQ 466 (468)
Q Consensus 396 -~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 466 (468)
......... . ....++.+.. ...+....+.+++.+||+.||++||||.||++.|+++...+..+
T Consensus 236 ~~~~~~~~~~-~------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 236 PSVEEMRKVV-C------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp CCHHHHHHHH-T------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred chHHHHHHHH-h------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 111111110 0 1111111111 12345667889999999999999999999999999987655444
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=384.21 Aligned_cols=250 Identities=24% Similarity=0.284 Sum_probs=206.0
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 45788899999999999999997 5789999999864321 223346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998743 35899999999999999999999887 999999999999999999999999999865422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.......+||+.|+|||++.+..++.++||||+||++|||++|++||.+.+.. ..... +...
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~~-----------i~~~ 220 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFEL-----------ILME 220 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH-----------HHHC
T ss_pred --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----HHHHH-----------HhcC
Confidence 22345678999999999999999999999999999999999999999763311 11111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
. ...+.....++.+++..|++.||++||+ ++|+++
T Consensus 221 ~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 E-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 1122334556788999999999999995 788875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=385.04 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=211.8
Q ss_pred hhccCCcceEcccCCcceEEEEc------CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCC-CCCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 253 (468)
.+.|+..+.||+|+||.||+|++ .+++.||||+++.... ......+.+|+.+++++ +|||||+++++|.+++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 45677889999999999999975 3467899999875432 23345688999999998 6999999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKR----------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 317 (468)
..++||||+++|+|.++++... ...+++..+.+++.||+.||+|||+.+ ++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986543 225899999999999999999999887 999999999999
Q ss_pred EcCCCceEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcC
Q 012213 318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRRPVGDFGEEGLD 396 (468)
Q Consensus 318 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 396 (468)
++.++.+|++|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |.+||...... ..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HH
Confidence 99999999999999998765444445556789999999999999999999999999999999999 55555443321 11
Q ss_pred HHHHHHHhhcccccchhhhccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhcc
Q 012213 397 IVQWTKMQTNSSKEGVVKILDQRL-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQAQ 460 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 460 (468)
+. ++++... ...+......+.+++.+||+.||++||||+||+++|+++.
T Consensus 257 ~~---------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 FY---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HH---------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---------------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 1111111 1222334567889999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-49 Score=380.09 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=203.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCC-CCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|++ .+|+.||||++..... .....+.+.+|+.+++.++|||||++++++.+++..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 45688889999999999999997 4689999999864321 223346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999886443 4788999999999999999999777 999999999999999999999999999876422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+. .+.. ..+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~-----------~~i~~~ 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTY-----------EKILNA 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH-----------HHHHHC
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHH-----------HHHHcC
Confidence 2456899999999999999999999999999999999999999975321 1111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
.. ..+......+.+++.+|+..||.+|| |++|+++
T Consensus 217 ~~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 EL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11 12223345678899999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-49 Score=369.84 Aligned_cols=253 Identities=26% Similarity=0.319 Sum_probs=203.6
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCc-------hhHHHHHHHHHhCCC-CCCccceeEEEec
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSH-------DNGLSAEIRTLGKIR-HRNIVRLKAFCSN 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 251 (468)
.++|+..+.||+|+||+||+|++ .+|+.||||++......... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 56788899999999999999997 57899999998754433221 135788999999997 9999999999999
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
++..++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999999743 35899999999999999999999888 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhh
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQT 405 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 405 (468)
++.+... .......||+.|+|||.+. ...++.++||||+||++|||+||+.||.+.... ..+... .
T Consensus 157 a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----~~~~~i-~ 228 (277)
T d1phka_ 157 SCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMI-M 228 (277)
T ss_dssp CEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH-H
T ss_pred eeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH----HHHHHH-H
Confidence 9876532 2234567999999999875 345788999999999999999999999763311 001000 0
Q ss_pred cccccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 406 NSSKEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 406 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.... . . ..........++.+++.+|++.||++|||++||++
T Consensus 229 ~~~~-~---~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNY-Q---F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCC-C---C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCC-C---C----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 0 0 01112234567889999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-49 Score=370.07 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=201.9
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC-CchhHHHHHHHHHhCCCCCCccceeEEEecCCe---
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET--- 254 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 254 (468)
+.++|+..+.||+|+||+||+|.+ .+|+.||||++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 356788899999999999999997 578999999997543322 233568999999999999999999999876543
Q ss_pred -eEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 255 -NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 255 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++..+++|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred eEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 68999999999999988643 35899999999999999999999887 9999999999999999999999999987
Q ss_pred cccccC-CCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 334 YLQDTG-ASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 334 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
...... .........||+.|+|||++.+..++.++|||||||++|||+||++||.+... .+............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIP- 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCC-
Confidence 654322 22234456799999999999999999999999999999999999999975321 11111111111000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHhcc
Q 012213 413 VKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-TMREVVQMLAQAQ 460 (468)
Q Consensus 413 ~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-t~~ev~~~L~~~~ 460 (468)
. .......+..+.+++.+|++.||++|| |++++.+.|.++.
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 011112345678899999999999999 8999999998775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-49 Score=380.46 Aligned_cols=247 Identities=21% Similarity=0.230 Sum_probs=204.2
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccC-CCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 258 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++.... ......+.+.+|+.+++.++|||||++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46788889999999999999997 468999999985422 1223346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999998643 35899999999999999999999887 999999999999999999999999999876421
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.. ...... .+...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~-----------~i~~~ 253 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYE-----------KIVSG 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH-----------HHHHC
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHH-----------HHhcC
Confidence 235679999999999999999999999999999999999999997532 111111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCC-----CCHHHHHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVER-----PTMREVVQ 454 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~R-----Pt~~ev~~ 454 (468)
. ...+......+.+++..|++.||++| ||++|+++
T Consensus 254 ~-~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 K-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C-CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 11222345567889999999999999 48999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=377.73 Aligned_cols=252 Identities=24% Similarity=0.290 Sum_probs=199.4
Q ss_pred chhhhccCCc-ceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhC-CCCCCccceeEEEec---
Q 012213 178 DDILECVKDN-NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK-IRHRNIVRLKAFCSN--- 251 (468)
Q Consensus 178 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~--- 251 (468)
..+.++|++. +.||+|+||+||+|.+ .+++.||||++.. ...+.+|+.++.+ .+|||||++++++.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3446778765 5699999999999997 5689999999853 1567889988654 589999999999865
Q ss_pred -CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEe
Q 012213 252 -KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVA 327 (468)
Q Consensus 252 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 327 (468)
....++|||||++|+|.+++.......+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccc
Confidence 456799999999999999998655567999999999999999999999887 999999999999986 5679999
Q ss_pred eccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc
Q 012213 328 DFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS 407 (468)
Q Consensus 328 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 407 (468)
|||+|+..... .......||+.|+|||++.+..++.++|||||||++|||+||++||.+..... ......
T Consensus 157 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~----- 226 (335)
T d2ozaa1 157 DFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMK----- 226 (335)
T ss_dssp CCTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred ccceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHH-----
Confidence 99999876532 22345679999999999999999999999999999999999999996532211 000000
Q ss_pred cccchhhhccccC-CCCC--HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKILDQRL-SNTP--LSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~~d~~~-~~~~--~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+..... ...+ .....++.+++.+|++.||++|||+.|+++
T Consensus 227 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 -----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111111 0111 233467889999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=374.16 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=204.4
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEE
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL 257 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 257 (468)
+++++|+..+.||+|+||+||+|.+. +|+.||||.+... ......+.+|+++|+.++|||||++++++.+++..++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 56788999999999999999999985 6889999998543 2223568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CceEEeeccccccc
Q 012213 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD--FEAHVADFGLAKYL 335 (468)
Q Consensus 258 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~ 335 (468)
||||+++|+|.+++... +..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999999643 345899999999999999999999887 9999999999999854 57999999999876
Q ss_pred cccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKI 415 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (468)
.. ........+|+.|+|||...+..++.++||||+||++|||++|+.||...... +. ...+
T Consensus 155 ~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~-----------~~~i 215 (321)
T d1tkia_ 155 KP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QI-----------IENI 215 (321)
T ss_dssp CT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH-----------HHHH
T ss_pred cc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HH-----------HHHH
Confidence 42 22234567899999999999999999999999999999999999999763211 11 1111
Q ss_pred ccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 416 LDQRLSNTPL----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 416 ~d~~~~~~~~----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... .+. ....++.+++..|+..||++|||++|+++
T Consensus 216 ~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 216 MNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTCCC-CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhCCCC-CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 111 12345788999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-48 Score=379.83 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=198.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHH---HHHHHHHhCCCCCCccceeEEEecCCee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGL---SAEIRTLGKIRHRNIVRLKAFCSNKETN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~ 255 (468)
.++|+..+.||+|+||.||+|++. +|+.||||++..... .......+ ..++.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 456888899999999999999975 689999999853221 11111223 3447788888999999999999999999
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999999643 35889999999999999999999888 999999999999999999999999999876
Q ss_pred cccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhh
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVK 414 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (468)
... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ......
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~------------ 219 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR------------ 219 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHH------------
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH------------
Confidence 532 2345679999999999864 568999999999999999999999997643221 111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 012213 415 ILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPT-----MREVVQ 454 (468)
Q Consensus 415 ~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt-----~~ev~~ 454 (468)
.........+......+.+++.+|++.||++||| ++|+++
T Consensus 220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111111122234456788999999999999999 688864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=371.13 Aligned_cols=274 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
++|+..+.||+|+||+||+|.+ .+|+.||||+++.........+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5678889999999999999997 568999999996544433344779999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
|+.+ ++.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence 9964 5555555455567999999999999999999999888 999999999999999999999999999876422
Q ss_pred CccccccccCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---cchhhhc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---EGVVKIL 416 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 416 (468)
........||+.|+|||...... ++.++||||+||++|||++|+.||.+.+... .+..-......... .......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhcccccccc
Confidence 23344567999999999877655 5789999999999999999999997532110 01100000000000 0000000
Q ss_pred ccc-----CCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCC
Q 012213 417 DQR-----LSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKP 462 (468)
Q Consensus 417 d~~-----~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~ 462 (468)
+.. ....+ ......+.+++.+|++.||++|||++|+++ .++++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 000 00111 122356788999999999999999999998 46666544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=375.73 Aligned_cols=248 Identities=24% Similarity=0.286 Sum_probs=200.0
Q ss_pred hccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCC-CCCchhHHHHHHHHHh-CCCCCCccceeEEEecCCeeEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLG-KIRHRNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 258 (468)
++|+..+.||+|+||+||+|.++ +|+.||||++..... .....+.+..|+.++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46788899999999999999985 688999999864321 1222345667777655 68999999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecccccccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 338 (468)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997433 4889999999999999999999887 999999999999999999999999999866422
Q ss_pred CCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchhhhccc
Q 012213 339 GASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVVKILDQ 418 (468)
Q Consensus 339 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 418 (468)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.... ..+... ...
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i------------~~~ 218 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSI------------RMD 218 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HHC
T ss_pred --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHH------------HcC
Confidence 23345568999999999999999999999999999999999999999753211 011111 001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 012213 419 RLSNTPLSEAMQVFFVAMLCVQEHGVERPTMR-EVV 453 (468)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~-ev~ 453 (468)
. ...+......+.+++.+|++.||++|||+. |++
T Consensus 219 ~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 219 N-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp C-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1 112223345678999999999999999995 675
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=370.65 Aligned_cols=265 Identities=21% Similarity=0.279 Sum_probs=195.9
Q ss_pred cceEcccCCcceEEEEcC-CCcEEEEEEecccCCCC---CchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEecc
Q 012213 187 NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262 (468)
Q Consensus 187 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 262 (468)
.++||+|+||+||+|.++ +|+.||||++....... .....+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999984 68999999986433221 11356889999999999999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCCc
Q 012213 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342 (468)
Q Consensus 263 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 342 (468)
+++++..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence 9888777664 3345888999999999999999999888 9999999999999999999999999998765322 2
Q ss_pred cccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccchh---hhcc-
Q 012213 343 CMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGVV---KILD- 417 (468)
Q Consensus 343 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d- 417 (468)
......||+.|+|||++.. ..++.++|||||||++|||+||++||....... .+............+... ....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence 2345679999999998865 457999999999999999999999997532110 011000000000000000 0000
Q ss_pred ---ccCCCCCH-----HHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 418 ---QRLSNTPL-----SEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 418 ---~~~~~~~~-----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
......+. .....+.+++.+|++.||++|||++|+++ .|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 00011111 12356889999999999999999999987 45544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.8e-48 Score=364.87 Aligned_cols=265 Identities=21% Similarity=0.274 Sum_probs=199.8
Q ss_pred hccCCcceEcccCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEec
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 261 (468)
++|+..+.||+|+||+||+|.+++|+.||||++..........+.+.+|+.++++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 46778899999999999999999999999999966544344447899999999999999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCCC
Q 012213 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341 (468)
Q Consensus 262 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 341 (468)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 98777766654 3356999999999999999999999887 9999999999999999999999999998765322
Q ss_pred ccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch---hhhc-
Q 012213 342 ECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV---VKIL- 416 (468)
Q Consensus 342 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 416 (468)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..... .+............... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhh
Confidence 223445689999999988654 56899999999999999999999997633111 01110000000000000 0000
Q ss_pred -cccC--------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 -DQRL--------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 -d~~~--------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+... ..........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0011123456788999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=362.67 Aligned_cols=242 Identities=21% Similarity=0.355 Sum_probs=194.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCC----CchhHHHHHHHHHhCCC--CCCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 253 (468)
..+|+..+.||+|+||+||+|.+ .+|+.||||++....... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35688889999999999999997 468999999986543221 11234678999999886 899999999999999
Q ss_pred eeEEEEeccCC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CceEEeeccc
Q 012213 254 TNLLVYEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGL 331 (468)
Q Consensus 254 ~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 331 (468)
..++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 6777777543 35899999999999999999999887 9999999999999854 7999999999
Q ss_pred cccccccCCCccccccccCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
|+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .. ...
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i-~~~--- 219 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI-IRG--- 219 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH-HHC---
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HH-hhc---
Confidence 9865422 2345679999999999887765 567899999999999999999996411 00 000
Q ss_pred chhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 411 GVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 411 ~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
.. ..+.....++.+++.+|++.||++|||++|+++
T Consensus 220 --------~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 --------QV-FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------cc-CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 011122356788999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=359.52 Aligned_cols=271 Identities=20% Similarity=0.240 Sum_probs=199.0
Q ss_pred hhccCCcceEcccCCcceEEEEcC-C-CcEEEEEEecccCCCCCchhHHHHHHHHHhCC---CCCCccceeEEEec----
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-N-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSN---- 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 251 (468)
.++|+..+.||+|+||+||+|.+. + ++.||||++............+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 467888999999999999999973 4 56799999875444333334567788776655 79999999999853
Q ss_pred -CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeecc
Q 012213 252 -KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330 (468)
Q Consensus 252 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 330 (468)
....+++|||++++++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 345789999998877654443 34456899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccccc
Q 012213 331 LAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKE 410 (468)
Q Consensus 331 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
+++.... ........||+.|+|||++.+..++.++||||+||++|||+||++||.+.... ..+.............
T Consensus 162 ~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred hhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchh
Confidence 9986542 23345678999999999999999999999999999999999999999763211 0011100000000000
Q ss_pred ch-------hhhcccc----CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhc
Q 012213 411 GV-------VKILDQR----LSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQA 459 (468)
Q Consensus 411 ~~-------~~~~d~~----~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 459 (468)
.. ....... ...........+.+++.+|++.||++|||++|+++ .++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 00 0000000 00111223355778999999999999999999986 35554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=349.85 Aligned_cols=267 Identities=20% Similarity=0.259 Sum_probs=195.7
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec--------
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-------- 251 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 251 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++...........++.+|+.+|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57888999999999999999997 578999999986554444445778999999999999999999998855
Q ss_pred CCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
....++||||++++.+..+.. ....++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 345789999998877765553 3345888999999999999999999887 99999999999999999999999999
Q ss_pred cccccccCCC--ccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc-
Q 012213 332 AKYLQDTGAS--ECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS- 407 (468)
Q Consensus 332 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 407 (468)
++.+...... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... ....-.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence 9876532221 222345799999999998754 6899999999999999999999999753211 000000000000
Q ss_pred cccchhhh--------ccccC-CCCCHH-------HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 408 SKEGVVKI--------LDQRL-SNTPLS-------EAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 408 ~~~~~~~~--------~d~~~-~~~~~~-------~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
..+..... +.... ...... ....+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000 00000 011111 1234668999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-44 Score=342.62 Aligned_cols=261 Identities=18% Similarity=0.239 Sum_probs=203.6
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC-CCccceeEEEecCCeeEEE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 258 (468)
-++|+..+.||+|+||+||+|++. +|+.||||.+...... ..+.+|++.+..++| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 356888999999999999999974 6889999987543322 347889999999965 8999999999999999999
Q ss_pred EeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCceEEeeccccc
Q 012213 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----DFEAHVADFGLAK 333 (468)
Q Consensus 259 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~ 333 (468)
|||+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 80 me~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999 7899998864 3346899999999999999999999777 999999999999975 5789999999999
Q ss_pred cccccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc
Q 012213 334 YLQDTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS 408 (468)
Q Consensus 334 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ...+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-HHHHHHHHhccC
Confidence 87533221 123456799999999999999999999999999999999999999976432211 111111000000
Q ss_pred ccchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 409 KEGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 409 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.....++. . ..+.++.+++..|++.+|++||+++.+.+.|+++
T Consensus 234 ~~~~~~l~----~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPLRELC----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCHHHHT----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCChHHhc----C----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00011110 1 1234577889999999999999999999888775
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-45 Score=345.17 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=197.0
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccce-eEEEecCCeeEEEE
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVY 259 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~ 259 (468)
++|+..+.||+|+||+||+|.+ .+|+.||||.+...... .++..|+++++.++|+|++.. .++..+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4688889999999999999987 56899999987643322 458899999999987776555 55557778889999
Q ss_pred eccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCceEEeecccccccc
Q 012213 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQ 336 (468)
Q Consensus 260 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~ 336 (468)
||+ ++++.+.+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 83 e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 83 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999 5677666543 3345899999999999999999999888 999999999999864 5579999999999875
Q ss_pred ccCCC-----ccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--CHHHHHHHhhcccc
Q 012213 337 DTGAS-----ECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGL--DIVQWTKMQTNSSK 409 (468)
Q Consensus 337 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 409 (468)
..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 43321 223456799999999999999999999999999999999999999976432221 1111111110000
Q ss_pred cchhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHhc
Q 012213 410 EGVVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQMLAQA 459 (468)
Q Consensus 410 ~~~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 459 (468)
.... ....+.++.+++..|++.+|++||+++++.+.|+.+
T Consensus 237 --~~~~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 --IEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHHH--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred --hhHh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 112235678899999999999999999999988865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=345.08 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=203.9
Q ss_pred hccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCCeeEEEEe
Q 012213 182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260 (468)
Q Consensus 182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 260 (468)
++|+..+.||+|+||+||+|++ .+++.||||+++..........++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4678889999999999999997 578899999997655545556788999999999999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccccccCC
Q 012213 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340 (468)
Q Consensus 261 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 340 (468)
++.++++..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred ecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 9999998888753 345889999999999999999999887 9999999999999999999999999998765322
Q ss_pred CccccccccCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc---cchhhhc
Q 012213 341 SECMSAVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---EGVVKIL 416 (468)
Q Consensus 341 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 416 (468)
.......++..|+|||.+.... ++.++|||||||++|||++|+.||...................... ....+..
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2233456788999999887655 6899999999999999999999975422111101100000000000 0000000
Q ss_pred c----------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 417 D----------QRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 417 d----------~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
+ .............+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011122233456778999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=354.12 Aligned_cols=268 Identities=27% Similarity=0.325 Sum_probs=195.0
Q ss_pred ccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC------Cee
Q 012213 183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ETN 255 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 255 (468)
.|+..++||+|+||+||+|++. +|+.||||++..... ...+|+.++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4677789999999999999985 689999999864322 234799999999999999999998543 246
Q ss_pred EEEEeccCCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccc
Q 012213 256 LLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAK 333 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~ 333 (468)
++||||++++.+..+.+. .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 899999986644443321 23446999999999999999999999777 99999999999999875 89999999998
Q ss_pred cccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccch
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEGV 412 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
.+... .......||+.|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+............+.+
T Consensus 172 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 172 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp ECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred hccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhh
Confidence 76432 22345679999999998764 57899999999999999999999999753311 111111110000000000
Q ss_pred hhh----ccccC---------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCCC
Q 012213 413 VKI----LDQRL---------SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKPN 463 (468)
Q Consensus 413 ~~~----~d~~~---------~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~~ 463 (468)
... .+... ..........+.+++.+|++.||++|||++|+++ .+++++.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 000 00000 0011123456788999999999999999999996 466665443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=359.60 Aligned_cols=269 Identities=23% Similarity=0.348 Sum_probs=196.7
Q ss_pred hhhhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC----
Q 012213 179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE---- 253 (468)
Q Consensus 179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 253 (468)
++.++|+..+.||+|+||+||+|.+. +|+.||||++..........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 34678889999999999999999974 6899999998754333333467889999999999999999999997655
Q ss_pred --eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccc
Q 012213 254 --TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331 (468)
Q Consensus 254 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 331 (468)
..++||||+ +++|.++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 6678777753 24999999999999999999999888 99999999999999999999999999
Q ss_pred cccccccCCCccccccccCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcc---
Q 012213 332 AKYLQDTGASECMSAVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNS--- 407 (468)
Q Consensus 332 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 407 (468)
|+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||.+.+.. ..+..........
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAE 241 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHH
Confidence 9875422 345678999999998865 45789999999999999999999999764211 0011111000000
Q ss_pred -----cccc---hh----hhccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhcc
Q 012213 408 -----SKEG---VV----KILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQ 460 (468)
Q Consensus 408 -----~~~~---~~----~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~ 460 (468)
.... .. ......+..........+.+++.+|+..||++|||++|+++ .|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00 00000001111223345678999999999999999999997 355543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=351.84 Aligned_cols=264 Identities=19% Similarity=0.259 Sum_probs=194.5
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecCC----ee
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TN 255 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 255 (468)
.++|+..+.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|+.+|++++|||++++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45688899999999999999987 579999999986432 2223357889999999999999999999996543 23
Q ss_pred EEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccccc
Q 012213 256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335 (468)
Q Consensus 256 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 335 (468)
+++++|+.+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 4555667799999999643 4899999999999999999999888 999999999999999999999999999876
Q ss_pred cccCC-CccccccccCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccc----
Q 012213 336 QDTGA-SECMSAVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSK---- 409 (468)
Q Consensus 336 ~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 409 (468)
..... ........||+.|+|||.+. +..++.++||||+||++|||++|+.||....... .. +.........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~-~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QL-NHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HH-HHHhhhccCCChhh
Confidence 53322 22234567999999999874 4567899999999999999999999997633110 00 1000000000
Q ss_pred ------cchhhhc--cccCCCCCH-----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 410 ------EGVVKIL--DQRLSNTPL-----SEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 410 ------~~~~~~~--d~~~~~~~~-----~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
....... .......+. ....++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000011111 11245788999999999999999999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=348.41 Aligned_cols=255 Identities=24% Similarity=0.265 Sum_probs=201.4
Q ss_pred hhccCCcceEcccCCcceEEEEc----CCCcEEEEEEecccCC--CCCchhHHHHHHHHHhCCCC-CCccceeEEEecCC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~ 253 (468)
.++|+..+.||+|+||+||+|.. .+|+.||||.+..... .....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 46788999999999999999985 2478999999864321 12223568899999999976 89999999999999
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..+++|||+++|+|.+++.... .++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999996443 4678889999999999999999887 9999999999999999999999999998
Q ss_pred cccccCCCccccccccCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhcccccc
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSSKEG 411 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
.+... .........|++.|+|||.+.+. .++.++|||||||++|||+||+.||........ .........
T Consensus 178 ~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~------ 249 (322)
T d1vzoa_ 178 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRIL------ 249 (322)
T ss_dssp ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHH------
T ss_pred hhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcc------
Confidence 76532 22233456799999999988654 478899999999999999999999976443221 111111110
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 012213 412 VVKILDQRLSNTPLSEAMQVFFVAMLCVQEHGVERP-----TMREVVQ 454 (468)
Q Consensus 412 ~~~~~d~~~~~~~~~~~~~~~~l~~~c~~~~P~~RP-----t~~ev~~ 454 (468)
... ...+.....++.+++.+|++.||++|| |++|+++
T Consensus 250 -----~~~-~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 -----KSE-PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----HCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----cCC-CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 110 112234567788899999999999999 4788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=347.75 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=190.4
Q ss_pred hhccCCcceEcccCCcceEEEEcC-CCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEec------CC
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------KE 253 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 253 (468)
.++|+..+.||+|+||+||+|.+. +|+.||||++...........++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 477999999999999999999985 69999999997654444444578899999999999999999999964 36
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..++||||+.++.+. .+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 779999999765544 443 23889999999999999999999888 9999999999999999999999999988
Q ss_pred cccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHH------------HHH
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIV------------QWT 401 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~------------~~~ 401 (468)
.... ........+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.+... ... .|.
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred cccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHH
Confidence 6542 223345678999999999999999999999999999999999999996532100 000 000
Q ss_pred ------HHhhcc----cccchhhhccccC----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 402 ------KMQTNS----SKEGVVKILDQRL----SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 402 ------~~~~~~----~~~~~~~~~d~~~----~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
...... ........+.... ..........+.+++.+|+..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000111111111 1112234567889999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-43 Score=341.86 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=196.1
Q ss_pred hhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecC--CeeE
Q 012213 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNK--ETNL 256 (468)
Q Consensus 181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~ 256 (468)
.++|+..+.||+|+||+||+|++ .+|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 45788999999999999999998 56899999998532 2367899999999995 99999999998743 4588
Q ss_pred EEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-ceEEeeccccccc
Q 012213 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYL 335 (468)
Q Consensus 257 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~ 335 (468)
+||||+++++|.++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 109 ~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 9999999999987652 4899999999999999999999888 99999999999998765 6999999999876
Q ss_pred cccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCH------------HHHHH
Q 012213 336 QDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDI------------VQWTK 402 (468)
Q Consensus 336 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~------------~~~~~ 402 (468)
... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... ..|..
T Consensus 181 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 181 HPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 532 223456789999999997765 47999999999999999999999997643211100 01111
Q ss_pred Hhhcccccchhhhcccc--------C-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 012213 403 MQTNSSKEGVVKILDQR--------L-SNTPLSEAMQVFFVAMLCVQEHGVERPTMREVVQ 454 (468)
Q Consensus 403 ~~~~~~~~~~~~~~d~~--------~-~~~~~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~ 454 (468)
................. . .........++.+++.+|+..||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11011000111111000 0 0111223456788999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=345.08 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=198.7
Q ss_pred hhhccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCccceeEEEecC-----C
Q 012213 180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----E 253 (468)
Q Consensus 180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 253 (468)
+.++|+..+.||+|+||+||+|.+ .+|+.||||++..........+++.+|+.+++.++|||+|++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 356788999999999999999997 5799999999875444333445788999999999999999999998643 3
Q ss_pred eeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 254 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
..+++++|+.+|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 446777888899999999643 4999999999999999999999887 9999999999999999999999999997
Q ss_pred cccccCCCccccccccCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHhhccc----
Q 012213 334 YLQDTGASECMSAVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRRPVGDFGEEGLDIVQWTKMQTNSS---- 408 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 408 (468)
... .......||+.|+|||...+. .++.++||||+||++|||++|++||.+.+.. .............
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHH
Confidence 543 223456789999999986665 4689999999999999999999999753211 0000000000000
Q ss_pred -----ccchhhhccc--cCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHhccCC
Q 012213 409 -----KEGVVKILDQ--RLSNTP-----LSEAMQVFFVAMLCVQEHGVERPTMREVVQ--MLAQAQKP 462 (468)
Q Consensus 409 -----~~~~~~~~d~--~~~~~~-----~~~~~~~~~l~~~c~~~~P~~RPt~~ev~~--~L~~~~~~ 462 (468)
.......... ...... ......+.+++.+|++.||++|||++|+++ .+.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 0000000000 001111 112345778999999999999999999997 56655433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-38 Score=304.90 Aligned_cols=269 Identities=19% Similarity=0.182 Sum_probs=191.4
Q ss_pred ccCCcceEcccCCcceEEEEc-CCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-----------CCCccceeEEEe
Q 012213 183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----------HRNIVRLKAFCS 250 (468)
Q Consensus 183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 250 (468)
+|+..+.||+|+||+||+|++ .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 488899999999999999997 578999999986321 22356778888887775 578999999875
Q ss_pred c--CCeeEEEEeccCCCC-hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCc---
Q 012213 251 N--KETNLLVYEYMPNGS-LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFE--- 323 (468)
Q Consensus 251 ~--~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~--- 323 (468)
. ....+++++++..+. ............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 4 345566666665443 3333344455568899999999999999999997 66 999999999999987653
Q ss_pred ---eEEeeccccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC-cC---
Q 012213 324 ---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGDFGEEG-LD--- 396 (468)
Q Consensus 324 ---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~-~~--- 396 (468)
++++|||.+...... .....||+.|+|||+.....++.++||||+||+++||++|+.||...+... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999765422 245679999999999999999999999999999999999999997632211 10
Q ss_pred -HHHHHHHhhccccc------chhhhccc--------------------cCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 012213 397 -IVQWTKMQTNSSKE------GVVKILDQ--------------------RLSNTPLSEAMQVFFVAMLCVQEHGVERPTM 449 (468)
Q Consensus 397 -~~~~~~~~~~~~~~------~~~~~~d~--------------------~~~~~~~~~~~~~~~l~~~c~~~~P~~RPt~ 449 (468)
+............+ ......+. ............+.+++.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111100000000 00000000 0122345677889999999999999999999
Q ss_pred HHHHH--HHHhccCC
Q 012213 450 REVVQ--MLAQAQKP 462 (468)
Q Consensus 450 ~ev~~--~L~~~~~~ 462 (468)
+|+++ .+++....
T Consensus 323 ~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGM 337 (362)
T ss_dssp HHHHTCGGGTTCTTC
T ss_pred HHHhcCcccCCCCCc
Confidence 99987 35544333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.2e-25 Score=192.90 Aligned_cols=170 Identities=16% Similarity=0.182 Sum_probs=118.7
Q ss_pred CcceEcccCCcceEEEEcCCCcEEEEEEecccCCC----C--------C----chhHHHHHHHHHhCCCCCCccceeEEE
Q 012213 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG----S--------S----HDNGLSAEIRTLGKIRHRNIVRLKAFC 249 (468)
Q Consensus 186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~--------~----~~~~~~~e~~~l~~l~h~niv~l~~~~ 249 (468)
.++.||+|+||+||+|.+.+|+.||||.++..... . . .......|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46899999999999999989999999987532110 0 0 012345678889999999999888763
Q ss_pred ecCCeeEEEEeccCCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCceEEeec
Q 012213 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329 (468)
Q Consensus 250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 329 (468)
..+++|||+++..+.++ +......++.|++.|++|||+.+ |+||||||+|||++++ .++|+||
T Consensus 84 ----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred ----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 23799999987655432 33445678999999999999888 9999999999999965 5899999
Q ss_pred cccccccccCCCccccccccCccccCccccCCCCCCcchhhHHHHHHH
Q 012213 330 GLAKYLQDTGASECMSAVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 377 (468)
Q Consensus 330 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l 377 (468)
|+|............. ..... -.+. ....|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHH---HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9997654221110000 00000 0011 235678899999975443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.65 E-value=5.1e-17 Score=153.23 Aligned_cols=109 Identities=31% Similarity=0.474 Sum_probs=101.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|.+.|.+|..++.+++|+.|++++|.+++.+| +++.+++|+.|||++|+|+|.+|++|+++++|+.|||++|+|+|
T Consensus 204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence 45788888899999999999999999999997665 79999999999999999999999999999999999999999999
Q ss_pred CCCCcccccccCcccccCCCCCCCCCCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPHLCGSYLNPC 110 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~lcg~~~~~c 110 (468)
.+|+++++.++..+++++|+.+||.++..|
T Consensus 283 ~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 283 EIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 999999999999999999999999887777
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.54 E-value=3.9e-15 Score=129.59 Aligned_cols=105 Identities=21% Similarity=0.314 Sum_probs=86.2
Q ss_pred CCCCcccccC-CcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGII-PVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~-p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|++.+ +..|+++++|+.|+|++|++++..+..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|+
T Consensus 36 Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~ 115 (192)
T d1w8aa_ 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred eCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCcccc
Confidence 6788888655 456788888999999999988777888888899999999999988655667888899999999999998
Q ss_pred CCCCC-cccccccCcccccCCCCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
+.+|. |..+.++..+.+++|++.|.+
T Consensus 116 ~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 116 CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccCHHHhcCCccccccccccccccccc
Confidence 77774 777888888888888887664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=8.8e-15 Score=117.43 Aligned_cols=96 Identities=21% Similarity=0.343 Sum_probs=85.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+| .++++++|++|||++|+|+ .+|..++.+++|++|++++|.++ .+| .+..+++|+.|++++|+++.
T Consensus 5 Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~ 79 (124)
T d1dcea3 5 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ 79 (124)
T ss_dssp CTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCS
T ss_pred cCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCC
Confidence 6899999 777 5999999999999999999 79999999999999999999999 576 59999999999999999986
Q ss_pred CCC--CcccccccCcccccCCCC
Q 012213 81 EIP--EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p--~~~~~~~~~~~~~~~n~~ 101 (468)
..+ .+..++++..+++++|+.
T Consensus 80 ~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 80 SAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp SSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCchhhcCCCCCCEEECCCCcC
Confidence 543 467778899999999974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.41 E-value=4.8e-14 Score=132.43 Aligned_cols=101 Identities=29% Similarity=0.544 Sum_probs=92.5
Q ss_pred CCCCcccc--cCCcccccCCCCCEEEccC-CcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcc
Q 012213 1 MSRNNFSG--IIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNN 77 (468)
Q Consensus 1 l~~N~l~g--~~p~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~ 77 (468)
|++|.++| .+|.++++|++|++|+|++ |+++|.||.+|++|++|++|||++|+++|..|..+..+..|+.+++++|+
T Consensus 57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~ 136 (313)
T d1ogqa_ 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence 46788988 5899999999999999997 89999999999999999999999999999889889999999999999999
Q ss_pred cCCCCC-CcccccccCcccccCCCC
Q 012213 78 FSGEIP-EFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 78 l~~~~p-~~~~~~~~~~~~~~~n~~ 101 (468)
+.+.+| .+..+..+..+.+++|..
T Consensus 137 ~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 137 LSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccCchhhccCcccceeecccccc
Confidence 999988 488888888899888853
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=3.6e-13 Score=112.51 Aligned_cols=103 Identities=17% Similarity=0.127 Sum_probs=87.2
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCc-ccccCC-ccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNH-LSGPIP-VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~-l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
++|+++ .+|..+..+++|+.|+|++|+ |+ .|| ..|.++++|+.|+|++|+|+..-|..|..+++|+.|+|++|+|+
T Consensus 16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp CSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred cCCCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 567777 788899999999999998764 88 565 57999999999999999999655677999999999999999999
Q ss_pred CCCCCcccccccCcccccCCCCCCCCC
Q 012213 80 GEIPEFGQYSFFNSTSFTGNPHLCGSY 106 (468)
Q Consensus 80 ~~~p~~~~~~~~~~~~~~~n~~lcg~~ 106 (468)
..++.......+..+++++|++.|.+.
T Consensus 94 ~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 94 SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred ccChhhhccccccccccCCCcccCCch
Confidence 666654444478899999999998763
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=3e-13 Score=125.05 Aligned_cols=105 Identities=19% Similarity=0.220 Sum_probs=94.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|++++|++++..|..|..+++|+.|++++|++++
T Consensus 136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~ 215 (284)
T d1ozna_ 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (284)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred hccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccc
Confidence 57899996556788899999999999999997677889999999999999999998889999999999999999999998
Q ss_pred CCCC-cccccccCcccccCCCCCCCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGNPHLCGS 105 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n~~lcg~ 105 (468)
.+|. ++.+.++..+++++|++.|.|
T Consensus 216 ~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 216 LPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ccccccccccccCEEEecCCCCCCCc
Confidence 7774 778889999999999999875
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.32 E-value=1.1e-12 Score=113.78 Aligned_cols=99 Identities=18% Similarity=0.165 Sum_probs=87.9
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccC-CccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPI-PVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
.++|+|+ .||..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|+|+
T Consensus 15 Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~ 91 (192)
T d1w8aa_ 15 CTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91 (192)
T ss_dssp CTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred EeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccc
Confidence 4789999 8998774 68999999999998756 556899999999999999999888889999999999999999999
Q ss_pred CCCCC-cccccccCcccccCCCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNPHL 102 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~~l 102 (468)
+.+|. |..+..+..+++++|...
T Consensus 92 ~l~~~~F~~l~~L~~L~L~~N~l~ 115 (192)
T d1w8aa_ 92 EISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp EECSSSSTTCTTCCEEECCSSCCC
T ss_pred ccCHHHHhCCCcccccccCCcccc
Confidence 87775 888999999999999643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2.4e-12 Score=117.64 Aligned_cols=95 Identities=20% Similarity=0.162 Sum_probs=70.9
Q ss_pred cccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCCccccccc
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFF 91 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~ 91 (468)
..+..+.+|+.|++++|.++...|..+..+++|+.|++++|+|++..|..|..+++|+.|+|++|+|+..++.+..+.++
T Consensus 118 ~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L 197 (266)
T d1p9ag_ 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLL 197 (266)
T ss_dssp STTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCC
T ss_pred cccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCC
Confidence 33344444555555555555333445677889999999999999766667889999999999999999444457778889
Q ss_pred CcccccCCCCCCCCC
Q 012213 92 NSTSFTGNPHLCGSY 106 (468)
Q Consensus 92 ~~~~~~~n~~lcg~~ 106 (468)
+.+.++||||.|.|.
T Consensus 198 ~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 198 PFAFLHGNPWLCNCE 212 (266)
T ss_dssp SEEECCSCCBCCSGG
T ss_pred CEEEecCCCCCCCcc
Confidence 999999999999864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.1e-12 Score=110.11 Aligned_cols=96 Identities=14% Similarity=0.126 Sum_probs=57.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcc-cccccccccccccCcccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~ 79 (468)
|++|+|+ .||..+..+++|++||||+|+|+ .++ .+..+++|++|+|++|+++ .+|+. +..+++|+.|++++|+++
T Consensus 25 L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~ 100 (162)
T d1a9na_ 25 LRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV 100 (162)
T ss_dssp CTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC
T ss_pred CCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccceecccccc
Confidence 4566666 55655556666666666666666 453 4666666666666666666 34443 345666666666666665
Q ss_pred CCC--CCcccccccCcccccCCC
Q 012213 80 GEI--PEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~--p~~~~~~~~~~~~~~~n~ 100 (468)
... ..+..++++..+++++|+
T Consensus 101 ~~~~l~~l~~l~~L~~L~l~~N~ 123 (162)
T d1a9na_ 101 ELGDLDPLASLKSLTYLCILRNP 123 (162)
T ss_dssp CGGGGGGGGGCTTCCEEECCSSG
T ss_pred ccccccccccccccchhhcCCCc
Confidence 321 124445556666666664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.23 E-value=6.9e-12 Score=100.14 Aligned_cols=77 Identities=19% Similarity=0.262 Sum_probs=69.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCC--cccccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP--KEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p--~~~~~l~~L~~l~ls~N~l 78 (468)
|++|+|+ .+|..++.+++|+.|++++|+|+ .+| .++++++|+.|++++|.++ .+| ..+..+++|+.|++++|++
T Consensus 27 ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 27 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEECCCCcC
Confidence 6899998 78989999999999999999999 676 5999999999999999998 465 4689999999999999999
Q ss_pred CCC
Q 012213 79 SGE 81 (468)
Q Consensus 79 ~~~ 81 (468)
+..
T Consensus 103 ~~~ 105 (124)
T d1dcea3 103 CQE 105 (124)
T ss_dssp GGS
T ss_pred CcC
Confidence 854
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.12 E-value=5.3e-11 Score=110.72 Aligned_cols=103 Identities=19% Similarity=0.197 Sum_probs=76.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|.+++.+|..+.+++.+++|++++|++++..|..+.++++|++|+|++|.|+ .+|++|..+++|+.|+|++|+|+.
T Consensus 178 l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 4677777777778888888888888888888666777888888888888888887 678888888888888888888874
Q ss_pred CCCC-c------ccccccCcccccCCCCCCC
Q 012213 81 EIPE-F------GQYSFFNSTSFTGNPHLCG 104 (468)
Q Consensus 81 ~~p~-~------~~~~~~~~~~~~~n~~lcg 104 (468)
.... | .....+..+++++|++.+.
T Consensus 257 i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 3221 1 2334566777888876544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=2e-11 Score=102.30 Aligned_cols=86 Identities=13% Similarity=0.066 Sum_probs=76.4
Q ss_pred ccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCC-ccccccc
Q 012213 13 EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSFF 91 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~ 91 (468)
.+.++.+|+.|||++|+|+ .||..+..+++|+.||||+|.|+ .++ .|..+++|+.|++++|+++...+. +..++.+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 5778889999999999999 78887889999999999999999 675 689999999999999999976665 4568899
Q ss_pred CcccccCCCC
Q 012213 92 NSTSFTGNPH 101 (468)
Q Consensus 92 ~~~~~~~n~~ 101 (468)
..+++++|.-
T Consensus 90 ~~L~L~~N~i 99 (162)
T d1a9na_ 90 TELILTNNSL 99 (162)
T ss_dssp CEEECCSCCC
T ss_pred ccceeccccc
Confidence 9999999864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=2.5e-10 Score=94.80 Aligned_cols=78 Identities=21% Similarity=0.138 Sum_probs=66.3
Q ss_pred CCCC-cccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 1 MSRN-NFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 1 l~~N-~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
|++| .|+..-+..|.++++|+.|+|++|+|+..-|..|..+++|++|+|++|+|+ .+|..+....+|+.|+|++|.|.
T Consensus 38 l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 3445 588444567999999999999999999555778999999999999999999 78887666668999999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.95 E-value=7.2e-12 Score=108.86 Aligned_cols=87 Identities=14% Similarity=0.171 Sum_probs=64.9
Q ss_pred CCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCCccccc
Q 012213 10 IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYS 89 (468)
Q Consensus 10 ~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~ 89 (468)
+|.+++.|++|++|+|++|+|+ .++ .+.+|++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. ++.+..+.
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~ 115 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLV 115 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cccccccc
Confidence 3456778888888888888888 675 5888888888888888887 677666666678888888888774 45566667
Q ss_pred ccCcccccCCC
Q 012213 90 FFNSTSFTGNP 100 (468)
Q Consensus 90 ~~~~~~~~~n~ 100 (468)
++..+++++|.
T Consensus 116 ~L~~L~L~~N~ 126 (198)
T d1m9la_ 116 NLRVLYMSNNK 126 (198)
T ss_dssp HSSEEEESEEE
T ss_pred cccccccccch
Confidence 77777777764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=5.5e-10 Score=102.58 Aligned_cols=98 Identities=18% Similarity=0.148 Sum_probs=59.2
Q ss_pred CCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCC
Q 012213 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEI 82 (468)
Q Consensus 3 ~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~ 82 (468)
.|.++...|..+.++++|++|+|++|.+.+..+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|+|++.+
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 45555444566666667777777666666444555666666666666666666433345566666666666666666554
Q ss_pred CC-cccccccCcccccCCC
Q 012213 83 PE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 83 p~-~~~~~~~~~~~~~~n~ 100 (468)
|. +..+.++..+.+++|.
T Consensus 170 ~~~f~~l~~L~~l~l~~N~ 188 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNR 188 (284)
T ss_dssp TTTTTTCTTCCEEECCSSC
T ss_pred hhhhccccccchhhhhhcc
Confidence 43 4555556666666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=8.7e-10 Score=100.21 Aligned_cols=96 Identities=22% Similarity=0.298 Sum_probs=57.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+.++++|+.|+|++|.+.+..+..+..+.+|..|++++|.+++
T Consensus 62 L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 62 LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (266)
T ss_dssp CTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred ccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccce
Confidence 5677777 555 3567777777777777777 456667777777777777766664344444555555555555555554
Q ss_pred CCCC-cccccccCcccccCC
Q 012213 81 EIPE-FGQYSFFNSTSFTGN 99 (468)
Q Consensus 81 ~~p~-~~~~~~~~~~~~~~n 99 (468)
.++. +..+..+..+++++|
T Consensus 139 l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTS
T ss_pred eccccccccccchhcccccc
Confidence 4332 333444444444444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.89 E-value=1.5e-09 Score=100.69 Aligned_cols=98 Identities=17% Similarity=0.230 Sum_probs=86.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
+++|+++ .+|..+ +++|+.|++++|..++..|..+.+++.++.|++++|.+++..|..+.++++|+.|+|++|+|+.
T Consensus 157 l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~ 233 (305)
T d1xkua_ 157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233 (305)
T ss_dssp CCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS
T ss_pred cccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc
Confidence 4677887 677654 6899999999999998999999999999999999999998778889999999999999999996
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.++.+..+++++.+++++|+-
T Consensus 234 lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 234 VPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp CCTTTTTCSSCCEEECCSSCC
T ss_pred cccccccccCCCEEECCCCcc
Confidence 555688899999999999863
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.89 E-value=7.4e-10 Score=105.99 Aligned_cols=91 Identities=21% Similarity=0.335 Sum_probs=68.0
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
++|++++ + ..+..+++++.|+|++|++++ ++ .+..+++|+.|+|++|+|+ .+| .+.++++|+.|++++|+|++.
T Consensus 293 ~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 293 NENQLED-I-SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSC-C-GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBC
T ss_pred ccccccc-c-cccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCC
Confidence 4455553 2 346777888888888888884 44 3788888888888888887 465 588888888888888888866
Q ss_pred CCCcccccccCcccccCC
Q 012213 82 IPEFGQYSFFNSTSFTGN 99 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~~n 99 (468)
+| +..++++..+++++|
T Consensus 367 ~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 367 TP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp GG-GTTCTTCSEEECCCE
T ss_pred hh-hccCCCCCEeeCCCC
Confidence 55 677778888887776
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.81 E-value=4.3e-09 Score=91.04 Aligned_cols=81 Identities=20% Similarity=0.301 Sum_probs=39.5
Q ss_pred cccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCCCCCcccccccCc
Q 012213 14 IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNS 93 (468)
Q Consensus 14 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~ 93 (468)
+..|++|++|+|++|++++ +++ ++++++|++|++++|.+. .+| .+..++.|+.|++++|.+.. ++.+..+..+..
T Consensus 58 l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~~~~~~l~~L~~ 132 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-IDPLKNLTNLNR 132 (199)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSE
T ss_pred cccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccccccccccc-ccccchhhhhHH
Confidence 4455555555555555552 322 555555555555555554 333 24555555555555555443 222344444555
Q ss_pred ccccCC
Q 012213 94 TSFTGN 99 (468)
Q Consensus 94 ~~~~~n 99 (468)
+.+++|
T Consensus 133 L~l~~n 138 (199)
T d2omxa2 133 LELSSN 138 (199)
T ss_dssp EECCSS
T ss_pred hhhhhh
Confidence 555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.81 E-value=5.7e-11 Score=103.04 Aligned_cols=96 Identities=23% Similarity=0.263 Sum_probs=83.0
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .++ .+++|++|+.|+|++|+|+ .+|..+..+.+|+.|++++|.++ .++ .+..+++|+.|++++|+++.
T Consensus 55 Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 55 LSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp CSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCC
T ss_pred CcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhcc
Confidence 6789998 776 5999999999999999999 89887788889999999999999 565 58899999999999999985
Q ss_pred CC--CCcccccccCcccccCCCC
Q 012213 81 EI--PEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~--p~~~~~~~~~~~~~~~n~~ 101 (468)
.. ..+..++++..+++++|+.
T Consensus 130 ~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 130 WGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccccccccCCCccceeecCCCcc
Confidence 43 2467788899999999963
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=4.3e-09 Score=91.91 Aligned_cols=92 Identities=12% Similarity=0.171 Sum_probs=55.9
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
+.+.+++.++. ..|.+|+.|++++|+++ .++ .+..+++|+.|+|++|.+++ +| .++.+++|+.|++++|++++
T Consensus 32 ~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~- 104 (210)
T d1h6ta2 32 KKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD- 104 (210)
T ss_dssp TCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-
T ss_pred CcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-
Confidence 34445544432 24556677777777766 344 36667777777777777763 44 35666777777777777663
Q ss_pred CCCcccccccCcccccCCC
Q 012213 82 IPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~~n~ 100 (468)
+|.+..+.++..+++++|.
T Consensus 105 l~~l~~l~~L~~L~l~~~~ 123 (210)
T d1h6ta2 105 LSSLKDLKKLKSLSLEHNG 123 (210)
T ss_dssp GGGGTTCTTCCEEECTTSC
T ss_pred ccccccccccccccccccc
Confidence 4455566666666666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.77 E-value=5.2e-09 Score=91.37 Aligned_cols=72 Identities=24% Similarity=0.348 Sum_probs=43.7
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
++|.++ .++ .+..+++|++|+|++|++++ +| .+++|++|++|++++|+++ .+| .+..+++|+.|++++|.++
T Consensus 54 ~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~ 125 (210)
T d1h6ta2 54 NNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS 125 (210)
T ss_dssp TTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC
T ss_pred cCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc
Confidence 455665 333 35666667777777776663 44 3566666677777666666 355 3566666666666666554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.73 E-value=4.8e-09 Score=92.71 Aligned_cols=89 Identities=16% Similarity=0.304 Sum_probs=65.2
Q ss_pred CCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCCC
Q 012213 2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE 81 (468)
Q Consensus 2 ~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~ 81 (468)
+++++... ..+.++++|+.|++++|++++ ++ .++++++|+.|||++|+++ .+|+ ++.+++|+.|+|++|++++
T Consensus 137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~- 209 (227)
T d1h6ua2 137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD- 209 (227)
T ss_dssp CSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCB-
T ss_pred hhhhhchh--hhhcccccccccccccccccc-ch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCC-
Confidence 34555432 246777888888888888873 33 3788888888888888888 4653 7888888888888888884
Q ss_pred CCCcccccccCccccc
Q 012213 82 IPEFGQYSFFNSTSFT 97 (468)
Q Consensus 82 ~p~~~~~~~~~~~~~~ 97 (468)
+|.+..+.++..++++
T Consensus 210 i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 210 VSPLANTSNLFIVTLT 225 (227)
T ss_dssp CGGGTTCTTCCEEEEE
T ss_pred CcccccCCCCCEEEee
Confidence 4456777777777665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.68 E-value=1.5e-08 Score=87.46 Aligned_cols=93 Identities=19% Similarity=0.335 Sum_probs=75.1
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|++ +++ ++++++|+.|++++|.+. .+| .+.++++|+.|++++|.+.. ++ .+..+++|+.|++++|+++
T Consensus 69 Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~- 141 (199)
T d2omxa2 69 FSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLELSSNTIS- 141 (199)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCC-
T ss_pred cccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccccccccccc-cc-ccchhhhhHHhhhhhhhhc-
Confidence 68899995 443 899999999999999998 566 48889999999999988874 43 5778889999999999887
Q ss_pred CCCCcccccccCcccccCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~ 100 (468)
.+|.+..+..+..+.+.+|.
T Consensus 142 ~~~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 142 DISALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp CCGGGTTCTTCSEEECCSSC
T ss_pred cccccccccccccccccccc
Confidence 45566777777888877764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.67 E-value=7.7e-09 Score=98.66 Aligned_cols=70 Identities=21% Similarity=0.375 Sum_probs=62.3
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN 76 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N 76 (468)
|++|+|++ ++ .+..+++|+.|+|++|+|+ .+| ++.+|++|++|+|++|++++ +|+ +.++++|+.|+|++|
T Consensus 314 ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~-l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 314 LYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISD-LTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCC-Chh-hccCCCCCEeeCCCC
Confidence 57899995 44 3899999999999999999 566 79999999999999999996 554 899999999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=1e-07 Score=85.77 Aligned_cols=132 Identities=16% Similarity=0.115 Sum_probs=90.1
Q ss_pred cCCcceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCC-CCCccceeEEEecCCeeEEEEeccCCCChhhhc
Q 012213 193 GGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271 (468)
Q Consensus 193 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 271 (468)
++.+.||+... +++.++||+......... ..+.+|...+..+. +--+.+++.+...++..++||+++++.++.+..
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~--~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTT--YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTST--TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccch--hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 33467998865 566788888754433332 34778888876653 334567788888888899999999998876544
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------------------
Q 012213 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------------------------------------------------- 302 (468)
Q Consensus 272 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------------- 302 (468)
... .....++.++++.+..||+..
T Consensus 102 ~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 102 EDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp TTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 211 112334555666666666411
Q ss_pred -------CCCeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 303 -------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 303 -------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
...++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999876677999987753
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.53 E-value=3.1e-08 Score=87.30 Aligned_cols=69 Identities=17% Similarity=0.274 Sum_probs=59.2
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSH 75 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~ 75 (468)
+++|++++ ++ .++++++|+.|+|++|+++ .+| .+.++++|++|+|++|+++ .+|+ +.++++|+.|++++
T Consensus 158 l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~-~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 158 IGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEEE
T ss_pred cccccccc-ch-hhcccccceecccCCCccC-CCh-hhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEeeC
Confidence 46788874 33 4899999999999999999 565 4999999999999999999 5764 89999999999984
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.45 E-value=1.9e-07 Score=87.36 Aligned_cols=88 Identities=25% Similarity=0.255 Sum_probs=69.5
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|+.|++++|+++
T Consensus 45 Ls~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~- 111 (353)
T d1jl5a_ 45 LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE- 111 (353)
T ss_dssp CTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-
T ss_pred eCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-
Confidence 6789998 78853 568999999999999 889765 46888899999988 56642 145899999999998
Q ss_pred CCCCcccccccCcccccCCCC
Q 012213 81 EIPEFGQYSFFNSTSFTGNPH 101 (468)
Q Consensus 81 ~~p~~~~~~~~~~~~~~~n~~ 101 (468)
.+|.++.+..+..+.+++|..
T Consensus 112 ~lp~~~~l~~L~~L~l~~~~~ 132 (353)
T d1jl5a_ 112 KLPELQNSSFLKIIDVDNNSL 132 (353)
T ss_dssp SCCCCTTCTTCCEEECCSSCC
T ss_pred cccchhhhccceeeccccccc
Confidence 566777888888888877754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=1.2e-07 Score=84.20 Aligned_cols=94 Identities=16% Similarity=0.167 Sum_probs=76.2
Q ss_pred CCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeeccCCcccccCCc-cccccccccccccc-CcccC
Q 012213 3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFS-HNNFS 79 (468)
Q Consensus 3 ~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls-~N~l~ 79 (468)
++.|+ .+|.++. ++++.|||++|+|+ .+|. .|.++++|++|+|++|.+...+|+ .|..++.++.+++. .|+++
T Consensus 17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~ 92 (242)
T d1xwdc1 17 ESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 92 (242)
T ss_dssp SCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred CCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence 45677 8887663 58999999999999 5655 689999999999999998866654 57889999999876 46787
Q ss_pred CCCCC-cccccccCcccccCCC
Q 012213 80 GEIPE-FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 80 ~~~p~-~~~~~~~~~~~~~~n~ 100 (468)
...+. +..+.+++.+.+.+|.
T Consensus 93 ~~~~~~~~~l~~L~~l~l~~~~ 114 (242)
T d1xwdc1 93 YINPEAFQNLPNLQYLLISNTG 114 (242)
T ss_dssp EECTTSEECCTTCCEEEEESCC
T ss_pred ccccccccccccccccccchhh
Confidence 77765 6778889999998874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=2.3e-07 Score=82.26 Aligned_cols=90 Identities=16% Similarity=0.137 Sum_probs=71.7
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCc-cccccccccEeecc-CCcccccCCcccccccccccccccCccc
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVS-WNQLNASLPKEMGNMKSLTSADFSHNNF 78 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~l~ls-~N~l~g~~p~~~~~l~~L~~l~ls~N~l 78 (468)
|++|+|+...+..|.++++|++|+|++|.+...+|. .|.++++++.|+++ .|++....|..|.++++|+.|++++|.+
T Consensus 36 Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l 115 (242)
T d1xwdc1 36 FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 115 (242)
T ss_dssp EESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred CcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 468999843345789999999999999999876754 68899999999986 4788877777899999999999999999
Q ss_pred CCCCCCccccccc
Q 012213 79 SGEIPEFGQYSFF 91 (468)
Q Consensus 79 ~~~~p~~~~~~~~ 91 (468)
+.. |.+..+..+
T Consensus 116 ~~~-~~~~~~~~l 127 (242)
T d1xwdc1 116 KHL-PDVHKIHSL 127 (242)
T ss_dssp CSC-CCCTTTCBS
T ss_pred ccc-ccccccccc
Confidence 854 433333333
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=3.3e-08 Score=82.23 Aligned_cols=45 Identities=24% Similarity=0.230 Sum_probs=21.7
Q ss_pred CCccccccccccEeeccCCcccccCC---cccccccccccccccCcccC
Q 012213 34 IPVQITQIHILNYLNVSWNQLNASLP---KEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 34 ~p~~~~~l~~L~~l~ls~N~l~g~~p---~~~~~l~~L~~l~ls~N~l~ 79 (468)
++....++++|++||||+|+|+ .++ ..+..+++|+.|+|++|.++
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc
Confidence 3333344555555555555554 222 22344555555555555555
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.29 E-value=2.1e-06 Score=76.45 Aligned_cols=130 Identities=18% Similarity=0.110 Sum_probs=85.6
Q ss_pred eEcccCC-cceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCC--CCccceeEEEecCCeeEEEEeccCCC
Q 012213 189 VIGRGGA-GVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVYEYMPNG 265 (468)
Q Consensus 189 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 265 (468)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||+|++|-
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 67899988888888999754322 1346777777766632 33667788888888889999999886
Q ss_pred ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------
Q 012213 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH--------------------------------------------- 300 (468)
Q Consensus 266 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~l~~LH~--------------------------------------------- 300 (468)
++.+.. ... ...+.++++.|.-||.
T Consensus 92 ~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 92 DLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp ETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 654321 110 1112233333333332
Q ss_pred ------c----CCCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 301 ------D----CSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 301 ------~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
. ....++|+|+.|.||+++++..+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12338999999999999987667899998765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.03 E-value=4.2e-06 Score=77.85 Aligned_cols=76 Identities=28% Similarity=0.269 Sum_probs=62.8
Q ss_pred CCCCcccccCCcccccCCCCCEEEccCCcccccCCccccccccccEeeccCCcccccCCcccccccccccccccCcccCC
Q 012213 1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG 80 (468)
Q Consensus 1 l~~N~l~g~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~ 80 (468)
|++|+|+ .+|..+ .+|+.|++++|+++ .++.-. +.|++|||++|.++ .+|. ++.+++|+.|++++|.+++
T Consensus 65 Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 65 ASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp CCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC
T ss_pred CCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---cccccccccccccc-cccc-hhhhccceeeccccccccc
Confidence 6899999 899654 57899999999999 676421 46999999999998 6885 6899999999999999987
Q ss_pred CCCCcc
Q 012213 81 EIPEFG 86 (468)
Q Consensus 81 ~~p~~~ 86 (468)
.++...
T Consensus 135 ~~~~~~ 140 (353)
T d1jl5a_ 135 LPDLPP 140 (353)
T ss_dssp CCCCCT
T ss_pred cccccc
Confidence 665433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.02 E-value=2.4e-07 Score=76.85 Aligned_cols=73 Identities=22% Similarity=0.150 Sum_probs=56.8
Q ss_pred CcccccCCCCCEEEccCCccccc--CCccccccccccEeeccCCcccccCCc-ccccccccccccccCcccCCCCCC
Q 012213 11 PVEIGHCLLLTYLDLSQNHLSGP--IPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFSGEIPE 84 (468)
Q Consensus 11 p~~~~~l~~L~~L~l~~n~l~g~--~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~~~~p~ 84 (468)
+....++++|++|+||+|+|+.. ++..+..|++|+.|||++|.++ .+++ .+.....|+.|++++|.++.....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~ 133 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRD 133 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCccc
Confidence 33345789999999999999932 3456788999999999999999 5665 333445789999999999876553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.77 E-value=6.8e-05 Score=70.97 Aligned_cols=77 Identities=18% Similarity=0.191 Sum_probs=47.9
Q ss_pred ceEcccCCcceEEEEcCC-CcEEEEEEecccCC--C---CCchhHHHHHHHHHhCCC-C--CCccceeEEEecCCeeEEE
Q 012213 188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK--G---SSHDNGLSAEIRTLGKIR-H--RNIVRLKAFCSNKETNLLV 258 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 258 (468)
+.||.|....||+....+ ++.|+||.-..... . .....+...|.+.++.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998755 67899997543211 1 112234556777776552 2 345555554 45566899
Q ss_pred EeccCCCC
Q 012213 259 YEYMPNGS 266 (468)
Q Consensus 259 ~e~~~~gs 266 (468)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.49 E-value=8.1e-06 Score=73.96 Aligned_cols=86 Identities=15% Similarity=0.149 Sum_probs=65.9
Q ss_pred ccccCCCCCEEEccCCccccc-CCccccccccccEeeccCCcccccCCcccccccccccccccCc-ccCCC-CCC-cccc
Q 012213 13 EIGHCLLLTYLDLSQNHLSGP-IPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN-NFSGE-IPE-FGQY 88 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n~l~g~-~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N-~l~~~-~p~-~~~~ 88 (468)
......+|++|||+++.+++. ++.-+.++++|++|+|+++.+++..+..++.+++|+.|+++++ .++.. +.. ...+
T Consensus 41 ~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~ 120 (284)
T d2astb2 41 EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120 (284)
T ss_dssp SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC
T ss_pred hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHH
Confidence 344567899999999998754 4556788999999999999999888888999999999999995 56521 111 2345
Q ss_pred cccCcccccC
Q 012213 89 SFFNSTSFTG 98 (468)
Q Consensus 89 ~~~~~~~~~~ 98 (468)
++++.+++++
T Consensus 121 ~~L~~L~ls~ 130 (284)
T d2astb2 121 SRLDELNLSW 130 (284)
T ss_dssp TTCCEEECCC
T ss_pred Hhcccccccc
Confidence 6777777765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=1.4e-05 Score=76.99 Aligned_cols=100 Identities=11% Similarity=0.116 Sum_probs=69.9
Q ss_pred CCCCcccccC-CcccccCCCCCEEEccCCccc----ccCCccccccccccEeeccCCcccc----cCCccccc-cccccc
Q 012213 1 MSRNNFSGII-PVEIGHCLLLTYLDLSQNHLS----GPIPVQITQIHILNYLNVSWNQLNA----SLPKEMGN-MKSLTS 70 (468)
Q Consensus 1 l~~N~l~g~~-p~~~~~l~~L~~L~l~~n~l~----g~~p~~~~~l~~L~~l~ls~N~l~g----~~p~~~~~-l~~L~~ 70 (468)
|++|++++.- ..-+..+++|++|+|++|+++ ..|+..+..+++|+.|||++|.++. .+...+.. ..+|+.
T Consensus 9 ~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~ 88 (460)
T d1z7xw1 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQK 88 (460)
T ss_dssp EESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCE
T ss_pred eeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCE
Confidence 3567776421 234566889999999999988 2455667889999999999999862 12233322 347999
Q ss_pred ccccCcccCCC----CC-CcccccccCcccccCCC
Q 012213 71 ADFSHNNFSGE----IP-EFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 71 l~ls~N~l~~~----~p-~~~~~~~~~~~~~~~n~ 100 (468)
|+|++|+++.. ++ .+....+++.+++++|.
T Consensus 89 L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~ 123 (460)
T d1z7xw1 89 LSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123 (460)
T ss_dssp EECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSB
T ss_pred EECCCCCccccccccccchhhcccccccccccccc
Confidence 99999998753 22 24556778888888875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=1.8e-05 Score=76.18 Aligned_cols=83 Identities=16% Similarity=0.107 Sum_probs=45.5
Q ss_pred CCCCEEEccCCcccccCCc----cccccccccEeeccCCcccc----cCCcccc-cccccccccccCcccCCC----CCC
Q 012213 18 LLLTYLDLSQNHLSGPIPV----QITQIHILNYLNVSWNQLNA----SLPKEMG-NMKSLTSADFSHNNFSGE----IPE 84 (468)
Q Consensus 18 ~~L~~L~l~~n~l~g~~p~----~~~~l~~L~~l~ls~N~l~g----~~p~~~~-~l~~L~~l~ls~N~l~~~----~p~ 84 (468)
..|+.+++++|.++..-.. .+..+.+|+.|||++|.++. .++..+. ..+.|+.|+|++|+|+.. +++
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 4577777777776643222 23344567777777777653 1333332 345577777777776531 111
Q ss_pred -cccccccCcccccCCC
Q 012213 85 -FGQYSFFNSTSFTGNP 100 (468)
Q Consensus 85 -~~~~~~~~~~~~~~n~ 100 (468)
+.....+..+++++|+
T Consensus 392 ~l~~~~~L~~L~Ls~N~ 408 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNC 408 (460)
T ss_dssp HHHHCCCCCEEECCSSS
T ss_pred HHhcCCCCCEEECCCCc
Confidence 2233556666666664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.14 E-value=0.00015 Score=65.27 Aligned_cols=83 Identities=19% Similarity=0.188 Sum_probs=48.2
Q ss_pred CCCCCEEEccCC--ccccc-CCccccccccccEeeccCC-cccccCCcccccccccccccccCc-ccCCCCC-Ccccccc
Q 012213 17 CLLLTYLDLSQN--HLSGP-IPVQITQIHILNYLNVSWN-QLNASLPKEMGNMKSLTSADFSHN-NFSGEIP-EFGQYSF 90 (468)
Q Consensus 17 l~~L~~L~l~~n--~l~g~-~p~~~~~l~~L~~l~ls~N-~l~g~~p~~~~~l~~L~~l~ls~N-~l~~~~p-~~~~~~~ 90 (468)
+++|+.|+++++ .++.. +..-..++++|+.|+|++| .+++..+..+..+++|+.|+++++ .++.... .++.+++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 356777777653 23321 3333455677777777664 466556666777777777777763 5554332 3455556
Q ss_pred cCcccccCC
Q 012213 91 FNSTSFTGN 99 (468)
Q Consensus 91 ~~~~~~~~n 99 (468)
++.+++.++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 666666543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.04 E-value=7.4e-05 Score=69.28 Aligned_cols=89 Identities=12% Similarity=0.081 Sum_probs=59.6
Q ss_pred cccccCCCCCEEEccCCccccc-----CCccccccccccEeeccCCccccc----CCcccccccccccccccCcccCCCC
Q 012213 12 VEIGHCLLLTYLDLSQNHLSGP-----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFSGEI 82 (468)
Q Consensus 12 ~~~~~l~~L~~L~l~~n~l~g~-----~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~~~~ 82 (468)
..+..+..|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|++++.-
T Consensus 180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g 259 (344)
T d2ca6a1 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 259 (344)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchh
Confidence 3455677888888888887632 334567788888888888887632 4456677888888888888876431
Q ss_pred C-Cc----c--cccccCcccccCCC
Q 012213 83 P-EF----G--QYSFFNSTSFTGNP 100 (468)
Q Consensus 83 p-~~----~--~~~~~~~~~~~~n~ 100 (468)
. .+ . ....+..+++++|.
T Consensus 260 ~~~l~~~l~~~~~~~L~~L~ls~N~ 284 (344)
T d2ca6a1 260 AAAVVDAFSKLENIGLQTLRLQYNE 284 (344)
T ss_dssp HHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred hHHHHHHhhhccCCCCCEEECCCCc
Confidence 1 11 1 12356667777764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.0013 Score=60.12 Aligned_cols=134 Identities=13% Similarity=0.148 Sum_probs=75.2
Q ss_pred cceEEEEcCCCcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCC-----cccee--EEEecCCeeEEEEeccCCCChh
Q 012213 196 GVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-----IVRLK--AFCSNKETNLLVYEYMPNGSLG 268 (468)
Q Consensus 196 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-----iv~l~--~~~~~~~~~~lv~e~~~~gsL~ 268 (468)
-.||++..++|+.|++|...... ...+++..|...+..+.... .+..- ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 57999999999999999865322 22366778888776663221 11111 1223456678899999864332
Q ss_pred h-----h---------ccc-------CCCCCCCHH-------------------HHHHHHHHHHHHHHHhh----hcCCC
Q 012213 269 E-----V---------LHG-------KRGSFLKWE-------------------MRLKIAIEAAKGLSYLH----HDCSP 304 (468)
Q Consensus 269 ~-----~---------l~~-------~~~~~l~~~-------------------~~~~i~~~ia~~l~~LH----~~~~~ 304 (468)
. + +|. ......++. .+..+...+.+.++.+. .....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 010 001111111 11111222222233332 22245
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecccccc
Q 012213 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKY 334 (468)
Q Consensus 305 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 334 (468)
.++|+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 68999999999999754 45899997763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.90 E-value=9.7e-05 Score=68.48 Aligned_cols=86 Identities=12% Similarity=0.159 Sum_probs=62.2
Q ss_pred ccCCCCCEEEccCCcccc----cCCccccccccccEeeccCCccccc-----CCcccccccccccccccCcccCCC----
Q 012213 15 GHCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNAS-----LPKEMGNMKSLTSADFSHNNFSGE---- 81 (468)
Q Consensus 15 ~~l~~L~~L~l~~n~l~g----~~p~~~~~l~~L~~l~ls~N~l~g~-----~p~~~~~l~~L~~l~ls~N~l~~~---- 81 (468)
.....|+.|++++|+++. .+...+..+.+|+.|+|++|.++.. +...+..+++|+.|+|++|.++..
T Consensus 155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~ 234 (344)
T d2ca6a1 155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234 (344)
T ss_dssp HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc
Confidence 356789999999998862 2444567788999999999998632 345577888999999999987532
Q ss_pred C-CCcccccccCcccccCCC
Q 012213 82 I-PEFGQYSFFNSTSFTGNP 100 (468)
Q Consensus 82 ~-p~~~~~~~~~~~~~~~n~ 100 (468)
+ ..+.....+..+++++|.
T Consensus 235 L~~~l~~~~~L~~L~Ls~n~ 254 (344)
T d2ca6a1 235 LAIALKSWPNLRELGLNDCL 254 (344)
T ss_dssp HHHHGGGCTTCCEEECTTCC
T ss_pred ccccccccccchhhhhhcCc
Confidence 1 123455667777777664
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.49 E-value=0.0053 Score=57.47 Aligned_cols=72 Identities=18% Similarity=0.246 Sum_probs=46.6
Q ss_pred ceEcccCCcceEEEEcCC--------CcEEEEEEecccCCCCCchhHHHHHHHHHhCCCCCCc-cceeEEEecCCeeEEE
Q 012213 188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLV 258 (468)
Q Consensus 188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 258 (468)
+.|+-|-.-.+|+...++ ...|.++..- . . .......+|..+++.+.-.++ .++++++.. .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 568888888999988654 2456666542 2 1 122345678888877743344 467777643 789
Q ss_pred EeccCCCCh
Q 012213 259 YEYMPNGSL 267 (468)
Q Consensus 259 ~e~~~~gsL 267 (468)
+||+++-.+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.15 E-value=0.0044 Score=56.00 Aligned_cols=31 Identities=26% Similarity=0.331 Sum_probs=27.3
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEeeccccc
Q 012213 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333 (468)
Q Consensus 303 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 333 (468)
+.+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4559999999999999998777899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.89 E-value=0.0014 Score=53.44 Aligned_cols=84 Identities=10% Similarity=0.013 Sum_probs=54.0
Q ss_pred cCCCCCEEEccCC-ccccc----CCccccccccccEeeccCCccccc----CCcccccccccccccccCcccCCCCC-C-
Q 012213 16 HCLLLTYLDLSQN-HLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFSGEIP-E- 84 (468)
Q Consensus 16 ~l~~L~~L~l~~n-~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~~~~p-~- 84 (468)
+.+.|+.|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|+.|+|++|.++..-- .
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4578999999874 45522 223466778899999999888632 22234556788999999998874211 1
Q ss_pred ---cccccccCcccccCC
Q 012213 85 ---FGQYSFFNSTSFTGN 99 (468)
Q Consensus 85 ---~~~~~~~~~~~~~~n 99 (468)
+..-..+..+++++|
T Consensus 93 ~~aL~~n~sL~~L~l~~n 110 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQ 110 (167)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHHhCCcCCEEECCCC
Confidence 223345666777665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.53 E-value=0.002 Score=52.47 Aligned_cols=67 Identities=18% Similarity=0.120 Sum_probs=51.4
Q ss_pred ccccCCCCCEEEccCCccccc----CCccccccccccEeeccCCccccc----CCcccccccccccccccCcccC
Q 012213 13 EIGHCLLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
.+...+.|+.|+|++|.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+.
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 456678899999999999843 223456778999999999998842 2234667788999999999765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.85 E-value=0.023 Score=45.68 Aligned_cols=65 Identities=14% Similarity=0.132 Sum_probs=46.8
Q ss_pred ccCCCCCEEEccC-Cccccc----CCccccccccccEeeccCCccccc----CCcccccccccccccccCcccC
Q 012213 15 GHCLLLTYLDLSQ-NHLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFS 79 (468)
Q Consensus 15 ~~l~~L~~L~l~~-n~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~ 79 (468)
.+.+.|+.|+|++ |.++.. +-..+...+.|+.|+|++|.++.. +-..+...++|+.+++++|.++
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 4678899999997 556522 223456788999999999988632 2223556678999999998876
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.42 E-value=0.037 Score=44.40 Aligned_cols=67 Identities=16% Similarity=0.199 Sum_probs=48.7
Q ss_pred ccccCCCCCEEEccCCcccccC----CccccccccccEeeccCCccccc----CCcccccccccccc--cccCcccC
Q 012213 13 EIGHCLLLTYLDLSQNHLSGPI----PVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSA--DFSHNNFS 79 (468)
Q Consensus 13 ~~~~l~~L~~L~l~~n~l~g~~----p~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l--~ls~N~l~ 79 (468)
.+...++|+.|+|++|.++..- -..+...++|+.|++++|.++.. +-..+...++|+.+ ++++|.+.
T Consensus 41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 4456889999999999987432 23456789999999999998632 23456777888864 45667664
|